Citrus Sinensis ID: 036407
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 576 | 2.2.26 [Sep-21-2011] | |||||||
| Q9STJ8 | 651 | Receptor-like serine/thre | yes | no | 0.916 | 0.811 | 0.527 | 1e-139 | |
| O64639 | 683 | Receptor-like serine/thre | no | no | 0.937 | 0.790 | 0.480 | 1e-130 | |
| Q9SAH3 | 692 | Putative receptor-like pr | no | no | 0.253 | 0.210 | 0.516 | 6e-39 | |
| Q9XI96 | 699 | Proline-rich receptor-lik | no | no | 0.277 | 0.228 | 0.496 | 3e-32 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.277 | 0.223 | 0.476 | 1e-30 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.291 | 0.405 | 0.44 | 2e-30 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.274 | 0.310 | 0.475 | 4e-30 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.279 | 0.246 | 0.473 | 4e-30 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.288 | 0.364 | 0.445 | 4e-30 | |
| C0LGD7 | 953 | Probable LRR receptor-lik | no | no | 0.281 | 0.169 | 0.464 | 7e-30 |
| >sp|Q9STJ8|Y4539_ARATH Receptor-like serine/threonine-protein kinase At4g25390 OS=Arabidopsis thaliana GN=At4g25390 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 496 bits (1277), Expect = e-139, Method: Compositional matrix adjust.
Identities = 318/603 (52%), Positives = 396/603 (65%), Gaps = 75/603 (12%)
Query: 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQGEREFYNELYF 63
FSYS LRRA SFS + LGQGGFG VF T+ ++VAVKVMDSGSLQGE EF NEL+F
Sbjct: 87 FSYSSLRRATGSFSQANRLGQGGFGVVFRGTISGGENVAVKVMDSGSLQGEGEFQNELFF 146
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV 123
A+ L+ HVV V+GFS + KR R+LLVY+LM NGNLQDALLH++ PELM+W +RF +AV
Sbjct: 147 AAKLDSP-HVVPVIGFSHDRKRRRLLLVYKLMDNGNLQDALLHRRCPELMDWNRRFLVAV 205
Query: 124 DIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGENKN 183
+IA GI +LHSL PPVIHGDIKPSN+LLD F AKI+DFGLARL
Sbjct: 206 NIADGIKHLHSLEPPVIHGDIKPSNVLLDSLFSAKIADFGLARL---------------- 249
Query: 184 KAAELESNCGAAVEDCGSVVETESVNTTTTATAFEDLSVG-IDQSPETFLKMTQKQTQST 242
KA ++E + + GS+VE E + TT T +ED + G +DQSPE+ K+ + S
Sbjct: 250 KAEQVEISVAPERDGDGSMVE-EVESVVTTVTGYEDFNFGLVDQSPESVAKVPGSVSASP 308
Query: 243 EAL--------------EKKASV-----------------DENVKEDVKVKEYVIEWIGT 271
EA E SV E+ E +VKEYV++WIG+
Sbjct: 309 EATTVVSVSPEMGEKTDEDGGSVVVMKKGKESESKDWWWKQESNVERGRVKEYVMQWIGS 368
Query: 272 AIGNERP-KSDWIGRDTGSSSSVGGKVDRKKSRKRLDWWVSLDEDKEENVKNLKRERRRR 330
+ ERP +SDWI SSSS K KK+ KRLDWW+SL+E+ E K +R
Sbjct: 369 EVKKERPSRSDWIEAAALSSSSS--KKLEKKTSKRLDWWLSLEEEDENKKKKKRRM---- 422
Query: 331 PAREWWKEEYCEELAKKKKKKKRALGTNSDDDWWPRDEELYVERKKKSKTRSRSRSSIG- 389
REWWK+EY ELAKK+KKKK+ + E + S ++ R S G
Sbjct: 423 -VREWWKDEYRRELAKKRKKKKKMT----------LEAEFCSDDGSSSVSQWRRGSGSGS 471
Query: 390 SLDWWLEGFSGELY-RARHNSYDSAASGEIPKSGGVTSTPSMRGTVCYVAPEY-GAGGDI 447
S+DWWL+G SGE + RAR NS+DS SGEI KS G++STPSMRGTVCY APEY ++
Sbjct: 472 SIDWWLDGLSGERWLRARGNSHDS-VSGEIAKSCGISSTPSMRGTVCYAAPEYCNLDNNV 530
Query: 448 SEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVV 507
SEKCDVYSYGVLLLVLI+GRRPL++TGS SE QRANLMSWAR LAR GKL++LVDQ +
Sbjct: 531 SEKCDVYSYGVLLLVLISGRRPLEMTGS-ASEIQRANLMSWARKLARRGKLVDLVDQK-L 588
Query: 508 KSLDREQALLCITVALLCLQKSPALRPSMEEVVGMLTGKLEAPKLPAEFSPSPPSRIPFK 567
++LD+EQA+LCI VALLCLQ+ P RPSM+EV+GML G++ P+LP+EFSPSPP + K
Sbjct: 589 QNLDQEQAVLCIKVALLCLQRLPISRPSMKEVLGMLKGEVNLPELPSEFSPSPPLKTTRK 648
Query: 568 SRK 570
R+
Sbjct: 649 QRR 651
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O64639|Y2559_ARATH Receptor-like serine/threonine-protein kinase At2g45590 OS=Arabidopsis thaliana GN=At2g45590 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 466 bits (1198), Expect = e-130, Method: Compositional matrix adjust.
Identities = 303/631 (48%), Positives = 385/631 (61%), Gaps = 91/631 (14%)
Query: 4 RFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDS--GSLQGEREFYN 59
RFSYS LRRA +SFS S LG GGFGSV+ A S+AVKVMD+ GSLQGEREF+N
Sbjct: 79 RFSYSQLRRATNSFSESTHLGHGGFGSVYKADFPSGGDSLAVKVMDTSAGSLQGEREFHN 138
Query: 60 ELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF 119
EL +S L HVVS+LGFSS+ + +++LVYELM+N +LQDALL +K ELM+W KRF
Sbjct: 139 ELSLSSHLIGSPHVVSLLGFSSDRRGRKLILVYELMANRSLQDALLDRKCVELMDWNKRF 198
Query: 120 SIAVDIAKGIAYL-HSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQAD 178
IA DIAKGI +L H +P +IHGDIKPSNILLD +F AKI DFGLAR+KS +
Sbjct: 199 EIATDIAKGIEFLHHCCDPIIIHGDIKPSNILLDSDFKAKIGDFGLARVKS--------E 250
Query: 179 GENKNKAAELESNCGAAVEDCGSVV-ETESVNTTTTATAFEDLSVGIDQSPETFLKMTQK 237
+ E E VED GS++ ETESV T FE+ + ++ SPET
Sbjct: 251 DFDTRILIEEEDKSKDVVEDNGSILEETESV-----ITVFEEGNNVVNLSPETCGISVLT 305
Query: 238 QTQSTEALEKKASVDENVKEDVKVKEYVIEWIGTA------IGNERPKSDWIGRDTG-SS 290
+T ++ EK EN + E +G A I + + + DTG S
Sbjct: 306 ETVASPG-EKSGLSPENCAVSILTVE-----VGAASPAMASIPSPETCAISVLTDTGLSP 359
Query: 291 SSVGGKVDRKKSRKRLDWWVSLDED-------KEENVKNLKRE------RRRRPA----- 332
S KV K+ DWW D + + +VK+ E ++ RP+
Sbjct: 360 ESSKLKVGSKR-----DWWWKQDNNGGSRGGIESGSVKDYVMEWIGSEIKKERPSNNKEW 414
Query: 333 ----------------------REWWKEEYCEELAKKKKKKKRAL-----GTNSDDDWWP 365
REWWKEE+CEEL +KK+KKK+ +S D W+
Sbjct: 415 INNGDGSSSVSKKKKKEKKRKPREWWKEEFCEELTRKKRKKKKKKKRGLSSISSIDSWFH 474
Query: 366 RDEEL-YVERKKKSKTRSRSRSSIGSLDWWLEGFSGEL--YRARHNSYDSA--ASGEIPK 420
RD+ V + T+ + R+SI DWW++G SGEL + NS DS + K
Sbjct: 475 RDDGASSVHDHNLNPTKRKKRNSI---DWWVDGLSGELKSVMGKKNSQDSGLWCDVNVQK 531
Query: 421 SGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEF 480
SGGV+STPSMRGTVCY+APE G GG +SEKCDVYS+GVLLLVL++GRRPLQVT SPMSEF
Sbjct: 532 SGGVSSTPSMRGTVCYIAPECGGGGVLSEKCDVYSFGVLLLVLVSGRRPLQVTASPMSEF 591
Query: 481 QRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVV 540
+RANL+SWA+ LA NGKL+ELVD++ + SL++EQA+LCIT+ALLCLQ+SP RP+M+E+V
Sbjct: 592 ERANLISWAKQLACNGKLLELVDKS-IHSLEKEQAVLCITIALLCLQRSPVKRPTMKEIV 650
Query: 541 GMLTGKLEAPKLPAEFSPSPPSRIPFKSRKK 571
ML+G E P LP EFSPSPP PFKSRKK
Sbjct: 651 EMLSGVSEPPHLPFEFSPSPPMGFPFKSRKK 681
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SAH3|Y1887_ARATH Putative receptor-like protein kinase At1g80870 OS=Arabidopsis thaliana GN=At1g80870 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 162 bits (410), Expect = 6e-39, Method: Compositional matrix adjust.
Identities = 77/149 (51%), Positives = 111/149 (74%), Gaps = 3/149 (2%)
Query: 424 VTSTPSMRGTVCYVAPEYGAGG-DISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQR 482
++ST SMRGT+CY+APEYG G + EK D+YS+GVL+LV+++GRRPL V SPM + ++
Sbjct: 543 LSSTTSMRGTLCYIAPEYGGGCCYLMEKGDIYSFGVLILVIVSGRRPLHVLASPM-KLEK 601
Query: 483 ANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGM 542
ANL+SW R LA++G ++ELVD+ + ++E+A LCI +AL CLQK+P LRP + EVV +
Sbjct: 602 ANLVSWCRQLAQSGNVLELVDEKLKDGYNKEEAGLCINLALACLQKAPELRPDVSEVVRI 661
Query: 543 LTGKLEAPKLPAEFSPSPPSRIPFKSRKK 571
L G+++ EFSPSPP ++ + SR K
Sbjct: 662 LRGEMDISSTAFEFSPSPPGKV-YGSRSK 689
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XI96|PERK7_ARATH Proline-rich receptor-like protein kinase PERK7 OS=Arabidopsis thaliana GN=PERK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 140 bits (353), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 82/165 (49%), Positives = 105/165 (63%), Gaps = 5/165 (3%)
Query: 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATL-HDQSVAVKVMDSGSLQGEREFYNELYF 63
F+Y L A FS RLLGQGGFG V L + + +AVK + +GS QGEREF E+
Sbjct: 324 FTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEVEI 383
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV 123
S + H+VS++G+ SN R LLVYE + N L+ LH K +M+W R IA+
Sbjct: 384 ISRVHHR-HLVSLVGYCSNAGGQR-LLVYEFLPNDTLE-FHLHGKSGTVMDWPTRLKIAL 440
Query: 124 DIAKGIAYLH-SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
AKG+AYLH +P +IH DIK SNILLDHNF AK++DFGLA+L
Sbjct: 441 GSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKL 485
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 135 bits (339), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 80/168 (47%), Positives = 107/168 (63%), Gaps = 8/168 (4%)
Query: 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQGEREFYNELYF 63
F+Y L RA + FS + LLGQGGFG VF L + + VAVK + GS QGEREF E+
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401
Query: 64 ASLLEQDDHVVSVLGFS-SNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIA 122
S + H+V+++G+ ++ +R LLVYE + N L+ LH K MEW R IA
Sbjct: 402 ISRVHHR-HLVALVGYCIADAQR---LLVYEFVPNNTLE-FHLHGKGRPTMEWSSRLKIA 456
Query: 123 VDIAKGIAYLH-SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
V AKG++YLH + NP +IH DIK SNIL+D F AK++DFGLA++ S
Sbjct: 457 VGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIAS 504
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 134 bits (337), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 77/175 (44%), Positives = 108/175 (61%), Gaps = 7/175 (4%)
Query: 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHDQS--VAVKVMDSGSLQGEREFYNELY 62
FS+ L A +F L+G+GGFG V+ L VAVK +D LQG +EF E+
Sbjct: 67 FSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFIVEVL 126
Query: 63 FASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPEL-MEWCKRFSI 121
SLL H+V+++G+ ++ + LLVYE MS G+L+D LL P ++ ++W R I
Sbjct: 127 MLSLLHHK-HLVNLIGYCADGDQR--LLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRI 183
Query: 122 AVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQN 175
A+ A G+ YLH NPPVI+ D+K +NILLD F AK+SDFGLA+L VG+ Q+
Sbjct: 184 ALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQH 238
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 133 bits (335), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 78/164 (47%), Positives = 104/164 (63%), Gaps = 6/164 (3%)
Query: 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHDQS-VAVKVMDSGSLQGEREFYNELYF 63
F+Y L +A +FS + LLGQGGFG V L D + VA+K + SGS QGEREF E+
Sbjct: 131 FTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAEIQT 190
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV 123
S + H+VS+LG+ + LLVYE + N L+ LH+K +MEW KR IA+
Sbjct: 191 ISRVHHR-HLVSLLGYCITGAQR--LLVYEFVPNKTLE-FHLHEKERPVMEWSKRMKIAL 246
Query: 124 DIAKGIAYLH-SLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
AKG+AYLH NP IH D+K +NIL+D ++ AK++DFGLAR
Sbjct: 247 GAAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLAR 290
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 133 bits (334), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 79/167 (47%), Positives = 103/167 (61%), Gaps = 6/167 (3%)
Query: 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATL-HDQSVAVKVMDSGSLQGEREFYNELYF 63
F+Y L RA + FS + LLGQGGFG V L + VAVK + +GS QGEREF E+
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV 123
S + H+VS++G+ + LLVYE + N NL+ LH K MEW R IA+
Sbjct: 328 ISRVHHR-HLVSLIGYCMAGVQR--LLVYEFVPNNNLE-FHLHGKGRPTMEWSTRLKIAL 383
Query: 124 DIAKGIAYLH-SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
AKG++YLH NP +IH DIK SNIL+D F AK++DFGLA++ S
Sbjct: 384 GSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIAS 430
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 133 bits (334), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 78/175 (44%), Positives = 104/175 (59%), Gaps = 9/175 (5%)
Query: 3 HRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNE 60
H F++ L A +F P LG+GGFG V+ L Q VAVK +D LQG REF E
Sbjct: 72 HTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVE 131
Query: 61 LYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPP--ELMEWCKR 118
+ SLL + +V+++G+ ++ + LLVYE M G+L+D L H PP E ++W R
Sbjct: 132 VLMLSLLHHPN-LVNLIGYCADGDQR--LLVYEFMPLGSLEDHL-HDLPPDKEALDWNMR 187
Query: 119 FSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGE 172
IA AKG+ +LH NPPVI+ D K SNILLD F K+SDFGLA+L G+
Sbjct: 188 MKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGD 242
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 132 bits (332), Expect = 7e-30, Method: Compositional matrix adjust.
Identities = 78/168 (46%), Positives = 105/168 (62%), Gaps = 6/168 (3%)
Query: 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHDQSV-AVKVMDSGSLQGEREFYNELYF 63
F+Y+ L A D+F+ S +GQGG+G V+ TL +V A+K GSLQGE+EF E+
Sbjct: 613 FTYAELALATDNFNSSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKEFLTEIEL 672
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV 123
S L + +VS+LGF + +LVYE M NG L+D + K E +++ R IA+
Sbjct: 673 LSRLHHRN-LVSLLGFCD--EEGEQMLVYEYMENGTLRDNI-SVKLKEPLDFAMRLRIAL 728
Query: 124 DIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
AKGI YLH+ NPP+ H DIK SNILLD F AK++DFGL+RL V
Sbjct: 729 GSAKGILYLHTEANPPIFHRDIKASNILLDSRFTAKVADFGLSRLAPV 776
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 576 | ||||||
| 449528684 | 681 | PREDICTED: LOW QUALITY PROTEIN: receptor | 0.961 | 0.813 | 0.581 | 0.0 | |
| 449460772 | 682 | PREDICTED: receptor-like serine/threonin | 0.961 | 0.812 | 0.588 | 0.0 | |
| 224134603 | 639 | predicted protein [Populus trichocarpa] | 0.944 | 0.851 | 0.622 | 0.0 | |
| 359490239 | 633 | PREDICTED: receptor-like serine/threonin | 0.927 | 0.843 | 0.588 | 1e-173 | |
| 255541374 | 681 | ATP binding protein, putative [Ricinus c | 0.932 | 0.788 | 0.532 | 1e-165 | |
| 359489512 | 664 | PREDICTED: receptor-like serine/threonin | 0.944 | 0.819 | 0.553 | 1e-163 | |
| 147777060 | 669 | hypothetical protein VITISV_015041 [Viti | 0.894 | 0.769 | 0.572 | 1e-160 | |
| 449454626 | 654 | PREDICTED: receptor-like serine/threonin | 0.968 | 0.853 | 0.522 | 1e-158 | |
| 449521812 | 654 | PREDICTED: LOW QUALITY PROTEIN: receptor | 0.968 | 0.853 | 0.522 | 1e-157 | |
| 224122520 | 631 | predicted protein [Populus trichocarpa] | 0.859 | 0.784 | 0.526 | 1e-157 |
| >gi|449528684|ref|XP_004171333.1| PREDICTED: LOW QUALITY PROTEIN: receptor-like serine/threonine-protein kinase At4g25390-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 674 bits (1738), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/633 (58%), Positives = 449/633 (70%), Gaps = 79/633 (12%)
Query: 1 PPHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATL--HDQSVAVKVMDSGSLQGEREFY 58
PPHRFSYS+LRRA +SFSPSR LGQGGFGSV++ TL + +AVK+MDSGSLQGEREF
Sbjct: 64 PPHRFSYSLLRRATESFSPSRRLGQGGFGSVYYGTLPQTHKEIAVKLMDSGSLQGEREFQ 123
Query: 59 NELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR 118
NEL+FAS ++ VVSVLGF S+ KR RMLLVYEL+ NGNLQDALLH+K PELMEW KR
Sbjct: 124 NELFFASKIDSS-FVVSVLGFCSDQKRRRMLLVYELLHNGNLQDALLHRKCPELMEWKKR 182
Query: 119 FSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK---SVGENQN 175
FS+AVDIAKG+ +LH L+PPVIHGDIKPSN+LLDH F AKI DFGL+RLK S E +
Sbjct: 183 FSVAVDIAKGLEHLHGLDPPVIHGDIKPSNVLLDHCFSAKIGDFGLSRLKLENSPFEVEV 242
Query: 176 QADG----ENKNKAAELESNCGAAVEDCGSVVETESVNTTTTATAFEDLSVGIDQSPETF 231
+ G E K + E ESN G VEDCGSV E + T FE+ +VG+DQSPE+F
Sbjct: 243 KVKGGVEEEKKERKEEHESNRGCVVEDCGSVAE----EAESVTTGFEEFNVGVDQSPESF 298
Query: 232 LKMTQKQT-----------------------------------QSTEALEKKA------- 249
L++ +T + ++EKK+
Sbjct: 299 LRIPVSETSPETVDVTSPETALGVAAMASPSEGAFDRASFENGKEPNSVEKKSIKNSISG 358
Query: 250 -----SVDENVKEDVKVKEYVIEWIGTAIGNERPKSDWIGRDTGSSSSVGGKVDRKKSRK 304
+ V VKEYV+EWIG+ I ERPKS+WI ++SS G V + + +K
Sbjct: 359 KDWWWKQENGVGTSGNVKEYVMEWIGSEIKRERPKSEWI-----AASSSGRSVKKSEKKK 413
Query: 305 ---RLDWWVSLDEDKEENVKNLKRERRRRPAREWWKEEYCEELAKKKKKKKRALGTNSDD 361
RL+WW+++D++K + KNLK+E+RR P REWWKEEYCEELAKK+KK+ + + D
Sbjct: 414 NKKRLEWWMAMDDEK--SAKNLKKEKRR-PVREWWKEEYCEELAKKRKKRPQKGAGSCDG 470
Query: 362 ---DWWPRDEELYVERKKKSKTRSRSRSSIGSLDWWLEGFSGELYRARHNSYDSAASGEI 418
D+WP D+E+Y R KK + RSRS S GS+DWWL+G SGEL++ R S+DS G+
Sbjct: 471 KEPDFWPVDDEMY--RDKKKRNRSRSHGSRGSIDWWLDGLSGELWKTRGTSHDSTG-GDF 527
Query: 419 PKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMS 478
PKSGG++STPSMRGT+CY+APEYG GGD+SEK DVYSYGVLLLVLIAGRRPLQVT SP+S
Sbjct: 528 PKSGGISSTPSMRGTMCYIAPEYGGGGDLSEKSDVYSYGVLLLVLIAGRRPLQVTNSPLS 587
Query: 479 EFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEE 538
EFQRANL+SWARHLAR GKLI+LVDQ+ ++SLDR+QALLCI VALLCLQK PA RPSM+E
Sbjct: 588 EFQRANLLSWARHLARAGKLIDLVDQS-IQSLDRDQALLCIKVALLCLQKLPARRPSMKE 646
Query: 539 VVGMLTGKLEAPKLPAEFSPSPPSRIPFKSRKK 571
VVGMLTG LE P+LP E SPSPPSR P KS +K
Sbjct: 647 VVGMLTGGLEPPQLPTELSPSPPSRFPVKSHRK 679
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460772|ref|XP_004148119.1| PREDICTED: receptor-like serine/threonine-protein kinase At4g25390-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 668 bits (1724), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/634 (58%), Positives = 450/634 (70%), Gaps = 80/634 (12%)
Query: 1 PPHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATL--HDQSVAVKVMDSGSLQGEREFY 58
PPHRFSYS+LRRA DSFSPSR LGQGGFGSV++ TL + +AVK+MDSGSLQGEREF
Sbjct: 64 PPHRFSYSLLRRATDSFSPSRRLGQGGFGSVYYGTLPQTHKEIAVKLMDSGSLQGEREFQ 123
Query: 59 NELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR 118
NEL+FAS ++ VVSVLGF S+ KR RMLLVYEL+ NGNLQDALLH+K PELMEW KR
Sbjct: 124 NELFFASKIDSS-FVVSVLGFCSDQKRRRMLLVYELLHNGNLQDALLHRKCPELMEWKKR 182
Query: 119 FSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK---SVGENQN 175
FS+AVDIAKG+ +LH L+PPVIHGDIKPSN+LLDH F AKI DFGL+RLK S E +
Sbjct: 183 FSVAVDIAKGLEHLHGLDPPVIHGDIKPSNVLLDHCFSAKIGDFGLSRLKLENSPFEVEV 242
Query: 176 QADG----ENKNKAAELESNCGAAVEDCGSVVETESVNTTTTATAFEDLSVGIDQSPETF 231
+ G E K + E ESN G VEDCGSV E + T FE+ +VG+DQSPE+F
Sbjct: 243 KVKGGVEEEKKERKEEHESNRGCVVEDCGSVAE----EAESVTTGFEEFNVGVDQSPESF 298
Query: 232 LKMTQKQT-----------------------------------QSTEALEKKA------- 249
L++ +T + ++EKK+
Sbjct: 299 LRIPVSETSPETVDVTSPETALGVAAMASPSEGAFDRASFENGKEPNSVEKKSIKNSISG 358
Query: 250 -----SVDENVKEDVKVKEYVIEWIGTAIGNERPKSDWIGRDTGSSSSVGGKVDRKKSRK 304
+ V VKEYV+EWIG+ I ERPKS+WI ++SS G V + + +K
Sbjct: 359 KDWWWKQENGVGTSGNVKEYVMEWIGSEIKRERPKSEWI-----AASSSGRSVKKSEKKK 413
Query: 305 ---RLDWWVSLDEDKEENVKNLKRERRRRPAREWWKEEYCEELAKKKKKKKRALGTNSDD 361
RL+WW+++D++K + KNLK+E+RR P REWWKEEYCEELAKK+KKKK G S D
Sbjct: 414 NKKRLEWWMAMDDEK--SAKNLKKEKRR-PVREWWKEEYCEELAKKRKKKKPQKGAGSCD 470
Query: 362 ----DWWPRDEELYVERKKKSKTRSRSRSSIGSLDWWLEGFSGELYRARHNSYDSAASGE 417
D+WP D+E+Y R KK + RSRS S GS+DWWL+G SGEL++ R S+DS G+
Sbjct: 471 GKEPDFWPVDDEMY--RDKKKRNRSRSHGSRGSIDWWLDGLSGELWKTRGTSHDSTG-GD 527
Query: 418 IPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPM 477
PKSGG++STPSMRGT+CY+APEYG GGD+SEK DVYSYGVLLLVLIAGRRPLQVT SP+
Sbjct: 528 FPKSGGISSTPSMRGTMCYIAPEYGGGGDLSEKSDVYSYGVLLLVLIAGRRPLQVTNSPL 587
Query: 478 SEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSME 537
SEFQRANL+SWARHLAR GKLI+LVDQ+ ++SLDR+QALLCI VALLCLQK PA RPSM+
Sbjct: 588 SEFQRANLLSWARHLARAGKLIDLVDQS-IQSLDRDQALLCIKVALLCLQKLPARRPSMK 646
Query: 538 EVVGMLTGKLEAPKLPAEFSPSPPSRIPFKSRKK 571
EVVGMLTG LE P+LP E SPSPPSR P KS +K
Sbjct: 647 EVVGMLTGGLEPPQLPTELSPSPPSRFPVKSHRK 680
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224134603|ref|XP_002321863.1| predicted protein [Populus trichocarpa] gi|222868859|gb|EEF05990.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 660 bits (1702), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/594 (62%), Positives = 440/594 (74%), Gaps = 50/594 (8%)
Query: 1 PPHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHDQ-SVAVKVMDSGSLQGEREFYN 59
PPH FSY+ LRRA ++FSPS LGQGGFGSV+H TL ++ +VAVKVMD GSLQGEREF N
Sbjct: 65 PPHGFSYTTLRRATNNFSPSLRLGQGGFGSVYHGTLPNEFNVAVKVMDLGSLQGEREFQN 124
Query: 60 ELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF 119
EL FAS L+ ++V+ +GFS + K +LLVY+LM NGNLQDALLH+K EL++W KRF
Sbjct: 125 ELLFASKLDSS-YIVAAIGFSYDRKHRSLLLVYDLMQNGNLQDALLHRKCVELVDWNKRF 183
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQN---- 175
SIAVDIAKGI YLH L+PPVIHGDIKPSNILLD F AK++DFGLA LK NQN
Sbjct: 184 SIAVDIAKGIEYLHGLDPPVIHGDIKPSNILLDQCFNAKVADFGLAWLKIDQSNQNDQKQ 243
Query: 176 -QADGENKNKA--------AELESNCGAAVEDCGSVVE-TESVNTTTTATAFEDLSVGID 225
+ GE +K AELESN G +D GSVVE TESV T +F SV
Sbjct: 244 CEVKGEESDKINGGLELKRAELESNNGG--DDYGSVVEDTESVTTGFDEFSFWGGSVA-- 299
Query: 226 QSPETFLKMTQKQTQSTEALEK--KASVDENVKEDVKVKEYVIEWIGTAIGNERPKSDWI 283
++K T+S + K E+ VK+YV+EWIGT I ERP SDWI
Sbjct: 300 --------GSEKGTKSVSRKDWWWKQENGGATAENRGVKDYVMEWIGTEIKKERPNSDWI 351
Query: 284 GRDTGSSSSVGGKVDRKKSRKRLDWWVSLDEDKEENVKNLKRERRRRPAREWWKEEYCEE 343
G + S+S GK+D+KK+RKRLDWWVSLD+D +E V K+E+RR P REWWKEEYCEE
Sbjct: 352 GASSSSNSQPVGKIDKKKNRKRLDWWVSLDDDNDEKVS--KKEKRRLP-REWWKEEYCEE 408
Query: 344 L---AKKKKKKKRALGTNSD-----DDWWPRDEELYVERKKKSKTRSRSRSSIGSLDWWL 395
L KKKKKKKR +G SD +DWWPRD E+Y ERKKK RS+SR S GS++W
Sbjct: 409 LEKKNKKKKKKKREMGMTSDGNNEAEDWWPRDVEMYGERKKK---RSKSRGSRGSIEW-- 463
Query: 396 EGFSGELYRARHNSYDSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYS 455
FSGEL+R N++DS SGEIPKS G++STPSMRGTVCYVAPEYG GG++SEK DVYS
Sbjct: 464 --FSGELFRGNRNNHDSL-SGEIPKSSGISSTPSMRGTVCYVAPEYGGGGNLSEKSDVYS 520
Query: 456 YGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQA 515
+GVLLLVLIAGRRPLQVT SPMSEFQRANLM WAR+LAR GKL++LVD++ V+SLDR+QA
Sbjct: 521 FGVLLLVLIAGRRPLQVTTSPMSEFQRANLMHWARNLARAGKLLDLVDKS-VQSLDRDQA 579
Query: 516 LLCITVALLCLQKSPALRPSMEEVVGMLTGKLEAPKLPAEFSPSPPSRIPFKSR 569
LCITVAL+CLQKSPA RPSM+EVVGMLTG+ +AP+LP EFSPSPP+R+PFKS+
Sbjct: 580 TLCITVALICLQKSPAHRPSMKEVVGMLTGESQAPQLPTEFSPSPPTRVPFKSK 633
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359490239|ref|XP_002271104.2| PREDICTED: receptor-like serine/threonine-protein kinase At2g45590-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 614 bits (1583), Expect = e-173, Method: Compositional matrix adjust.
Identities = 350/595 (58%), Positives = 424/595 (71%), Gaps = 61/595 (10%)
Query: 1 PPHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQGEREFYN 59
PP+R+SYSVLR A SFS + LGQGGFGSV+ TL + +AVKVMDSGSLQGEREF N
Sbjct: 74 PPYRYSYSVLRHATSSFSAANRLGQGGFGSVYRGTLKSGKEIAVKVMDSGSLQGEREFQN 133
Query: 60 ELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF 119
EL+FA ++ + ++V V+GFSS+ +R RM+LVYELMSNGNLQDALL +K ELM+W KRF
Sbjct: 134 ELFFAGRIDSN-YIVPVIGFSSDRRRQRMILVYELMSNGNLQDALLDRKCSELMDWKKRF 192
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADG 179
IA+D+AKGI YLHSL+PP IHGDIKPSNILLD F AKI DFGLA+ KS E+Q +A
Sbjct: 193 EIAMDVAKGIEYLHSLDPPAIHGDIKPSNILLDRCFSAKIGDFGLAKSKS--EDQVEA-- 248
Query: 180 ENKNKAAELESNCGAAVEDCGSVVETESVNTTTTATAFEDLSVGIDQSPETFLKMTQKQT 239
K EL S G AV+D SVVE +T + AT FE++SV ++QSPE+F +
Sbjct: 249 ----KKKELVSCGGGAVDDNASVVE----DTESVATGFEEMSVNVEQSPESFAVDAVASS 300
Query: 240 QSTEALE-----------KKASV--------DENVKEDVKVKEYVIEWIGTAIGNERPKS 280
+E + KK V D E VK+YV EW+G + E P
Sbjct: 301 PGSETFDRVSVESVGGKRKKNMVGKDGWPRQDNGAMEVGSVKDYVREWMGMELRKESPND 360
Query: 281 DWIGRDTGSSSSVGGKVDRKKSRKRLDWWVSLDEDKEENVKNLKRERRRRPAREWWKEEY 340
WIG +SS G +D+ + +K + ++ +RRPAREWWKEE+
Sbjct: 361 HWIG-----ASSSGANLDKLEKKK----------------EKSWKKEKRRPAREWWKEEF 399
Query: 341 CEELAKKKKKKKRALGTNSDD----DWWPRDEELYVERKKKSKTRSRSRSSIGSLDWWLE 396
CEELA+KKKKK + D +WWP DE++YV+RKKKSK SR S S+DWWL+
Sbjct: 400 CEELARKKKKKMKRQKGRDKDFGGENWWPTDEDMYVDRKKKSKRSSRGGSKG-SVDWWLD 458
Query: 397 GFSGELYRARHNSYDSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSY 456
G SGEL+RAR NS+DSA GEIPKSGG++STPSMRGT+CYVAPEYG GGD+SEKCDVYS+
Sbjct: 459 GLSGELWRARRNSHDSAG-GEIPKSGGISSTPSMRGTMCYVAPEYGGGGDVSEKCDVYSF 517
Query: 457 GVLLLVLIAGRRPLQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQAL 516
GVLLLV+IAGRRPLQVT SPM+EFQRANL+SWAR+LAR GKLI LVDQ+ ++SLDREQAL
Sbjct: 518 GVLLLVVIAGRRPLQVTASPMAEFQRANLISWARNLARAGKLINLVDQS-IQSLDREQAL 576
Query: 517 LCITVALLCLQKSPALRPSMEEVVGMLTGKLEAPKLPAEFSPSPPSRIPFKSRKK 571
LCI VAL+CLQKSPA RPSM+EVVGML+G E PKLP EFSPSPPSR PFKS+KK
Sbjct: 577 LCIMVALICLQKSPARRPSMKEVVGMLSGDSEPPKLPFEFSPSPPSRFPFKSQKK 631
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541374|ref|XP_002511751.1| ATP binding protein, putative [Ricinus communis] gi|223548931|gb|EEF50420.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1514), Expect = e-165, Method: Compositional matrix adjust.
Identities = 334/627 (53%), Positives = 413/627 (65%), Gaps = 90/627 (14%)
Query: 3 HRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATL--HDQSVAVKVMD-SGSLQGEREFYN 59
RFSYS+LR A SFS S LG GGFGSV+ A + +Q +AVK+MD +GSLQGEREF+N
Sbjct: 87 RRFSYSLLRSATASFSTSNRLGHGGFGSVYKAIIPSTNQPLAVKLMDPNGSLQGEREFHN 146
Query: 60 ELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF 119
EL AS L+ H+VS+LGFSS+ +R +++LVYELM N +LQDALL +K ELM W KRF
Sbjct: 147 ELSLASSLDSP-HIVSLLGFSSDRRRKKLILVYELMENRSLQDALLDRKCEELMNWRKRF 205
Query: 120 SIAVDIAKGIAYLHSL-NPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQAD 178
I D+AKGI YLH NPPV HGDIKPSNILLD +F AKI DFGLARLK+
Sbjct: 206 DIVSDVAKGIEYLHHFCNPPVTHGDIKPSNILLDADFNAKIGDFGLARLKT--------- 256
Query: 179 GENKNKAAELESNCGAAVEDCGSVVETESVNTTTTATAFEDLSV--GIDQSPETFL---- 232
+ + E++ ED GS++E T + TA+ED S GID+SPE+F
Sbjct: 257 ---EETVEKKEASFVVVAEDNGSILE----ETESVVTAYEDSSTVAGIDRSPESFAVRVL 309
Query: 233 ------KMTQKQTQSTEALEKKASVDE--------------------------------- 253
+M S E K S+ E
Sbjct: 310 DSDASPEMATAAVVSPEMGMDKGSISEMGFDKVSVDSGKDLVNGGKKGGSRRDWWWKQDN 369
Query: 254 -NVKEDVKVKEYVIEWIGTAIGNERPKSDWIGRDTGSSSSVGGKVD------RKKSRKRL 306
E +VK+YV+EWIG+ I ERPK++WI + +S + RKK +KRL
Sbjct: 370 GGGSESGRVKDYVMEWIGSEIKKERPKNEWIASPSSVDNSNVLRTKSLSIEPRKKHKKRL 429
Query: 307 DWWVSLDEDKEENVKNLKRERRRRPAREWWKEEYCEELAKKKKKKKRALG-TNSDDDWWP 365
DWW SLDE++ + K+++ R+P REWWKEE+CEEL KKKKKR L +N D WW
Sbjct: 430 DWWASLDEERMQ-----KKDKYRKP-REWWKEEFCEELT--KKKKKRGLNSSNGGDSWWQ 481
Query: 366 RDEELYVERKKKSKTRSRSRSSIGSLDWWLEGFSGELYRARHNSYDSAASGEIPKSGGVT 425
+D+ L E KKK+K RSR GS+DWWL+GFSGEL R NS D SGEIPKSGGV+
Sbjct: 482 KDDNLVQETKKKNK-RSR-----GSIDWWLDGFSGELRNGRRNSQD-WLSGEIPKSGGVS 534
Query: 426 STPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANL 485
STPSMRGTVCY+APEYG GG +SEKCDVYS+GVLLLV+++GRRPLQVT SPMSEF+RANL
Sbjct: 535 STPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLLLVVVSGRRPLQVTASPMSEFERANL 594
Query: 486 MSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGMLTG 545
+SWAR LA NGKL++LVD + + SLD++QALLCIT+ALLCLQ+SP RP+M+E+VGML+G
Sbjct: 595 ISWARQLAYNGKLLDLVDPS-IHSLDKDQALLCITIALLCLQRSPTKRPTMKEIVGMLSG 653
Query: 546 KLEAPKLPAEFSPSPPSRIPFKSRKKG 572
+ E P LP EFSPSPPS PFKSRKK
Sbjct: 654 ETEPPHLPFEFSPSPPSNFPFKSRKKA 680
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359489512|ref|XP_002272077.2| PREDICTED: receptor-like serine/threonine-protein kinase At2g45590-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 580 bits (1495), Expect = e-163, Method: Compositional matrix adjust.
Identities = 348/629 (55%), Positives = 424/629 (67%), Gaps = 85/629 (13%)
Query: 1 PPHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATL-HDQSVAVKVMDSGSLQGEREFYN 59
PPHRFSYS+LRRA SFSPS LGQGGFGSV+ L Q VAVK+MDSGSLQGEREF N
Sbjct: 60 PPHRFSYSLLRRATSSFSPSNRLGQGGFGSVYKGVLPSGQEVAVKLMDSGSLQGEREFNN 119
Query: 60 ELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF 119
EL A + ++VV + GFSS+ +R R++LVYELM+N +LQDALL +K ELM+W KRF
Sbjct: 120 ELSLAGKVVDCEYVVRIQGFSSDRRRRRLVLVYELMTNRSLQDALLDRKCVELMQWKKRF 179
Query: 120 SIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV-GENQNQA 177
+IA+DIAKG+ YLHS +P +IHGDIKPSNILLD +F AKI+DFGLAR V G+ +
Sbjct: 180 AIAIDIAKGLQYLHSYCDPSIIHGDIKPSNILLDGDFNAKIADFGLARCTGVDGDLEGLV 239
Query: 178 DGENKNKAAELESNCGAAVEDCGSVV-ETESVNTTTTATAFEDLSVGI---DQSPETFLK 233
+GE K K E VED GS++ ETESV T ED G D SPE+ ++
Sbjct: 240 EGERKKK----EGLDAVGVEDNGSILEETESVLT----VGIEDGGAGAGDPDPSPESCVR 291
Query: 234 MTQKQTQST-------------EALEKKASVDENVK------------------------ 256
+T ++ E+ K SVD +
Sbjct: 292 AQDVETATSPEIDMGLDKASTLESCFDKMSVDSGKEIIGCGKGKGGRKKGDSGRDWWWRQ 351
Query: 257 ------EDVKVKEYVIEWIGTAIGNERPKSDWIG-----RDTGSSSSVGGKVDRKKSRKR 305
E +VK+YV+EWIG+ I ERPK++W+ D G S+ K + KK +KR
Sbjct: 352 DSGWGSESGRVKDYVMEWIGSEIRKERPKNEWVESSGPLEDHGLST----KNEPKKRKKR 407
Query: 306 LDWWVSLDEDKEENVKNLKRERRRRPAREWWKEEYCEELAKKKKKKKRALGTNSDDD--- 362
L+WW SLDEDK K+E+ R+P REWWKEE+CEEL+ +K KKKR L ++ D
Sbjct: 408 LEWWASLDEDKIR-----KKEKNRKP-REWWKEEFCEELS-RKNKKKRTLKSSIGGDGEL 460
Query: 363 WWPRDEELYVERKKKSKTRSRSRSSIGSLDWWLEGFSGELYRARHNSYDSAASGEIPKSG 422
WW RDEE VE +KK K+RS S+DWWL+G SGEL R NS D SGEIPKSG
Sbjct: 461 WWQRDEE-SVETRKKRKSRSSR-----SIDWWLDGLSGELRNGRRNSQD-WMSGEIPKSG 513
Query: 423 GVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQR 482
GV+STPSMRGT+CY+APEYG GG +SEKCDVYS+GVLLLVLI+GRRPLQVT SPMSEF+R
Sbjct: 514 GVSSTPSMRGTMCYIAPEYGGGGQLSEKCDVYSFGVLLLVLISGRRPLQVTASPMSEFER 573
Query: 483 ANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGM 542
ANL+SWAR LARNGKL++LVD + ++SLDREQ LLCIT+ALLCLQ+SPA RPSM E+VGM
Sbjct: 574 ANLISWARQLARNGKLLDLVDTS-IQSLDREQGLLCITIALLCLQRSPAKRPSMNEIVGM 632
Query: 543 LTGKLEAPKLPAEFSPSPPSRIPFKSRKK 571
L+G+ E P LP EFSPSPPS PFKSRKK
Sbjct: 633 LSGETEPPHLPFEFSPSPPSNFPFKSRKK 661
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147777060|emb|CAN70068.1| hypothetical protein VITISV_015041 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1473), Expect = e-160, Method: Compositional matrix adjust.
Identities = 329/575 (57%), Positives = 404/575 (70%), Gaps = 60/575 (10%)
Query: 1 PPHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQGEREFYN 59
PP+R+SYSVLR A SFS + LGQGGFGSV+ TL + +AVKVMDSGSLQGEREF N
Sbjct: 74 PPYRYSYSVLRHATSSFSAANRLGQGGFGSVYRGTLKSGKEIAVKVMDSGSLQGEREFQN 133
Query: 60 ELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF 119
EL+FA ++ + ++V V+GFSS+ +R RM+LVYELMSNGNLQDALL +K ELM+W KRF
Sbjct: 134 ELFFAGRIDSN-YIVPVIGFSSDRRRQRMILVYELMSNGNLQDALLDRKCSELMDWKKRF 192
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS-------VGE 172
IA+D+AKGI YLHSL+PP IHGDIKPSNILLD F AKI DFGLA+ KS V +
Sbjct: 193 EIAMDVAKGIEYLHSLDPPAIHGDIKPSNILLDRCFSAKIGDFGLAKSKSEDQVVVVVVD 252
Query: 173 NQNQADGENKNKAAELESNCGAAVEDCGSVVETESVNTTTTATAFEDLSVGIDQSPETFL 232
+ + +G + K EL S G AV+D SVVE +T + AT FE++SV ++QSPE+F
Sbjct: 253 DAIKMNGREEAKKKELVSCGGGAVDDNASVVE----DTESVATGFEEMSVNVEQSPESFA 308
Query: 233 KMTQKQTQSTEALE-----------KKASV--------DENVKEDVKVKEYVIEWIGTAI 273
+ +E + KK V D E VK+YV EW+G +
Sbjct: 309 VDAVASSPGSETFDRVSVESVGGKRKKNMVGKDGWPRQDNGAMEVGSVKDYVREWMGMEL 368
Query: 274 GNERPKSDWIGRDTGSSSSVGGKVDRKKSRKRLDWWVSLDEDKEENVKNLKRERRRRPAR 333
E P WIG +SS G +D+ + +K + ++ +RRPAR
Sbjct: 369 RKESPNDHWIG-----ASSSGANLDKLEKKK----------------EKSWKKEKRRPAR 407
Query: 334 EWWKEEYCEELAKKKKKKKRALGTNSDD----DWWPRDEELYVERKKKSKTRSRSRSSIG 389
EWWKEE+CEELA+KKKKK + D +WWP DE++YV+RKKKSK SR S
Sbjct: 408 EWWKEEFCEELARKKKKKMKRQKGRDKDFGGENWWPTDEDMYVDRKKKSKRSSRGGSKG- 466
Query: 390 SLDWWLEGFSGELYRARHNSYDSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISE 449
S+DWWL+G SGEL+RAR NS+DSA GEIPKSGG++STPSMRGT+CYVAPEYG GGDISE
Sbjct: 467 SVDWWLDGLSGELWRARRNSHDSAX-GEIPKSGGISSTPSMRGTMCYVAPEYGGGGDISE 525
Query: 450 KCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKS 509
KCDVYS+GVLLLV+IAGRRPLQVT SPM+EFQRANL+SWAR+LAR GKLI LVDQ+ ++S
Sbjct: 526 KCDVYSFGVLLLVVIAGRRPLQVTASPMAEFQRANLISWARNLARAGKLINLVDQS-IQS 584
Query: 510 LDREQALLCITVALLCLQKSPALRPSMEEVVGMLT 544
LDREQALLCI VAL+CLQKSPA RPSM+EVVGML+
Sbjct: 585 LDREQALLCIMVALICLQKSPARRPSMKEVVGMLS 619
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454626|ref|XP_004145055.1| PREDICTED: receptor-like serine/threonine-protein kinase At2g45590-like [Cucumis sativus] gi|449474838|ref|XP_004154299.1| PREDICTED: receptor-like serine/threonine-protein kinase At2g45590-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 564 bits (1453), Expect = e-158, Method: Compositional matrix adjust.
Identities = 311/595 (52%), Positives = 411/595 (69%), Gaps = 37/595 (6%)
Query: 2 PHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATL-HDQSVAVKVMDS-GSLQGEREFYN 59
P RFSYS+LRRA SFSPS LG GGFGSV+ A L SVAVK+MDS GSLQGEREF+N
Sbjct: 71 PRRFSYSLLRRATASFSPSNRLGHGGFGSVYKAVLPSGLSVAVKIMDSPGSLQGEREFHN 130
Query: 60 ELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF 119
EL AS+L+ + ++VS+LG SS+ +R R++LVYELM N +LQDAL +K PELM W KRF
Sbjct: 131 ELSIASVLD-NPNIVSLLGHSSDRRRRRLILVYELMPNRSLQDALFDRKCPELMPWRKRF 189
Query: 120 SIAVDIAKGIAYLHSL-NPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQAD 178
I++ IA + YLH NPPVIHGDIKPSNILLD +F AKI DFGLARLKS E+
Sbjct: 190 EISLRIASALQYLHHFCNPPVIHGDIKPSNILLDADFEAKIGDFGLARLKSEEEDCGGGG 249
Query: 179 GENKNKAAELESNCGAAVEDCGSVVETESVNTTTTATAFEDLSVGIDQSPETFLKMTQKQ 238
++ + E+ + G+ +E+ SV+ + + V + SPE + +
Sbjct: 250 -DDGGRVREVIGDNGSILEETESVLTSGFEENIGMDRLPDSCVVTVLDSPEMVATLGTDK 308
Query: 239 TQSTEALEKKASVDE---------------------NVKEDVKVKEYVIEWIGTAIGNER 277
+E + SV+ + E +VK+YV+EWIG I +R
Sbjct: 309 VSLSEGNFDRISVESGKERKKGGSGRDWWWKQETAVDGSESGRVKDYVMEWIGNEIKKDR 368
Query: 278 PKSDWIGRDTGSSSSVGGKVDRKKSRKRLDWWVSLDEDKEENVKNLKRERRRRPAREWWK 337
PKS+W+ ++ +SS G K+++KK ++RL+WW SLDE + K+E+ R+ REWWK
Sbjct: 369 PKSEWVESESSVASSSG-KMEQKKQKRRLEWWASLDEGRMR-----KKEKSRKKPREWWK 422
Query: 338 EEYCEELAKKKKKKKRALGTNSDDDWWPRDEELYVERKKKSKTRSRSRSSIGSLDWWLEG 397
EE+CEELA+KKKKK+ A ++ + WW RDE+ ER+KK +++ GS+DWWL+G
Sbjct: 423 EEFCEELARKKKKKELA-SSSCRELWWQRDEDSTKERRKKKVNNNKNSK--GSIDWWLDG 479
Query: 398 FSGELYRARHNSYDSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYG 457
SG+L + NS D A+ +IPKSGG++STPSMRGTVCY+APEYG GG ISEKCDVYS+G
Sbjct: 480 LSGDLRNGKRNSID-GATNDIPKSGGISSTPSMRGTVCYIAPEYGGGGQISEKCDVYSFG 538
Query: 458 VLLLVLIAGRRPLQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALL 517
VLLLVL++GRRPLQV SP+SEF+RANL+SWAR LARNGKL++LVD + + SLD+EQALL
Sbjct: 539 VLLLVLVSGRRPLQVMASPISEFERANLISWARQLARNGKLLDLVDPS-IHSLDKEQALL 597
Query: 518 CITVALLCLQKSPALRPSMEEVVGMLTGKLEAPKLPAEFSPSPPSRIPFKSRKKG 572
CIT+ALLCLQ+SP+ RP+M+E+V +L+G+ E P LP EFSPSPPS FKS++K
Sbjct: 598 CITIALLCLQRSPSKRPNMKEIVAVLSGEAEPPHLPFEFSPSPPSNFLFKSQRKA 652
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449521812|ref|XP_004167923.1| PREDICTED: LOW QUALITY PROTEIN: receptor-like serine/threonine-protein kinase At2g45590-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 563 bits (1450), Expect = e-157, Method: Compositional matrix adjust.
Identities = 311/595 (52%), Positives = 410/595 (68%), Gaps = 37/595 (6%)
Query: 2 PHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATL-HDQSVAVKVMDS-GSLQGEREFYN 59
P RFSYS+LRRA SFSPS LG GGFGSV+ A L SVAVK+MDS GSLQGEREF+N
Sbjct: 71 PRRFSYSLLRRATASFSPSNRLGHGGFGSVYKAVLPSGLSVAVKIMDSPGSLQGEREFHN 130
Query: 60 ELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF 119
EL AS+L+ + ++VS+LG SS+ +R R++LVYELM N +LQDAL +K PELM W KRF
Sbjct: 131 ELSIASVLD-NPNIVSLLGHSSDRRRRRLILVYELMPNRSLQDALFDRKCPELMPWRKRF 189
Query: 120 SIAVDIAKGIAYLHSL-NPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQAD 178
I++ IA + YLH NPPVIHGDIKPSNILLD +F AKI DFGLARLKS E+
Sbjct: 190 EISLRIASALQYLHHFCNPPVIHGDIKPSNILLDADFEAKIGDFGLARLKSEEEDCGGGG 249
Query: 179 GENKNKAAELESNCGAAVEDCGSVVETESVNTTTTATAFEDLSVGIDQSPETFLKMTQKQ 238
++ + E+ + G+ +E+ SV+ + + V + SPE + +
Sbjct: 250 -DDGGRVREVIGDNGSILEETESVLTSGFEENIGMDRLPDSCVVTVLDSPEMVATLGTDK 308
Query: 239 TQSTEALEKKASVDE---------------------NVKEDVKVKEYVIEWIGTAIGNER 277
+E + SV+ + E +VK+YV+EWIG I R
Sbjct: 309 VSLSEGNFDRISVESGKERKKGGSGRDWWWKQETAVDGSESGRVKDYVMEWIGNEIKKXR 368
Query: 278 PKSDWIGRDTGSSSSVGGKVDRKKSRKRLDWWVSLDEDKEENVKNLKRERRRRPAREWWK 337
PKS+W+ ++ +SS G K+++KK ++RL+WW SLDE + K+E+ R+ REWWK
Sbjct: 369 PKSEWVESESSVASSSG-KMEQKKQKRRLEWWASLDEGRMR-----KKEKSRKKPREWWK 422
Query: 338 EEYCEELAKKKKKKKRALGTNSDDDWWPRDEELYVERKKKSKTRSRSRSSIGSLDWWLEG 397
EE+CEELA+KKKKK+ A ++ + WW RDE+ ER+KK +++ GS+DWWL+G
Sbjct: 423 EEFCEELARKKKKKELA-SSSCRELWWQRDEDSTKERRKKKVNNNKNSK--GSIDWWLDG 479
Query: 398 FSGELYRARHNSYDSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYG 457
SG+L + NS D A+ +IPKSGG++STPSMRGTVCY+APEYG GG ISEKCDVYS+G
Sbjct: 480 LSGDLRNGKRNSID-GATNDIPKSGGISSTPSMRGTVCYIAPEYGGGGQISEKCDVYSFG 538
Query: 458 VLLLVLIAGRRPLQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALL 517
VLLLVL++GRRPLQV SP+SEF+RANL+SWAR LARNGKL++LVD + + SLD+EQALL
Sbjct: 539 VLLLVLVSGRRPLQVMASPISEFERANLISWARQLARNGKLLDLVDPS-IHSLDKEQALL 597
Query: 518 CITVALLCLQKSPALRPSMEEVVGMLTGKLEAPKLPAEFSPSPPSRIPFKSRKKG 572
CIT+ALLCLQ+SP+ RP+M+E+V +L+G+ E P LP EFSPSPPS FKS++K
Sbjct: 598 CITIALLCLQRSPSKRPNMKEIVAVLSGEAEPPHLPFEFSPSPPSNFLFKSQRKA 652
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122520|ref|XP_002318857.1| predicted protein [Populus trichocarpa] gi|222859530|gb|EEE97077.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 563 bits (1450), Expect = e-157, Method: Compositional matrix adjust.
Identities = 335/636 (52%), Positives = 398/636 (62%), Gaps = 141/636 (22%)
Query: 1 PPHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHDQ-SVAVKVMDSGSLQGEREFYN 59
PPHRFSY+ LRRA + FSPS LGQGGFGSV+H TL ++ +VAVKVMDSGSLQGEREF N
Sbjct: 64 PPHRFSYTTLRRATNKFSPSLRLGQGGFGSVYHGTLPNELNVAVKVMDSGSLQGEREFQN 123
Query: 60 ELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF 119
EL FAS L+ ++V+ LGFS + K +L+VYELM NGNLQDALLH+K EL++W KRF
Sbjct: 124 ELLFASKLDSC-YIVTALGFSYDRKHRSLLIVYELMQNGNLQDALLHRKCVELVDWKKRF 182
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVG-------- 171
SIAVDIAKGI YLHSL+PPVIHGDIKPSNILLD F AK++DFGLA LK
Sbjct: 183 SIAVDIAKGIEYLHSLDPPVIHGDIKPSNILLDQCFNAKVADFGLAWLKIDNSNQNDQNQ 242
Query: 172 ----------ENQNQADGENKNKAAELESNCGAAVEDCGSVVETESVNTTTTATAFEDLS 221
E ++ +G + K ELESN G ED GSVVE T + T F++ +
Sbjct: 243 CNQGQCEVKVEESDKINGGVELKKVELESNNGG--EDYGSVVE----ETDSVTTGFDEFN 296
Query: 222 VGIDQ------SPETFLKMTQK------------------------------------QT 239
+ +DQ SPET ++ Q+
Sbjct: 297 LVVDQLPVCMTSPETLEAVSASPETGGVGVLLEGNLDVGSIEGGKELVNGEKNNGGGIQS 356
Query: 240 QSTEALEKKASVDENVKEDVKVKEYVIEWIGTAIGNERPKSDWIGRDTGSSSSVGGKVDR 299
+S + K E+ VK+YV+EW+GT I RPK+D
Sbjct: 357 ESRKDWWLKQEKGGTTAENGGVKDYVMEWLGTEINKGRPKND------------------ 398
Query: 300 KKSRKRLDWWVSLDEDKEENVKNLKRERRRRPAREWWKEEYCEEL-AKKKKKKKRALGTN 358
DK E V LK+E+RR PAREWWKEEYCEEL K KKKKKR +G
Sbjct: 399 ---------------DKGEKV--LKKEKRR-PAREWWKEEYCEELEKKNKKKKKREMGMT 440
Query: 359 SDD-----DWWPRDEELYVERKKKSKTRSRSRSSIGSLDWWLEGFSGELYRARHNSYDSA 413
SDD DWWPRDEE GEL+R NS+DS
Sbjct: 441 SDDNNGGEDWWPRDEEF-----------------------------GELFRGNQNSHDSL 471
Query: 414 ASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVT 473
SGEIP+SGG++STPSMRGTVCY APEYG GG++SEK DVYS+GVLLLVLIAGRRPLQVT
Sbjct: 472 -SGEIPESGGISSTPSMRGTVCYAAPEYGGGGNLSEKSDVYSFGVLLLVLIAGRRPLQVT 530
Query: 474 GSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALR 533
PMSEFQRANLM WAR+LAR+GKL++LVD++ V+SLDREQA LCIT+ALLCLQKSPA R
Sbjct: 531 TLPMSEFQRANLMHWARNLARSGKLLDLVDKS-VQSLDREQATLCITIALLCLQKSPAHR 589
Query: 534 PSMEEVVGMLTGKLEAPKLPAEFSPSPPSRIPFKSR 569
PSM EVVGMLTG+ P+LP+EFSPSPP+R PFKS+
Sbjct: 590 PSMTEVVGMLTGESHVPQLPSEFSPSPPTRFPFKSK 625
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 576 | ||||||
| TAIR|locus:2138014 | 651 | AT4G25390 [Arabidopsis thalian | 0.536 | 0.474 | 0.471 | 2.4e-125 | |
| TAIR|locus:2043629 | 683 | AT2G45590 [Arabidopsis thalian | 0.397 | 0.335 | 0.560 | 1.2e-124 | |
| TAIR|locus:2165301 | 654 | AT5G51770 [Arabidopsis thalian | 0.536 | 0.472 | 0.471 | 1.2e-121 | |
| TAIR|locus:2025742 | 692 | AT1G80870 [Arabidopsis thalian | 0.267 | 0.222 | 0.506 | 6.7e-76 | |
| TAIR|locus:2099009 | 400 | AT3G58690 [Arabidopsis thalian | 0.279 | 0.402 | 0.470 | 1.6e-49 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.291 | 0.405 | 0.44 | 6e-49 | |
| TAIR|locus:2183835 | 433 | AT5G11020 [Arabidopsis thalian | 0.270 | 0.360 | 0.434 | 1e-46 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.293 | 0.370 | 0.438 | 3.2e-46 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.286 | 0.454 | 0.441 | 3.8e-46 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.291 | 0.431 | 0.434 | 5.6e-46 |
| TAIR|locus:2138014 AT4G25390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 637 (229.3 bits), Expect = 2.4e-125, Sum P(2) = 2.4e-125
Identities = 157/333 (47%), Positives = 199/333 (59%)
Query: 2 PHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQGEREFYNE 60
P FSYS LRRA SFS + LGQGGFG VF T+ ++VAVKVMDSGSLQGE EF NE
Sbjct: 84 PREFSYSSLRRATGSFSQANRLGQGGFGVVFRGTISGGENVAVKVMDSGSLQGEGEFQNE 143
Query: 61 LYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS 120
L+FA+ L+ HVV V+GFS + KR R+LLVY+LM NGNLQDALLH++ PELM+W +RF
Sbjct: 144 LFFAAKLDSP-HVVPVIGFSHDRKRRRLLLVYKLMDNGNLQDALLHRRCPELMDWNRRFL 202
Query: 121 IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQA--- 177
+AV+IA GI +LHSL PPVIHGDIKPSN+LLD F AKI+DFGLARLK+ + A
Sbjct: 203 VAVNIADGIKHLHSLEPPVIHGDIKPSNVLLDSLFSAKIADFGLARLKAEQVEISVAPER 262
Query: 178 DGENKNKAAELES--NCGAAVEDCGXXXXXXXXXXXX----XXXXFEDLSVGIDQSPETF 231
DG+ + E+ES ED + + + SPE
Sbjct: 263 DGDG-SMVEEVESVVTTVTGYEDFNFGLVDQSPESVAKVPGSVSASPEATTVVSVSPEMG 321
Query: 232 LKMTQKQTQSTEALEK-KASXXX-------XXXXXXXXXXXXIEWIGTAIGNERP-KSDW 282
K T + S ++K K S ++WIG+ + ERP +SDW
Sbjct: 322 EK-TDEDGGSVVVMKKGKESESKDWWWKQESNVERGRVKEYVMQWIGSEVKKERPSRSDW 380
Query: 283 IGRDTGSSSSVGGKVDRKKSRKRLDWWVSLDED 315
I SSSS K+++K S KRLDWW+SL+E+
Sbjct: 381 IEAAALSSSS-SKKLEKKTS-KRLDWWLSLEEE 411
|
|
| TAIR|locus:2043629 AT2G45590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 650 (233.9 bits), Expect = 1.2e-124, Sum P(3) = 1.2e-124
Identities = 135/241 (56%), Positives = 167/241 (69%)
Query: 340 YCEELAXXXXXXX----RALGT-NSDDDWWPRDEELYVEXXXXXXXXXXXXXXIGSLDWW 394
+CEEL R L + +S D W+ RD+ S+DWW
Sbjct: 444 FCEELTRKKRKKKKKKKRGLSSISSIDSWFHRDDG--ASSVHDHNLNPTKRKKRNSIDWW 501
Query: 395 LEGFSGEL--YRARHNSYDSA--ASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEK 450
++G SGEL + NS DS + KSGGV+STPSMRGTVCY+APE G GG +SEK
Sbjct: 502 VDGLSGELKSVMGKKNSQDSGLWCDVNVQKSGGVSSTPSMRGTVCYIAPECGGGGVLSEK 561
Query: 451 CDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSL 510
CDVYS+GVLLLVL++GRRPLQVT SPMSEF+RANL+SWA+ LA NGKL+ELVD+++ SL
Sbjct: 562 CDVYSFGVLLLVLVSGRRPLQVTASPMSEFERANLISWAKQLACNGKLLELVDKSI-HSL 620
Query: 511 DREQALLCITVALLCLQKSPALRPSMEEVVGMLTGKLEAPKLPAEFSPSPPSRIPFKSRK 570
++EQA+LCIT+ALLCLQ+SP RP+M+E+V ML+G E P LP EFSPSPP PFKSRK
Sbjct: 621 EKEQAVLCITIALLCLQRSPVKRPTMKEIVEMLSGVSEPPHLPFEFSPSPPMGFPFKSRK 680
Query: 571 K 571
K
Sbjct: 681 K 681
|
|
| TAIR|locus:2165301 AT5G51770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 1.2e-121, Sum P(2) = 1.2e-121
Identities = 156/331 (47%), Positives = 194/331 (58%)
Query: 1 PPHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHDQS----VAVKVMDSGSLQGERE 56
P H FSYS LR+A SFSP LGQGGFGSVF TL S VAVKVMDSGSLQGERE
Sbjct: 74 PLHEFSYSSLRKATASFSPENRLGQGGFGSVFRGTLSPSSGGGNVAVKVMDSGSLQGERE 133
Query: 57 FYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWC 116
F NEL+FA L+ HVVSV+GFS +R R++LVYELM GNLQDALLH++ PELM W
Sbjct: 134 FQNELFFAGKLDSP-HVVSVIGFSRR-RRSRLILVYELMDIGNLQDALLHRRSPELMIWN 191
Query: 117 KRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQ-- 174
+RF +A+DIAKGI +LHSLNP VIHGD+KPSN+LLD F AKISDFGLARLKS
Sbjct: 192 RRFLVAIDIAKGIEHLHSLNPCVIHGDLKPSNVLLDRFFSAKISDFGLARLKSEHVEVKV 251
Query: 175 -NQADG-ENKNKAAELESNCGAAVEDCGXXXXXXXXXXXXXXXXFEDLSVGIDQSPETFL 232
+++D E+ E + C E + SPET +
Sbjct: 252 VSESDVVEDYGSVVEEVESVVTNTTGCDESNFGFTDQSPVPLSSPEMVEQVPMTSPETVV 311
Query: 233 KMTQKQTQSTEALEK----KASX----XXXXXXXXXXXXXXIEWIGTAIGNERPKSDWIG 284
++ + + LE ++ ++WIG+ + ER SDWI
Sbjct: 312 SVSPEMGEKGSVLEVGNVVRSKDWWWKQEGNVGRGKGKEYVMQWIGSEVKEERQSSDWIA 371
Query: 285 RDTGSSSSVGGKVDRKKSRKRLDWWVSLDED 315
+T G KV++KKS KRL+WW+SLDE+
Sbjct: 372 -ETAEG---GKKVEKKKSSKRLEWWLSLDEE 398
|
|
| TAIR|locus:2025742 AT1G80870 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 404 (147.3 bits), Expect = 6.7e-76, Sum P(4) = 6.7e-76
Identities = 80/158 (50%), Positives = 116/158 (73%)
Query: 415 SGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGD-ISEKCDVYSYGVLLLVLIAGRRPLQVT 473
SG++ S ++ST SMRGT+CY+APEYG G + EK D+YS+GVL+LV+++GRRPL V
Sbjct: 535 SGDL-FSRELSSTTSMRGTLCYIAPEYGGGCCYLMEKGDIYSFGVLILVIVSGRRPLHVL 593
Query: 474 GSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALR 533
SPM + ++ANL+SW R LA++G ++ELVD+ + ++E+A LCI +AL CLQK+P LR
Sbjct: 594 ASPM-KLEKANLVSWCRQLAQSGNVLELVDEKLKDGYNKEEAGLCINLALACLQKAPELR 652
Query: 534 PSMEEVVGMLTGKLEAPKLPAEFSPSPPSRIPFKSRKK 571
P + EVV +L G+++ EFSPSPP ++ + SR K
Sbjct: 653 PDVSEVVRILRGEMDISSTAFEFSPSPPGKV-YGSRSK 689
|
|
| TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 348 (127.6 bits), Expect = 1.6e-49, Sum P(2) = 1.6e-49
Identities = 81/172 (47%), Positives = 111/172 (64%)
Query: 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQGEREFYNELYF 63
F++ L A FS S ++G GGFG V+ L+D + VA+K+MD QGE EF E+
Sbjct: 75 FTFKQLHSATGGFSKSNVVGNGGFGLVYRGVLNDGRKVAIKLMDHAGKQGEEEFKMEVEL 134
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDAL-LHKK----PPELMEWCKR 118
S L + +++++LG+ S+ H+ LLVYE M+NG LQ+ L L + PP L +W R
Sbjct: 135 LSRL-RSPYLLALLGYCSD-NSHK-LLVYEFMANGGLQEHLYLPNRSGSVPPRL-DWETR 190
Query: 119 FSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
IAV+ AKG+ YLH ++PPVIH D K SNILLD NF AK+SDFGLA++ S
Sbjct: 191 MRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFGLAKVGS 242
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 339 (124.4 bits), Expect = 6.0e-49, Sum P(2) = 6.0e-49
Identities = 77/175 (44%), Positives = 108/175 (61%)
Query: 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHDQS--VAVKVMDSGSLQGEREFYNELY 62
FS+ L A +F L+G+GGFG V+ L VAVK +D LQG +EF E+
Sbjct: 67 FSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFIVEVL 126
Query: 63 FASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPEL-MEWCKRFSI 121
SLL H+V+++G+ ++ + LLVYE MS G+L+D LL P ++ ++W R I
Sbjct: 127 MLSLLHHK-HLVNLIGYCADGDQR--LLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRI 183
Query: 122 AVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQN 175
A+ A G+ YLH NPPVI+ D+K +NILLD F AK+SDFGLA+L VG+ Q+
Sbjct: 184 ALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQH 238
|
|
| TAIR|locus:2183835 AT5G11020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 319 (117.4 bits), Expect = 1.0e-46, Sum P(2) = 1.0e-46
Identities = 70/161 (43%), Positives = 97/161 (60%)
Query: 7 YSVLRRAADSFSPSRLLGQGGFGSVFHATLHDQ-SVAVKVMDSGSLQGEREFYNELYFAS 65
Y++L F S +LGQGGFG V+ ATL + S AVK +D + +EF +E+ S
Sbjct: 131 YNILEEGTSGFKESNILGQGGFGCVYSATLENNISAAVKKLDCANEDAAKEFKSEVEILS 190
Query: 66 LLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDI 125
L Q +++S+LG+S+N +VYELM N +L+ L + W R IA+D+
Sbjct: 191 KL-QHPNIISLLGYSTNDTAR--FIVYELMPNVSLESHLHGSSQGSAITWPMRMKIALDV 247
Query: 126 AKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+G+ YLH +P +IH D+K SNILLD NF AKISDFGLA
Sbjct: 248 TRGLEYLHEHCHPAIIHRDLKSSNILLDSNFNAKISDFGLA 288
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 335 (123.0 bits), Expect = 3.2e-46, Sum P(2) = 3.2e-46
Identities = 78/178 (43%), Positives = 105/178 (58%)
Query: 3 HRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNE 60
H F++ L A +F P LG+GGFG V+ L Q VAVK +D LQG REF E
Sbjct: 72 HTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVE 131
Query: 61 LYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPP--ELMEWCKR 118
+ SLL + +V+++G+ ++ + LLVYE M G+L+D L H PP E ++W R
Sbjct: 132 VLMLSLLHHPN-LVNLIGYCADGDQR--LLVYEFMPLGSLEDHL-HDLPPDKEALDWNMR 187
Query: 119 FSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQN 175
IA AKG+ +LH NPPVI+ D K SNILLD F K+SDFGLA+L G+ +
Sbjct: 188 MKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSH 245
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 328 (120.5 bits), Expect = 3.8e-46, Sum P(2) = 3.8e-46
Identities = 76/172 (44%), Positives = 109/172 (63%)
Query: 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELY 62
F++ L A +F L+G+GGFG V+ L + Q VAVK +D LQG+REF E+
Sbjct: 35 FTFRELATATKNFRQECLIGEGGFGRVYKGKLENPAQVVAVKQLDRNGLQGQREFLVEVL 94
Query: 63 FASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPEL-MEWCKRFSI 121
SLL + +V+++G+ ++ + LLVYE M G+L+D LL +P + ++W R I
Sbjct: 95 MLSLLHHRN-LVNLIGYCADGDQR--LLVYEYMPLGSLEDHLLDLEPGQKPLDWNTRIKI 151
Query: 122 AVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGE 172
A+ AKGI YLH +PPVI+ D+K SNILLD + AK+SDFGLA+L VG+
Sbjct: 152 ALGAAKGIEYLHDEADPPVIYRDLKSSNILLDPEYVAKLSDFGLAKLGPVGD 203
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 319 (117.4 bits), Expect = 5.6e-46, Sum P(2) = 5.6e-46
Identities = 76/175 (43%), Positives = 107/175 (61%)
Query: 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELY 62
F + L A +SF L+G+GGFG V+ + Q VAVK +D LQG REF E++
Sbjct: 59 FKFRELATATNSFRQEFLIGEGGFGRVYKGKMEKTGQVVAVKQLDRNGLQGNREFLVEIF 118
Query: 63 FASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPEL-MEWCKRFSI 121
SLL + + +++G+ + + LLV+E M G+L+D LL + ++W R I
Sbjct: 119 RLSLLHHPN-LANLIGYCLDGDQR--LLVHEFMPLGSLEDHLLDVVVGQQPLDWNSRIRI 175
Query: 122 AVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQN 175
A+ AKG+ YLH NPPVI+ D K SNILL+ +F AK+SDFGLA+L SVG+ QN
Sbjct: 176 ALGAAKGLEYLHEKANPPVIYRDFKSSNILLNVDFDAKLSDFGLAKLGSVGDTQN 230
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9STJ8 | Y4539_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5273 | 0.9166 | 0.8110 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 576 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-33 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-31 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-29 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-29 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-16 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-15 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-13 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-12 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-11 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-10 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-09 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-08 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 7e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-07 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-07 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-05 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-05 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-04 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-04 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-04 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-04 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-04 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-04 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-04 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-04 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 0.001 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 0.001 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.001 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.001 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 0.001 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 0.002 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 0.002 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.002 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.002 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 0.002 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.002 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.002 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 0.002 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 0.003 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.003 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.003 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 0.003 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 11/158 (6%)
Query: 23 LGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGERE-FYNELYFASLLEQDDHVVSVLGF 79
LG+GGFG+V+ A + VA+K++ E E+ L ++V + G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59
Query: 80 SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPV 139
+ + LV E G+L+D LL + +L E + I + I +G+ YLHS +
Sbjct: 60 FEDENH--LYLVMEYCEGGSLKD-LLKENEGKLSED-EILRILLQILEGLEYLHSNG--I 113
Query: 140 IHGDIKPSNILLDH-NFCAKISDFGLARLKSVGENQNQ 176
IH D+KP NILLD N K++DFGL++L + ++ +
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK 151
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 56/161 (34%), Positives = 81/161 (50%), Gaps = 17/161 (10%)
Query: 21 RLLGQGGFGSVFHATL------HDQSVAVKVM-DSGSLQGEREFYNELYFASLLEQDDH- 72
+ LG+G FG V+ TL + VAVK + + S Q EF E A ++ + DH
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLRE---ARIMRKLDHP 61
Query: 73 -VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAY 131
+V +LG + + +++V E M G+L D L +P EL S A+ IA+G+ Y
Sbjct: 62 NIVKLLGVCT--EEEPLMIVMEYMPGGDLLDYLRKNRPKEL-SLSDLLSFALQIARGMEY 118
Query: 132 LHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGE 172
L S N IH D+ N L+ N KISDFGL+R +
Sbjct: 119 LESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 53/162 (32%), Positives = 76/162 (46%), Gaps = 18/162 (11%)
Query: 20 SRLLGQGGFGSVFHATL------HDQSVAVKVM-DSGSLQGEREFYNELYFASLLEQDDH 72
+ LG+G FG V+ L VAVK + + S Q EF E A ++ + DH
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLRE---ARIMRKLDH 60
Query: 73 --VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIA 130
VV +LG + + + +V E M G+L L +K + S A+ IA+G+
Sbjct: 61 PNVVKLLGVCT--EEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGME 116
Query: 131 YLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGE 172
YL S N IH D+ N L+ N KISDFGL+R +
Sbjct: 117 YLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 156
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 54/168 (32%), Positives = 83/168 (49%), Gaps = 18/168 (10%)
Query: 21 RLLGQGGFGSVFHATL------HDQSVAVKVMDSGSLQGER-EFYNELYFASLLEQDDH- 72
+ LG+G FG V+ TL + VAVK + G+ + ER EF E AS++++ H
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEE---ASIMKKLSHP 61
Query: 73 -VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAY 131
+V +LG + + + +V E M G+L D L ++ +A+ IAKG+ Y
Sbjct: 62 NIVRLLGVCT--QGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEY 117
Query: 132 LHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADG 179
L S N +H D+ N L+ N KISDFGL+R + + G
Sbjct: 118 LESKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGG 163
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 50/165 (30%), Positives = 73/165 (44%), Gaps = 17/165 (10%)
Query: 21 RLLGQGGFGSVFHATLHDQS-----VAVKVMDSGSLQGER-EFYNELYFASLLEQDDHVV 74
+ LG+G FG V+ L + VAVK + + + ER +F E L +VV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHP-NVV 59
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IAVDIAKG 128
+LG + + + LV E M G+L D L +P S A+ IAKG
Sbjct: 60 RLLGVCT--EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGEN 173
+ YL S +H D+ N L+ + KISDFGL+R +
Sbjct: 118 MEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 51/152 (33%), Positives = 77/152 (50%), Gaps = 15/152 (9%)
Query: 21 RLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGERE-FYNELYFASLLEQDDH--VVS 75
LG+G FG V+ A + VA+KV+ ++ +RE E+ +L++ H +V
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREI---KILKKLKHPNIVR 61
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL 135
+ + + + LV E G+L D LL K+ L E RF I + YLHS
Sbjct: 62 LYDVFEDEDK--LYLVMEYCEGGDLFD-LLKKRGR-LSEDEARF-YLRQILSALEYLHSK 116
Query: 136 NPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
++H D+KP NILLD + K++DFGLAR
Sbjct: 117 G--IVHRDLKPENILLDEDGHVKLADFGLARQ 146
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 9e-29
Identities = 50/173 (28%), Positives = 86/173 (49%), Gaps = 26/173 (15%)
Query: 16 SFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSG--------SLQGEREFYNELYFAS 65
++ LLG+G FGSV+ A D + +AVK ++ +L+ E + L
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL---- 56
Query: 66 LLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHK--KPPELMEWCKRFSIAV 123
Q ++V G + +++ + + E +S G+L LL K K PE + ++++
Sbjct: 57 ---QHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPV--IRKYTR-- 108
Query: 124 DIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQ 176
I +G+AYLHS ++H DIK +NIL+D + K++DFG A+ E
Sbjct: 109 QILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 12/154 (7%)
Query: 21 RLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSV 76
R LG G FG+V+ A + VAVK++ + ++ +L + H +V +
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN 136
+ + + LV E G+L D L P + + IA+ I +G+ YLHS
Sbjct: 64 IDAFEDKDH--LYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHSNG 118
Query: 137 PPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
+IH D+KP NILLD N KI+DFGLA+
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKLLK 150
|
Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 8e-21
Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 27/160 (16%)
Query: 17 FSPSRLLGQGGFGSVFHATLHDQS---VAVKVMDSGSLQGEREFYNELYFASLLEQDDH- 72
F +G+GGFG V+ A H ++ VA+KV+ S + + + NE+ L++ H
Sbjct: 2 FEILEKIGKGGFGEVYKAR-HKRTGKEVAIKVIKLESKEKKEKIINEIQI---LKKCKHP 57
Query: 73 -VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IAVDI 125
+V G S K+ + +V E S G+L+D L + + + ++
Sbjct: 58 NIVKYYG--SYLKKDELWIVMEFCSGGSLKDLLKS--------TNQTLTESQIAYVCKEL 107
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
KG+ YLHS +IH DIK +NILL + K+ DFGL+
Sbjct: 108 LKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLS 145
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 94.0 bits (232), Expect = 1e-20
Identities = 49/156 (31%), Positives = 72/156 (46%), Gaps = 9/156 (5%)
Query: 16 SFSPSRLLGQGGFGSVFHATLHDQSVAVKVMD---SGSLQGEREFYNELYFASLLEQDDH 72
S+ R LG+G FG V+ A + VA+KV+ + F E+ + L +
Sbjct: 1 SYRILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYL 132
+V + F + LV E + G+L+D L + + I I + YL
Sbjct: 60 IVKLYDFFQDEGSL--YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 133 HSLNPPVIHGDIKPSNILLDHN-FCAKISDFGLARL 167
HS +IH DIKP NILLD + K+ DFGLA+L
Sbjct: 118 HSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKL 151
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 22/185 (11%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGER---EFYNELYFASLLEQ 69
D F +++G+G F +V A + + A+K++D L E+ E L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEK--EVLTRL 58
Query: 70 DDH--VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIA 126
+ H ++ + F + V E NG L + +K L E C RF A +I
Sbjct: 59 NGHPGIIKLYYTFQDE---ENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAA-EIL 112
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGENKNKAA 186
+ YLHS +IH D+KP NILLD + KI+DFG A++ + N + NK A
Sbjct: 113 LALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKV----LDPNSSPESNKGDAT 166
Query: 187 ELESN 191
++S
Sbjct: 167 NIDSQ 171
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 36/169 (21%)
Query: 21 RLLGQGGFGSVFHATLH-------DQSVAVK-VMDSGSLQGEREFYNELYFASLLEQDD- 71
R LGQG FG V+ + VA+K V ++ S++ EF NE AS++++ +
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNE---ASVMKEFNC 68
Query: 72 -HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPE-------------LMEWCK 117
HVV +LG S L+V ELM+ G+L+ L ++P ++
Sbjct: 69 HHVVRLLGVVS--TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM-- 124
Query: 118 RFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
A +IA G+AYL + +H D+ N ++ + KI DFG+ R
Sbjct: 125 ----AAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 49/155 (31%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 20 SRLLGQGGFGSVF---HATLHDQS---VAVKVMD-SGSLQGEREFYNELYFASLLEQDDH 72
+ LG+G FG V + L D + VAVK ++ SG Q +F E+ L ++
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHEN 67
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYL 132
+V G P + L+ E + +G+L+D L + ++ FS I KG+ YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS--SQICKGMDYL 125
Query: 133 HSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
S IH D+ NIL++ KISDFGLA++
Sbjct: 126 GSQR--YIHRDLAARNILVESEDLVKISDFGLAKV 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 57/169 (33%), Positives = 81/169 (47%), Gaps = 38/169 (22%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS-VAVKVMDSGSLQGEREFYNELYFASLLEQDDH- 72
+S R LG G FG V+ T + + VAVK + G++ E F E A ++++ H
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQE---AQIMKKLRHD 61
Query: 73 -------VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP-------PELMEWCKR 118
V S + + +V E MS G+L D L K P+L++
Sbjct: 62 KLVQLYAVCS--------EEEPIYIVTEYMSKGSLLDFL--KSGEGKKLRLPQLVD---- 107
Query: 119 FSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+A IA+G+AYL S N IH D+ NIL+ N KI+DFGLARL
Sbjct: 108 --MAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARL 152
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 22 LLGQGGFGSVFHATLHDQSVAVKVM--DSGSLQGEREFYNELYFASLLEQDDHVVSVLG- 78
+G+G FG V Q VAVK + DS + Q F E + L + +V +LG
Sbjct: 13 TIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPN-LVQLLGV 68
Query: 79 -FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNP 137
NP + +V E M+ G+L D L + ++ ++ A+D+ +G+ YL N
Sbjct: 69 VLQGNP----LYIVTEYMAKGSLVD-YLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN- 122
Query: 138 PVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADG 179
+H D+ N+L+ + AK+SDFGLA+ +Q Q G
Sbjct: 123 -FVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSG 159
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 35/165 (21%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS---VAVKV--MDSGSLQGEREFYNELYFASLLEQ 69
+ F LG+G +GSV+ A H ++ VA+KV ++ + +E S+L+Q
Sbjct: 3 EVFDILEKLGEGSYGSVYKAI-HKETGQVVAIKVVPVEEDLQEIIKEI-------SILKQ 54
Query: 70 --DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWC-KRFS---IAV 123
++V G S K + +V E G++ D +M+ K + IA
Sbjct: 55 CDSPYIVKYYG--SYFKNTDLWIVMEYCGAGSVSD---------IMKITNKTLTEEEIAA 103
Query: 124 ---DIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
KG+ YLHS IH DIK NILL+ AK++DFG++
Sbjct: 104 ILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 50/151 (33%), Positives = 74/151 (49%), Gaps = 18/151 (11%)
Query: 23 LGQGGFGSVFHATLHDQS---VAVKVMD-SGSLQGEREFYNELYFASLLEQD-DHVVSVL 77
LGQG G V+ H + A+K + G + ++ EL +L + +VV
Sbjct: 9 LGQGSSGVVYKV-RHKPTGKIYALKKIHVDGDEEFRKQLLREL--KTLRSCESPYVVKCY 65
Query: 78 G-FSSNPKRHRMLLVYELMSNGNLQDAL-LHKKPPELMEWCKRFSIAVDIAKGIAYLHSL 135
G F K + +V E M G+L D L K PE + IA I KG+ YLH+
Sbjct: 66 GAF---YKEGEISIVLEYMDGGSLADLLKKVGKIPEPV--LA--YIARQILKGLDYLHTK 118
Query: 136 NPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+IH DIKPSN+L++ KI+DFG+++
Sbjct: 119 RH-IIHRDIKPSNLLINSKGEVKIADFGISK 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 12/146 (8%)
Query: 23 LGQGGFGSVFHAT-LHD-QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFS 80
+G+G G V+ AT + VA+K M Q + NE+ L+ +D +++ +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEI----LIMKDCKHPNIVDYY 81
Query: 81 SNPKRHRML-LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPV 139
+ L +V E M G+L D ++ + + E + + ++ +G+ YLHS N V
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTD-IITQNFVRMNE-PQIAYVCREVLQGLEYLHSQN--V 137
Query: 140 IHGDIKPSNILLDHNFCAKISDFGLA 165
IH DIK NILL + K++DFG A
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 15/168 (8%)
Query: 23 LGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQ--DDHVVSVLG 78
+ +G +G VF A A+KV+ + + + L +L Q +VV +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58
Query: 79 FSSNPKRHRMLLVYELMSNGNLQDALLHKKP--PELMEWCKRFSIAVDIAKGIAYLHSLN 136
+ S + + LV E + G+L +LL E + R IA +I + YLHS
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDV---ARIYIA-EIVLALEYLHSNG 113
Query: 137 PPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGENKNK 184
+IH D+KP NIL+D N K++DFGL+++ V N D E ++K
Sbjct: 114 --IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (185), Expect = 6e-15
Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 28/163 (17%)
Query: 21 RLLGQGGFGSVFHAT-LHDQS-VAVKVMD-SGSLQGEREF-YNELYFASLLEQDDH--VV 74
+ +G+G FG V+ D +K +D S + ERE NE +L++ +H ++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNE---VKILKKLNHPNII 62
Query: 75 SVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKP-------PELMEWCKRFSIAVDIA 126
F K + +V E G+L + +K ++++W V +
Sbjct: 63 KYYESFEEKGK---LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF------VQLC 113
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
+ YLHS ++H DIKP NI L N K+ DFG++++ S
Sbjct: 114 LALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLS 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 49/168 (29%), Positives = 71/168 (42%), Gaps = 13/168 (7%)
Query: 17 FSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSG---SLQGEREFYNELYFASLLEQDD 71
F R++G+G FG V D + A+K M+ R NE +L++ +
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNER---RILQELN 58
Query: 72 HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAY 131
H V + S M LV +L+ G+L+ L K E +F +I + Y
Sbjct: 59 HPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK--FSEEQVKF-WICEIVLALEY 115
Query: 132 LHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADG 179
LHS +IH DIKP NILLD I+DF +A + G
Sbjct: 116 LHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSG 161
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (185), Expect = 8e-15
Identities = 49/164 (29%), Positives = 80/164 (48%), Gaps = 32/164 (19%)
Query: 17 FSPSRLLGQGGFGSVFHAT--LHDQSVAVKVM-----DSG----SLQGEREFYNELYFAS 65
+ LG+G +G V+ A + VA+K + + G +L RE S
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL---REI-------S 50
Query: 66 LLEQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPEL-MEWCKRFSIA 122
LL++ H +V +L ++ + LV+E +L+ L K+P L K SI
Sbjct: 51 LLKELKHPNIVKLLDVIHTERK--LYLVFEYCDM-DLK-KYLDKRPGPLSPNLIK--SIM 104
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ +G+AY HS ++H D+KP NIL++ + K++DFGLAR
Sbjct: 105 YQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 52/154 (33%), Positives = 77/154 (50%), Gaps = 13/154 (8%)
Query: 21 RLLGQGGFGSVFHATLHDQS-------VAVKVMDSGSLQGERE-FYNELYFASLLEQDDH 72
+ LG G FG V AT + S VAVK++ + ERE +EL S L ++
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYL 132
+V++LG + +L++ E G+L + L +K + S + +AKG+A+L
Sbjct: 101 IVNLLGACT--IGGPILVITEYCCYGDLLN-FLRRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 133 HSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
S N IH D+ N+LL H KI DFGLAR
Sbjct: 158 ASKN--CIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 46/154 (29%), Positives = 80/154 (51%), Gaps = 20/154 (12%)
Query: 21 RLLGQGGFGSVFHATLHDQ-SVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGF 79
R LG G FG V+ ++ VAVK + G++ + +F E A ++++ H + +
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAE---AQIMKKLRHPKLIQLY 67
Query: 80 SSNPKRHRMLLVYELMSNGNLQDALLHKKP-----PELMEWCKRFSIAVDIAKGIAYLHS 134
+ + +V ELM G+L + L P+L++ +A +A G+AYL +
Sbjct: 68 AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLID------MAAQVASGMAYLEA 121
Query: 135 LNPPVIHGDIKPSNILL-DHNFCAKISDFGLARL 167
N IH D+ N+L+ ++N C K++DFGLAR+
Sbjct: 122 QN--YIHRDLAARNVLVGENNIC-KVADFGLARV 152
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 49/156 (31%), Positives = 75/156 (48%), Gaps = 13/156 (8%)
Query: 21 RLLGQGGFGSVFHATLHDQ-SVAVKVMDSGSLQGERE-FYNELYFASLLEQDDH--VVSV 76
+G+G FG V+ L VAVK S + F E A +L+Q DH +V +
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQE---AEILKQYDHPNIVKL 57
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN 136
+G ++ + +V EL+ G+L L +K + K +++D A G+ YL S N
Sbjct: 58 IGVCV--QKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 137 PPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGE 172
IH D+ N L+ N KISDFG++R + G
Sbjct: 114 --CIHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 17/161 (10%)
Query: 14 ADSFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGSLQGER-EFYNELYFASLL 67
+ +++G G FG V L + VA+K + +GS +R +F E AS++
Sbjct: 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTE---ASIM 59
Query: 68 EQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDI 125
Q DH ++ + G + K ++++ E M NG+L D L + + + + I
Sbjct: 60 GQFDHPNIIRLEGVVT--KSRPVMIITEYMENGSL-DKFLRENDGKF-TVGQLVGMLRGI 115
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
A G+ YL +N +H D+ NIL++ N K+SDFGL+R
Sbjct: 116 ASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 54/166 (32%), Positives = 77/166 (46%), Gaps = 25/166 (15%)
Query: 23 LGQGGFGSVFHATLHDQS-----VAVKVM-DSGSLQGEREFYNELYFASLLEQDDH--VV 74
LG G FGSV +S VAVK + G++EF E AS++ Q DH +V
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLRE---ASVMAQLDHPCIV 59
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALL---HKKPPELMEWCKRFSIAVDIAKGIAY 131
++G ++LV EL G L L +L E A +A G+AY
Sbjct: 60 RLIGVCKGEP---LMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAY 110
Query: 132 LHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQA 177
L S + +H D+ N+LL + AKISDFG++R G + +A
Sbjct: 111 LESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 52/156 (33%), Positives = 81/156 (51%), Gaps = 13/156 (8%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHV 73
++ + LG G FG V+ + VA+K + GS+ E F E A+L++Q H
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAE---ANLMKQLQHP 61
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPE--LMEWCKRFSIAVDIAKGIAY 131
V ++ + + ++ E M NG+L D L K PE + K +A IA+G+A+
Sbjct: 62 RLVRLYAVVTQE-PIYIITEYMENGSLVDFL---KTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 132 LHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+ N IH D++ +NIL+ C KI+DFGLARL
Sbjct: 118 IERKN--YIHRDLRAANILVSETLCCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 22/157 (14%)
Query: 21 RLLGQGGFGSVFHA--TLHDQSVAVKVM---DSGSLQGEREFYNELYFASLLEQDDHVVS 75
+ +G G +G V A + VA+K + + +R E+ L + ++++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR-ILREIKLLRHL-RHENIIG 63
Query: 76 VLGFSSNPKRHRM---LLVYELMSNGNLQDALLH---KKPPELMEWCKRFSIAVDIAKGI 129
+L P +V ELM + LH K P L + ++ I +G+
Sbjct: 64 LLDILRPPSPEDFNDVYIVTELM------ETDLHKVIKSPQPLTDDHIQY-FLYQILRGL 116
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
YLHS N VIH D+KPSNIL++ N KI DFGLAR
Sbjct: 117 KYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 25/161 (15%)
Query: 20 SRLLGQGGFGSVFHATLHDQS--VAVKVMDSGSLQGER-----EFYNELYFASLLEQDDH 72
+G G FG V+ A D +AVK + +Q E +E+ +LE H
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEI---RIQDNDPKTIKEIADEM---KVLELLKH 58
Query: 73 --VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP-PELMEWCKRFSIAVDIAKGI 129
+V G + R ++ + E S G L++ L H + E + + +++ + +G+
Sbjct: 59 PNLVKYYGVEVH--REKVYIFMEYCSGGTLEELLEHGRILDEHV--IRVYTL--QLLEGL 112
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA-RLKS 169
AYLHS ++H DIKP+NI LDHN K+ DFG A +LK+
Sbjct: 113 AYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 54/175 (30%), Positives = 83/175 (47%), Gaps = 36/175 (20%)
Query: 21 RLLGQGGFGSVFHAT----LHDQS---VAVKVM-DSGSLQGEREFYNELYFASLLEQDDH 72
R +GQG FG VF A L + VAVK++ + S + +F E A+L+ + DH
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE---AALMAEFDH 67
Query: 73 --VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP-------------------PE 111
+V +LG + K M L++E M+ G+L + L H+ P P
Sbjct: 68 PNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 112 LMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ ++ IA +A G+AYL +H D+ N L+ N KI+DFGL+R
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 26/166 (15%)
Query: 23 LGQGGFGSVFHATL-------HDQSVAVKVM-DSGSLQGEREFYNELYFASLLEQDDHVV 74
LG+G FG V+ L SVA+K + ++ + ++EF E S L Q ++V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIV 71
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELME------------WCKRF-SI 121
+LG + + ML +E +++G+L + L+ P + C F I
Sbjct: 72 CLLGVCTKEQPTCML--FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
A+ IA G+ YL S + +H D+ N L+ KISDFGL+R
Sbjct: 130 AIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRD 173
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 41/157 (26%), Positives = 80/157 (50%), Gaps = 28/157 (17%)
Query: 23 LGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGERE-----FYNELYFASLLEQDDH--V 73
+G+G +G V+ A + VA+K + ++ E+E E+ LL++ H +
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREI---KLLQKLRHPNI 60
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK----PPELMEWCKRFSIAVDIAKGI 129
V + ++ + + +V+E M + +L L + ++ + K+ + +G+
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQ------LLEGL 113
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
YLHS ++H DIK SNIL++++ K++DFGLAR
Sbjct: 114 QYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 24/171 (14%)
Query: 7 YSVLRRAADSFSPSRLLGQGGFGSVFHATLHDQS---VAVKVMDSGSLQG--EREFYNEL 61
Y +L R +G+G G VF A ++ VA+K + L+G + E+
Sbjct: 2 YKILGR----------IGEGAHGIVFKAK-DRETGETVALKKVALRRLEGGIPNQALREI 50
Query: 62 YFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSI 121
Q +VV +L P +LV E M + L + L ++ P K +
Sbjct: 51 KALQAC-QHPYVVKLLDVF--PHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMR 106
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGE 172
+ KG+AY+H+ ++H D+KP+N+L+ + KI+DFGLARL S E
Sbjct: 107 M--LLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 54/168 (32%), Positives = 78/168 (46%), Gaps = 31/168 (18%)
Query: 21 RLLGQGGFGSVFHATLHD--------QSVAVKVMDSGSLQGER-EFYNELYFASLLEQDD 71
LG G FG V+ T D VAVK + G+ E+ EF E A L+ +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKE---AHLMSNFN 57
Query: 72 H--VVSVLG--FSSNPKRHRMLLVYELMSNGNL----QDALLHKKPPELMEWCKRFSIAV 123
H +V +LG + P ++ ELM G+L +DA + + P L+ + I +
Sbjct: 58 HPNIVKLLGVCLLNEP----QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL 113
Query: 124 DIAKGIAYLHSLNPPVIHGDIKPSNILL-----DHNFCAKISDFGLAR 166
D+AKG YL ++ IH D+ N L+ D + KI DFGLAR
Sbjct: 114 DVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 60/166 (36%), Positives = 85/166 (51%), Gaps = 30/166 (18%)
Query: 21 RLLGQGGFGSVFHATLHD-------QSVAVK-VMDSGSLQGEREFYNELYFASLLE--QD 70
R LGQG FG V+ D VAVK V +S SL+ EF NE AS+++
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE---ASVMKGFTC 68
Query: 71 DHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----------PELMEWCKRFS 120
HVV +LG S K L+V ELM++G+L+ L +P P L E +
Sbjct: 69 HHVVRLLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ--- 123
Query: 121 IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+A +IA G+AYL++ +H D+ N ++ H+F KI DFG+ R
Sbjct: 124 MAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 53/151 (35%), Positives = 76/151 (50%), Gaps = 19/151 (12%)
Query: 23 LGQGGFGSVFHATLHDQS-VAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSS 81
LGQG FG V+ T + + VA+K + G++ E F E L D V S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 82 NPKRHRMLLVYELMSNGNLQDALL-----HKKPPELMEWCKRFSIAVDIAKGIAYLHSLN 136
P + +V E M G+L D L + K P+L++ +A IA G+AY+ +N
Sbjct: 73 EP----IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD------MAAQIADGMAYIERMN 122
Query: 137 PPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
IH D++ +NIL+ N KI+DFGLARL
Sbjct: 123 --YIHRDLRAANILVGDNLVCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 57/154 (37%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 22 LLGQGGFGSVFHATLHDQ-SVAVKVMDSGSLQGER-EFYNELYFASLLEQDDH--VVSVL 77
LLG+G FG VF TL D+ VAVK Q + +F +E A +L+Q DH +V ++
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSE---ARILKQYDHPNIVKLI 58
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNP 137
G + +R + +V EL+ G+ L KK + +F A+D A G+AYL S N
Sbjct: 59 GVCT--QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF--ALDAAAGMAYLESKN- 113
Query: 138 PVIHGDIKPSNILLDHNFCAKISDFGLARLKSVG 171
IH D+ N L+ N KISDFG++R + G
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 54/169 (31%), Positives = 76/169 (44%), Gaps = 24/169 (14%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVM-DSGSLQGEREFYNELYFASL 66
DS + R LG G FG V+ + VAVK + +S S Q E +F E S
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 67 LEQDDHVVSVLG--FSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFS 120
++V ++G F P+ ++ ELM+ G+L+ L +P P +
Sbjct: 66 F-NHQNIVRLIGVSFERLPR----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 121 IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH---NFCAKISDFGLAR 166
A D+AKG YL + IH DI N LL AKI+DFG+AR
Sbjct: 121 CARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 5e-13
Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 21/167 (12%)
Query: 22 LLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGE--REFYNELYFASLLEQDDH--VVS 75
L+G+G FG V+ VA+K + ++ E + E+ LL+ H +V
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEID---LLKNLKHPNIVK 63
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHK--KPPELMEWCKRFSIAVDIAKGIAYLH 133
+G + ++ E NG+L+ ++ K PE + + + +G+AYLH
Sbjct: 64 YIGSIET-SDS-LYIILEYAENGSLRQ-IIKKFGPFPESL--VAVY--VYQVLQGLAYLH 116
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLA-RLKSVGENQNQADG 179
VIH DIK +NIL + K++DFG+A +L V ++ G
Sbjct: 117 --EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVG 161
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 6e-13
Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 27/156 (17%)
Query: 23 LGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFS 80
LG G FGSV+ A + + VA+K M +++FY+ +L E V S+ +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLRE----VKSLRKLN 55
Query: 81 SNP----------KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIA 130
+P + + V+E M GNL + +K E R SI I +G+A
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR-SIIYQILQGLA 113
Query: 131 YLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
++H H D+KP N+L+ KI+DFGLAR
Sbjct: 114 HIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 52/170 (30%), Positives = 86/170 (50%), Gaps = 23/170 (13%)
Query: 21 RLLGQGGFGSVFHATLHDQS------VAVKVM-DSGSLQGEREFYNELYFASLLEQDDHV 73
++LG G FG+V+ + VA+KV+ + S + +E +E Y + ++ HV
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHP-HV 71
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK----PPELMEWCKRFSIAVDIAKGI 129
V +LG + ++ L+ +LM G L D + + K L+ WC V IAKG+
Sbjct: 72 VRLLGICLSS---QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC------VQIAKGM 122
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADG 179
+YL ++H D+ N+L+ KI+DFGLA+L V E + A+G
Sbjct: 123 SYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG 170
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 52/149 (34%), Positives = 76/149 (51%), Gaps = 17/149 (11%)
Query: 23 LGQGGFGSVFHATLHDQ-SVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSS 81
LG G FG V + Q VA+K++ GS+ E EF E A ++ + H V +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEE---AKVMMKLSHEKLVQLYGV 67
Query: 82 NPKRHRMLLVYELMSNG----NLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNP 137
K+ + +V E MSNG L++ +P +L+E CK D+ +G+AYL S
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK------DVCEGMAYLESKQ- 120
Query: 138 PVIHGDIKPSNILLDHNFCAKISDFGLAR 166
IH D+ N L+D C K+SDFGL+R
Sbjct: 121 -FIHRDLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 12 RAADSFSPSRLLGQGGFGSVFHATLHDQS-VAVKVMDSGSLQGEREFYNELYFASLLEQD 70
R + F+ R LG G FG V+ ++ VA+K++ S L +++F E+ L
Sbjct: 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHK 62
Query: 71 DHVVSVLGF--SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKG 128
H++S+ P + ++ ELM G+L A L +++ +A +A+G
Sbjct: 63 -HLISLFAVCSVGEP----VYIITELMEKGSLL-AFLRSPEGQVLPVASLIDMACQVAEG 116
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+AYL N IH D+ NIL+ + K++DFGLARL
Sbjct: 117 MAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARL 153
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 53/159 (33%), Positives = 76/159 (47%), Gaps = 19/159 (11%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS-VAVKVMDSGSLQGEREFYNELYFASLLEQDDHV 73
+S + LG G FG V+ T + + VAVK + G++ E F E L D V
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLV 64
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDAL-----LHKKPPELMEWCKRFSIAVDIAKG 128
S P + +V E MS G+L D L K P L++ +A +A G
Sbjct: 65 QLYAVVSEEP----IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVD------MAAQVAAG 114
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+AY+ +N IH D++ +NIL+ KI+DFGLARL
Sbjct: 115 MAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 11/156 (7%)
Query: 23 LGQGGFGSVFHATLHDQSV--AVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSVLG 78
LG+G FG V D A+KV+ + +E + L ++L + +H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK-LH 59
Query: 79 FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPP 138
++ + + LV E G L + L K+ E RF A +I + YLHSL
Sbjct: 60 YAFQTEEK-LYLVLEYAPGGEL-FSHLSKEGR-FSEERARFYAA-EIVLALEYLHSLG-- 113
Query: 139 VIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQ 174
+I+ D+KP NILLD + K++DFGLA+ S ++
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR 149
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 26/165 (15%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQ-----SVAVKVMDSGSLQGERE-FYNELYFASLLE 68
+ + R +G+G FG V+ +VAVK + + RE F E A ++
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQE---AYIMR 62
Query: 69 QDDH--VVSVLGF-SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSI---A 122
Q DH +V ++G + NP + +V EL G L+ L K S+ +
Sbjct: 63 QFDHPHIVKLIGVITENP----VWIVMELAPLGELRSYLQVNK-----YSLDLASLILYS 113
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
++ +AYL S +H DI N+L+ C K+ DFGL+R
Sbjct: 114 YQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRY 156
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 46/151 (30%), Positives = 72/151 (47%), Gaps = 21/151 (13%)
Query: 23 LGQGGFGSVFHA--TLHDQSVAVKVM------DSGSLQGEREFYNELYFASLLEQDDHVV 74
+G G +G V+ A + VA+KV+ D +Q E S+L++ H
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQE---------ISMLKECRHPN 61
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS 134
V F S +R ++ +V E G+LQD + L E + + + KG+AYLH
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAY-VCRETLKGLAYLHE 119
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
IH DIK +NILL + K++DFG++
Sbjct: 120 TG--KIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 41/156 (26%), Positives = 76/156 (48%), Gaps = 21/156 (13%)
Query: 21 RLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFASLLE-------QDD 71
+ LG+G + V+ A + VA+K + G + ++ N F +L E +
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGIN---FTALREIKLLQELKHP 62
Query: 72 HVVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIA 130
+++ +L F + LV+E M +L+ ++ K L + S + +G+
Sbjct: 63 NIIGLLDVFGHKSNIN---LVFEFME-TDLE-KVIKDKSIVLTPADIK-SYMLMTLRGLE 116
Query: 131 YLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
YLHS ++H D+KP+N+L+ + K++DFGLAR
Sbjct: 117 YLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 28/167 (16%)
Query: 21 RLLGQGGFGSVFHATLH----DQS---VAVKVM-DSGSLQGEREFYNELYFASLLEQDDH 72
R LG+G FG VF + + VAVK + ++ S ++F E + Q ++
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHEN 69
Query: 73 VVSVLGF--SSNPKRHRMLLVYELMSNGNLQ--------DALLHKKPPELMEWCKRFS-- 120
+V G +P ++V+E M +G+L DA K P M
Sbjct: 70 IVKFYGVCTEGDP----PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 121 -IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
IAV IA G+ YL S + +H D+ N L+ ++ KI DFG++R
Sbjct: 126 QIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 50/157 (31%), Positives = 76/157 (48%), Gaps = 11/157 (7%)
Query: 17 FSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVV 74
F+ R +G G FG+V+ A ++ VA+K M Q ++ + + L+Q H
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 75 SVLGFSSNPKRHRMLLVYE--LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYL 132
++ + H LV E L S ++ + +HKKP + +E +I +G+AYL
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIA---AICHGALQGLAYL 131
Query: 133 HSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
HS IH DIK NILL K++DFG A L S
Sbjct: 132 HSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 26/165 (15%)
Query: 21 RLLGQGGFGSVFHATLHDQS-------VAVKVMDSGSLQGEREFYNELYFASLLEQDDHV 73
R LG+G FG VF A ++ VAVK + S ++F+ E + L Q +H+
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHI 69
Query: 74 VSVLGF--SSNPKRHRMLLVYELMSNGNLQ--------DALLHKK--PPELMEWCKRFSI 121
V G +P +++V+E M +G+L DA+L + P + + I
Sbjct: 70 VKFYGVCVEGDP----LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
A IA G+ YL S + +H D+ N L+ N KI DFG++R
Sbjct: 126 AQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 13/147 (8%)
Query: 23 LGQGGFGSVFHATLHDQ-SVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSVLGF 79
LG G FG V + VA+K++ G++ E +F E A ++ + H +V + G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEE---AKVMMKLSHPNLVQLYGV 67
Query: 80 SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPV 139
+ K+ + +V E M+NG L + L +K EW + D+ + + YL S
Sbjct: 68 CT--KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG--F 121
Query: 140 IHGDIKPSNILLDHNFCAKISDFGLAR 166
IH D+ N L+ + K+SDFGLAR
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 48/158 (30%), Positives = 65/158 (41%), Gaps = 27/158 (17%)
Query: 22 LLGQGGFGSVFHATLHDQS-----VAVKVMDSGSLQG-EREFYNELYFASLLEQDDH--V 73
LG G FG V VAVK + S L +F E A+++ DH +
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKE---AAIMHSLDHENL 58
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPE-----LMEWCKRFSIAVDIAKG 128
+ + G H +++V EL G+L D L L ++ V IA G
Sbjct: 59 IRLYGVVLT---HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYA------VQIANG 109
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ YL S IH D+ NILL + KI DFGL R
Sbjct: 110 MRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 49/166 (29%), Positives = 77/166 (46%), Gaps = 21/166 (12%)
Query: 17 FSPSRLLGQGGFGSVFHATLHD-----QSVAVKVMD-SGSLQGE-REFYNELYFASLLEQ 69
++LG+G FGSV L VAVK M E EF +E A+ ++
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSE---AACMKD 57
Query: 70 DDH--VVSVLGF----SSNPKRHRMLLVYELMSNGNLQDALLHKK---PPELMEWCKRFS 120
DH V+ ++G SS K + +++ M +G+L LL+ + PE +
Sbjct: 58 FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK 117
Query: 121 IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
VDIA G+ YL + N IH D+ N +L + ++DFGL++
Sbjct: 118 FMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 11/152 (7%)
Query: 22 LLGQGGFGSV---FHATLHDQS---VAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVS 75
LG+G FGSV + L D + VAVK + + + R+F E+ L Q D++V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVK 69
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL 135
G + R + LV E + G+L+D L + E ++ K A I KG+ YL S
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK 127
Query: 136 NPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+H D+ NIL++ KI DFGL ++
Sbjct: 128 R--YVHRDLATRNILVESENRVKIGDFGLTKV 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 30/166 (18%)
Query: 17 FSPSRLLGQGGFGSVFHAT-LHD-QSVAVKVMDSGSL-QGERE-FYNEL-YFASLLEQDD 71
F + LG+G +GSV+ L D Q A+K +D GS+ Q ERE NE+ AS+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV--NHP 59
Query: 72 HVVS-----VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP-----PELMEWCKRFSI 121
+++S + G +++ +V E G+L A+ +K PE W I
Sbjct: 60 NIISYKEAFLDG-------NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RI 108
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+ + +G+ LH ++H D+K +NILL N KI D G++++
Sbjct: 109 FIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKV 152
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 23/170 (13%)
Query: 21 RLLGQGGFGSVFHATLHDQS------VAVKVM-DSGSLQGEREFYNELYFASLLEQDDHV 73
++LG G FG+V+ VA+KV+ ++ S + +E +E Y + + +V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYV 71
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK----PPELMEWCKRFSIAVDIAKGI 129
+LG + LV +LM G L D + K +L+ WC V IAKG+
Sbjct: 72 CRLLGICLTST---VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWC------VQIAKGM 122
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADG 179
+YL + ++H D+ N+L+ KI+DFGLARL + E + ADG
Sbjct: 123 SYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG 170
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 48/146 (32%), Positives = 74/146 (50%), Gaps = 9/146 (6%)
Query: 23 LGQGGFGSVFHATLHDQS-VAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSS 81
LGQG FG V+ T + + VA+K + G++ E F E L + V S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 82 NPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIH 141
P + +V E MS G+L D L + + + + +A IA G+AY+ +N +H
Sbjct: 73 EP----IYIVTEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVH 125
Query: 142 GDIKPSNILLDHNFCAKISDFGLARL 167
D++ +NIL+ N K++DFGLARL
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 45/154 (29%), Positives = 81/154 (52%), Gaps = 8/154 (5%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS-VAVKVMDSGSLQGEREFYNELYFASLLEQDDHV 73
+S + LG G FG V+ ++ + VAVK + G++ + F E A+L++ H
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEE---ANLMKTLQHD 61
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLH 133
V ++ K + ++ E M+ G+L D L + +++ K + IA+G+AY+
Sbjct: 62 KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE 120
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
N IH D++ +N+L+ + KI+DFGLAR+
Sbjct: 121 RKN--YIHRDLRAANVLVSESLMCKIADFGLARV 152
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 55/169 (32%), Positives = 79/169 (46%), Gaps = 20/169 (11%)
Query: 10 LRRAADSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGE--REFYNELYFAS 65
L F ++G+G +G V+ A Q VA+K+MD + E +E YN L S
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 66 LLEQDDH--VVSVLG--FSSNP--KRHRMLLVYELMSNGNLQDAL--LHKKPPELMEWCK 117
+H + + G NP ++ LV EL G++ D + L KK L E
Sbjct: 61 -----NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWI 115
Query: 118 RFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ I + +G+AYLH VIH DIK NILL N K+ DFG++
Sbjct: 116 AY-ILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSA 161
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 53/171 (30%), Positives = 86/171 (50%), Gaps = 24/171 (14%)
Query: 13 AADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVK-VMDSGSLQGEREFYNELYFA 64
A + + SR LGQG FG V+ + VA+K V ++ S++ EF NE A
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE---A 60
Query: 65 SLLEQDD--HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPE-------LMEW 115
S++++ + HVV +LG S + L++ ELM+ G+L+ L +P
Sbjct: 61 SVMKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118
Query: 116 CKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
K +A +IA G+AYL++ +H D+ N ++ +F KI DFG+ R
Sbjct: 119 KKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 9/154 (5%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS-VAVKVMDSGSLQGEREFYNELYFASLLEQDDHV 73
+S + LG G FG V+ AT + + VAVK M GS+ E F E L+ D
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHD--- 61
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLH 133
++ + + + ++ E M+ G+L D L K + IA+G+A++
Sbjct: 62 -KLVKLHAVVTKEPIYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
N IH D++ +NIL+ + KI+DFGLAR+
Sbjct: 120 QRN--YIHRDLRAANILVSASLVCKIADFGLARV 151
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 22/159 (13%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD----QSVAVKVMDSGSLQGEREFYN-ELYFASLLEQ 69
+ F+ +G+G FG V+ A D Q VA+KV+D + E E E+ F S +
Sbjct: 1 ELFTLLECIGKGSFGEVYKA--IDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-R 57
Query: 70 DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV---DIA 126
++ G S K ++ ++ E G+ D L K E IA ++
Sbjct: 58 SPYITKYYG--SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDE-------TYIAFILREVL 108
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
G+ YLH IH DIK +NILL K++DFG++
Sbjct: 109 LGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 39/154 (25%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 23 LGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQG--EREFYNELYFASLLEQDDH--VVSV 76
+G+G +G V+ A L + VA+K + + E+ LL++ +H ++ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREI---KLLKELNHPNIIKL 63
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKK---PPELMEWCKRFSIAVDIAKGIAYLH 133
L + + LV+E M +L + ++ P L++ S + +G+A+ H
Sbjct: 64 L--DVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIK-----SYLYQLLQGLAFCH 115
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
S ++H D+KP N+L++ K++DFGLAR
Sbjct: 116 SHG--ILHRDLKPENLLINTEGVLKLADFGLARS 147
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 49/163 (30%), Positives = 75/163 (46%), Gaps = 24/163 (14%)
Query: 23 LGQGGFGSVFHATLHDQS-------VAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVS 75
LG+G FG VF A H+ VAVK + S ++F E ++L Q H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVR 71
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQ--------DALL----HKKPPELMEWCKRFSIAV 123
G + + +L+V+E M +G+L DA + P + + +IA
Sbjct: 72 FYGVCTEGRP--LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 124 DIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
IA G+ YL SL+ +H D+ N L+ KI DFG++R
Sbjct: 130 QIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 54/154 (35%), Positives = 77/154 (50%), Gaps = 21/154 (13%)
Query: 23 LGQGGFGSVFHA--TLHDQSVAVK-VMDSGSLQG-EREFYNELYFASLLEQDDH--VVSV 76
+G G FG V A L Q+VA+K +M S + Y EL LL+ H ++S+
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYREL---KLLKHLRHENIISL 74
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS--IAVDIAKGIAYLHS 134
+P + V EL+ G LL +P E K+F I +G+ Y+HS
Sbjct: 75 SDIFISP-LEDIYFVTELL--GTDLHRLLTSRPLE-----KQFIQYFLYQILRGLKYVHS 126
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168
V+H D+KPSNIL++ N KI DFGLAR++
Sbjct: 127 AG--VVHRDLKPSNILINENCDLKICDFGLARIQ 158
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 50/174 (28%), Positives = 82/174 (47%), Gaps = 23/174 (13%)
Query: 17 FSPSRLLGQGGFGSVFHATLHDQS------VAVKVM-DSGSLQGEREFYNELYFASLLEQ 69
F ++LG G FG+V+ + VA+K + ++ S + +E +E Y + ++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 67
Query: 70 DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK----PPELMEWCKRFSIAVDI 125
+ HV +LG + L+ +LM G L D + K L+ WC V I
Sbjct: 68 NPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQI 118
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADG 179
AKG+ YL ++H D+ N+L+ KI+DFGLA+L E + A+G
Sbjct: 119 AKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 6e-11
Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 20/165 (12%)
Query: 23 LGQGGFGSVFHAT--LHDQSVAVK-VMDS-GSLQGEREFYNELYFASLLEQDDHVVSVLG 78
LG+G +G V+ A + VA+K + D+ + + + E+ F L ++V +L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74
Query: 79 F--SSNPKRHRMLLVYELMSNGNLQDALLHK--KPPELMEWCKRFSIAVDIAKGIAYLHS 134
+ N K + LV+E M + LH + L + KR+ I + K + Y+HS
Sbjct: 75 VIKAENDKD--IYLVFEYM------ETDLHAVIRANILEDVHKRY-IMYQLLKALKYIHS 125
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLAR-LKSVGENQNQAD 178
N VIH D+KPSNILL+ + K++DFGLAR L + EN
Sbjct: 126 GN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 25/166 (15%)
Query: 21 RLLGQGGFGSVFHATLHDQS-------VAVKVMDSGSLQGEREFYNELYFASLLEQDDHV 73
R LG+G FG VF A ++ S VAVK + +L ++F E + L Q +H+
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHI 69
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPEL-------------MEWCKRFS 120
V G + +++V+E M +G+L L P + + +
Sbjct: 70 VKFYGVCGDGDP--LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 121 IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
IA IA G+ YL S + +H D+ N L+ N KI DFG++R
Sbjct: 128 IASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 17/150 (11%)
Query: 23 LGQGGFGSVFHAT-LHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSS 81
+G G FG V+ L + VA+K + G++ E +F E A ++ + H V +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEE---AQVMMKLSHPKLVQLYGV 67
Query: 82 NPKRHRMLLVYELMSNGNLQDALLHKK----PPELMEWCKRFSIAVDIAKGIAYLHSLNP 137
+R + LV+E M +G L D L ++ L+ C +D+ +G+AYL S N
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC------LDVCEGMAYLESSN- 120
Query: 138 PVIHGDIKPSNILLDHNFCAKISDFGLARL 167
VIH D+ N L+ N K+SDFG+ R
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRF 149
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 28/170 (16%)
Query: 22 LLGQGGFGSVFHATLHDQSV----AVKVM-DSGSLQGEREFYNELYFASLLEQDDHVVSV 76
++G+G FG V A + + A+K M + S R+F EL L +++++
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIA-------------- 122
LG + R + L E +GNL D L + ++E F+IA
Sbjct: 74 LGACEH--RGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 123 --VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
D+A+G+ YL IH D+ NIL+ N+ AKI+DFGL+R + V
Sbjct: 129 FAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 48/149 (32%), Positives = 77/149 (51%), Gaps = 9/149 (6%)
Query: 23 LGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN 82
+G+G FG+V Q VAVK + + F E + L ++V +LG +
Sbjct: 14 IGEGEFGAVLQGEYTGQKVAVKNIKCDVTA--QAFLEETAVMTKL-HHKNLVRLLGVILH 70
Query: 83 PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHG 142
+ +V ELMS GNL + L + L+ + ++D+A+G+ YL S ++H
Sbjct: 71 NGLY---IVMELMSKGNLVN-FLRTRGRALVSVIQLLQFSLDVAEGMEYLES--KKLVHR 124
Query: 143 DIKPSNILLDHNFCAKISDFGLARLKSVG 171
D+ NIL+ + AK+SDFGLAR+ S+G
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMG 153
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 43/168 (25%), Positives = 80/168 (47%), Gaps = 29/168 (17%)
Query: 22 LLGQGGFGSVFHATLHD-------QSVAVKVMDSGSLQGE-REFYNELYFASLLEQDDHV 73
LG+G FG V A +VAVK++ + + + + +E+ ++ + ++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR--------------- 118
+++LG + + + +V E ++GNL+D L ++PP E+
Sbjct: 79 INLLGVCT--QEGPLYVVVEYAAHGNLRDFLRARRPPG--EYASPDDPRPPEETLTQKDL 134
Query: 119 FSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
S A +A+G+ +L S IH D+ N+L+ + KI+DFGLAR
Sbjct: 135 VSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 43/161 (26%), Positives = 78/161 (48%), Gaps = 24/161 (14%)
Query: 17 FSPSRLLGQGGFGSVFHATLH----DQSVAV-KVMDSGSL--QGEREFYNELYFASLLEQ 69
+ P R+LG+G FG ATL+ D S+ V K ++ L + R+ NE+ SLL+
Sbjct: 2 YIPIRVLGKGAFGE---ATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH 58
Query: 70 DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK----PPELMEWCKRFSIAVDI 125
+ +++ ++ + +L+ E + G L D ++ +K E++ W I
Sbjct: 59 PN-IIAY--YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQI 110
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
++Y+H ++H DIK NI L K+ DFG+++
Sbjct: 111 VSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISK 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 51/171 (29%), Positives = 77/171 (45%), Gaps = 32/171 (18%)
Query: 15 DSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDS--GSLQGEREFYNELYFASLLEQD 70
D + +G G +G V A T + VA+K + S + Y EL LL+
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYREL---RLLKHM 71
Query: 71 DH--VVSVLGF----SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS---- 120
DH V+ +L SS + LV LM A L+ +++ C++ S
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYLVTHLM------GADLNN----IVK-CQKLSDDHI 120
Query: 121 --IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
+ I +G+ Y+HS +IH D+KPSNI ++ + KI DFGLAR
Sbjct: 121 QFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTD 169
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 15 DSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGS--LQGEREFYNEL----YFASL 66
+ P +G G +G V A T + VA+K + + EL +F
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKH- 63
Query: 67 LEQDDHVVSVLGFSSNPKRH--RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVD 124
D+++++ P + +V +LM + +L ++H P L E R+ +
Sbjct: 64 ----DNIIAIRDILRPPGADFKDVYVVMDLMES-DLHH-IIHSDQP-LTEEHIRYFL-YQ 115
Query: 125 IAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ +G+ Y+HS N VIH D+KPSN+L++ + +I DFG+AR
Sbjct: 116 LLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 4e-10
Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 23/170 (13%)
Query: 21 RLLGQGGFGSVFHATLHDQS------VAVKVM-DSGSLQGEREFYNELYFASLLEQDDHV 73
++LG G FG+V+ + VA+K++ ++ + EF +E + ++ H+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHP-HL 71
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK----PPELMEWCKRFSIAVDIAKGI 129
V +LG +P + LV +LM +G L D + K L+ WC V IAKG+
Sbjct: 72 VRLLGVCLSPT---IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC------VQIAKGM 122
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADG 179
YL ++H D+ N+L+ KI+DFGLARL E + ADG
Sbjct: 123 MYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 170
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 43/149 (28%), Positives = 74/149 (49%), Gaps = 13/149 (8%)
Query: 23 LGQGGFGSVFHATL--HDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSVLG 78
LG G +G V+ + +VAVK + +++ E EF E A+++++ H +V +LG
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE---AAVMKEIKHPNLVQLLG 69
Query: 79 FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPP 138
+ + ++ E M+ GNL D L + + + +A I+ + YL N
Sbjct: 70 VCT--REPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 139 VIHGDIKPSNILLDHNFCAKISDFGLARL 167
IH D+ N L+ N K++DFGL+RL
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRL 153
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 17/162 (10%)
Query: 14 ADSFSPSRLLGQGGFGSVFHATL-----HDQSVAVKVMDSGSLQGER-EFYNELYFASLL 67
A +++G G FG V L + VA+K + +G + +R +F +E AS++
Sbjct: 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSE---ASIM 59
Query: 68 EQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDI 125
Q DH ++ + G + K +++V E M NG+L DA L K + + + I
Sbjct: 60 GQFDHPNIIHLEGVVTKSKP--VMIVTEYMENGSL-DAFLRKHDGQFTV-IQLVGMLRGI 115
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
A G+ YL + +H D+ NIL++ N K+SDFGL+R+
Sbjct: 116 ASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRV 155
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 29/163 (17%)
Query: 22 LLGQGGFGSVFHA--TLHDQSVAVK-VMDSGSLQGE-----REFYNELYFASL--LEQDD 71
+G+G +G+V+ A + VA+K V S +G RE A L LE +
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI------ALLKQLESFE 59
Query: 72 H--VVSVLGFSSNPKRHR---MLLVYELMSNGNLQD--ALLHKKPPELMEWCKRFSIAVD 124
H +V +L P+ R + LV+E + QD L K P + +
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVD----QDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 125 IAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+ +G+ +LHS ++H D+KP NIL+ + KI+DFGLAR+
Sbjct: 116 LLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 17/155 (10%)
Query: 21 RLLGQGGFGSVFHATLH-----DQSVAVKVMDSGSLQGER-EFYNELYFASLLEQDDH-- 72
+++G G FG VF L + +VA+K + G + +R +F +E AS++ Q H
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSE---ASIMGQFSHHN 67
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYL 132
++ + G + K +++ E M NG L D L E + + + IA G+ YL
Sbjct: 68 IIRLEGVVT--KFKPAMIITEYMENGAL-DKYLRDHDGEFSSY-QLVGMLRGIAAGMKYL 123
Query: 133 HSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+N +H D+ NIL++ N K+SDFGL+R+
Sbjct: 124 SDMN--YVHRDLAARNILVNSNLECKVSDFGLSRV 156
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 54/170 (31%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 17 FSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDS--GSLQGEREFYNELYFASLLEQDDH 72
P R +G G FG V+ T + VA+K M + +L + + EL + D+
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDN- 60
Query: 73 VVSVLGFSSNPKR---HRMLLVYELMSNGNLQDALLHK---KPPELM-EWCKRFSIAVDI 125
V+S L P + +V ELM + LHK P L + K F I
Sbjct: 61 VLSALDILQPPHIDPFEEIYVVTELMQSD------LHKIIVSPQPLSSDHVKVF--LYQI 112
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQN 175
+G+ YLHS ++H DIKP N+L++ N KI DFGLAR++ E+++
Sbjct: 113 LRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH 160
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 34/84 (40%), Positives = 49/84 (58%), Gaps = 14/84 (16%)
Query: 90 LVYELMSNGNLQDALLHK--KPPELM--EWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIK 145
+VYELM D LH+ + + + + C+ F + +G+ Y+HS N V+H D+K
Sbjct: 86 IVYELM------DTDLHQIIRSSQTLSDDHCQYF--LYQLLRGLKYIHSAN--VLHRDLK 135
Query: 146 PSNILLDHNFCAKISDFGLARLKS 169
PSN+LL+ N KI DFGLAR S
Sbjct: 136 PSNLLLNANCDLKICDFGLARTTS 159
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 50/171 (29%), Positives = 75/171 (43%), Gaps = 49/171 (28%)
Query: 22 LLGQGGFGSVFHATLHDQS---VAVK--VMDSGS-------------LQGEREFYNELYF 63
L+G G FGSV+ ++ S +AVK + S S L E EL
Sbjct: 7 LIGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-- 63
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVY-------ELMSN-GNLQDALLHKKPPELMEW 115
Q +++V LG S + + L Y L++N G ++ L+
Sbjct: 64 -----QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR--------- 109
Query: 116 CKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ I KG+ YLH N +IH DIK +NIL+D+ KISDFG+++
Sbjct: 110 ----NFVRQILKGLNYLH--NRGIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 52/163 (31%), Positives = 79/163 (48%), Gaps = 20/163 (12%)
Query: 23 LGQGGFGSVFHATLHD--QSVAVKVMD-SGSLQGER-EFYNELYFASLLEQDDHVVSVLG 78
+G+G FG VF + A+K +D S + ER E +E A +L + D +
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDE---ARVLAKLDSSYIIRY 64
Query: 79 FSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIAKGIAYLHS 134
+ S + ++ +V E NG+L LL + PE W RF I + + G+A+LHS
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHK-LLKMQRGRPLPEDQVW--RFFIQILL--GLAHLHS 119
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQA 177
++H DIK N+ LD KI D G+A K + +N N A
Sbjct: 120 --KKILHRDIKSLNLFLDAYDNVKIGDLGVA--KLLSDNTNFA 158
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 53/220 (24%), Positives = 83/220 (37%), Gaps = 56/220 (25%)
Query: 15 DSFSPSRLLGQGGFGSVFHAT-LHDQSV-AVKVM---------DSGSLQGEREFY----- 58
D F +++G+G FG V+ V A+KV+ ++ ER+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 59 ---NELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK--PPELM 113
+LY++ QD+ + LV E M G+L + L+ K P E
Sbjct: 61 PWIVKLYYSF---QDEE--------------HLYLVMEYMPGGDLMNLLIRKDVFPEETA 103
Query: 114 EWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA-RLKSVGE 172
RF IA ++ + +H L IH DIKP NIL+D + K++DFGL ++ +
Sbjct: 104 ----RFYIA-ELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156
Query: 173 N-------QNQADGENKNKAAELESNCGAAVEDCGSVVET 205
N +N S V T
Sbjct: 157 REYYLNDSHNLLFRDNVLVRRRDHKQ---RRVRANSTVGT 193
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 58/169 (34%), Positives = 87/169 (51%), Gaps = 27/169 (15%)
Query: 17 FSPSRLLGQGGFGSVFHATLHD-----QSVAVKVM--DSGSLQGEREFYNELYFASLLEQ 69
F+ R+LG+G FGSV A L Q VAVK++ D S EF E A+ +++
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLRE---AACMKE 57
Query: 70 DDH--VVSVLGFS--SNPKRHRM---LLVYELMSNGNLQDALLHKK----PPEL-MEWCK 117
DH V+ ++G S S K R+ +++ M +G+L LL + P L ++
Sbjct: 58 FDHPNVIKLIGVSLRSRAKG-RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV 116
Query: 118 RFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
RF I DIA G+ YL S N IH D+ N +L+ N ++DFGL++
Sbjct: 117 RFMI--DIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 17/153 (11%)
Query: 22 LLGQGGFGSVFHATL-----HDQSVAVKVMDSG-SLQGEREFYNELYFASLLEQDDH--V 73
++G G FG V L + VA+K + SG + + R+F +E AS++ Q DH +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSE---ASIMGQFDHPNI 67
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLH 133
+ + G + + ++++ E M NG L D+ L + + + + IA G+ YL
Sbjct: 68 IHLEGVVTKSRP--VMIITEFMENGAL-DSFLRQNDGQFTV-IQLVGMLRGIAAGMKYLS 123
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+N +H D+ NIL++ N K+SDFGL+R
Sbjct: 124 EMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 42/164 (25%), Positives = 67/164 (40%), Gaps = 20/164 (12%)
Query: 14 ADSFSPSRLLGQGGFGSVFH--ATLHDQSVAVKVMDSGSLQGER-EFYNELYFASLLEQD 70
++ + + L VAVKV+ + R +F E+ S L D
Sbjct: 24 CEADGLQDFSEKAFAENDNADAPVL----VAVKVLRPDASDNAREDFLKEVKILSRL-SD 78
Query: 71 DHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSI--------A 122
++ +LG + + ++ E M NG+L L C S+ A
Sbjct: 79 PNIARLLGVCTVDPP--LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMA 136
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
IA G+ YL SLN +H D+ N L+ N+ KI+DFG++R
Sbjct: 137 TQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 21/159 (13%)
Query: 23 LGQGGFGSVFHAT-LHDQSVAV-KVMDSGSL-QGERE-FYNELYFASLLE--QDDHVVSV 76
+G+G FG+V D + V K +D G++ + E++ +E+ ++L + ++V
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEV---NILRELKHPNIVRY 64
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDAL-----LHKKPPELMEWCKRFSIAVDIAKGIAY 131
+ + +V E G+L + K E W I + +
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLLLALYE 120
Query: 132 LHSLNPP---VIHGDIKPSNILLDHNFCAKISDFGLARL 167
H+ + P V+H D+KP+NI LD N K+ DFGLA++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 43/165 (26%), Positives = 73/165 (44%), Gaps = 20/165 (12%)
Query: 22 LLGQGGFGSVFHATLHD--QSVAVKVM-DSGSLQGEREF-YNELYFASLLEQDDHVVSVL 77
++G+G +G V + VA+K +S + ++ E+ L + ++V++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE-NIVNLK 66
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIAKGIAYLH 133
++ R+ LV+E + L+ LL P P+ + S + + IAY H
Sbjct: 67 EAFR--RKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVR-----SYIWQLLQAIAYCH 117
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQAD 178
S N +IH DIKP NIL+ + K+ DFG AR D
Sbjct: 118 SHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 3e-09
Identities = 50/156 (32%), Positives = 76/156 (48%), Gaps = 9/156 (5%)
Query: 17 FSPSRLLGQGGFGSVF--HATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVV 74
F+ R +G G FG+V+ ++ VA+K M Q ++ + + L++ H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDAL-LHKKPPELMEWCKRFSIAVDIAKGIAYLH 133
S+ + H LV E G+ D L +HKKP + +E +I +G+AYLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA---AITHGALQGLAYLH 142
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
S N +IH DIK NILL K++DFG A + S
Sbjct: 143 SHN--MIHRDIKAGNILLTEPGQVKLADFGSASIAS 176
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 3e-09
Identities = 43/169 (25%), Positives = 70/169 (41%), Gaps = 37/169 (21%)
Query: 15 DSFSPSRLLGQGGFGSVFHATL--HDQSVAVKVMDSGS---LQGEREFYNELYFASLLEQ 69
D F + LG G FG V + A+K++ L+ NE +L+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEK---RILQS 57
Query: 70 DDH--VVSVLGFSSNPKRHRMLLVY----ELMSNGNLQDALLHKKPPELMEWCKRFSI-- 121
H +V++ G + +++ Y EL S +K RF
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFS--------HLRK-------SGRFPEPV 102
Query: 122 ----AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
A + + YLHSL+ +++ D+KP N+LLD + KI+DFG A+
Sbjct: 103 ARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 52/150 (34%), Positives = 74/150 (49%), Gaps = 9/150 (6%)
Query: 23 LGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFS 80
+G G FG+V+ AT ++ VAVK M Q ++ + + L+Q H ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 81 SNPKRHRMLLVYELMSNGNLQDAL-LHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPV 139
K H LV E G+ D L +HKKP + +E +I +G+AYLHS N +
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA---AITHGALQGLAYLHSHN--M 142
Query: 140 IHGDIKPSNILLDHNFCAKISDFGLARLKS 169
IH DIK NILL K++DFG A S
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSS 172
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 50/169 (29%), Positives = 82/169 (48%), Gaps = 7/169 (4%)
Query: 23 LGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSV-LGF 79
LG+GGFG V + + + A K +D L+ + L +LE+ + V L +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 80 SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPV 139
+ K H + LV LM+ G+L+ + + L E + + I GI +LHS++ +
Sbjct: 61 AFESKTH-LCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHSMD--I 116
Query: 140 IHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGENKNKAAEL 188
++ D+KP N+LLD ++SD GLA G+ Q G N A E+
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEI 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 44/167 (26%), Positives = 81/167 (48%), Gaps = 27/167 (16%)
Query: 23 LGQGGFGSVFHATL---------HDQSVAVKVM-DSGSLQGEREFYNELYFASLLEQDDH 72
LG+G FG V A +VAVK++ D+ + + + +E+ L+ + +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPP-------------ELMEWCKRF 119
++++LG + + + ++ E + GNL++ L ++PP E + +
Sbjct: 80 IINLLGVCT--QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
S A +A+G+ YL S IH D+ N+L+ + KI+DFGLAR
Sbjct: 138 SCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 24/43 (55%), Positives = 32/43 (74%), Gaps = 2/43 (4%)
Query: 125 IAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
I +G+ Y+HS N V+H D+KPSN+LL+ N KI DFGLAR+
Sbjct: 115 ILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARI 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 18/155 (11%)
Query: 21 RLLGQGGFGSVFHATLHDQS-----VAVKVMDS-GSLQGEREFYNELYFASLLEQDDH-- 72
R++G+G FG V+H TL D AVK ++ L+ +F E ++ +D
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKE----GIIMKDFSHP 56
Query: 73 -VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAY 131
V+S+LG P L+V M +G+L++ + + ++ F + V AKG+ Y
Sbjct: 57 NVLSLLGICL-PSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV--AKGMEY 113
Query: 132 LHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
L S +H D+ N +LD +F K++DFGLAR
Sbjct: 114 LAS--KKFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 53/159 (33%), Positives = 74/159 (46%), Gaps = 27/159 (16%)
Query: 21 RLLGQGGFGSVFHATLHDQS--VAVK---VMDSGSLQGE--REFYNELYFASLLEQDDH- 72
LLG G FGSV+ D AVK + D G E ++ E+ +LL + H
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEI---ALLSKLQHP 62
Query: 73 -VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK----PPELMEWCKRFSIAVDIAK 127
+V LG + L EL+ G+L A L KK P ++ R I
Sbjct: 63 NIVQYLGTEREEDNLYIFL--ELVPGGSL--AKLLKKYGSFPEPVIRLYTR-----QILL 113
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
G+ YLH N +H DIK +NIL+D N K++DFG+A+
Sbjct: 114 GLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 48/156 (30%), Positives = 76/156 (48%), Gaps = 9/156 (5%)
Query: 17 FSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVV 74
FS R +G G FG+V+ A + + VA+K M Q ++ + + L++ H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDAL-LHKKPPELMEWCKRFSIAVDIAKGIAYLH 133
++ + H LV E G+ D L +HKKP + +E ++ +G+AYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA---AVTHGALQGLAYLH 132
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
S N +IH D+K NILL K+ DFG A + +
Sbjct: 133 SHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 43/145 (29%), Positives = 66/145 (45%), Gaps = 15/145 (10%)
Query: 23 LGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFS 80
+G+G G V AT + VAVK MD Q +NE+ ++ H V +S
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEV---VIMRDYQHPNIVEMYS 83
Query: 81 SNPKRHRMLLVYELMSNGNLQDALLHKK--PPELMEWCKRFSIAVDIAKGIAYLHSLNPP 138
S + +V E + G L D + H + ++ C + K +++LH+
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLA------VLKALSFLHAQG-- 135
Query: 139 VIHGDIKPSNILLDHNFCAKISDFG 163
VIH DIK +ILL + K+SDFG
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 16/170 (9%)
Query: 21 RLLGQGGFGSV----FHATLHD--QSVAVKVMDSG-SLQGEREFYNELYFASLLEQDDHV 73
R+LG+G FG V + + VAVK + Q + E+ L + ++
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE-NI 68
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLH 133
V G S + L+ E + G+L+D L P + + A I +G+AYLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGEN--QNQADGEN 181
S + IH D+ N+LLD++ KI DFGLA+ G + + DG++
Sbjct: 125 SQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 22/167 (13%)
Query: 22 LLGQGGFGSVFHATLHDQ----SVAVKVM-DSGSLQGEREFYNELYFASLLEQDDHVVSV 76
++G+G FG V A + + A+K++ + S R+F EL L +++++
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPEL-------------MEWCKRFSIAV 123
LG N R + + E GNL D L + E + + A
Sbjct: 69 LGACEN--RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 124 DIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
D+A G+ YL IH D+ N+L+ N +KI+DFGL+R + V
Sbjct: 127 DVATGMQYLS--EKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV 171
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 23/52 (44%), Positives = 32/52 (61%), Gaps = 2/52 (3%)
Query: 125 IAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQ 176
I G+ Y+HS N V+H D+KP N+L++ + KI DFGLAR S +N
Sbjct: 114 ILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA 163
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 50/171 (29%), Positives = 77/171 (45%), Gaps = 11/171 (6%)
Query: 23 LGQGGFGSVFHATLHD--QSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVL 77
LG+GGFG V + + A K +D L +GE+ NE + +VS L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVS-L 58
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNP 137
++ K + LV LM+ G+L+ + + P E F A I G+ +LH
Sbjct: 59 AYAFETKDD-LCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA-QIICGLEHLHQRR- 115
Query: 138 PVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGENKNKAAEL 188
+++ D+KP N+LLD + +ISD GLA G+ G A E+
Sbjct: 116 -IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEV 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 47/162 (29%), Positives = 73/162 (45%), Gaps = 15/162 (9%)
Query: 23 LGQGGFGSVFHATLHDQS--VAVKVMDSGSLQGEREFYNEL-YFASLLEQDDHVVSVLGF 79
+G G V+ A + VA+K +D L+ + +EL + Q +H V +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRID---LEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 80 SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV---DIAKGIAYLHSLN 136
+S + LV +S G+L D + P ++ IA ++ KG+ YLHS
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD---EAIIATVLKEVLKGLEYLHSNG 122
Query: 137 PPVIHGDIKPSNILLDHNFCAKISDFGL-ARLKSVGENQNQA 177
IH DIK NILL + KI+DFG+ A L G+ +
Sbjct: 123 --QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV 162
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 11/161 (6%)
Query: 13 AADSFSPSRLLGQGGFGSVFH--ATLHDQSVAVKVMDSGSLQGEREF-YNELYFASLLEQ 69
AA S+ LG+G + +V+ + ++ Q VA+KV+ S++ E + + ASLL+
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVI---SMKTEEGVPFTAIREASLLKG 59
Query: 70 DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
H VL + + V+E M Q + H P + + +G+
Sbjct: 60 LKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQH---PGGLHPYNVRLFMFQLLRGL 116
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
AY+H + ++H D+KP N+L+ + K++DFGLAR KS+
Sbjct: 117 AYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSI 155
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 36/90 (40%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGD 143
++ R+ LV+E + + L D L K P L E R I +GI + HS N +IH D
Sbjct: 71 RKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVR-KYLFQILRGIEFCHSHN--IIHRD 125
Query: 144 IKPSNILLDHNFCAKISDFGLAR-LKSVGE 172
IKP NIL+ + K+ DFG AR L + GE
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLAAPGE 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 10/149 (6%)
Query: 22 LLGQGGFGSVFHATLHD--QSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSV 76
++G+GGFG V+ D + A+K +D + QGE NE SL+ D V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN 136
+ ++ + +LM+ G+L L + E RF A +I G+ ++H N
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRF-YATEIILGLEHMH--N 115
Query: 137 PPVIHGDIKPSNILLDHNFCAKISDFGLA 165
V++ D+KP+NILLD + +ISD GLA
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 50/173 (28%), Positives = 79/173 (45%), Gaps = 36/173 (20%)
Query: 23 LGQGGFGSVF-------------HATLHDQS-----VAVKVMDSGSLQGER-EFYNELYF 63
LG+G FG V +L VAVK++ + + R +F E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 64 ASLLEQDDHVVSVLG--FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSI 121
S L +D +++ +L +S+P + ++ E M NG+L L +P E E +I
Sbjct: 73 MSRL-KDPNIIRLLAVCITSDP----LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 122 --------AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
A IA G+ YL SLN +H D+ N L+ N+ KI+DFG++R
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 45/175 (25%), Positives = 82/175 (46%), Gaps = 27/175 (15%)
Query: 15 DSFSPSRLLGQGGFGSVFHATL---------HDQSVAVKVM-DSGSLQGEREFYNELYFA 64
D + + LG+G FG V A +VAVK++ D + + + +E+
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 65 SLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPEL------------ 112
++ + +++++LG + + + ++ E S GNL++ L ++PP +
Sbjct: 75 KMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE 132
Query: 113 -MEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
M + S +A+G+ YL S IH D+ N+L+ N KI+DFGLAR
Sbjct: 133 QMTFKDLVSCTYQVARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 20/160 (12%)
Query: 21 RLLGQGGFGSVFHATLHD----QSVAVKVMDSGSLQGE-----REFYNELYFASLLEQDD 71
+LLGQG FG V+ +D + +AVK + E E+ L Q +
Sbjct: 8 KLLGQGAFGRVY--LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHE 64
Query: 72 HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAY 131
+V G + + + + E M G+++D L K L E R I +G+ Y
Sbjct: 65 RIVQYYGCLRDDET--LSIFMEYMPGGSVKDQL--KAYGALTETVTR-KYTRQILEGVEY 119
Query: 132 LHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA-RLKSV 170
LHS ++H DIK +NIL D K+ DFG + RL+++
Sbjct: 120 LHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 4e-08
Identities = 45/167 (26%), Positives = 69/167 (41%), Gaps = 37/167 (22%)
Query: 23 LGQGGFGSVF--HATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVS---VL 77
LG GGFG V +++ A+K + + Q +H+ S +L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETG-------------QQEHIFSEKEIL 47
Query: 78 GFSSNP---KRHR---------MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDI 125
++P K +R ML+ E G L L + E+ RF IA +
Sbjct: 48 EECNHPFIVKLYRTFKDKKYIYMLM--EYCLGGELWTIL--RDRGLFDEYTARFYIAC-V 102
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGE 172
YLH+ +I+ D+KP N+LLD N K+ DFG A+ G+
Sbjct: 103 VLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 39/145 (26%), Positives = 66/145 (45%), Gaps = 26/145 (17%)
Query: 41 VAVKVMDSGSLQGER-EFYNELYFASLLEQDDHVVSVLG--FSSNPKRHRMLLVYELMSN 97
VAVK++ + + R +F E+ S L +D +++ +LG +P + ++ E M N
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRL-KDPNIIRLLGVCVDEDP----LCMITEYMEN 103
Query: 98 GNLQDALLHKK----------------PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIH 141
G+L L + + +A+ IA G+ YL SLN +H
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVH 161
Query: 142 GDIKPSNILLDHNFCAKISDFGLAR 166
D+ N L+ N KI+DFG++R
Sbjct: 162 RDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 52/184 (28%), Positives = 77/184 (41%), Gaps = 32/184 (17%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD------QSVAVK-VMDSGSLQGEREFYNELYFASLL 67
D + S LL +G FG +F+ L D + V VK V D S E + LL
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQE---SCLL 62
Query: 68 EQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSI---- 121
H ++ +L +L Y M+ GNL+ L + L E ++
Sbjct: 63 YGLSHQNILPILHVCIEDGEPPFVL-YPYMNWGNLKLFL---QQCRLGEANNPQALSTQQ 118
Query: 122 ----AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR------LKSVG 171
A+ IA G++YLH VIH DI N ++D KI+D L+R +G
Sbjct: 119 LVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 172 ENQN 175
+N+N
Sbjct: 177 DNEN 180
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 29/168 (17%)
Query: 23 LGQGGFGSVFHATL---------HDQSVAVKVMDSGSLQGE-REFYNELYFASLLEQDDH 72
LG+G FG V A VAVK++ S + + + + +E+ ++ + +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR-------------- 118
++++LG + + + ++ E S GNL++ L ++PP ME+C
Sbjct: 86 IINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPG-MEYCYNPTQVPEEQLSFKDL 142
Query: 119 FSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
S A +A+G+ YL S IH D+ N+L+ + KI+DFGLAR
Sbjct: 143 VSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 10/162 (6%)
Query: 22 LLGQGGFGSVFHA-TLHDQSVAVK--VMD-SGSLQGEREFYNELYFASLLEQDDHVVSVL 77
+LG+G +G+V+ T Q +AVK +D S L E+E+ LL+ HV V
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNP 137
+ + + + E + G++ L P +CK I G+AYLH+
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC- 122
Query: 138 PVIHGDIKPSNILLDHNFCAKISDFGLA-RLKSVGENQNQAD 178
V+H DIK +N++L N K+ DFG A RL VG + ++
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN 163
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 44/162 (27%), Positives = 74/162 (45%), Gaps = 13/162 (8%)
Query: 15 DSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
+F + +G+G F V+ A L + VA+K + + + + L LL+Q DH
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP-----PELMEWCKRFSIAVDIAK 127
+ +S + + + +V EL G+L + H K PE W K F V +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW-KYF---VQLCS 117
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
+ ++HS ++H DIKP+N+ + K+ D GL R S
Sbjct: 118 ALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFS 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 43/147 (29%), Positives = 79/147 (53%), Gaps = 15/147 (10%)
Query: 23 LGQGGFGSVFHA--TLHDQSVAVKVMDSG-SLQGEREFYNELYFASLLEQDDHVVSVLGF 79
LG G G+V+ A L + +AVKV+ +++ +++ +EL +L + D + +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSEL---EILYKCDSPYIIGFY 65
Query: 80 SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPV 139
+ +R+ + E M G+L +++K PE + IAV + KG+ YL SL +
Sbjct: 66 GAFFVENRISICTEFMDGGSLD---VYRKIPEHV----LGRIAVAVVKGLTYLWSLK--I 116
Query: 140 IHGDIKPSNILLDHNFCAKISDFGLAR 166
+H D+KPSN+L++ K+ DFG++
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 42/163 (25%), Positives = 79/163 (48%), Gaps = 25/163 (15%)
Query: 21 RLLGQGGFGSVFHAT------LHDQSVA-VKVMDSGSLQGEREFYNELYFASLLE--QDD 71
+L+G GGFG V+ +++Q+VA ++ +++ ++ E YN +Y + ++
Sbjct: 18 KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI 77
Query: 72 HVVSVLG---------FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIA 122
H + LG F +R +L+ +L+ N + K +L++ +I
Sbjct: 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIK-----NIM 132
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
D+ + Y+H + HGDIKP NI++D N I D+G+A
Sbjct: 133 KDMLTTLEYIHEHG--ISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 23/45 (51%), Positives = 31/45 (68%), Gaps = 1/45 (2%)
Query: 121 IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
IAV I K + YLHS VIH D+KPSN+L++ N K+ DFG++
Sbjct: 108 IAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 32/178 (17%)
Query: 17 FSPSRL-----LGQGGFGSVFHA---------TLHDQSVAVKVM-DSGSLQGEREFYNEL 61
S +RL LG+G FG V A +VAVK++ D + + + +E+
Sbjct: 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEM 68
Query: 62 YFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPEL---MEWCK- 117
++ + +++++LG + + + ++ E S GNL++ L ++PP + + CK
Sbjct: 69 EMMKMIGKHKNIINLLGACT--QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 118 ---------RFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
S A +A+G+ YL S IH D+ N+L+ + KI+DFGLAR
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLAS--QKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 49/152 (32%), Positives = 75/152 (49%), Gaps = 16/152 (10%)
Query: 22 LLGQGGFGSVFHATLHD--QSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDH---V 73
++G+GGFG V+ D + A+K +D + QGE NE SL+ D V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLH 133
F + K + + +LM+ G+L L + E RF A +I G+ ++H
Sbjct: 61 CMSYAFHTPDK---LSFILDLMNGGDLHYHL--SQHGVFSEAEMRF-YAAEIILGLEHMH 114
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
N V++ D+KP+NILLD + +ISD GLA
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 10/164 (6%)
Query: 8 SVLRRAADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFAS 65
S LR A F ++G G +G V+ Q A+KVMD + E E E+
Sbjct: 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLK 67
Query: 66 LLEQDDHVVSVLG--FSSNPKRH--RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSI 121
++ + G +P H ++ LV E G++ D + + K L E + I
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-I 126
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+I +G+A+LH+ VIH DIK N+LL N K+ DFG++
Sbjct: 127 CREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 18/156 (11%)
Query: 22 LLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQD-------DH 72
L+G+G +G V+ A + +AVK ++ + R + L + DH
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 73 --VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIA 130
+V LGF + + + L Y + G++ L + E RF + +G+A
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEY--VPGGSIGSCL--RTYGRFEEQLVRF-FTEQVLEGLA 122
Query: 131 YLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
YLHS ++H D+K N+L+D + KISDFG+++
Sbjct: 123 YLHSKG--ILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 49/161 (30%), Positives = 71/161 (44%), Gaps = 25/161 (15%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS--VAVKVMD---------SGSLQGEREFYNELYF 63
D F +++G+G FG V D A+K + ++ ER+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDI------ 54
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV 123
L E D+ V L +S + + + L+ E + G++ LL KK E RF IA
Sbjct: 55 --LAEADNPWVVKLYYSFQDENY-LYLIMEYLPGGDMM-TLLMKKD-TFTEEETRFYIA- 108
Query: 124 DIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164
+ I +H L IH DIKP N+LLD K+SDFGL
Sbjct: 109 ETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 30/167 (17%)
Query: 23 LGQGGFGSVFHATL------HDQSVAVKVM-DSGSLQGEREFYNELYFASLLEQDDH--V 73
LG+ FG ++ L H Q VA+K + D + Q EF E ASL+ + H +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQE---ASLMAELHHPNI 69
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP--------------PELMEWCKRF 119
V +LG + + + +++E ++ G+L + L+ + P ++
Sbjct: 70 VCLLGVVT--QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
IA+ IA G+ YL S +H D+ NIL+ KISD GL+R
Sbjct: 128 HIAIQIAAGMEYLSS--HFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 21/39 (53%), Positives = 28/39 (71%), Gaps = 2/39 (5%)
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
GI YLH + ++H DIK +NIL+D+ KI+DFGLAR
Sbjct: 127 GINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 25/83 (30%), Positives = 42/83 (50%), Gaps = 17/83 (20%)
Query: 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIA------VDIAKGIAYLHSLNPPVIHGD 143
+V E + + +L+ + K P F + + + G+A+LH ++H D
Sbjct: 83 MVMEYVEH-DLKSLMETMKQP--------FLQSEVKCLMLQLLSGVAHLHDNW--ILHRD 131
Query: 144 IKPSNILLDHNFCAKISDFGLAR 166
+K SN+LL++ KI DFGLAR
Sbjct: 132 LKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 48/167 (28%), Positives = 74/167 (44%), Gaps = 22/167 (13%)
Query: 22 LLGQGGFGSVFHATLHDQSV----AVKVM-DSGSLQGEREFYNELYFASLLEQDDHVVSV 76
++G+G FG V A + + A+K M + S R+F EL L +++++
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR-------------FSIAV 123
LG + R + L E +GNL D L + E A
Sbjct: 62 LGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 124 DIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
D+A+G+ YL IH D+ NIL+ N+ AKI+DFGL+R + V
Sbjct: 120 DVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 164
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 43/164 (26%), Positives = 67/164 (40%), Gaps = 17/164 (10%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQSV--AVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
F +LLG+G G VF L A+KV+D + + L +L DH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV------DIA 126
++S + LV + G L L ++ P K S V ++
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLL--QRQPG-----KCLSEEVARFYAAEVL 113
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
+ YLH L +++ D+KP NILL + +SDF L++ V
Sbjct: 114 LALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 40/174 (22%)
Query: 23 LGQGGFGSVFHA--TLHDQSVAVK--VMDSGSLQGEREFY-----NELYFASLLEQDD-- 71
+GQG FG VF A Q VA+K +M++ E+E + E+ LL+ ++
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMEN-----EKEGFPITALREIKILQLLKHENVV 74
Query: 72 ---HVVSVLGFSSNPKRHRMLLVYE--------LMSNGNLQDALLHKKPPELMEWCKRFS 120
+ N + LV+E L+SN N++ L K ++M+
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIK--KVMK------ 126
Query: 121 IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQ 174
+ G+ Y+H ++H D+K +NIL+ + K++DFGLAR S+ +N
Sbjct: 127 ---MLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLARAFSLSKNS 175
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 16/160 (10%)
Query: 22 LLGQGGFGSVF---HATLHDQSVAVKVMDS-GSLQGEREFYNELYFASLLEQDDHVVSVL 77
++G+G +G V H + K DS + + + EL L+Q++ V
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQ--DALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL 135
F +R ++ LV+E + L+ + + + PPE K S + K I + H
Sbjct: 68 AFR---RRGKLYLVFEYVEKNMLELLEEMPNGVPPE-----KVRSYIYQLIKAIHWCHKN 119
Query: 136 NPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQN 175
+ ++H DIKP N+L+ HN K+ DFG AR S G N N
Sbjct: 120 D--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 23/43 (53%), Positives = 28/43 (65%), Gaps = 2/43 (4%)
Query: 121 IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163
IA + KG++YLHS +IH DIKPSNILL K+ DFG
Sbjct: 110 IAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 21/46 (45%), Positives = 30/46 (65%), Gaps = 1/46 (2%)
Query: 121 IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
IAV + KG+ YLH +IH D+KPSNIL++ K+ DFG++
Sbjct: 105 IAVAVLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 45/150 (30%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 21 RLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQD-DHVVSV- 76
+++G+G FG V A + AVKV+ ++ ++E + + ++L ++ H V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN 136
L +S ++ V + ++ G L L ++ E RF A +IA + YLHSLN
Sbjct: 61 LHYSFQTA-DKLYFVLDYVNGGELFFHLQRER--SFPEPRARF-YAAEIASALGYLHSLN 116
Query: 137 PPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+I+ D+KP NILLD ++DFGL +
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 49/176 (27%), Positives = 76/176 (43%), Gaps = 34/176 (19%)
Query: 1 PPHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHDQS--VAVKVM-----DSGSLQG 53
P S S L R +G G G+V+ A+KV+ D+ Q
Sbjct: 67 PSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQI 119
Query: 54 EREFYNELYFASLLEQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPE 111
RE +L +H VV + ++LL E M G+L+ + +
Sbjct: 120 CREI-------EILRDVNHPNVVKCHDMFDHNGEIQVLL--EFMDGGSLEGTHIADEQ-F 169
Query: 112 LMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
L + +A I GIAYLH + ++H DIKPSN+L++ KI+DFG++R+
Sbjct: 170 LAD------VARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRI 217
|
Length = 353 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 43/159 (27%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 21 RLLGQGGFGSVFHATLHDQ----SVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VV 74
+ LG+G FGSV L+ VAVK M ++ E + L A +++ DH V+
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKI-AICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 75 SVLGF----SSNPKRHRMLLVYELMSNGNLQDALLHKK---PPELMEWCKRFSIAVDIAK 127
++G + +++ M +G+L LL+ + P+ + DIA
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
G+ YL S + IH D+ N +L+ N ++DFGL++
Sbjct: 124 GMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 38/145 (26%), Positives = 69/145 (47%), Gaps = 8/145 (5%)
Query: 25 QGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYN-ELYFASLLEQDDHVVSVLGFSS 81
+G FGSV+ A A+KV+ + + + N + A ++ Q + + S
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 82 NPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIH 141
+ + LV E ++ G+ +L+ +W K++ ++ G+ LH +IH
Sbjct: 66 FQSKDYLYLVMEYLNGGDCA-SLIKTLGGLPEDWAKQY--IAEVVLGVEDLHQRG--IIH 120
Query: 142 GDIKPSNILLDHNFCAKISDFGLAR 166
DIKP N+L+D K++DFGL+R
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSR 145
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 21 RLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDD--HVVSV 76
R LG G G VF A + D+ VAVK + Q + E+ L+ D+ V V
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 77 LGFSSNP---------KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAK 127
LG S + + + + +V E M +L + L E E + F + +
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSE--EHARLF--MYQLLR 125
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLD-HNFCAKISDFGLARL 167
G+ Y+HS N V+H D+KP+N+ ++ + KI DFGLAR+
Sbjct: 126 GLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 17 FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVV 74
F+ +G+G FG VF + + VA+K++D + E E + ++L Q D
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE--ITVLSQCDSPY 63
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS 134
+ S K ++ ++ E + G+ D L P ++ + +I +I KG+ YLHS
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS 119
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
IH DIK +N+LL + K++DFG+A
Sbjct: 120 EKK--IHRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 4e-07
Identities = 49/163 (30%), Positives = 73/163 (44%), Gaps = 12/163 (7%)
Query: 10 LRRAADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFASLL 67
LR A F L+G G +G V+ Q A+KVMD + E E E+
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKY 59
Query: 68 EQDDHVVSVLG--FSSNPK--RHRMLLVYELMSNGNLQDALLHKKPPELME-WCKRFSIA 122
++ + G NP ++ LV E G++ D + + K L E W I
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YIC 117
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+I +G+++LH VIH DIK N+LL N K+ DFG++
Sbjct: 118 REILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 13/161 (8%)
Query: 16 SFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHV 73
+F + +G+G F V+ AT L + VA+K + + + + + LL+Q +H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP-----PELMEWCKRFSIAVDIAKG 128
+ S + + + +V EL G+L + + K PE W K F V +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW-KYF---VQLCSA 118
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
+ ++HS V+H DIKP+N+ + K+ D GL R S
Sbjct: 119 VEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 13/153 (8%)
Query: 21 RLLGQGGFGSVFHATLHD--QSVAVKVM--DSGSLQGERE---FYNELYFASLLEQDDHV 73
+LLG+G FG V+ D + +AVK + D S + +E E+ L D +
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD-RI 66
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLH 133
V G +P+ ++ + E M G+++D L K L E R I +G++YLH
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTR-RYTRQILQGVSYLH 123
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
S ++H DIK +NIL D K+ DFG ++
Sbjct: 124 S--NMIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 17 FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVV 74
F+ +G+G FG VF + Q VA+K++D + E E + ++L Q D
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQE--ITVLSQCDSPY 63
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV---DIAKGIAY 131
+ S K ++ ++ E + G+ D LL P + F IA +I KG+ Y
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFD------EFQIATMLKEILKGLDY 116
Query: 132 LHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
LHS IH DIK +N+LL K++DFG+A
Sbjct: 117 LHSEKK--IHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 10/151 (6%)
Query: 17 FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVV 74
F+ +G+G FG V+ + + VA+K++D + E E + ++L Q D
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQE--ITVLSQCDSPY 63
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS 134
+ S K ++ ++ E + G+ D L P +E +I +I KG+ YLHS
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHS 119
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
IH DIK +N+LL K++DFG+A
Sbjct: 120 ERK--IHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 45/165 (27%), Positives = 68/165 (41%), Gaps = 39/165 (23%)
Query: 23 LGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGE--------REFYNELYFASLLEQDDH 72
LG+G + +V+ L Q VA+K + L+ E RE ASLL+ H
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI---RLEHEEGAPFTAIRE-------ASLLKDLKH 62
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS-------IAVDI 125
V + + LV+E + + M+ C +
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQL 112
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
+G+AY H V+H D+KP N+L+ K++DFGLAR KSV
Sbjct: 113 LRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSV 155
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 48/152 (31%), Positives = 72/152 (47%), Gaps = 11/152 (7%)
Query: 21 RLLGQGGFGSVFHATLHD--QSVAVKVM--DSGSLQGEREFYNELYFASLLEQDDH--VV 74
+LLGQG FG V+ D + +AVK + D S + +E LL+ H +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS 134
G +P + + E M G+++D L K L E R I +G++YLHS
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTR-KYTRQILEGVSYLHS 124
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
++H DIK +NIL D K+ DFG ++
Sbjct: 125 --NMIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 39/138 (28%), Positives = 69/138 (50%), Gaps = 19/138 (13%)
Query: 41 VAVKVMDSGSLQGER-EFYNELYFASLLEQDDHVVSVLGF--SSNPKRHRMLLVYELMSN 97
VAVK++ + + R +F E+ S L ++ +++ +LG S +P + ++ E M N
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRLLGVCVSDDP----LCMITEYMEN 101
Query: 98 GNL---------QDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSN 148
G+L + H + +AV IA G+ YL SLN +H D+ N
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRN 159
Query: 149 ILLDHNFCAKISDFGLAR 166
L+ +++ KI+DFG++R
Sbjct: 160 CLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS--VAVKVM-DSGSLQGEREFYNELYFASLLEQDD 71
D F +++G+G FG V D A+K++ + L+ E+ + L+E D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 72 HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAY 131
V + +S KR+ + L+ E + G++ L+ K L E +F IA + I
Sbjct: 61 AWVVKMFYSFQDKRN-LYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIA-ETVLAIDA 116
Query: 132 LHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164
+H L IH DIKP N+LLD K+SDFGL
Sbjct: 117 IHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 49/165 (29%), Positives = 74/165 (44%), Gaps = 31/165 (18%)
Query: 16 SFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSL--------------QGEREFYNEL 61
+F R+LG+GGFG V A +V +G + +GE NE
Sbjct: 1 TFRHYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGEAMALNE- 50
Query: 62 YFASLLEQ-DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS 120
+LE+ + V L ++ K + LV LM+ G+L+ + + P E F
Sbjct: 51 --KQILEKVNSRFVVSLAYAYETK-DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF- 106
Query: 121 IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
A +I G+ LH +++ D+KP NILLD +ISD GLA
Sbjct: 107 YAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 14/152 (9%)
Query: 21 RLLGQGGFGSVFHATLHDQSV--AVKVMDSGSLQGEREFYNELYFAS----LLEQDDHVV 74
+++G+G FG V A + AVKV+ ++ ++E E + S LL+ H
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKE---EKHIMSERNVLLKNVKHPF 57
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS 134
V S ++ V + ++ G L L ++ +E RF A +IA + YLHS
Sbjct: 58 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARF-YAAEIASALGYLHS 114
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
LN +++ D+KP NILLD ++DFGL +
Sbjct: 115 LN--IVYRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 21/44 (47%), Positives = 27/44 (61%), Gaps = 2/44 (4%)
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVG 171
GI +LHS +IH D+KPSNI++ + KI DFGLAR
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 23/158 (14%)
Query: 21 RLLGQGGFGSVFHATLHDQS------VAVKVM-DSGSLQGEREFYNELYFASLLEQDDHV 73
+LLG G FG+V + VA+K + D Q +E + + L+ ++
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA-YI 71
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK----PPELMEWCKRFSIAVDIAKGI 129
V +LG + LV +L G+L D + + P L+ WC V IAKG+
Sbjct: 72 VRLLGICPGAS---LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC------VQIAKGM 122
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
YL ++H ++ NILL + +I+DFG+A L
Sbjct: 123 YYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADL 158
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 42/171 (24%), Positives = 76/171 (44%), Gaps = 23/171 (13%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS----VAVKVMDSGSLQGERE-----FYNELYFAS 65
D++ +G+G +G V+ A D++ VA+K L+ + E E+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKA--RDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQ 55
Query: 66 LLEQDDHVVSVLGF----SSNPKRHRMLLVYELMSNGNLQDALLH-KKPPELMEWCKRFS 120
+L + ++V +L N K + LV+E + + + + + P + S
Sbjct: 56 MLSESIYIVRLLDVEHVEEKNGKPS-LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKS 114
Query: 121 IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN-FCAKISDFGLARLKSV 170
+ KG+A+ H V+H D+KP N+L+D KI+D GL R S+
Sbjct: 115 FMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 47/165 (28%), Positives = 74/165 (44%), Gaps = 45/165 (27%)
Query: 23 LGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGE---------REFYNELYFASLLE--Q 69
+G+G +G V+ A L + VA+K + L+ E RE SLL+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI---RLETEDEGVPSTAIREI-------SLLKELN 56
Query: 70 DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAK-- 127
++V +L + +++ LV+E + D L K M+ + + K
Sbjct: 57 HPNIVRLLDVVHS--ENKLYLVFEFL------DLDLKK----YMDSSPLTGLDPPLIKSY 104
Query: 128 ------GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
GIAY HS V+H D+KP N+L+D K++DFGLAR
Sbjct: 105 LYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 52/171 (30%)
Query: 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVS--- 75
++LG+G FG V A L D+ AVKV+ ++ QDD V
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKD----------------VILQDDDVECTMT 44
Query: 76 ---VLGFSSNP-----------KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS- 120
VL + + R+ V E ++ G+L + H ++ RF
Sbjct: 45 EKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDL---MFH------IQRSGRFDE 95
Query: 121 -----IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
A +I G+ +LH +I+ D+K N+LLD KI+DFG+ +
Sbjct: 96 PRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 43/144 (29%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 23 LGQGGFGSVFHATLHDQS--VAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFS 80
+G+G G V AT+ VAVK MD Q +NE+ ++ H V ++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVV---IMRDYQHENVVEMYN 84
Query: 81 SNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVI 140
S + +V E + G L D + H + M + ++ + + K ++ LH+ VI
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQG--VI 138
Query: 141 HGDIKPSNILLDHNFCAKISDFGL 164
H DIK +ILL H+ K+SDFG
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 45/150 (30%), Positives = 74/150 (49%), Gaps = 10/150 (6%)
Query: 21 RLLGQGGFGSVFHATLHDQSV--AVKVMDSGSLQGEREFYNELYFAS-LLEQDDHVVSVL 77
+++G+G FG V A AVKV+ ++ ++E + + + LL+ H V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLH-KKPPELMEWCKRFSIAVDIAKGIAYLHSLN 136
S ++ V + ++ G L H ++ +E RF A ++A I YLHSLN
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARF-YAAEVASAIGYLHSLN 116
Query: 137 PPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+I+ D+KP NILLD ++DFGL +
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 38/173 (21%)
Query: 21 RLLGQGGFGSVFHA---TLHD--QSVAVKVM----------DSGSLQGEREFYNELYFAS 65
++LG+GG+G VF T D + A+KV+ D+ + ER +
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAER---------N 52
Query: 66 LLEQDDH---VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLH-KKPPELMEWCKRFSI 121
+LE H V + F + K + L+ E +S G L +H ++ ME F +
Sbjct: 53 ILEAVKHPFIVDLIYAFQTGGK---LYLILEYLSGGEL---FMHLEREGIFMEDTACFYL 106
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQ 174
+ +I+ + +LH +I+ D+KP NILLD K++DFGL + +S+ E
Sbjct: 107 S-EISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGT 155
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 11/160 (6%)
Query: 14 ADSFSPSRLLGQGGFGSVFH--ATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDD 71
ADS+ LG+G + +V+ + ++ + VA+KV+ +G + + ASLL+
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTP--FTAIREASLLKGLK 61
Query: 72 HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELM-EWCKRFSIAVDIAKGIA 130
H VL + + LV+E + Q + K P L E K F + +G++
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQ--YMDKHPGGLHPENVKLF--LFQLLRGLS 117
Query: 131 YLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
Y+H ++H D+KP N+L+ K++DFGLAR KSV
Sbjct: 118 YIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSV 155
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 24/52 (46%), Positives = 30/52 (57%), Gaps = 6/52 (11%)
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL----DHNFCAKISDFGLARL 167
S+ I G+ YLHS N V+H D+KP+NIL+ KI D GLARL
Sbjct: 112 SLLWQILNGVHYLHS-NW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 13/161 (8%)
Query: 16 SFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHV 73
+F + +G+G F V+ AT L VA+K + L + + + LL+Q +H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP-----PELMEWCKRFSIAVDIAKG 128
+ ++S + + + +V EL G+L + H K PE W K F V +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW-KYF---VQLCSA 118
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
+ ++HS V+H DIKP+N+ + K+ D GL R S
Sbjct: 119 LEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 44/174 (25%)
Query: 10 LRRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVM------------DSGSLQGER-- 55
LR A+ F +++G+G FG V H S V M DS ER
Sbjct: 38 LRMKAEDFDVIKVIGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 56 ------EFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP 109
E+ +L++A QDD ++ + +V E M G+L + + +
Sbjct: 97 MAHANSEWIVQLHYAF---QDD-------------KY-LYMVMEYMPGGDLVNLMSNYDI 139
Query: 110 PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163
PE +W RF A ++ + +HS+ IH D+KP N+LLD + K++DFG
Sbjct: 140 PE--KWA-RFYTA-EVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 21/47 (44%), Positives = 30/47 (63%), Gaps = 2/47 (4%)
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ + + +G+ YLH +IH D+K SN+LL C KI+DFGLAR
Sbjct: 112 CLMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 9/111 (8%)
Query: 436 YVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQ-RANLMSWARHLAR 494
YVAPE DI+EK D+Y +G++L+ L+ G+ P EF +++ WAR+
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA------EFGVHGSIVEWARYCYS 897
Query: 495 NGKLIELVDQAVVK--SLDREQALLCITVALLCLQKSPALRPSMEEVVGML 543
+ L +D ++ S+++ + + + +AL C P RP +V+ L
Sbjct: 898 DCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 7/152 (4%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS--VAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
+ F +++G+G FG V D A+K++ + + + + +L + D
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYL 132
+ V F S + + L+ E + G++ L+ K L E +F IA + I +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIA-ETVLAIDSI 117
Query: 133 HSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164
H L IH DIKP N+LLD K+SDFGL
Sbjct: 118 HQLG--FIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 20/157 (12%)
Query: 19 PSRL-----LGQGGFGSVFHATLHDQ-SVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
PS L LG G FG V Q VA+K ++ G++ E +F E A ++ + H
Sbjct: 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEE---AKVMMKLSH 58
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK---PPELMEWCKRFSIAVDIAKGI 129
V + ++ + +V E M NG L + L ++ +++ S+ D+ +G+
Sbjct: 59 PKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDVCEGM 113
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
YL + IH D+ N L+ K+SDFG+ R
Sbjct: 114 EYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 40/161 (24%), Positives = 77/161 (47%), Gaps = 20/161 (12%)
Query: 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQD-DHVVSVL 77
++LG+G FG VF A L +Q A+K + + + + + +L +H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSI------AVDIAKGIAY 131
+ + + + V E ++ G+L + H ++ C +F + A +I G+ +
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL---MFH------IQSCHKFDLPRATFYAAEIICGLQF 111
Query: 132 LHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGE 172
LHS +++ D+K NILLD + KI+DFG+ + +G+
Sbjct: 112 LHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD 150
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 22/48 (45%), Positives = 29/48 (60%), Gaps = 7/48 (14%)
Query: 121 IAVDIAKGIAYL---HSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+ V I K + YL H VIH D+KPSNILLD + K+ DFG++
Sbjct: 119 MTVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 44/147 (29%), Positives = 71/147 (48%), Gaps = 11/147 (7%)
Query: 23 LGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSVLG 78
+GQGG+G VF A D + VA+K M L E + L +L +V +L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 79 FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPP 138
++ + + L E + G+ + L + L E RF +A ++ + + LH L
Sbjct: 68 YAFQDDEY-LYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMA-EMFEAVDALHELG-- 121
Query: 139 VIHGDIKPSNILLDHNFCAKISDFGLA 165
IH D+KP N L+D + K++DFGL+
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 23 LGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSVLGFS 80
+G+G FG V VAVK + + + + F E AS++ Q H +V +LG
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAE---ASVMTQLRHSNLVQLLGVI 68
Query: 81 SNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVI 140
K + +V E M+ G+L D L + L C ++D+ + + YL + N +
Sbjct: 69 VEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC-LLKFSLDVCEAMEYLEANN--FV 124
Query: 141 HGDIKPSNILLDHNFCAKISDFGLARLKS 169
H D+ N+L+ + AK+SDFGL + S
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEAS 153
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 16/157 (10%)
Query: 11 RRAADSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLE 68
R DSF +G+G G V AT + VAVK MD Q +NE+ ++
Sbjct: 21 REYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEV----VIM 73
Query: 69 QDDHVVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAK 127
+D H +V+ ++S + +V E + G L D + H + M + ++ + + +
Sbjct: 74 RDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLR 129
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164
++YLH N VIH DIK +ILL + K+SDFG
Sbjct: 130 ALSYLH--NQGVIHRDIKSDSILLTSDGRIKLSDFGF 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 44/199 (22%), Positives = 80/199 (40%), Gaps = 31/199 (15%)
Query: 22 LLGQGGFGSVFHATLHDQS--------VAVKVMDSGSLQGERE-----FYNELYFASLLE 68
LG G FG V+ + + V G + ER+ +E+ + E
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI--IKE 64
Query: 69 QDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLH-KKPPELMEWCKRFSIAVDIAK 127
Q H V + + + R+ +V +L+ L + K+ + + ++I V +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGENKNKAAE 187
+ YLH ++H D+ P+NI+L + I+DFGLA+ K ++
Sbjct: 125 ALRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--------------QKQPESK 169
Query: 188 LESNCGAAVEDCGSVVETE 206
L S G + C +V+ E
Sbjct: 170 LTSVVGTILYSCPEIVKNE 188
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 23/157 (14%)
Query: 21 RLLGQGGFGSVFHATLHDQS--VAVKVMD--SGSLQGEREFYNELYFASLLEQDDHVVSV 76
+ +G+G FG ++ A S +K +D ++ + E+ LL + H V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVI---LLAKMKHPNIV 62
Query: 77 LGFSSNPKRHRMLLVYE------LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIA 130
F+S + R+ +V E LM N Q +L + +++ W V I+ G+
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED-QILSW------FVQISLGLK 115
Query: 131 YLHSLNPPVIHGDIKPSNILLDHN-FCAKISDFGLAR 166
++H + ++H DIK NI L N AK+ DFG+AR
Sbjct: 116 HIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 44/165 (26%), Positives = 71/165 (43%), Gaps = 26/165 (15%)
Query: 23 LGQGGFGSVFHATL-------HDQSVAVKVM-DSGSLQGEREFYNELYFASLLEQDDHVV 74
LG+ FG V+ L Q+VA+K + D EF +E S L Q ++V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIV 71
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP-------------PELMEWCKRFSI 121
+LG + K + +++ S+ +L + L+ + P +E I
Sbjct: 72 CLLGVVT--KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
IA G+ +L S + V+H D+ N+L+ KISD GL R
Sbjct: 130 VTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 24/164 (14%)
Query: 10 LRRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQ 69
L+ A+ + +++G+G FG V H S V M L + E A E+
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAM---KLLSKFEMIKRSDSAFFWEE 93
Query: 70 DDHVVSVLGFSSNP----------KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF 119
D ++ F+++P + +V E M G+L + + + PE +W K +
Sbjct: 94 RD----IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--KWAKFY 147
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163
+ V +A + +HS+ +IH D+KP N+LLD + K++DFG
Sbjct: 148 TAEVVLA--LDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 3/80 (3%)
Query: 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKP 146
R+ L++E +S +L+ L + M+ S I +GI + HS V+H D+KP
Sbjct: 73 RLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKP 129
Query: 147 SNILLDHNFCAKISDFGLAR 166
N+L+D+ K++DFGLAR
Sbjct: 130 QNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 23/46 (50%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 121 IAVDIAKGIAYL-HSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
IAV K + YL L +IH D+KPSNILLD N K+ DFG++
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 34/112 (30%), Positives = 55/112 (49%), Gaps = 24/112 (21%)
Query: 65 SLLEQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIA 122
SLL++ +H +V +L + + LV+E + QD KK M+ I
Sbjct: 51 SLLKELNHPNIVKLLDVIHTENK--LYLVFEFLH----QDL---KK---FMDASPLSGIP 98
Query: 123 VDIAK--------GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ + K G+A+ HS V+H D+KP N+L++ K++DFGLAR
Sbjct: 99 LPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 25/89 (28%), Positives = 42/89 (47%), Gaps = 5/89 (5%)
Query: 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGD 143
++ ++ LV+E + L + L K P + E + I + + + H N IH D
Sbjct: 71 RKRKLHLVFEYCDHTVLNE--LEKNPRGVPEHLIK-KIIWQTLQAVNFCHKHN--CIHRD 125
Query: 144 IKPSNILLDHNFCAKISDFGLARLKSVGE 172
+KP NIL+ K+ DFG AR+ +
Sbjct: 126 VKPENILITKQGQIKLCDFGFARILTGPG 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 48/156 (30%), Positives = 75/156 (48%), Gaps = 13/156 (8%)
Query: 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLLEQ- 69
+F R+LG+GGFG V + + A K ++ ++ GE NE +LE+
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNE---KQILEKV 57
Query: 70 DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
+ V L ++ K + LV +M+ G+L+ + + P E F A +I G+
Sbjct: 58 NSQFVVNLAYAYETK-DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF-YAAEILCGL 115
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
LH N ++ D+KP NILLD +ISD GLA
Sbjct: 116 EDLHREN--TVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 20/150 (13%)
Query: 23 LGQGGFGSVFHA-TLHD-QSVAVKVM-----DSGSLQGEREFYNELYFASLLEQDDHVVS 75
+G G +G V+ A LH + AVK++ D SL + F ++++ H
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIF--------MVKECKHCNI 68
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL 135
V F S R ++ + E G+LQD + H P + + + + +G+AYLHS
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGP--LSELQIAYVCRETLQGLAYLHSK 125
Query: 136 NPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+H DIK +NILL N K++DFG+A
Sbjct: 126 GK--MHRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 10/150 (6%)
Query: 21 RLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGEREFYNELYFAS-LLEQDDHVVSVL 77
+++G+G FG V A L + AVKV+ + +E + + + LL+ H V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLH-KKPPELMEWCKRFSIAVDIAKGIAYLHSLN 136
S ++ V + ++ G L H ++ E RF A +IA + YLHS+N
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAA-EIASALGYLHSIN 116
Query: 137 PPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+++ D+KP NILLD ++DFGL +
Sbjct: 117 --IVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 44/178 (24%), Positives = 74/178 (41%), Gaps = 50/178 (28%)
Query: 21 RLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFY--NELYFASLLEQDD------- 71
++LG+G FG V A L+G EF+ L +LE DD
Sbjct: 1 KVLGKGSFGKVMLA---------------ELKGTNEFFAIKALKKDVVLEDDDVECTMVE 45
Query: 72 -HVVSVLG--------FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSI- 121
V+++ F + + + V E ++ G+L + H ++ RF
Sbjct: 46 RRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDL---MFH------IQSSGRFDEA 96
Query: 122 -----AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQ 174
A +I G+ +LH +I+ D+K N+LLD + KI+DFG+ + GE +
Sbjct: 97 RARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK 152
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 48/156 (30%), Positives = 75/156 (48%), Gaps = 13/156 (8%)
Query: 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLLEQ- 69
+F R+LG+GGFG V + + A K ++ ++ GE NE +LE+
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNE---KQILEKV 57
Query: 70 DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
+ V L ++ K + LV LM+ G+L+ + H E F A +I G+
Sbjct: 58 NSRFVVSLAYAYETK-DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGL 115
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
LH +++ D+KP NILLD + +ISD GLA
Sbjct: 116 EDLH--QERIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 21/40 (52%), Positives = 30/40 (75%), Gaps = 2/40 (5%)
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
KG+A+ HS N V+H D+KP N+L++ N K++DFGLAR
Sbjct: 110 KGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 25/163 (15%)
Query: 15 DSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVM---DSGSLQGEREFYNELYFASLLEQ 69
D + +G G FG V + + A+KVM + L+ E+ +NE +L++
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNE---KRVLKE 57
Query: 70 DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IAV 123
H + F + + + ++ E + G L L + RFS A
Sbjct: 58 VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG---------RFSNSTGLFYAS 108
Query: 124 DIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+I + YLHS +++ D+KP NILLD K++DFG A+
Sbjct: 109 EIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 31/98 (31%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 69 QDDHVVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAK 127
+ ++VS G F + + + E M G+L D + K P +E + IAV + +
Sbjct: 61 RSPYIVSFYGAFLNENN---ICMCMEFMDCGSL-DRIYKKGGPIPVEILGK--IAVAVVE 114
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
G+ YL++++ ++H DIKPSNIL++ K+ DFG++
Sbjct: 115 GLTYLYNVHR-IMHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 29/173 (16%)
Query: 23 LGQGGFGSVFHATLH----DQSVAVKVM----DSGSLQGEREFYNELYFASLLEQDD--H 72
LG G FG+V +++VAVK++ + +L+ E L A++++Q D +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDEL-----LREANVMQQLDNPY 57
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALL---HKKPPELMEWCKRFSIAVDIAKGI 129
+V ++G + +LV EL G L L H + E + S+ G+
Sbjct: 58 IVRMIGIC---EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GM 108
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGENK 182
YL N +H D+ N+LL AKISDFGL++ EN +A K
Sbjct: 109 KYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 14/154 (9%)
Query: 23 LGQGGFGSVFHATLH--DQSVAVK-VMDSGSLQGEREFYNELYFASLLEQDDH--VVSVL 77
+G+G FG VF L + VAVK ++ + +F E A +L+Q H +V ++
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQE---ARILKQYSHPNIVRLI 59
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNP 137
G + ++ + +V EL+ G+ L + P ++ + + + A G+ YL S +
Sbjct: 60 GVCT--QKQPIYIVMELVQGGDFLTFLRTEGPRLKVK--ELIQMVENAAAGMEYLESKH- 114
Query: 138 PVIHGDIKPSNILLDHNFCAKISDFGLARLKSVG 171
IH D+ N L+ KISDFG++R + G
Sbjct: 115 -CIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 27/156 (17%)
Query: 23 LGQGGFGSVFHATLHDQS----VAVKVMDSGSLQGER-EFYNELYFASLLEQDDHVVSVL 77
LG G FG V + VA+KV+ + + + R E E L+ + ++V ++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD-NPYIVRMI 61
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKPP-------ELMEWCKRFSIAVDIAKGIA 130
G + ++LV E+ S G L L KK ELM ++ G+
Sbjct: 62 GVC---EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMH---------QVSMGMK 109
Query: 131 YLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
YL N +H D+ N+LL + AKISDFGL++
Sbjct: 110 YLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 25/168 (14%)
Query: 17 FSPSRLLGQGGFGSVFHATLHD-------QSVAVKVMDSG-SLQGEREFYNELYFASLLE 68
+ P +G G +G+V+ A +SV V+ + G L RE + LE
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVRE----VALLKRLE 57
Query: 69 QDDH-----VVSVLGFSSNPKRHRMLLVYELMSNGNLQD--ALLHKKPPELMEWCKRFSI 121
DH ++ V S + ++ LV+E + QD L K PP + +
Sbjct: 58 AFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD----QDLRTYLDKVPPPGLPAETIKDL 113
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
+G+ +LH+ ++H D+KP NIL+ K++DFGLAR+ S
Sbjct: 114 MRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 24/111 (21%), Positives = 40/111 (36%), Gaps = 17/111 (15%)
Query: 429 SMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSW 488
+ GT Y+APE G + D++S GV+L L+ G+ P F + +
Sbjct: 155 TFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP----------FPGDDQLLE 204
Query: 489 ARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEV 539
K + + ++ L+ L K P R + EE
Sbjct: 205 LFKKIGKPKPPFPPPEWDISPEAKD--LIR-----KLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 34/175 (19%)
Query: 21 RLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSLQGE-REFYNELYFASLLEQDDH 72
+ LG+G FG V AT +VAVK++ + E R+ +E +LL+Q +H
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEF---NLLKQVNH 62
Query: 73 --VVSVLGFSSNPKRHRMLLVYE-------------------LMSNGNLQDALLHKKPPE 111
V+ + G S +++ Y L S+GN + L
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 112 LMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ S A I++G+ YL + ++H D+ N+L+ KISDFGL+R
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 46/159 (28%), Positives = 68/159 (42%), Gaps = 24/159 (15%)
Query: 23 LGQGGFGSVF----HATLHDQSVAVKVMD-SGSLQGEREF------YNELYFASLLEQDD 71
+G G FG V ++ V VK + S S+Q + +F Y L ++LL+
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 72 HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF--SIAVDIAKGI 129
V + LLV E G+L+ L + ELM +A +IA G+
Sbjct: 63 QCTEVTPY---------LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGL 113
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168
+LH N IH D+ N LL + KI D+GL+ K
Sbjct: 114 LHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNK 150
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 24/157 (15%)
Query: 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREF---YNELYFASLLEQDDHVVS 75
R+LG+G FG V A L + AVKV+ + + + E SL +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IAVDIAKGI 129
+ P R + V E ++ G+L + H ++ +RF A +I +
Sbjct: 61 LYCCFQTPDR--LFFVMEFVNGGDL---MFH------IQKSRRFDEARARFYAAEITSAL 109
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+LH +I+ D+K N+LLDH K++DFG+ +
Sbjct: 110 MFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 50/168 (29%), Positives = 82/168 (48%), Gaps = 19/168 (11%)
Query: 6 SYSVLRRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGE---REFYNELY 62
+++VL+R + P QG + + A L D++VA+K + S Q + + Y EL
Sbjct: 12 TFTVLKRYQN-LKPIGSGAQGIVCAAYDAVL-DRNVAIKKL-SRPFQNQTHAKRAYRELV 68
Query: 63 FASLLEQDDHVVSVLGFSSNPKR----HRMLLVYELMSNGNLQDALLHKKPPELMEWCKR 118
+ + ++S+L + K + LV ELM + NL + + E M +
Sbjct: 69 LMKCVNHKN-IISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY--- 123
Query: 119 FSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ + GI +LHS +IH D+KPSNI++ + KI DFGLAR
Sbjct: 124 --LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 20/162 (12%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS---VAVKVMDSGSLQGEREFYNELYFASLLEQDD 71
+ F+ R LG G FG V AT ++ VA+K + + +++ + +L +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 72 HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IAVDI 125
H V + S + LV E + G L K RF A I
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK---------RFPNDVGCFYAAQI 140
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
YL SLN +++ D+KP N+LLD + K++DFG A++
Sbjct: 141 VLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180
|
Length = 340 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 32/166 (19%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS---VAVKVMDSGSLQGERE--FYNELYFASLLEQ 69
F L+G+G FG V + A+KVM L + F+ E E+
Sbjct: 1 KDFDVKSLVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEE-------ER 52
Query: 70 DDHVVSVLGFSSNP----------KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF 119
D +L S++P + + LV E G+L +LL++ + E +F
Sbjct: 53 D-----ILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL-SLLNRYEDQFDEDMAQF 106
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+A ++ I +H + +H DIKP N+L+D K++DFG A
Sbjct: 107 YLA-ELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSA 149
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 42/148 (28%), Positives = 65/148 (43%), Gaps = 9/148 (6%)
Query: 23 LGQGGFGSVFHATLHDQS--VAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSV-LGF 79
+G+G FG V D A+K + + E + L ++L Q + V L F
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 80 SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPV 139
S ++ LV ++ G L L ++ RF A ++ + LH N V
Sbjct: 61 SFQSP-EKLYLVLAFINGGELFHHL--QREGRFDLSRARFYTA-ELLCALENLHKFN--V 114
Query: 140 IHGDIKPSNILLDHNFCAKISDFGLARL 167
I+ D+KP NILLD+ + DFGL +L
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKL 142
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 23/47 (48%), Positives = 29/47 (61%), Gaps = 2/47 (4%)
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
S + +AKG+++L S N IH D+ NILL H KI DFGLAR
Sbjct: 218 SFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLAR 262
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 51/193 (26%), Positives = 77/193 (39%), Gaps = 42/193 (21%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVV 74
+ F +++G+G FG V V+ D+G + + F +Q HV
Sbjct: 1 EDFHTVKVIGKGAFGEV---------RLVQKKDTGKIYAMKTLLKSEMFKK--DQLAHVK 49
Query: 75 S---VLGFSSNP----------KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSI 121
+ VL S +P + L+ E + G+L L+ K E RF +
Sbjct: 50 AERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI--KYDTFSEDVTRFYM 107
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA-------------RLK 168
A + I +H L IH DIKP NIL+D K+SDFGL+ +L
Sbjct: 108 A-ECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164
Query: 169 SVGENQNQADGEN 181
N+N+ D N
Sbjct: 165 QGKSNKNRIDNRN 177
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 39/158 (24%), Positives = 71/158 (44%), Gaps = 21/158 (13%)
Query: 23 LGQGGFGSVFHA--TLHDQSVAVKVMD----SGSLQGEREFYNE--LYFASLLEQDDHVV 74
LG+G +G V A TL + VA+K + S + +R+ ++F +L E +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRE-----L 71
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IAVDIAKG 128
++ + ++ VY NL ++ ++++ R + I + I G
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNG 131
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ LH +H D+ P+NI ++ KI+DFGLAR
Sbjct: 132 LNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 36/170 (21%)
Query: 10 LRRAADSFSPSRLLGQGGFGSV-----------FHATLHDQSVAVKVMDSGSLQGERE-- 56
LR A+ + +++G+G FG V + L + +K DS ER+
Sbjct: 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 57 -FYNELYFASLLE--QDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELM 113
F N + L QDD + +V E M G+L + + + PE
Sbjct: 98 AFANSPWVVQLFYAFQDDRY--------------LYMVMEYMPGGDLVNLMSNYDVPE-- 141
Query: 114 EWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163
+W + ++ V +A + +HS+ IH D+KP N+LLD + K++DFG
Sbjct: 142 KWARFYTAEVVLA--LDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 19/40 (47%), Positives = 26/40 (65%), Gaps = 2/40 (5%)
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ + Y+H+ N V H D+KP NIL + + KI DFGLAR
Sbjct: 114 RALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 28/181 (15%)
Query: 11 RRAADSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFY---------- 58
+R D F +G+G +G V+ A D + VA+K + L E+E +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV---RLDNEKEGFPITAIREIKI 59
Query: 59 -NELYFASLLEQDDHVVSVLGFSSNPKRHR-MLLVYELMSN---GNLQDALLHKKPPELM 113
+L +++ + V K LV+E M + G L+ L+H +
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119
Query: 114 EWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGEN 173
+ K+ + +G+ Y H N +H DIK SNILL++ K++DFGLARL + E+
Sbjct: 120 SFMKQ------LLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 174 Q 174
+
Sbjct: 172 R 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 22 LLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGE---REFYNELYFASLLEQDDH--VV 74
+G G +GSV A + VA+K + S Q E + Y EL +LL+ H V+
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYREL---TLLKHMQHENVI 77
Query: 75 SVLG-FSSNPKRHRMLLVYELMS--NGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAY 131
+L F+S Y +M +LQ + H + +++ + + G+ Y
Sbjct: 78 GLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-----LVYQMLCGLKY 132
Query: 132 LHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+HS +IH D+KP N+ ++ + KI DFGLAR
Sbjct: 133 IHSAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 18/162 (11%)
Query: 21 RLLGQGGFGSVF---HATLHDQS--VAVKVMDSGSLQGEREF----YNELYFASLLEQDD 71
R+LG G +G VF HD A+KV+ ++ + + E + +
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 72 HVVSV-LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIA 130
+V++ F ++ K H L+ + ++ G L L ++ E R IA +I +
Sbjct: 66 FLVTLHYAFQTDTKLH---LILDYVNGGELFTHLYQREHFTESE--VRVYIA-EIVLALD 119
Query: 131 YLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGE 172
+LH L +I+ DIK NILLD ++DFGL++ E
Sbjct: 120 HLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 23/173 (13%)
Query: 6 SYSVLRRAADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGE---REFYNE 60
+++VL+R + + +G G G V A T+ +VAVK + S Q + + Y E
Sbjct: 16 TFTVLKR----YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL-SRPFQNQTHAKRAYRE 70
Query: 61 LYFASLLEQDDHVVSVLGFSSNPKR----HRMLLVYELMSNGNLQDALLHKKPPELMEWC 116
L + + ++S+L + K + LV ELM + NL + + E M +
Sbjct: 71 LVLLKCVNHKN-IISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY- 127
Query: 117 KRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
+ + GI +LHS +IH D+KPSNI++ + KI DFGLAR
Sbjct: 128 ----LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 72 HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALL-HKKP-PELMEWCKRFSIAVDIAKGI 129
+++ ++ + K R+ LV+ELM + NL + + K+P PE + S + K +
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEK----RVKSYMYQLLKSL 113
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
++H + H DIKP NIL+ + K++DFG R
Sbjct: 114 DHMHRNG--IFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 22/46 (47%), Positives = 31/46 (67%), Gaps = 2/46 (4%)
Query: 125 IAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
I +G+AY H V+H D+KP N+L++ K++DFGLAR KSV
Sbjct: 113 ILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSV 156
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 7e-05
Identities = 42/157 (26%), Positives = 74/157 (47%), Gaps = 10/157 (6%)
Query: 11 RRAADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFASLLE 68
R + F + +G G +G V+ A + A+KV+ L+ +F +++
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMK 61
Query: 69 QDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKG 128
H V F S +R ++ + E G+LQD + H P + + ++ + +G
Sbjct: 62 DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQG 118
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+ YLHS +H DIK +NILL N K++DFG++
Sbjct: 119 LYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 23/43 (53%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 125 IAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA-KISDFGLAR 166
I +GIAY HS V+H D+KP N+L+D A K++DFGLAR
Sbjct: 111 ILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 24/49 (48%), Positives = 29/49 (59%), Gaps = 4/49 (8%)
Query: 118 RFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
RFS V A+G+ +L S N IH D+ N+LL AKI DFGLAR
Sbjct: 216 RFSSQV--AQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 29/161 (18%)
Query: 17 FSPSRLLGQGGFGSVFHATLHDQSV--AVKVM---------DSGSLQGEREFYNELYFAS 65
F + +G G FG V D + A+K + + ++ ER+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDI-------- 54
Query: 66 LLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK--PPELMEWCKRFSIAV 123
L E D+ V L +S K + + V + + G++ L+ +L RF IA
Sbjct: 55 LAEADNEWVVKLYYSFQDKDN-LYFVMDYIPGGDMMSLLIRLGIFEEDL----ARFYIA- 108
Query: 124 DIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164
++ I +H + IH DIKP NIL+D + K++DFGL
Sbjct: 109 ELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 9e-05
Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 12/154 (7%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGERE---FYNELYFASLLEQ 69
+ F +++G+G FG V L D+ A+K+++ + E F E L+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER--DVLVNG 58
Query: 70 DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
D+ ++ L ++ + + + LV + G+L LL K L E RF +A ++ I
Sbjct: 59 DNQWITTLHYAFQDENN-LYLVMDYYVGGDLL-TLLSKFEDRLPEDMARFYLA-EMVIAI 115
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163
+H L+ +H DIKP NIL+D N +++DFG
Sbjct: 116 DSVHQLH--YVHRDIKPDNILMDMNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 9e-05
Identities = 45/151 (29%), Positives = 77/151 (50%), Gaps = 11/151 (7%)
Query: 21 RLLGQGGFGSVF---HATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVS 75
++LGQG FG VF T D Q A+KV+ +L+ ++ L E + +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL 135
L ++ + ++ L+ + + G+L L K E +F +A ++A + +LHSL
Sbjct: 62 KLHYAFQTE-GKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELALALDHLHSL 117
Query: 136 NPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+I+ D+KP NILLD K++DFGL++
Sbjct: 118 G--IIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 32/117 (27%), Positives = 49/117 (41%), Gaps = 15/117 (12%)
Query: 425 TSTPSMRGTVCYVAPE-YGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRA 483
+S + GT Y+APE G K DV+S GV+L L+ G+ P F
Sbjct: 153 SSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP----------FSGE 202
Query: 484 NLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVV 540
N++ + + R D+ S E + CL K P+ RP+ EE++
Sbjct: 203 NILDQLQLIRRILGPPLEFDEPKWSSGSEE----AKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 44.3 bits (103), Expect = 1e-04
Identities = 25/132 (18%), Positives = 36/132 (27%), Gaps = 11/132 (8%)
Query: 412 SAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAG---GDISEKCDVYSYGVLLLVLIAGRR 468
S + GT Y+APE G S D++S G+ L L+ G
Sbjct: 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209
Query: 469 PLQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQK 528
P + + + + L L LL L K
Sbjct: 210 PFE---GEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLL-----KKLLAK 261
Query: 529 SPALRPSMEEVV 540
P R S +
Sbjct: 262 DPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 48/152 (31%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 23 LGQGGFGSVFHA--TLHDQSVAVKVMDS--GSLQGEREFYNELYFASLLEQDDHVVSVLG 78
+G G +GSV A T Q VAVK + SL R Y EL ++ ++ V+ +L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN-VIGLLD 81
Query: 79 F----SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS 134
+S + + LV LM +L + + K +L + +F I + +G+ Y+HS
Sbjct: 82 VFTPATSIENFNEVYLVTNLMG-ADLNNIV---KCQKLSDEHVQFLI-YQLLRGLKYIHS 136
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+IH D+KPSN+ ++ + +I DFGLAR
Sbjct: 137 AG--IIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 12/154 (7%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGERE---FYNELYFASLLEQ 69
D F +++G+G FG V + ++ A+K+++ + E F E L+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNV--LVNG 58
Query: 70 DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
D ++ L ++ + + + LV + G+L LL K L E RF IA ++ I
Sbjct: 59 DCQWITTLHYAFQDENY-LYLVMDYYVGGDLL-TLLSKFEDRLPEDMARFYIA-EMVLAI 115
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163
+H L+ +H DIKP N+LLD N +++DFG
Sbjct: 116 HSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 41/157 (26%), Positives = 65/157 (41%), Gaps = 22/157 (14%)
Query: 23 LGQGGFGSVF-----HATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVL 77
LG+G FG+V+ A ++ +K + G L A LL + DH V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE-AQLLSKLDHPAIVK 66
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKK-------PPELMEWCKRFSIAVDIAKGIA 130
+S +R ++ E +L L K ++ EW + + V
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH------ 120
Query: 131 YLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
Y+H ++H D+K NI L +N KI DFG++RL
Sbjct: 121 YMHQRR--ILHRDLKAKNIFLKNNL-LKIGDFGVSRL 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 42/167 (25%), Positives = 69/167 (41%), Gaps = 23/167 (13%)
Query: 16 SFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSLQG-EREFYNEL-YFASL 66
+ LG+G FG VF A + V VK + + + EF EL F L
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 67 LEQDDHVVSVLGFSSNPKRHRMLLVY-ELMSNGNLQDALLHKKP------PELMEWCKRF 119
+VV +LG + H M+L Y +L G+L+ L K P + ++
Sbjct: 66 --SHKNVVRLLGLCREAEPHYMILEYTDL---GDLKQFLRATKSKDEKLKPPPLSTKQKV 120
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
++ IA G+ +L + +H D+ N L+ K+S L++
Sbjct: 121 ALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 25/113 (22%), Positives = 36/113 (31%), Gaps = 53/113 (46%)
Query: 429 SMRGTVCYVAPE-YGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMS 487
++ GT Y+APE G SEK D++S GV+L +
Sbjct: 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE-----------------------LP 188
Query: 488 WARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVV 540
+ L R LQK P RPS +E++
Sbjct: 189 ELKDLIRK-----------------------------MLQKDPEKRPSAKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 34/144 (23%), Positives = 58/144 (40%), Gaps = 8/144 (5%)
Query: 21 RLLGQGGFGSVFHATLHDQSVAVKV--MDSGSLQGEREFYNELYFASLLEQDDHVVSVLG 78
+ + + VAVK +DS S + + E+ + L+ + + V
Sbjct: 8 KCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 79 FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPP 138
F + + +V LM+ G+ +D L P L E F I D+ + Y+HS
Sbjct: 68 FIVD---SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDYIHSKG-- 121
Query: 139 VIHGDIKPSNILLDHNFCAKISDF 162
IH +K S+ILL + +S
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 37/156 (23%), Positives = 62/156 (39%), Gaps = 24/156 (15%)
Query: 23 LGQGGFGSVFHATLHD-----QSVAVKVMDSGSLQGEREF------YNELYFASLLEQDD 71
+G G FG V H + V ++ S + + F Y EL ++L+
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 72 HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF--SIAVDIAKGI 129
+ + + LLV E G+L++ L + K +A ++A G+
Sbjct: 63 QCIESIPY---------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGL 113
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+LH + IH D+ N L + KI D+GLA
Sbjct: 114 LWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 39/149 (26%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 23 LGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSVL- 77
LG G FG V A + A+K + + ++ + S+L + H +V+++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNP 137
F +R+ + E + G L L +K +F A ++ YLHS +
Sbjct: 86 SFQDE---NRVYFLLEFVVGGELFTHL--RKAGRFPNDVAKFYHA-ELVLAFEYLHSKD- 138
Query: 138 PVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+I+ D+KP N+LLD+ K++DFG A+
Sbjct: 139 -IIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 23 LGQGGFGSVFHATLHDQSV--AVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFS 80
LG G FG V+ A + + A K++ S + +F E+ S + + V +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 81 SNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVI 140
K ++ E G L D+++ + L E R+ + + + + +LHS VI
Sbjct: 73 YENKLWILI---EFCDGGAL-DSIMLELERGLTEPQIRY-VCRQMLEALNFLHSHK--VI 125
Query: 141 HGDIKPSNILLDHNFCAKISDFGL-ARLKS 169
H D+K NILL + K++DFG+ A+ KS
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKS 155
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 44/160 (27%), Positives = 72/160 (45%), Gaps = 26/160 (16%)
Query: 21 RLLGQGGFGSVFHATLHD-------QSVAVKVMDSGS-------LQGEREFYNELYFASL 66
R LG+G FG V +D + VAVK + S L+ E E LY
Sbjct: 10 RDLGEGHFGKV-ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY---- 64
Query: 67 LEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIA 126
+++V G + + + L+ E + +G+L++ L K ++ ++ AV I
Sbjct: 65 ---HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKY--AVQIC 119
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
KG+ YL S +H D+ N+L++ KI DFGL +
Sbjct: 120 KGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 19/44 (43%), Positives = 30/44 (68%), Gaps = 2/44 (4%)
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
+G++Y H ++H D+KP N+L++ K++DFGLAR KSV
Sbjct: 114 RGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSV 155
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 20/42 (47%), Positives = 30/42 (71%), Gaps = 2/42 (4%)
Query: 125 IAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
I +G+ Y+HS + +IH D+KPSN+ ++ + KI DFGLAR
Sbjct: 129 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 47/176 (26%), Positives = 73/176 (41%), Gaps = 54/176 (30%)
Query: 17 FSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLE-----QDD 71
F+ +LG+G FG V + ER+ +ELY +L+ QDD
Sbjct: 2 FNFLMVLGKGSFGKV-------------------MLAERKGTDELYAIKILKKDVIIQDD 42
Query: 72 HVVS------VLGFSSNP----KRH-------RMLLVYELMSNGNL----QDALLHKKPP 110
V VL P + H R+ V E ++ G+L Q K+P
Sbjct: 43 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPH 102
Query: 111 ELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ A +IA G+ +LHS +I+ D+K N++LD KI+DFG+ +
Sbjct: 103 AVF-------YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 34/149 (22%), Positives = 56/149 (37%), Gaps = 16/149 (10%)
Query: 21 RLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVV-SVLGF 79
+LL G V+ D+ +K + S + + E+ LL + V VL
Sbjct: 4 KLLKGGLTNRVYLLGTKDEDYVLK--INPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 80 SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPV 139
L+ E + + + + ++ IA +A+ +A LH L V
Sbjct: 62 G--ESDGWSYLLMEW----------IEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLV 109
Query: 140 -IHGDIKPSNILLDHNFCAKISDFGLARL 167
HGD+ P NIL+D I D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 8/75 (10%)
Query: 93 ELMSNGNLQDALLHK--KPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNIL 150
E M G+L D +L K + PE + SIAV +G+ YL ++H D+KPSNIL
Sbjct: 79 EHMDGGSL-DQVLKKAGRIPE--NILGKISIAV--LRGLTYLRE-KHKIMHRDVKPSNIL 132
Query: 151 LDHNFCAKISDFGLA 165
++ K+ DFG++
Sbjct: 133 VNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 21 RLLGQGGFGSVFHATLHD--QSVAVKVM--DSGSLQGEREFYNELYFASLLE--QDDHVV 74
+LLGQG FG V+ D + +A K + D S + +E LL+ Q + +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS 134
G + + + E M G+++D L K L E R I +G++YLHS
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTR-KYTRQILEGMSYLHS 124
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLA-RLKSV 170
++H DIK +NIL D K+ DFG + RL+++
Sbjct: 125 --NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 6 SYSVLRRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGE---REFYNELY 62
+++VL+R + P QG + + A L +++VA+K + S Q + + Y EL
Sbjct: 19 TFTVLKRYQN-LKPIGSGAQGIVCAAYDAIL-ERNVAIKKL-SRPFQNQTHAKRAYRELV 75
Query: 63 FASLLEQDDHVVSVLGFSSNPKR----HRMLLVYELMSNGNLQDALLHKKPPELMEWCKR 118
+ + ++ +L + K + +V ELM + NL + + E M +
Sbjct: 76 LMKCVNHKN-IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY--- 130
Query: 119 FSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ + GI +LHS +IH D+KPSNI++ + KI DFGLAR
Sbjct: 131 --LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 4e-04
Identities = 16/47 (34%), Positives = 24/47 (51%)
Query: 423 GVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRP 469
+ T + GT Y+APE G + D +S GVLL ++ G+ P
Sbjct: 146 EGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 48/169 (28%), Positives = 82/169 (48%), Gaps = 21/169 (12%)
Query: 23 LGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQ--DDHVVSVLG 78
LG+GGFG V + + A K ++ L+ + + + +L + +VS L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS-LA 59
Query: 79 FSSNPKRHRMLLVYELMSNGNLQDAL--LHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN 136
++ K + LV +M+ G+L+ + + ++ P E F A I G+ +LH
Sbjct: 60 YAFQTKTD-LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTA-QIISGLEHLHQRR 117
Query: 137 PPVIHGDIKPSNILLDHNFCAKISDFGLA-RLKSVGENQNQADGENKNK 184
+I+ D+KP N+LLD++ +ISD GLA LK DG++K K
Sbjct: 118 --IIYRDLKPENVLLDNDGNVRISDLGLAVELK---------DGQSKTK 155
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 44/168 (26%), Positives = 72/168 (42%), Gaps = 40/168 (23%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-----------------QGER 55
D F +++G+G FG V + Q A+K+++ + G+R
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 56 EFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEW 115
+ L++A QD++ + LV + G+L LL K L E
Sbjct: 61 RWITNLHYAF---QDEN--------------NLYLVMDYYVGGDLL-TLLSKFEDRLPED 102
Query: 116 CKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163
RF +A ++ I +H L +H DIKP N+LLD N +++DFG
Sbjct: 103 MARFYLA-EMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 19/44 (43%), Positives = 29/44 (65%), Gaps = 2/44 (4%)
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
+G+ Y H V+H D+KP N+L++ K++DFGLAR KS+
Sbjct: 115 RGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSI 156
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 22/176 (12%)
Query: 21 RLLGQGGFGSVF--HATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH-VVSVL 77
+LLG+G FG V + A+K++ + + E + L + +L+ H ++ L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNP 137
+S K R+ V E ++ G L H + + +I + YLHS
Sbjct: 61 KYSFQTK-DRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHS--G 114
Query: 138 PVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGENKNKAAELESNCG 193
+++ D+K N++LD + KI+DFGL + E AA +++ CG
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK-------------EGITDAATMKTFCG 157
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 13/156 (8%)
Query: 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLLEQ- 69
+F R+LG+GGFG V + + A K ++ ++ GE NE +LE+
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE---KRILEKV 57
Query: 70 DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
+ V L ++ K + LV +M+ G+L+ + + P E F A ++ G+
Sbjct: 58 NSRFVVSLAYAYETK-DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF-YAAELCCGL 115
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
L +++ D+KP NILLD +ISD GLA
Sbjct: 116 EDLQ--RERIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 39/144 (27%), Positives = 67/144 (46%), Gaps = 11/144 (7%)
Query: 23 LGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFS 80
+GQG G+V+ A Q VA+K M+ + NE+ ++ ++ H V
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEIL---VMRENKHPNIVNYLD 83
Query: 81 SNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVI 140
S + +V E ++ G+L D + M+ + ++ + + + +LHS VI
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VI 137
Query: 141 HGDIKPSNILLDHNFCAKISDFGL 164
H DIK NILL + K++DFG
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 40/149 (26%), Positives = 69/149 (46%), Gaps = 17/149 (11%)
Query: 23 LGQGGFGSVFHATLHDQSV--AVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFS 80
LG G FG V+ A + V A KV+D+ S E E + + +L DH V
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 81 SNPKRHRMLLVYELMSNGNLQDALLH-KKP---PELMEWCKRFSIAVDIAKGIAYLHSLN 136
+ + + ++ E + G + +L ++P P++ CK+ + + YLH
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ------TLEALNYLH--E 121
Query: 137 PPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+IH D+K NIL + K++DFG++
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 40/152 (26%), Positives = 73/152 (48%), Gaps = 23/152 (15%)
Query: 23 LGQGGFGSVFHATLHDQSV--AVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSVLG 78
LG G FG V+ A + A KV+++ S E E + + +L +H +V +LG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 79 -FSSNPKRHRMLLVYELMSNGNLQDALLHK----KPPELMEWCKRFSIAVDIAKGIAYLH 133
F + K + ++ E G + +L P++ C++ + + + YLH
Sbjct: 77 AFYWDGK---LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ------MLEALQYLH 127
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
S+ +IH D+K N+LL + K++DFG++
Sbjct: 128 SMK--IIHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 38/144 (26%), Positives = 69/144 (47%), Gaps = 11/144 (7%)
Query: 23 LGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFS 80
+GQG G+VF A Q VA+K ++ + NE+ L ++ ++V+ L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFL--D 83
Query: 81 SNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVI 140
S + +V E ++ G+L D + M+ + ++ + + + +LH+ VI
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHA--NQVI 137
Query: 141 HGDIKPSNILLDHNFCAKISDFGL 164
H DIK N+LL + K++DFG
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 46/165 (27%), Positives = 70/165 (42%), Gaps = 17/165 (10%)
Query: 8 SVLRRAADSFSPSRLL------GQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYN 59
+ LR D P LL G+G G V A + VAVK+MD Q +N
Sbjct: 8 AALRMVVDQGDPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN 67
Query: 60 ELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF 119
E+ ++ H V + S + ++ E + G L D + + E +
Sbjct: 68 EVV---IMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEE----QIA 120
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164
++ + + + YLHS VIH DIK +ILL + K+SDFG
Sbjct: 121 TVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGF 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 48/184 (26%), Positives = 74/184 (40%), Gaps = 29/184 (15%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQSVAVK---VMDSGSLQGEREFY-NE-LYFASLLEQ 69
D F + LG+G FG V+ A+L ++ + V+ + G E + NE + A
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSC 191
Query: 70 DDHVVSVLGFSSNPKRHRMLLV---------YELMSNGNLQ---DALLHKKPPELMEWCK 117
D V L S+ K LV +LM + + L K +L + +
Sbjct: 192 ADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLE 251
Query: 118 RFSIAV-----DIAKGIAYLHSLNPPVIHGDIKPSNILLDH---NFCAKISDFGLARLKS 169
R + + I + LHS ++H D+KP NI+ +F KI D G A
Sbjct: 252 RENKIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSF--KIIDLGAAADLR 307
Query: 170 VGEN 173
VG N
Sbjct: 308 VGIN 311
|
Length = 566 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 41/149 (27%), Positives = 72/149 (48%), Gaps = 9/149 (6%)
Query: 21 RLLGQGGFGSVF--HATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH-VVSVL 77
+LLG+G FG V + A+K++ + + E + + + +L+ H ++ L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNP 137
++ R+ V E + G L L ++ E RF A +I + YLHS +
Sbjct: 61 KYAFQ-THDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGA-EIVSALEYLHSRD- 115
Query: 138 PVIHGDIKPSNILLDHNFCAKISDFGLAR 166
V++ DIK N++LD + KI+DFGL +
Sbjct: 116 -VVYRDIKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 44/158 (27%), Positives = 70/158 (44%), Gaps = 17/158 (10%)
Query: 14 ADSFSPSRLLGQGGFGSVFHATLHDQS-----VAVKVM-DSGSLQGEREFYNELYFASLL 67
S R+LG G FG + L S VA+ + S + R F E A L
Sbjct: 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAE---ALTL 60
Query: 68 EQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDI 125
Q DH +V + G + + + M++V E MSNG L D+ L K +L+ + + +
Sbjct: 61 GQFDHSNIVRLEGVIT--RGNTMMIVTEYMSNGAL-DSFLRKHEGQLVA-GQLMGMLPGL 116
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163
A G+ YL + +H + +L++ + KIS F
Sbjct: 117 ASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 40/166 (24%), Positives = 68/166 (40%), Gaps = 20/166 (12%)
Query: 17 FSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGERE-----FYNELYFASLLEQDD 71
+ +G+G +G VF A + +Q E E+ LE +
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 72 H-----VVSVLGFSSNPKRHRMLLVYELMSNG---NLQDALLHKKPPELMEWCKRFSIAV 123
H + V S + ++ LV+E + L P E ++ +
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-----DMMF 117
Query: 124 DIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
+ +G+ +LHS V+H D+KP NIL+ + K++DFGLAR+ S
Sbjct: 118 QLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYS 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 13/151 (8%)
Query: 21 RLLGQGGFGSVF----HATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH-VVS 75
+LLG+G FG V AT + A+K++ + + E + L + +L+ H ++
Sbjct: 1 KLLGKGTFGKVILVREKAT--GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL 135
L +S R+ V E + G L L ++ E RF A +I + YLHS
Sbjct: 59 ALKYSFQTH-DRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGA-EIVSALGYLHSC 114
Query: 136 NPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ V++ D+K N++LD + KI+DFGL +
Sbjct: 115 D--VVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 41/174 (23%), Positives = 71/174 (40%), Gaps = 42/174 (24%)
Query: 21 RLLGQGGFGSVFHATLHDQS--VAVKVMDSG------------------SLQGEREFYNE 60
++LG+G FG V A L + AVK + +L E F
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 61 LYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS 120
LY + +H + V E ++ G+L + H + + +
Sbjct: 61 LY--CTFQTKEH---------------LFFVMEFLNGGDL---MFHIQDKGRFDLYRATF 100
Query: 121 IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQ 174
A +I G+ +LHS +I+ D+K N++LD + KI+DFG+ + G+N+
Sbjct: 101 YAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR 152
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 48/176 (27%), Positives = 72/176 (40%), Gaps = 54/176 (30%)
Query: 17 FSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLE-----QDD 71
F+ +LG+G FG V A ER+ +ELY +L+ QDD
Sbjct: 2 FNFLMVLGKGSFGKVMLA-------------------ERKGTDELYAIKILKKDVVIQDD 42
Query: 72 HV------VSVLGFSSNP-----------KRHRMLLVYELMSNGNL----QDALLHKKPP 110
V VL S P R+ V E ++ G+L Q K+P
Sbjct: 43 DVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPH 102
Query: 111 ELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ A +IA G+ +LHS +I+ D+K N++LD KI+DFG+ +
Sbjct: 103 AVF-------YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 12/174 (6%)
Query: 14 ADSFSPSRLLGQGGFGSVF--HATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDD 71
+D++ +G+G +G VF + AVK++D E E E L
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE-EIEAEYNILKALSDHP 75
Query: 72 HVVSVLG--FSSNPKR-HRMLLVYELMSNGNLQDAL--LHKKPPELMEWCKRFSIAVDIA 126
+VV G + + K ++ LV EL + G++ D + K+ + E + I +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-ILHEAL 134
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL-ARLKSVGENQNQADG 179
G+ +LH IH D+K +NILL K+ DFG+ A+L S +N + G
Sbjct: 135 MGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 186
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 0.001
Identities = 29/125 (23%), Positives = 53/125 (42%), Gaps = 18/125 (14%)
Query: 414 ASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVT 473
+ + T S+RGT ++APE G + D++S G ++ + G+ P
Sbjct: 147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206
Query: 474 GSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALR 533
G+PM A L + +G+ E+ + E+A + CL++ P R
Sbjct: 207 GNPM-----AALY----KIGSSGEPPEIPEHLS------EEAKDFL---RKCLRRDPKKR 248
Query: 534 PSMEE 538
P+ +E
Sbjct: 249 PTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 20/48 (41%), Positives = 29/48 (60%), Gaps = 6/48 (12%)
Query: 426 STPSMRGTVCYVAPE----YGAGGDISEKCDVYSYGVLLLVLIAGRRP 469
SM+G+V ++APE Y G S K D++S G ++L + AGRRP
Sbjct: 166 QNMSMQGSVFWMAPEVIHSYSQG--YSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 25/66 (37%), Positives = 30/66 (45%), Gaps = 4/66 (6%)
Query: 411 DSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPL 470
D SGE+ S T T GT Y+APE G S DV+S G+ LL + R P
Sbjct: 148 DFGVSGELVNSLAGTFT----GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
Query: 471 QVTGSP 476
G P
Sbjct: 204 PPEGEP 209
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 43/170 (25%), Positives = 78/170 (45%), Gaps = 37/170 (21%)
Query: 15 DSFSPSRLLGQGGFGSVF---HATLHDQSVAVKVMDSGSL----QGEREFYNE--LYFAS 65
+ F +L+ G +G+V+ H Q A+K ++ +L Q ++ F L FA
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETR-QRFAMKKINKQNLILRNQIQQVFVERDILTFA- 58
Query: 66 LLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDI 125
++ VVS+ S KRH + +V E + G+ L + + VD+
Sbjct: 59 ---ENPFVVSMFC-SFETKRH-LCMVMEYVEGGDCATLLKNIGA-----------LPVDM 102
Query: 126 AK--------GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
A+ + YLH+ ++H D+KP N+L+ K++DFGL+++
Sbjct: 103 ARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 49/164 (29%), Positives = 72/164 (43%), Gaps = 22/164 (13%)
Query: 21 RLLGQGGFGSVF---HATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVL 77
R++G+G +G V H T Q V K+ + + ER+ + A LL Q H V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQE--AQLLSQLKHPNIVA 63
Query: 78 GFSSNPKRHRML-LVYELMSNGNLQDALLHKKP---PE--LMEWCKRFSIAVDIAKGIAY 131
S +L +V G+L L +K PE ++EW V IA + Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMALQY 117
Query: 132 LHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQN 175
LH + ++H D+K N+ L K+ D G+AR V ENQ
Sbjct: 118 LHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIAR---VLENQC 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 14/151 (9%)
Query: 23 LGQGGFGSVFHATLHDQS--VAVKVMDSGSLQGEREFYNEL-----YFASLLEQDDHVVS 75
+G+G FG V+ D A+KV+ + ++E + + +LL++ +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL 135
L FS + LV + MS G L L +K E +F IA ++ + +LH
Sbjct: 61 -LKFSFQTDSD-LYLVTDYMSGGELFWHL--QKEGRFSEDRAKFYIA-ELVLALEHLHKY 115
Query: 136 NPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ +++ D+KP NILLD + DFGL++
Sbjct: 116 D--IVYRDLKPENILLDATGHIALCDFGLSK 144
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 40/153 (26%), Positives = 69/153 (45%), Gaps = 21/153 (13%)
Query: 23 LGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGE-----REFYNELYFASLLEQDDHVVS 75
LG+G + +V+ + VA+K + + +G RE SL+++ H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREI-------SLMKELKHENI 60
Query: 76 VLGFSSNPKRHRMLLVYELMSNG--NLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLH 133
V ++++LV+E M D + + K F+ + KGIA+ H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNT-VKSFTY--QLLKGIAFCH 117
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
V+H D+KP N+L++ K++DFGLAR
Sbjct: 118 ENR--VLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 25/85 (29%), Positives = 40/85 (47%), Gaps = 14/85 (16%)
Query: 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKP 146
++V E + L+D L++ E +E + +I + + LHS +IHGD+
Sbjct: 73 NFIIVMEYIEGEPLKD-LINSNGMEELELSR------EIGRLVGKLHSAG--IIHGDLTT 123
Query: 147 SNILLDHNFCAKIS--DFGLARLKS 169
SN++L KI DFGLA
Sbjct: 124 SNMILSGG---KIYLIDFGLAEFSK 145
|
Length = 211 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 0.002
Identities = 28/128 (21%), Positives = 41/128 (32%), Gaps = 60/128 (46%)
Query: 432 GTVCYVAPE------YGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANL 485
GT Y++PE Y + K D++S G +L L + P F+ NL
Sbjct: 165 GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP----------FEGENL 208
Query: 486 MSWARHLARN--------------GKLIELVDQAVVKSLDREQALLCITVALLCLQKSPA 531
+ LA +L LV LQK P
Sbjct: 209 LE----LALKILKGQYPPIPSQYSSELRNLVSS--------------------LLQKDPE 244
Query: 532 LRPSMEEV 539
RPS+ ++
Sbjct: 245 ERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 27/110 (24%), Positives = 44/110 (40%), Gaps = 20/110 (18%)
Query: 432 GTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSWARH 491
GT Y+APE G S K D++S G LL + P + M + R+
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE--ARSMQDL---------RY 211
Query: 492 LARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVG 541
+ GK + + S D + + LQ P LRP+ ++++
Sbjct: 212 KVQRGKYPPI---PPIYSQDLQNFI------RSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 42/172 (24%), Positives = 78/172 (45%), Gaps = 18/172 (10%)
Query: 11 RRAADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMD-SGSLQGERE--------FYN 59
+ A + SR+LG G G+V A + AVKV+D G + ++ N
Sbjct: 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLN 87
Query: 60 ELYFASLLEQDDHVVSVLGFSSNPKRHRML-LVYELMSNGNLQDALLHK-KPPELMEWCK 117
+F+ + +D NP+ M+ LV + + G+L+ + + K +
Sbjct: 88 CDFFSIVKCHEDFAKKD---PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHE 144
Query: 118 RFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
+ + + + ++HS + +IH DIK +NILL N K+ DFG +++ +
Sbjct: 145 AGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGDFGFSKMYA 194
|
Length = 496 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 28/163 (17%)
Query: 23 LGQGGFGSVFHATL------------HDQSVAVKVMDSGSLQGEREFYNELYFASLLEQD 70
LGQG F +++ L + SV +KV+ S F+ S L
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQL-SH 60
Query: 71 DHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIA 130
H+V + G + ++V E + G L D LH++ + K +A +A +
Sbjct: 61 KHLVKLYGVCVRDEN---IMVEEYVKFGPL-DVFLHREKNNVSLHWK-LDVAKQLASALH 115
Query: 131 YLHSLNPPVIHGDIKPSNILL-------DHNFCAKISDFGLAR 166
YL ++HG++ NIL+ + K+SD G+
Sbjct: 116 YLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 18/42 (42%), Positives = 28/42 (66%), Gaps = 2/42 (4%)
Query: 125 IAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ KG+ Y+H+ +IH D+KP N+ ++ + KI DFGLAR
Sbjct: 127 MLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 46/177 (25%), Positives = 72/177 (40%), Gaps = 54/177 (30%)
Query: 16 SFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLE-----QD 70
F+ +LG+G FG V A ER+ +ELY +L+ QD
Sbjct: 1 DFNFLMVLGKGSFGKVMLA-------------------ERKGTDELYAIKILKKDVVIQD 41
Query: 71 DHV------VSVLGFSSNP----KRH-------RMLLVYELMSNGNL----QDALLHKKP 109
D V VL P + H R+ V E ++ G+L Q K+P
Sbjct: 42 DDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP 101
Query: 110 PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ A +I+ G+ +LH +I+ D+K N++LD KI+DFG+ +
Sbjct: 102 QAVF-------YAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 42/159 (26%), Positives = 77/159 (48%), Gaps = 28/159 (17%)
Query: 21 RLLGQGGFGSVFHATL--HDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLG 78
R++G+G + V L +DQ A+KV+ ++E ++ ++ + HV
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVV-------KKELVHDDEDIDWVQTEKHVFEQA- 52
Query: 79 FSSNP----------KRHRMLLVYELMSNGNLQDALLH-KKPPELMEWCKRFSIAVDIAK 127
SSNP R+ LV E ++ G+L + H ++ +L E RF A +I
Sbjct: 53 -SSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARF-YAAEICI 107
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ +LH +I+ D+K N+LLD + K++D+G+ +
Sbjct: 108 ALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 53/180 (29%), Positives = 79/180 (43%), Gaps = 42/180 (23%)
Query: 21 RLLGQGGFGSVFHA------TLHDQSVAVK----VMDSGSLQGE--REFYNELYFASLLE 68
+ LG G F S + A TL +AVK V ++ S Q E E+ + L
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTL----MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 69 QDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIA-- 126
H++ +LG ++ H L V E M+ G++ LL K F AV I
Sbjct: 62 HP-HIIRMLG-ATCEDSHFNLFV-EWMAGGSVS-HLLSKYGA--------FKEAVIINYT 109
Query: 127 ----KGIAYLHSLNPPVIHGDIKPSNILLDHN-FCAKISDFGLA-----RLKSVGENQNQ 176
+G++YLH +IH D+K +N+L+D +I+DFG A + GE Q Q
Sbjct: 110 EQLLRGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 34/136 (25%), Positives = 58/136 (42%), Gaps = 20/136 (14%)
Query: 411 DSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPL 470
D SGE+ S + T GT Y++PE GG + K DV+S G+ ++ L G+ P
Sbjct: 147 DFGVSGELINS--IADT--FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202
Query: 471 QVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQA----LLCITVALLCL 526
S + + + + M +++L+ Q V + R + CL
Sbjct: 203 --AFSNIDDDGQDDPMG----------ILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACL 250
Query: 527 QKSPALRPSMEEVVGM 542
K P RP+ +++ M
Sbjct: 251 LKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 25/59 (42%), Positives = 31/59 (52%), Gaps = 4/59 (6%)
Query: 108 KPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
K P +E +S V A+G+ +L S IH D+ NILL N KI DFGLAR
Sbjct: 167 KEPLTLEDLISYSFQV--ARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 41/151 (27%), Positives = 69/151 (45%), Gaps = 9/151 (5%)
Query: 17 FSPSRLLGQGGFGSVFHATLHDQSV--AVKVMDSGSLQGEREFYNELYFASLLEQDDHVV 74
F + LG G FG V A D A+K + + + + +L + D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP-PELMEWCKRFSIAVDIAKGIAYLH 133
V + S + + V + + G++ L+ + PE++ RF IA ++ I +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIA-ELTLAIESVH 118
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164
+ IH DIKP NIL+D + K++DFGL
Sbjct: 119 KMG--FIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 40/151 (26%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 21 RLLGQGGFGSVF----HATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH-VVS 75
+LLG+G FG V AT A+K++ + + E + L +L+ H ++
Sbjct: 1 KLLGKGTFGKVILVKEKATGR--YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL 135
L +S R+ V E + G L H + + +I + YLHS
Sbjct: 59 ALKYSFQ-THDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHS- 113
Query: 136 NPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
V++ D+K N++LD + KI+DFGL +
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 37/154 (24%), Positives = 68/154 (44%), Gaps = 11/154 (7%)
Query: 21 RLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREF--YNELYFASLLEQDDHVVSV 76
R++G+G FG V + V +K + + + NE LL H +
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS---HPNII 62
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN 136
+ + + +++V E G L + + K+ L++ V I + ++H+
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAE-YIQKRCNSLLDEDTILHFFVQILLALHHVHTKL 121
Query: 137 PPVIHGDIKPSNILLD-HNFCAKISDFGLARLKS 169
++H D+K NILLD H KI DFG++++ S
Sbjct: 122 --ILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 11/144 (7%)
Query: 23 LGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFS 80
+GQG G+V+ A Q VA+K M+ + NE+ ++ ++ + V
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEIL---VMRENKNPNIVNYLD 83
Query: 81 SNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVI 140
S + +V E ++ G+L D + M+ + ++ + + + +LHS VI
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHS--NQVI 137
Query: 141 HGDIKPSNILLDHNFCAKISDFGL 164
H DIK NILL + K++DFG
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 576 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.98 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.76 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.75 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.74 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.74 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.69 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.64 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.63 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.59 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.58 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.58 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.32 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.21 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.18 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.04 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.0 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.89 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.82 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.81 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.78 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.73 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.66 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.57 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.41 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.34 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.26 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.24 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.15 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.11 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.09 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.09 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.06 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.01 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.94 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.88 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.86 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.75 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.68 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.55 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.52 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.42 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.37 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.28 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.25 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.24 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.14 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.13 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.88 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.85 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.8 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.42 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.06 | |
| PLN02236 | 344 | choline kinase | 96.05 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.96 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.81 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.77 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.55 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.43 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.23 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.98 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.76 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 94.68 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.6 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.57 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.18 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.14 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.64 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 93.62 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 92.19 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.19 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 92.09 | |
| PTZ00384 | 383 | choline kinase; Provisional | 90.4 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 90.07 | |
| PTZ00296 | 442 | choline kinase; Provisional | 89.98 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 89.01 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 88.71 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=390.84 Aligned_cols=289 Identities=45% Similarity=0.733 Sum_probs=246.6
Q ss_pred CCCCChHHHHhhcCCCCccceeeccCcEEEEEEEECC-ceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEe
Q 036407 2 PHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFS 80 (576)
Q Consensus 2 ~~~fs~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~g-~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~ 80 (576)
++.|++.+|+.+|++|.....||+|+||.||+|...+ ..||||.+.........+|.+|+.++.+++| +|++.++|||
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H-~Nlv~LlGyC 140 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRH-PNLVKLLGYC 140 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCC-cCcccEEEEE
Confidence 4569999999999999999999999999999999985 8999998875543314459999999999995 9999999999
Q ss_pred eCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEE
Q 036407 81 SNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKI 159 (576)
Q Consensus 81 ~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKL 159 (576)
.+... ..+||+||+++|+|.+++...... .++|.++++|+.+++.||+|||. ..++|+||||||+|||||.++.+||
T Consensus 141 ~e~~~-~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGE-HRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCc-eEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 98732 689999999999999999875543 58999999999999999999998 5568999999999999999999999
Q ss_pred ccccccccccC-CCCCcCcCCCCccccchhhhccCCCCCCCCcceecccccccccccccccccccccCcchhHhhhhccc
Q 036407 160 SDFGLARLKSV-GENQNQADGENKNKAAELESNCGAAVEDCGSVVETESVNTTTTATAFEDLSVGIDQSPETFLKMTQKQ 238 (576)
Q Consensus 160 iDFGlA~~~~~-~~~~~~~~gt~~y~APEl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (576)
+|||+|+..+. ..
T Consensus 219 sDFGLa~~~~~~~~------------------------------------------------------------------ 232 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDT------------------------------------------------------------------ 232 (361)
T ss_pred cCccCcccCCcccc------------------------------------------------------------------
Confidence 99999964332 10
Q ss_pred chhHHHHhhhcccccccchhhhhHHHHHHHHhhhcCCCCCCCCcccCCCCCcccccccccccccccccccccccchhHHH
Q 036407 239 TQSTEALEKKASVDENVKEDVKVKEYVIEWIGTAIGNERPKSDWIGRDTGSSSSVGGKVDRKKSRKRLDWWVSLDEDKEE 318 (576)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (576)
T Consensus 233 -------------------------------------------------------------------------------- 232 (361)
T KOG1187|consen 233 -------------------------------------------------------------------------------- 232 (361)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred HHHhhhhhhccccccchhhhHHHHHHHHHHHhhhhccCCCCCCCCCCCChhhHHHHhccccccccccCCCCCcccccccc
Q 036407 319 NVKNLKRERRRRPAREWWKEEYCEELAKKKKKKKRALGTNSDDDWWPRDEELYVERKKKSKTRSRSRSSIGSLDWWLEGF 398 (576)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (576)
T Consensus 233 -------------------------------------------------------------------------------- 232 (361)
T KOG1187|consen 233 -------------------------------------------------------------------------------- 232 (361)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cchhhhhhccccCccccCCCCCCCcceeeccccCccccccccccCCCCcccccceeehhHHHHHHHhCCCCccccCCCch
Q 036407 399 SGELYRARHNSYDSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMS 478 (576)
Q Consensus 399 ~~~~~~~~~~~~d~~~~~~i~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~G~~l~eli~g~~pf~~~~~~~~ 478 (576)
.+..+. .||.+|+|||+...+..+.|+|||||||+|+||++|+.|.+....
T Consensus 233 ------------------------~~~~~~--~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~--- 283 (361)
T KOG1187|consen 233 ------------------------SVSTTV--MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP--- 283 (361)
T ss_pred ------------------------ceeeec--CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC---
Confidence 000001 799999999999999999999999999999999999998875441
Q ss_pred hhhhhhHHHHHHHhccccchhhhhhhHHh-hhcCH-HHHHHHHHHHHhhcccCCCCCCCHHHHHHHhccccCC
Q 036407 479 EFQRANLMSWARHLARNGKLIELVDQAVV-KSLDR-EQALLCITVALLCLQKSPALRPSMEEVVGMLTGKLEA 549 (576)
Q Consensus 479 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~cl~~dP~~Rps~~~v~~~l~~~~e~ 549 (576)
....++..|+..+.....+.+++|+.+. ...+. ++...+..++.+|++.+|..||+|.||+.+|+.+...
T Consensus 284 -~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 284 -RGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred -cccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 2234589999998888899999999986 45553 6888899999999999999999999999999665544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=364.03 Aligned_cols=153 Identities=35% Similarity=0.569 Sum_probs=132.5
Q ss_pred hcCCCCccceeeccCcEEEEEEEECCce-EEEEEeecCCchh--HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLHDQS-VAVKVMDSGSLQG--EREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~g~~-VAVK~i~~~s~~~--~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
..+.+.+.+.||+|+||+||+|.+.|.. ||||++....... ...|.+|+.++.+|+| |||+.++|+|..+.. .++
T Consensus 39 ~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~H-pNIV~f~G~~~~~~~-~~~ 116 (362)
T KOG0192|consen 39 DPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRH-PNIVQFYGACTSPPG-SLC 116 (362)
T ss_pred ChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCC-CCeeeEEEEEcCCCC-ceE
Confidence 3445566777999999999999999988 9999997644333 4589999999999988 999999999987632 789
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC-cEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF-CAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g-~vKLiDFGlA~~~ 168 (576)
|||||+++|+|.+++... ....+++..++.++.+|+.|+.|||++++ ||||||||+|||++.++ ++||+|||+++..
T Consensus 117 iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceee
Confidence 999999999999999774 22348899999999999999999999887 99999999999999997 9999999999754
Q ss_pred c
Q 036407 169 S 169 (576)
Q Consensus 169 ~ 169 (576)
.
T Consensus 195 ~ 195 (362)
T KOG0192|consen 195 V 195 (362)
T ss_pred c
Confidence 3
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=351.09 Aligned_cols=146 Identities=26% Similarity=0.361 Sum_probs=129.3
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
+++.+..||+|..|+||+++++ ++.+|+|.+..+. ....+++.+|++++..+.+ |+||.+++.|+.+.. .++|+|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~s-pyIV~~ygaF~~~~~-~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQS-PYIVGFYGAFYSNGE-EISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCC-CCeeeEeEEEEeCCc-eEEeeh
Confidence 5667889999999999999987 8999999996443 3445789999999999966 999999999998733 699999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||++|+|...+...+. +++...-.|+.+|++||.|||. ++ ||||||||+|||++..|.+||+|||+++.+
T Consensus 158 EYMDgGSLd~~~k~~g~---i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGR---IPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred hhcCCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 99999999999887644 7888888999999999999996 88 999999999999999999999999998754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=359.37 Aligned_cols=148 Identities=31% Similarity=0.518 Sum_probs=134.2
Q ss_pred CCCCccceeeccCcEEEEEEEE-C-CceEEEEEeecC---CchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATL-H-DQSVAVKVMDSG---SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~-~-g~~VAVK~i~~~---s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
..|...++||+|+|+.||.++. . |+.||+|++.+. ....++.+.+||++.+.|.| ||||+++.+|.+. +++|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~H-pnIV~f~~~FEDs--~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKH-PNIVQFYHFFEDS--NNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCC-CcEEeeeeEeecC--CceE
Confidence 4699999999999999999987 3 899999999753 23446789999999999988 9999999999887 8999
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
||+|+|..++|.++++.+.. +++..+..+++||+.||.|||+++ |+|||||..|+||+++..+||+|||+|..+.
T Consensus 95 ivLELC~~~sL~el~Krrk~---ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRKP---LTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EEEEecCCccHHHHHHhcCC---CCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeec
Confidence 99999999999999986554 889999999999999999999999 9999999999999999999999999998765
Q ss_pred C
Q 036407 170 V 170 (576)
Q Consensus 170 ~ 170 (576)
.
T Consensus 170 ~ 170 (592)
T KOG0575|consen 170 Y 170 (592)
T ss_pred C
Confidence 4
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=344.32 Aligned_cols=151 Identities=26% Similarity=0.431 Sum_probs=135.4
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecC--CchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSG--SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~--s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
...++|.+.+.||+|+|++||+|+++ +..||||.+.+. ..+..+-+..||.+|+.++| +|||.+++++..+ +.
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H-~nIV~l~d~~~~~--~~ 83 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKH-PNIVRLLDCIEDD--DF 83 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCC-cceeeEEEEEecC--Ce
Confidence 34589999999999999999999976 789999999765 34455678999999999997 9999999999887 79
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC------CcEEEcc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN------FCAKISD 161 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~------g~vKLiD 161 (576)
+|||||||+||+|.++++.++. +++.+++.++.||+.||++||+++ ||||||||+||||+.. -.+||+|
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIAD 158 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIAD 158 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecc
Confidence 9999999999999999998764 889999999999999999999999 9999999999999865 4689999
Q ss_pred ccccccccC
Q 036407 162 FGLARLKSV 170 (576)
Q Consensus 162 FGlA~~~~~ 170 (576)
||+|+....
T Consensus 159 FGfAR~L~~ 167 (429)
T KOG0595|consen 159 FGFARFLQP 167 (429)
T ss_pred cchhhhCCc
Confidence 999987654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=345.48 Aligned_cols=150 Identities=31% Similarity=0.474 Sum_probs=129.6
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchh-------HHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG-------EREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~-------~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
..+.|.+.+.||+|+||.|-+|..+ ++.||||++++..... ...+.+|+.+|.+|.| ||||++++++..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~H-P~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSH-PNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCC-CCEEEEeeeeecC
Confidence 4567889999999999999999765 8999999998643322 2346799999999988 9999999999887
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC---CcEEEc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN---FCAKIS 160 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~---g~vKLi 160 (576)
...||||||++||+|.+.+...+. +.+...+.++.|++.|+.|||++| |+||||||+|||+..+ ..+||+
T Consensus 249 --ds~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 249 --DSSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred --CceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEec
Confidence 778999999999999999877654 556666789999999999999999 9999999999999876 689999
Q ss_pred cccccccccC
Q 036407 161 DFGLARLKSV 170 (576)
Q Consensus 161 DFGlA~~~~~ 170 (576)
|||+|+....
T Consensus 322 DFGlAK~~g~ 331 (475)
T KOG0615|consen 322 DFGLAKVSGE 331 (475)
T ss_pred ccchhhcccc
Confidence 9999987653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=340.53 Aligned_cols=156 Identities=27% Similarity=0.426 Sum_probs=132.9
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
..+|+++++||.|+||.||++... +..+|.|.++-+.. +..+.+..|+.+|+.|+| |||+++++.....+...++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~H-pNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNH-PNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCC-chHHHHHHHhhhccchhhH
Confidence 346889999999999999999754 89999999974433 345678999999999998 9999998865555556699
Q ss_pred EEEeccCCCCHHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHHHHhCCC--CeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 90 LVYELMSNGNLQDALLHK-KPPELMEWCKRFSIAVDIAKGIAYLHSLNP--PVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~-~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~--~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
||||+|.+|+|...+++. .....+++..+|+++.|++.||.+||...+ .|+||||||.||+|+.+|.+||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999999773 345569999999999999999999998333 39999999999999999999999999998
Q ss_pred cccC
Q 036407 167 LKSV 170 (576)
Q Consensus 167 ~~~~ 170 (576)
.+..
T Consensus 177 ~l~s 180 (375)
T KOG0591|consen 177 FLSS 180 (375)
T ss_pred Hhcc
Confidence 7654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=338.66 Aligned_cols=148 Identities=26% Similarity=0.412 Sum_probs=130.8
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
...++|++++.||+|+||+||.++.. ++.||+|++++... ........|..+|..+.| |+|+.+...|... .
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~h-PFiv~l~ysFQt~--~ 98 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKH-PFIVKLIYSFQTE--E 98 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCC-CcEeeeEEecccC--C
Confidence 34678999999999999999999865 78999999986543 234567899999999766 9999997666555 9
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+|||+||+.||.|..+|.+.+. +++..+..|+.+|+.||.|||+.| ||||||||+||||+.+|.++|+|||+++
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k 173 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCK 173 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccch
Confidence 99999999999999999987665 889999999999999999999999 9999999999999999999999999997
Q ss_pred c
Q 036407 167 L 167 (576)
Q Consensus 167 ~ 167 (576)
.
T Consensus 174 ~ 174 (357)
T KOG0598|consen 174 E 174 (357)
T ss_pred h
Confidence 4
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=343.13 Aligned_cols=151 Identities=25% Similarity=0.354 Sum_probs=131.4
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhH---HHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGE---REFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~---~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
+...++|++++.||+|+||.||+|+-+ |+.||+|++++...... ..++.|-.+|....+ +.||+++..|.+.
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds-~~vVKLyYsFQD~-- 213 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDS-PWVVKLYYSFQDK-- 213 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCC-CcEEEEEEEecCC--
Confidence 456789999999999999999999855 89999999987654433 456777788888555 9999997777665
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
.++||||||++||++.++|..... +++..+..|+.+++.|+..||+.| +|||||||+|+|||..|.+||+|||++
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~---L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDT---LTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCc---CchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeecccccc
Confidence 999999999999999999987554 888889999999999999999999 999999999999999999999999998
Q ss_pred cccc
Q 036407 166 RLKS 169 (576)
Q Consensus 166 ~~~~ 169 (576)
..+.
T Consensus 289 ~gl~ 292 (550)
T KOG0605|consen 289 TGLD 292 (550)
T ss_pred chhh
Confidence 6443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.81 Aligned_cols=154 Identities=28% Similarity=0.407 Sum_probs=134.1
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhH---HHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGE---REFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~---~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
+....+|.+.+.||+|+|++|++|+.. ++.||||++.+.....+ .-+..|-..|.+|.+||.|++|+..|.+.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~-- 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE-- 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc--
Confidence 345578999999999999999999865 89999999976443222 34567777899998889999997777666
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
..+|+|+||+++|+|.++|...+. +++.-+..++.+|+.||+|||.+| ||||||||+||||+.+|.++|+|||.|
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeecccc
Confidence 899999999999999999988765 888888899999999999999999 999999999999999999999999999
Q ss_pred ccccCC
Q 036407 166 RLKSVG 171 (576)
Q Consensus 166 ~~~~~~ 171 (576)
+.+...
T Consensus 222 K~l~~~ 227 (604)
T KOG0592|consen 222 KILSPS 227 (604)
T ss_pred ccCChh
Confidence 987654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=333.84 Aligned_cols=154 Identities=30% Similarity=0.480 Sum_probs=127.4
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
...++|++.+.||+|+||.||+|... ++.||||++..... .....+.+|+.++..+.+|+||+.+++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 34578999999999999999999742 46799999974332 23456899999999997779999999988654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCC------------------------------------------------------
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKP------------------------------------------------------ 109 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~------------------------------------------------------ 109 (576)
...+++||||+++|+|.+++.....
T Consensus 84 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 84 -NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 3568999999999999998865321
Q ss_pred -----CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 110 -----PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 110 -----~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++..
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~ 224 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDI 224 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeeccccccc
Confidence 112566778889999999999999999 999999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=332.62 Aligned_cols=150 Identities=29% Similarity=0.453 Sum_probs=132.2
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecC----Cc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSG----SL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPK 84 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~----s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s 84 (576)
...+.|.+.+.||+|+||+|+.|+.. +..||+|++... .. ...+.+.+|+.++..+.+||||++++.++...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~- 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP- 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence 45679999999999999999999865 799999977653 11 23456678999999999779999999999887
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC-CcEEEcccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN-FCAKISDFG 163 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~-g~vKLiDFG 163 (576)
..+++|||||.||+|.+.+...+. +.+..+..++.|++.|++|||++| |+||||||+|||++.+ +.+||+|||
T Consensus 93 -~~~~ivmEy~~gGdL~~~i~~~g~---l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 93 -TKIYIVMEYCSGGDLFDYIVNKGR---LKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred -CeEEEEEEecCCccHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccc
Confidence 669999999999999999988544 677889999999999999999999 9999999999999999 999999999
Q ss_pred ccccc
Q 036407 164 LARLK 168 (576)
Q Consensus 164 lA~~~ 168 (576)
++...
T Consensus 167 ~s~~~ 171 (370)
T KOG0583|consen 167 LSAIS 171 (370)
T ss_pred ccccc
Confidence 98755
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=328.90 Aligned_cols=150 Identities=24% Similarity=0.384 Sum_probs=135.5
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhH-HHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGE-REFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~-~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
-...+.|++.+.||.|..+.||+|+.. ++.||||+++.+.+... ..+.+|+..++.+.| |||+.++..|... ..
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~H-PNIv~~~~sFvv~--~~ 98 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDH-PNIVTYHCSFVVD--SE 98 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCC-CCcceEEEEEEec--ce
Confidence 456789999999999999999999876 89999999998766555 778999999988877 9999999888877 89
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
+|+||.||.+|++.+++...-+.+ +++..+..|+++++.||.|||++| .||||||+.||||+.+|.+||+|||++.
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeee
Confidence 999999999999999998865433 888899999999999999999999 9999999999999999999999999754
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.97 Aligned_cols=142 Identities=18% Similarity=0.317 Sum_probs=123.4
Q ss_pred ceeeccCcEEEEEEEECCceEEEEEeecCCchh---HHHHHHHHHHHHHhccCCceEEEEEEeeC--CCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQG---EREFYNELYFASLLEQDDHVVSVLGFSSN--PKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~---~~~~l~EI~iLs~L~h~pNIv~Llg~~~~--~s~~~l~LVmE~~ 95 (576)
..||+|+++.||+|.++++.||||.+....... ...+.+|+.++.++.| +||+++++++.. .....+++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDS-NNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCC-CCEEEEeeeEEecccCCCceEEEEEeC
Confidence 689999999999999999999999997543322 3567799999999988 899999999876 4446789999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++|+|.+++..... +++.....++.+++.||.|||+ .+ ++||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~g~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~ 173 (283)
T PHA02988 105 TRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKIL 173 (283)
T ss_pred CCCcHHHHHhhCCC---CChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence 99999999876543 6778888999999999999998 47 889999999999999999999999987643
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=354.23 Aligned_cols=157 Identities=25% Similarity=0.375 Sum_probs=136.7
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEE-eeCC---
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGF-SSNP--- 83 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~-~~~~--- 83 (576)
+.+...++++.+.|.+|+|+.||+|... +..||+|++-.......+.+.+||.+|+.|+.|+|||.+++. ....
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 4455667788999999999999999976 389999999877777778899999999999999999999993 3221
Q ss_pred C-CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccc
Q 036407 84 K-RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDF 162 (576)
Q Consensus 84 s-~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDF 162 (576)
. .-.++|+||||.||.|.+++..+.... +++..+++|+.++++|+.+||...+||||||||-+||||+.+|..|||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 1 245789999999999999998765544 88999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q 036407 163 GLARL 167 (576)
Q Consensus 163 GlA~~ 167 (576)
|.+..
T Consensus 191 GSatt 195 (738)
T KOG1989|consen 191 GSATT 195 (738)
T ss_pred ccccc
Confidence 98754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=341.40 Aligned_cols=148 Identities=29% Similarity=0.425 Sum_probs=133.5
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
...|....+||+|+.|.||.++.. ++.||||.+.......++-+.+|+.+|..+.| +|||.++..+... +.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H-~NiVnfl~Sylv~--deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHH-PNIVNFLDSYLVG--DELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccc-hHHHHHHHHhccc--ceeEEE
Confidence 356888899999999999999755 78899999998877778889999999999977 9999999887776 889999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccccC
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
|||++||+|.+.+.... +++.++..|++++++||.|||.+| |+|||||.+|||++.+|.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 99999999999887643 788899999999999999999999 99999999999999999999999999876543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=338.24 Aligned_cols=146 Identities=28% Similarity=0.440 Sum_probs=130.4
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
++|-+.++||+|+||.||+|+.+ .+.||||.+.+... +....+.+|++++..|+| |||+.+++.|... .++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkH-pniv~m~esfEt~--~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKH-PNIVEMLESFETS--AHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCC-cchhhHHHhhccc--ceEEE
Confidence 68999999999999999999866 68999999965332 334568999999999999 9999999998776 89999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|+|||.| +|.+++...+. +++..+..++.+++.||.|||+++ |+|||+||.|||++..|.+|++|||+|+...
T Consensus 79 Vte~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMS 151 (808)
T ss_pred Eehhhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcc
Confidence 9999966 99999987554 889999999999999999999999 9999999999999999999999999998654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.33 Aligned_cols=150 Identities=33% Similarity=0.447 Sum_probs=130.1
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
..++...+.||+|+||.||++... +..+|||.+........+.+.+|+.+|+.|. |+|||+++|.........++++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeEee
Confidence 346788999999999999999977 6899999997653222556899999999999 5999999997554422478999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC-CCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH-NFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~-~g~vKLiDFGlA~~~ 168 (576)
|||+++|+|.+++...+. .+++..+..+.+||+.||.|||++| |+||||||+|||++. ++.+||+|||+++..
T Consensus 95 mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 999999999999988764 3889999999999999999999999 999999999999999 799999999988754
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.63 Aligned_cols=148 Identities=35% Similarity=0.551 Sum_probs=131.0
Q ss_pred CCCccceeeccCcEEEEEEEECCc-eEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEec
Q 036407 16 SFSPSRLLGQGGFGSVFHATLHDQ-SVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~g~-~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
.+.+.+.||+|.||.||.|.+.+. .||+|.+.... ...+.|..|+.+|.+|+| +|||+++++|..+ ..++|||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H-~~lV~l~gV~~~~--~piyIVtE~ 282 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRH-EKLVKLYGVCTKQ--EPIYIVTEY 282 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcc-cCeEEEEEEEecC--CceEEEEEe
Confidence 344678999999999999999975 99999998654 344678999999999998 9999999999987 589999999
Q ss_pred cCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccccC
Q 036407 95 MSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 95 ~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
++.|+|.++|..... ..+...+.+.++.||+.|++||.+++ +|||||-..|||++++..+||+|||+|+.+..
T Consensus 283 m~~GsLl~yLr~~~~-~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREG-GLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred cccCcHHHHhhhcCC-CccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccccCC
Confidence 999999999987332 33777888999999999999999999 99999999999999999999999999995443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=317.96 Aligned_cols=147 Identities=24% Similarity=0.355 Sum_probs=126.9
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
+.|+.+.++|+|+||+||+++.+ |+.||||.+.... ....+-.++||++|+.|.| +|+|.++.+|.-. ..++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH-~NLVnLiEVFrrk--rklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKH-ENLVNLIEVFRRK--RKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhccc-chHHHHHHHHHhc--ceeEE
Confidence 57889999999999999999876 8999999996422 2223567999999999988 9999999998776 89999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|+|||+. ++.+-+.....+ ++...+..|+.|++.|+.|||+++ ||||||||+||||+.+|.+||||||+|+.+.
T Consensus 79 VFE~~dh-TvL~eLe~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 79 VFEYCDH-TVLHELERYPNG--VPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred Eeeecch-HHHHHHHhccCC--CCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhc
Confidence 9999977 555555554433 788889999999999999999999 9999999999999999999999999999765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=334.99 Aligned_cols=154 Identities=29% Similarity=0.397 Sum_probs=134.1
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHH-HHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGER-EFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~-~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
....++|.++++||.|.||.||+|+.. ++.||||.++......++ .-++|+..|.+|..|+||++++..+.+... .
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~ 84 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-I 84 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-e
Confidence 345689999999999999999999865 889999999754433332 347899999999967999999999887743 9
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++|||||+ .+|+++++.+. ..+++..+..|+.||++||+|+|++| +.|||+||+|||+.....+||+|||+|+.
T Consensus 85 L~fVfE~Md-~NLYqLmK~R~--r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 85 LYFVFEFMD-CNLYQLMKDRN--RLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred EeeeHHhhh-hhHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEecccccccc
Confidence 999999995 59999999874 45999999999999999999999999 99999999999999899999999999986
Q ss_pred ccC
Q 036407 168 KSV 170 (576)
Q Consensus 168 ~~~ 170 (576)
+..
T Consensus 160 v~S 162 (538)
T KOG0661|consen 160 VRS 162 (538)
T ss_pred ccc
Confidence 654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=307.35 Aligned_cols=146 Identities=27% Similarity=0.393 Sum_probs=124.7
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.|++.+.||+|+||.||+|... ++.||||.+..... .....+.+|+.++..+.| +|++.+.+.+... ..+++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~iv~~~~~~~~~--~~~~l 77 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS-RFVVSLAYAYETK--DALCL 77 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCC-CcEEEEEEEEccC--CeEEE
Confidence 4788899999999999999864 78999999865332 223457889999999977 9999999888766 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||||+++|+|.+.+..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..
T Consensus 78 v~e~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~ 151 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQ 151 (285)
T ss_pred EEEecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence 9999999999887765332 23678888999999999999999999 99999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.40 Aligned_cols=150 Identities=28% Similarity=0.484 Sum_probs=126.4
Q ss_pred cCCCCccceeeccCcEEEEEEEEC------------------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH------------------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVV 74 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~------------------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv 74 (576)
.++|++.+.||+|+||.||+|... +..||+|.+.... ......+.+|+.++..+.| +||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKD-PNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCC-CCee
Confidence 468899999999999999999742 2469999987543 2334578999999999977 9999
Q ss_pred EEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCC----------------CChhhHHHHHHHHHHHHHHHHHHHhCCCC
Q 036407 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----------------PELMEWCKRFSIAVDIAKGIAYLHSLNPP 138 (576)
Q Consensus 75 ~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~----------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~ 138 (576)
++++++... ..+++||||+.+++|.+++..... ...+++..++.++.||+.||.|||+++
T Consensus 83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-- 158 (304)
T cd05096 83 RLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158 (304)
T ss_pred EEEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 999998876 678999999999999998865321 112566778899999999999999999
Q ss_pred eeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 139 VIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 139 IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|+|+||||+|||++.++.+||+|||+++..
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~ 188 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNL 188 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceec
Confidence 999999999999999999999999988644
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=311.63 Aligned_cols=145 Identities=23% Similarity=0.325 Sum_probs=125.4
Q ss_pred CCCccceeeccCcEEEEEEEE-----CCceEEEEEeecCC----chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 16 SFSPSRLLGQGGFGSVFHATL-----HDQSVAVKVMDSGS----LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~-----~g~~VAVK~i~~~s----~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
+|++.+.||+|+||.||+++. .++.||+|++.... ......+..|+.++..+.+|+||+.+++.+... .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--A 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--C
Confidence 588999999999999999875 36889999996432 122346788999999998889999998887765 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+++||||+++|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 89999999999999998876443 678888889999999999999999 9999999999999999999999999876
Q ss_pred c
Q 036407 167 L 167 (576)
Q Consensus 167 ~ 167 (576)
.
T Consensus 154 ~ 154 (332)
T cd05614 154 E 154 (332)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.14 Aligned_cols=144 Identities=26% Similarity=0.390 Sum_probs=126.5
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++.+.||+|+||.||+|+.. ++.||||++..... .....+..|+.++..+.| +||+.+++++... ..+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~iv~~~~~~~~~--~~~~ 77 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS-EWLVKLLYAFQDD--EYLY 77 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCC-CCCccEEEEEEcC--CEEE
Confidence 47999999999999999999875 78999999975322 233567889999999986 9999999988766 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
|||||+++++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 78 lv~e~~~g~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~ 149 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLGV---LSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSK 149 (333)
T ss_pred EEEeCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCc
Confidence 99999999999999876443 677888889999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.71 Aligned_cols=151 Identities=33% Similarity=0.463 Sum_probs=126.7
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
.++|++.+.||+|+||.||+|... +..||||++.... ......+.+|+.++..+.+||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-- 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG-- 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence 457999999999999999999631 4579999986432 233457889999999996679999999998776
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCC--------------------------------------------------------
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKP-------------------------------------------------------- 109 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~-------------------------------------------------------- 109 (576)
...++|||||++|+|.+++.....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 678999999999999998865321
Q ss_pred ----------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 110 ----------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 110 ----------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||+++..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 264 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDI 264 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceec
Confidence 012567778899999999999999999 999999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=310.85 Aligned_cols=146 Identities=24% Similarity=0.358 Sum_probs=127.7
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
.++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +||+.+++.+... ..+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~--~~~ 93 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH-PFIVNMMCSFQDE--NRV 93 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEcC--CEE
Confidence 468999999999999999999876 78899999975322 233567899999999977 9999999998876 789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|+||||+++++|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGR---FPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 999999999999998876543 677778889999999999999999 99999999999999999999999998764
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=304.59 Aligned_cols=146 Identities=25% Similarity=0.368 Sum_probs=123.3
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +||+.+++.+... ..+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQ-ENIVELKEAFRRR--GKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCC-ccccchhhhEecC--CEEEE
Confidence 47999999999999999999976 68899999975322 224567889999999987 9999999888765 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||||++++.+..+..... .+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 78 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 78 VFEYVEKNMLELLEEMPN---GVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNL 150 (287)
T ss_pred EEecCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence 999998876654433222 2677888899999999999999999 999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=326.69 Aligned_cols=154 Identities=29% Similarity=0.382 Sum_probs=134.1
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.-.+.|+.+++||+|.||.||+|+.. |+.||+|.+..+.. .......+||.+|++|.| |||++|.+.........
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~H-pNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDH-PNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCC-CcccceeeEEEecCCce
Confidence 34567889999999999999999865 88999999976542 334567899999999988 99999999988876689
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+|||+|||++ +|.-++....-. +++.+++.|+.||+.||.|||.+| |+|||||.+|||||.+|.+||+|||+|++
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vk--ft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVK--FTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcc--cChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceee
Confidence 9999999976 888877664322 788999999999999999999999 99999999999999999999999999997
Q ss_pred ccCC
Q 036407 168 KSVG 171 (576)
Q Consensus 168 ~~~~ 171 (576)
+...
T Consensus 268 y~~~ 271 (560)
T KOG0600|consen 268 YTPS 271 (560)
T ss_pred ccCC
Confidence 7653
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=336.39 Aligned_cols=149 Identities=26% Similarity=0.439 Sum_probs=127.7
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
+...++|.++++||+|+||+|+++..+ ++.||||+++++.. ++.+..+.|-+++.....||.++.++..+. +.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ--T~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ--TK 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccc--cC
Confidence 456789999999999999999999877 68999999987643 334567888888888888899988866655 44
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
.++|+||||+.||++..+++. +.+++..+..|+.+|+.||.|||++| |||||||.+|||||.+|.+||+|||++
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred CeEEEEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEecccccc
Confidence 999999999999995433332 23889999999999999999999999 999999999999999999999999999
Q ss_pred cc
Q 036407 166 RL 167 (576)
Q Consensus 166 ~~ 167 (576)
+.
T Consensus 516 Ke 517 (694)
T KOG0694|consen 516 KE 517 (694)
T ss_pred cc
Confidence 74
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.97 Aligned_cols=145 Identities=25% Similarity=0.384 Sum_probs=126.6
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++.+.||+|+||.||+|... ++.||||++..... .....+.+|+.++..+.| +||+++++++... ..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~--~~~~ 77 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH-PFIIRLFWTEHDQ--RFLY 77 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCC-CcHhhhHhhhccC--CeEE
Confidence 47899999999999999999876 78999999964322 234567889999999987 9999998887665 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+||||+++++|.+++..... +++..+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~ 150 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKK 150 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchh
Confidence 99999999999998876543 677888889999999999999999 99999999999999999999999998753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=303.60 Aligned_cols=149 Identities=30% Similarity=0.532 Sum_probs=125.8
Q ss_pred CCCCccceeeccCcEEEEEEEECC-------ceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~g-------~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
++|++.+.||+|+||.||+|...+ ..||+|.+..... .....+.+|+.++..+.| +||+.+++++... .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~~~~~~~~~--~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH-PNIVCLLGVCTKE--Q 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCC-cccceEEEEEcCC--C
Confidence 478899999999999999998642 5699999864432 334568899999999977 9999999998765 6
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCC-------------ChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPP-------------ELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH 153 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~-------------~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~ 153 (576)
..|++|||+++++|.+++...... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~ 159 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGE 159 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcC
Confidence 789999999999999998764221 23677788899999999999999999 999999999999999
Q ss_pred CCcEEEccccccccc
Q 036407 154 NFCAKISDFGLARLK 168 (576)
Q Consensus 154 ~g~vKLiDFGlA~~~ 168 (576)
++.++|+|||++...
T Consensus 160 ~~~~~L~dfg~~~~~ 174 (283)
T cd05048 160 GLTVKISDFGLSRDI 174 (283)
T ss_pred CCcEEECCCcceeec
Confidence 999999999988643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=332.30 Aligned_cols=139 Identities=28% Similarity=0.447 Sum_probs=122.2
Q ss_pred CCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEec
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
+....++-||.|+.|.||+|+++++.||||.++. .-..+|..|.+|+| +||+.+.|+|... ..+||||||
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e-------lkETdIKHLRkLkH-~NII~FkGVCtqs--PcyCIiMEf 193 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE-------LKETDIKHLRKLKH-PNIITFKGVCTQS--PCYCIIMEF 193 (904)
T ss_pred HHhhhhhhhccCcccceeeeeccCceehhHHHhh-------hhhhhHHHHHhccC-cceeeEeeeecCC--ceeEEeeec
Confidence 3334578899999999999999999999999852 22456778899988 9999999999876 899999999
Q ss_pred cCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 95 MSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 95 ~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|..|.|.++|+.... +.......+..+|+.|+.|||.+. |||||||.-||||..+..+||+|||.++..
T Consensus 194 Ca~GqL~~VLka~~~---itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRP---ITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred cccccHHHHHhccCc---cCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhh
Confidence 999999999988654 566677789999999999999999 999999999999999999999999988754
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=302.98 Aligned_cols=147 Identities=31% Similarity=0.482 Sum_probs=126.2
Q ss_pred CCC-CccceeeccCcEEEEEEEEC------CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 15 DSF-SPSRLLGQGGFGSVFHATLH------DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 15 d~Y-~i~e~LG~GsfG~Vyka~~~------g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
++| ++.+.||+|+||.||++.+. +..||+|.+..... .....+.+|+.++..+.| +||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH-ENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCCc
Confidence 345 88999999999999887632 57899999875432 234578899999999976 9999999998776557
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+++||||+++++|.+++.... +++..++.++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||+++
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~~----l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHcC----CCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeeccccc
Confidence 7899999999999999886532 788889999999999999999999 9999999999999999999999999886
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 156 ~~ 157 (283)
T cd05080 156 AV 157 (283)
T ss_pred cc
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=303.08 Aligned_cols=149 Identities=26% Similarity=0.390 Sum_probs=121.8
Q ss_pred CCCCccceeeccCcEEEEEEEEC---CceEEEEEeecCCc--hhHHHHHHHHHHHHHhc--cCCceEEEEEEeeC---CC
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH---DQSVAVKVMDSGSL--QGEREFYNELYFASLLE--QDDHVVSVLGFSSN---PK 84 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~---g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~--h~pNIv~Llg~~~~---~s 84 (576)
.+|++.+.||+|+||.||+|+.. +..||||.+..... .....+.+|+.++..+. .|+||+++++++.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999863 57899999864332 22345667887777775 35999999998853 23
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
...+++||||+. ++|.+++...... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 467899999995 6898888654322 2678888999999999999999999 99999999999999999999999998
Q ss_pred ccc
Q 036407 165 ARL 167 (576)
Q Consensus 165 A~~ 167 (576)
+..
T Consensus 157 ~~~ 159 (290)
T cd07862 157 ARI 159 (290)
T ss_pred eEe
Confidence 864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=321.55 Aligned_cols=153 Identities=31% Similarity=0.439 Sum_probs=127.1
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
...++|++.+.||+|+||.||+|+.. +..||||.+..... .....+.+|+.++..+..|+||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 33457999999999999999998742 25799999975432 23456889999999996669999999998776
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCC------------------------------------------------------
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKP------------------------------------------------------ 109 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~------------------------------------------------------ 109 (576)
..+++|||||++|+|.+++.....
T Consensus 115 --~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 115 --GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred --CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 788999999999999998854210
Q ss_pred -------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 110 -------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 110 -------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
...+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++..
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~ 262 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDI 262 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeec
Confidence 112567788899999999999999999 999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=303.07 Aligned_cols=146 Identities=24% Similarity=0.441 Sum_probs=125.5
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-----CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
..+|++.+.||+|+||.||+|... +..||+|.++.... .....+.+|+..+..+.| +||+++++++... ..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~--~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDH-SNIVRLEGVITRG--NT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEecC--CC
Confidence 356889999999999999999753 46899999975432 334568899999999876 9999999998765 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
+++||||+++++|.+++..... .+++..++.++.|++.||+|||+++ ++|+||||+|||++.++.++++|||.+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCcccc
Confidence 9999999999999998876432 3778889999999999999999999 9999999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=311.96 Aligned_cols=138 Identities=24% Similarity=0.342 Sum_probs=119.8
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+.||+|+||.||+++.. ++.||||++..... .....+..|+.++..+.| +||+.+++.+... ..+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~--~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRH-PFLTALKYSFQTH--DRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCCCEEEEEEcC--CEEEEEEeCC
Confidence 47999999999999865 78999999975322 223467789999999977 9999999888776 7899999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
++++|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~ 143 (323)
T cd05571 78 NGGELFFHLSRERV---FSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCK 143 (323)
T ss_pred CCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 99999988876443 678888889999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=331.89 Aligned_cols=154 Identities=27% Similarity=0.453 Sum_probs=134.3
Q ss_pred CChHHHHhhcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchh--HHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQG--EREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 5 fs~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~--~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
.+..++.+-.+...+.+.||+|.||+||+|++.| .||||+++...... -+.|.+|+..+++-+| .||+.+.|+|..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH-~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRH-ENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcch-hhheeeehhhcC
Confidence 4455666667777889999999999999999977 58999998755433 4679999999999988 899999999988
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccc
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDF 162 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDF 162 (576)
+ .. .||+-+|+|-+|+.+++.... .++..+...|+.||++|+.|||.++ |||+|||..||+|+++++|||+||
T Consensus 460 p--~~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 460 P--PL-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred C--ce-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecc
Confidence 6 43 999999999999999976543 3777888999999999999999999 999999999999999999999999
Q ss_pred ccccc
Q 036407 163 GLARL 167 (576)
Q Consensus 163 GlA~~ 167 (576)
|++..
T Consensus 533 GLatv 537 (678)
T KOG0193|consen 533 GLATV 537 (678)
T ss_pred cceee
Confidence 99863
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=297.31 Aligned_cols=148 Identities=29% Similarity=0.512 Sum_probs=127.1
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
.++|++.++||+|+||.||+|... +..||+|.+..... ..+.+.+|+.++..+.| +||+++++.+... ..++++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQH-DKLVRLYAVVTKE--EPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCC-CCeeeEEEEEcCC--CCcEEEE
Confidence 467899999999999999999866 57799999865432 34678899999999977 9999999888765 7789999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||+++++|.+++..... ..+++..++.++.+++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 81 EYMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred ecCCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceec
Confidence 99999999998865432 23677788889999999999999999 999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=308.02 Aligned_cols=148 Identities=29% Similarity=0.407 Sum_probs=131.4
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
.++|+++..||.|+||.|.+++.+ +..||+|++.+... +..+...+|.++|+.+.| |+++++.+.+.+. ..+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~-PFlv~l~~t~~d~--~~l 119 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSH-PFLVKLYGTFKDN--SNL 119 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccC-ceeEEEEEeeccC--CeE
Confidence 467889999999999999999876 78999999976543 334567899999999986 9999998887766 899
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+|||||.+||.|..+++..++ +++..++.|+.||+.||+|||+++ |++|||||+|||||.+|.+||+|||+|+..
T Consensus 120 ymvmeyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEEEeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 999999999999999987655 888899999999999999999999 999999999999999999999999999865
Q ss_pred c
Q 036407 169 S 169 (576)
Q Consensus 169 ~ 169 (576)
.
T Consensus 195 ~ 195 (355)
T KOG0616|consen 195 S 195 (355)
T ss_pred c
Confidence 3
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=307.66 Aligned_cols=145 Identities=26% Similarity=0.458 Sum_probs=123.0
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC---CCeE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK---RHRM 88 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s---~~~l 88 (576)
+|++.+.||+|+||.||+|+.. +..||||.+.... ......+.+|+.++..+.| +||+.+++++.... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRH-PDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCC-CCEeeecceEeccCCCCCceE
Confidence 5889999999999999999865 7899999986422 2234568899999999977 99999998876432 2468
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|+||||| +++|.+.+..... +++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||+++.
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDD---LTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEEecC-CCCHHHHHHhccc---CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999999 4689888875443 678888899999999999999999 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=310.69 Aligned_cols=144 Identities=25% Similarity=0.348 Sum_probs=124.8
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
+|++++.||+|+||.||+|+.. ++.||||++.... ......+..|+.++..+.|+++|+.+++.+... ..+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEE
Confidence 5889999999999999999876 5789999997532 223456788889999998878898998888766 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
||||+++|+|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.
T Consensus 79 v~E~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGK---FKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCK 149 (324)
T ss_pred EEcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcce
Confidence 9999999999988876443 677788889999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.12 Aligned_cols=147 Identities=23% Similarity=0.353 Sum_probs=125.5
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
..++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.+++.+.| +||+.+++++... ..++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~--~~~~ 79 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKH-ANIVLLHDIIHTK--ETLT 79 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCC-CCcCeEEEEEecC--CeEE
Confidence 3578999999999999999999875 78999999975432 223457889999999977 9999999998766 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+||||+. ++|.+.+..... .++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 80 lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 152 (303)
T cd07869 80 LVFEYVH-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARA 152 (303)
T ss_pred EEEECCC-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCccee
Confidence 9999995 688877765432 2677788889999999999999999 99999999999999999999999998763
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.68 Aligned_cols=152 Identities=32% Similarity=0.487 Sum_probs=126.5
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
.++|++.+.||+|+||.||+|+.. ++.||+|++..... .....+..|+.++.++.+|+||+.+++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence 457999999999999999999642 36899999864332 22346788999999997779999999988654 3
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCC--------------------------------------------------------
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKP-------------------------------------------------------- 109 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~-------------------------------------------------------- 109 (576)
..++++|||+++++|.+.+.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 678899999999999998864321
Q ss_pred --CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 110 --PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 110 --~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..+
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~ 223 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDI 223 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhc
Confidence 113677888999999999999999999 999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.98 Aligned_cols=146 Identities=24% Similarity=0.316 Sum_probs=127.8
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.++|++.+.||+|+||.||+++.. +..+|+|.+..... .....+.+|+.++..+.| +||+++++++... +.+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSD--GEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEEC--CEEEE
Confidence 578999999999999999999876 78899999875422 234578999999999987 9999999998776 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||||+++++|.+++..... +++..+..++.|++.||.|||+ ++ |+|+||||+|||++.++.++|+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (331)
T ss_pred EeecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccc
Confidence 9999999999999876443 6778888999999999999997 46 99999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=298.99 Aligned_cols=150 Identities=31% Similarity=0.530 Sum_probs=131.4
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
...+|.+.+.||.|+||.||+|... ++.+++|.+..........+..|+.++..+.| +|++.+++++... ..+++|
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~~~lv 80 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH-KHLISLFAVCSVG--EPVYII 80 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCC-cchhheeeeEecC--CCeEEE
Confidence 4567899999999999999999876 68899999976655556678999999999976 9999999998776 778999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||+++++|.+++..... ..+++..+..++.+|+.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 81 TELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred EeecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhc
Confidence 999999999999976432 23678888999999999999999999 999999999999999999999999988644
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=312.96 Aligned_cols=148 Identities=24% Similarity=0.342 Sum_probs=128.8
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +||+.+++.+... ..+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~~~~~~~~~--~~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN-PWVVKLYYSFQDE--NYLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceEEEEEcC--CeEE
Confidence 47999999999999999999875 78999999975321 223457789999999976 9999999988876 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
+||||+++|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++....
T Consensus 78 lv~E~~~~g~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKDT---FTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred EEECCCCCcHHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999998876443 788889999999999999999999 9999999999999999999999999987654
Q ss_pred C
Q 036407 170 V 170 (576)
Q Consensus 170 ~ 170 (576)
.
T Consensus 153 ~ 153 (364)
T cd05599 153 K 153 (364)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=307.19 Aligned_cols=147 Identities=29% Similarity=0.504 Sum_probs=124.6
Q ss_pred CCCCccceeeccCcEEEEEEEEC--Cc----eEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQ----SVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~----~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.+|++.+.||+|+||.||+|+.. +. .||||.+.... ......+..|+.++..+.| +||+++++++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~g~~~~~---~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTS---T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEcCC---C
Confidence 56999999999999999999863 33 48999986433 2345678899999999977 9999999998754 4
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
.++|+||+++|+|.+.+..... .++...++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEcccccccc
Confidence 6799999999999998876432 2667788889999999999999999 99999999999999999999999999875
Q ss_pred cc
Q 036407 168 KS 169 (576)
Q Consensus 168 ~~ 169 (576)
..
T Consensus 159 ~~ 160 (316)
T cd05108 159 LG 160 (316)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=305.82 Aligned_cols=160 Identities=24% Similarity=0.325 Sum_probs=140.2
Q ss_pred HHHhhcCCCCccceeeccCcEEEEEEE--ECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCC---
Q 036407 9 VLRRAADSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNP--- 83 (576)
Q Consensus 9 ~lk~~~d~Y~i~e~LG~GsfG~Vyka~--~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~--- 83 (576)
++.+...+|++.+.||+|+|+.||+++ .+++.||+|.+...+..+.+..++|+..-+++.| ||+++++++....
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s-~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNS-PNVLRLVDHQLREEKD 93 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCC-cchHHHHHHHHHhhcc
Confidence 455677899999999999999999997 3478999999987777788899999999999988 9999998876532
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCC-CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKP-PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDF 162 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~-~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDF 162 (576)
.....||++.|...|+|.+.+..... +..+++.+++.|+.+|+.||.+||+..+|++|+||||.|||++..+.++|+||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 33668999999999999999977553 34799999999999999999999999999999999999999999999999999
Q ss_pred ccccccc
Q 036407 163 GLARLKS 169 (576)
Q Consensus 163 GlA~~~~ 169 (576)
|.+....
T Consensus 174 GS~~~a~ 180 (302)
T KOG2345|consen 174 GSATQAP 180 (302)
T ss_pred cCccccc
Confidence 9876543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=320.36 Aligned_cols=153 Identities=26% Similarity=0.399 Sum_probs=130.7
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch--------------hHHHHHHHHHHHHHhccCCceE
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ--------------GEREFYNELYFASLLEQDDHVV 74 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~--------------~~~~~l~EI~iLs~L~h~pNIv 74 (576)
....+.|++...||+|.||+|-+|+.. ++.||||++.+.... ..+.+.+||.+|++|.| +|||
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H-~nVV 171 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH-PNVV 171 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC-cCee
Confidence 455689999999999999999999876 799999999653221 12478999999999988 9999
Q ss_pred EEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC
Q 036407 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN 154 (576)
Q Consensus 75 ~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~ 154 (576)
+|+....++....+|||+|||..|.+...= .....+.+.+++.|+++++.||.|||.+| ||||||||+|+||+.+
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCC
Confidence 999999999999999999999888774321 11112788899999999999999999999 9999999999999999
Q ss_pred CcEEEcccccccccc
Q 036407 155 FCAKISDFGLARLKS 169 (576)
Q Consensus 155 g~vKLiDFGlA~~~~ 169 (576)
|++||+|||++....
T Consensus 247 g~VKIsDFGVs~~~~ 261 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFP 261 (576)
T ss_pred CcEEeeccceeeecc
Confidence 999999999986543
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=313.08 Aligned_cols=148 Identities=26% Similarity=0.386 Sum_probs=128.8
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|.+.+.||+|+||.||+|+.. ++.||||++..... .....+..|+.++..+.| +||+.+++.+... ..+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~--~~~~ 77 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS-PWIVKLYYSFQDE--EHLY 77 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCC-CCccchhhheecC--CeEE
Confidence 47999999999999999999976 88999999975321 234567889999999876 9999999888766 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
+||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDV---FPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 99999999999999876532 778888899999999999999999 9999999999999999999999999987554
Q ss_pred C
Q 036407 170 V 170 (576)
Q Consensus 170 ~ 170 (576)
.
T Consensus 153 ~ 153 (350)
T cd05573 153 K 153 (350)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=307.71 Aligned_cols=145 Identities=25% Similarity=0.355 Sum_probs=124.5
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
+|.+.+.||+|+||.||+|+.. ++.||||++..... .....+..|..++..+.+|++|+.+++.+... ..+++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEE
Confidence 5888999999999999999876 57899999975322 22335677788888888889999998888766 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||||+++|+|.+.+..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 79 v~E~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~ 150 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred EEcCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCcee
Confidence 9999999999988866543 677888999999999999999999 99999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.38 Aligned_cols=149 Identities=29% Similarity=0.494 Sum_probs=125.4
Q ss_pred CCCCccceeeccCcEEEEEEEE------CCceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATL------HDQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~------~g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
++|++.+.||+|+||.||+|.. .+..+++|.+..... .....+.+|+.++..+.| +||+++++++... ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~--~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH-PNIVCLLGVVTQE--QP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCC-CCeeeEEEEEecC--Cc
Confidence 5678899999999999999974 257899999974332 333568899999999976 9999999998766 67
Q ss_pred EEEEEeccCCCCHHHHHHhcCC--------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC
Q 036407 88 MLLVYELMSNGNLQDALLHKKP--------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH 153 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~--------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~ 153 (576)
.|+||||+++++|.+++..... ...+++.++..++.+++.||.|||+++ ++|+||||+|||++.
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~ 159 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGE 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcC
Confidence 8999999999999998854321 123677888899999999999999999 999999999999999
Q ss_pred CCcEEEccccccccc
Q 036407 154 NFCAKISDFGLARLK 168 (576)
Q Consensus 154 ~g~vKLiDFGlA~~~ 168 (576)
++.++|+|||+++..
T Consensus 160 ~~~~kl~dfg~~~~~ 174 (283)
T cd05090 160 QLHVKISDLGLSREI 174 (283)
T ss_pred CCcEEeccccccccc
Confidence 999999999988654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.38 Aligned_cols=156 Identities=28% Similarity=0.490 Sum_probs=130.6
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEee
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSS 81 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~ 81 (576)
+....++|++.+.||+|+||.||++... ...+|+|.+.... ......+.+|+.++..+..|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4556678999999999999999999864 2579999987532 2333568899999999965699999999887
Q ss_pred CCCCCeEEEEEeccCCCCHHHHHHhcC-------------CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCC
Q 036407 82 NPKRHRMLLVYELMSNGNLQDALLHKK-------------PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSN 148 (576)
Q Consensus 82 ~~s~~~l~LVmE~~~gGsL~d~L~~~~-------------~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeN 148 (576)
.. ..++++|||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+|+||||+|
T Consensus 87 ~~--~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 87 QE--GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred CC--CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 65 67899999999999999986531 1234778888999999999999999999 9999999999
Q ss_pred eEEcCCCcEEEcccccccccc
Q 036407 149 ILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 149 ILLd~~g~vKLiDFGlA~~~~ 169 (576)
||++.++.++|+|||+++...
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~ 183 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIH 183 (293)
T ss_pred EEEcCCCeEEeCccccccccc
Confidence 999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.69 Aligned_cols=147 Identities=24% Similarity=0.363 Sum_probs=127.9
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++.+.||+|+||.||+|+.. ++.||||++..... .....+..|+.++..+.| +||+.+++.+... ..+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~-~~iv~~~~~~~~~--~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS-LWVVKMFYSFQDK--LNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCC-CCcceEEEEEecC--CeEE
Confidence 57999999999999999999875 78999999975322 223467788999999876 9999999988766 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
||||||++|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++...
T Consensus 78 lv~E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKDT---LTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred EEEcCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999999876543 778888999999999999999999 9999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=324.49 Aligned_cols=152 Identities=26% Similarity=0.370 Sum_probs=133.8
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchh--HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG--EREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~--~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
.++|..++.||.|+||.++.++.+ +..||+|.++...... +....+|+.+++++.| |||+.+++.+...+ ..+|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~h-P~iv~y~ds~~~~~-~~l~ 80 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLH-PNIVEYKDSFEEDG-QLLC 80 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccC-CCeeeeccchhcCC-ceEE
Confidence 478999999999999999988766 6899999998654433 3467999999999877 99999999998762 3499
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|||+||+||++.+.+.... +..+++.+++.++.|++.|+.|||+.. |+|||||+.|||+..++.++|+|||+|+...
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999999998766 345899999999999999999999988 9999999999999999999999999998765
Q ss_pred C
Q 036407 170 V 170 (576)
Q Consensus 170 ~ 170 (576)
.
T Consensus 158 ~ 158 (426)
T KOG0589|consen 158 P 158 (426)
T ss_pred C
Confidence 4
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=294.03 Aligned_cols=146 Identities=27% Similarity=0.450 Sum_probs=125.9
Q ss_pred CCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE 93 (576)
++|++.+.||+|+||.||++... +..+|+|.+.... .....+.+|+.++..+.| +||+++++++... ..+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSH-PKLVQLYGVCTQQ--KPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCC-CCceeEEEEEccC--CCEEEEEE
Confidence 45788899999999999999876 4589999886433 234578899999999987 9999999998766 77899999
Q ss_pred ccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 94 LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 94 ~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|+++|+|.+.+..... .+++..++.++.+++.||.|||+++ |+|+||+|+||+++.++.++|+|||.+...
T Consensus 80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~ 150 (256)
T cd05114 80 FMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYV 150 (256)
T ss_pred cCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCcccc
Confidence 9999999998875432 2677888999999999999999999 999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=296.76 Aligned_cols=150 Identities=30% Similarity=0.460 Sum_probs=130.3
Q ss_pred CCCCccceeeccCcEEEEEEEEC------CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~------g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
.+|++.+.||+|+||.||++... +..||+|.+..........+.+|+.++..+.| +||+.+++++.......+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH-DNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-CCeeEEEEEEccCCCCce
Confidence 57889999999999999999742 67899999976555555678999999999977 999999998876655778
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++...
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999999865432 2678888899999999999999999 999999999999999999999999988754
Q ss_pred c
Q 036407 169 S 169 (576)
Q Consensus 169 ~ 169 (576)
.
T Consensus 159 ~ 159 (284)
T cd05081 159 P 159 (284)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=306.24 Aligned_cols=137 Identities=24% Similarity=0.381 Sum_probs=118.7
Q ss_pred eeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCC
Q 036407 23 LGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSN 97 (576)
Q Consensus 23 LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~g 97 (576)
||+|+||.||+|+.. ++.||+|++.... ......+..|+.++..+.| +||+.+++.+... ..+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNC-PFIVPLKFSFQSP--EKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CcEeceeeEEecC--CeEEEEEcCCCC
Confidence 799999999999875 6889999996432 2233567789999999976 9999999888766 789999999999
Q ss_pred CCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 98 GNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 98 GsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|+|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++.
T Consensus 78 g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 78 GELFHHLQREGR---FDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred CcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 999998876443 677888889999999999999999 99999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=297.65 Aligned_cols=150 Identities=29% Similarity=0.498 Sum_probs=128.4
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCch-hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSLQ-GEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~~-~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
.++|.+.+.||+|+||.||+|... ++.||||.+...... ....+.+|+.++..+.| +||+.+++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~-- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH-ENIVKFYGVCTEG-- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCC-CCchheeeEEecC--
Confidence 456889999999999999999753 367999999754433 45678999999999987 9999999998876
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCC-----------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKP-----------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN 154 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~-----------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~ 154 (576)
..+++||||+++++|.+++..... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~ 158 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYD 158 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCC
Confidence 789999999999999999875431 123677788899999999999999999 9999999999999999
Q ss_pred CcEEEccccccccc
Q 036407 155 FCAKISDFGLARLK 168 (576)
Q Consensus 155 g~vKLiDFGlA~~~ 168 (576)
+.++|+|||++...
T Consensus 159 ~~~kl~d~g~~~~~ 172 (280)
T cd05049 159 LVVKIGDFGMSRDV 172 (280)
T ss_pred CeEEECCcccceec
Confidence 99999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.23 Aligned_cols=146 Identities=23% Similarity=0.401 Sum_probs=125.1
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.++|++.+.||.|+||.||+|+.. +..||+|.+..... .....+.+|+.++..+.| +||+++++++... ..+++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~--~~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKH-ANIVTLHDIIHTE--RCLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCC-CCEeeEEEEEcCC--CeEEE
Confidence 367999999999999999999875 78999999864332 223467899999999977 9999999998765 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||||+.+ +|.+.+..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 v~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~ 152 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARA 152 (288)
T ss_pred EEeCCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceee
Confidence 9999964 89888865432 2677788889999999999999999 99999999999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=299.02 Aligned_cols=152 Identities=32% Similarity=0.527 Sum_probs=126.7
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
...++|++.+.||+|+||.||+|... +..||||.+.... ......+.+|+.++..+.| +||+.+++++...
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEcCC
Confidence 46788999999999999999999754 3569999986432 2334568899999999876 9999999988665
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCC-------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKP-------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC 156 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~-------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~ 156 (576)
...++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 82 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 82 --QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFT 157 (277)
T ss_pred --CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCC
Confidence 678999999999999998865321 112456778889999999999999999 999999999999999999
Q ss_pred EEEccccccccc
Q 036407 157 AKISDFGLARLK 168 (576)
Q Consensus 157 vKLiDFGlA~~~ 168 (576)
++|+|||++...
T Consensus 158 ~~l~dfg~~~~~ 169 (277)
T cd05062 158 VKIGDFGMTRDI 169 (277)
T ss_pred EEECCCCCcccc
Confidence 999999987643
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.83 Aligned_cols=139 Identities=24% Similarity=0.330 Sum_probs=120.1
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+.||+|+||.||+++.. ++.||||++..... .....+.+|+.++..+.| +||+.+++.+... ..+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~--~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRH-PFLTSLKYSFQTK--DRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceEEEEEcC--CEEEEEEeCC
Confidence 46999999999999865 78999999975322 233567889999999877 9999999888766 7899999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++++|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~g~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~ 144 (328)
T cd05593 78 NGGELFFHLSRERV---FSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (328)
T ss_pred CCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCcc
Confidence 99999888865433 678888899999999999999999 99999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=301.79 Aligned_cols=149 Identities=31% Similarity=0.524 Sum_probs=127.6
Q ss_pred CCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.+|.+.+.||+|+||.||+|+.. +..+++|.+..........+.+|+.+++.+.| +||+++++++... ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH-EHIVKFYGVCGDG--DP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCC-CCcceEEEEEccC--Cc
Confidence 45788899999999999999742 35688999876555555678999999999977 9999999998766 67
Q ss_pred EEEEEeccCCCCHHHHHHhcCC-------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC
Q 036407 88 MLLVYELMSNGNLQDALLHKKP-------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN 154 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~-------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~ 154 (576)
+++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGAN 159 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccC
Confidence 8999999999999999875431 123678889999999999999999999 9999999999999999
Q ss_pred CcEEEccccccccc
Q 036407 155 FCAKISDFGLARLK 168 (576)
Q Consensus 155 g~vKLiDFGlA~~~ 168 (576)
+.++|+|||++...
T Consensus 160 ~~~~l~dfg~a~~~ 173 (291)
T cd05094 160 LLVKIGDFGMSRDV 173 (291)
T ss_pred CcEEECCCCccccc
Confidence 99999999988643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=293.76 Aligned_cols=150 Identities=29% Similarity=0.480 Sum_probs=129.4
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
..++|++.+.||+|++|.||+|... ++.||||.+..... ..+.+.+|+.++..+.| +|++++++++... +.+++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~lv 79 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRH-PKLIQLYAVCTLE--EPIYIV 79 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCC-CCccceeEEEecC--CCeeee
Confidence 3467899999999999999999865 57899999875432 34568899999999986 9999999988766 778999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|||+++++|.+++..... ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 80 TELMKYGSLLEYLQGGAG-RALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred eecccCCcHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 999999999999876442 23678888999999999999999999 9999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=292.50 Aligned_cols=147 Identities=25% Similarity=0.453 Sum_probs=126.6
Q ss_pred cCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEe
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE 93 (576)
..+|.+.+.||+|+||.||++...+..+|+|.+.... ....+.+|+.++..+.| +|++++++++... ....++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~-~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRH-SNLVQLLGVIVEE-KGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCC-CCeeeEEEEEEcC-CCceEEEEE
Confidence 3578899999999999999999999999999986432 34568899999999977 9999999876543 367899999
Q ss_pred ccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 94 LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 94 ~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|+++++|.+++..... ..+++..++.++.+|+.||.|||+++ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~ 151 (256)
T cd05082 81 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKE 151 (256)
T ss_pred CCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCcccee
Confidence 9999999998876443 23677888899999999999999999 99999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.87 Aligned_cols=138 Identities=25% Similarity=0.339 Sum_probs=119.4
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+.||+|+||.||+++.. +..||+|++..... .....+..|+.++..+.| +||+.+++.+... ..+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~i~~~~~~~~~~--~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTH--DRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCcceeeEEecC--CEEEEEEeCC
Confidence 47999999999999865 78999999975321 223456789999999977 9999999988766 7899999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
++++|...+..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 78 ~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~ 143 (323)
T cd05595 78 NGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCK 143 (323)
T ss_pred CCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhc
Confidence 99999888866443 678888999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=304.19 Aligned_cols=139 Identities=21% Similarity=0.344 Sum_probs=120.9
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+.||+|+||.||+++.. ++.||||++..... .....+..|+.++..+.+|+||+.+++.+... ..+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence 47999999999999875 78899999975322 22345778888998987779999999988776 7899999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
++|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++
T Consensus 79 ~~g~L~~~~~~~~~---l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~ 144 (329)
T cd05588 79 SGGDLMFHMQRQRK---LPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144 (329)
T ss_pred CCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCcccc
Confidence 99999988865433 788889999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=295.74 Aligned_cols=148 Identities=27% Similarity=0.449 Sum_probs=127.5
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
..+|.+.+.||+|+||.||+|... ++.||+|.+.... .....+.+|+.++..+.| +|++++++++... ..+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~lv 80 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKH-PNLVQLLGVCTRE--PPFYII 80 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCC-CChhheEEEEcCC--CCcEEE
Confidence 346788899999999999999875 7889999986433 334578899999999987 9999999998766 778999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~ 154 (263)
T cd05052 81 TEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLM 154 (263)
T ss_pred EEeCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCcccccc
Confidence 999999999998866432 23677888899999999999999999 999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=309.03 Aligned_cols=148 Identities=28% Similarity=0.402 Sum_probs=127.8
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC---CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH---DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~---g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
...++|.+.+.||+|+||.||+|... +..||+|.+.... ......+.+|+.++..+.| |||+.+++++...
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~-- 103 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH-PFCVNLYGSFKDE-- 103 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCCcceEEEEEeC--
Confidence 34568999999999999999999864 2579999986432 2233467889999999976 9999999998776
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
..+|+||||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a 178 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKR---FPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFA 178 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCC
Confidence 789999999999999999876543 678888899999999999999999 999999999999999999999999987
Q ss_pred cc
Q 036407 166 RL 167 (576)
Q Consensus 166 ~~ 167 (576)
..
T Consensus 179 ~~ 180 (340)
T PTZ00426 179 KV 180 (340)
T ss_pred ee
Confidence 64
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.32 Aligned_cols=140 Identities=24% Similarity=0.377 Sum_probs=118.5
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+.||+|+||.||+|+.. ++.||||++..... .....+..|..++..+.+|+||+.+++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 47999999999999876 67899999975321 22344566777777766779999999888765 7899999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++|+|...+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~gg~L~~~~~~~~~---~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~ 145 (316)
T cd05592 79 NGGDLMFHIQSSGR---FDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKE 145 (316)
T ss_pred CCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence 99999988876443 677888889999999999999999 99999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.90 Aligned_cols=140 Identities=25% Similarity=0.404 Sum_probs=120.2
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+.||+|+||.||+|+.. ++.||||++..... .....+..|..++..+.+|+||+.+++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeCC
Confidence 46999999999999876 67899999975322 22345678888888887789999999998876 7899999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++++|...+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 79 ~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 79 NGGDLMFQIQRSRK---FDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKE 145 (321)
T ss_pred CCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeeccccee
Confidence 99999988865443 677788889999999999999999 99999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=323.94 Aligned_cols=148 Identities=20% Similarity=0.222 Sum_probs=126.5
Q ss_pred CCCccceeeccCcEEEEEEEEC---CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH---DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~---g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
.|.+.+.||+|++|.||+|... +..||+|.+..........+..|+.++..+.| +||+++++++... +.+||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~~~~~~~~~--~~~~lv~ 144 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDH-FGIVKHFDDFKSD--DKLLLIM 144 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEEEC--CEEEEEE
Confidence 4899999999999999999754 56788888765544445567889999999977 9999999998876 7899999
Q ss_pred eccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 93 ELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||+++|+|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 9999999998876421 2223677888889999999999999999 999999999999999999999999998754
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=303.17 Aligned_cols=140 Identities=21% Similarity=0.339 Sum_probs=120.4
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+.||+|+||.||+|+.. ++.||+|++..... .....+..|+.++..+.+|+||+.+++++... ..+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeCC
Confidence 47999999999999875 68899999975322 22345778888888887779999999988776 7899999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++++|...+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++.
T Consensus 79 ~~~~L~~~~~~~~~---l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 79 NGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred CCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 99999888765443 778888899999999999999999 99999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.58 Aligned_cols=140 Identities=27% Similarity=0.452 Sum_probs=120.3
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+.||+|+||.||+|+.. ++.||||++..... .....+..|+.++..+.+|+||+.+++++... ..+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcCC
Confidence 47999999999999875 68899999975321 23345678888888887779999999988766 7899999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++++|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+++.
T Consensus 79 ~~g~L~~~i~~~~~---l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 79 NGGDLMFHIQKSRR---FDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred CCchHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 99999988876443 678888889999999999999999 99999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=290.64 Aligned_cols=149 Identities=28% Similarity=0.475 Sum_probs=123.5
Q ss_pred CCccceeeccCcEEEEEEEEC-----CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC----C
Q 036407 17 FSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPK----R 85 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s----~ 85 (576)
|.+.+.||+|+||.||+|... +..||||.+..... .....+.+|+..+..+.| +||+++++++.... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH-PNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCC-CCeeeEEeeeccCCccccC
Confidence 567899999999999999864 36799999875332 234578899999999876 99999999876542 2
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC---CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKK---PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDF 162 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~---~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDF 162 (576)
...++||||+++++|...+.... ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+||
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCc
Confidence 35799999999999998885432 1224788889999999999999999999 999999999999999999999999
Q ss_pred cccccc
Q 036407 163 GLARLK 168 (576)
Q Consensus 163 GlA~~~ 168 (576)
|+++..
T Consensus 158 g~~~~~ 163 (273)
T cd05035 158 GLSKKI 163 (273)
T ss_pred cceeec
Confidence 988754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=309.98 Aligned_cols=146 Identities=23% Similarity=0.309 Sum_probs=127.0
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.|++++.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +||+++++.+... ..+|+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~--~~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN-EWVVKLYYSFQDK--DNLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCC-CCeeeeEEEEecC--CEEEE
Confidence 5889999999999999999875 68999999975332 223467889999999977 9999999998876 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
||||+++|+|.+++..... +++..+..++.||+.||.|||..+ |+||||||+|||++.++.++|+|||++....
T Consensus 79 v~E~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~ 152 (381)
T cd05626 79 VMDYIPGGDMMSLLIRMEV---FPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFR 152 (381)
T ss_pred EEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence 9999999999998876443 677888889999999999999999 9999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=300.38 Aligned_cols=148 Identities=28% Similarity=0.494 Sum_probs=124.7
Q ss_pred CCCCccceeeccCcEEEEEEEEC--C--ceEEEEEeecC-CchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--D--QSVAVKVMDSG-SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g--~~VAVK~i~~~-s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++.+.||+|+||.||+|+.. + ..+++|.+... .....+.+.+|+.++.++.+|+||+.+++++... ..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Ccce
Confidence 57899999999999999999865 2 34688887632 2233457889999999997779999999988765 6789
Q ss_pred EEEeccCCCCHHHHHHhcCC-------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc
Q 036407 90 LVYELMSNGNLQDALLHKKP-------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC 156 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~-------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~ 156 (576)
+||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCe
Confidence 99999999999999865321 123677888899999999999999999 999999999999999999
Q ss_pred EEEccccccc
Q 036407 157 AKISDFGLAR 166 (576)
Q Consensus 157 vKLiDFGlA~ 166 (576)
+||+|||++.
T Consensus 158 ~kl~dfg~~~ 167 (297)
T cd05089 158 SKIADFGLSR 167 (297)
T ss_pred EEECCcCCCc
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=291.76 Aligned_cols=148 Identities=26% Similarity=0.496 Sum_probs=127.4
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-----CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.++|++.+.||+|+||.||+|... ...||||.+..... .....+..|+.++..+.| +||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDH-PNIIRLEGVVTKS--RP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCC-CCcceEeEEEecC--Cc
Confidence 467899999999999999999874 35799999865432 234568889999999977 9999999988765 77
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||++..
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhc
Confidence 8999999999999999876432 3678888999999999999999999 99999999999999999999999999875
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 156 ~ 156 (266)
T cd05033 156 L 156 (266)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=325.77 Aligned_cols=150 Identities=29% Similarity=0.448 Sum_probs=133.1
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
-.+-|++.+-||.|+.|.|-+|++. |+..|||++.+... .....+.+||-+|+.+.| ||++.+++++... .+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~H-pnVl~LydVwe~~--~~ 86 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEH-PNVLRLYDVWENK--QH 86 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcC-CCeeeeeeeeccC--ce
Confidence 3467899999999999999999864 89999999976532 223568999999999988 9999999999877 89
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+|+|+||+++|.|.+++...++ +++..+.+++.||+.|+.|||+.+ |+||||||+|+||+..+.+||+|||+|.+
T Consensus 87 lylvlEyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsL 161 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASL 161 (786)
T ss_pred EEEEEEecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeec
Confidence 9999999999999999988765 788888899999999999999999 99999999999999999999999999976
Q ss_pred ccC
Q 036407 168 KSV 170 (576)
Q Consensus 168 ~~~ 170 (576)
...
T Consensus 162 e~~ 164 (786)
T KOG0588|consen 162 EVP 164 (786)
T ss_pred ccC
Confidence 544
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=298.65 Aligned_cols=149 Identities=32% Similarity=0.525 Sum_probs=128.0
Q ss_pred CCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
++|.+.+.||+|+||.||++... +..+|+|.+..........+.+|+.++..+.| +|++++++++... ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH-EHIVKFYGVCVEG--DP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEecC--Cc
Confidence 57889999999999999999742 35689999875554555678999999999987 9999999998766 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCC----------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcE
Q 036407 88 MLLVYELMSNGNLQDALLHKKP----------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA 157 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~----------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~v 157 (576)
+++||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLV 159 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCcE
Confidence 8999999999999999875431 123788899999999999999999999 9999999999999999999
Q ss_pred EEccccccccc
Q 036407 158 KISDFGLARLK 168 (576)
Q Consensus 158 KLiDFGlA~~~ 168 (576)
+|+|||++...
T Consensus 160 kl~dfg~~~~~ 170 (288)
T cd05093 160 KIGDFGMSRDV 170 (288)
T ss_pred EeccCCccccc
Confidence 99999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=303.75 Aligned_cols=142 Identities=24% Similarity=0.376 Sum_probs=119.0
Q ss_pred CCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhc--cCCceEEEEEEeeCCCCCeEE
Q 036407 17 FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLE--QDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~--h~pNIv~Llg~~~~~s~~~l~ 89 (576)
|++.+.||+|+||.||+|... ++.||||++.... ......+..|++++..+. .|+||+++++++... ..+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE--DHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC--CEEE
Confidence 678899999999999999875 7899999997532 122345666766654433 249999999998766 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
+||||+++++|...+... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 79 lv~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05589 79 FVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCK 149 (324)
T ss_pred EEEcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCc
Confidence 999999999998877542 2778888999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=294.17 Aligned_cols=149 Identities=25% Similarity=0.424 Sum_probs=121.1
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch--hHHHHHHHHHHHHHhc--cCCceEEEEEEeeCC---CCC
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ--GEREFYNELYFASLLE--QDDHVVSVLGFSSNP---KRH 86 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~--~~~~~l~EI~iLs~L~--h~pNIv~Llg~~~~~---s~~ 86 (576)
+|++.+.||+|+||.||+|+.. ++.||+|.+...... ....+.+|+.++..+. .|+||+.+++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999875 788999998653221 1234567777777764 359999999987642 235
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+++|||++. ++|.+++...... .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPP-GLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCccc
Confidence 6899999996 5888888654322 2678889999999999999999999 9999999999999999999999999876
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 157 ~~ 158 (288)
T cd07863 157 IY 158 (288)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=303.04 Aligned_cols=140 Identities=25% Similarity=0.382 Sum_probs=119.5
Q ss_pred cceeeccCcEEEEEEEE-----CCceEEEEEeecCCc----hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 20 SRLLGQGGFGSVFHATL-----HDQSVAVKVMDSGSL----QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~-----~g~~VAVK~i~~~s~----~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
++.||+|+||.||+++. .++.||||++..... .....+..|+.++..+.| +||+.+++.+... +.+|+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~~~~~~~~~--~~~~l 77 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH-PFIVDLIYAFQTG--GKLYL 77 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCC-CchhceeeEEecC--CeEEE
Confidence 36899999999999975 368899999974321 223456789999999987 9999999988766 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||||+.+++|.+.+..... +.+..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++.
T Consensus 78 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 78 ILEYLSGGELFMHLEREGI---FMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred EEeCCCCchHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 9999999999998876543 567777889999999999999999 99999999999999999999999998753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=294.55 Aligned_cols=149 Identities=28% Similarity=0.459 Sum_probs=132.0
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchh--HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG--EREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~--~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
++|...+.||+|.||.||+|+.. |+.||||.+......+ ....++||..|+.+.| +||+.+++.+... ..+.|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h-~nIi~LiD~F~~~--~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKH-PNIIELIDVFPHK--SNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccC-cchhhhhhhccCC--CceEE
Confidence 57888999999999999999976 8999999998654332 3467999999999986 9999999998776 78899
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccccC
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
|+||++. +|...++.... .++...++.++.+++.||+|||+++ |+||||||.|+|++.+|.+||+|||+|+.+..
T Consensus 79 VfEfm~t-dLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 79 VFEFMPT-DLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred EEEeccc-cHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 9999976 99999987654 3778889999999999999999999 99999999999999999999999999998765
Q ss_pred C
Q 036407 171 G 171 (576)
Q Consensus 171 ~ 171 (576)
+
T Consensus 154 p 154 (318)
T KOG0659|consen 154 P 154 (318)
T ss_pred C
Confidence 4
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.71 Aligned_cols=139 Identities=24% Similarity=0.330 Sum_probs=118.8
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+.||+|+||.||+++.. ++.||+|++..... .....+..|+.++..+.| +||+.+++.+... ..+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~h-p~i~~~~~~~~~~--~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTALKYSFQTH--DRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCCceEEEEEcC--CEEEEEEeCC
Confidence 47999999999999864 78999999975322 223456788888888876 9999999888766 7899999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++++|...+..... +++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~ 145 (325)
T cd05594 78 NGGELFFHLSRERV---FSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE 145 (325)
T ss_pred CCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCee
Confidence 99999988865443 6788888999999999999997 78 99999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=313.31 Aligned_cols=149 Identities=23% Similarity=0.342 Sum_probs=127.0
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
....++|++.+.||+|+||.||+++.. ++.||+|++.... ......+..|+.++..+.| +||+.+++++...
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h-~~iv~~~~~~~~~-- 115 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS-EWIVQLHYAFQDD-- 115 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCcceEEEEEecC--
Confidence 345678999999999999999999875 7899999996422 1223456788999998876 9999999888766
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
..+|+||||+++|+|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~~----l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNYD----IPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccce
Confidence 78999999999999999886532 566777889999999999999999 999999999999999999999999988
Q ss_pred ccc
Q 036407 166 RLK 168 (576)
Q Consensus 166 ~~~ 168 (576)
...
T Consensus 190 ~~~ 192 (370)
T cd05596 190 MKM 192 (370)
T ss_pred eec
Confidence 643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=316.19 Aligned_cols=154 Identities=28% Similarity=0.422 Sum_probs=128.1
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
....++|++.+.||+|+||.||+|... +..||||++..... ...+.+.+|+.++..+..||||+.+++++..
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 445678899999999999999999753 24699999965432 3345789999999999866999999999976
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCC-----------------------------------------------------
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKP----------------------------------------------------- 109 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~----------------------------------------------------- 109 (576)
. ..+|||||||++|+|.+++.....
T Consensus 113 ~--~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 113 S--GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred C--CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 5 789999999999999988754210
Q ss_pred ----------------------------------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCe
Q 036407 110 ----------------------------------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNI 149 (576)
Q Consensus 110 ----------------------------------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNI 149 (576)
...+++..++.++.||+.||.|||+.+ |+|+||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Ni 268 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhE
Confidence 012566677889999999999999999 99999999999
Q ss_pred EEcCCCcEEEccccccccc
Q 036407 150 LLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 150 LLd~~g~vKLiDFGlA~~~ 168 (576)
|++.++.++|+|||+++..
T Consensus 269 ll~~~~~~kL~DfGla~~~ 287 (400)
T cd05105 269 LLAQGKIVKICDFGLARDI 287 (400)
T ss_pred EEeCCCEEEEEeCCcceec
Confidence 9999999999999998644
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.85 Aligned_cols=152 Identities=24% Similarity=0.336 Sum_probs=132.8
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
.+.|+.+..|++|+||.||+|+.+ ++.||+|.++.... .-...-++||.++.+++| +||+.+..+....+.+.+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H-~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARH-PNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCC-CCeeeeEEEEeccccceee
Confidence 356888999999999999999876 78999999975432 113456899999999986 9999999998888888899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
||||||++ +|..++...... +...+++.++.|++.||.|||.++ |+||||||+|+|+.+.|.+||+|||+|+.++
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~--F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQP--FLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhc
Confidence 99999977 899888876532 677888889999999999999999 9999999999999999999999999999876
Q ss_pred CC
Q 036407 170 VG 171 (576)
Q Consensus 170 ~~ 171 (576)
.+
T Consensus 229 sp 230 (419)
T KOG0663|consen 229 SP 230 (419)
T ss_pred CC
Confidence 54
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.15 Aligned_cols=151 Identities=25% Similarity=0.310 Sum_probs=131.5
Q ss_pred hhcCCCCccceeeccCcEEEEEEEECC--ceEEEEEeecCCchh---HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQG---EREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~g--~~VAVK~i~~~s~~~---~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
...++|++++.||.|.-|.||+++..+ ..+|+|++.+..... ..++..|-.||+.+.| |.++.|+..+..+ .
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDH-PFlPTLYa~fet~--~ 150 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDH-PFLPTLYASFETD--K 150 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCC-Cccchhhheeecc--c
Confidence 445678899999999999999999884 889999998755433 3466778888999988 9999999988776 8
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
..|+|||||+||+|..+.+.+. .+.+++..++.|+.+|+.||+|||-.| ||+|||||+||||.++|.+.|+||.++.
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccc
Confidence 9999999999999987666544 455889999999999999999999999 9999999999999999999999999886
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 228 ~~ 229 (459)
T KOG0610|consen 228 RC 229 (459)
T ss_pred cC
Confidence 54
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=292.74 Aligned_cols=154 Identities=28% Similarity=0.410 Sum_probs=130.4
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC----
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK---- 84 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s---- 84 (576)
+...+.|++.+.||+|+||.||+|... ++.||+|.+.... .....+..|+.++..+.+|+|++++++++....
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 345678999999999999999999875 6889999986543 334578899999999977799999999886532
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
...+|+||||+.+++|.+++..... ..+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCC
Confidence 2568999999999999998876332 23678888899999999999999999 99999999999999999999999998
Q ss_pred cccc
Q 036407 165 ARLK 168 (576)
Q Consensus 165 A~~~ 168 (576)
+...
T Consensus 158 ~~~~ 161 (272)
T cd06637 158 SAQL 161 (272)
T ss_pred ceec
Confidence 7643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=302.20 Aligned_cols=147 Identities=29% Similarity=0.411 Sum_probs=122.1
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC---
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK--- 84 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s--- 84 (576)
...++|++.+.||+|+||.||++... +..||||.+.... ......+.+|+.++..+.| +||+.+++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH-KNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCC-CCEeeeeeeeccCCCcc
Confidence 45689999999999999999999865 7899999996432 2334567899999999977 99999999876432
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 85 -RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 85 -~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
...+|+||||+.+ +|.+.+... ++...+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~-----~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIHME-----LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHhcc-----CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCC
Confidence 2467999999965 666655321 566778889999999999999999 9999999999999999999999999
Q ss_pred cccc
Q 036407 164 LARL 167 (576)
Q Consensus 164 lA~~ 167 (576)
+++.
T Consensus 169 ~a~~ 172 (359)
T cd07876 169 LART 172 (359)
T ss_pred Cccc
Confidence 8753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=289.09 Aligned_cols=148 Identities=28% Similarity=0.522 Sum_probs=130.7
Q ss_pred cCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEe
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE 93 (576)
.++|++.+.||.|+||.||+|...++.||+|.+..... ...++.+|+.++..+.| +|++++++++... ...++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRH-PNLVQLLGVVLQG--NPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCC-cceeeeEEEEcCC--CCeEEEEE
Confidence 46789999999999999999999999999999975443 45678999999999987 9999999998764 78899999
Q ss_pred ccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 94 LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 94 ~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.++..
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~ 152 (256)
T cd05039 81 YMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEA 152 (256)
T ss_pred ecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccccccc
Confidence 9999999998876542 23778889999999999999999999 999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=311.27 Aligned_cols=151 Identities=22% Similarity=0.348 Sum_probs=129.0
Q ss_pred HHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 9 VLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 9 ~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
.+....++|++.+.||+|+||.||+++.. ++.||+|++.... ......+..|+.++..+.| +||+++++.+...
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~h-p~iv~~~~~~~~~ 115 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFCAFQDD 115 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCEeeEEEEEEcC
Confidence 34455689999999999999999999876 6889999986422 1223457788888888876 9999999988766
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
..+|+||||+++|+|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 116 --~~~~lv~Ey~~gg~L~~~l~~~~----~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 116 --KYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred --CEEEEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecc
Confidence 78999999999999999886532 567788889999999999999999 9999999999999999999999999
Q ss_pred ccccc
Q 036407 164 LARLK 168 (576)
Q Consensus 164 lA~~~ 168 (576)
++...
T Consensus 188 ~a~~~ 192 (370)
T cd05621 188 TCMKM 192 (370)
T ss_pred cceec
Confidence 98654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=296.73 Aligned_cols=149 Identities=28% Similarity=0.458 Sum_probs=124.0
Q ss_pred CCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
.+|++.+.||.|+||.||+|... +..||||.+..... .....+..|+.++..+.| +||+.+++++... .
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~--~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH-PNIVCLLGVVTKE--Q 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEcCC--C
Confidence 35778899999999999999753 46799999975432 223567889988888877 9999999998776 6
Q ss_pred eEEEEEeccCCCCHHHHHHhcCC-------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC
Q 036407 87 RMLLVYELMSNGNLQDALLHKKP-------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH 153 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~-------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~ 153 (576)
.+++++||+.+++|.+++..... ...++...++.++.|++.||.|||+++ |+|+||||+|||++.
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~ 159 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFD 159 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecC
Confidence 78999999999999998853211 123667778889999999999999999 999999999999999
Q ss_pred CCcEEEccccccccc
Q 036407 154 NFCAKISDFGLARLK 168 (576)
Q Consensus 154 ~g~vKLiDFGlA~~~ 168 (576)
++.+||+|||+++..
T Consensus 160 ~~~~kl~Dfg~~~~~ 174 (283)
T cd05091 160 KLNVKISDLGLFREV 174 (283)
T ss_pred CCceEeccccccccc
Confidence 999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=305.00 Aligned_cols=147 Identities=29% Similarity=0.424 Sum_probs=122.3
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCC----
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNP---- 83 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~---- 83 (576)
...++|++.+.||+|+||.||++... ++.||||.+.... ......+.+|+.++..+.| +||+.+++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH-KNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCC-Cchhceeeeeecccccc
Confidence 45689999999999999999999864 7889999986532 2234567889999999877 9999999987643
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
....+++||||+++ +|.+.+... ++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCc
Confidence 22468999999965 676666431 567778889999999999999999 9999999999999999999999999
Q ss_pred cccc
Q 036407 164 LARL 167 (576)
Q Consensus 164 lA~~ 167 (576)
+++.
T Consensus 165 ~~~~ 168 (355)
T cd07874 165 LART 168 (355)
T ss_pred cccc
Confidence 9864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=304.47 Aligned_cols=139 Identities=25% Similarity=0.411 Sum_probs=118.9
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+.||+|+||.||+|+.. ++.||||.+..... ........|..++..+.+|+||+.+++.+... ..+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECCC
Confidence 47999999999999875 68899999975321 22345677788887776779999999988766 7899999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+++|.+.+..... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+++
T Consensus 79 ~~g~L~~~i~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~ 144 (316)
T cd05620 79 NGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCK 144 (316)
T ss_pred CCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCe
Confidence 99999988876433 677788889999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=296.65 Aligned_cols=146 Identities=29% Similarity=0.400 Sum_probs=125.0
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch---hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~---~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.|++.+.||+|+||.||++... ++.||||.+...... ....+.+|+.++..+.| +||+.+++.+... ..+|+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~~~l 77 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSLAYAYETK--DALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCC-CCEeeeeeeecCC--CeEEE
Confidence 4888999999999999999865 789999999653322 23456789999999976 9999999888766 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 78 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVE 151 (285)
T ss_pred EEeccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence 9999999999988765432 23788888999999999999999999 99999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.56 Aligned_cols=143 Identities=26% Similarity=0.412 Sum_probs=121.7
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.++|+..+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +||+.+++++... ..+++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNH-PNVVKCHDMFDHN--GEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCC-CCcceeeeEeccC--CeEEE
Confidence 456778899999999999999875 78999999964432 234578899999999987 9999999998765 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||||+++++|.... ...+..+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++...
T Consensus 150 v~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 150 LLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred EEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 99999999986421 1345667789999999999999999 999999999999999999999999988644
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.35 Aligned_cols=143 Identities=26% Similarity=0.391 Sum_probs=118.0
Q ss_pred cceeeccCcEEEEEEEEC----CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 20 SRLLGQGGFGSVFHATLH----DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~----g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
..+||+|+||.||+|+.. ++.||+|.+.... ....+.+|+.++..+.| +||+++++.+.......+|+||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKH-PNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCC-CCCcceeeeEecCCCcEEEEEEecc
Confidence 468999999999999854 4789999986432 23457889999999987 9999999998776667899999999
Q ss_pred CCCCHHHHHHhcC------CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE----cCCCcEEEcccccc
Q 036407 96 SNGNLQDALLHKK------PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL----DHNFCAKISDFGLA 165 (576)
Q Consensus 96 ~gGsL~d~L~~~~------~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL----d~~g~vKLiDFGlA 165 (576)
. ++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||++
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 58888775421 1123677888999999999999999999 9999999999999 45678999999998
Q ss_pred ccc
Q 036407 166 RLK 168 (576)
Q Consensus 166 ~~~ 168 (576)
+..
T Consensus 160 ~~~ 162 (317)
T cd07868 160 RLF 162 (317)
T ss_pred ecc
Confidence 754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=290.46 Aligned_cols=149 Identities=24% Similarity=0.384 Sum_probs=126.9
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++.+.||+|+||.||+|+.. ++.||||.+.... ......+.+|+.+++.+.| +|++++++++... ...+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH-PNVIKYLDSFIED--NELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC-cceeeeeeeEEEC--CeEE
Confidence 58999999999999999999864 7899999886422 2333467899999999977 9999999988766 7889
Q ss_pred EEEeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+|+||+++++|.+++.... ....++...++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 9999999999998886422 1233677888899999999999999999 999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=304.42 Aligned_cols=139 Identities=27% Similarity=0.401 Sum_probs=120.3
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+.||+|+||.||+|+.. ++.||||++.... ......+..|+.++..+.+|+||+++++++... ..+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 47999999999999875 6789999997532 123345678888888887779999999988766 7899999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
++++|...+..... +++..+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||+++
T Consensus 79 ~~~~L~~~~~~~~~---l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 144 (318)
T cd05570 79 NGGDLMFHIQRSGR---FDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCK 144 (318)
T ss_pred CCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCe
Confidence 99999988876543 778888999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=293.90 Aligned_cols=163 Identities=28% Similarity=0.393 Sum_probs=138.6
Q ss_pred CCCCCChHHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEE
Q 036407 1 PPHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLG 78 (576)
Q Consensus 1 ~~~~fs~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg 78 (576)
++++.+++++....+.|++.+.||.|+||.||+|+.. ++.+|+|++.... .....+..|+.++..+.+|+|++++++
T Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~ 80 (282)
T cd06636 2 SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYG 80 (282)
T ss_pred ChhhhhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEee
Confidence 3566788898889999999999999999999999875 6889999986543 233567889999999977799999999
Q ss_pred EeeCC----CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC
Q 036407 79 FSSNP----KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN 154 (576)
Q Consensus 79 ~~~~~----s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~ 154 (576)
++... ....+|++|||+.+++|.+++..... ..+++..++.++.||+.||.|||+++ |+|+||+|+||+++.+
T Consensus 81 ~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~ 157 (282)
T cd06636 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTEN 157 (282)
T ss_pred ehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC
Confidence 88532 24688999999999999998876432 22667778889999999999999999 9999999999999999
Q ss_pred CcEEEcccccccc
Q 036407 155 FCAKISDFGLARL 167 (576)
Q Consensus 155 g~vKLiDFGlA~~ 167 (576)
+.++|+|||++..
T Consensus 158 ~~~~l~dfg~~~~ 170 (282)
T cd06636 158 AEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEeeCcchhh
Confidence 9999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=310.32 Aligned_cols=146 Identities=22% Similarity=0.313 Sum_probs=126.8
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
.+|++++.||+|+||.||+++.. ++.||||++..... .....+.+|+.++..+.| +||+.+++.+... +.+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~~~~~~~~~--~~~~ 77 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN-EWVVKLYYSFQDK--DNLY 77 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCC-CCcceEEEEEEcC--CEEE
Confidence 36899999999999999999865 78999999864321 223457889999999987 9999999988776 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+|||||++|+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++..+
T Consensus 78 lv~E~~~~g~L~~~i~~~~~---~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLGI---FEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred EEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999999999876442 677788889999999999999999 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=301.83 Aligned_cols=140 Identities=26% Similarity=0.394 Sum_probs=118.9
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+.||+|+||.||+|+.. ++.||||++..... .....+..|..++..+.+||||+.+++++... ..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeCC
Confidence 47999999999999876 67899999975321 22345667777887766679999999998766 7899999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++|+|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 79 ~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 79 NGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred CCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 99999998876433 677788889999999999999999 99999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=286.98 Aligned_cols=149 Identities=23% Similarity=0.393 Sum_probs=128.1
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++.+.||.|+||.||+|... ++.||+|.++... ......+.+|+.++..+.| +|++.+++.+... +..+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~-~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH-PNVIKYLASFIEN--NELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCeeeeeeeeecC--CeEE
Confidence 68999999999999999999875 7899999886422 2234578899999999977 9999999998766 7889
Q ss_pred EEEeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||||+++++|..++.... ....++..+++.++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeec
Confidence 9999999999999886532 2233678889999999999999999999 999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=325.05 Aligned_cols=159 Identities=23% Similarity=0.292 Sum_probs=131.1
Q ss_pred hHHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 7 YSVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 7 ~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
..+++...++|.+.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +|++.++..+..
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h-~~iv~~~~~~~~ 102 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDF-FSIVKCHEDFAK 102 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCC-CcEEEeecceec
Confidence 3456677899999999999999999999864 78999999975432 334567889988888876 899998776653
Q ss_pred CCC------CeEEEEEeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC
Q 036407 83 PKR------HRMLLVYELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF 155 (576)
Q Consensus 83 ~s~------~~l~LVmE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g 155 (576)
... ..+++||||+++|+|.+.+.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNG 180 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCC
Confidence 321 24789999999999999886532 2234778888999999999999999999 99999999999999999
Q ss_pred cEEEccccccccc
Q 036407 156 CAKISDFGLARLK 168 (576)
Q Consensus 156 ~vKLiDFGlA~~~ 168 (576)
.+||+|||+++..
T Consensus 181 ~vkL~DFGls~~~ 193 (496)
T PTZ00283 181 LVKLGDFGFSKMY 193 (496)
T ss_pred CEEEEecccCeec
Confidence 9999999998754
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=292.77 Aligned_cols=150 Identities=28% Similarity=0.466 Sum_probs=130.1
Q ss_pred CCCCccceeeccCcEEEEEEEEC------CceEEEEEeecCCch-hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH------DQSVAVKVMDSGSLQ-GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~------g~~VAVK~i~~~s~~-~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
..|++.+.||+|+||.||+++.. +..+|||.+...... ....+.+|+.++..+.| +||+++++++.......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~-~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH-ENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCC-CChheEEeeeecCCCCc
Confidence 46788899999999999999864 578999999755443 45678999999999976 99999999988765678
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999876442 2778888999999999999999999 99999999999999999999999998875
Q ss_pred cc
Q 036407 168 KS 169 (576)
Q Consensus 168 ~~ 169 (576)
..
T Consensus 159 ~~ 160 (284)
T cd05038 159 LP 160 (284)
T ss_pred cc
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=296.09 Aligned_cols=152 Identities=33% Similarity=0.532 Sum_probs=125.8
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
...++|++.+.||+|+||.||+|..+ +..||+|.+.... ......+.+|+.++..+.| +||+++++++...
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~ 81 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC-HHVVRLLGVVSKG 81 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEcCC
Confidence 45688999999999999999998643 3479999886433 2334567889999999976 9999999988766
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCC-------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKP-------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC 156 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~-------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~ 156 (576)
...++||||+++|+|.+++..... ........+..++.||+.||.|||+++ |+|+||||+||+++.++.
T Consensus 82 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~ 157 (288)
T cd05061 82 --QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT 157 (288)
T ss_pred --CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCc
Confidence 678999999999999999975321 112345667889999999999999999 999999999999999999
Q ss_pred EEEccccccccc
Q 036407 157 AKISDFGLARLK 168 (576)
Q Consensus 157 vKLiDFGlA~~~ 168 (576)
++|+|||+++..
T Consensus 158 ~~L~Dfg~~~~~ 169 (288)
T cd05061 158 VKIGDFGMTRDI 169 (288)
T ss_pred EEECcCCccccc
Confidence 999999988654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=295.34 Aligned_cols=141 Identities=26% Similarity=0.355 Sum_probs=118.2
Q ss_pred eeccCcEEEEEEEEC--CceEEEEEeecCCch---hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCC
Q 036407 23 LGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSN 97 (576)
Q Consensus 23 LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~---~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~g 97 (576)
||+|+||.||++... ++.||||.+...... ....+..|+.++..+.| +||+.+.+++... ..+|+||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS-RFIVSLAYAFQTK--TDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCC-CcEeeeeEEEcCC--CeEEEEEeCCCC
Confidence 799999999999865 789999998653322 22456789999999955 9999998888766 789999999999
Q ss_pred CCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 98 GNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 98 GsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|+|.+.+.... ....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++...
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 147 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVEL 147 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceec
Confidence 99988775422 2223788889999999999999999999 999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=304.22 Aligned_cols=147 Identities=24% Similarity=0.328 Sum_probs=127.6
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
..++|++.+.||.|+||.||++... +..+|+|.+..... .....+.+|+.++..+.| +||+.+++++... +.++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~~~ 79 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSD--GEIS 79 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCC-CcccceeEEEEEC--CEEE
Confidence 3578999999999999999999876 67899998875432 234568899999999976 9999999998876 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+||||+++++|.+++..... +++..+..++.+++.||.|||+ ++ |+|+||||+|||++.++.++|+|||++..
T Consensus 80 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 99999999999999876443 6777888899999999999997 57 99999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.13 Aligned_cols=139 Identities=22% Similarity=0.301 Sum_probs=121.8
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
..+|++.+.||+|+||.||++... ++.||+|.... ..+.+|+.++..|.| +||+++++++... ...++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~H-pnIv~~~~~~~~~--~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINH-PSIIQLKGTFTYN--KFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCC-CCCCCEeEEEEEC--CeeEEE
Confidence 468999999999999999999875 78899997542 346789999999987 9999999998776 788999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+|++ +++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 162 ~e~~-~~~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 162 LPRY-KTDLYCYLAAKRN---IAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred EecC-CCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 9999 4688888765433 677888999999999999999999 99999999999999999999999998853
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=310.39 Aligned_cols=146 Identities=25% Similarity=0.331 Sum_probs=126.8
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|.+.+.||+|+||.||+++.. ++.||||++..... .....+.+|+.++..+.| +||+++++++... ..+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~~~~~~~~~--~~~~ 77 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS-PWVVSLYYSFQDA--QYLY 77 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCC-CCcceEEEEEEcC--CeeE
Confidence 47899999999999999999865 78999999864321 223467889999999877 9999999998776 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||||+++|+|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+++..
T Consensus 78 lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDT---FSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999999998876443 677888889999999999999999 999999999999999999999999998744
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=292.64 Aligned_cols=151 Identities=31% Similarity=0.516 Sum_probs=127.1
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK 84 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s 84 (576)
..++|.+.+.||+|+||.||+|... +..||+|.+.... ......+.+|+.++..+.| +||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~- 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSTG- 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCC-CceeEEEEEEcCC-
Confidence 3467889999999999999999864 2679999986543 2334568889999999876 9999999998776
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCC-------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcE
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKP-------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA 157 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~-------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~v 157 (576)
..+++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+
T Consensus 82 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 -QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred -CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCE
Confidence 778999999999999999865332 112567788889999999999999999 9999999999999999999
Q ss_pred EEccccccccc
Q 036407 158 KISDFGLARLK 168 (576)
Q Consensus 158 KLiDFGlA~~~ 168 (576)
+|+|||+++..
T Consensus 159 kl~dfg~~~~~ 169 (277)
T cd05032 159 KIGDFGMTRDI 169 (277)
T ss_pred EECCcccchhh
Confidence 99999987643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=289.67 Aligned_cols=146 Identities=28% Similarity=0.455 Sum_probs=125.6
Q ss_pred CCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE 93 (576)
.+|++.+.||+|+||.||++... +..+|+|.+..... ....+.+|+.++..+.| +||+++++++... ...++|||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSH-PNLVQLYGVCTKQ--RPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCC-CCEEEEEEEEcCC--CceEEEEe
Confidence 35788999999999999999876 46799999864332 34568889999999976 9999999988766 67899999
Q ss_pred ccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 94 LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 94 ~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 80 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~ 150 (256)
T cd05059 80 YMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYV 150 (256)
T ss_pred cCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceec
Confidence 9999999998875432 3678888999999999999999999 999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=301.98 Aligned_cols=145 Identities=23% Similarity=0.359 Sum_probs=124.9
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
+|+..+.||+|+||.||+|+.. ++.||||++..... .....+..|+.++..+.|+++|+.+++++... ..+|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEE
Confidence 4778899999999999999875 78999999975321 22345778888888888888999898887766 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||||+++|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++.
T Consensus 79 v~Ey~~~g~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~ 150 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred EEcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccc
Confidence 9999999999998876443 778888999999999999999999 99999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=285.57 Aligned_cols=147 Identities=26% Similarity=0.378 Sum_probs=127.1
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+|.+.+.||+|++|.||+|... ++.|++|.+.... ......+.+|+.+++.+.| +|++.+++++... ..+++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS-SYIIRYYESFLDK--GKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCC-CCeehheeeeccC--CEEEEE
Confidence 4788899999999999999875 7899999986432 2345678899999999976 9999999998766 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||+++++|.+++..... ..++...++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~ 151 (256)
T cd08529 78 MEYAENGDLHKLLKMQRG-RPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151 (256)
T ss_pred EEeCCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceec
Confidence 999999999998876422 23778888899999999999999999 999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=294.95 Aligned_cols=146 Identities=28% Similarity=0.441 Sum_probs=120.7
Q ss_pred CCCCccceeeccCcEEEEEEEEC--Cc----eEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQ----SVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~----~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
++|++.+.||+|+||.||+|... +. .+++|.+..... ....++..|+..+..+.| +||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h-~~iv~~~~~~~~---~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDH-AYIVRLLGICPG---AS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCC-CCcceEEEEECC---Cc
Confidence 57888999999999999999874 33 477888753322 223456777778888877 999999998753 45
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
.++++||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCcccee
Confidence 7899999999999999876432 2678888999999999999999999 99999999999999999999999998865
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 159 ~ 159 (279)
T cd05111 159 L 159 (279)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=296.05 Aligned_cols=148 Identities=28% Similarity=0.468 Sum_probs=123.8
Q ss_pred CCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
+|++.+.||+|+||.||+|... ...+++|.+..... .....+.+|+.++..+.| +||+++++.+... ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH-PHVIKLYGACSQD--GP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCC-CCEeeEEEEEecC--CC
Confidence 4788999999999999999753 25688888865432 334578899999999977 9999999988766 67
Q ss_pred EEEEEeccCCCCHHHHHHhcC---------------------CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCC
Q 036407 88 MLLVYELMSNGNLQDALLHKK---------------------PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKP 146 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~---------------------~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKP 146 (576)
.++++||+.+++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp 155 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAA 155 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhh
Confidence 899999999999999886421 1123677888999999999999999999 99999999
Q ss_pred CCeEEcCCCcEEEccccccccc
Q 036407 147 SNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 147 eNILLd~~g~vKLiDFGlA~~~ 168 (576)
+|||++.++.++|+|||+++..
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~ 177 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDV 177 (290)
T ss_pred heEEEcCCCcEEeccccccccc
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=302.00 Aligned_cols=147 Identities=24% Similarity=0.307 Sum_probs=126.0
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|.+.+.||+|+||.||+++.. ++.||||++..... .....+..|+.++..+.| +||+.+++.+... ..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~-~~i~~~~~~~~~~--~~~~ 77 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS-PWIPQLQYAFQDK--DNLY 77 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceeeEEecC--CeEE
Confidence 47899999999999999999875 78999999975322 233457788888887765 9999999888765 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||||+++++|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 78 lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred EEECCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 99999999999999876532 2778888889999999999999999 999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=302.12 Aligned_cols=140 Identities=23% Similarity=0.353 Sum_probs=121.4
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+.||+|+||.||+|+.. ++.||+|++..... .....+..|+.++..+.+|+||+.+++.+... ..+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeCC
Confidence 47999999999999875 68899999975432 22345778889999998889999999988766 7899999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++++|...+..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 79 ~~~~L~~~~~~~~~---l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 79 NGGDLMFHMQRQRK---LPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred CCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEecccccee
Confidence 99999988865443 788889999999999999999999 99999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=290.77 Aligned_cols=146 Identities=32% Similarity=0.508 Sum_probs=126.4
Q ss_pred CCCCccceeeccCcEEEEEEEECC-ceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~g-~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE 93 (576)
++|++.+.||+|+||.||.+...+ ..+|||.+..... ....+.+|+.++..+.| +||+++++++... ..+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSH-EKLVQLYGVCTKQ--RPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCC-CCeeeEEEEEccC--CCcEEEEE
Confidence 467889999999999999998764 4699999875432 34578999999999986 9999999998766 67899999
Q ss_pred ccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 94 LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 94 ~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|+.+++|.+++..... .+++..++.++.||+.||.|||+.+ ++|+||||.||+++.++.++|+|||.++..
T Consensus 80 ~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~ 150 (256)
T cd05113 80 YMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYV 150 (256)
T ss_pred cCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceec
Confidence 9999999998876432 3788889999999999999999999 999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=288.58 Aligned_cols=148 Identities=32% Similarity=0.554 Sum_probs=126.5
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
..++|++.+.||+|+||.||+|... +..+|+|.+..... ....+.+|+.++..+.| +|++.+++++.. ...+++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~-~~i~~~~~~~~~---~~~~lv 78 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRH-DKLVQLYAVVSE---EPIYIV 78 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCC-CceEEEEeEECC---CCcEEE
Confidence 3568999999999999999999865 57799999875433 34578999999999977 999999988743 457899
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||+++++|.+++..... ..+++..++.++.+++.||.|||+++ |+|+||||+||+++.++.++|+|||++...
T Consensus 79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred EEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeec
Confidence 999999999998875432 23678889999999999999999999 999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.64 Aligned_cols=139 Identities=24% Similarity=0.354 Sum_probs=110.1
Q ss_pred HHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhcc-----CCceEEEEEEee
Q 036407 9 VLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQ-----DDHVVSVLGFSS 81 (576)
Q Consensus 9 ~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h-----~pNIv~Llg~~~ 81 (576)
++....++|++.++||+|+||.||+|+.. ++.||||+++... ........|+.++..+.+ +.+++.++.++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34455789999999999999999999865 6889999996432 222345667777776654 245888888876
Q ss_pred CCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCC
Q 036407 82 NPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNF 155 (576)
Q Consensus 82 ~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g 155 (576)
.. ..++|+||+++ +++|.+++..... +++..+..|+.||+.||.|||+ .+ |+||||||+|||++.++
T Consensus 202 ~~-~~~~~iv~~~~-g~~l~~~l~~~~~---l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 202 NE-TGHMCIVMPKY-GPCLLDWIMKHGP---FSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSD 269 (467)
T ss_pred cC-CceEEEEEecc-CCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCC
Confidence 54 36899999998 7789888866543 7788888999999999999997 58 99999999999998765
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.28 Aligned_cols=147 Identities=27% Similarity=0.412 Sum_probs=122.1
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCC----
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNP---- 83 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~---- 83 (576)
...++|++.+.||+|+||.||++... ++.||||.+.... ......+.+|+.++..+.| +||+.+++.+...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH-KNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCC-CCccccceeeccccccc
Confidence 35689999999999999999999865 7889999996432 2234567889999999876 9999999877543
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
....+|+||||+++ +|.+.+... ++...+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHhc-----CCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCC
Confidence 22468999999964 777766432 566778889999999999999999 9999999999999999999999999
Q ss_pred cccc
Q 036407 164 LARL 167 (576)
Q Consensus 164 lA~~ 167 (576)
+++.
T Consensus 172 ~a~~ 175 (364)
T cd07875 172 LART 175 (364)
T ss_pred Cccc
Confidence 9864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=306.24 Aligned_cols=152 Identities=32% Similarity=0.496 Sum_probs=126.6
Q ss_pred cCCCCccceeeccCcEEEEEEEE-------CCceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATL-------HDQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~-------~g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
.++|++.+.||+|+||.||+|+. .++.||||++..... .....+.+|+.++..+.+|+||+.+++++....
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC-
Confidence 46899999999999999999973 257899999975432 233568899999999988899999999886542
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCC--------------------------------------------------------
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKP-------------------------------------------------------- 109 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~-------------------------------------------------------- 109 (576)
..+++|||||++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 578999999999999998865321
Q ss_pred --------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 110 --------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 110 --------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
...+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~ 229 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDI 229 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEeccccccc
Confidence 012466777889999999999999999 999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=289.05 Aligned_cols=138 Identities=29% Similarity=0.453 Sum_probs=117.8
Q ss_pred eeeccCcEEEEEEEEC----CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 22 LLGQGGFGSVFHATLH----DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 22 ~LG~GsfG~Vyka~~~----g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
.||+|+||.||+|.+. +..+|+|++..... .....+..|+.++..+.| +||+.+++++.. ...++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~---~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN-PYIVRMIGICEA---ESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCC-CCcceEEEEEcC---CCcEEEEecC
Confidence 6899999999999653 67899999864332 234578899999999977 999999998753 4578999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++++|.+++..... +++..+..++.|++.||.|||+++ |+|+||||.||+++.++.++|+|||++...
T Consensus 78 ~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~ 145 (257)
T cd05116 78 ELGPLNKFLQKNKH---VTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKAL 145 (257)
T ss_pred CCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCcccccc
Confidence 99999998875433 678888999999999999999999 999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=299.40 Aligned_cols=152 Identities=29% Similarity=0.488 Sum_probs=128.1
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC---------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH---------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~---------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
-.++|.+.+.||+|+||.||+++.. ...+|+|.+.... ......+..|+.++..+..|+||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3478999999999999999999753 2469999997542 23345688899999999666999999999877
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCC-------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCe
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKP-------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNI 149 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~-------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNI 149 (576)
. ..+|+||||+.+++|.+++..... ...+++.+++.++.|++.||.|||+++ ++|+||||+||
T Consensus 96 ~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Ni 171 (307)
T cd05098 96 D--GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNV 171 (307)
T ss_pred C--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHhe
Confidence 6 678999999999999999976432 123677888999999999999999999 99999999999
Q ss_pred EEcCCCcEEEccccccccc
Q 036407 150 LLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 150 LLd~~g~vKLiDFGlA~~~ 168 (576)
+++.++.++|+|||++...
T Consensus 172 ll~~~~~~kL~dfg~a~~~ 190 (307)
T cd05098 172 LVTEDNVMKIADFGLARDI 190 (307)
T ss_pred EEcCCCcEEECCCcccccc
Confidence 9999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=288.97 Aligned_cols=147 Identities=25% Similarity=0.377 Sum_probs=128.5
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
.++|++.+.||+|+||.||+|+.. ++.||+|++..........+.+|+.++..+.| +||+.+++.+... ..+++|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h-~~ii~~~~~~~~~--~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKH-CNIVAYFGSYLSR--EKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCC-CCeeeeeEEEEeC--CEEEEE
Confidence 457999999999999999999864 78899999975544445567889999999987 9999999998766 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||+++++|.+++..... +++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 85 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKI 156 (267)
T ss_pred EeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceee
Confidence 999999999998865433 677888889999999999999999 999999999999999999999999988644
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=286.96 Aligned_cols=140 Identities=27% Similarity=0.457 Sum_probs=120.8
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCC
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSN 97 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~g 97 (576)
+.||+|+||.||+|... ++.||+|.+.... ......+.+|+.++..+.| +||+++++++... ..+++||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSH-PNIVRLIGVCTQK--QPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEcCC--CCeEEEEeeccC
Confidence 47999999999999874 7889999876432 2334678999999999976 9999999998776 678999999999
Q ss_pred CCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 98 GNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 98 GsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 78 ~~L~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 143 (252)
T cd05084 78 GDFLTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSRE 143 (252)
T ss_pred CcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcc
Confidence 999998865432 2678888999999999999999999 99999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=292.90 Aligned_cols=148 Identities=27% Similarity=0.425 Sum_probs=127.2
Q ss_pred CCCccceeeccCcEEEEEEEEC------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
.|++.+.||+|+||.||++++. +..||+|.+.... ......+.+|+.++..+.| +|++.+++++.......+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH-ENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCC-CCeeeeeeEEecCCCCce
Confidence 4688999999999999999742 6789999986543 2334578999999999977 999999999887655778
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCcccccc
Confidence 999999999999998865432 2678888999999999999999999 999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=288.26 Aligned_cols=149 Identities=30% Similarity=0.531 Sum_probs=127.2
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
...++|++.++||+|+||.||+|... ++.||+|.+..... ....+.+|+.++..+.| +|++.+++++.. ..+++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQH-PRLVRLYAVVTQ---EPIYI 77 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCC-cCeeeEEEEEcc---CCcEE
Confidence 34578999999999999999999875 68899999875443 34578899999999976 999999987643 56899
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+|||+.+++|.+++..... ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 78 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred EEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeec
Confidence 9999999999998865432 23677888899999999999999999 999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=297.39 Aligned_cols=154 Identities=29% Similarity=0.489 Sum_probs=129.0
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC---------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEe
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH---------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFS 80 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~---------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~ 80 (576)
....++|.+.+.||+|+||.||+|+.. +..||+|.+.... ......+.+|+.++..+.+|+||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 455678999999999999999999742 3469999986432 233457889999999996669999999998
Q ss_pred eCCCCCeEEEEEeccCCCCHHHHHHhcCC-------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCC
Q 036407 81 SNPKRHRMLLVYELMSNGNLQDALLHKKP-------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPS 147 (576)
Q Consensus 81 ~~~s~~~l~LVmE~~~gGsL~d~L~~~~~-------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPe 147 (576)
... ..+++||||+.+++|.+++..... ...+++.++..++.||+.||.|||+++ |+|+||||+
T Consensus 91 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~ 166 (304)
T cd05101 91 TQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAAR 166 (304)
T ss_pred ecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccc
Confidence 776 788999999999999999876422 123667788889999999999999999 999999999
Q ss_pred CeEEcCCCcEEEccccccccc
Q 036407 148 NILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 148 NILLd~~g~vKLiDFGlA~~~ 168 (576)
||+++.++.++|+|||+++..
T Consensus 167 Nili~~~~~~kl~D~g~~~~~ 187 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDV 187 (304)
T ss_pred eEEEcCCCcEEECCCccceec
Confidence 999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.30 Aligned_cols=388 Identities=20% Similarity=0.211 Sum_probs=245.8
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccC-------CceEEEEEEee--C
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQD-------DHVVSVLGFSS--N 82 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~-------pNIv~Llg~~~--~ 82 (576)
.++|.+.++||-|.|++||+++.+ .+.||+|+.+.. ..-.+..+.||.+|+.++.. .+||+|+++|. .
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 368889999999999999999977 688999998643 23346789999999988753 47999999886 4
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEcc
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISD 161 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiD 161 (576)
+++.++|||+|++ |.+|..+|......+ ++...++.|++||+.||.|||+ +| |||.||||+|||+-.+ +
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~~~------e 225 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLCST------E 225 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeeecc------c
Confidence 6678999999999 889999987654332 7888999999999999999997 88 9999999999998433 1
Q ss_pred ccccccccCCCCCcCcCCCCccccchhhhccCCCCCCCCcceecccccccccccccccccccccCcchhHhhhhcccchh
Q 036407 162 FGLARLKSVGENQNQADGENKNKAAELESNCGAAVEDCGSVVETESVNTTTTATAFEDLSVGIDQSPETFLKMTQKQTQS 241 (576)
Q Consensus 162 FGlA~~~~~~~~~~~~~gt~~y~APEl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (576)
...++..... +......|
T Consensus 226 ~~~~~~~~~a-------~e~~~~~p------------------------------------------------------- 243 (590)
T KOG1290|consen 226 IDPAKDAREA-------GEATTSLP------------------------------------------------------- 243 (590)
T ss_pred cchhhhhhhh-------ccccccCC-------------------------------------------------------
Confidence 1111110000 00000000
Q ss_pred HHHHhhhcccccccchhhhhHHHHHHHHhhhcCCCCCCCCcccCCCCCcccccccccccccccccccccccchhHHHHHH
Q 036407 242 TEALEKKASVDENVKEDVKVKEYVIEWIGTAIGNERPKSDWIGRDTGSSSSVGGKVDRKKSRKRLDWWVSLDEDKEENVK 321 (576)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (576)
..+++..+++++..+......+ .-.+++
T Consensus 244 -------------------------------------------~~s~s~~~t~~d~~~~~~~~~~---------s~~~~k 271 (590)
T KOG1290|consen 244 -------------------------------------------KMSPSAVSTRPDALQRMAAEPM---------SKSKFK 271 (590)
T ss_pred -------------------------------------------CCCcccccccccccchhhcccc---------chhhHH
Confidence 0011111111111111111000 012233
Q ss_pred hhhhhhccccccchhhhHHHHHHHHHHHhhhhccCC----------------CCCCCCCCCChhhHH-----------H-
Q 036407 322 NLKRERRRRPAREWWKEEYCEELAKKKKKKKRALGT----------------NSDDDWWPRDEELYV-----------E- 373 (576)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~-----------~- 373 (576)
++|+..+++ .+++... |.+..-..+-...+. .
T Consensus 272 ~~~kk~~r~--------------------~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~ 331 (590)
T KOG1290|consen 272 KMKKKLKRQ--------------------AKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNR 331 (590)
T ss_pred HHHHHHhhh--------------------hhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCC
Confidence 333322221 1111111 111110000000000 0
Q ss_pred ---Hhccc-------------cccccccCCCCCcccc---ccccc---------chhhhhhccccCccccCCCCCCCcce
Q 036407 374 ---RKKKS-------------KTRSRSRSSIGSLDWW---LEGFS---------GELYRARHNSYDSAASGEIPKSGGVT 425 (576)
Q Consensus 374 ---~~~~~-------------~~~~~~~~~~~~~~~~---~~~~~---------~~~~~~~~~~~d~~~~~~i~~~~~~~ 425 (576)
..|.. ..+.+.....++...+ .-..+ ..--.++++++|||.+=|..+.
T Consensus 332 ~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~kh---- 407 (590)
T KOG1290|consen 332 ENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKH---- 407 (590)
T ss_pred ccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhh----
Confidence 00000 0011111111111111 00000 1124678999999999999887
Q ss_pred eeccccCccccccccccCCCCcccccceeehhHHHHHHHhCCCCccccCCCchhhhhhhHHHHHHHhccccchhhhhhhH
Q 036407 426 STPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQA 505 (576)
Q Consensus 426 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~G~~l~eli~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (576)
.+..+.|..|+|||++.|..|+..+||||++|+++||+||.+.|+......+....++++..++.+...+..+.+-...
T Consensus 408 -FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~ 486 (590)
T KOG1290|consen 408 -FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKY 486 (590)
T ss_pred -hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcc
Confidence 5677999999999999999999999999999999999999999999888888888888888887765544443332221
Q ss_pred Hhh---------------------------hcCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhccccCCCCCC
Q 036407 506 VVK---------------------------SLDREQALLCITVALLCLQKSPALRPSMEEVVGMLTGKLEAPKLP 553 (576)
Q Consensus 506 ~~~---------------------------~~~~~~~~~~~~~~~~cl~~dP~~Rps~~~v~~~l~~~~e~~~~~ 553 (576)
-.+ .++.+++..+-+|+.-||+.+|.+||||.+.|. .-++...+.+
T Consensus 487 SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~--hPwLn~~~~~ 559 (590)
T KOG1290|consen 487 SRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK--HPWLNPVAGP 559 (590)
T ss_pred hHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc--CccccCCCCC
Confidence 111 345689999999999999999999999998873 2444444333
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=288.75 Aligned_cols=149 Identities=27% Similarity=0.452 Sum_probs=121.2
Q ss_pred CCccceeeccCcEEEEEEEECC----ceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCC----CCC
Q 036407 17 FSPSRLLGQGGFGSVFHATLHD----QSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNP----KRH 86 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~g----~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~----s~~ 86 (576)
|.+.+.||+|+||.||+|.... ..+|+|.+.... ......+..|+.++..+.| +||+++++++... ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH-PNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEccCCcccCCC
Confidence 3567899999999999998752 258999886532 2334568889999999976 9999999987532 224
Q ss_pred eEEEEEeccCCCCHHHHHHhcC---CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKK---PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~---~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
..+++|||+.+|+|.+++.... ....+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCC
Confidence 5789999999999998874321 1233678888999999999999999999 9999999999999999999999999
Q ss_pred ccccc
Q 036407 164 LARLK 168 (576)
Q Consensus 164 lA~~~ 168 (576)
+++..
T Consensus 158 ~~~~~ 162 (272)
T cd05075 158 LSKKI 162 (272)
T ss_pred ccccc
Confidence 98754
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.50 Aligned_cols=150 Identities=32% Similarity=0.552 Sum_probs=127.9
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
..+|+..++||+|+||.||++... +..+++|.+..........+.+|+.++..+.| +||+.+++++... .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQH-QHIVRFYGVCTEG--R 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCC-CCCceEEEEEecC--C
Confidence 356788999999999999999642 46789998876555556789999999999976 9999999988766 6
Q ss_pred eEEEEEeccCCCCHHHHHHhcCC------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC
Q 036407 87 RMLLVYELMSNGNLQDALLHKKP------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN 154 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~ 154 (576)
..+++|||+++++|.+++..... ...+++..++.++.||+.||.|||+++ ++|+||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~ 158 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQG 158 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCC
Confidence 78999999999999999876432 123677888999999999999999999 9999999999999999
Q ss_pred CcEEEccccccccc
Q 036407 155 FCAKISDFGLARLK 168 (576)
Q Consensus 155 g~vKLiDFGlA~~~ 168 (576)
+.++|+|||++...
T Consensus 159 ~~~kL~dfg~~~~~ 172 (280)
T cd05092 159 LVVKIGDFGMSRDI 172 (280)
T ss_pred CCEEECCCCceeEc
Confidence 99999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.31 Aligned_cols=147 Identities=27% Similarity=0.415 Sum_probs=128.4
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchh-HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG-EREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~-~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
..|..+++||+|.||.||+|... ++.||+|++......+ .+.+.+|+.+++.+.+ +||..+++.+... ..+|++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~-~~it~yygsyl~g--~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDS-PNITEYYGSYLKG--TKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCc-chHHhhhhheeec--ccHHHH
Confidence 45778899999999999999875 7899999998765433 4678999999999998 9999999998877 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
||||.||++.+++..... +.+..+.-|+++++.||.|||..+ .+|||||+.|||+..+|.+||+|||++....
T Consensus 90 Mey~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred HHHhcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeee
Confidence 999999999999876543 355566668899999999999999 9999999999999999999999999986543
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.15 Aligned_cols=153 Identities=22% Similarity=0.334 Sum_probs=129.6
Q ss_pred hHHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEee
Q 036407 7 YSVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSS 81 (576)
Q Consensus 7 ~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~ 81 (576)
...+....++|++.+.||+|+||.||+++.. ++.||+|++.... ......+..|+.++..+.| +||+.+++.+.
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~h-p~iv~~~~~~~ 113 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFYAFQ 113 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCCeEEEEEE
Confidence 3445566789999999999999999999876 6889999986422 1223456788888888866 99999999887
Q ss_pred CCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcc
Q 036407 82 NPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISD 161 (576)
Q Consensus 82 ~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiD 161 (576)
.. ..+|+||||+++|+|.+++.... ++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 114 ~~--~~~~lv~Ey~~gg~L~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 114 DD--RYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred cC--CEEEEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEe
Confidence 65 78999999999999999886543 567778889999999999999999 99999999999999999999999
Q ss_pred ccccccc
Q 036407 162 FGLARLK 168 (576)
Q Consensus 162 FGlA~~~ 168 (576)
||++...
T Consensus 186 fG~a~~~ 192 (371)
T cd05622 186 FGTCMKM 192 (371)
T ss_pred CCceeEc
Confidence 9998654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=308.50 Aligned_cols=145 Identities=22% Similarity=0.299 Sum_probs=126.1
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.|++++.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +||+++++.+... ..+|+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h-~~iv~~~~~~~~~--~~~~l 78 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN-EWVVRLYYSFQDK--DNLYF 78 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCC-CcCCeEEEEEEeC--CEEEE
Confidence 5889999999999999999875 68899999975322 223467889999999977 9999999998866 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||||++|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++...
T Consensus 79 v~E~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMGI---FPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred EEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 9999999999998876432 677888889999999999999999 999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=288.56 Aligned_cols=148 Identities=26% Similarity=0.500 Sum_probs=126.1
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--C---ceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--D---QSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g---~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.++|+..+.||+|+||.||+|+.. + ..+|+|.+.... ......+.+|+.++..+.| +|++++.+++... ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH-HNIIRLEGVVTKF--KP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCC-CCeeEEEEEEccC--CC
Confidence 457888999999999999999864 2 369999986543 2334678899999999977 9999999998766 67
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
.++||||+++++|.+++..... .+++.++..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCcccee
Confidence 8999999999999998865432 2677888899999999999999999 99999999999999999999999998764
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 157 ~ 157 (268)
T cd05063 157 L 157 (268)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.78 Aligned_cols=152 Identities=32% Similarity=0.465 Sum_probs=127.9
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
...++|.+.+.||+|+||.||++... +..+|||.+.... ......+.+|+.++.++.+|+||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 33457889999999999999999742 3579999986543 223456889999999996669999999998766
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
+.+++||||+.+++|.+++..... ..+++.++..++.+++.||.|||+++ |+|+||||+|||++.++.++|+|||
T Consensus 112 --~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 --GPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred --CceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCCc
Confidence 678999999999999998875432 23688889999999999999999999 9999999999999999999999999
Q ss_pred ccccc
Q 036407 164 LARLK 168 (576)
Q Consensus 164 lA~~~ 168 (576)
+++..
T Consensus 187 ~~~~~ 191 (302)
T cd05055 187 LARDI 191 (302)
T ss_pred ccccc
Confidence 87643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=291.40 Aligned_cols=148 Identities=30% Similarity=0.500 Sum_probs=124.3
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--Cc----eEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQ----SVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~----~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
.++|++.+.||+|+||.||+|... +. .||+|.++... ......+.+|+.++..+.| +||+.+++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~--- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS-PYVCRLLGICLTS--- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCC-CCCceEEEEEcCC---
Confidence 467889999999999999999853 33 48999986543 2335578889988888876 9999999988653
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
..++++||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||+++
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCcee
Confidence 46899999999999998876432 2677888999999999999999999 9999999999999999999999999887
Q ss_pred ccc
Q 036407 167 LKS 169 (576)
Q Consensus 167 ~~~ 169 (576)
...
T Consensus 158 ~~~ 160 (279)
T cd05109 158 LLD 160 (279)
T ss_pred ecc
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=309.38 Aligned_cols=150 Identities=28% Similarity=0.440 Sum_probs=135.6
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHH---HHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGER---EFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~---~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
..+|++.+.||+|.||+|-++... |+.||||.++++...+++ .+.+||++|+.|.| |||+.++.+|... ..+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNH-PhII~IyEVFENk--dKI 128 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNH-PHIIQIYEVFENK--DKI 128 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCC-CceeehhhhhcCC--ceE
Confidence 357899999999999999999764 899999999876655544 57899999999988 9999999998876 889
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
.|||||..+|.|++++..++. +++..+..+++||+.|+.|||+++ ++|||||.+|||||.++.+||+|||++..+
T Consensus 129 vivMEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEEEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhh
Confidence 999999999999999998775 889999999999999999999999 999999999999999999999999998776
Q ss_pred cCC
Q 036407 169 SVG 171 (576)
Q Consensus 169 ~~~ 171 (576)
...
T Consensus 204 ~~~ 206 (668)
T KOG0611|consen 204 ADK 206 (668)
T ss_pred ccc
Confidence 543
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=286.19 Aligned_cols=139 Identities=32% Similarity=0.526 Sum_probs=119.8
Q ss_pred ceeeccCcEEEEEEEEC--C---ceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEec
Q 036407 21 RLLGQGGFGSVFHATLH--D---QSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g---~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
+.||+|+||.||+|++. + ..+|+|.+..... .....+.+|+.++..+.| +|++.+++++.. ..+++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH-PCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCC-CCeeeEEEEEcC---CceEEEEEe
Confidence 47999999999999764 2 6799999975544 245678899999999976 999999998753 467999999
Q ss_pred cCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 95 MSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 95 ~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+++++|.+++..... +++..++.++.|++.||.|||.++ ++|+||||+|||++.++.++|+|||+++..
T Consensus 77 ~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 77 APLGPLLKYLKKRRE---IPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred CCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEecccccccee
Confidence 999999999876542 678889999999999999999999 999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=297.82 Aligned_cols=148 Identities=30% Similarity=0.513 Sum_probs=124.2
Q ss_pred CCCCccceeeccCcEEEEEEEEC--Cc--eEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQ--SVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~--~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++.+.||+|+||.||+|... +. .+++|.+.... ......+.+|+.++..+.+|+||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--CCce
Confidence 57889999999999999999864 33 45777765322 233456888999999997679999999998766 7789
Q ss_pred EEEeccCCCCHHHHHHhcCC-------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc
Q 036407 90 LVYELMSNGNLQDALLHKKP-------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC 156 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~-------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~ 156 (576)
+||||+++++|.+++..... ...+++.+++.++.|++.||.|||+++ ++|+||||+|||++.++.
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCCCc
Confidence 99999999999999865321 123678889999999999999999999 999999999999999999
Q ss_pred EEEccccccc
Q 036407 157 AKISDFGLAR 166 (576)
Q Consensus 157 vKLiDFGlA~ 166 (576)
++|+|||++.
T Consensus 163 ~kl~dfg~~~ 172 (303)
T cd05088 163 AKIADFGLSR 172 (303)
T ss_pred EEeCccccCc
Confidence 9999999874
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=285.12 Aligned_cols=146 Identities=26% Similarity=0.381 Sum_probs=126.3
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch-----hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ-----GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~-----~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
++|.+.+.||+|++|.||++... ++.||+|.+...... ....+.+|+.++..+.| +||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~ 78 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH-ERIVQYYGCLRDD--ET 78 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCC-CCeeeeEEEEccC--Ce
Confidence 57999999999999999999864 789999998643221 22467889999999976 9999999998876 68
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++|+||+++++|.+.+..... +++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 9999999999999998876543 677788889999999999999999 99999999999999999999999998764
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 154 ~ 154 (263)
T cd06625 154 L 154 (263)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=293.14 Aligned_cols=144 Identities=41% Similarity=0.652 Sum_probs=121.6
Q ss_pred ccceeeccCcEEEEEEEEC------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 19 PSRLLGQGGFGSVFHATLH------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 19 i~e~LG~GsfG~Vyka~~~------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+.+.||.|.||.||+|.+. +..|+||.++... ......+.+|+..+..++| +||+++++++... ..+++|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~g~~~~~--~~~~lv 79 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRH-PNIVKLYGFCIEN--EPLFLV 79 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSB-TTBE-EEEEEESS--SSEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccc-ccccccccccccc--cccccc
Confidence 5689999999999999887 5789999996533 2336789999999999955 9999999999954 569999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||+++|+|.+++..... ..+++..++.|+.||+.||.|||+++ ++|++|+++|||++.++.+||+|||++...
T Consensus 80 ~e~~~~g~L~~~L~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNK-EPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp EE--TTEBHHHHHHHTCT-TTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred cccccccccccccccccc-cccccccccccccccccccccccccc--cccccccccccccccccccccccccccccc
Confidence 999999999999988622 22788889999999999999999999 999999999999999999999999988654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=285.55 Aligned_cols=147 Identities=24% Similarity=0.348 Sum_probs=126.0
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
+|++.+.||.|+||.||++... ++.||+|.+.... ....+.+.+|+.++..+.| +|++.+++.+... ..+++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKH-PNIVAFKESFEAD--GHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCC-CCcceEEEEEEEC--CEEEEEE
Confidence 5788999999999999999865 7889999986433 3334567889999999977 9999999988766 7899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||+++++|.+.+..... ..++...++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||.+...
T Consensus 78 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 150 (255)
T cd08219 78 EYCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150 (255)
T ss_pred eeCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceee
Confidence 99999999998865332 23677888899999999999999999 999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=288.16 Aligned_cols=149 Identities=25% Similarity=0.391 Sum_probs=126.9
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|.+.+.||.|+||.||++... ++.+|||.+..... .....+.+|+.++..+.| +||+.+++++... ..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-PNVIKYYASFIED--NELN 78 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccC-CchhhhhheeEeC--CeEE
Confidence 57889999999999999999864 78999998864322 233578899999999976 9999999988766 7889
Q ss_pred EEEeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++|||+++++|.+++.... ....+++..++.++.+|+.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 9999999999999886422 2234788888999999999999999999 999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=289.14 Aligned_cols=147 Identities=32% Similarity=0.534 Sum_probs=124.8
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
.++|++.+.||+|+||.||+|... ...||+|.+.... .....+.+|+.++..+.| +||+++++++.. ...++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~-~~i~~~~~~~~~---~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH-EKLVQLYAVVSE---EPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCC-CCcceEEEEECC---CCcEEEE
Confidence 467999999999999999999876 4579999987533 234578899999999976 999999887643 4579999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+...
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 80 EYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred EcCCCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeec
Confidence 99999999999875332 23677888899999999999999999 999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=291.42 Aligned_cols=150 Identities=34% Similarity=0.511 Sum_probs=125.6
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
.++|.+.+.||+|+||.||+|... +..||+|.+.... ......+..|+.++..+.| +||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~-- 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH-QNIVRLIGVSFER-- 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEccC--
Confidence 467899999999999999999874 3678999886433 2334568899999999977 9999999988766
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCC----CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC---cEE
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF---CAK 158 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~----~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g---~vK 158 (576)
...++||||+++++|.+++..... ...+++..+..++.||+.||.|||+++ ++|+||||+||+++.++ .++
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceE
Confidence 667999999999999999876432 123778888999999999999999999 99999999999998654 589
Q ss_pred Eccccccccc
Q 036407 159 ISDFGLARLK 168 (576)
Q Consensus 159 LiDFGlA~~~ 168 (576)
|+|||+++..
T Consensus 160 l~dfg~~~~~ 169 (277)
T cd05036 160 IADFGMARDI 169 (277)
T ss_pred eccCcccccc
Confidence 9999988754
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.85 Aligned_cols=148 Identities=23% Similarity=0.367 Sum_probs=118.8
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCC------C
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNP------K 84 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~------s 84 (576)
...+|++.+.||+|+||.||+|... ++.||||.+.... ....+|+.++..+.| +||+.+++++... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h-~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNH-INIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCC-CCCcceeeeEeecccccCCC
Confidence 3467999999999999999999874 7899999885432 234578999999977 9999998876432 2
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC-cEEEccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHK-KPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF-CAKISDF 162 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~-~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g-~vKLiDF 162 (576)
...+++||||++ ++|.+++... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeecc
Confidence 235789999996 4777766542 12234778888899999999999999999 99999999999998665 7999999
Q ss_pred cccccc
Q 036407 163 GLARLK 168 (576)
Q Consensus 163 GlA~~~ 168 (576)
|+++..
T Consensus 216 Gla~~~ 221 (440)
T PTZ00036 216 GSAKNL 221 (440)
T ss_pred ccchhc
Confidence 998744
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.16 Aligned_cols=138 Identities=28% Similarity=0.448 Sum_probs=114.7
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHH-HHHhccCCceEEEEEEeeCCCCCeEEEEEec
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYF-ASLLEQDDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~i-Ls~L~h~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
+.||+|+||.||+|+.. ++.||||++..... .....+..|... +..+.| +||+.+++.+... ..+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~h-p~iv~~~~~~~~~--~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKH-PFLVGLHYSFQTA--DKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCC-CCCCCeeEEEEeC--CEEEEEEcC
Confidence 47999999999999875 78999999975322 122344555544 455655 9999999888766 789999999
Q ss_pred cCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 95 MSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 95 ~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
+++++|...+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 78 ~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~ 144 (323)
T cd05575 78 VNGGELFFHLQRERS---FPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCK 144 (323)
T ss_pred CCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCc
Confidence 999999988876443 677888889999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.02 Aligned_cols=147 Identities=24% Similarity=0.362 Sum_probs=127.4
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++.+.||+|+||.||+++.. ++.||||++.... ......+..|+.++..+.| +||+.+++.+... ..+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~--~~~~ 77 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG-AWVVKMFYSFQDK--RNLY 77 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCEeeEEEEEEcC--CEEE
Confidence 47899999999999999999875 7899999997432 1223467788999999877 9999999888766 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
+||||+++|+|.+++..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDT---LSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred EEEeCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999998876543 678888889999999999999999 9999999999999999999999999987554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=299.86 Aligned_cols=140 Identities=27% Similarity=0.374 Sum_probs=120.5
Q ss_pred cceeeccCcEEEEEEEE-----CCceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 20 SRLLGQGGFGSVFHATL-----HDQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~-----~g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
++.||+|+||.||+++. .++.||+|++..... .....+..|+.++..+.| +||+++++++... ..+|+||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~--~~~~lv~ 77 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNH-PFIVKLHYAFQTE--GKLYLIL 77 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCC-CCcccEEEEEEcC--CEEEEEE
Confidence 36899999999999874 368899999975332 223456789999999977 9999999998766 7899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||+++++|.+.+..... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++..
T Consensus 78 e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 78 DFLRGGDLFTRLSKEVM---FTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred cCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 99999999998865433 778889999999999999999999 99999999999999999999999998764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=288.23 Aligned_cols=148 Identities=27% Similarity=0.517 Sum_probs=126.3
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-----CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.++|++.+.||+|+||.||+|... +..+|+|.+..... .....+.+|+.++..+.| +||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH-PNIIHLEGVVTKS--KP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEecC--Cc
Confidence 357889999999999999999763 34699999865432 234578899999999976 9999999998765 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+|+||||+++++|.+++..... .+++.+++.++.|++.||.|||+++ ++|+||||+|||++.++.++|+|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 8999999999999999876432 2677888899999999999999999 99999999999999999999999998875
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 156 ~ 156 (267)
T cd05066 156 L 156 (267)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=289.46 Aligned_cols=150 Identities=29% Similarity=0.490 Sum_probs=127.8
Q ss_pred cCCCCccceeeccCcEEEEEEEECC------------------ceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLHD------------------QSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVV 74 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~g------------------~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv 74 (576)
.++|++.+.||+|+||.||+|.... ..||+|.+..... .....+.+|+.++..+.| +|++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSD-PNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCC-CCEe
Confidence 4689999999999999999987542 4589999875432 345678899999999977 9999
Q ss_pred EEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCC--------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCC
Q 036407 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP--------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKP 146 (576)
Q Consensus 75 ~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~--------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKP 146 (576)
.+++++... ..+++|||++++++|.+++..... ...+++..++.++.|++.||.|||+++ |+|+||||
T Consensus 83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp 158 (296)
T cd05051 83 RLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLAT 158 (296)
T ss_pred EEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccch
Confidence 999998776 788999999999999999876431 123778889999999999999999999 99999999
Q ss_pred CCeEEcCCCcEEEccccccccc
Q 036407 147 SNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 147 eNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||+++.++.++|+|||+++..
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~ 180 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNL 180 (296)
T ss_pred hceeecCCCceEEccccceeec
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=286.65 Aligned_cols=141 Identities=27% Similarity=0.395 Sum_probs=121.6
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
++|++.+.||+|+||.||+|+.. ++.||+|.+.... ......+.+|+.++..+.| +||+.+++++... ...++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-PYIIGFYGAFFVE--NRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCC-CCeeeEEEEEEEC--CEEEEE
Confidence 46888999999999999999864 7889999987543 2334568899999999977 9999999998876 788999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|||+++++|.... .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..
T Consensus 78 ~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~ 144 (279)
T cd06619 78 TEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQ 144 (279)
T ss_pred EecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence 9999999986432 1456677889999999999999999 99999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=313.99 Aligned_cols=151 Identities=29% Similarity=0.418 Sum_probs=128.0
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccC-----CceEEEEEEeeCCCC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQD-----DHVVSVLGFSSNPKR 85 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~-----pNIv~Llg~~~~~s~ 85 (576)
+..+|.+.+.||+|+||.|-+|... ++.||||+++.. ..-..+...|+.+|..|+.+ -|+|++++++.+.
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr-- 260 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR-- 260 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc--
Confidence 3447889999999999999999865 799999999743 33345678899999999832 4899999999998
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC--cEEEcccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF--CAKISDFG 163 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g--~vKLiDFG 163 (576)
+++|||+|.+ .-+|.++++...-.+ ++...+..++.||+.||.+||+.+ ||||||||+||||...+ .+||+|||
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecc
Confidence 9999999999 559999998866433 788889999999999999999999 99999999999997654 78999999
Q ss_pred ccccccC
Q 036407 164 LARLKSV 170 (576)
Q Consensus 164 lA~~~~~ 170 (576)
.+.....
T Consensus 337 SSc~~~q 343 (586)
T KOG0667|consen 337 SSCFESQ 343 (586)
T ss_pred cccccCC
Confidence 9875443
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.51 Aligned_cols=139 Identities=27% Similarity=0.436 Sum_probs=113.8
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHH-HHHhccCCceEEEEEEeeCCCCCeEEEEEec
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYF-ASLLEQDDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~i-Ls~L~h~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
+.||+|+||.||+|+.. ++.||+|++..... .....+..|... +..+.| +||+.+++.+... ..+|+||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-~~Iv~~~~~~~~~--~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH-PFLVGLHFSFQTA--DKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCC-CCCCceeEEEEcC--CeEEEEEeC
Confidence 47999999999999875 67899999974321 122344455444 455555 9999999888766 789999999
Q ss_pred cCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 95 MSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 95 ~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++++|.+.+..... +.+..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||+++.
T Consensus 78 ~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~ 145 (325)
T cd05602 78 INGGELFYHLQRERC---FLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKE 145 (325)
T ss_pred CCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence 999999998876433 566777889999999999999999 99999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=281.22 Aligned_cols=144 Identities=33% Similarity=0.564 Sum_probs=124.6
Q ss_pred ceeeccCcEEEEEEEEC-----CceEEEEEeecCCchh-HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEec
Q 036407 21 RLLGQGGFGSVFHATLH-----DQSVAVKVMDSGSLQG-EREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s~~~-~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
+.||+|+||.||+|... +..|++|.+....... ...+.+|+..+..+.| +|++++++++... ..+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~--~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGH-PNVVRLLGVCTEE--EPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCC-CChheeeeeecCC--CceEEEEEe
Confidence 47999999999999876 6789999997544332 5678899999999985 9999999988774 789999999
Q ss_pred cCCCCHHHHHHhcCC------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 95 MSNGNLQDALLHKKP------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 95 ~~gGsL~d~L~~~~~------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+++++|.+++..... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+...
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccc
Confidence 999999999877521 133788999999999999999999999 999999999999999999999999988754
Q ss_pred c
Q 036407 169 S 169 (576)
Q Consensus 169 ~ 169 (576)
.
T Consensus 156 ~ 156 (262)
T cd00192 156 Y 156 (262)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=296.71 Aligned_cols=149 Identities=28% Similarity=0.435 Sum_probs=124.6
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCC---
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNP--- 83 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~--- 83 (576)
-.+.++|.+.+.||.|+||.||+|... ++.||||.+..... .....+.+|+.++..+.| +||+.+++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKH-ENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCC-Cchhhhhhhhcccccc
Confidence 356789999999999999999999865 68899999864322 223467789999999987 9999998876532
Q ss_pred -CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccc
Q 036407 84 -KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDF 162 (576)
Q Consensus 84 -s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDF 162 (576)
.....|++++++ +++|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~~----l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQK----LSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCC
Confidence 224578999998 789988775422 678888999999999999999999 999999999999999999999999
Q ss_pred ccccc
Q 036407 163 GLARL 167 (576)
Q Consensus 163 GlA~~ 167 (576)
|++..
T Consensus 163 g~~~~ 167 (343)
T cd07878 163 GLARQ 167 (343)
T ss_pred cccee
Confidence 98763
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=285.37 Aligned_cols=147 Identities=33% Similarity=0.546 Sum_probs=124.8
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
.++|++.+.||+|+||.||+|... +..+|+|.+.... .....+.+|+.++..+.| +|++.+++++.. ...++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRH-DKLVPLYAVVSE---EPIYIVT 79 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCC-CCeeeEEEEEcC---CCcEEEE
Confidence 467899999999999999999876 4579999886443 234578899999999987 999999887743 4579999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||+.+++|.+++..... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 80 EFMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred EcCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEc
Confidence 99999999998876432 23677888899999999999999999 999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=291.87 Aligned_cols=148 Identities=28% Similarity=0.492 Sum_probs=124.6
Q ss_pred CCCCccceeeccCcEEEEEEEECC----------------ceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLHD----------------QSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVL 77 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~g----------------~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Ll 77 (576)
.+|++.+.||+|+||.||+++..+ ..||+|.+.... ......+.+|+.++..+.| +|++.++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKN-PNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCcCeEE
Confidence 578999999999999999987532 248999987542 2334578899999999987 9999999
Q ss_pred EEeeCCCCCeEEEEEeccCCCCHHHHHHhcCC---------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCC
Q 036407 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKP---------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSN 148 (576)
Q Consensus 78 g~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~---------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeN 148 (576)
+++... ..+++||||+.+++|.+++..... ...+++..++.++.+++.||.|||+++ ++|+||||+|
T Consensus 84 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~N 159 (295)
T cd05097 84 GVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRN 159 (295)
T ss_pred EEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhh
Confidence 998766 788999999999999998865321 112567788889999999999999999 9999999999
Q ss_pred eEEcCCCcEEEcccccccc
Q 036407 149 ILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 149 ILLd~~g~vKLiDFGlA~~ 167 (576)
|+++.++.+||+|||++..
T Consensus 160 ill~~~~~~kl~dfg~~~~ 178 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRN 178 (295)
T ss_pred EEEcCCCcEEecccccccc
Confidence 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=291.00 Aligned_cols=146 Identities=31% Similarity=0.429 Sum_probs=124.0
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch---hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~---~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.|++.+.||+|+||.||++... ++.||||.+...... ....+.+|+.++..+.| ++++.+++.+... ..+|+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~i~~~~~~~~~~--~~~~l 77 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNS-RFVVSLAYAYETK--DALCL 77 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCC-CCeeeeeEEEecC--CEEEE
Confidence 3778899999999999999875 789999998654322 23456789999999977 9999998888766 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||||+++++|.+.+..... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 78 v~e~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVH 151 (285)
T ss_pred EEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceee
Confidence 9999999999988865332 22677888899999999999999999 99999999999999999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=289.50 Aligned_cols=154 Identities=26% Similarity=0.350 Sum_probs=128.8
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK 84 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s 84 (576)
...++|.+.+.||+|+||.||+|... +..|++|.+.... ......+.+|+.++..+.| +|++++++++...
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~- 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH-QNILPILHVCIED- 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEecC-
Confidence 34578999999999999999999865 3778999886432 2334568899999999966 9999999987654
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCC-----ChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEE
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPP-----ELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKI 159 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~-----~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKL 159 (576)
....+++++|+.+++|.+++...... ..+++..++.++.+++.||.|||+++ ++|+||||+||+++.++.++|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEE
Confidence 36779999999999999988664321 34778889999999999999999999 999999999999999999999
Q ss_pred cccccccccc
Q 036407 160 SDFGLARLKS 169 (576)
Q Consensus 160 iDFGlA~~~~ 169 (576)
+|||+++.+.
T Consensus 159 ~d~g~~~~~~ 168 (280)
T cd05043 159 TDNALSRDLF 168 (280)
T ss_pred CCCCCccccc
Confidence 9999987543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=290.55 Aligned_cols=140 Identities=29% Similarity=0.416 Sum_probs=117.7
Q ss_pred eeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCC
Q 036407 23 LGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSN 97 (576)
Q Consensus 23 LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~g 97 (576)
||+|+||.||+++.. ++.||+|.+..... .....+..|+.++..+.| +||+.+++.+... ..+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~i~~~~~~~~~~--~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLAYAFESK--THLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCC-CcEEEEEEEEecC--CeEEEEEecCCC
Confidence 799999999999865 78999999864322 123345678999999966 9999999888765 789999999999
Q ss_pred CCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 98 GNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 98 GsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 78 ~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~ 145 (277)
T cd05607 78 GDLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVEL 145 (277)
T ss_pred CCHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeec
Confidence 999988765432 22677888889999999999999999 999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=299.68 Aligned_cols=138 Identities=26% Similarity=0.444 Sum_probs=114.7
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHH-HHHhccCCceEEEEEEeeCCCCCeEEEEEec
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYF-ASLLEQDDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~i-Ls~L~h~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
+.||+|+||.||+|+.. ++.||||++..... .....+..|... +..+.| +||+.+++.+... ..+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-p~iv~~~~~~~~~--~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH-PFLVGLHYSFQTT--EKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCC-CCCccEEEEEecC--CEEEEEEcC
Confidence 46999999999999865 78999999964321 222345566554 444545 9999999888766 789999999
Q ss_pred cCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 95 MSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 95 ~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
+++++|...+..... +++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||+++
T Consensus 78 ~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~ 144 (325)
T cd05604 78 VNGGELFFHLQRERS---FPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCK 144 (325)
T ss_pred CCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcc
Confidence 999999888765443 678888889999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=287.87 Aligned_cols=142 Identities=31% Similarity=0.535 Sum_probs=119.1
Q ss_pred ceeeccCcEEEEEEEEC--C--ceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLH--D--QSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g--~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+.||+|+||.||+|... + ..+++|.+.... ......+..|+.++.++.+|+||+++++++... ..+++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEEEeC
Confidence 36899999999999875 2 246888886432 234457889999999997779999999998776 6789999999
Q ss_pred CCCCHHHHHHhcCC-------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccc
Q 036407 96 SNGNLQDALLHKKP-------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDF 162 (576)
Q Consensus 96 ~gGsL~d~L~~~~~-------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDF 162 (576)
++++|.+++..... ...+++.+++.++.|++.||.|||+++ ++|+||||+|||++.++.++|+||
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCC
Confidence 99999999865321 123677888999999999999999999 999999999999999999999999
Q ss_pred cccc
Q 036407 163 GLAR 166 (576)
Q Consensus 163 GlA~ 166 (576)
|++.
T Consensus 157 gl~~ 160 (270)
T cd05047 157 GLSR 160 (270)
T ss_pred CCcc
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=282.01 Aligned_cols=140 Identities=34% Similarity=0.523 Sum_probs=120.2
Q ss_pred ceeeccCcEEEEEEEEC-CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCCC
Q 036407 21 RLLGQGGFGSVFHATLH-DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNG 98 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~gG 98 (576)
++||+|+||.||+|... +..+|+|.+..... .....+.+|+.++..+.| +||+.+++++... ...++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDH-PNIVKLIGVCTQR--QPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCC-CCcCeEEEEEecC--CccEEEEECCCCC
Confidence 47899999999999865 67899999875432 234468899999999976 9999999998776 6789999999999
Q ss_pred CHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 99 NLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 99 sL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+|.+.+..... .+++..+..++.+++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 78 ~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~ 142 (250)
T cd05085 78 DFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQ 142 (250)
T ss_pred cHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCcccee
Confidence 99998865432 2678888899999999999999999 99999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=282.89 Aligned_cols=143 Identities=36% Similarity=0.569 Sum_probs=124.5
Q ss_pred CCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHH--HHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 17 FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGER--EFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~--~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
|++.+.||+|+||.||+++.. ++.||+|++......... ....|+.++..+.| +||+.+++++... ..+++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~--~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRH-PNIVQILDVFQDD--NYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTB-TTBCHEEEEEEES--SEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccc-ccccccccccccc--ccccccc
Confidence 678899999999999999987 567999999876543332 34568999999965 9999999998875 8899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|++.+++|.+++..... ++...++.++.||+.||.+||+.+ |+|+||||+||+++.++.++|+|||.+..
T Consensus 78 ~~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKP---LSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVK 147 (260)
T ss_dssp EEETTEBHHHHHHHHSS---BBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred ccccccccccccccccc---cccccccccccccccccccccccc--ccccccccccccccccccccccccccccc
Confidence 99999999999984333 688889999999999999999999 99999999999999999999999998764
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=286.21 Aligned_cols=147 Identities=27% Similarity=0.507 Sum_probs=125.6
Q ss_pred CCCCccceeeccCcEEEEEEEEC--C---ceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--D---QSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g---~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
..|++.+.||+|+||.||+|... + ..||||.+.... ......+..|+.++..+.| +||+++++++... ..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~--~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH-PNIIHLEGVVTKS--RPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-cCcceEEEEECCC--Cce
Confidence 45788999999999999999865 2 369999987542 3334678999999999976 9999999988665 778
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++||||+++++|.+++..... .+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCcccccc
Confidence 999999999999998876432 2678888999999999999999999 999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=294.88 Aligned_cols=139 Identities=28% Similarity=0.422 Sum_probs=114.7
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHH-HHHhccCCceEEEEEEeeCCCCCeEEEEEec
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYF-ASLLEQDDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~i-Ls~L~h~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
+.||+|+||.||+|+.. ++.||+|++..... .....+..|+.. +..+.| +||+.+++.+... ..+|+||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-~~iv~~~~~~~~~--~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKH-PFLVGLHYSFQTA--EKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCC-CCccceeeEEEcC--CEEEEEEcC
Confidence 47999999999999875 78899999975322 222345556554 455555 9999999888766 789999999
Q ss_pred cCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 95 MSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 95 ~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++++|...+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 78 VNGGELFFHLQRERC---FLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred CCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 999999888765433 667778889999999999999999 99999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=286.53 Aligned_cols=147 Identities=24% Similarity=0.380 Sum_probs=128.5
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
.++|.+.+.||+|+||.||+|+.. ++.||+|.+..........+.+|+.++..+.| +||+.+++.+... ..+++|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h-~~ii~~~~~~~~~--~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH-SNIVAYFGSYLRR--DKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCC-CCeeeEEEEEEeC--CEEEEE
Confidence 357889999999999999999864 78999999976544444567889999999977 9999999988766 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||+++++|.+++..... +++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 85 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQI 156 (267)
T ss_pred EeccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence 999999999998876543 678889999999999999999999 999999999999999999999999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=295.85 Aligned_cols=151 Identities=28% Similarity=0.508 Sum_probs=126.8
Q ss_pred cCCCCccceeeccCcEEEEEEEEC---------CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH---------DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~---------g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
.++|.+.+.||+|+||.||++... ...+|+|.+..... .....+.+|+.++..+..|+||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357889999999999999999742 35689999874332 33456889999999997669999999998765
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCC-------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeE
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKP-------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNIL 150 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~-------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNIL 150 (576)
..+++||||+++++|.+++..... ...+++..+..++.||+.||.|||+++ ++|+||||+|||
T Consensus 91 --~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nil 166 (314)
T cd05099 91 --GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVL 166 (314)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEE
Confidence 678999999999999999876421 123677888899999999999999999 999999999999
Q ss_pred EcCCCcEEEccccccccc
Q 036407 151 LDHNFCAKISDFGLARLK 168 (576)
Q Consensus 151 Ld~~g~vKLiDFGlA~~~ 168 (576)
++.++.++|+|||+++..
T Consensus 167 l~~~~~~kL~Dfg~~~~~ 184 (314)
T cd05099 167 VTEDNVMKIADFGLARGV 184 (314)
T ss_pred EcCCCcEEEccccccccc
Confidence 999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.41 Aligned_cols=153 Identities=25% Similarity=0.424 Sum_probs=132.9
Q ss_pred hhcCCCCccceeeccCcEEEEEEE--ECCceEEEEEeecCCchh--HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQG--EREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~--~~g~~VAVK~i~~~s~~~--~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.+++-|.+.+.||+|.|++|-+++ ++|+.||||++.+...+. ...+.+|++.|+.++| ||||+++.+...+ ..
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQH-pNiVRLYEViDTQ--TK 91 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQH-PNIVRLYEVIDTQ--TK 91 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcC-cCeeeeeehhccc--ce
Confidence 567889999999999999999886 679999999998765543 3578999999999988 9999999988766 88
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEc-CCCcEEEccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLD-HNFCAKISDFGLAR 166 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd-~~g~vKLiDFGlA~ 166 (576)
+|||+|+-++|+|.+++-.+..+ +.+..+.+|+.||+.|+.|||+.. +|||||||+|+++- .-|.+||+|||++.
T Consensus 92 lyLiLELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccc
Confidence 99999999999999988654432 788889999999999999999988 99999999998775 55899999999988
Q ss_pred cccCC
Q 036407 167 LKSVG 171 (576)
Q Consensus 167 ~~~~~ 171 (576)
.+.++
T Consensus 168 kf~PG 172 (864)
T KOG4717|consen 168 KFQPG 172 (864)
T ss_pred cCCCc
Confidence 76654
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=290.62 Aligned_cols=144 Identities=24% Similarity=0.389 Sum_probs=117.8
Q ss_pred cceeeccCcEEEEEEEEC----CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 20 SRLLGQGGFGSVFHATLH----DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~----g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
..+||+|+||.||+|+.. +..||+|.+.... ....+.+|+.++..+.| +||+.+++++.......+++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKH-PNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCC-CCeeeEEEEEeccCCCeEEEEEeee
Confidence 358999999999999864 4689999986432 23457889999999987 9999999998766668899999999
Q ss_pred CCCCHHHHHHhcC------CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE----cCCCcEEEcccccc
Q 036407 96 SNGNLQDALLHKK------PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL----DHNFCAKISDFGLA 165 (576)
Q Consensus 96 ~gGsL~d~L~~~~------~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL----d~~g~vKLiDFGlA 165 (576)
. ++|.+.+.... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||+ +.++.+||+|||++
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 57877764321 1223677888899999999999999999 9999999999999 45679999999998
Q ss_pred cccc
Q 036407 166 RLKS 169 (576)
Q Consensus 166 ~~~~ 169 (576)
+...
T Consensus 160 ~~~~ 163 (317)
T cd07867 160 RLFN 163 (317)
T ss_pred eccC
Confidence 7543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=287.98 Aligned_cols=146 Identities=27% Similarity=0.405 Sum_probs=125.3
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+|++.+.||+|++|.||+|+.. +..||||.+..... .....+.+|+.++..+.| +|++++++++... ..+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH-PNIVCLQDVLMQE--SRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCC-CCEeeeEEEEeeC--CeEEEE
Confidence 5888999999999999999875 78999999864322 223567889999999986 9999999998865 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|||+. ++|.+++........+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 150 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARA 150 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceee
Confidence 99996 589888866443344788889999999999999999999 99999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=301.90 Aligned_cols=146 Identities=33% Similarity=0.556 Sum_probs=122.8
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC---CCeE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK---RHRM 88 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s---~~~l 88 (576)
+|++.+.||+|+||.||++... ++.||||.+.... ......+.+|+.++..++| +||+.+++++.... ...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKH-DNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCC-CCcCCHhheecCCCccccceE
Confidence 4788999999999999999864 7899999986432 2234578899999999977 99999999887552 1278
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|+||||+. ++|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQP---LSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 99999995 588877765432 778888999999999999999999 999999999999999999999999988643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=295.96 Aligned_cols=146 Identities=23% Similarity=0.326 Sum_probs=123.9
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++.+.||+|+||.||+++.. ++.||+|++..... .....+..|+.++..+.| ++|+.+++.+... ..+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~--~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN-QWITTLHYAFQDE--NNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCC-CCEeeEEEEEecC--CEEE
Confidence 47899999999999999999876 67899999864221 122346778888877766 9999999988766 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+||||+++|+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 78 lv~ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~ 151 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLK 151 (332)
T ss_pred EEEeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchhee
Confidence 99999999999999976332 2677788889999999999999999 99999999999999999999999998764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=280.68 Aligned_cols=148 Identities=22% Similarity=0.354 Sum_probs=125.1
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+|++.+.||.|++|.||++... ++.||+|.+..... .....+.+|+.+++.+.| +|++.+++.+... ...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~-~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKH-PNIVAYRESWEGE-DGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCC-CCeeeeeeeecCC-CCEEEEE
Confidence 5889999999999999999865 68899999865332 233467889999999977 9999998876543 2578999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||+++++|.+.+..... ..+++.+++.++.+++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~e~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152 (257)
T ss_pred ecccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEe
Confidence 999999999998876432 23688889999999999999999999 999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=291.34 Aligned_cols=147 Identities=25% Similarity=0.370 Sum_probs=128.5
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
....+|++.+.||+|+||.||+|+.. ++.|++|.+..........+.+|+.++..+.| +|++.+++.+... ...|
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h-~~v~~~~~~~~~~--~~~~ 93 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVG--DELW 93 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCC-CCEeeEEEEEEeC--CEEE
Confidence 34568999999999999999999864 78999999976555556678899999988876 9999999988765 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+||||+++++|.+++.... +++.++..++.|++.||.|||..+ |+|+||||+||+++.++.++|+|||++..
T Consensus 94 lv~e~~~~~~L~~~~~~~~----~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 94 VVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred EeecccCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchh
Confidence 9999999999999886432 567788889999999999999999 99999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=292.26 Aligned_cols=146 Identities=24% Similarity=0.398 Sum_probs=124.3
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.++|.+.+.||+|+||.||+|+.. ++.||+|.+..... .....+.+|+.++..+.| +||+.+++++... ..+++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~~~l 81 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIVHTD--KSLTL 81 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCC-CCcceEEEEEeeC--CeEEE
Confidence 367999999999999999999865 68899999875432 223457789999999977 9999999998766 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||||+.+ +|.+.+..... .++...+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 82 v~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 153 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARA 153 (309)
T ss_pred EEeCCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcccccee
Confidence 9999964 88887765432 2677788889999999999999999 99999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=284.63 Aligned_cols=139 Identities=29% Similarity=0.460 Sum_probs=118.0
Q ss_pred eeeccCcEEEEEEEEC----CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccC
Q 036407 22 LLGQGGFGSVFHATLH----DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMS 96 (576)
Q Consensus 22 ~LG~GsfG~Vyka~~~----g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~ 96 (576)
.||+|+||.||+|.+. +..||+|++..... .....+.+|+.++..+.| +||+.+++++.. ..+++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h-~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN-PYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCC-CCeEEEEEEEcC---CCeEEEEEeCC
Confidence 4899999999999764 45699999865432 234568899999999976 999999998753 46899999999
Q ss_pred CCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 97 NGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 97 gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+|||++.++.++|+|||++...
T Consensus 78 ~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 145 (257)
T cd05115 78 GGPLNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKAL 145 (257)
T ss_pred CCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccc
Confidence 9999998865332 3788889999999999999999999 999999999999999999999999988644
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=280.55 Aligned_cols=150 Identities=23% Similarity=0.387 Sum_probs=127.6
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+|++.+.||.|+||.||++... ++.||+|.+..... .....+..|+.+++.+.| +|++++++++.......++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKH-PNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCC-CccceeeeeeecCCCCEEEEE
Confidence 5888999999999999999864 68899999865332 334568889999999987 999999998876666788999
Q ss_pred EeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHH-----hCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 92 YELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLH-----SLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLH-----s~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
|||+++++|.+++.... ....+++..++.++.+|+.||.||| +.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEeccccc
Confidence 99999999999886531 1234778889999999999999999 778 999999999999999999999999987
Q ss_pred ccc
Q 036407 166 RLK 168 (576)
Q Consensus 166 ~~~ 168 (576)
...
T Consensus 158 ~~~ 160 (265)
T cd08217 158 KIL 160 (265)
T ss_pred ccc
Confidence 644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=283.26 Aligned_cols=150 Identities=35% Similarity=0.542 Sum_probs=129.2
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
...++|.+.+.||+|+||.||+|... +..+|||.+..... ....+..|+.+++.+.| +|++++++++... ..+++
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~~ 78 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRH-DKLVQLYAVCSEE--EPIYI 78 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCC-CCEeeeeeeeecC--CceEE
Confidence 45678999999999999999999876 57799999875433 34578899999999987 9999999988765 67899
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||||+++++|.+++..... ..+++..+..++.+++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred EEeccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceec
Confidence 9999999999999876432 23678888999999999999999999 999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=287.19 Aligned_cols=161 Identities=25% Similarity=0.336 Sum_probs=134.3
Q ss_pred CChHHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 5 fs~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
+.++.+....++|++.+.||+|+||.||++... ++.+|+|++.... .....+..|+.++..+..|+|++++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 456777788999999999999999999999875 6889999886422 2235678899999999766999999998753
Q ss_pred ---CCCCeEEEEEeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEE
Q 036407 83 ---PKRHRMLLVYELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAK 158 (576)
Q Consensus 83 ---~s~~~l~LVmE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vK 158 (576)
.....+++||||+++++|.+++.... ....+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEE
Confidence 23467999999999999998875421 2233677888889999999999999999 99999999999999999999
Q ss_pred Eccccccccc
Q 036407 159 ISDFGLARLK 168 (576)
Q Consensus 159 LiDFGlA~~~ 168 (576)
|+|||++...
T Consensus 165 l~dfg~~~~~ 174 (286)
T cd06638 165 LVDFGVSAQL 174 (286)
T ss_pred EccCCceeec
Confidence 9999987644
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=283.68 Aligned_cols=144 Identities=32% Similarity=0.550 Sum_probs=124.9
Q ss_pred CCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEec
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
++|++.+.||+|+||.||++...++.||+|.+.... ....+.+|+.++..+.| +|++++++++... ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~---~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHH-KNLVRLLGVILHN---GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCC-CCcCeEEEEEcCC---CcEEEEEC
Confidence 468899999999999999999889999999986432 33578899999999977 9999999987653 46999999
Q ss_pred cCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 95 MSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 95 ~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+.+++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 80 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 80 MSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARV 149 (254)
T ss_pred CCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCcccee
Confidence 999999999876442 23677888899999999999999999 99999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=281.79 Aligned_cols=146 Identities=29% Similarity=0.433 Sum_probs=125.3
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchh---------HHHHHHHHHHHHHhccCCceEEEEEEeeCCC
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG---------EREFYNELYFASLLEQDDHVVSVLGFSSNPK 84 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~---------~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s 84 (576)
+|.+...||+|++|.||+|... ++.+|+|.+....... ...+..|+.+++.+.| +||+++++++...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~- 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH-ENIVQYLGSSLDA- 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeC-
Confidence 4778899999999999999864 6889999886543221 1457889999999977 9999999998776
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
..+++||||+++++|.+++..... ++...+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 79 -DHLNIFLEYVPGGSVAALLNNYGA---FEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred -CccEEEEEecCCCCHHHHHHhccC---ccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCC
Confidence 788999999999999999876543 677888899999999999999999 99999999999999999999999998
Q ss_pred ccccc
Q 036407 165 ARLKS 169 (576)
Q Consensus 165 A~~~~ 169 (576)
++...
T Consensus 153 ~~~~~ 157 (267)
T cd06628 153 SKKLE 157 (267)
T ss_pred Ccccc
Confidence 87543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=288.16 Aligned_cols=146 Identities=30% Similarity=0.423 Sum_probs=124.5
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch---hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~---~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.|+..+.||+|+||.||++... ++.||+|.+...... ....+.+|+.++..+.| +|++.+.+.+... ..+|+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~i~~~~~~~~~~--~~~~l 77 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS-QFVVNLAYAYETK--DALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC-cCceeEEEEEecC--CEEEE
Confidence 3778899999999999999875 789999998654322 23457789999999977 9999998888766 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||||+++++|.+++...... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 78 v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~ 151 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNP-GFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVK 151 (285)
T ss_pred EEEeccCccHHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCccee
Confidence 99999999999888654322 3788889999999999999999999 99999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.13 Aligned_cols=138 Identities=22% Similarity=0.308 Sum_probs=114.7
Q ss_pred eeccCcEEEEEEEEC--CceEEEEEeecCCchh---HHHHHHHHHHHHHhc--cCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 23 LGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG---EREFYNELYFASLLE--QDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 23 LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~---~~~~l~EI~iLs~L~--h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
||+|+||.||+|+.. ++.||||++....... ......|..++..+. +|+||+.++..+... ..+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcCC
Confidence 799999999999875 7899999996432221 223445555665554 679999999888776 7899999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++|+|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 79 ~~g~L~~~l~~~~~---~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 79 SGGELFWHLQKEGR---FSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred CCChHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 99999988876443 778888999999999999999999 99999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.99 Aligned_cols=149 Identities=33% Similarity=0.485 Sum_probs=121.5
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC---eEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH---RML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~---~l~ 89 (576)
-.|...+++|+|+||.||+|... ++.||||..-.+. .-..+|+.+|.++.| |||+.++.++...... ++.
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~H-pNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDH-PNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCC-cCeeeEEEEEEecCCCchhHHH
Confidence 35778899999999999999875 6899999884332 223578888998888 9999999888765444 567
Q ss_pred EEEeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC-CcEEEcccccccc
Q 036407 90 LVYELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN-FCAKISDFGLARL 167 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~-g~vKLiDFGlA~~ 167 (576)
+||||++. +|.+.+++.. ....++...++-+..||++||.|||..+ |+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 99999965 9998887521 1112666777889999999999999999 9999999999999976 8999999999997
Q ss_pred ccCC
Q 036407 168 KSVG 171 (576)
Q Consensus 168 ~~~~ 171 (576)
+..+
T Consensus 176 L~~~ 179 (364)
T KOG0658|consen 176 LVKG 179 (364)
T ss_pred eccC
Confidence 7654
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=308.56 Aligned_cols=155 Identities=30% Similarity=0.447 Sum_probs=128.3
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCch-hHHHHHHHHHHHHHhccCCceEEEEEEee
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSLQ-GEREFYNELYFASLLEQDDHVVSVLGFSS 81 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~~-~~~~~l~EI~iLs~L~h~pNIv~Llg~~~ 81 (576)
+....++|.+.+.||+|+||.||+|+.. +..||||+++..... ....+.+|+.++..+..|+||+.+++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4455567888999999999999999864 357999999754322 23468899999999985699999999987
Q ss_pred CCCCCeEEEEEeccCCCCHHHHHHhcCC----------------------------------------------------
Q 036407 82 NPKRHRMLLVYELMSNGNLQDALLHKKP---------------------------------------------------- 109 (576)
Q Consensus 82 ~~s~~~l~LVmE~~~gGsL~d~L~~~~~---------------------------------------------------- 109 (576)
.. ..+++||||+.+|+|.+++.....
T Consensus 112 ~~--~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 112 KG--GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred cC--CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 76 678999999999999998865321
Q ss_pred -------------------------------------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCC
Q 036407 110 -------------------------------------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKP 146 (576)
Q Consensus 110 -------------------------------------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKP 146 (576)
...+++..++.++.||+.||.|||+.+ |+|+||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp 267 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAA 267 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCc
Confidence 012456677889999999999999998 99999999
Q ss_pred CCeEEcCCCcEEEccccccccc
Q 036407 147 SNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 147 eNILLd~~g~vKLiDFGlA~~~ 168 (576)
+|||++.++.++|+|||+++..
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~ 289 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDI 289 (401)
T ss_pred ceEEEeCCCEEEEEecCcceec
Confidence 9999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=282.45 Aligned_cols=149 Identities=32% Similarity=0.510 Sum_probs=126.4
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
...++|++.+.||+|+||.||++... +..+|+|.+.... .....+.+|+.++..+.| +|++.+++.+.. ...++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQH-DKLVKLHAVVTK---EPIYI 77 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCC-CCcceEEEEEcC---CCeEE
Confidence 34678999999999999999999865 5679999886543 234578889999999976 999999888765 56799
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+|||+++++|.+++..... ..+++..++.++.+++.||.|||+.+ ++|+||+|+||+++..+.++|+|||.+...
T Consensus 78 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred EEEeCCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeec
Confidence 9999999999999876432 23677788889999999999999999 999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=284.74 Aligned_cols=146 Identities=27% Similarity=0.379 Sum_probs=127.8
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
++|++.+.||.|+||.||+|+.. ++.||+|.+.... ......+.+|+.+++.+.| +|++.+++++... ..+++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRS-PYITKYYGSFLKG--SKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCC-CCeeeeeEEEEEC--CeEEEE
Confidence 47889999999999999999875 7899999987543 2334567899999999986 9999999988766 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
+||+++++|.+++... .+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 78 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 78 MEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLT 149 (274)
T ss_pred EEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeec
Confidence 9999999999988764 2678889999999999999999999 9999999999999999999999999887543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=284.62 Aligned_cols=147 Identities=27% Similarity=0.490 Sum_probs=125.1
Q ss_pred cCCCCccceeeccCcEEEEEEEECC-----ceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLHD-----QSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~g-----~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.++|.+.+.||+|+||.||+|.... ..++||...... ....+.+.+|+.++..+.| +|++++++++.. ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~---~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH-PHIVKLIGVITE---NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCC-CchhceeEEEcC---CC
Confidence 3568889999999999999998642 468999886544 3445678999999999977 999999998864 45
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
.++||||+++++|.+++..... .+++..++.++.+++.||.|||+++ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeee
Confidence 6899999999999999876432 2678888999999999999999999 99999999999999999999999998764
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 157 ~ 157 (270)
T cd05056 157 L 157 (270)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=287.19 Aligned_cols=147 Identities=23% Similarity=0.370 Sum_probs=128.6
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
.+.|++.+.||+|+||.||+|+.. +..+++|.+..........+..|+.++..+.| +|++.+++.+... ..+++|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNH-PYIVKLLGAFYWD--GKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCC-CcEeeeEEEEEeC--CeEEEE
Confidence 467999999999999999999875 68899999976655556678889999999987 9999999988766 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|||+++++|..++..... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 88 ~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 88 IEFCPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred EecCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCcccee
Confidence 999999999887755332 2678889999999999999999999 99999999999999999999999998753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=288.46 Aligned_cols=149 Identities=28% Similarity=0.499 Sum_probs=125.2
Q ss_pred CCCCccceeeccCcEEEEEEEEC------------------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH------------------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVS 75 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~------------------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~ 75 (576)
++|++.+.||+|+||.||++... ...+|+|.+.... ......+.+|+.++..+.| +||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKD-PNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcce
Confidence 46899999999999999998532 2368999987542 2334678899999999976 99999
Q ss_pred EEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCC--------ChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCC
Q 036407 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPP--------ELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPS 147 (576)
Q Consensus 76 Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~--------~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPe 147 (576)
+++++... ..+++||||+++++|.+++...... ..+++.++..++.|++.||.|||+++ ++|+||||+
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~ 159 (296)
T cd05095 84 LLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATR 159 (296)
T ss_pred EEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChh
Confidence 99998776 6789999999999999988764321 23566788999999999999999999 999999999
Q ss_pred CeEEcCCCcEEEccccccccc
Q 036407 148 NILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 148 NILLd~~g~vKLiDFGlA~~~ 168 (576)
|||++.++.++|+|||++...
T Consensus 160 Nili~~~~~~~l~dfg~~~~~ 180 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNL 180 (296)
T ss_pred eEEEcCCCCEEeccCcccccc
Confidence 999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=296.51 Aligned_cols=147 Identities=22% Similarity=0.311 Sum_probs=125.3
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++.+.||+|+||.||+++.. ++.||||++.+... .....+..|+.++..+.| +||+.+++.+... ..+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~--~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR-RWITNLHYAFQDE--NNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCCCceEEEEecC--CeEE
Confidence 57999999999999999999875 78999999974221 223457788888888765 9999999988766 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||||+++++|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++...
T Consensus 78 lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred EEEecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 99999999999999865332 2677888889999999999999999 999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=295.05 Aligned_cols=147 Identities=22% Similarity=0.308 Sum_probs=124.6
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++.+.||+|+||.||+++.. ++.||+|++..... .....+..|+.++..+.| +||+.+++++... +.+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~l~~~~~~~--~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC-QWITTLHYAFQDE--NYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEcC--CEEE
Confidence 57999999999999999999876 68899999864221 223346777777777766 9999999988766 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||||+++|+|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++...
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999976332 2677788889999999999999999 999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=281.33 Aligned_cols=154 Identities=25% Similarity=0.335 Sum_probs=129.5
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
++..++++.....||+|+||.||+|... +..|++|.+........+.+.+|+.++..++| +||+++++++... ..
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~--~~ 79 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKH-RNIVQYLGSDSEN--GF 79 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCC-CCeeeeeeeeccC--CE
Confidence 4556777778889999999999999865 57899999876655556688999999999977 9999999998776 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC-CCcEEEccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH-NFCAKISDFGLAR 166 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~-~g~vKLiDFGlA~ 166 (576)
+++|+||+++++|.+++.........+...+..++.||+.||.|||+.+ |+|+||||+||+++. .+.++|+|||++.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999999999998876422111266777889999999999999999 999999999999976 6799999999875
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 158 ~~ 159 (268)
T cd06624 158 RL 159 (268)
T ss_pred ec
Confidence 43
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=282.59 Aligned_cols=142 Identities=30% Similarity=0.499 Sum_probs=116.5
Q ss_pred ceeeccCcEEEEEEEEC-----CceEEEEEeecC-CchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEec
Q 036407 21 RLLGQGGFGSVFHATLH-----DQSVAVKVMDSG-SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~-s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
+.||+|+||.||+|... ...+|+|.+... .......+.+|+.+++.+.| +|++.+++++.... ...++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~-~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSH-PNVLSLLGICLPSE-GSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCC-CCcceEEEEeecCC-CCcEEEEec
Confidence 46899999999999853 357999988532 23344578889999999876 99999999776432 567899999
Q ss_pred cCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 95 MSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 95 ~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+.+++|.+++...... .+...+..++.||+.||.|||+.+ ++|+||||+|||++.++.++|+|||+++..
T Consensus 79 ~~~~~L~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 79 MKHGDLRNFIRSETHN--PTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred CCCCCHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccc
Confidence 9999999998754322 455667788999999999999999 999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=279.14 Aligned_cols=146 Identities=25% Similarity=0.372 Sum_probs=128.6
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
++|++.+.||.|+||.||+|... ++.+++|.+..........+.+|+.++..+.| +|++++++++... ..+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~--~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRH-PNIVAYFGSYLRR--DKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCC-CChhceEEEEEeC--CEEEEEE
Confidence 67899999999999999999865 67899999976554456778999999999977 9999999988766 7899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||+.+++|.+++..... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 80 e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 80 EYCGGGSLQDIYQVTRG--PLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred eCCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchh
Confidence 99999999998876422 2678888999999999999999999 99999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=304.33 Aligned_cols=151 Identities=30% Similarity=0.468 Sum_probs=133.3
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch---hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~---~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
...+.|.+.+.||.|.||.||+++.. |+.+|+|.+.+.... ....+.+|+.+|+.+..||||+.+++.+... .
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~--~ 109 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP--D 109 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--C
Confidence 45678999999999999999999876 789999999765443 3458999999999999779999999999887 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC----CcEEEccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN----FCAKISDF 162 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~----g~vKLiDF 162 (576)
.+++|||+|.||.|.+.+... . +++..+..++.|++.++.|||+.| |+||||||+|+|+... +.++++||
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 999999999999999998776 2 788899999999999999999999 9999999999999643 57999999
Q ss_pred cccccccC
Q 036407 163 GLARLKSV 170 (576)
Q Consensus 163 GlA~~~~~ 170 (576)
|++.....
T Consensus 184 Gla~~~~~ 191 (382)
T KOG0032|consen 184 GLAKFIKP 191 (382)
T ss_pred CCceEccC
Confidence 99986543
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=289.25 Aligned_cols=149 Identities=24% Similarity=0.360 Sum_probs=128.4
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch---hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~---~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++.+.||+|+||.||+|... ++.||+|.+...... ....+..|+.++..+.| +||+++++.+... ...|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~~~ 77 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH-PFLPTLYASFQTE--TYLC 77 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCC-CCchhheeeeecC--CEEE
Confidence 47889999999999999999875 689999999765433 33568889999999986 9999999988765 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
+||||+.+++|.+++..... ..+++..+..++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPG-KCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EEEEecCCCCHHHHHHhCCC-CccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 99999999999998875432 23778888889999999999999999 9999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=284.13 Aligned_cols=161 Identities=24% Similarity=0.331 Sum_probs=134.9
Q ss_pred CChHHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 5 fs~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
+++..+..+.++|.+.+.||+|+||.||++... ++.+|+|.+.... .....+.+|+.++..+.+|+|++.+++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 455677888999999999999999999999875 7889999986432 2245678899999999667999999998865
Q ss_pred CC---CCeEEEEEeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEE
Q 036407 83 PK---RHRMLLVYELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAK 158 (576)
Q Consensus 83 ~s---~~~l~LVmE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vK 158 (576)
.. ...+++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEE
Confidence 32 257899999999999999886421 2223678889999999999999999999 99999999999999999999
Q ss_pred Eccccccccc
Q 036407 159 ISDFGLARLK 168 (576)
Q Consensus 159 LiDFGlA~~~ 168 (576)
|+|||++...
T Consensus 169 l~dfg~~~~~ 178 (291)
T cd06639 169 LVDFGVSAQL 178 (291)
T ss_pred Eeecccchhc
Confidence 9999987643
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=280.31 Aligned_cols=142 Identities=32% Similarity=0.459 Sum_probs=122.9
Q ss_pred ceeeccCcEEEEEEEEC---C--ceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEec
Q 036407 21 RLLGQGGFGSVFHATLH---D--QSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~---g--~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
+.||+|++|.||+|.+. + ..||||.+..... .....+.+|+.+++.+.| +||+.+++++.. ..+++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH-ENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCC-CCccceeEEEcC---CeEEEEEEe
Confidence 46899999999999864 2 3689999987655 455678999999999987 999999998865 678999999
Q ss_pred cCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 95 MSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 95 ~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
+++++|.+.+..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~ 148 (257)
T cd05040 77 APLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALP 148 (257)
T ss_pred cCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEecccccccccc
Confidence 999999999876542 33788889999999999999999999 9999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=320.67 Aligned_cols=169 Identities=21% Similarity=0.298 Sum_probs=141.7
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
.++|.+.+.||.|+||.||+|+.. ++.||||++..... .....+..|+.++..+.| +||+.++..+... ..+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~--~~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS-PFIVHLYYSLQSA--NNV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCC-CCcCeEEEEEEEC--CEE
Confidence 468999999999999999999987 78999999975432 223567888888888877 9999999887765 789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||||||+.+++|.+++..... +++..++.|+.||+.||.|||.++ |+||||||+|||++.++.++|+|||+++..
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~---l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGY---FDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 999999999999998876443 667788899999999999999999 999999999999999999999999999866
Q ss_pred cCCC-CCcCcCCCCccccchhhh
Q 036407 169 SVGE-NQNQADGENKNKAAELES 190 (576)
Q Consensus 169 ~~~~-~~~~~~gt~~y~APEl~~ 190 (576)
.... ......+++.|.+||...
T Consensus 155 ~~~~~~~~~~~~t~~~~~pe~~~ 177 (669)
T cd05610 155 LNRELNMMDILTTPSMAKPKNDY 177 (669)
T ss_pred cCCcccccccccCccccCccccc
Confidence 4432 233467888889888443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=284.59 Aligned_cols=144 Identities=22% Similarity=0.356 Sum_probs=125.3
Q ss_pred CCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEec
Q 036407 17 FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
|++.+.||+|+||.||+|... +..+++|.+..........+.+|+.++..+.| +|++.+++++... ...++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~ii~~~~~~~~~--~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH-PNIVKLLDAFYYE--NNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCC-CCeeeEEEEEeeC--CEEEEEEEe
Confidence 677889999999999999876 67889999876555556678899999999976 9999999988776 789999999
Q ss_pred cCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 95 MSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 95 ~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++++|..++..... .+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++..
T Consensus 84 ~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 84 CAGGAVDAVMLELER--PLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred cCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEcccccccc
Confidence 999999887764322 2778888999999999999999999 99999999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=280.13 Aligned_cols=147 Identities=29% Similarity=0.515 Sum_probs=126.2
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
..+|++.+.||.|+||.||++... +..+|+|.+..... ....+.+|+.++..+.| +|++++++++... ...++||
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~~~~v~ 78 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSH-PKLVQLYGVCTER--SPICLVF 78 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCC-CCeeeEEEEEccC--CceEEEE
Confidence 356888999999999999999876 78899999864332 34578899999999977 9999999988765 6789999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||+++++|.+++..... .+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 79 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 150 (256)
T cd05112 79 EFMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFV 150 (256)
T ss_pred EcCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeec
Confidence 99999999998875432 2677888889999999999999999 999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=289.77 Aligned_cols=149 Identities=26% Similarity=0.358 Sum_probs=130.0
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
.....+|++.+.||+|+||.||++... ++.||+|.+........+.+.+|+.++..+.| +|++.+++++... ..+
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~--~~~ 91 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVG--DEL 91 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCC-CCEeeEEEEEecC--CEE
Confidence 344578999999999999999999864 78999999976555556678899999998866 9999999998766 789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++||||+++++|.+++.... +++..+..++.+++.||.|||+.+ ++|+||||+|||++.++.++|+|||++...
T Consensus 92 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred EEeecccCCCCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 99999999999999886532 567788889999999999999999 999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=279.57 Aligned_cols=148 Identities=26% Similarity=0.388 Sum_probs=125.9
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-----chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-----LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-----~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.+|++.+.||+|+||.||.|... +..||||.+.... ......+.+|+.++..+.| +||+.+++++.......
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH-ERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCC-CCeeeEEeEeccCCCce
Confidence 47889999999999999999865 7899999886322 1223467889999999976 99999999887655567
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++||||+++++|.+.+..... +++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999998876443 567778889999999999999999 99999999999999999999999998764
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 156 ~ 156 (265)
T cd06652 156 L 156 (265)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=278.59 Aligned_cols=145 Identities=29% Similarity=0.393 Sum_probs=127.9
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
++|++.+.||+|+||.||+|... +..+++|.+..... ...+.+|+.+++.+.| +|++.+++.+... ..+|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~--~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDS-PYIVKYYGSYFKN--TDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCC-CcEeeeeeeeecC--CcEEEEE
Confidence 67999999999999999999876 68899999865422 5678999999999955 9999999998876 7899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||+.+++|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 78 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~ 149 (256)
T cd06612 78 EYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQL 149 (256)
T ss_pred ecCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhc
Confidence 99999999998865432 3678888999999999999999999 999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=295.05 Aligned_cols=153 Identities=27% Similarity=0.473 Sum_probs=126.9
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC---------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEee
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH---------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSS 81 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~---------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~ 81 (576)
....+|.+.+.||+|+||.||+|... ...||+|.+.... ......+.+|+.++.++..|+||+++++++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 33457899999999999999999742 2368999886432 2234578899999999966699999999987
Q ss_pred CCCCCeEEEEEeccCCCCHHHHHHhcCC-------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCC
Q 036407 82 NPKRHRMLLVYELMSNGNLQDALLHKKP-------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSN 148 (576)
Q Consensus 82 ~~s~~~l~LVmE~~~gGsL~d~L~~~~~-------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeN 148 (576)
.. ..++++|||+++++|.+++..... ...+++.++..++.|++.||.|||+++ ++|+||||+|
T Consensus 89 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~N 164 (334)
T cd05100 89 QD--GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARN 164 (334)
T ss_pred cC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccce
Confidence 66 678999999999999999875321 123667788889999999999999999 9999999999
Q ss_pred eEEcCCCcEEEccccccccc
Q 036407 149 ILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 149 ILLd~~g~vKLiDFGlA~~~ 168 (576)
||++.++.++|+|||+++..
T Consensus 165 ill~~~~~~kL~Dfg~~~~~ 184 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDV 184 (334)
T ss_pred EEEcCCCcEEECCcccceec
Confidence 99999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=280.16 Aligned_cols=148 Identities=25% Similarity=0.372 Sum_probs=126.4
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-----hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-----QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-----~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.+|.+.+.||+|+||.||+|... +..|++|.+..... .....+.+|+.++..+.| +||+.+++++.......
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH-ERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCC-CCeeeEEEEEEcCCCCE
Confidence 37889999999999999999864 78999999864321 223467889999999976 99999999887655578
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++++||+++++|.+.+..... +++..++.++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGA---LTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999998876443 677778889999999999999999 99999999999999999999999998764
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 156 ~ 156 (266)
T cd06651 156 L 156 (266)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=285.29 Aligned_cols=147 Identities=24% Similarity=0.347 Sum_probs=130.1
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+++|++.+.||.|+||.||++... +..+|+|.+..........+..|+.++..+.| +|++.+++.+... ..+|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH-PNIVGLYEAYFYE--NKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCC-CceeEEEEEEecC--CeEEEE
Confidence 467999999999999999999875 78899999976655556678899999999985 9999999998765 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~e~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 81 IEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred eeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchh
Confidence 999999999998876432 2778888999999999999999999 99999999999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=286.60 Aligned_cols=150 Identities=31% Similarity=0.532 Sum_probs=126.6
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
.++|++.+.||+|+||.||+|... +..||+|.+..... .....+.+|+.++..+.| +|++.+++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h-~~iv~~~~~~~~~-- 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH-PNIVKLLGVCAVG-- 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCC-CchheEEEEEcCC--
Confidence 467999999999999999999852 57899999865432 334568899999999977 9999999988765
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCC-------------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCC
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKP-------------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKP 146 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~-------------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKP 146 (576)
..+++||||+++++|.+++..... ...+++..++.++.|++.||.|||.++ ++|+||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p 158 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLAT 158 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccH
Confidence 678999999999999999864321 112567788899999999999999999 99999999
Q ss_pred CCeEEcCCCcEEEccccccccc
Q 036407 147 SNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 147 eNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||+++.++.++|+|||++...
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~ 180 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNI 180 (288)
T ss_pred hheEecCCCceEECccccceec
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=277.40 Aligned_cols=147 Identities=26% Similarity=0.435 Sum_probs=126.9
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+|++.+.||.|+||.||.++.. ++.+++|.+.... ......+.+|+.++.++.| +||+.+++++... ..++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~--~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH-PNIIAYYNHFMDD--NTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCC-CCeeEEEeEEecC--CeEEEE
Confidence 5889999999999999888764 7889999986533 2334568899999999976 9999999999876 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||+++++|.+.+..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~ 151 (256)
T cd08221 78 MEYANGGTLYDKIVRQKG-QLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKIL 151 (256)
T ss_pred EEecCCCcHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence 999999999998876532 23678888899999999999999999 999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=287.66 Aligned_cols=145 Identities=23% Similarity=0.305 Sum_probs=125.6
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
++|++.+.||+|+||.||++... +..+|+|.+..... .....+.+|+.++..+.| +||+++++.+... +.+++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNS-PYIVGFYGAFYSD--GEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeC--CEEEEE
Confidence 47899999999999999999875 67899999865422 234568899999999976 9999999998776 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|||+++++|.+++..... +++..+..++.|++.||.|||+ ++ ++|+||||+|||++.++.++|+|||++..
T Consensus 78 ~ey~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGR---IPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 149 (308)
T ss_pred eeccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCccc
Confidence 999999999999876533 6777888999999999999997 68 99999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=279.68 Aligned_cols=154 Identities=28% Similarity=0.385 Sum_probs=130.9
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC----C
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK----R 85 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s----~ 85 (576)
...++|++.+.||+|++|.||+|... ++.+++|++..... ....+.+|+.++..+..|+||+++++++.... .
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45689999999999999999999875 67899999875443 34578899999999976799999999987542 4
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
..+++||||+++++|.+++.... ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCcc
Confidence 56899999999999999886532 1223778888999999999999999999 99999999999999999999999998
Q ss_pred cccc
Q 036407 165 ARLK 168 (576)
Q Consensus 165 A~~~ 168 (576)
+...
T Consensus 160 ~~~~ 163 (275)
T cd06608 160 SAQL 163 (275)
T ss_pred ceec
Confidence 7643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=302.46 Aligned_cols=142 Identities=23% Similarity=0.315 Sum_probs=121.5
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC----CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH----DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~----g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
...+|.+.+.||.|+||.||++... +..||+|.+... ....+|+.++..+.| +||+++++++... ..+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h-~~iv~~~~~~~~~--~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISH-RAIINLIHAYRWK--STV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCC-CCccceeeeEeeC--CEE
Confidence 3467999999999999999999754 467999988643 235689999999977 9999999888765 789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|+|||++. ++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++...
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~---l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGP---LPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 99999994 688888854332 788889999999999999999999 999999999999999999999999988643
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=282.25 Aligned_cols=147 Identities=24% Similarity=0.377 Sum_probs=126.0
Q ss_pred CCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCch-hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSLQ-GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~~-~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
++|++.+.||.|+||.||+|+.. .+.+++|.+...... ....+.+|+.++.++.| +|++.+++++... .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH-KNVVRLLGLCREA--E 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCC-cceeeeEEEECCC--C
Confidence 57889999999999999999853 357999988654332 34578999999999976 9999999988765 6
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCC------hhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPE------LMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKIS 160 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~------~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLi 160 (576)
..|+||||+++++|.+++....... .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEc
Confidence 7899999999999999987644211 3788889999999999999999999 9999999999999999999999
Q ss_pred cccccc
Q 036407 161 DFGLAR 166 (576)
Q Consensus 161 DFGlA~ 166 (576)
|||++.
T Consensus 160 ~~~~~~ 165 (275)
T cd05046 160 LLSLSK 165 (275)
T ss_pred cccccc
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=276.25 Aligned_cols=141 Identities=32% Similarity=0.504 Sum_probs=122.1
Q ss_pred ceeeccCcEEEEEEEEC-CceEEEEEeecCCch-hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCCC
Q 036407 21 RLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQ-GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNG 98 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~-~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~gG 98 (576)
++||.|+||.||++... ++.||+|.+...... ....+.+|+.++..+.| +||+.+++++... ...++||||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH-PNIVKLIGVCVQK--QPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCeEEEEEEEecC--CCeEEEEEcCCCC
Confidence 47999999999999876 799999998754433 45678899999999987 9999999998766 7789999999999
Q ss_pred CHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 99 NLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 99 sL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+|.+++..... .++...++.++.+++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~l~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~ 143 (251)
T cd05041 78 SLLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREE 143 (251)
T ss_pred cHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccc
Confidence 99998865432 2677788889999999999999999 999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=290.19 Aligned_cols=147 Identities=31% Similarity=0.529 Sum_probs=122.2
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--Cc----eEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQ----SVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~----~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
.++|+..+.||+|+||.||+|... +. .+|+|.+..... .....+.+|+.++..+.| +||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~~--- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH-PHLVRLLGVCLSP--- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcccEEEEEcCC---
Confidence 457888999999999999999763 33 578888865432 223467889999999966 9999999988653
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
..++++||+++|+|.+.+..... .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred CceeeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccccc
Confidence 46799999999999998876432 2677788899999999999999999 9999999999999999999999999886
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 158 ~~ 159 (303)
T cd05110 158 LL 159 (303)
T ss_pred cc
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=283.01 Aligned_cols=148 Identities=30% Similarity=0.516 Sum_probs=126.3
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--C----ceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--D----QSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g----~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
.++|++.+.||+|+||.||+|... + ..+|+|.+..... .....+.+|+.++..+.| +|++++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~---~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH-PHVVRLLGICLS---S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEec---C
Confidence 357889999999999999999864 2 3589998865543 334578899999999977 999999998875 5
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
..++||||+++|+|.+++...... +++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccc
Confidence 789999999999999988764332 678889999999999999999999 9999999999999999999999999987
Q ss_pred ccc
Q 036407 167 LKS 169 (576)
Q Consensus 167 ~~~ 169 (576)
...
T Consensus 158 ~~~ 160 (279)
T cd05057 158 LLD 160 (279)
T ss_pred ccc
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.28 Aligned_cols=140 Identities=24% Similarity=0.302 Sum_probs=120.4
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
...+|++.+.||+|+||.||+|+.. ++.||+|+.... ....|+.++..+.| +||+++++++... ...++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNH-PSVIRMKDTLVSG--AITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCC-CCCcChhheEEeC--CeeEE
Confidence 3457999999999999999999976 578999986432 23568888999987 9999999998876 78899
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
|||++. ++|.+++..... .+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.
T Consensus 135 v~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~ 205 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRSR--PLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQ 205 (357)
T ss_pred EEEccC-CcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCcccc
Confidence 999994 688888765432 2778889999999999999999999 9999999999999999999999999875
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=278.55 Aligned_cols=145 Identities=26% Similarity=0.408 Sum_probs=125.0
Q ss_pred CCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCc------hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSL------QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~------~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
+|++.+.||.|+||.||+|... ++.+|+|.+..... .....+.+|+.+++.+.| +||+.+++++... ..+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH-VNIVQYLGTCLDD--NTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCC-CCEeeEeeEeecC--CeE
Confidence 4788999999999999999864 78899999864321 112457889999999977 9999999998876 889
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++|+||+++++|.+++..... +++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGP---LPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999999999876443 677788889999999999999999 999999999999999999999999987644
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=324.44 Aligned_cols=149 Identities=32% Similarity=0.512 Sum_probs=130.8
Q ss_pred CCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCch-hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSLQ-GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~~-~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
.+.+..+.||+|+||+||+|+.. ...||||.++..... .+++|.+|+.++..|.| +|||+++|.|... .
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H-~nIVrLlGVC~~~--~ 562 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQH-PNIVRLLGVCREG--D 562 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccC-CCeEEEEEEEccC--C
Confidence 34557789999999999999865 356999999865544 67889999999999988 9999999999987 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCC-----------ChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPP-----------ELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF 155 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~-----------~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g 155 (576)
.+|||+|||..|||.++|....+. ..++..+.+.|+.||+.|+.||-++. +|||||-..|+|+..+.
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGENL 640 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccce
Confidence 899999999999999999875432 12677889999999999999999998 99999999999999999
Q ss_pred cEEEccccccccc
Q 036407 156 CAKISDFGLARLK 168 (576)
Q Consensus 156 ~vKLiDFGlA~~~ 168 (576)
.|||+|||+++.+
T Consensus 641 ~VKIsDfGLsRdi 653 (774)
T KOG1026|consen 641 VVKISDFGLSRDI 653 (774)
T ss_pred EEEecccccchhh
Confidence 9999999998753
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=281.12 Aligned_cols=145 Identities=28% Similarity=0.414 Sum_probs=125.3
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
..|+..+.||.|+||.||+|... +..||+|.+.... ......+.+|+.++..+.| +|++.+++.+... ..+++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKG--TKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEEC--CEEEEE
Confidence 45778899999999999999864 7889999987543 2334568889999999977 9999999998776 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||+++++|.+++.... ++...+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~i~~~~----l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 81 MEYLGGGSALDLLRAGP----FDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred EecCCCCcHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceec
Confidence 99999999999886432 567788889999999999999999 999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=279.69 Aligned_cols=148 Identities=21% Similarity=0.365 Sum_probs=121.6
Q ss_pred CCCccceeeccCcEEEEEEEEC---CceEEEEEeecCC----------chhHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH---DQSVAVKVMDSGS----------LQGEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~---g~~VAVK~i~~~s----------~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
+|++.+.||+|+||.||+|... ++.+|+|.+.... ......+..|+.++.....|+|++.+++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4888999999999999999875 4789999885321 11224567788877765556999999999876
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEc
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHK-KPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKIS 160 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~-~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLi 160 (576)
. ..+++||||+++++|.+++... .....++...++.++.|++.||.|||+ .+ ++|+||+|.||+++.++.++|+
T Consensus 81 ~--~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 81 N--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred C--CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEe
Confidence 6 7899999999999999887542 122237788899999999999999996 67 9999999999999999999999
Q ss_pred ccccccc
Q 036407 161 DFGLARL 167 (576)
Q Consensus 161 DFGlA~~ 167 (576)
|||++..
T Consensus 157 dfg~~~~ 163 (269)
T cd08528 157 DFGLAKQ 163 (269)
T ss_pred cccceee
Confidence 9998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=284.28 Aligned_cols=145 Identities=28% Similarity=0.369 Sum_probs=126.2
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.++|++.+.||+|+||.||++... ++.||+|++.... ......+.+|+.++..+.| +||+++++++... ..+++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~--~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS-PYIVSFYGAFLNE--NNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCC-CCcceEeeeEecC--CEEEE
Confidence 357889999999999999999876 7889999886543 2335678899999999976 9999999999877 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
||||+++++|.+++...+. +++..+..++.+++.||.|||+ ++ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~ 152 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGP---IPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSG 152 (284)
T ss_pred EEecCCCCCHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCccc
Confidence 9999999999988876433 6778888899999999999997 67 9999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=283.48 Aligned_cols=148 Identities=24% Similarity=0.302 Sum_probs=126.6
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
++|++.+.||+|+||.||+++.. +..||+|.+.... ......+.+|+.++..+.| +||+.+++.+... +.+++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~--~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS-PYIVDFYGAFFIE--GAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCC-CcHHhhhhheecC--CeEEEE
Confidence 46889999999999999999876 7899999886432 2234578899999999976 9999999987765 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|||+++++|..++........+++..+..++.+++.||.|||+ ++ |+|+||||+||+++.++.++|+|||++..
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 152 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGN 152 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999999998888664222347888899999999999999996 58 99999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=287.20 Aligned_cols=146 Identities=25% Similarity=0.400 Sum_probs=128.1
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
...+|++.+.||.|+||.||+|... ++.|++|.+..........+.+|+.++..+.| +|++.+++++... ..+++
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~--~~~~l 93 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKN-PNIVNFLDSFLVG--DELFV 93 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCC-CceeeeeeeEecC--ceEEE
Confidence 3456999999999999999999854 78999999976555556678899999999976 9999999998765 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|+||+++++|..++.... +++.++..++.+++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 94 v~e~~~~~~L~~~~~~~~----l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 94 VMEYLAGGSLTDVVTETC----MDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred EEEecCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchh
Confidence 999999999999886432 678889999999999999999999 99999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=324.94 Aligned_cols=159 Identities=23% Similarity=0.373 Sum_probs=128.8
Q ss_pred hHHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 7 YSVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 7 ~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
+.+.....++|.+++.||.|+||.||+|+.. +..||+|.+..... .....+..|+.++..|.| +||+.+++++..
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~H-PNIVrl~d~f~d 83 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH-KNIVRYIDRFLN 83 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCC-CCcCeEEEEEEe
Confidence 4445566789999999999999999999876 67899999875432 234578899999999987 999999998877
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCC-----CCeeecccCCCCeEEcCC--
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLN-----PPVIHGDIKPSNILLDHN-- 154 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g-----~~IVHrDLKPeNILLd~~-- 154 (576)
.....+||||||+++++|.++|.... ....+++..++.|+.||+.||.|||..+ ..|+|+||||+||||+..
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 66678999999999999999886532 1223788899999999999999999843 239999999999999642
Q ss_pred ---------------CcEEEccccccc
Q 036407 155 ---------------FCAKISDFGLAR 166 (576)
Q Consensus 155 ---------------g~vKLiDFGlA~ 166 (576)
+.+||+|||++.
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr 190 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSK 190 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccc
Confidence 236777777664
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=279.68 Aligned_cols=148 Identities=26% Similarity=0.315 Sum_probs=123.7
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
++|++.+.||+|+||.||+++.. ++.||||.+..... .....+..|+.++.+..+|+|++++++++... ..+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEEE
Confidence 47899999999999999999875 78999999875432 33456677777766666779999999998765 679999
Q ss_pred EeccCCCCHHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHHHHhC-CCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 92 YELMSNGNLQDALLHK-KPPELMEWCKRFSIAVDIAKGIAYLHSL-NPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~-~~~~~ls~~~vl~I~~qIl~AL~yLHs~-g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|||++ ++|.+++... .....+++..++.++.||+.||.|||++ + ++|+||||+||+++.++.+||+|||++..
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~ 153 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGY 153 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99996 6888877542 2223478889999999999999999986 8 99999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=274.57 Aligned_cols=146 Identities=35% Similarity=0.592 Sum_probs=126.0
Q ss_pred CCccceeeccCcEEEEEEEECC------ceEEEEEeecCCch-hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 17 FSPSRLLGQGGFGSVFHATLHD------QSVAVKVMDSGSLQ-GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~g------~~VAVK~i~~~s~~-~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
+++.+.||.|+||.||++.... ..||+|.+...... ....+..|+.++..+.| +|++.+++++... ...+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDH-PNIVKLLGVCTEE--EPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCC-CchheEEEEEcCC--CeeE
Confidence 4578899999999999998763 78999999755433 45678899999999955 9999999998876 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++|||+++++|.+++....... +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhcc-CCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceec
Confidence 9999999999999987643211 678888999999999999999999 999999999999999999999999987654
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=294.64 Aligned_cols=153 Identities=24% Similarity=0.360 Sum_probs=129.2
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch--hHHHHHHHHHHHHHhccCCc-eEEEEEEeeCCC----
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ--GEREFYNELYFASLLEQDDH-VVSVLGFSSNPK---- 84 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~--~~~~~l~EI~iLs~L~h~pN-Iv~Llg~~~~~s---- 84 (576)
...|..+++||+|+||+||+|+.. |+.||+|.++..... ......+|+.++..|+| +| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~-~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSH-ANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCC-CcceEEEEeeeeecccccc
Confidence 445778889999999999999865 889999999865432 34567899999999999 66 999999987653
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCC-ChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPP-ELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~-~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
...++|||||++. +|..++...... ..++...++.++.||+.||+|||+++ |+||||||.||||+..|.+||+|||
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccc
Confidence 2488999999965 999999875531 23566788999999999999999999 9999999999999999999999999
Q ss_pred ccccccC
Q 036407 164 LARLKSV 170 (576)
Q Consensus 164 lA~~~~~ 170 (576)
+|+....
T Consensus 166 lAra~~i 172 (323)
T KOG0594|consen 166 LARAFSI 172 (323)
T ss_pred hHHHhcC
Confidence 9986554
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=284.34 Aligned_cols=145 Identities=27% Similarity=0.404 Sum_probs=123.8
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+.|+..+.||+|+||.||+|... +..||+|.+..... .....+.+|+.+++.+.| +||+.+++.+... ..+++|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYITRYYGSYLKG--TKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCC-CccHhhhcccccC--CceEEE
Confidence 34667789999999999999865 67899999874432 334568899999999976 9999999988765 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||+++++|.+.+... .+++..+..++.+++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06642 81 MEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred EEccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccc
Confidence 9999999999887542 2677888899999999999999999 999999999999999999999999987643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=275.81 Aligned_cols=147 Identities=20% Similarity=0.327 Sum_probs=126.2
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+|++.+.||+|+||.||.++.. ++.||+|.+.... ......+.+|+.+++.+.| +||+.+++++... +..++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH-PNIVQYQESFEEN--GNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCC-CCeeeeEeeecCC--CeEEEE
Confidence 5889999999999999999865 7889999986432 2334578899999999987 9999999988765 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||+.+++|.+.+...... .+++.+++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~ 151 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGV-LFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151 (256)
T ss_pred EecCCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence 9999999999988654321 2677888899999999999999999 999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=279.37 Aligned_cols=143 Identities=34% Similarity=0.551 Sum_probs=119.1
Q ss_pred ceeeccCcEEEEEEEECC--------ceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 21 RLLGQGGFGSVFHATLHD--------QSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~g--------~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+.||+|+||.||+|+... ..+|||.+.... ......+.+|+.+++.+.| +||+++++++... ...++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNH-PNIVKLLGVCLLN--EPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCC-CCeeeEeeeecCC--CCeEEE
Confidence 368999999999998642 578999886433 2334578899999999977 9999999998765 678999
Q ss_pred EeccCCCCHHHHHHhcC----CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC-----cEEEccc
Q 036407 92 YELMSNGNLQDALLHKK----PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF-----CAKISDF 162 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~----~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g-----~vKLiDF 162 (576)
|||+++++|.+++.... ....+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+||
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCc
Confidence 99999999999886532 1123677888899999999999999999 99999999999999877 8999999
Q ss_pred cccccc
Q 036407 163 GLARLK 168 (576)
Q Consensus 163 GlA~~~ 168 (576)
|++...
T Consensus 156 g~~~~~ 161 (269)
T cd05044 156 GLARDI 161 (269)
T ss_pred cccccc
Confidence 988644
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=279.28 Aligned_cols=139 Identities=23% Similarity=0.385 Sum_probs=114.5
Q ss_pred ceeeccCcEEEEEEEEC--------------CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 21 RLLGQGGFGSVFHATLH--------------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--------------g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
+.||+|+||.||+|+.. ...+++|.+..........+..|+.++..+.| |||+++++++... .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~h-p~iv~~~~~~~~~--~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSH-KHIVLLYGVCVRD--V 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCC-CCEeeEEEEEecC--C
Confidence 46899999999999743 23588898865444444567888888888877 9999999998766 6
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc-------EEE
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC-------AKI 159 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~-------vKL 159 (576)
..++||||+++++|..++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++. +++
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEe
Confidence 77999999999999887765432 2677888899999999999999999 999999999999987653 788
Q ss_pred ccccccc
Q 036407 160 SDFGLAR 166 (576)
Q Consensus 160 iDFGlA~ 166 (576)
+|||++.
T Consensus 154 ~d~g~~~ 160 (262)
T cd05077 154 SDPGIPI 160 (262)
T ss_pred CCCCCCc
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=290.51 Aligned_cols=154 Identities=29% Similarity=0.435 Sum_probs=131.6
Q ss_pred HHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeec--CCchhHHHHHHHHHHHHHhccCCceEEEEEEeeC--
Q 036407 9 VLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDS--GSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN-- 82 (576)
Q Consensus 9 ~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~--~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~-- 82 (576)
+...+...|..++.||.|+||.|+.+..+ |+.||||.+.. .....-++..+|+.++..++| +||+.+++.+..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~H-eNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRH-ENIIGLLDIFRPPS 94 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcC-CCcceEEeeccccc
Confidence 33456677888899999999999999876 89999999863 333445688999999999996 999999998765
Q ss_pred -CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcc
Q 036407 83 -PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISD 161 (576)
Q Consensus 83 -~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiD 161 (576)
...+.+|+|+|+| .-+|...++.... ++...+..++.|++.||.|+|+.+ |+||||||.|+|++.+..+||+|
T Consensus 95 ~~~f~DvYiV~elM-etDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 95 RDKFNDVYLVFELM-ETDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred ccccceeEEehhHH-hhHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEecc
Confidence 4567899999999 4599999887654 667778889999999999999999 99999999999999999999999
Q ss_pred cccccccc
Q 036407 162 FGLARLKS 169 (576)
Q Consensus 162 FGlA~~~~ 169 (576)
||+|+...
T Consensus 169 FGLAR~~~ 176 (359)
T KOG0660|consen 169 FGLARYLD 176 (359)
T ss_pred ccceeecc
Confidence 99998654
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=274.30 Aligned_cols=147 Identities=22% Similarity=0.386 Sum_probs=124.5
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+|++.+.||+|+||.||++... ++.+|||.+..... .....+.+|+.+++.+.| +|++.+++.+... ..+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH-PNIIEYYENFLED--KALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCC-CchhheeeeEecC--CEEEEE
Confidence 5889999999999999998864 78899999975432 234578899999999976 9999999887655 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC-CcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN-FCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~-g~vKLiDFGlA~~~ 168 (576)
|||+++++|.+++..... ..+++..+..++.+++.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++...
T Consensus 78 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred EecCCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 999999999999876432 23677888899999999999999999 9999999999999855 46799999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=285.97 Aligned_cols=146 Identities=23% Similarity=0.372 Sum_probs=125.1
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.++|.+.+.||.|+||.||+|+.. ++.||+|.+..... .....+.+|+.++..+.| +||+.+++++... ..+++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~nI~~~~~~~~~~--~~~~l 81 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIIHTE--KSLTL 81 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCC-CCcceEEEEEecC--CeEEE
Confidence 367999999999999999999875 78899999875432 223467789999999977 9999999998766 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||||+. ++|.+.+..... .+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++..
T Consensus 82 v~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 153 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARA 153 (301)
T ss_pred EEeccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence 999996 589888765432 2677888889999999999999999 99999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=276.58 Aligned_cols=145 Identities=24% Similarity=0.377 Sum_probs=124.4
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc------hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL------QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~------~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
+|+..+.||+|+||.||++... ++.||+|.+..... .....+.+|+.++..++| +|++++++++... +.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~--~~ 77 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH-PHIIRMLGATCED--SH 77 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCC-CceehhhceeccC--Ce
Confidence 4788899999999999999863 78999999964321 123568899999999977 9999999998766 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC-cEEEccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF-CAKISDFGLAR 166 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g-~vKLiDFGlA~ 166 (576)
+++|+||+++++|.+++..... +++..+..++.||+.||.|||+++ ++|+||+|+||+++.++ .++|+|||.+.
T Consensus 78 ~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 78 FNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEEEEeccCCCcHHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 9999999999999999876443 677888899999999999999999 99999999999998776 58999999876
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 153 ~~ 154 (268)
T cd06630 153 RL 154 (268)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=273.78 Aligned_cols=150 Identities=27% Similarity=0.363 Sum_probs=129.0
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
++|++.+.||.|+||.||+|... +..+++|++..... .....+.+|+.+++.+.| +|++.+++.+... ..+++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH-PNVVKYYTSFVVG--DELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCC-CCEEEEEEEEeeC--CEEEEE
Confidence 47899999999999999999864 68899999875432 244578899999999877 9999999988766 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
||++++++|.+.+........+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 999999999999876433234788888999999999999999999 9999999999999999999999999886544
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=290.79 Aligned_cols=149 Identities=23% Similarity=0.392 Sum_probs=127.2
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
..+.|++-+.||+|+|+.|+++... |+.+|+|+++... ..+.+.+.+|+++...|+| |||+.++..+... +..
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqH-P~IvrL~~ti~~~--~~~ 85 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEE--SFH 85 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCC-CcEeehhhhhccc--cee
Confidence 4578999999999999999998654 8889999987543 2356789999999999998 9999999888766 889
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC---CcEEEcccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN---FCAKISDFGLA 165 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~---g~vKLiDFGlA 165 (576)
|||+|+++|++|..-+-.+ ..+++..+-.+++||+.||+|+|.++ |||||+||+|+|+... .-+||+|||+|
T Consensus 86 ylvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EEEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999999997655443 34778888899999999999999999 9999999999999643 46899999999
Q ss_pred cccc
Q 036407 166 RLKS 169 (576)
Q Consensus 166 ~~~~ 169 (576)
....
T Consensus 161 i~l~ 164 (355)
T KOG0033|consen 161 IEVN 164 (355)
T ss_pred EEeC
Confidence 8665
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=274.00 Aligned_cols=138 Identities=27% Similarity=0.414 Sum_probs=116.1
Q ss_pred ceeeccCcEEEEEEEECCc------------eEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 21 RLLGQGGFGSVFHATLHDQ------------SVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~g~------------~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
+.||+|+||.||+|..... .+++|.+...... ...+.+|+.+++.+.| +||+.+++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h-~~i~~~~~~~~~---~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSH-KHLVKLYGVCVR---DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCC-cchhheeeEEec---CCc
Confidence 4799999999999987632 3778877644332 5678899999999976 999999998876 456
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC-------cEEEcc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF-------CAKISD 161 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g-------~vKLiD 161 (576)
++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++ .++|+|
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCC
Confidence 999999999999998876542 2677788899999999999999999 99999999999999887 799999
Q ss_pred cccccc
Q 036407 162 FGLARL 167 (576)
Q Consensus 162 FGlA~~ 167 (576)
||++..
T Consensus 152 fg~a~~ 157 (259)
T cd05037 152 PGIPIT 157 (259)
T ss_pred CCcccc
Confidence 998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=280.29 Aligned_cols=150 Identities=27% Similarity=0.328 Sum_probs=128.0
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
++|+..+.||.|++|.||++... ++.+|+|.+..... .....+.+|+.+++.+.| +||+.+++++.......+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKS-PYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCC-CCeeeeeeEEEccCCCeEEEE
Confidence 47889999999999999999975 68899999875433 345678999999999976 999999999877666789999
Q ss_pred EeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 92 YELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|||+++++|.+++.... ....++...+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeecccccc
Confidence 99999999998775421 2223677788899999999999999999 99999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=322.46 Aligned_cols=149 Identities=28% Similarity=0.336 Sum_probs=126.7
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++.++||+|+||.||+|... ++.||||++..... ....++.+|+.++..+.| |||+.+++++... +..+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~H-PNIVkl~~v~~d~--~~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH-PGIVPVYSICSDG--DPVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCC-cCcCeEEEEEeeC--CEEE
Confidence 68999999999999999999875 78999999965322 224578899999999987 9999999998766 7899
Q ss_pred EEEeccCCCCHHHHHHhcCC--------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcc
Q 036407 90 LVYELMSNGNLQDALLHKKP--------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISD 161 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~--------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiD 161 (576)
+||||++|++|.+++..... ....+...++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEe
Confidence 99999999999998864211 112345667889999999999999999 99999999999999999999999
Q ss_pred ccccccc
Q 036407 162 FGLARLK 168 (576)
Q Consensus 162 FGlA~~~ 168 (576)
||+++..
T Consensus 157 FGLAk~i 163 (932)
T PRK13184 157 WGAAIFK 163 (932)
T ss_pred cCcceec
Confidence 9998765
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=277.44 Aligned_cols=146 Identities=23% Similarity=0.349 Sum_probs=125.3
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
++|++.+.||+|++|.||+|+.. ++.||+|.+..... .....+.+|+.++..+.| +|++.+++++... ..+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~--~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH-PNLVNLIEVFRRK--RKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCC-CCEeeeeeEEeeC--CEEEE
Confidence 57899999999999999999875 78999999864321 223467899999999987 9999999998766 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||||++++.|..++..... +++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 78 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARIL 150 (286)
T ss_pred EEeccCccHHHHHHhCCCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceec
Confidence 9999998888776654332 678889999999999999999999 999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=303.07 Aligned_cols=141 Identities=24% Similarity=0.258 Sum_probs=121.8
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
..+|.+.+.||+|+||.||++... ++.||||.... ..+.+|+.++..|.| +||+.+++++... ...++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~H-pnIv~l~~~~~~~--~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSH-PAVLALLDVRVVG--GLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCC-CCCCcEEEEEEEC--CEEEEE
Confidence 347999999999999999999876 67899996432 235789999999987 9999999998766 788999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||++ .++|.+++..... .+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++..
T Consensus 239 ~e~~-~~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 239 LPKY-RSDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFA 310 (461)
T ss_pred EEcc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceec
Confidence 9999 4688888765432 3788899999999999999999999 999999999999999999999999998643
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=281.66 Aligned_cols=138 Identities=25% Similarity=0.395 Sum_probs=113.7
Q ss_pred ceeeccCcEEEEEEEEC---------CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 21 RLLGQGGFGSVFHATLH---------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~---------g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+.||+|+||.||+|... ...+++|.+........+.+..|+.++..+.| +|++.+++++... ...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h-~~iv~~~~~~~~~--~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSH-KHLVLNYGVCVCG--DESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCC-CChhheeeEEEeC--CCcEEE
Confidence 46999999999999753 23488888865444445678888889988876 9999999998876 678999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc--------EEEcccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC--------AKISDFG 163 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~--------vKLiDFG 163 (576)
|||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++. ++++|||
T Consensus 78 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999999999876443 2677888889999999999999999 999999999999987765 4666666
Q ss_pred cc
Q 036407 164 LA 165 (576)
Q Consensus 164 lA 165 (576)
++
T Consensus 154 ~~ 155 (258)
T cd05078 154 IS 155 (258)
T ss_pred cc
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=282.82 Aligned_cols=138 Identities=25% Similarity=0.383 Sum_probs=112.7
Q ss_pred eeeccCcEEEEEEEEC--------------------------CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEE
Q 036407 22 LLGQGGFGSVFHATLH--------------------------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVS 75 (576)
Q Consensus 22 ~LG~GsfG~Vyka~~~--------------------------g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~ 75 (576)
.||+|+||.||+|... ...|++|++..........+..|+.+++.+.| +||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h-~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSH-IHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCC-CCeee
Confidence 6999999999998741 13488898865443334567888888888877 99999
Q ss_pred EEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC
Q 036407 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF 155 (576)
Q Consensus 76 Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g 155 (576)
+++++... ...++||||+++++|..++..... .+++..+..++.||+.||.|||+++ |+|+||||+|||++..+
T Consensus 81 ~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRG--SENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeC--CceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccC
Confidence 99999876 678999999999999988865332 2677788899999999999999999 99999999999997643
Q ss_pred -------cEEEccccccc
Q 036407 156 -------CAKISDFGLAR 166 (576)
Q Consensus 156 -------~vKLiDFGlA~ 166 (576)
.++++|||++.
T Consensus 155 ~~~~~~~~~kl~d~g~~~ 172 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSF 172 (274)
T ss_pred cccCccceeeecCCcccc
Confidence 37888888753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=287.19 Aligned_cols=142 Identities=18% Similarity=0.205 Sum_probs=120.0
Q ss_pred ccceeecc--CcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 19 PSRLLGQG--GFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 19 i~e~LG~G--sfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
++++||+| +|+.||++... ++.||||.+..... .....+..|+.+++.+.| +||+++++++... +.+++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~--~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNH-PNIVPYRATFIAD--NELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEEC--CEEEEEE
Confidence 56889999 78899999865 78999999975432 223457788888888876 9999999999876 7899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
||+++++|.+++...... .+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.++++||+...
T Consensus 79 e~~~~~~l~~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 79 SFMAYGSAKDLICTHFMD-GMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred eccCCCcHHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhh
Confidence 999999999988654322 2678888999999999999999999 9999999999999999999999998543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=282.26 Aligned_cols=145 Identities=22% Similarity=0.400 Sum_probs=125.9
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++.+.||+|+||.||++... ++.|++|.+..... .....+..|+.++..+.| +||+.+++.+... ..++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~--~~~~ 77 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN-PFVVSMFCSFETK--RHLC 77 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC-CCeeeeEEEEecC--CEEE
Confidence 47899999999999999999876 68899999875432 223467789999998876 9999999888765 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+||||+++++|.+++..... +++..+..++.+++.||.|||+++ ++|+||||+||+++.++.++|+|||+++.
T Consensus 78 lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 78 MVMEYVEGGDCATLLKNIGA---LPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred EEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 99999999999999876543 677888889999999999999999 99999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=282.05 Aligned_cols=149 Identities=25% Similarity=0.369 Sum_probs=124.9
Q ss_pred CCCccceeeccCcEEEEEEEE----CCceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 16 SFSPSRLLGQGGFGSVFHATL----HDQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~----~g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
+|++.+.||+|+||.||+|.. .++.||+|.+.... ......+.+|+.++..+.| +||+.+++++.......+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH-ENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCC-CCccceEEEEeCCCCceE
Confidence 488899999999999999987 46899999997632 2233567889999999987 999999999987766789
Q ss_pred EEEEeccCCCCHHHHHHhcCC--CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC----CCcEEEccc
Q 036407 89 LLVYELMSNGNLQDALLHKKP--PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH----NFCAKISDF 162 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~--~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~----~g~vKLiDF 162 (576)
++||||+++ +|.+.+..... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++. ++.+||+||
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 999999964 77776654221 124778888999999999999999999 999999999999999 899999999
Q ss_pred cccccc
Q 036407 163 GLARLK 168 (576)
Q Consensus 163 GlA~~~ 168 (576)
|++...
T Consensus 157 g~~~~~ 162 (316)
T cd07842 157 GLARLF 162 (316)
T ss_pred cccccc
Confidence 988754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=307.10 Aligned_cols=145 Identities=33% Similarity=0.456 Sum_probs=123.9
Q ss_pred CCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 17 FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
|..++.||+|+||.||-++.. .+.||||.+.-... ..-+.++.|++.|..|.| ||++.+.|.|.-. ...|||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~H-PntieYkgCyLre--~TaWLV 104 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRH-PNTIEYKGCYLRE--HTAWLV 104 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccC-CCcccccceeecc--chHHHH
Confidence 567789999999999999865 68899999964322 223579999999999999 9999999988766 667999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|||| -|+..+++.-...+ +.+..+..|+.+.+.||+|||+.+ .||||||..|||+.+.|.|||+|||.|....
T Consensus 105 MEYC-lGSAsDlleVhkKp--lqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 105 MEYC-LGSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHHH-hccHHHHHHHHhcc--chHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcC
Confidence 9999 45888888664432 778888889999999999999999 9999999999999999999999999887543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=325.08 Aligned_cols=266 Identities=23% Similarity=0.426 Sum_probs=207.8
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
.....|...+.||+|+||.||+|+.. +..||||.+...... ...|+.++.++.| |||+++++++... ...|
T Consensus 687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~H-pnIv~~~~~~~~~--~~~~ 759 (968)
T PLN00113 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQH-PNIVKLIGLCRSE--KGAY 759 (968)
T ss_pred HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCC-CCcceEEEEEEcC--CCCE
Confidence 33456788899999999999999864 789999998643221 2345778888866 9999999999876 6789
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhC-CCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL-NPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~-g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||||+++|+|.+++.. +++..+..|+.||+.||+|||.. .++|+||||||+||+++.++.+++. ||.+...
T Consensus 760 lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred EEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 99999999999999863 67788889999999999999943 2339999999999999988877764 4432211
Q ss_pred cCCCCCcCcCCCCccccchhhhccCCCCCCCCcceecccccccccccccccccccccCcchhHhhhhcccchhHHHHhhh
Q 036407 169 SVGENQNQADGENKNKAAELESNCGAAVEDCGSVVETESVNTTTTATAFEDLSVGIDQSPETFLKMTQKQTQSTEALEKK 248 (576)
Q Consensus 169 ~~~~~~~~~~gt~~y~APEl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (576)
..
T Consensus 833 ~~------------------------------------------------------------------------------ 834 (968)
T PLN00113 833 CT------------------------------------------------------------------------------ 834 (968)
T ss_pred cc------------------------------------------------------------------------------
Confidence 00
Q ss_pred cccccccchhhhhHHHHHHHHhhhcCCCCCCCCcccCCCCCcccccccccccccccccccccccchhHHHHHHhhhhhhc
Q 036407 249 ASVDENVKEDVKVKEYVIEWIGTAIGNERPKSDWIGRDTGSSSSVGGKVDRKKSRKRLDWWVSLDEDKEENVKNLKRERR 328 (576)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (576)
T Consensus 835 -------------------------------------------------------------------------------- 834 (968)
T PLN00113 835 -------------------------------------------------------------------------------- 834 (968)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccccchhhhHHHHHHHHHHHhhhhccCCCCCCCCCCCChhhHHHHhccccccccccCCCCCcccccccccchhhhhhcc
Q 036407 329 RRPAREWWKEEYCEELAKKKKKKKRALGTNSDDDWWPRDEELYVERKKKSKTRSRSRSSIGSLDWWLEGFSGELYRARHN 408 (576)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (576)
T Consensus 835 -------------------------------------------------------------------------------- 834 (968)
T PLN00113 835 -------------------------------------------------------------------------------- 834 (968)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCccccCCCCCCCcceeeccccCccccccccccCCCCcccccceeehhHHHHHHHhCCCCccccCCCchhhhhhhHHHH
Q 036407 409 SYDSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSW 488 (576)
Q Consensus 409 ~~d~~~~~~i~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~G~~l~eli~g~~pf~~~~~~~~~~~~~~~~~~ 488 (576)
.....||+.|||||++.+..++.++|||||||++|||++|+.||+.... ....+..|
T Consensus 835 ------------------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-----~~~~~~~~ 891 (968)
T PLN00113 835 ------------------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-----VHGSIVEW 891 (968)
T ss_pred ------------------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-----CCCcHHHH
Confidence 0112578999999999999999999999999999999999999964331 23456677
Q ss_pred HHHhccccchhhhhhhHHhh--hcCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhccccCCCCC
Q 036407 489 ARHLARNGKLIELVDQAVVK--SLDREQALLCITVALLCLQKSPALRPSMEEVVGMLTGKLEAPKL 552 (576)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~cl~~dP~~Rps~~~v~~~l~~~~e~~~~ 552 (576)
++...........+++.+.. ..+..+...+.+++.+||+.||.+||+|+||+++|++....++.
T Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~ 957 (968)
T PLN00113 892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957 (968)
T ss_pred HHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccc
Confidence 77665555555556655432 33456777899999999999999999999999999988765543
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=280.97 Aligned_cols=145 Identities=26% Similarity=0.396 Sum_probs=122.8
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch--hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ--GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~--~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+|++.+.||+|+||.||+|+.. ++.||+|.+...... ....+.+|+.++..+.| +|++++++++... ..+++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~~~~~~~~~--~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLYDVLHSD--KKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCC-CCeeeHHHHhccC--CceEEE
Confidence 4888999999999999999875 789999998653221 23457789999999977 9999999988765 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||+. ++|.+.+..... .+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++...
T Consensus 78 ~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 149 (284)
T cd07839 78 FEYCD-QDLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAF 149 (284)
T ss_pred EecCC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence 99996 588877765332 2788889999999999999999999 999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=274.55 Aligned_cols=142 Identities=27% Similarity=0.374 Sum_probs=117.4
Q ss_pred ceeeccCcEEEEEEEEC----CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLH----DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~----g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+.||+|+||.||+|... +..+|+|.+..... .....+.+|+.++..+.| +||+++++.+... ..+++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQH-SNLLQCLGQCTEV--TPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCC-CCEeeEEEEEcCC--CCcEEEEECC
Confidence 36899999999999754 35689998865432 333468889999999977 9999999988766 6789999999
Q ss_pred CCCCHHHHHHhcCC--CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 96 SNGNLQDALLHKKP--PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 96 ~gGsL~d~L~~~~~--~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++|+|.+++..... ....++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~ 149 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHN 149 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCcccccc
Confidence 99999998865321 112455667788999999999999999 99999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=272.45 Aligned_cols=145 Identities=29% Similarity=0.425 Sum_probs=125.2
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-----hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-----QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-----~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
+|+..+.||+|++|.||+|... ++.|++|.+..... .....+.+|+.++..+.| +|++++++++... ..+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~--~~~ 77 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQYLGTEREE--DNL 77 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCC-CCchheeeeEecC--CeE
Confidence 4778899999999999999875 78999999865331 234568899999999976 9999999988766 789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++++||+++++|.+++..... +++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGS---FPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceec
Confidence 999999999999998876442 677788889999999999999999 999999999999999999999999987643
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=272.04 Aligned_cols=146 Identities=29% Similarity=0.406 Sum_probs=129.2
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
++|++.+.||.|++|.||+|... ++.|+||.+..... .....+.+|+..+..+.| +|++.+++++... ..+++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCES-PYVVKCYGAFYKE--GEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCeeeEEEEEccC--CeEEEE
Confidence 46889999999999999999876 78999999976543 345678999999999986 9999999998776 889999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||+++++|.+++..... ++...++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~ 150 (264)
T cd06623 78 LEYMDGGSLADLLKKVGK---IPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL 150 (264)
T ss_pred EEecCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceec
Confidence 999999999999876532 7788889999999999999999 99 999999999999999999999999987644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=278.06 Aligned_cols=151 Identities=24% Similarity=0.341 Sum_probs=125.0
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC---CCe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPK---RHR 87 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s---~~~ 87 (576)
++|++.+.||+|+||.||+|... ++.||||.+..... .....+.+|+.++..+.+|+||+++++++.... ...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47899999999999999999875 78999999865322 123567889999999988899999998876542 134
Q ss_pred EEEEEeccCCCCHHHHHHhcCC--CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC-CCcEEEccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKP--PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH-NFCAKISDFGL 164 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~--~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~-~g~vKLiDFGl 164 (576)
.|+||||+++ +|.+++..... ...+++..++.++.||+.||.|||.++ |+|+||+|+||+++. ++.++|+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence 7999999975 88887765322 234688899999999999999999999 999999999999998 88999999998
Q ss_pred cccc
Q 036407 165 ARLK 168 (576)
Q Consensus 165 A~~~ 168 (576)
+...
T Consensus 158 ~~~~ 161 (295)
T cd07837 158 GRAF 161 (295)
T ss_pred ceec
Confidence 7643
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=285.48 Aligned_cols=147 Identities=29% Similarity=0.442 Sum_probs=123.2
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecC--CchhHHHHHHHHHHHHHhccCCceEEEEEEeeCC----
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSG--SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNP---- 83 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~--s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~---- 83 (576)
.+.++|++.+.||+|+||.||+|... ++.||||.+... .......+.+|+.++..+.| +||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNH-KNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCC-CCCcceeeeeccCCCcc
Confidence 46789999999999999999999864 789999998642 22333567789999999977 9999999987643
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
....+|+||||+. ++|.+.+... ++...+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCc
Confidence 2246899999995 5888777542 566778889999999999999999 9999999999999999999999999
Q ss_pred cccc
Q 036407 164 LARL 167 (576)
Q Consensus 164 lA~~ 167 (576)
+++.
T Consensus 164 ~~~~ 167 (353)
T cd07850 164 LART 167 (353)
T ss_pred ccee
Confidence 8864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=305.17 Aligned_cols=153 Identities=21% Similarity=0.245 Sum_probs=126.7
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
|++....|+++++||+|+.+.||++... .+.||+|.+.... .....-+.+|+..|.+|+.+.+|+++++|-..+ +
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d--~ 433 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD--G 433 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC--c
Confidence 3455567999999999999999999876 5778888775322 233356899999999999999999999998876 8
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+|||||+=+ .+|...|...... .+--.++.|+.|++.|+.++|++| |||.||||.|+|+ -.|.+||+|||+|.
T Consensus 434 ~lYmvmE~Gd-~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLl-VkG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 434 YLYMVMECGD-IDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLL-VKGRLKLIDFGIAN 507 (677)
T ss_pred eEEEEeeccc-ccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEE-EeeeEEeeeechhc
Confidence 9999999874 4999999876543 222267789999999999999999 9999999999998 56889999999998
Q ss_pred cccC
Q 036407 167 LKSV 170 (576)
Q Consensus 167 ~~~~ 170 (576)
.+..
T Consensus 508 aI~~ 511 (677)
T KOG0596|consen 508 AIQP 511 (677)
T ss_pred ccCc
Confidence 7654
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=275.56 Aligned_cols=147 Identities=24% Similarity=0.378 Sum_probs=123.3
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch-hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ-GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~-~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++++|.+.+.||+|+||.||+|... ++.||+|.+...... ....+.+|+.++..+.| +||+.+++++... ...|
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~--~~~~ 79 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH-ANIVLLHDIIHTK--ETLT 79 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCC-CCEeEEEEEEecC--CeEE
Confidence 4678999999999999999999864 789999998654322 23467789999999977 9999999998765 7889
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+||||+. ++|.+.+..... .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||+++.
T Consensus 80 lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 152 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARA 152 (291)
T ss_pred EEEeccc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccc
Confidence 9999995 677776654322 2566677789999999999999999 99999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=300.10 Aligned_cols=153 Identities=29% Similarity=0.422 Sum_probs=131.1
Q ss_pred hcCCCCccceeeccCcEEEEEEEE--CCceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATL--HDQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~--~g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
..+.|+..+.||+|+||.||-++. +|+.||+|.+.+... ..+...++|-.++.++.. +.||.+-..+... ..
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s-~FiVslaYAfeTk--d~ 259 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSS-PFIVSLAYAFETK--DA 259 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhcc-CcEEEEeeeecCC--Cc
Confidence 446788999999999999998764 489999999865332 345567899999999988 8888886665555 89
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+|+||..|+||+|.-+|...+.+. +++..+..|+.+|+.||.+||..+ ||+||+||+|||||+.|.++|+|+|+|..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~g-F~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPG-FDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCC-CchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEe
Confidence 999999999999998888766543 889999999999999999999999 99999999999999999999999999987
Q ss_pred ccCC
Q 036407 168 KSVG 171 (576)
Q Consensus 168 ~~~~ 171 (576)
++.+
T Consensus 337 i~~g 340 (591)
T KOG0986|consen 337 IPEG 340 (591)
T ss_pred cCCC
Confidence 7654
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=279.21 Aligned_cols=146 Identities=27% Similarity=0.429 Sum_probs=124.8
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
++|++.+.||+|+||.||+|... ++.||+|.+..... .....+.+|+.++..+.| +||+++++++... ..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRH-ENLVNLIEVFRRK--KRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCC-cchhhHHHhcccC--CeEEE
Confidence 47889999999999999999975 78999998864322 224567889999999976 9999999998765 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||||+++++|..+...... +++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 78 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTL 150 (286)
T ss_pred EEecCCccHHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence 9999999888876654332 678889999999999999999999 999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=273.62 Aligned_cols=145 Identities=28% Similarity=0.401 Sum_probs=126.5
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+|++.+.||+|+||.||+|... ++.||||.+..... .....+.+|+.+++.+.| +|++.+++++... ..+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~--~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQH-PYVVKLLDVFPHG--SGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCC-CCCcceeeEEecC--CeeEEE
Confidence 5888999999999999999875 78999999975442 234578899999999985 9999999998775 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||+ +++|.+++..... .+++.+++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~e~~-~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~ 149 (286)
T cd07832 78 MEYM-PSDLSEVLRDEER--PLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLF 149 (286)
T ss_pred eccc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence 9999 9999998865432 3788889999999999999999999 999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=283.01 Aligned_cols=151 Identities=30% Similarity=0.484 Sum_probs=127.2
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecC--CchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSG--SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~--s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.+.++|.+.+.||+|+||.||+|... ++.+|||.+... .......+.+|+.++..+.+|+||+++++++.......
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 45678999999999999999999874 788999988542 22333467789999999955599999999987665568
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+|+||||+. ++|...+... .+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 899999996 5898877653 2677788889999999999999999 99999999999999999999999998875
Q ss_pred cc
Q 036407 168 KS 169 (576)
Q Consensus 168 ~~ 169 (576)
..
T Consensus 157 ~~ 158 (337)
T cd07852 157 LS 158 (337)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=270.97 Aligned_cols=146 Identities=29% Similarity=0.465 Sum_probs=127.5
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch--hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ--GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~--~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+|.+.+.||+|+||.||+|... ++.|++|.+...... ....+..|+.++..+.| +||+.+++.+... ..+++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~--~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-PNLVKYYGVEVHR--EKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCC-CChhheeeeEecC--CEEEEE
Confidence 5888999999999999999864 789999999765442 45678999999999977 9999999987765 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
+||+++++|.+++..... +++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 78 ~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~ 150 (264)
T cd06626 78 MEYCSGGTLEELLEHGRI---LDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLK 150 (264)
T ss_pred EecCCCCcHHHHHhhcCC---CChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccC
Confidence 999999999998876432 567778889999999999999999 9999999999999999999999999887544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=304.00 Aligned_cols=156 Identities=33% Similarity=0.483 Sum_probs=135.2
Q ss_pred CChHHHHhhcCCCCccceeeccCcEEEEEEEEC--C---ce-EEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEE
Q 036407 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATLH--D---QS-VAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVS 75 (576)
Q Consensus 5 fs~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g---~~-VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~ 75 (576)
...+.+....++-.+.++||+|+||.||+|++. + .. ||||...... .....++++|.++|..+.| +||++
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H-~NVVr 225 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNH-PNVVR 225 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCC-CCEEE
Confidence 445566677788888899999999999999875 1 23 8999987522 3445689999999999988 99999
Q ss_pred EEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC
Q 036407 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF 155 (576)
Q Consensus 76 Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g 155 (576)
++|++... ..++||||+|.||+|.++|..... .++..+...++.+.+.||+|||+++ ++||||-.+|+|++.++
T Consensus 226 ~yGVa~~~--~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~ 299 (474)
T KOG0194|consen 226 FYGVAVLE--EPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKG 299 (474)
T ss_pred EEEEEcCC--CccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCC
Confidence 99999988 789999999999999999987654 3778888999999999999999999 99999999999999999
Q ss_pred cEEEcccccccc
Q 036407 156 CAKISDFGLARL 167 (576)
Q Consensus 156 ~vKLiDFGlA~~ 167 (576)
.+||+|||+++.
T Consensus 300 ~vKISDFGLs~~ 311 (474)
T KOG0194|consen 300 VVKISDFGLSRA 311 (474)
T ss_pred eEEeCccccccC
Confidence 999999999764
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=275.77 Aligned_cols=142 Identities=27% Similarity=0.398 Sum_probs=116.9
Q ss_pred ceeeccCcEEEEEEEEC----CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLH----DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~----g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+.||+|+||.||+|... ...+|+|.+..... .....+.+|+..+..+.| +||+++++.+... ..+++||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h-~nii~~~~~~~~~--~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNH-PNVLQCLGQCIES--IPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCC-CCcceEEEEECCC--CceEEEEEeC
Confidence 36899999999999643 35688888754332 233567889999988876 9999999998766 7789999999
Q ss_pred CCCCHHHHHHhcCC--CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 96 SNGNLQDALLHKKP--PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 96 ~gGsL~d~L~~~~~--~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++|+|.+++..... ....++..+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++..
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 149 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALE 149 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccc
Confidence 99999999876432 122456677889999999999999999 99999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=273.84 Aligned_cols=146 Identities=27% Similarity=0.338 Sum_probs=127.2
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
++|++.+.||.|+||.||++... ++.+|+|.+..... .....+.+|+.+++.+.| +||+.+++.+... ..++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~--~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNS-PYIVGFYGAFYNN--GDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCC-CchhhhheeeecC--CEEEEE
Confidence 46888999999999999999886 78899999876532 344578899999999985 9999999988776 889999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+||+.+++|.+++.... ..+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+..
T Consensus 78 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~ 150 (265)
T cd06605 78 MEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQ 150 (265)
T ss_pred EEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchh
Confidence 99999999999887643 236778888899999999999999 88 99999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=277.33 Aligned_cols=146 Identities=23% Similarity=0.363 Sum_probs=124.9
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch-hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ-GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~-~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.++|++.+.||+|++|.||+|... ++.||||.+...... ....+.+|+.+++.+.| +||+.+++++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~--~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKH-ANIVTLHDIIHTK--KTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCC-cceeeEEEEEecC--CeEEE
Confidence 478999999999999999999875 789999998653321 22356789999999976 9999999998765 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||||+. ++|.+++..... .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++..
T Consensus 81 v~e~~~-~~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 152 (291)
T cd07844 81 VFEYLD-TDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARA 152 (291)
T ss_pred EEecCC-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccc
Confidence 999997 499888865433 3677888889999999999999999 99999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=274.54 Aligned_cols=146 Identities=23% Similarity=0.390 Sum_probs=125.5
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhc--cCCceEEEEEEeeCCCCCeEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLE--QDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~--h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.|++.+.||.|+||.||+|... ++.||+|.+..... .....+.+|+.+++.+. .|+|++.+++++... ..+|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG--PRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--CEEEE
Confidence 4788899999999999999864 78999999875432 33456788999999997 359999999988765 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
||||+++++|.+++... .+++..++.++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999999887653 2678888899999999999999999 9999999999999999999999999876543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=276.49 Aligned_cols=145 Identities=26% Similarity=0.425 Sum_probs=125.6
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch-----hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ-----GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~-----~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
+|.+.+.||.|+||.||+|... ++.||||.+...... ....+..|+.++..+.| +||+++++++... ..+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~--~~~ 77 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH-PNIIGLLDVFGHK--SNI 77 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCC-CCChhhhheeecC--CEE
Confidence 4788899999999999999875 789999999754432 23456789999999986 9999999998875 789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 78 NLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred EEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999999 889999887644 13788889999999999999999999 999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=276.44 Aligned_cols=149 Identities=23% Similarity=0.339 Sum_probs=127.0
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchh--HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG--EREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~--~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
.++|++.+.||+|+||.||+|... ++.+|+|.+....... ...+.+|+.++..+.| +||+.+++++.......+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQH-PNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCC-CCEEEEEEEEEecCCCcEE
Confidence 357999999999999999999976 7889999997543221 2356789999999986 9999999998776668899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||||+. ++|.+++..... .+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 83 lv~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred EEehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 9999996 599888865432 3778888999999999999999999 999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=271.72 Aligned_cols=146 Identities=25% Similarity=0.325 Sum_probs=122.1
Q ss_pred CCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEe
Q 036407 17 FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE 93 (576)
|++.+.||+|+||.||+|... ++.||+|.+..... .......+|+.++.++..|+|++++++++.....+.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678899999999999999874 78899999865322 222345678888888886799999999988765578999999
Q ss_pred ccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 94 LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 94 ~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|+. ++|.+.+..... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++...
T Consensus 81 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~ 149 (282)
T cd07831 81 LMD-MNLYELIKGRKR--PLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGI 149 (282)
T ss_pred cCC-ccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEeccccccc
Confidence 996 588877765332 3788889999999999999999999 999999999999999 99999999987643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=284.35 Aligned_cols=144 Identities=28% Similarity=0.418 Sum_probs=124.3
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
+.|.....||+|+||.||++... +..||||.+..........+.+|+..+..+.| +|++.+++.+... +..++||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~ii~~~~~~~~~--~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHH-ENVVDMYNSYLVG--DELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCC-CcHHHHHHheecC--CeEEEEE
Confidence 44556678999999999999864 78999999876555555678899999999876 9999999888766 7899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||+++++|.+++.... +++..+..++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++..
T Consensus 99 e~~~~~~L~~~~~~~~----l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (292)
T cd06658 99 EFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167 (292)
T ss_pred eCCCCCcHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence 9999999998875422 667788899999999999999999 99999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=278.17 Aligned_cols=145 Identities=27% Similarity=0.424 Sum_probs=126.8
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|.+.+.||+|+||.||++... ++.||+|.+..... .....+.+|+.++..+.| +||+.+++++... ..++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH-PFLVNLYGSFQDD--SNLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCccceeeEEEcC--CeEE
Confidence 47899999999999999999875 78999999864322 234568899999999985 9999999998776 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+||||+++++|.+.+..... ++...+..++.||+.||.|||+.+ ++|+||+|.|||++.++.++|+|||++..
T Consensus 78 ~v~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~ 150 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSGR---FPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKR 150 (290)
T ss_pred EEEecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence 99999999999998876543 678888889999999999999999 99999999999999999999999998754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=273.75 Aligned_cols=144 Identities=26% Similarity=0.408 Sum_probs=123.1
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch----------hHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ----------GEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~----------~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
+|.+.+.||.|+||.||+|... ++.+|+|.+...... ..+.+..|+.++..+.| +|++.+++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH-LNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCC-CCcceEEEEeccC
Confidence 5778899999999999999764 788999988642111 12356789999999976 9999999998766
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
..+++||||+++++|.+.+..... +++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 81 --~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 81 --EYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred --CceEEEEecCCCCcHHHHHhhccC---CCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeecc
Confidence 788999999999999998876532 677788889999999999999999 9999999999999999999999999
Q ss_pred cccc
Q 036407 164 LARL 167 (576)
Q Consensus 164 lA~~ 167 (576)
++..
T Consensus 154 ~~~~ 157 (272)
T cd06629 154 ISKK 157 (272)
T ss_pred cccc
Confidence 8754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=282.29 Aligned_cols=148 Identities=28% Similarity=0.442 Sum_probs=123.5
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCC---CCC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNP---KRH 86 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~---s~~ 86 (576)
+.++|++.+.||+|+||.||+|+.. ++.||||.+.... ......+.+|+.++..+.| +||+.+++++... ...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKH-ENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCC-CCcCchhheeecccccccc
Confidence 4578999999999999999999864 7899999986422 2234567889999999986 9999998876543 225
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+++|+||+. ++|...+.... +++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~----l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 82 DVYIVQELME-TDLYKLIKTQH----LSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred eEEEEehhcc-cCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECccccee
Confidence 6899999995 58887775432 677888899999999999999999 9999999999999999999999999876
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 155 ~~ 156 (336)
T cd07849 155 IA 156 (336)
T ss_pred ec
Confidence 44
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=272.66 Aligned_cols=146 Identities=25% Similarity=0.414 Sum_probs=125.6
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
+|++.+.||.|++|.||+|+.. +..||||.+..... .....+.+|+.++..+.| +|++.+++++... +.+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~--~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH-ENIVRLHDVIHTE--NKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcC-CCEeeeeeeEeeC--CcEEEEE
Confidence 5889999999999999999975 78899999975432 224567789999999976 9999999998876 7889999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||+++ +|.+++........+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~ 149 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARA 149 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhh
Confidence 99974 88888866443334788889999999999999999999 99999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=276.46 Aligned_cols=146 Identities=25% Similarity=0.399 Sum_probs=124.3
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+|++.+.||.|++|.||+|+.. ++.||||.+..... .....+.+|+.++..+.| +||+++++++... ..+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~--~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-PNIVKLLDVIHTE--NKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCC-CCCcchhhhcccC--CcEEEE
Confidence 5889999999999999999875 78999999864332 223568899999999977 9999999998765 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||+. ++|..++..... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~e~~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~ 150 (284)
T cd07860 78 FEFLH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF 150 (284)
T ss_pred eeccc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence 99995 688888765432 23678889999999999999999999 999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=273.39 Aligned_cols=149 Identities=31% Similarity=0.505 Sum_probs=121.1
Q ss_pred CCccceeeccCcEEEEEEEEC-----CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC----
Q 036407 17 FSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR---- 85 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~---- 85 (576)
|.+.+.||+|+||.||+|... +..+|||++.... ......+.+|+.++..+.| +|++++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH-PNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCC-CCcceEEEEEccCCCCCcc
Confidence 667889999999999999753 5789999986432 2234568899999999976 999999998765321
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC---CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKK---PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDF 162 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~---~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDF 162 (576)
...+++++|+.+++|.+++.... ....++...++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+||
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECcc
Confidence 23478899999999988774321 1123677788999999999999999999 999999999999999999999999
Q ss_pred cccccc
Q 036407 163 GLARLK 168 (576)
Q Consensus 163 GlA~~~ 168 (576)
|+++..
T Consensus 158 g~~~~~ 163 (273)
T cd05074 158 GLSKKI 163 (273)
T ss_pred cccccc
Confidence 988643
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=276.73 Aligned_cols=147 Identities=25% Similarity=0.352 Sum_probs=124.2
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
++|++.+.||+|+||.||+|... ++.||||.+.... ......+.+|+.+++.+.| +||+.+++++... ..+++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRH-ENIVNLKEAFRRK--GRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCC-CCeeehhheEEEC--CEEEE
Confidence 47899999999999999999875 6889999986432 2234578899999999986 9999999998775 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
||||++++.+..+...... ++...+..++.+|+.||.|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 78 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 78 VFEYVERTLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALR 151 (288)
T ss_pred EEecCCCCHHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence 9999987666554443322 678888899999999999999999 9999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=279.01 Aligned_cols=148 Identities=26% Similarity=0.365 Sum_probs=128.2
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
...++|.+.+.||+|+||.||++... ++.||+|.+..........+.+|+.++..+.| +|++.+++.+... ...+
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~--~~~~ 92 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKH-PNIVNYLDSYLVG--DELW 92 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCC-CCeeehhheeeeC--CcEE
Confidence 34578999999999999999999753 78899999875544555678899999999976 9999999988766 7889
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+|+||+++++|.+++.... +++..+..++.+++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~~~~----l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 93 VVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (293)
T ss_pred EEEecCCCCcHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence 9999999999999886532 567778889999999999999999 999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=273.84 Aligned_cols=144 Identities=28% Similarity=0.416 Sum_probs=123.6
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
-|++.+.||.|+||.||+|... ++.||||.+..... .....+.+|+..+..+.| +||+.+++++... ..+++||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~--~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKD--TKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCEeEEEEEEEeC--CeEEEEE
Confidence 4678899999999999999864 68899999864332 233567889999999977 9999999998766 7899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||+++++|.+++... .+++..+..++.+++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 82 e~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 82 EYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQL 151 (277)
T ss_pred EeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceec
Confidence 999999999887642 2677888899999999999999999 999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=270.42 Aligned_cols=148 Identities=26% Similarity=0.405 Sum_probs=126.8
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-----chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-----LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-----~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.+|++.+.||+|+||.||+|... +..||+|.+.... ......+.+|+.++..+.| +||+.+++++.......
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH-DRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCC-CCcceEEEEEEcCCCCE
Confidence 47899999999999999999864 7899999885321 1223467889999999976 99999999887765678
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++++||+++++|.+.+..... +++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGA---LTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999998876443 567778889999999999999999 99999999999999999999999998864
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 156 ~ 156 (264)
T cd06653 156 I 156 (264)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=275.52 Aligned_cols=138 Identities=30% Similarity=0.447 Sum_probs=112.8
Q ss_pred eeeccCcEEEEEEEEC--CceEEEEEeecCCch---hHHHHHHHHHHHHHh--ccCCceEEEEEEeeCCCCCeEEEEEec
Q 036407 22 LLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLL--EQDDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 22 ~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~---~~~~~l~EI~iLs~L--~h~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
.||+|+||.||++... ++.+|+|.+...... ....+..|..++..+ .+|+|++.+++.+... +.+++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEec
Confidence 4899999999999875 789999998654321 122344454444443 2458999998888765 688999999
Q ss_pred cCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 95 MSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 95 ~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
+++++|.+++..... +++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 79 ~~~~~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~ 145 (279)
T cd05633 79 MNGGDLHYHLSQHGV---FSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLAC 145 (279)
T ss_pred CCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcce
Confidence 999999988876443 788889999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=270.12 Aligned_cols=141 Identities=24% Similarity=0.404 Sum_probs=115.8
Q ss_pred ceeeccCcEEEEEEEEC-C---ceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLH-D---QSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~-g---~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+.||+|+||.||++... + ..+++|.+.... ......+.+|+.++..+.| +||+++++.+... ..+|+||||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~--~~~~lv~e~~ 77 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH-PNILQCLGQCVEA--IPYLLVFEYC 77 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCC-cchhheEEEecCC--CccEEEEecC
Confidence 36999999999999743 2 346677765433 2345678999999999877 9999999998866 6789999999
Q ss_pred CCCCHHHHHHhcCC-CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 96 SNGNLQDALLHKKP-PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 96 ~gGsL~d~L~~~~~-~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
++++|.+++..... ....+...++.++.||+.||.|||+.+ ++|+||||+|||++.++.++|+|||++.
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~ 147 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGP 147 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEeccccccc
Confidence 99999999875422 223556677789999999999999999 9999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=277.31 Aligned_cols=147 Identities=31% Similarity=0.427 Sum_probs=123.9
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
....|++.+.||+|+||.||+|... ++.||+|.+..... .....+.+|+.++..+.| +|++++++++... ..
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~~~~~~~~~--~~ 89 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH-PNTIEYKGCYLRE--HT 89 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEEeC--Ce
Confidence 3466999999999999999999864 78999999864322 223468899999999976 9999999998876 67
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
.++||||+. |+|.+.+..... .+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||++..
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCccee
Confidence 899999996 577776654332 2678888899999999999999999 99999999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=279.88 Aligned_cols=144 Identities=26% Similarity=0.375 Sum_probs=124.4
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
..|.....||.|+||.||++... ++.||+|.+..........+.+|+.++..+.| +|++.+++++... ..+++||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~--~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH-QNVVEMYKSYLVG--EELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCC-CchhhhhhheeeC--CeEEEEE
Confidence 44556678999999999999864 78999999976554555678899999999976 9999999988765 7899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||+++++|..++.... +++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 98 e~~~~~~L~~~~~~~~----~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~ 166 (297)
T cd06659 98 EFLQGGALTDIVSQTR----LNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQ 166 (297)
T ss_pred ecCCCCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhh
Confidence 9999999998775422 677888899999999999999999 99999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=273.74 Aligned_cols=149 Identities=28% Similarity=0.390 Sum_probs=131.5
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
....+.|++...||+|++|.||+|... +..+++|.+..... ....+.+|+..+..+.| +|++.+++.+... ...
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~~ 90 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKH-PNIVDYYDSYLVG--DEL 90 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCC-CCeeEEEEEEEEC--CEE
Confidence 356778999999999999999999986 78999999976544 45678899999999977 9999999998877 789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++|+||+++++|.+++.... ..++...+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 165 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQ 165 (286)
T ss_pred EEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhh
Confidence 99999999999999998754 13778888999999999999999999 99999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-32 Score=270.55 Aligned_cols=148 Identities=20% Similarity=0.306 Sum_probs=121.0
Q ss_pred HHHHhhcCCCCcccee--eccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 8 SVLRRAADSFSPSRLL--GQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 8 ~~lk~~~d~Y~i~e~L--G~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
+++....++|++.+.+ |+|+||.||++... +..+|+|.+....... .|+.....+.+|+|++++++.+...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 4445556788888887 99999999999865 7889999986432211 1222333344679999999998876
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC-cEEEccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF-CAKISDF 162 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g-~vKLiDF 162 (576)
+.+|+||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++ .++|+||
T Consensus 82 --~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 82 --KGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred --CeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecC
Confidence 68999999999999999987654 2788899999999999999999999 99999999999999988 9999999
Q ss_pred ccccc
Q 036407 163 GLARL 167 (576)
Q Consensus 163 GlA~~ 167 (576)
|++..
T Consensus 155 g~~~~ 159 (267)
T PHA03390 155 GLCKI 159 (267)
T ss_pred cccee
Confidence 98753
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=262.52 Aligned_cols=147 Identities=31% Similarity=0.470 Sum_probs=129.1
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEe
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE 93 (576)
+|.+.+.||+|++|.||++... +..+++|++..........+.+|+..+..+.| +|++.+++.+... ...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH-PNIVKYYGSYLKK--DELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCC-CCEeEEEEEEecC--CeEEEEEe
Confidence 4788899999999999999976 78899999976655456788999999999986 9999999988776 78899999
Q ss_pred ccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 94 LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 94 ~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|+++++|.+++.... ..+++..+..++.+++.||.+||..+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 149 (253)
T cd05122 78 FCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149 (253)
T ss_pred cCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccc
Confidence 999999999887653 22778888899999999999999999 9999999999999999999999999876543
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=275.20 Aligned_cols=143 Identities=28% Similarity=0.390 Sum_probs=124.3
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEe
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE 93 (576)
.|...+.||.|++|.||++... ++.+++|.+..........+.+|+.++..+.| +|++.+++++... ...++|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h-~~vv~~~~~~~~~--~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH-PNIVEMYSSYLVG--DELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCC-CChheEEEEEEcC--CeEEEEEe
Confidence 5666789999999999999864 68899999875554555678899999999876 9999999988765 78899999
Q ss_pred ccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 94 LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 94 ~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|+++++|.+++... . ++...+..++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||++..
T Consensus 97 ~~~~~~L~~~~~~~-~---~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 97 FLEGGALTDIVTHT-R---MNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred ccCCCCHHHHHHhC-C---CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchh
Confidence 99999999988762 2 677788899999999999999999 99999999999999999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=264.94 Aligned_cols=148 Identities=22% Similarity=0.410 Sum_probs=128.4
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+|++.+.||.|+||.||++... +..|++|.+..... .....+..|++++..+.| +|++.+++.+... ..+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~~~~~~~~~~~~--~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH-PNIIKYYESFEEK--GKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCC-CChhheEEEEecC--CEEEEE
Confidence 5888999999999999999976 78999999975433 345578899999999986 9999999988776 889999
Q ss_pred EeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+|++++++|.+.+.... ....++...+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 153 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVL 153 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeec
Confidence 99999999999887642 1233788889999999999999999999 999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=274.42 Aligned_cols=149 Identities=26% Similarity=0.374 Sum_probs=126.5
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchh--HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG--EREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~--~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
.++|++.+.||.|+||.||+|... ++.||+|.+....... ...+.+|+.++..+.| +|++++++++.......++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH-PNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCC-CCCcceEEEEecCCCCeEE
Confidence 468999999999999999999875 7899999986443221 2346789999999987 9999999998776557789
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 85 lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999996 48888876533 23678888999999999999999999 999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=262.68 Aligned_cols=148 Identities=28% Similarity=0.412 Sum_probs=129.3
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+|.+.+.||+|++|.||+|... ++.|++|++..... .....+.+|+..++.+.| +|++.+++.+.......+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-PNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCC-CCEeeEEEEEecCCCCeEEEE
Confidence 4788899999999999999976 78999999975542 335678899999999986 999999998876544788999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
+|++++++|.+++.... .+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 99999999999987654 2788889999999999999999999 9999999999999999999999999876544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=269.62 Aligned_cols=147 Identities=24% Similarity=0.428 Sum_probs=124.5
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+|.+.+.||+|+||.||+|... +..+|+|.+..... .....+.+|+.+++.++| +|++++++.+... ..+++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h-~~i~~~~~~~~~~--~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKH-PNIVTFFASFQEN--GRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCC-CChhhhhheeccC--CeEEEE
Confidence 5788999999999999999875 68899999865322 234567899999999977 9999999988765 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC-cEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF-CAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g-~vKLiDFGlA~~~ 168 (576)
+||+++++|.+.+..... ..+++..+..++.+++.||.|||+++ ++|+||+|+||+++.++ .++|+|||.+...
T Consensus 78 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 78 MEYCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred EecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 999999999998876432 23678888999999999999999999 99999999999999886 4699999987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=275.27 Aligned_cols=148 Identities=26% Similarity=0.313 Sum_probs=119.8
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
++|...+.||+|+||.||++... ++.||+|.+..... .....+.+|+.++.++..|+||+++++++... ...+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEEE
Confidence 45667889999999999999875 78999999875432 33456889999999998569999999988765 678999
Q ss_pred EeccCCCCHHHHHHh--cCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 92 YELMSNGNLQDALLH--KKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 92 mE~~~gGsL~d~L~~--~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|||+. ++|.++... ......+++..+..++.+++.||+|||+ .+ ++|+||||+||+++.++.++|+|||++..
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 99985 466554321 1111237788889999999999999997 58 99999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=272.33 Aligned_cols=152 Identities=26% Similarity=0.393 Sum_probs=125.2
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC---
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPK--- 84 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s--- 84 (576)
...++|++.+.||+|+||.||+|... ++.||||.+..... .....+.+|+.+++.+.| +||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKH-ENVVNLIEICRTKATPY 87 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCC-CCccceEEEEecccccc
Confidence 34568999999999999999999875 78999999864322 223356789999999977 99999999876542
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcc
Q 036407 85 ---RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISD 161 (576)
Q Consensus 85 ---~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiD 161 (576)
....++||||+. ++|.+.+..... .+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 88 NRYKGSFYLVFEFCE-HDLAGLLSNKNV--KFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred cCCCceEEEEEcCCC-cCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECc
Confidence 246799999995 588877765332 2678889999999999999999999 99999999999999999999999
Q ss_pred cccccccc
Q 036407 162 FGLARLKS 169 (576)
Q Consensus 162 FGlA~~~~ 169 (576)
||++....
T Consensus 163 fg~~~~~~ 170 (310)
T cd07865 163 FGLARAFS 170 (310)
T ss_pred CCCccccc
Confidence 99987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=273.90 Aligned_cols=146 Identities=24% Similarity=0.348 Sum_probs=125.4
Q ss_pred CCCccceeeccCcEEEEEEEE-----CCceEEEEEeecCCc----hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 16 SFSPSRLLGQGGFGSVFHATL-----HDQSVAVKVMDSGSL----QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~-----~g~~VAVK~i~~~s~----~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
+|++.+.||.|+||.||+++. .+..||+|++..... .....+..|+.++..+.+|+||+.+++.+... .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--T 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--C
Confidence 478899999999999999985 478899999975322 22356788999999998889999998887765 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+++||||+++++|.+++..... +++..+..++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRER---FKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 88999999999999998876543 667778888899999999999999 9999999999999999999999999876
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 154 ~~ 155 (290)
T cd05613 154 EF 155 (290)
T ss_pred ec
Confidence 43
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=275.91 Aligned_cols=144 Identities=31% Similarity=0.430 Sum_probs=121.7
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
..|...+.||+|+||.||+++.. +..+|+|.+..... .....+.+|+.+++.+.| +|++.+++++... ...+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~--~~~~ 101 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH-PNSIEYKGCYLRE--HTAW 101 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCC-CCEEEEEEEEeeC--CeEE
Confidence 34788899999999999999864 78899999864322 223468889999999976 9999999998776 6789
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
+||||+. |+|.+.+..... .+++..+..++.+++.||.|||+++ |+|+||+|+||+++.++.++|+|||++.
T Consensus 102 lv~e~~~-g~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~ 173 (317)
T cd06635 102 LVMEYCL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSAS 173 (317)
T ss_pred EEEeCCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCcc
Confidence 9999996 578777754332 2678888899999999999999999 9999999999999999999999999765
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=266.05 Aligned_cols=139 Identities=24% Similarity=0.352 Sum_probs=115.3
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCCchh---HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG---EREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~---~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+.||+|+||.||+|... ++.||||.+....... ...+..|..++.....|+|++++++.+... ..+++|+||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK--DYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC--CeEEEEEecc
Confidence 57899999999999874 7899999986543222 123445555555554669999999998765 7899999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
++++|.+++..... ++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 80 ~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~ 145 (260)
T cd05611 80 NGGDCASLIKTLGG---LPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSR 145 (260)
T ss_pred CCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccce
Confidence 99999999876543 677888899999999999999999 9999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=273.73 Aligned_cols=151 Identities=21% Similarity=0.275 Sum_probs=107.6
Q ss_pred hhcCCCCccceeeccCcEEEEEEEECC-----ceEEEEEeecCCchh--HH---------HHHHHHHHHHHhccCCceEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLHD-----QSVAVKVMDSGSLQG--ER---------EFYNELYFASLLEQDDHVVS 75 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~g-----~~VAVK~i~~~s~~~--~~---------~~l~EI~iLs~L~h~pNIv~ 75 (576)
...++|++.++||+|+||.||+|...+ ..+|+|+........ +. ....++..+..+.| ++++.
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h-~~i~~ 87 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDH-LGIPK 87 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCC-CCCCc
Confidence 455789999999999999999998653 356677643322111 11 11122222333444 88888
Q ss_pred EEEEeeCCCC--CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC
Q 036407 76 VLGFSSNPKR--HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH 153 (576)
Q Consensus 76 Llg~~~~~s~--~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~ 153 (576)
+++.+..... ...+++++++ ..++.+.+..... .++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~ 161 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKC---KNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDG 161 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhcc---CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcC
Confidence 8876554322 2447788887 4477766654322 356667889999999999999999 999999999999999
Q ss_pred CCcEEEcccccccccc
Q 036407 154 NFCAKISDFGLARLKS 169 (576)
Q Consensus 154 ~g~vKLiDFGlA~~~~ 169 (576)
++.++|+|||+++...
T Consensus 162 ~~~~~l~DFGla~~~~ 177 (294)
T PHA02882 162 NNRGYIIDYGIASHFI 177 (294)
T ss_pred CCcEEEEEcCCceeec
Confidence 9999999999987553
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=267.45 Aligned_cols=146 Identities=25% Similarity=0.370 Sum_probs=124.6
Q ss_pred CCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 17 FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
|++.+.||+|+||.||+|... ++.+|+|.+.... ......+.+|+.++..+.| +|++.+++++.......+++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH-PNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccC-CCeeeheeeEecCCCCcEEEEe
Confidence 678899999999999999876 6899999997653 2233567889999999986 9999999998765447899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||++ ++|.+++..... .+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 80 e~~~-~~l~~~~~~~~~--~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~ 150 (287)
T cd07840 80 EYMD-HDLTGLLDSPEV--KFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPY 150 (287)
T ss_pred cccc-ccHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeec
Confidence 9996 488888765432 3778889999999999999999999 999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=270.33 Aligned_cols=144 Identities=30% Similarity=0.402 Sum_probs=125.8
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
+|++.+.||.|+||.||+|... ++.||+|.+..... .....+.+|+.+++.+.| +||+.+++.+... ..+++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH-PFLVNLWYSFQDE--ENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCC-CChHHHHHhhcCC--CeEEE
Confidence 5889999999999999999876 78999999975332 234578899999999977 9999998887665 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|+||+.+++|.+.+..... +++..+..++.||+.||.|||.++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 78 v~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~ 149 (258)
T cd05578 78 VVDLLLGGDLRYHLSQKVK---FSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATK 149 (258)
T ss_pred EEeCCCCCCHHHHHHhcCC---cCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccc
Confidence 9999999999998876532 677888899999999999999999 99999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=265.71 Aligned_cols=148 Identities=26% Similarity=0.446 Sum_probs=125.7
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+|++.+.||+|+||.||+++.. ++.+|+|.+..... .....+.+|+.+++.+.| +||+.+++.+... ...++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH-PNIISYKEAFLDG--NKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCC-CCchhhhhhhccC--CEEEEE
Confidence 5888999999999999999765 68899999875332 234567889999999986 9999999888766 889999
Q ss_pred EeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||+++++|.+++.... ....+++..++.++.+++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++...
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~ 153 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVL 153 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhh
Confidence 99999999999886622 1233677888999999999999999999 999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=299.88 Aligned_cols=148 Identities=27% Similarity=0.403 Sum_probs=127.4
Q ss_pred CccceeeccCcEEEEEEEEC--CceEEEEEeecC----CchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 18 SPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSG----SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 18 ~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~----s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+....||+|+|-+||+|..+ |..||--.++.. .....++|..|+.+|+.|+| +||++++.+|.+.....+-+|
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H-~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKH-PNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCC-CceeeeeeheecCCCceeeee
Confidence 35579999999999999865 666666554432 22334789999999999998 999999999999877788999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC-CcEEEcccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN-FCAKISDFGLARLKS 169 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~-g~vKLiDFGlA~~~~ 169 (576)
+|++..|+|.++.+..+. ++...++.+++||+.||.|||++.|||||||||.+||+|+.+ |.|||+|+|+|....
T Consensus 122 TEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999999988765 677788999999999999999999999999999999999865 899999999997643
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=270.72 Aligned_cols=147 Identities=25% Similarity=0.400 Sum_probs=122.0
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
++|++.+.||.|++|.||+|... ++.||+|.+..... .....+.+|+.++..+.| +|++++++++... ..+++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH-GNIVRLQDVVHSE--KRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccC-CCEeeEEEEEecC--CeEEE
Confidence 57999999999999999999865 78899999864332 223467889999999976 9999999998766 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC-CCcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH-NFCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~-~g~vKLiDFGlA~~~ 168 (576)
||||+. ++|.+.+...... .+++..+..++.||+.||.|||+++ ++|+||+|+||+++. ++.+||+|||++...
T Consensus 79 v~e~~~-~~l~~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 79 VFEYLD-LDLKKHMDSSPDF-AKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEeccc-ccHHHHHHhCCCC-CcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 999995 5888877654332 2466777889999999999999999 999999999999985 457899999988643
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=277.87 Aligned_cols=149 Identities=28% Similarity=0.497 Sum_probs=124.5
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC---C
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK---R 85 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s---~ 85 (576)
+..+|.+.+.||.|+||.||+|+.. ++.||||.+.... ......+.+|+.++..+.| +||+++++++.... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDH-ENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCC-CCccchHHheeccccccc
Confidence 4568999999999999999999865 7899999986432 2233467789999999976 99999998776432 2
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
..+|+|+||+. ++|.+.+..... +++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQT---LSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 45899999995 689888865433 778889999999999999999999 999999999999999999999999988
Q ss_pred ccc
Q 036407 166 RLK 168 (576)
Q Consensus 166 ~~~ 168 (576)
...
T Consensus 156 ~~~ 158 (337)
T cd07858 156 RTT 158 (337)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-33 Score=277.18 Aligned_cols=169 Identities=28% Similarity=0.396 Sum_probs=139.7
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--------hhHHHHHHHHHHHHHhccCCceEEEEEEee
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--------QGEREFYNELYFASLLEQDDHVVSVLGFSS 81 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--------~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~ 81 (576)
..-..|.-.+.||.|..++|-++..+ ++.+|+|++..... .-.+.-.+|+.+|.++..||+|+.+.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 33467888899999999999888765 78899999864211 112456789999999999999999999998
Q ss_pred CCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcc
Q 036407 82 NPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISD 161 (576)
Q Consensus 82 ~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiD 161 (576)
.+ ..+++|+|.|+.|.|.+++..... +++.....|++|++.|+.|||..+ |+||||||+|||++++..++|+|
T Consensus 94 s~--sF~FlVFdl~prGELFDyLts~Vt---lSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 94 SD--AFVFLVFDLMPRGELFDYLTSKVT---LSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred Cc--chhhhhhhhcccchHHHHhhhhee---ecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEec
Confidence 77 788999999999999999987554 788888899999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCcCcCCCCccccch
Q 036407 162 FGLARLKSVGENQNQADGENKNKAAE 187 (576)
Q Consensus 162 FGlA~~~~~~~~~~~~~gt~~y~APE 187 (576)
||++..+..+......||||+|.|||
T Consensus 167 FGFa~~l~~GekLrelCGTPgYLAPE 192 (411)
T KOG0599|consen 167 FGFACQLEPGEKLRELCGTPGYLAPE 192 (411)
T ss_pred cceeeccCCchhHHHhcCCCcccChh
Confidence 99999887765433344444444443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-33 Score=274.70 Aligned_cols=148 Identities=30% Similarity=0.445 Sum_probs=129.9
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
..++|++.+.||+|-||.||.|+.+ +..||+|++.+... ..+.++.+|+++.+.|+| |||.++++++.+. ..
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~h-pnilrlY~~fhd~--~r 96 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRH-PNILRLYGYFHDS--KR 96 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCC-ccHHhhhhheecc--ce
Confidence 4578899999999999999999977 57899999965432 334678999999999998 9999999999887 88
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.||++||...|.|...+..... ..+++.....++.|++.||.|||..+ ++||||||+|+|++..+.+||+|||-+-
T Consensus 97 iyLilEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSV 172 (281)
T ss_pred eEEEEEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCcee
Confidence 9999999999999998885443 23777888889999999999999998 9999999999999999999999999754
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=269.95 Aligned_cols=139 Identities=29% Similarity=0.448 Sum_probs=112.9
Q ss_pred eeeccCcEEEEEEEEC--CceEEEEEeecCCch---hHHHHHHHHHHHHHh--ccCCceEEEEEEeeCCCCCeEEEEEec
Q 036407 22 LLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLL--EQDDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 22 ~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~---~~~~~l~EI~iLs~L--~h~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
.||+|+||.||+++.. ++.||+|.+...... ....+..|..++..+ .+|++|+.+++.+... ..+++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEec
Confidence 4899999999999864 689999998754322 122344454444433 2459999998888766 789999999
Q ss_pred cCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 95 MSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 95 ~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+.+++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 79 ~~g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 79 MNGGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 99999998886543 3788899999999999999999999 99999999999999999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=261.92 Aligned_cols=146 Identities=25% Similarity=0.438 Sum_probs=128.0
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+|++.+.||+|++|.||++... ++.|++|.+..... .....+.+|+.++..+.| +|++.+++++... ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-PNIVKYIGSIETS--DSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCC-CCccEEEEEEEeC--CEEEEE
Confidence 5788999999999999999865 68899999976543 344678999999999976 9999999988765 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|||+++++|.+++..... +++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++....
T Consensus 78 ~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 150 (254)
T cd06627 78 LEYAENGSLRQIIKKFGP---FPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLN 150 (254)
T ss_pred EecCCCCcHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecC
Confidence 999999999998876532 788888999999999999999999 9999999999999999999999999887543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=266.24 Aligned_cols=138 Identities=23% Similarity=0.363 Sum_probs=120.3
Q ss_pred eeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCC
Q 036407 23 LGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSN 97 (576)
Q Consensus 23 LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~g 97 (576)
||.|++|.||+++.. ++.||+|++..... .....+.+|+.++..+.| +||+.+++.+... ..+++|+||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNH-PFIVKLYRTFKDK--KYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCC-CCEeeeeeeEEcC--CccEEEEecCCC
Confidence 689999999999987 78999999975332 234578899999999976 9999999988766 788999999999
Q ss_pred CCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 98 GNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 98 GsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++|.+++..... ++...+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~~L~~~l~~~~~---l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~ 143 (262)
T cd05572 78 GELWTILRDRGL---FDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKL 143 (262)
T ss_pred CcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCccccc
Confidence 999999876443 677888889999999999999999 999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=268.56 Aligned_cols=144 Identities=26% Similarity=0.408 Sum_probs=123.4
Q ss_pred CCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 17 FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
|++.+.||.|++|.||+|... +..||+|++..... .....+.+|+.+++.+.| +|++++++++... ...+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~iv~~~~~~~~~--~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH-PNIVRLLDVVHSE--NKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCC-CCccCHhheeccC--CeEEEEE
Confidence 678899999999999999864 88999999875432 223567889999999987 9999999998766 8899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||++ ++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 78 e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~ 148 (283)
T cd07835 78 EFLD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARA 148 (283)
T ss_pred eccC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccc
Confidence 9995 689988866442 23778889999999999999999999 99999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=276.77 Aligned_cols=155 Identities=26% Similarity=0.413 Sum_probs=129.1
Q ss_pred CCChHHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEE
Q 036407 4 RFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGF 79 (576)
Q Consensus 4 ~fs~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~ 79 (576)
.....++..+.++|.+.+.||+|+||.||+|... ++.||+|.+.... ......+.+|+.++..+.| +||+.++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~~iv~~~~~ 84 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH-ENVIGLLDV 84 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCC-Ccccceeee
Confidence 3456677788999999999999999999999854 7889999986432 2234567889999999977 999999988
Q ss_pred eeCC----CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC
Q 036407 80 SSNP----KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF 155 (576)
Q Consensus 80 ~~~~----s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g 155 (576)
+... .....|++++++ +++|.+++.... +++..++.++.||+.||.|||+++ |+|+||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~----l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK----LTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDC 157 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCC
Confidence 7532 224578888887 789988776432 677888899999999999999999 99999999999999999
Q ss_pred cEEEccccccc
Q 036407 156 CAKISDFGLAR 166 (576)
Q Consensus 156 ~vKLiDFGlA~ 166 (576)
.++|+|||++.
T Consensus 158 ~~kl~dfg~~~ 168 (345)
T cd07877 158 ELKILDFGLAR 168 (345)
T ss_pred CEEEecccccc
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=265.42 Aligned_cols=148 Identities=26% Similarity=0.421 Sum_probs=120.7
Q ss_pred CCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch--hHHHHHHHHHHHHHhc--cCCceEEEEEEeeCCCC---Ce
Q 036407 17 FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ--GEREFYNELYFASLLE--QDDHVVSVLGFSSNPKR---HR 87 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~--~~~~~l~EI~iLs~L~--h~pNIv~Llg~~~~~s~---~~ 87 (576)
|++.+.||+|+||.||+|+.. ++.||+|.+...... ....+.+|+.++..+. .|+|++++.+++..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999976 789999999743221 2345667887777775 35999999999876521 24
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++++|||+. ++|.+++...... .+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKP-GLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999996 4898887654322 3778889999999999999999999 99999999999999999999999998765
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 157 ~ 157 (287)
T cd07838 157 Y 157 (287)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=272.48 Aligned_cols=150 Identities=27% Similarity=0.384 Sum_probs=123.8
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchh--HHHHHHHHHHHHHhccCCceEEEEEEeeCCC-----
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG--EREFYNELYFASLLEQDDHVVSVLGFSSNPK----- 84 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~--~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s----- 84 (576)
.++|++.+.||.|+||.||+|+.. ++.+|||.+....... ...+.+|+.++..+.| +||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKH-PNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCC-CCccchhhheecccccccc
Confidence 579999999999999999999875 7889999986433222 2356789999999977 99999988765432
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 85 -RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 85 -~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
...+++||||+.+ +|...+..... .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~--~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSV--KLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCc
Confidence 2468999999954 77766654322 3788889999999999999999999 9999999999999999999999999
Q ss_pred cccccc
Q 036407 164 LARLKS 169 (576)
Q Consensus 164 lA~~~~ 169 (576)
++....
T Consensus 161 ~~~~~~ 166 (311)
T cd07866 161 LARPYD 166 (311)
T ss_pred cchhcc
Confidence 887543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=298.07 Aligned_cols=151 Identities=18% Similarity=0.247 Sum_probs=114.6
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC---CceEEEEEee--------------c---CCchhHHHHHHHHHHHHHhccCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH---DQSVAVKVMD--------------S---GSLQGEREFYNELYFASLLEQDD 71 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~---g~~VAVK~i~--------------~---~s~~~~~~~l~EI~iLs~L~h~p 71 (576)
...++|++++.||+|+||.||++..+ +...++|.+. + ........+.+|+.++..+.| +
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H-p 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH-E 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC-C
Confidence 34578999999999999999998653 1222222110 0 111223467899999999987 9
Q ss_pred ceEEEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCC--CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCe
Q 036407 72 HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP--PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNI 149 (576)
Q Consensus 72 NIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~--~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNI 149 (576)
||+.+++++... ...|+|++++. ++|.+++..... ........+..|+.||+.||.|||+++ |+||||||+||
T Consensus 224 nIv~l~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NI 298 (501)
T PHA03210 224 NILKIEEILRSE--ANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENI 298 (501)
T ss_pred CcCcEeEEEEEC--CeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHE
Confidence 999999998876 67899999994 577776643221 111234556789999999999999999 99999999999
Q ss_pred EEcCCCcEEEccccccccc
Q 036407 150 LLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 150 LLd~~g~vKLiDFGlA~~~ 168 (576)
|++.++.+||+|||+++.+
T Consensus 299 Ll~~~~~vkL~DFGla~~~ 317 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPF 317 (501)
T ss_pred EECCCCCEEEEeCCCceec
Confidence 9999999999999998754
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=298.94 Aligned_cols=143 Identities=27% Similarity=0.366 Sum_probs=120.3
Q ss_pred ceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCCC
Q 036407 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNG 98 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~gG 98 (576)
-.||+|.||+||-|+.. ...+|||.+........+-+..||..-+.|+| .|||+++|.+... +++-|.||.++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrH-kNIVrYLGs~sen--Gf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRH-KNIVRYLGSVSEN--GFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhh-HhHHHHhhccCCC--CeEEEEeecCCCC
Confidence 37999999999999866 56688999865444455667888999999998 9999999998765 7889999999999
Q ss_pred CHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEc-CCCcEEEccccccccc
Q 036407 99 NLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLD-HNFCAKISDFGLARLK 168 (576)
Q Consensus 99 sL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd-~~g~vKLiDFGlA~~~ 168 (576)
+|..++...=++-.-.+.+.-.|..||+.||.|||++. |||||||-+|+|++ -.|.+||+|||.++..
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRL 726 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRL 726 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhh
Confidence 99999977322211267788889999999999999999 99999999999997 4689999999988743
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=270.57 Aligned_cols=150 Identities=25% Similarity=0.332 Sum_probs=124.5
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
...++|++.+.||+|+||.||+|... ++.||||.+..... .....+..|+.++..+..|+||+.+++++... ..+
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~ 89 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SDV 89 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC--CeE
Confidence 34578999999999999999999987 78999999975432 23345677887777777679999999998776 789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|+||||+. ++|.+++..... .+++..+..++.+++.||.|||+ ++ |+|+||+|+||+++.++.++|+|||++..
T Consensus 90 ~~v~e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 90 FICMELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred EEEeeccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchh
Confidence 99999984 577776655332 37778888999999999999997 58 99999999999999999999999998754
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 165 ~ 165 (296)
T cd06618 165 L 165 (296)
T ss_pred c
Confidence 3
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=265.43 Aligned_cols=144 Identities=24% Similarity=0.391 Sum_probs=123.4
Q ss_pred CCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch--hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 17 FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ--GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~--~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
|++.+.||+|++|.||++... ++.+++|.+...... ....+.+|+.++..+.| +|++++++++... ..+++|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNH-PNIIKLLDVFRHK--GDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcC-CCcchHHHhhccC--CCEEEEE
Confidence 677899999999999999875 788999998654322 34578889999999986 9999999988766 7899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||+.+ +|.+.+..... .+++..+..++.+|+.||.|||+++ |+|+||+|+||+++.++.++|+|||.+...
T Consensus 78 e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~ 148 (283)
T cd05118 78 EFMDT-DLYKLIKDRQR--GLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSF 148 (283)
T ss_pred eccCC-CHHHHHHhhcc--cCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence 99965 88887766432 3778889999999999999999999 999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=268.03 Aligned_cols=139 Identities=29% Similarity=0.408 Sum_probs=118.8
Q ss_pred eeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCC
Q 036407 23 LGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSN 97 (576)
Q Consensus 23 LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~g 97 (576)
||+|+||.||++... ++.||+|.+..... .....+..|+.++..+.| +|++.+++.+... ..+|+||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFIVSLAYAFETK--DDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCC-CCEeeeeeEEecC--CeEEEEEecCCC
Confidence 689999999999765 78999999865322 224456789999999975 9999999888766 789999999999
Q ss_pred CCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 98 GNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 98 GsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++|.+.+..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 78 ~~L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~ 144 (277)
T cd05577 78 GDLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVE 144 (277)
T ss_pred CcHHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhh
Confidence 999998876542 23678888889999999999999999 99999999999999999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=276.44 Aligned_cols=148 Identities=26% Similarity=0.446 Sum_probs=124.8
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCC--CCCe
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNP--KRHR 87 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~--s~~~ 87 (576)
.++|++.+.||+|+||.||+|... ++.||+|.+..... .....+.+|+.++..+.| +||+.+++++... ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKH-DNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCC-CCccCHHHhccccCCCCce
Confidence 478999999999999999999865 78999999875322 234567789999999986 9999998876532 3367
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++||||+. ++|.+++..... +++..+..++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++..
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCC---CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 899999995 689888765433 778889999999999999999999 99999999999999999999999998865
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 157 ~ 157 (334)
T cd07855 157 L 157 (334)
T ss_pred e
Confidence 4
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=270.77 Aligned_cols=146 Identities=23% Similarity=0.339 Sum_probs=123.7
Q ss_pred CCCccceeeccCcEEEEEEEEC-----CceEEEEEeecCCc----hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGSL----QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s~----~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
+|++.+.||+|+||.||+++.. +..||||.+..... .....+.+|+.++..+.+|+||+.+++.+... .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--T 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC--C
Confidence 4788999999999999998742 57899999864322 22346788999999998889999998887665 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+++||||+.+++|.+.+..... +++..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||+++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCC---cCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 88999999999999988865432 677788889999999999999999 9999999999999999999999999876
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 154 ~~ 155 (288)
T cd05583 154 EF 155 (288)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=310.44 Aligned_cols=149 Identities=33% Similarity=0.520 Sum_probs=128.6
Q ss_pred CCCCccceeeccCcEEEEEEEEC---C----ceEEEEEeecC-CchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH---D----QSVAVKVMDSG-SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~---g----~~VAVK~i~~~-s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
.+-.+...||+|+||.||.|.+. + ..||||.+... +......|++|..+|+.+.| |||+.++|.|... .
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~H-pNiv~liGv~l~~--~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDH-PNIVSLIGVCLDS--G 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCC-cceeeEEEeecCC--C
Confidence 44557789999999999999875 2 23889988754 34556789999999999988 9999999999885 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcC----CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKK----PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDF 162 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~----~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDF 162 (576)
..+|++|||+||+|..+|+... ....+.-...+.++.+|+.|+.||+++. +|||||...|+||+....+||+||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEccc
Confidence 7899999999999999998752 1234677788899999999999999999 999999999999999999999999
Q ss_pred cccccc
Q 036407 163 GLARLK 168 (576)
Q Consensus 163 GlA~~~ 168 (576)
|+|+.+
T Consensus 847 GlArDi 852 (1025)
T KOG1095|consen 847 GLARDI 852 (1025)
T ss_pred chhHhh
Confidence 999844
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=272.29 Aligned_cols=140 Identities=30% Similarity=0.421 Sum_probs=121.4
Q ss_pred ccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccC
Q 036407 19 PSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMS 96 (576)
Q Consensus 19 i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~ 96 (576)
....||+|+||.||++... ++.||||.+..........+.+|+.++..+.| +|++++++.+... ...++||||++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~--~~~~lv~e~~~ 100 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVG--DELWVVMEFLE 100 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCC-cchhheeeEEEeC--CEEEEEEecCC
Confidence 3468999999999999874 78999999865544455678899999999987 9999999988776 78999999999
Q ss_pred CCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 97 NGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 97 gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++|.+.+.... +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 101 ~~~L~~~~~~~~----~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~ 165 (292)
T cd06657 101 GGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQ 165 (292)
T ss_pred CCcHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEccccccee
Confidence 999998775432 567788889999999999999999 99999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=270.52 Aligned_cols=145 Identities=19% Similarity=0.169 Sum_probs=120.7
Q ss_pred CccceeeccCcEEEEEEEECCceEEEEEeecC--CchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 18 SPSRLLGQGGFGSVFHATLHDQSVAVKVMDSG--SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 18 ~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~--s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
.+.+.+|.|+++.|+++..+++.||||+++.. .......+..|+.++..++| +||+.+++.+... ...+++|||+
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~~i~~~~~~~~~~--~~~~~~~e~~ 81 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQH-PNILPYVTSFIVD--SELYVVSPLM 81 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCC-cchhhhhheeecC--CeEEEEEecc
Confidence 34556666677777777777899999999754 22334578999999999987 9999999988766 7889999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++++|.+++...... .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||.+...
T Consensus 82 ~~~~l~~~l~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~ 151 (314)
T cd08216 82 AYGSCEDLLKTHFPE-GLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSM 151 (314)
T ss_pred CCCCHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceee
Confidence 999999988764322 2677788889999999999999999 999999999999999999999999987643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=271.33 Aligned_cols=139 Identities=20% Similarity=0.285 Sum_probs=116.9
Q ss_pred ceeecc--CcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEec
Q 036407 21 RLLGQG--GFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 21 e~LG~G--sfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
..||.| +|+.||+++.. ++.||||++..... ...+.+.+|+.++..+.| +||+.+++++... ..+++||||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~~--~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRH-PNIMTSWTVFTTG--SWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcceEeeeEecC--CceEEEEec
Confidence 466776 99999999874 89999999875432 223567888888888876 9999999999876 788999999
Q ss_pred cCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 95 MSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 95 ~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
+.+++|.+++...... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++++||+.+
T Consensus 81 ~~~~~l~~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~ 148 (328)
T cd08226 81 MAYGSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHL 148 (328)
T ss_pred ccCCCHHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHH
Confidence 9999999988764322 2677888889999999999999999 999999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=273.87 Aligned_cols=154 Identities=26% Similarity=0.420 Sum_probs=123.9
Q ss_pred CChHHHHhh----cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEE
Q 036407 5 FSYSVLRRA----ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSV 76 (576)
Q Consensus 5 fs~~~lk~~----~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~L 76 (576)
|+.+++... .++|.+.+.||+|+||.||+|+.. ++.||||.+..... .....+.+|+.++..+.| +||+.+
T Consensus 1 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~ 79 (342)
T cd07879 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQH-ENVIGL 79 (342)
T ss_pred CchhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCC-CCccch
Confidence 445555544 489999999999999999999864 78999999864321 123457889999999976 999999
Q ss_pred EEEeeCCC----CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEc
Q 036407 77 LGFSSNPK----RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLD 152 (576)
Q Consensus 77 lg~~~~~s----~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd 152 (576)
++++.... ...+++|+||+. .+|...+.. .+++..+..++.|++.||.|||+++ ++|+||||+||+++
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~ 151 (342)
T cd07879 80 LDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN 151 (342)
T ss_pred hheecccccCCCCceEEEEecccc-cCHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC
Confidence 98876432 245799999995 477665421 2677788889999999999999999 99999999999999
Q ss_pred CCCcEEEcccccccc
Q 036407 153 HNFCAKISDFGLARL 167 (576)
Q Consensus 153 ~~g~vKLiDFGlA~~ 167 (576)
.++.++|+|||+++.
T Consensus 152 ~~~~~kL~dfg~~~~ 166 (342)
T cd07879 152 EDCELKILDFGLARH 166 (342)
T ss_pred CCCCEEEeeCCCCcC
Confidence 999999999998753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=270.38 Aligned_cols=148 Identities=23% Similarity=0.366 Sum_probs=124.1
Q ss_pred hcCCCCc-cceeeccCcEEEEEEEEC--CceEEEEEeecCCchh--------------HHHHHHHHHHHHHhccCCceEE
Q 036407 13 AADSFSP-SRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG--------------EREFYNELYFASLLEQDDHVVS 75 (576)
Q Consensus 13 ~~d~Y~i-~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~--------------~~~~l~EI~iLs~L~h~pNIv~ 75 (576)
+.++|.. .+.||.|+||.||+|+.. ++.||||.+....... ...+.+|+.++..+.| +||+.
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~ 84 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH-ENIMG 84 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCC-cceee
Confidence 4567764 477999999999999865 7899999986533221 1246789999999977 99999
Q ss_pred EEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC
Q 036407 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF 155 (576)
Q Consensus 76 Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g 155 (576)
+++++... ..+++||||+. ++|.+.+..... ++...+..++.|++.||.|||+++ ++|+||+|+||+++.++
T Consensus 85 ~~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~ 156 (335)
T PTZ00024 85 LVDVYVEG--DFINLVMDIMA-SDLKKVVDRKIR---LTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKG 156 (335)
T ss_pred eeEEEecC--CcEEEEEeccc-cCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCC
Confidence 99998766 78999999996 689988865433 677888899999999999999999 99999999999999999
Q ss_pred cEEEcccccccccc
Q 036407 156 CAKISDFGLARLKS 169 (576)
Q Consensus 156 ~vKLiDFGlA~~~~ 169 (576)
.++|+|||++....
T Consensus 157 ~~kl~dfg~~~~~~ 170 (335)
T PTZ00024 157 ICKIADFGLARRYG 170 (335)
T ss_pred CEEECCccceeecc
Confidence 99999999887553
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=264.73 Aligned_cols=146 Identities=29% Similarity=0.398 Sum_probs=122.8
Q ss_pred CCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEe
Q 036407 17 FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE 93 (576)
|.+.+.||+|++|.||+|... ++.|+||.+..... .......+|+..+..+..|+|++.+++++... ...++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~--~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN--DELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcC--CcEEEEEe
Confidence 678899999999999999975 68899999864322 22334567888899998459999999988765 78999999
Q ss_pred ccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 94 LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 94 ~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|+ +++|.+.+..... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~~-~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~ 149 (283)
T cd07830 79 YM-EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREI 149 (283)
T ss_pred cC-CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceec
Confidence 99 7899988876442 23688889999999999999999999 999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=266.69 Aligned_cols=153 Identities=27% Similarity=0.379 Sum_probs=127.1
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC--
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPK-- 84 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s-- 84 (576)
....++|++.+.||+|+||.||+|... ++.||||.++.... .....+.+|+.++..+.| +|++.+++++....
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h-~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNH-RNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCC-CCeeeeeheecCcchh
Confidence 356789999999999999999999975 78899999975432 223467789999999976 99999999886542
Q ss_pred ------CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEE
Q 036407 85 ------RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAK 158 (576)
Q Consensus 85 ------~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vK 158 (576)
...+++|+||+++ +|...+..... .+++..++.++.||+.||.|||+++ |+|+||+|+||+++.++.++
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLV--HFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEE
Confidence 3478999999975 77776654322 2678889999999999999999999 99999999999999999999
Q ss_pred Ecccccccccc
Q 036407 159 ISDFGLARLKS 169 (576)
Q Consensus 159 LiDFGlA~~~~ 169 (576)
|+|||++....
T Consensus 157 l~dfg~~~~~~ 167 (302)
T cd07864 157 LADFGLARLYN 167 (302)
T ss_pred eCccccccccc
Confidence 99999886543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=280.71 Aligned_cols=148 Identities=24% Similarity=0.340 Sum_probs=124.2
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHH---HHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGER---EFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~---~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
...++|..+++||+|.||+|-+++.+ ++.||||++++.-.-... .-+.|-++|...+| |.+..+...+. +..
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~H-PFLt~LKYsFQ--t~d 241 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRH-PFLTSLKYSFQ--TQD 241 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccC-cHHHHhhhhhc--cCc
Confidence 45678999999999999999999866 899999999865443332 34566677777777 87777755554 448
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
++|+||||..||.|.-++.+.. .+++.....+..+|+.||.|||+++ ||+||||.+|+|+|.+|.+||+|||+++
T Consensus 242 rlCFVMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred eEEEEEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccch
Confidence 9999999999999988887644 3788888889999999999999999 9999999999999999999999999987
Q ss_pred c
Q 036407 167 L 167 (576)
Q Consensus 167 ~ 167 (576)
.
T Consensus 317 E 317 (516)
T KOG0690|consen 317 E 317 (516)
T ss_pred h
Confidence 3
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=273.53 Aligned_cols=151 Identities=25% Similarity=0.422 Sum_probs=126.2
Q ss_pred HHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC
Q 036407 9 VLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPK 84 (576)
Q Consensus 9 ~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s 84 (576)
++-...++|++.+.||+|+||.||++... +..||||.+..... .....+.+|+.++..+.| +||+.+++.+....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~ 87 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKH-ENVIGLLDVFTPDL 87 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCC-CCccceeeeecCCc
Confidence 34457789999999999999999999865 78999999864322 223467899999999977 99999999876542
Q ss_pred C----CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEc
Q 036407 85 R----HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKIS 160 (576)
Q Consensus 85 ~----~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLi 160 (576)
. ..+++||||+ +++|.+++... .+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEe
Confidence 1 3569999999 77998877642 2678888999999999999999999 9999999999999999999999
Q ss_pred ccccccc
Q 036407 161 DFGLARL 167 (576)
Q Consensus 161 DFGlA~~ 167 (576)
|||++..
T Consensus 161 dfg~~~~ 167 (343)
T cd07880 161 DFGLARQ 167 (343)
T ss_pred ecccccc
Confidence 9998753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=263.59 Aligned_cols=138 Identities=28% Similarity=0.413 Sum_probs=120.1
Q ss_pred eeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCC
Q 036407 23 LGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSN 97 (576)
Q Consensus 23 LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~g 97 (576)
||.|+||.||+++.. ++.+++|.+..... .....+.+|+.++..+.| +|++.+++.+... ..+|+|+||+++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS-PYVVKLYYSFQGK--KNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCC-cchhHHHHheecC--cEEEEEEecCCC
Confidence 689999999999976 78999999975443 334578889999999986 9999998887655 789999999999
Q ss_pred CCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 98 GNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 98 GsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++|.+++..... +++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~~L~~~l~~~~~---~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~ 143 (265)
T cd05579 78 GDLASLLENVGS---LDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVG 143 (265)
T ss_pred CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhc
Confidence 999998876442 678888999999999999999999 999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=269.83 Aligned_cols=146 Identities=31% Similarity=0.428 Sum_probs=121.8
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
...|...+.||+|+||.||+|+.. +..+|+|.+.... ......+.+|+.++..+.| +|++.+++++... ...
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~ 90 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLRE--HTA 90 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCC-CCcccEEEEEEcC--Cee
Confidence 345778899999999999999875 6889999986422 2233467889999999976 9999999998776 788
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++||||+. ++|.+.+..... .+++..+..++.+++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 91 ~lv~e~~~-~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 91 WLVMEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (308)
T ss_pred EEEEEccC-CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCccccee
Confidence 99999996 588777754332 2677888889999999999999999 99999999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=270.08 Aligned_cols=148 Identities=28% Similarity=0.397 Sum_probs=122.1
Q ss_pred CCCccceeeccCcEEEEEEEEC----CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeC--CCCCe
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH----DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSN--PKRHR 87 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~----g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~--~s~~~ 87 (576)
+|++.+.||+|+||.||+++.. +..||||.+.... ......+.+|+.++..+.+|+||+++++.+.. .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999875 4589999986422 12245678899999999877999999887543 22356
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++++++++. ++|.+.+..... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQP---LTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 789999985 689888865433 678888899999999999999999 99999999999999999999999999875
Q ss_pred cc
Q 036407 168 KS 169 (576)
Q Consensus 168 ~~ 169 (576)
..
T Consensus 155 ~~ 156 (332)
T cd07857 155 FS 156 (332)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=268.94 Aligned_cols=142 Identities=33% Similarity=0.444 Sum_probs=120.1
Q ss_pred CCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 17 FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
|...+.||+|+||.||+|+.. ++.|++|.+..... .....+..|+.++..+.| +|++.+++++... ...|+|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~~~lv 99 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH-PNTIEYKGCYLKE--HTAWLV 99 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCC-CCCccEEEEEEeC--CEEEEE
Confidence 667788999999999999864 78999999864322 223467889999999976 9999999998876 788999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
|||+. ++|.+.+..... .+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.
T Consensus 100 ~e~~~-~~l~~~l~~~~~--~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 100 MEYCL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred EecCC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCc
Confidence 99995 578777755332 2678888899999999999999999 9999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=297.58 Aligned_cols=145 Identities=23% Similarity=0.372 Sum_probs=127.6
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
+.|.++..||.|+||+||++..+ +-..|.|+|...+....+.++-||.||+.+.| |+|+.+++.|++. +.+||+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdH-P~ivkLl~ayy~e--nkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDH-PVIVKLLSAYYFE--NKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCC-hHHHHHHHHHhcc--CceEEEE
Confidence 45678899999999999999876 44567788876665666789999999999996 9999999998888 8899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
|||.||-....+...+.. +.+.++..+++|++.||.|||+++ |||||||..|||+.-+|.++|+|||++-
T Consensus 109 EFC~GGAVDaimlEL~r~--LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRV--LTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred eecCCchHhHHHHHhccc--cchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccc
Confidence 999999988888765543 888999999999999999999999 9999999999999999999999999864
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=264.40 Aligned_cols=148 Identities=27% Similarity=0.420 Sum_probs=127.7
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|.+.+.||+|+||.||++... +..||+|++..... .....+..|+.++..+..|+||+.+++.+... ..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--ENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC--ceEE
Confidence 47899999999999999999874 78999999865322 22356788899999998459999998887665 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
+|||++++++|.+.+..... +++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999999876542 788889999999999999999999 9999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=268.13 Aligned_cols=147 Identities=30% Similarity=0.458 Sum_probs=125.1
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC---CCeE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK---RHRM 88 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s---~~~l 88 (576)
+|++.+.||.|++|.||+|+.. ++.||||.+.... ......+..|+.++..+.| +||+.+++++.... ...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRH-ENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCC-cchhhhhhhhcccCcccccce
Confidence 5889999999999999999875 6899999987543 2334578899999999976 99999999876542 3478
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|+||||+. ++|.+.+.... .+++..++.++.+|+.||.|||+++ |+|+||||.|||++.++.++|+|||++...
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999996 58888876543 3788888999999999999999999 999999999999999999999999988754
Q ss_pred c
Q 036407 169 S 169 (576)
Q Consensus 169 ~ 169 (576)
.
T Consensus 154 ~ 154 (330)
T cd07834 154 D 154 (330)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=270.10 Aligned_cols=147 Identities=29% Similarity=0.442 Sum_probs=122.4
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC-------
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK------- 84 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s------- 84 (576)
..+|.+.+.||.|+||.||+|... ++.||+|.+..........+.+|+.++..+.| +||+.+++.+....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h-~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDH-DNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCC-CcchhhHhhhccccccccccc
Confidence 478999999999999999999875 78999999876555555678899999999976 99999987655432
Q ss_pred -----CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC-CCcEE
Q 036407 85 -----RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH-NFCAK 158 (576)
Q Consensus 85 -----~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~-~g~vK 158 (576)
...+|+||||+. ++|.+.+... .+++..++.++.||+.||.|||+.+ |+|+||||+||+++. ++.++
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEE
Confidence 135799999996 5888877543 2677888899999999999999999 999999999999974 55789
Q ss_pred Eccccccccc
Q 036407 159 ISDFGLARLK 168 (576)
Q Consensus 159 LiDFGlA~~~ 168 (576)
|+|||++...
T Consensus 156 l~dfg~~~~~ 165 (342)
T cd07854 156 IGDFGLARIV 165 (342)
T ss_pred ECCcccceec
Confidence 9999987643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=269.95 Aligned_cols=148 Identities=30% Similarity=0.443 Sum_probs=123.7
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
+..++++|++.+.||.|+||.||++... ++.||||.+.... ......+..|+.++..+.| ||++.+++++....
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~- 82 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH-ENIISLSDIFISPL- 82 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCC-CCeeeEeeeEecCC-
Confidence 3457889999999999999999999865 7889999885422 2234567889999999987 99999999886532
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
..+++|+||+ +++|.+.+.... ++...+..++.|++.||.|||+.+ |+|+||+|.||+++.++.++|+|||.+
T Consensus 83 ~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 83 EDIYFVTELL-GTDLHRLLTSRP----LEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred CcEEEEeehh-ccCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccc
Confidence 5788999999 668988776432 556667788999999999999999 999999999999999999999999987
Q ss_pred c
Q 036407 166 R 166 (576)
Q Consensus 166 ~ 166 (576)
.
T Consensus 156 ~ 156 (328)
T cd07856 156 R 156 (328)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=298.66 Aligned_cols=150 Identities=26% Similarity=0.514 Sum_probs=132.8
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-----CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.....+.+.||.|.||.|++|+++ ...||||.++.... +.+..|+.|..||-++.| |||+.|.|+.... ..
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH-PNIIrLEGVVTks--~P 704 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH-PNIIRLEGVVTKS--KP 704 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC-CcEEEEEEEEecC--ce
Confidence 344557899999999999999976 36799999987653 445679999999999988 9999999998766 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+.||+|||++|+|+.+|+.+.+. +...+...++++|+.|+.||-+++ +|||||...|||++.+..+|++|||+++.
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccceee
Confidence 89999999999999999876643 788889999999999999999999 99999999999999999999999999997
Q ss_pred ccC
Q 036407 168 KSV 170 (576)
Q Consensus 168 ~~~ 170 (576)
+.+
T Consensus 781 led 783 (996)
T KOG0196|consen 781 LED 783 (996)
T ss_pred ccc
Confidence 654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=273.63 Aligned_cols=149 Identities=27% Similarity=0.421 Sum_probs=124.5
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC--
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK-- 84 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s-- 84 (576)
....++|.+.+.||+|++|.||+|+.. +..||||.+.... ......+.+|+.+++.+.| +|++.+++++....
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDH-ENVIGLLDVFTPASSL 89 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccC-CCHHHHHHHhhccccc
Confidence 356789999999999999999999875 6889999986432 2233567789999999966 99999887665432
Q ss_pred --CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccc
Q 036407 85 --RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDF 162 (576)
Q Consensus 85 --~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDF 162 (576)
...+++|+||+ +++|.+++... .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+||
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEccc
Confidence 24589999999 67999888652 2678888999999999999999999 999999999999999999999999
Q ss_pred ccccc
Q 036407 163 GLARL 167 (576)
Q Consensus 163 GlA~~ 167 (576)
|++..
T Consensus 163 g~~~~ 167 (343)
T cd07851 163 GLARH 167 (343)
T ss_pred ccccc
Confidence 98753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=270.18 Aligned_cols=149 Identities=28% Similarity=0.423 Sum_probs=126.2
Q ss_pred hhcCCCCcc-ceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeC--CCCC
Q 036407 12 RAADSFSPS-RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN--PKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~-e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~--~s~~ 86 (576)
.++++|.+. ++||-|-.|+|-.+..+ ++.+|+|++. +.....+|++.--+...|+|||.+++++.. ....
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 578888876 68999999999988765 8899999985 234567777776677788999999998763 4457
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC---CCcEEEcccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH---NFCAKISDFG 163 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~---~g~vKLiDFG 163 (576)
.+.+|||+++||.|...+..++.. .+++.++-.|+.||+.|+.|||+.+ |.||||||+|+|... +..+||+|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~-afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQ-AFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccc-cchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccc
Confidence 788999999999999999887653 4889999999999999999999999 999999999999975 4578999999
Q ss_pred ccccc
Q 036407 164 LARLK 168 (576)
Q Consensus 164 lA~~~ 168 (576)
+|+..
T Consensus 210 FAK~t 214 (400)
T KOG0604|consen 210 FAKET 214 (400)
T ss_pred ccccc
Confidence 99854
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=308.48 Aligned_cols=155 Identities=24% Similarity=0.331 Sum_probs=130.5
Q ss_pred HHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 8 SVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 8 ~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
.+++-..++|.+++.||+|+||.|.+++.+ ++.||+|++++... ....-|..|-.+|....+ +=|+.++..|.+
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns-~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNS-EWIVQLHYAFQD 146 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCc-HHHHHHHHHhcC
Confidence 345667889999999999999999999886 78999999986332 233456777777766554 667777666655
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccc
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDF 162 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDF 162 (576)
. .++||||||++||+|..++..... +++.-+.+|+.+|+.||+-||+.| +|||||||+|||||..|.+||+||
T Consensus 147 ~--~~LYlVMdY~pGGDlltLlSk~~~---~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 E--RYLYLVMDYMPGGDLLTLLSKFDR---LPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred c--cceEEEEecccCchHHHHHhhcCC---ChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccc
Confidence 5 999999999999999999988763 788889999999999999999999 999999999999999999999999
Q ss_pred cccccccC
Q 036407 163 GLARLKSV 170 (576)
Q Consensus 163 GlA~~~~~ 170 (576)
|.+-.+..
T Consensus 220 GsClkm~~ 227 (1317)
T KOG0612|consen 220 GSCLKMDA 227 (1317)
T ss_pred hhHHhcCC
Confidence 98865543
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=258.12 Aligned_cols=144 Identities=27% Similarity=0.411 Sum_probs=123.7
Q ss_pred CCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 17 FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
|++.+.||+|.+|.||+|+.. ++.||+|.+.... ......+..|+.+++.+.| +|++.+++++... ..+++|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~--~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH-PNIVKLLDVIHTE--RKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCC-CCHHHHHhhhhcC--CceEEEe
Confidence 567889999999999999876 7899999997643 2223567889999999976 9999999988766 7899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||+. ++|.+++..... .+++..+..++.+++.||.|||+++ |+|+||+|+||+++.++.++|+|||++...
T Consensus 78 e~~~-~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~ 148 (282)
T cd07829 78 EYCD-MDLKKYLDKRPG--PLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAF 148 (282)
T ss_pred cCcC-cCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCccccc
Confidence 9996 599998876531 2778889999999999999999999 999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=285.11 Aligned_cols=152 Identities=27% Similarity=0.408 Sum_probs=134.1
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
....+.|.++..||+|.|++|.+++.. +..||||++.+... ...+.+.+|+.+|..|.| |||++++.+...+ .
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~H-PnIvkl~~v~~t~--~ 128 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNH-PNIVKLFSVIETE--A 128 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCC-cceeeeeeeeeec--c
Confidence 456688999999999999999999865 89999999976443 334568999999999988 9999999998877 8
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+|+||||+.+|.+.+++...+. ..+..+..++.|++.|++|||++. |+|||||.+||||+.+..+||+|||++.
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred eeEEEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccce
Confidence 89999999999999999988765 445777889999999999999999 9999999999999999999999999987
Q ss_pred cccC
Q 036407 167 LKSV 170 (576)
Q Consensus 167 ~~~~ 170 (576)
.+..
T Consensus 204 ~~~~ 207 (596)
T KOG0586|consen 204 FFDY 207 (596)
T ss_pred eecc
Confidence 6654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=259.47 Aligned_cols=147 Identities=21% Similarity=0.306 Sum_probs=117.9
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-----chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-----LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-----~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
+|.+.+.||+|+||.||+++.. +..+++|+++... ......+..|+.++..+.| +|++++++++... ...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~ 77 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH-PAIVKFHASFLER--DAF 77 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCC-CcHHHHHHHHhcC--Cce
Confidence 5888999999999999999865 3445566654311 1223456778888888876 9999998887665 678
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 89 LLVYELMSNGNLQDALLHK-KPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~-~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++..
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceee
Confidence 9999999999999888642 22234788889999999999999999999 999999999999975 6699999998764
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 155 ~ 155 (260)
T cd08222 155 L 155 (260)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=309.66 Aligned_cols=153 Identities=26% Similarity=0.365 Sum_probs=129.0
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
+..++-++.....||.|.||.||.|..- |+..|||-+..... ..-..+..|+.++..|.| ||++.++|.-.+.
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnH-pNlV~YyGVEvHR-- 1306 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNH-PNLVRYYGVEVHR-- 1306 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccC-ccccccCceeecH--
Confidence 4566778888899999999999999854 88899998864322 222356789999999988 9999999998776
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
...+|.||||++|+|.+++.+... .++....-+..|++.|+.|||++| ||||||||.||+|+.+|.+|++|||.|
T Consensus 1307 ekv~IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccce
Confidence 778999999999999999876432 566666667889999999999999 999999999999999999999999998
Q ss_pred ccccC
Q 036407 166 RLKSV 170 (576)
Q Consensus 166 ~~~~~ 170 (576)
..+..
T Consensus 1382 ~ki~~ 1386 (1509)
T KOG4645|consen 1382 VKIKN 1386 (1509)
T ss_pred eEecC
Confidence 76643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=304.25 Aligned_cols=153 Identities=27% Similarity=0.388 Sum_probs=125.8
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC---
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK--- 84 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s--- 84 (576)
.+-..+|+.+++||+|+||.||+++.+ |+.||||.|.... ......+.+|+.++++|.| |||++++..|.+..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnH-pNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNH-PNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCC-cceeeeehhhhccCCcc
Confidence 456778999999999999999999865 9999999997653 2233578999999999988 99999876654210
Q ss_pred --------------------------------------------------------------------------------
Q 036407 85 -------------------------------------------------------------------------------- 84 (576)
Q Consensus 85 -------------------------------------------------------------------------------- 84 (576)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred ----------------------------------CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHH
Q 036407 85 ----------------------------------RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIA 130 (576)
Q Consensus 85 ----------------------------------~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~ 130 (576)
...+||-||||+...|.+.+....... .....++++++|+.||.
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHH
Confidence 045789999998877777776644211 35668899999999999
Q ss_pred HHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 131 YLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 131 yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|+|++| ||||||||.||+|+.++.+||+|||+|...
T Consensus 712 YIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~ 747 (1351)
T KOG1035|consen 712 YIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDL 747 (1351)
T ss_pred HHHhCc--eeeccCCcceeEEcCCCCeeecccccchhh
Confidence 999999 999999999999999999999999998753
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=273.73 Aligned_cols=149 Identities=28% Similarity=0.403 Sum_probs=130.3
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
.-.+-|.++++||+|+||.||++.++ |+.+|||.+..+ .+.+++..||.+++.+.+ +++++++|.+.-. ..+|
T Consensus 30 ~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S-~yVVKYYGSYFK~--sDLW 104 (502)
T KOG0574|consen 30 PPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKS-KYVVKYYGSYFKH--SDLW 104 (502)
T ss_pred ChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCC-chhhhhhhhhccC--CceE
Confidence 44455788999999999999999866 899999998644 456789999999999999 9999999887655 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
+|||||-.|++.+.++.+.. .+.+..+-.+++.-+.||.|||... -+|||||..|||++-+|..||.|||+|..+.
T Consensus 105 IVMEYCGAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred eehhhcCCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhh
Confidence 99999999999999987654 3788888889999999999999987 8999999999999999999999999987543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=278.25 Aligned_cols=149 Identities=26% Similarity=0.349 Sum_probs=124.3
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
..+.+|..+..||+|+||+|-++..+ .+.||||+++++-. ++.+--+.|-++|......|.+++++..+..- .
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm--D 423 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM--D 423 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh--h
Confidence 44568899999999999999999876 47899999986532 22233466777777777767788876665544 8
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+|+||||+.||+|.-++++.+. +.+..+..|+.+|+.||-|||++| ||+||||.+||||+.+|.+||+|||+++
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeeccccc
Confidence 99999999999999998887654 666778889999999999999999 9999999999999999999999999987
Q ss_pred c
Q 036407 167 L 167 (576)
Q Consensus 167 ~ 167 (576)
.
T Consensus 499 E 499 (683)
T KOG0696|consen 499 E 499 (683)
T ss_pred c
Confidence 3
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=263.03 Aligned_cols=149 Identities=27% Similarity=0.347 Sum_probs=121.4
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
+..+++..||+|+.|.|+++++. |...|||.+..... ..-.+++..+.++.+...+|.||+.+|+|... ..+++.
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n--~dV~Ic 169 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN--TDVFIC 169 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC--chHHHH
Confidence 44557789999999999999877 69999999976443 33457888888888777689999999999987 678899
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEccccccccccC
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
||.|. -.+..++..-..+ +++..+=++..-++.||.||-+ ++ |+|||+||+|||+|..|.+||||||++..+..
T Consensus 170 MelMs-~C~ekLlkrik~p--iPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 170 MELMS-TCAEKLLKRIKGP--IPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHH-HHHHHHHHHhcCC--chHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeec
Confidence 99984 3666666654332 7777666778889999999986 77 99999999999999999999999999865543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=264.54 Aligned_cols=152 Identities=25% Similarity=0.404 Sum_probs=132.2
Q ss_pred ChHHHHhhcCCCCccceeeccCcEEEEEEE--ECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 6 SYSVLRRAADSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 6 s~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~--~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
++.++...+ .+.||+|+|+.|.-++ .++..||||++.+.....+.++.+|+.++..++.|+||++++.++.++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 344554444 5889999999998876 348999999998877777889999999999999999999999999887
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC---cEEEc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF---CAKIS 160 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g---~vKLi 160 (576)
..+|||||-+.||+|..++..+.. +++..+..++.+|+.||.|||..| |.||||||+|||..... -+||+
T Consensus 149 --~~FYLVfEKm~GGplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 --TRFYLVFEKMRGGPLLSHIQKRKH---FNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred --ceEEEEEecccCchHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeee
Confidence 889999999999999999987654 888999999999999999999999 99999999999997664 47999
Q ss_pred ccccccccc
Q 036407 161 DFGLARLKS 169 (576)
Q Consensus 161 DFGlA~~~~ 169 (576)
||.++..+.
T Consensus 222 DfDLgSg~k 230 (463)
T KOG0607|consen 222 DFDLGSGIK 230 (463)
T ss_pred ccccccccc
Confidence 999876443
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=250.75 Aligned_cols=138 Identities=29% Similarity=0.397 Sum_probs=119.5
Q ss_pred eeccCcEEEEEEEEC--CceEEEEEeecCCch---hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCC
Q 036407 23 LGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSN 97 (576)
Q Consensus 23 LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~---~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~g 97 (576)
||.|+||.||++... ++.+|+|.+...... ....+..|+.++..+.| +|++.+++.+... ..+++|||++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINH-PFIVKLHYAFQTE--EKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCC-CcHHHHHHHeecC--CeeEEEEecCCC
Confidence 689999999999875 789999998754332 34578889999999986 9999998887655 789999999999
Q ss_pred CCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 98 GNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 98 GsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++|.+++..... +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 143 (250)
T cd05123 78 GELFSHLSKEGR---FSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKEL 143 (250)
T ss_pred CcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceec
Confidence 999999876543 678888899999999999999999 999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=269.74 Aligned_cols=142 Identities=20% Similarity=0.279 Sum_probs=115.6
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccC-C----ceEEEEEEeeCCCC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQD-D----HVVSVLGFSSNPKR 85 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~-p----NIv~Llg~~~~~s~ 85 (576)
.+.+|.+...+|+|.||.|-.++.. +..||||+++.- ..-.+..+-|+.++.++.+. | -++++.+++...
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr-- 163 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR-- 163 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc--
Confidence 4789999999999999999999865 688999999632 23345778899999988543 2 266777777776
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISD 161 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiD 161 (576)
++.|||+|.+ |.++.+++....- ..++...+..|+.|++.++.|||+.+ ++|.||||+|||+......++-+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEec
Confidence 8999999999 7799999987543 23778899999999999999999999 99999999999997665555433
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=280.30 Aligned_cols=151 Identities=31% Similarity=0.520 Sum_probs=133.0
Q ss_pred hcCCCCccceeeccCcEEEEEEEECC-ceEEEEEeecCCchh-HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQG-EREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~g-~~VAVK~i~~~s~~~-~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
......+.++||+|.||.|.++...+ ..||||.++.+...+ +..|..||++|.+|+| |||+.++++|..+ ..+|+
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkh-PNIveLvGVC~~D--ePicm 612 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKH-PNIVELLGVCVQD--DPLCM 612 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCC-CCeeEEEeeeecC--CchHH
Confidence 34456688999999999999999886 899999998766544 4889999999999977 9999999999987 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|+||++.|+|.+++....... +.......|+.||+.|++||-+.+ +|||||-+.|+|++.++++||+|||+++.+=
T Consensus 613 I~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999998775443 445566779999999999999999 9999999999999999999999999998543
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=287.06 Aligned_cols=154 Identities=24% Similarity=0.366 Sum_probs=130.5
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC----CCe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK----RHR 87 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s----~~~ 87 (576)
..+...+.||+|+||.||+|+.+ |+.||||.++... ....++..+|+.++++|.| +|||++.+.-.... ...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh-~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNH-PNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCc-hhhhhhcccCCccccCccccc
Confidence 44567789999999999999865 8999999998643 4456678899999999995 99999988765554 456
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEc--CCC--cEEEcccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLD--HNF--CAKISDFG 163 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd--~~g--~vKLiDFG 163 (576)
..+|||||.||+|...+........+++...+.++..|+.||.|||++| |+||||||.||++- .+| ..||+|||
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 7899999999999999988665556999999999999999999999999 99999999999984 334 46999999
Q ss_pred ccccccCC
Q 036407 164 LARLKSVG 171 (576)
Q Consensus 164 lA~~~~~~ 171 (576)
.|+.++++
T Consensus 170 ~Arel~d~ 177 (732)
T KOG4250|consen 170 AARELDDN 177 (732)
T ss_pred ccccCCCC
Confidence 99876553
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=250.80 Aligned_cols=129 Identities=17% Similarity=0.152 Sum_probs=106.9
Q ss_pred cCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCCCCHHHH
Q 036407 26 GGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDA 103 (576)
Q Consensus 26 GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~ 103 (576)
|.++.||+++.. ++.||+|.+..... +..|...+.... |+|++.+++++... ...++||||+++++|.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~-~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHC-VPNMVCLHKYIVSE--DSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcC-CCceeehhhheecC--CeEEEEEecCCCCCHHHH
Confidence 899999999875 78999999975432 223333333333 49999999988765 789999999999999998
Q ss_pred HHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 104 LLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 104 L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+..... +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++++|||.+..
T Consensus 76 l~~~~~---l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~ 134 (237)
T cd05576 76 ISKFLN---IPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSE 134 (237)
T ss_pred HHHhcC---CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhc
Confidence 866443 678888999999999999999999 99999999999999999999999997643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=276.98 Aligned_cols=145 Identities=22% Similarity=0.326 Sum_probs=119.4
Q ss_pred CCCccceeeccCcEEEEEEEE--CCceEEEEEeecCCchhHH---HHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATL--HDQSVAVKVMDSGSLQGER---EFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~--~g~~VAVK~i~~~s~~~~~---~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
-|..++.||=|+||.|.+++- +...||+|.+++.....++ .+..|-.||....+ +=||+|+..|.+ ...+|+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn-~WVVrLyySFQD--kdnLYF 706 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADN-EWVVRLYYSFQD--KDNLYF 706 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCC-cceEEEEEEecc--CCceEE
Confidence 366789999999999999863 3678999999765443333 34566667776655 667777555554 489999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||+|++||++..+|...+ ++.+..+..|+.++..|+++.|.+| +|||||||+|||||.+|.+||+|||++.-+
T Consensus 707 VMdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EEeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccc
Confidence 999999999999887755 4888889999999999999999999 999999999999999999999999998643
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=280.84 Aligned_cols=161 Identities=28% Similarity=0.377 Sum_probs=138.4
Q ss_pred ChHHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeC-
Q 036407 6 SYSVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN- 82 (576)
Q Consensus 6 s~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~- 82 (576)
.++.+---++-|++++.||.|.+|.||+++.. ++..|+|++.... +.++++.-|..++..+.+|||++.+++++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34445566788999999999999999998754 7889999987654 3445788889999999999999999998864
Q ss_pred --CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEc
Q 036407 83 --PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKIS 160 (576)
Q Consensus 83 --~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLi 160 (576)
..++.+|||||||.+|+..|+++... +..+.+..+..|+++++.||.+||.+. ++|||||=.|||+..++.+||+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEe
Confidence 24588999999999999999998766 344888888899999999999999999 9999999999999999999999
Q ss_pred cccccccccC
Q 036407 161 DFGLARLKSV 170 (576)
Q Consensus 161 DFGlA~~~~~ 170 (576)
|||++..++.
T Consensus 166 DFGvSaQlds 175 (953)
T KOG0587|consen 166 DFGVSAQLDS 175 (953)
T ss_pred eeeeeeeeec
Confidence 9999875543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=280.36 Aligned_cols=144 Identities=25% Similarity=0.387 Sum_probs=121.3
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.++.|.+...+|.|+|+.|-.+... ++.+++|++.... ....+|+.++....+|+||+.+++.+.+. .+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~--~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDG--KEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCC--ceeee
Confidence 4678999999999999999888765 7889999997541 23456777888888999999999999877 88999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE-cCCCcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL-DHNFCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL-d~~g~vKLiDFGlA~~~ 168 (576)
|||.+.|+-|.+.+..... .. ..+..|+.+|+.|+.|||++| ++||||||+|||+ +..+.++|+|||.++..
T Consensus 394 v~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred eehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 9999999888776655332 22 556679999999999999999 9999999999999 58899999999998754
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=262.16 Aligned_cols=155 Identities=24% Similarity=0.336 Sum_probs=128.5
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC------CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH------DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~------g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
.....|+++..||+|.||.||+|... .+.+|||.++..+. .......+||.+++.|+| +|++.+..++...
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h-~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKH-PNVISLVKVFLSH 99 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcC-CcchhHHHHHhcc
Confidence 34568999999999999999999643 34799999974321 223457889999999988 9999998777654
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC----CcE
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKK--PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN----FCA 157 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~--~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~----g~v 157 (576)
...++|++||.+. +|.+.++... ....++...+..|+.||+.|+.|||+++ |+||||||.|||+..+ |.+
T Consensus 100 -d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 100 -DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred -CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCee
Confidence 4889999999976 9999886533 2345788899999999999999999999 9999999999999887 899
Q ss_pred EEccccccccccCC
Q 036407 158 KISDFGLARLKSVG 171 (576)
Q Consensus 158 KLiDFGlA~~~~~~ 171 (576)
||+|||+++.+..+
T Consensus 176 KIaDlGlaR~~~~p 189 (438)
T KOG0666|consen 176 KIADLGLARLFNNP 189 (438)
T ss_pred EeecccHHHHhhcc
Confidence 99999999987654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-30 Score=271.72 Aligned_cols=144 Identities=28% Similarity=0.469 Sum_probs=119.8
Q ss_pred cceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 20 SRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
.+.||+|.||+||-|+.+ |+.||||++.+-.+ +.+..+.+|+.+|..+.| |.|+.+.-.|..+ ..+++|||-+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~H-PGiV~le~M~ET~--ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHH-PGIVNLECMFETP--ERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCC-CCeeEEEEeecCC--ceEEEEehhh
Confidence 489999999999999865 89999999976443 345678999999999977 9999997777665 8999999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC---CcEEEccccccccccC
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN---FCAKISDFGLARLKSV 170 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~---g~vKLiDFGlA~~~~~ 170 (576)
. |+..+.+.....+ .++++.-..++.||+.||+|||..+ |+|+||||+|||+... -.+||||||+|+.++.
T Consensus 646 ~-GDMLEMILSsEkg-RL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 646 H-GDMLEMILSSEKG-RLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE 719 (888)
T ss_pred c-chHHHHHHHhhcc-cchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecch
Confidence 5 5665555443322 2788888889999999999999999 9999999999999754 3799999999998765
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=276.99 Aligned_cols=148 Identities=27% Similarity=0.448 Sum_probs=130.1
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEe
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE 93 (576)
+....++||-|.||.||.|.++ .-.||||.++.+.. ..++|+.|..+|+.+.| ||+++++|+|... ..+|||+|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikH-pNLVqLLGVCT~E--pPFYIiTE 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKH-PNLVQLLGVCTHE--PPFYIITE 343 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcC-ccHHHHhhhhccC--CCeEEEEe
Confidence 3446789999999999999988 56799999975543 34689999999999987 9999999999987 78999999
Q ss_pred ccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccccC
Q 036407 94 LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 94 ~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
||..|+|.++|++.... .++....+.++.||..|+.||...+ +|||||-..|.|+.++..+|+.|||+++++.-
T Consensus 344 fM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred cccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 99999999999886643 3666777889999999999999999 99999999999999999999999999997653
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-31 Score=280.78 Aligned_cols=150 Identities=23% Similarity=0.357 Sum_probs=129.3
Q ss_pred cCCCCccceeeccCcEEEEEEEECCce--EEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLHDQS--VAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~g~~--VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
..+++.+..||-|+||.|-+++..++. +|+|++++... ..++.+..|-.+|..+.+ +.|++++..+.+. .++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s-~fIvrLYrTfrd~--kyv 495 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRS-DFIVRLYRTFRDS--KYV 495 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCc-hHHHHHHHHhccc--hhh
Confidence 345667789999999999999887544 89999976543 234567788888888886 9999998877766 899
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||+||-|-||.|++.++.++. ++..+...|+..++.|++|||+++ ||+|||||+|++++.+|.+||.|||+|+.+
T Consensus 496 YmLmEaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHh
Confidence 999999999999999988765 777888889999999999999999 999999999999999999999999999987
Q ss_pred cCC
Q 036407 169 SVG 171 (576)
Q Consensus 169 ~~~ 171 (576)
..+
T Consensus 571 ~~g 573 (732)
T KOG0614|consen 571 GSG 573 (732)
T ss_pred ccC
Confidence 765
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=273.16 Aligned_cols=148 Identities=28% Similarity=0.492 Sum_probs=129.7
Q ss_pred CCCCccceeeccCcEEEEEEEEC----C--ceEEEEEeecC-CchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH----D--QSVAVKVMDSG-SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~----g--~~VAVK~i~~~-s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
+...+.++||.|.||.||+|.++ | -.||||.-+.+ ...+.+.|+.|..+|+.+.| |||++++|.|.. ..
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdH-phIikLIGv~~e---~P 464 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDH-PHIIKLIGVCVE---QP 464 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCC-cchhheeeeeec---cc
Confidence 33446789999999999999976 2 35888988753 44567889999999999988 999999999987 47
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
.|||||+++-|.|..++...... ++......++.||+.||.|||+.. +|||||-..|||+.....+||+|||+++.
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eeEEEecccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccchhhh
Confidence 89999999999999999886643 788888889999999999999999 99999999999999999999999999987
Q ss_pred ccC
Q 036407 168 KSV 170 (576)
Q Consensus 168 ~~~ 170 (576)
+..
T Consensus 541 ~ed 543 (974)
T KOG4257|consen 541 LED 543 (974)
T ss_pred ccc
Confidence 655
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=276.06 Aligned_cols=170 Identities=26% Similarity=0.296 Sum_probs=115.5
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC------CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEE-EEE---eeC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSV-LGF---SSN 82 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~------g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~L-lg~---~~~ 82 (576)
..++|.+.+.||+|+||.||+|+.. +..||||.+..... .+...++ . +....+ .++..+ .++ ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e-~-l~~~~~-~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE-R-VRRACP-NSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH-H-HHhhch-hhHHHHHHhhhccccc
Confidence 5689999999999999999999875 56899998853221 1111111 1 111111 111111 111 112
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCCCC-----------------hhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccC
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKPPE-----------------LMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIK 145 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~~~-----------------~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLK 145 (576)
.....++||+||+.+++|.+++....... ......+..++.||+.||.|||+++ |+|||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLK 282 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVK 282 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCC
Confidence 34478899999999999999886532110 0112345678999999999999999 9999999
Q ss_pred CCCeEEcC-CCcEEEccccccccccCCC--CCcCcCCCCccccchhh
Q 036407 146 PSNILLDH-NFCAKISDFGLARLKSVGE--NQNQADGENKNKAAELE 189 (576)
Q Consensus 146 PeNILLd~-~g~vKLiDFGlA~~~~~~~--~~~~~~gt~~y~APEl~ 189 (576)
|+|||++. ++.+||+|||+++....+. .....++++.|+|||..
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~ 329 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQY 329 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHh
Confidence 99999985 5799999999997654322 22345678888888843
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=264.92 Aligned_cols=150 Identities=33% Similarity=0.553 Sum_probs=125.6
Q ss_pred cCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHH--HhccCCceEEEEEEeeCCC--CCeEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFAS--LLEQDDHVVSVLGFSSNPK--RHRML 89 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs--~L~h~pNIv~Llg~~~~~s--~~~l~ 89 (576)
.....+.++||+|.||.||+|.++++.||||++.. ...+.+.+|-.+.+ .+.| +||++++++-...+ ...++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h-~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKH-ENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCH---HHHHHHHhHHHHHhccCccc-hhHHHhhchhccCCcccccee
Confidence 35567889999999999999999999999999953 33445666655543 4445 99999988765432 46899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-------CCCCeeecccCCCCeEEcCCCcEEEccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-------LNPPVIHGDIKPSNILLDHNFCAKISDF 162 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-------~g~~IVHrDLKPeNILLd~~g~vKLiDF 162 (576)
||++|.+.|+|.++|..+. ++|....+|+..+++||+|||+ ..|+|+|||||+.|||+..++++.|+||
T Consensus 285 LVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999998765 7899999999999999999995 3468999999999999999999999999
Q ss_pred cccccccCC
Q 036407 163 GLARLKSVG 171 (576)
Q Consensus 163 GlA~~~~~~ 171 (576)
|+|..+..+
T Consensus 361 GLAl~~~p~ 369 (534)
T KOG3653|consen 361 GLALRLEPG 369 (534)
T ss_pred ceeEEecCC
Confidence 999876643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=278.74 Aligned_cols=157 Identities=28% Similarity=0.461 Sum_probs=132.7
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC---------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEE
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH---------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGF 79 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~---------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~ 79 (576)
++...++..+.+.||+|.||.|++|... ...||||.+.... ......+..|+.+|..+.+|+||+.+++.
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3444455567779999999999999754 3469999987533 24457899999999999999999999999
Q ss_pred eeCCCCCeEEEEEeccCCCCHHHHHHhcC------CC-------ChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCC
Q 036407 80 SSNPKRHRMLLVYELMSNGNLQDALLHKK------PP-------ELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKP 146 (576)
Q Consensus 80 ~~~~s~~~l~LVmE~~~gGsL~d~L~~~~------~~-------~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKP 146 (576)
|... +.+++|+||+..|+|.+++.... .. ..+.....+.++.||+.|++||++.. ++||||-.
T Consensus 371 ~t~~--~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAa 446 (609)
T KOG0200|consen 371 CTQD--GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAA 446 (609)
T ss_pred eccC--CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhh
Confidence 9884 88999999999999999998755 00 12677888999999999999999988 99999999
Q ss_pred CCeEEcCCCcEEEccccccccccC
Q 036407 147 SNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 147 eNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
.|||+..+..+||+|||+|+....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~ 470 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYN 470 (609)
T ss_pred hhEEecCCCEEEEccccceeccCC
Confidence 999999999999999999986544
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=273.47 Aligned_cols=150 Identities=31% Similarity=0.459 Sum_probs=129.4
Q ss_pred CCCCccceeeccCcEEEEEEEEC---C--ceEEEEEeecCCch-hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH---D--QSVAVKVMDSGSLQ-GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~---g--~~VAVK~i~~~s~~-~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
+...+.++||+|.||+|++|.++ | ..||||++..+... ....|++|+.+|.+|.| +|+++|||...+ ...
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H-~hliRLyGvVl~---qp~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQH-PHLIRLYGVVLD---QPA 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccC-cceeEEeeeecc---chh
Confidence 34557799999999999999887 2 56999999876554 45689999999999999 999999999876 457
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
.||||+++.|+|.+.|.... ...+.......|+.||+.|+.||-.++ +|||||-..|+||.....+||+|||+.+.+
T Consensus 186 mMV~ELaplGSLldrLrka~-~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAK-KAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhcc-ccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceecc
Confidence 89999999999999998722 234666778899999999999999999 999999999999999999999999999876
Q ss_pred cCC
Q 036407 169 SVG 171 (576)
Q Consensus 169 ~~~ 171 (576)
+..
T Consensus 263 g~n 265 (1039)
T KOG0199|consen 263 GEN 265 (1039)
T ss_pred CCC
Confidence 654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=256.90 Aligned_cols=149 Identities=25% Similarity=0.314 Sum_probs=118.5
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
++++.+..||.|+||+|++-.++ |+..|||.++.... ....+++.|.....+-..+|||++++|.+... +..||.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E--GdcWiC 141 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE--GDCWIC 141 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC--Cceeee
Confidence 44456789999999999998776 89999999986544 55678999999888888899999999987766 788999
Q ss_pred EeccCCCCHHHHHHh--cCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLH--KKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~--~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||+|+ .+|..+... ......+++..+-.|..-.+.||.||-+ .. |||||+||+|||++..|.+||||||++..+
T Consensus 142 MELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 142 MELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred HHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhH
Confidence 99995 477655432 1111226666555666667899999976 55 999999999999999999999999998644
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=233.10 Aligned_cols=135 Identities=30% Similarity=0.464 Sum_probs=117.0
Q ss_pred CcEEEEEEEEC--CceEEEEEeecCCchh-HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCCCCHHHH
Q 036407 27 GFGSVFHATLH--DQSVAVKVMDSGSLQG-EREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDA 103 (576)
Q Consensus 27 sfG~Vyka~~~--g~~VAVK~i~~~s~~~-~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~ 103 (576)
+||.||+|... ++.+|+|++....... ...+.+|+..++.+.| +|++.+++.+... ...++++|++.+++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKH-PNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCC-CcHHHHHhheeeC--CEEEEEEeCCCCCCHHHH
Confidence 58999999986 5899999997654433 5688999999999955 9999999988766 788999999999999998
Q ss_pred HHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 104 LLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 104 L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
+..... ++...++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+....
T Consensus 78 ~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~ 138 (244)
T smart00220 78 LKKRGR---LSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLD 138 (244)
T ss_pred HHhccC---CCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeec
Confidence 876443 677888899999999999999999 9999999999999999999999999876543
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-29 Score=253.71 Aligned_cols=149 Identities=21% Similarity=0.322 Sum_probs=125.6
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchh---HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG---EREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~---~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
....+|++++.||.|+|++|..+++. .+.||+|++++.-..+ ...+..|-.+.....++|.++-++..+... .
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte--s 324 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE--S 324 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc--c
Confidence 44678999999999999999999876 6889999997643322 235666766777777778888877666554 8
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+++|.||++||+|.-++..+.. ++++.+..+..+|+.||.|||++| |++||||.+|+||+..|.+||+|+|+++
T Consensus 325 rlffvieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhh
Confidence 99999999999999877765443 888889999999999999999999 9999999999999999999999999987
Q ss_pred c
Q 036407 167 L 167 (576)
Q Consensus 167 ~ 167 (576)
.
T Consensus 400 e 400 (593)
T KOG0695|consen 400 E 400 (593)
T ss_pred c
Confidence 3
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-29 Score=260.04 Aligned_cols=154 Identities=30% Similarity=0.432 Sum_probs=129.3
Q ss_pred hcCCCCccceeeccCcEEEEEEEE--CCceEEEEEeecCC-chhH------HHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATL--HDQSVAVKVMDSGS-LQGE------REFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~--~g~~VAVK~i~~~s-~~~~------~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
..++|-++++||.|+|+.||++.. .++.||||+-..+. +.++ ....+|.++-..|.| +.||++++++..+
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDH-pRIVKlYDyfslD 539 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDH-PRIVKLYDYFSLD 539 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCc-ceeeeeeeeeeec
Confidence 456788899999999999999974 37899999875432 2222 245678888888888 9999999999876
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC---CCcEEEc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH---NFCAKIS 160 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~---~g~vKLi 160 (576)
+ ..+|-|+|||+|.+|.-+++.... +++..+..|+.||+.||.||.+..+||||-||||.||||.. .|.+||+
T Consensus 540 t-dsFCTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 T-DSFCTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred c-ccceeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 4 678999999999999988887554 88899999999999999999999999999999999999964 4789999
Q ss_pred cccccccccCC
Q 036407 161 DFGLARLKSVG 171 (576)
Q Consensus 161 DFGlA~~~~~~ 171 (576)
|||+++.++..
T Consensus 616 DFGLSKIMddd 626 (775)
T KOG1151|consen 616 DFGLSKIMDDD 626 (775)
T ss_pred ecchhhhccCC
Confidence 99999877653
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=255.19 Aligned_cols=152 Identities=28% Similarity=0.453 Sum_probs=124.2
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHH--HHHHhccCCceEEEEEEeeCC--CCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELY--FASLLEQDDHVVSVLGFSSNP--KRH 86 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~--iLs~L~h~pNIv~Llg~~~~~--s~~ 86 (576)
+-++....+.+.||+|.||.||+|.++|+.||||+|... ++....+|.+ .--+|+| +||..+++..... +-.
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRH-ENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR---DERSWFRETEIYQTVMLRH-ENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccccCCceEEEEeccc---chhhhhhHHHHHHHHHhcc-chhhhhhhccccCCCceE
Confidence 355667788999999999999999999999999999633 2333344443 3446666 9999888775433 336
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh------CCCCeeecccCCCCeEEcCCCcEEEc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS------LNPPVIHGDIKPSNILLDHNFCAKIS 160 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs------~g~~IVHrDLKPeNILLd~~g~vKLi 160 (576)
++|||++|.+.|+|.|+|.... ++....++++..++.||+|||- ..|+|.|||||+.|||+..+|.+-|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 8999999999999999998743 7778888999999999999993 44789999999999999999999999
Q ss_pred cccccccccC
Q 036407 161 DFGLARLKSV 170 (576)
Q Consensus 161 DFGlA~~~~~ 170 (576)
|+|+|-....
T Consensus 359 DLGLAv~h~~ 368 (513)
T KOG2052|consen 359 DLGLAVRHDS 368 (513)
T ss_pred eceeeEEecc
Confidence 9999865443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=254.28 Aligned_cols=154 Identities=24% Similarity=0.307 Sum_probs=126.7
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccC-----CceEEEEEEeeCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQD-----DHVVSVLGFSSNP 83 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~-----pNIv~Llg~~~~~ 83 (576)
+..-.+|.+....|+|-|+.|.+|... +..||||+|..+. .....-+.|+++|.+|... .|++.++..|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 345578999999999999999999865 7899999997543 3344568899999998642 3566666666555
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC-CcEEEccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN-FCAKISDF 162 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~-g~vKLiDF 162 (576)
+++|||||-+ .-+|.++|+..+..-.+....+..|+.|+..||..|-.+| |+|+||||+|||++.. ..+|||||
T Consensus 507 --nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 507 --NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred --ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccC
Confidence 8999999998 5699999988766555778888999999999999999999 9999999999999865 57899999
Q ss_pred cccccccC
Q 036407 163 GLARLKSV 170 (576)
Q Consensus 163 GlA~~~~~ 170 (576)
|.|.....
T Consensus 582 GSA~~~~e 589 (752)
T KOG0670|consen 582 GSASFASE 589 (752)
T ss_pred cccccccc
Confidence 99876544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=255.61 Aligned_cols=155 Identities=25% Similarity=0.379 Sum_probs=117.0
Q ss_pred hcCCCCccceeeccCcEEEEEEEE------------------CCceEEEEEeecCCchhHHH--------------HHHH
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATL------------------HDQSVAVKVMDSGSLQGERE--------------FYNE 60 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~------------------~g~~VAVK~i~~~s~~~~~~--------------~l~E 60 (576)
..++|++.++||+|+||.||+|.. .++.||||.+........+. ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467999999999999999999963 14679999986543222222 3346
Q ss_pred HHHHHHhccCCc----eEEEEEEeeCC------CCCeEEEEEeccCCCCHHHHHHhcCCC--------------------
Q 036407 61 LYFASLLEQDDH----VVSVLGFSSNP------KRHRMLLVYELMSNGNLQDALLHKKPP-------------------- 110 (576)
Q Consensus 61 I~iLs~L~h~pN----Iv~Llg~~~~~------s~~~l~LVmE~~~gGsL~d~L~~~~~~-------------------- 110 (576)
+.++.++.|+++ ++.++++|... .....||||||+.+++|.+++......
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777776432 35566666532 235689999999999999988643210
Q ss_pred -ChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 111 -ELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 111 -~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~ 360 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence 11245567889999999999999999 9999999999999999999999999986543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=222.08 Aligned_cols=149 Identities=24% Similarity=0.401 Sum_probs=128.0
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
..|...++||+|.||+||+|+.. ++.||+|.++.+.. ......++||-++..|+| .||+++++....+ ..+.+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkh-knivrl~dvlhsd--kkltl 78 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLHDVLHSD--KKLTL 78 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhh-cceeehhhhhccC--ceeEE
Confidence 45777899999999999999865 68899999976432 224578999999999998 9999998887665 88999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccccC
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
|+|||.. +|..++....+. ++...+..++.|++.||.|+|+++ ++|||+||.|+||+.+|.+|+.|||+++.++.
T Consensus 79 vfe~cdq-dlkkyfdslng~--~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 79 VFEFCDQ-DLKKYFDSLNGD--LDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred eHHHhhH-HHHHHHHhcCCc--CCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 9999954 888888775432 777888889999999999999999 99999999999999999999999999987765
Q ss_pred C
Q 036407 171 G 171 (576)
Q Consensus 171 ~ 171 (576)
+
T Consensus 154 p 154 (292)
T KOG0662|consen 154 P 154 (292)
T ss_pred c
Confidence 4
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=265.12 Aligned_cols=147 Identities=33% Similarity=0.465 Sum_probs=115.1
Q ss_pred CCccceeeccCcEE-EEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 17 FSPSRLLGQGGFGS-VFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 17 Y~i~e~LG~GsfG~-Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
|...+.+|.|+.|+ ||+|.+.++.||||.+-.... ....+||..++.-..|+||+++++ .+.+..++||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEe--eccCCceEEEEehHh
Confidence 44457888988765 599999999999999854332 356899999999988999988854 455558999999999
Q ss_pred CCCCHHHHHHhcCCCChhhH-HHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC---C--CcEEEcccccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEW-CKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH---N--FCAKISDFGLARLKS 169 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~-~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~---~--g~vKLiDFGlA~~~~ 169 (576)
..+|.+++........... ...+.++.|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++...
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 4699999977311000111 234668899999999999999 999999999999976 3 468999999998766
Q ss_pred CC
Q 036407 170 VG 171 (576)
Q Consensus 170 ~~ 171 (576)
.+
T Consensus 663 ~~ 664 (903)
T KOG1027|consen 663 GG 664 (903)
T ss_pred CC
Confidence 54
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=263.54 Aligned_cols=146 Identities=27% Similarity=0.434 Sum_probs=126.1
Q ss_pred CccceeeccCcEEEEEEEEC------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 18 SPSRLLGQGGFGSVFHATLH------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 18 ~i~e~LG~GsfG~Vyka~~~------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
+..++||+|+||.||+|.+- +.+||||++.... .+...+++.|...|..|.| +|+++++++|.... +-|
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldH-pnl~RLLgvc~~s~---~ql 774 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDH-PNLLRLLGVCMLST---LQL 774 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCC-chHHHHhhhcccch---HHH
Confidence 45689999999999999753 4689999997533 3445688999999999998 99999999998753 789
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccccC
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
|++|++.|+|.++++.+... +.....+.|..||++|+.|||.++ ++||||-..|+|+.....+||.|||+++....
T Consensus 775 vtq~mP~G~LlDyvr~hr~~--igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDN--IGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHhcccchHHHHHHHhhcc--ccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999999875543 566677889999999999999999 99999999999999999999999999997765
Q ss_pred C
Q 036407 171 G 171 (576)
Q Consensus 171 ~ 171 (576)
.
T Consensus 851 d 851 (1177)
T KOG1025|consen 851 D 851 (1177)
T ss_pred c
Confidence 4
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-28 Score=242.07 Aligned_cols=150 Identities=25% Similarity=0.422 Sum_probs=122.0
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeec--CCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCC------C
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDS--GSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNP------K 84 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~--~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~------s 84 (576)
..|.-..+||+|.||.||+|+.+ ++.||+|++-. ....-....++|+.++..|.| +|++.++..|... .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkH-env~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKH-ENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcc-hhHHHHHHHHhhccCCcccc
Confidence 45667789999999999999866 67788876532 222233567899999999988 9988887776532 2
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
...+||||.+|++ +|.-++...... ++...+..++.+++.||.|+|++. |+|||+|+.|+||+.+|.+||+|||+
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr--~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVR--FSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCcccc--ccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeecccc
Confidence 2458999999976 888888765332 777888999999999999999999 99999999999999999999999999
Q ss_pred cccccC
Q 036407 165 ARLKSV 170 (576)
Q Consensus 165 A~~~~~ 170 (576)
++.+..
T Consensus 171 ar~fs~ 176 (376)
T KOG0669|consen 171 ARAFST 176 (376)
T ss_pred ccceec
Confidence 986654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=242.46 Aligned_cols=149 Identities=25% Similarity=0.359 Sum_probs=129.0
Q ss_pred HHHHhhcCCCCccceeeccCcEEEEEEEE-----CCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 8 SVLRRAADSFSPSRLLGQGGFGSVFHATL-----HDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 8 ~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~-----~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
+.+..+...|.++++||.|.|++||++.. +.+.||+|.+...+. ..++.+|+++|..+..+.||+.+.+.+..
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 44567788899999999999999999863 367899999976543 35789999999999999999999888877
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC-CcEEEcc
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN-FCAKISD 161 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~-g~vKLiD 161 (576)
. +..++|+||+++....+++.. ++...+..+++.++.||.++|++| ||||||||.|+|.+.. +.-.|+|
T Consensus 107 n--d~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 107 N--DQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred C--CeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEe
Confidence 6 889999999999988888765 456677889999999999999999 9999999999999854 6789999
Q ss_pred ccccccc
Q 036407 162 FGLARLK 168 (576)
Q Consensus 162 FGlA~~~ 168 (576)
||+|...
T Consensus 177 FgLA~~~ 183 (418)
T KOG1167|consen 177 FGLAQRY 183 (418)
T ss_pred chhHHHH
Confidence 9999753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-25 Score=204.58 Aligned_cols=140 Identities=34% Similarity=0.558 Sum_probs=121.6
Q ss_pred eeccCcEEEEEEEEC--CceEEEEEeecCCch-hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCCCC
Q 036407 23 LGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ-GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGN 99 (576)
Q Consensus 23 LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~-~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~gGs 99 (576)
||+|.+|.||++... ++.+++|.+...... ....+.+|+..+..+.+ ++++.+++++... ...++++|++.+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~--~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH-PNIVKLYGVFEDE--NHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCC-CCeeeEeeeeecC--CeEEEEEecCCCCc
Confidence 689999999999987 899999999755432 34678999999999988 9999999998876 78899999999899
Q ss_pred HHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC-CCcEEEcccccccccc
Q 036407 100 LQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH-NFCAKISDFGLARLKS 169 (576)
Q Consensus 100 L~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~-~g~vKLiDFGlA~~~~ 169 (576)
|.+++.... ..++...+..++.+++.+|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+....
T Consensus 78 l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~ 144 (215)
T cd00180 78 LKDLLKENE--GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLT 144 (215)
T ss_pred HHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEcc
Confidence 999987642 12677888899999999999999999 999999999999999 8999999999876543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-26 Score=223.05 Aligned_cols=148 Identities=20% Similarity=0.445 Sum_probs=128.1
Q ss_pred hcCCCCccceeeccCcEEEEEEE--ECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~--~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
..++|++.+++|.|-|+.||.|. ..++.++||++++- ....+.+|+.+|..|..++||+.+++...++......|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 45789999999999999999998 44789999999753 33578999999999998899999999988887788899
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC-CcEEEcccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN-FCAKISDFGLARLKS 169 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~-g~vKLiDFGlA~~~~ 169 (576)
|+||+++-+...+... ++.-.+..++.+++.||.|||++| |.|||+||.|++|+.. -.++|+|.|+|..+.
T Consensus 113 iFE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred HhhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999988877765543 444567789999999999999999 9999999999999865 579999999998876
Q ss_pred CC
Q 036407 170 VG 171 (576)
Q Consensus 170 ~~ 171 (576)
++
T Consensus 185 p~ 186 (338)
T KOG0668|consen 185 PG 186 (338)
T ss_pred CC
Confidence 65
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-26 Score=264.67 Aligned_cols=92 Identities=15% Similarity=0.157 Sum_probs=73.5
Q ss_pred CceEEEEEEeeC-----CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccC
Q 036407 71 DHVVSVLGFSSN-----PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIK 145 (576)
Q Consensus 71 pNIv~Llg~~~~-----~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLK 145 (576)
+||..+++++.. .....++++||++ +++|.+++.... ..++...++.|+.||+.||.|||++| |+|||||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrDlK 107 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG--IVVHNVR 107 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC--eeeccCC
Confidence 455555555421 1124567788887 669999997532 23788899999999999999999999 9999999
Q ss_pred CCCeEEcCCCcEEEcccccccc
Q 036407 146 PSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 146 PeNILLd~~g~vKLiDFGlA~~ 167 (576)
|+||||+..+.+|++|||++..
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~ 129 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSD 129 (793)
T ss_pred chhEEEcccCcEEEeeccccCc
Confidence 9999999999999999998764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-26 Score=219.38 Aligned_cols=156 Identities=26% Similarity=0.310 Sum_probs=125.0
Q ss_pred HHHhhcCCCCccceeeccCcEEEEEEEE--CCceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 9 VLRRAADSFSPSRLLGQGGFGSVFHATL--HDQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 9 ~lk~~~d~Y~i~e~LG~GsfG~Vyka~~--~g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
.+...++.+..+..||+|+||.|-+-++ .|...|+|.+...- .+...+.+.|+.+..+...+|.++.++|.....
T Consensus 40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re-- 117 (282)
T KOG0984|consen 40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE-- 117 (282)
T ss_pred ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--
Confidence 3566777788889999999999866554 48999999996432 234457888888888888889999999876555
Q ss_pred CeEEEEEeccCCCCHHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 86 HRMLLVYELMSNGNLQDALLH-KKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~-~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
..+|+.||.++. +|..+... ...+..+++..+=+|+..|+.||.|||+ .. ++|||+||+||||+.+|.+|+||||
T Consensus 118 gdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 118 GDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred ccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccc
Confidence 789999999954 78766544 2223347777777899999999999998 45 9999999999999999999999999
Q ss_pred cccccc
Q 036407 164 LARLKS 169 (576)
Q Consensus 164 lA~~~~ 169 (576)
++..+.
T Consensus 195 IsG~L~ 200 (282)
T KOG0984|consen 195 ISGYLV 200 (282)
T ss_pred cceeeh
Confidence 986543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-26 Score=245.92 Aligned_cols=150 Identities=24% Similarity=0.342 Sum_probs=127.7
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchh--------HHHHHHHHHHHHHhc--cCCceEEEEEEeeC
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG--------EREFYNELYFASLLE--QDDHVVSVLGFSSN 82 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~--------~~~~l~EI~iLs~L~--h~pNIv~Llg~~~~ 82 (576)
.+|..++.+|.|+||.|+.|.++ ...|+||.+.+...-. ...+-.||.+|+.|. .|+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46889999999999999999987 5779999987543211 123568999999998 24999999999988
Q ss_pred CCCCeEEEEEecc-CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcc
Q 036407 83 PKRHRMLLVYELM-SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISD 161 (576)
Q Consensus 83 ~s~~~l~LVmE~~-~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiD 161 (576)
+ +++||+||.. +|.+|.+++..... +++..+..|+.||+.|+.+||++| |||||||=+|++++.+|.+||+|
T Consensus 641 d--d~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 D--DYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred C--CeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEee
Confidence 7 8999999985 56689998877655 788888999999999999999999 99999999999999999999999
Q ss_pred ccccccccCC
Q 036407 162 FGLARLKSVG 171 (576)
Q Consensus 162 FGlA~~~~~~ 171 (576)
||.+...+.+
T Consensus 714 fgsaa~~ksg 723 (772)
T KOG1152|consen 714 FGSAAYTKSG 723 (772)
T ss_pred ccchhhhcCC
Confidence 9988766554
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=232.33 Aligned_cols=160 Identities=24% Similarity=0.251 Sum_probs=123.2
Q ss_pred hHHHHhhcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecC-CchhHHHHHHHHHHHHHhccCCceEEEEE
Q 036407 7 YSVLRRAADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSG-SLQGEREFYNELYFASLLEQDDHVVSVLG 78 (576)
Q Consensus 7 ~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~-s~~~~~~~l~EI~iLs~L~h~pNIv~Llg 78 (576)
.++|..-.++++..-++.+|.||.||.|.+. .+.|-+|.++.. +.-....++.|--.+-.+. |+|+..+.+
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~s-H~nll~V~~ 354 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGAS-HPNLLSVLG 354 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCc-CCCccceeE
Confidence 3556666677889999999999999999764 234556655422 2222345666665555555 599999999
Q ss_pred EeeCCCCCeEEEEEeccCCCCHHHHHHhc-----CCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC
Q 036407 79 FSSNPKRHRMLLVYELMSNGNLQDALLHK-----KPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH 153 (576)
Q Consensus 79 ~~~~~s~~~l~LVmE~~~gGsL~d~L~~~-----~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~ 153 (576)
.+.+.. ...++++.++.-|+|..++... .....+...+...++.|++.|++|||.++ +||.||-..|.+|++
T Consensus 355 V~ie~~-~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDY-ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeecc-CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehh
Confidence 988753 5678889999889999999732 22234666777889999999999999999 999999999999999
Q ss_pred CCcEEEccccccccccC
Q 036407 154 NFCAKISDFGLARLKSV 170 (576)
Q Consensus 154 ~g~vKLiDFGlA~~~~~ 170 (576)
...+||+|=.+++..-+
T Consensus 432 ~LqVkltDsaLSRDLFP 448 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFP 448 (563)
T ss_pred heeEEeccchhccccCc
Confidence 99999999888876544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-26 Score=248.72 Aligned_cols=150 Identities=25% Similarity=0.356 Sum_probs=133.0
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
.-.++|+++..+|.|.||.||+++.. ++..|+|+++..-..+..-+.+|+-++..++| +||+.+++.+... ..+|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h-~nivay~gsylr~--dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRH-PNIVAYFGSYLRR--DKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCC-cChHHHHhhhhhh--cCcE
Confidence 55689999999999999999999866 78999999987666666778899999999988 9999999988766 7889
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
++||||.+|+|++.....+. +++.++-.++++.++||.|||.+| -+|||||=.|||+...|.+|+.|||++..+.
T Consensus 89 icMEycgggslQdiy~~Tgp---lselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred EEEEecCCCcccceeeeccc---chhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhh
Confidence 99999999999987665443 888899999999999999999999 9999999999999999999999999876543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=203.10 Aligned_cols=146 Identities=33% Similarity=0.517 Sum_probs=126.4
Q ss_pred CCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch-hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEe
Q 036407 17 FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ-GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~-~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE 93 (576)
|.+.+.||.|++|.||++... ++.+++|.+...... ....+.+|+..+..+.+ +|++.+++++... ...++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~-~~i~~~~~~~~~~--~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKH-PNIVKLYGVFEDP--EPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCC-CChhhheeeeecC--CceEEEEe
Confidence 567889999999999999986 588999999765444 56688899999999966 9999999988766 77899999
Q ss_pred ccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 94 LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 94 ~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
++++++|.+++...... +++..+..++.+++.+|.+||+++ ++|+||+|.||+++.++.++|+|||.+....
T Consensus 78 ~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 78 YCEGGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIH 149 (225)
T ss_pred ccCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence 99999999988764421 567788889999999999999998 9999999999999999999999999876543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-26 Score=227.05 Aligned_cols=147 Identities=31% Similarity=0.520 Sum_probs=116.1
Q ss_pred CCccceeeccCcEEEEEEEEC--CceEEEEEeec--CCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC---CeEE
Q 036407 17 FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDS--GSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR---HRML 89 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~--~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~---~~l~ 89 (576)
.+--+.||.|+||+||.+... ++.||+|.+.. .+.....++.+|+.+++-++| .|+...++....+.. ..+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkH-dNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRH-DNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhcc-ccHHHHHHhcCCCCchHHHHHH
Confidence 345678999999999998865 78899998842 223445678999999999988 898887776543321 3457
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
+|+|++ ..+|...+-.-+. ++...++-++.||+.||.|||+.+ |+||||||.|+|++.+..+||||||+++...
T Consensus 134 V~TELm-QSDLHKIIVSPQ~---Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVSPQA---LTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHH-HhhhhheeccCCC---CCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccc
Confidence 888888 4478776655443 555666668899999999999999 9999999999999999999999999998654
Q ss_pred C
Q 036407 170 V 170 (576)
Q Consensus 170 ~ 170 (576)
.
T Consensus 208 ~ 208 (449)
T KOG0664|consen 208 Q 208 (449)
T ss_pred h
Confidence 4
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=220.60 Aligned_cols=145 Identities=30% Similarity=0.420 Sum_probs=116.1
Q ss_pred hcCCCCccceeeccCcEEEEEEEE--CCceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC----
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATL--HDQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK---- 84 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~--~g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s---- 84 (576)
...+|..+..+|.|.- .|..+-. .++.||+|.+.... .....+..+|+..+..+.| +|++.++.++.-..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~-~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNH-KNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcc-cceeeeeeccCccccHHH
Confidence 3457888889999987 4555543 37899999885431 2233567889988888888 99999999886432
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
...+|+|||++. .+|...+... ++-.++..|+.|++.|+.|||+.| |+||||||+||++..++.+||.|||+
T Consensus 93 ~~e~y~v~e~m~-~nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 93 FQEVYLVMELMD-ANLCQVILME-----LDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HHhHHHHHHhhh-hHHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchh
Confidence 356789999994 5898877743 456677889999999999999999 99999999999999999999999999
Q ss_pred ccc
Q 036407 165 ARL 167 (576)
Q Consensus 165 A~~ 167 (576)
|+.
T Consensus 165 ar~ 167 (369)
T KOG0665|consen 165 ART 167 (369)
T ss_pred hcc
Confidence 864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=197.29 Aligned_cols=103 Identities=19% Similarity=0.223 Sum_probs=72.2
Q ss_pred cCccccccccccCCCCcccccceeehhHHHHHHHhCCCCccccCCCchhhhhhhHHHHHHHhccccchhhhhhhHHhhhc
Q 036407 431 RGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSL 510 (576)
Q Consensus 431 ~gt~~y~aPE~~~~~~~~~~~DiwS~G~~l~eli~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (576)
.||+.|||||++.+..++.++|||||||++|||++|+.||...... ...+..+...+..... .+ ...
T Consensus 65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~----~~----~~~ 131 (176)
T smart00750 65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-----SAILEILLNGMPADDP----RD----RSN 131 (176)
T ss_pred CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-----cHHHHHHHHHhccCCc----cc----ccc
Confidence 5789999999999999999999999999999999999999643311 1112222211111100 00 001
Q ss_pred CHHHH--HHHHHHHHhhcccCCCCCCCHHHHHHHhccc
Q 036407 511 DREQA--LLCITVALLCLQKSPALRPSMEEVVGMLTGK 546 (576)
Q Consensus 511 ~~~~~--~~~~~~~~~cl~~dP~~Rps~~~v~~~l~~~ 546 (576)
..... ..+.+++.+||+.||.+||++.||+..+...
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11222 3689999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.6e-23 Score=204.66 Aligned_cols=157 Identities=21% Similarity=0.408 Sum_probs=126.6
Q ss_pred CCChHHHH--hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEE
Q 036407 4 RFSYSVLR--RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGF 79 (576)
Q Consensus 4 ~fs~~~lk--~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~ 79 (576)
.+...+|+ ...+.|.+.+.||+|.||.+-+++++ ++.+|+|.+... ......|.+|+..--.|.+|.||+.-+..
T Consensus 11 ~I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~v 89 (378)
T KOG1345|consen 11 LIPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEV 89 (378)
T ss_pred ccccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHH
Confidence 34444554 34688999999999999999999987 578999998643 33456899999888888899999887665
Q ss_pred eeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC--CCcE
Q 036407 80 SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH--NFCA 157 (576)
Q Consensus 80 ~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~--~g~v 157 (576)
.. ++.+.+++++||++.|+|..-+...+ +-+.....++.|++.|+.|||+.+ +||||||.+||||-. ...+
T Consensus 90 aF-qt~d~YvF~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rv 162 (378)
T KOG1345|consen 90 AF-QTSDAYVFVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRV 162 (378)
T ss_pred Hh-hcCceEEEeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEE
Confidence 32 33468889999999999987776543 566777889999999999999999 999999999999943 3489
Q ss_pred EEccccccccc
Q 036407 158 KISDFGLARLK 168 (576)
Q Consensus 158 KLiDFGlA~~~ 168 (576)
||||||.....
T Consensus 163 KlcDFG~t~k~ 173 (378)
T KOG1345|consen 163 KLCDFGLTRKV 173 (378)
T ss_pred Eeeeccccccc
Confidence 99999987643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.6e-20 Score=177.44 Aligned_cols=147 Identities=33% Similarity=0.494 Sum_probs=123.1
Q ss_pred CCccceeeccCcEEEEEEEECCceEEEEEeecCCch---hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEe
Q 036407 17 FSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQ---GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~---~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE 93 (576)
|.+...||.|+|+.||.+... ..+++|.+...... ....+.+|+.++..+.++++++.+...+... ...+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE--GSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEEEEEEe
Confidence 677889999999999999887 78899999754332 3567899999999999966899999888554 55899999
Q ss_pred ccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC-cEEEccccccccc
Q 036407 94 LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF-CAKISDFGLARLK 168 (576)
Q Consensus 94 ~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g-~vKLiDFGlA~~~ 168 (576)
++.++++.+++........+.......++.|++.++.|+|..+ ++|||+||+||+++..+ .++++|||+++..
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 9999999976665431112677788889999999999999999 99999999999999988 7999999998743
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.2e-20 Score=190.73 Aligned_cols=147 Identities=24% Similarity=0.351 Sum_probs=119.7
Q ss_pred CCCccceeeccCcEEEEEEEECC---ceEEEEEeecCCchhHHHHHHHHHHHHHhc---cCCceEEEEEEeeCCCCCeEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLHD---QSVAVKVMDSGSLQGEREFYNELYFASLLE---QDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~g---~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~---h~pNIv~Llg~~~~~s~~~l~ 89 (576)
+|.+.++||+|+||.||.+.... ..+|+|............+..|+.++..+. +..++..++.... ......|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence 89999999999999999998764 368999887543333236778888888776 3357777777764 2336789
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC-----CcEEEccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN-----FCAKISDFGL 164 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~-----g~vKLiDFGl 164 (576)
|||+.+ |.+|.++..... ...++..++..|+.|++.+|.+||+.| ++||||||.|+++... ..+.|+|||+
T Consensus 98 iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 999999 899999886655 344888999999999999999999999 9999999999999865 4689999999
Q ss_pred ccc
Q 036407 165 ARL 167 (576)
Q Consensus 165 A~~ 167 (576)
++.
T Consensus 174 ar~ 176 (322)
T KOG1164|consen 174 ARR 176 (322)
T ss_pred Ccc
Confidence 984
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=190.65 Aligned_cols=166 Identities=17% Similarity=0.114 Sum_probs=126.2
Q ss_pred ChHHHHhhcCCCCccceeeccCcEEEEEEEEC---CceEEEEEeecC-----CchhHHHHHHHHHHHHHhccCCceE-EE
Q 036407 6 SYSVLRRAADSFSPSRLLGQGGFGSVFHATLH---DQSVAVKVMDSG-----SLQGEREFYNELYFASLLEQDDHVV-SV 76 (576)
Q Consensus 6 s~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~---g~~VAVK~i~~~-----s~~~~~~~l~EI~iLs~L~h~pNIv-~L 76 (576)
.-+......++|.+.+.||+|+||+||+|... ++.+|||.+... .......+.+|+.++..|.| +|++ .+
T Consensus 9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h-~~iv~~l 87 (365)
T PRK09188 9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRG-IGVVPQL 87 (365)
T ss_pred cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccC-CCCCcEE
Confidence 34556778899999999999999999999863 567899987532 11234568999999999988 6766 44
Q ss_pred EEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeeccc-CCCCeEEcCCC
Q 036407 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDI-KPSNILLDHNF 155 (576)
Q Consensus 77 lg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDL-KPeNILLd~~g 155 (576)
+.. +..||||||++|++|.. +. ... ...++.+++.||.|||++| |+|||| ||+|||++.++
T Consensus 88 ~~~------~~~~LVmE~~~G~~L~~-~~---~~~------~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~ 149 (365)
T PRK09188 88 LAT------GKDGLVRGWTEGVPLHL-AR---PHG------DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDG 149 (365)
T ss_pred EEc------CCcEEEEEccCCCCHHH-hC---ccc------hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCC
Confidence 432 34699999999999962 21 111 1346789999999999999 999999 99999999999
Q ss_pred cEEEccccccccccCCCCC---------cCcCCCCccccchhhh
Q 036407 156 CAKISDFGLARLKSVGENQ---------NQADGENKNKAAELES 190 (576)
Q Consensus 156 ~vKLiDFGlA~~~~~~~~~---------~~~~gt~~y~APEl~~ 190 (576)
.++|+|||+++........ ....+++.|.+||...
T Consensus 150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 9999999999866543211 1234677788888654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.1e-20 Score=208.25 Aligned_cols=143 Identities=25% Similarity=0.347 Sum_probs=99.7
Q ss_pred CccceeeccCcEEEEEEEEC--CceEEEEEee----cC-CchhH-HHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 18 SPSRLLGQGGFGSVFHATLH--DQSVAVKVMD----SG-SLQGE-REFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 18 ~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~----~~-s~~~~-~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
....++|.|++|.|+..... ...++.|.+. .. ..... ..+..|+-+-..|.| +|++..+...... ....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h-~~~~e~l~~~~~~--~~~~ 397 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSH-PNIIETLDIVQEI--DGIL 397 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccC-CchhhhHHHHhhc--ccch
Confidence 45689999999977766533 3333444332 11 11111 124556666666766 8876655444332 2223
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
-+||||++ +|..++..... +....+.-++.|++.||.|||.+| |.|||+||+|+++..+|.+||+|||.+....
T Consensus 398 ~~mE~~~~-Dlf~~~~~~~~---~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSNGK---LTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hhhhcccH-HHHHHHhcccc---cchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeec
Confidence 33999998 99988876532 555667778999999999999999 9999999999999999999999999876543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-18 Score=177.03 Aligned_cols=151 Identities=24% Similarity=0.334 Sum_probs=128.3
Q ss_pred hhcCCCCccceeeccCcEEEEEEE--ECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~--~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
...-.|++.++||+|+||+++.|+ +.+++||||.-...+ ..-++..|.+..+.|.+.+.|..++.|.... .+-.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG--~~Ni 100 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG--KYNI 100 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeecccc--chhh
Confidence 344579999999999999999997 458999999875332 2246788999999999999999997776544 6778
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC-----cEEEccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF-----CAKISDFGL 164 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g-----~vKLiDFGl 164 (576)
||+|++ |.+|.|++.-+++. ++..++..|+.|++.-++++|++. .|+|||||+|+||...+ .+.|+|||+
T Consensus 101 LVidLL-GPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccc
Confidence 999999 99999999887654 888899999999999999999999 99999999999997543 589999999
Q ss_pred cccccCC
Q 036407 165 ARLKSVG 171 (576)
Q Consensus 165 A~~~~~~ 171 (576)
|+.+-++
T Consensus 176 AK~YrDp 182 (449)
T KOG1165|consen 176 AKEYRDP 182 (449)
T ss_pred hhhhcCc
Confidence 9987655
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-18 Score=172.88 Aligned_cols=150 Identities=23% Similarity=0.331 Sum_probs=124.9
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
...++|+++++||+|+||.+|.|..- |+.||||+-... .....+.-|..+-..|++...|..++.+.... .+-.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~--~ynv 87 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEK--DYNV 87 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhcccc--ccce
Confidence 45689999999999999999999854 899999997532 22345777888888888877777777776655 6779
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC---CcEEEccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN---FCAKISDFGLAR 166 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~---g~vKLiDFGlA~ 166 (576)
|||+++ |++|.+++.-.... ++..+++-++-|++.-++|+|.++ ++||||||+|+|..-. ..+.++|||+|+
T Consensus 88 lVMdLL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeeecc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchh
Confidence 999999 99999998765543 778889999999999999999999 9999999999999643 578999999998
Q ss_pred cccC
Q 036407 167 LKSV 170 (576)
Q Consensus 167 ~~~~ 170 (576)
.+.+
T Consensus 163 ky~d 166 (341)
T KOG1163|consen 163 KYRD 166 (341)
T ss_pred hhcc
Confidence 7654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-19 Score=181.48 Aligned_cols=142 Identities=21% Similarity=0.458 Sum_probs=116.2
Q ss_pred CCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchh--HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQG--EREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~--~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
.++.++.+|.+...|..|+|++.|..+++|+++...... ...|..|+-.+..+.| |||..+++.|..+ .++.++.
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifsh-pnilpvlgacnsp--pnlv~is 266 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSH-PNILPVLGACNSP--PNLVIIS 266 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecC-CchhhhhhhccCC--CCceEee
Confidence 445577889999999999999999999999997544332 2457777767777766 9999999999887 8899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKIS 160 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLi 160 (576)
.|++.|+|+.++..... -.++..++..++.+++.|++|||+..+-|...-|.+.+++||++.+.+|.
T Consensus 267 q~mp~gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred eeccchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee
Confidence 99999999999987543 34677788899999999999999977645566788999999998877764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=6e-18 Score=164.62 Aligned_cols=140 Identities=16% Similarity=0.154 Sum_probs=103.9
Q ss_pred cceeeccCcEEEEEEEEC-CceEEEEEeecCCch--h------------------------HHHHHHHHHHHHHhccCCc
Q 036407 20 SRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQ--G------------------------EREFYNELYFASLLEQDDH 72 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~--~------------------------~~~~l~EI~iLs~L~h~pN 72 (576)
...||+|++|.||+|... |+.||||+++..... . ......|+..+..+.+ ++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVT-AG 80 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHH-CC
Confidence 578999999999999875 899999999754211 1 1122458888988875 44
Q ss_pred eEEEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHH-HhCCCCeeecccCCCCeEE
Q 036407 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYL-HSLNPPVIHGDIKPSNILL 151 (576)
Q Consensus 73 Iv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yL-Hs~g~~IVHrDLKPeNILL 151 (576)
+.....+.. ...+|||||++++++........ .++...+..++.|++.+|.+| |+.| |+||||||+|||+
T Consensus 81 v~~p~~~~~----~~~~iVmE~i~g~~l~~~~~~~~---~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILL----KSHVLVMEFIGDDGWAAPRLKDA---PLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEe----cCCEEEEEEeCCCCCcchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE
Confidence 322222211 12289999998877654433222 267788899999999999999 6889 9999999999999
Q ss_pred cCCCcEEEccccccccccC
Q 036407 152 DHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 152 d~~g~vKLiDFGlA~~~~~ 170 (576)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred E-CCcEEEEEccccccCCC
Confidence 8 57899999999875544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-17 Score=159.54 Aligned_cols=142 Identities=19% Similarity=0.168 Sum_probs=107.2
Q ss_pred ccceeeccCcEEEEEEEEC-CceEEEEEeecCCch--h------------------------HHHHHHHHHHHHHhccCC
Q 036407 19 PSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQ--G------------------------EREFYNELYFASLLEQDD 71 (576)
Q Consensus 19 i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~--~------------------------~~~~l~EI~iLs~L~h~p 71 (576)
+...||+|++|.||+|... |+.||||+++..... . ...+..|+..+.++.+ +
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYE-A 79 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHh-C
Confidence 3578999999999999875 899999999764211 0 1124578888888877 6
Q ss_pred ceEEEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeE
Q 036407 72 HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNIL 150 (576)
Q Consensus 72 NIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNIL 150 (576)
++.....+... ..+|||||++|+++......... ++...+..++.+++.+|.+||+ .| |+|+||||+|||
T Consensus 80 ~i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~---~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIl 150 (190)
T cd05145 80 GVPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVP---LEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNIL 150 (190)
T ss_pred CCCCceEEEec----CCEEEEEEecCCCchhhhhhhcc---CCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEE
Confidence 65443333322 23899999988755433222222 5566788899999999999999 99 999999999999
Q ss_pred EcCCCcEEEccccccccccCC
Q 036407 151 LDHNFCAKISDFGLARLKSVG 171 (576)
Q Consensus 151 Ld~~g~vKLiDFGlA~~~~~~ 171 (576)
++ ++.++|+|||++.....+
T Consensus 151 l~-~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred EE-CCCEEEEEcccceecCCC
Confidence 98 889999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.1e-18 Score=169.24 Aligned_cols=142 Identities=16% Similarity=0.166 Sum_probs=114.4
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHH---------HHHHHHHHHHhccCCceEEEEEEee
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGERE---------FYNELYFASLLEQDDHVVSVLGFSS 81 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~---------~l~EI~iLs~L~h~pNIv~Llg~~~ 81 (576)
+...++|++++.||.|+||.||++..++..+|||++.......+.. +.+|+..+.+|.| ++|..+..++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~-~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRS-EGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHH-CCCCcceEeee
Confidence 3678999999999999999999987777889999997544333322 5788889999977 89988887755
Q ss_pred CCC------CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC
Q 036407 82 NPK------RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF 155 (576)
Q Consensus 82 ~~s------~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g 155 (576)
... ....+|||||++|.+|.+... ++. ....+++.+|..||+.| ++|+|++|.||+++.+|
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC
Confidence 332 245799999999999977632 222 24568999999999999 99999999999999888
Q ss_pred cEEEcccccccc
Q 036407 156 CAKISDFGLARL 167 (576)
Q Consensus 156 ~vKLiDFGlA~~ 167 (576)
++|+|||....
T Consensus 173 -i~liDfg~~~~ 183 (232)
T PRK10359 173 -LRIIDLSGKRC 183 (232)
T ss_pred -EEEEECCCccc
Confidence 99999997653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.2e-18 Score=196.04 Aligned_cols=141 Identities=24% Similarity=0.247 Sum_probs=108.3
Q ss_pred CCCccceeeccCcEEEEEEEECCceEEEEEeecCC-chhHH---HHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGS-LQGER---EFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s-~~~~~---~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
.|...+-||++.|=+|.+|+.+...|+||++-+.. .-... +-+.|++ ..+..+||+..+.-.-... ...|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t~--kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVTD--KAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHhh--HHHHHH
Confidence 57778999999999999999987779999996432 22222 2333344 4445569988775554433 556777
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
=+|.. .+|+|.+..+. .+...+.+-|+.|++.||..+|..| |+|+|||.+||||.....+.|+||..-+
T Consensus 100 Rqyvk-hnLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 100 RQYVK-HNLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred HHHHh-hhhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccC
Confidence 78874 48988887654 3666667779999999999999999 9999999999999999999999997543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.2e-18 Score=184.41 Aligned_cols=138 Identities=22% Similarity=0.310 Sum_probs=111.9
Q ss_pred eeccCcEEEEEEE-----ECCceEEEEEeecCCchh--HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 23 LGQGGFGSVFHAT-----LHDQSVAVKVMDSGSLQG--EREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 23 LG~GsfG~Vyka~-----~~g~~VAVK~i~~~s~~~--~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
+|+|.||.|++++ ..+.-||+|+.++..... ......|..++..+..++.++.+...+..+ ..+++++++.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~--~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD--GKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc--cchhHhhhhc
Confidence 7899999999864 236789999987543321 123455666777777679999988777666 8899999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
.||+|...+..... +.+.....+...++.+++++|+.+ |+|+|+|++||+++.+|.+++.|||+++.
T Consensus 80 rgg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske 146 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKE 146 (612)
T ss_pred ccchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhH
Confidence 99999877765443 667777788899999999999999 99999999999999999999999998764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.7e-16 Score=154.17 Aligned_cols=142 Identities=17% Similarity=0.217 Sum_probs=107.7
Q ss_pred CCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhcc----CCceEEEEEEeeCCCC-Ce-EEE
Q 036407 17 FSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQ----DDHVVSVLGFSSNPKR-HR-MLL 90 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h----~pNIv~Llg~~~~~s~-~~-l~L 90 (576)
+.-.++||+|+||.||.....+. .+||++..........+.+|+.++..+.| |+||+.+++++....+ +. +.+
T Consensus 4 L~~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cCCcceecCCCceEEEECCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 44568999999999996222233 46998876544456679999999999953 6999999999887532 34 347
Q ss_pred EEec--cCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHH-HHHHhCCCCeeecccCCCCeEEcC----CCcEEEcc-c
Q 036407 91 VYEL--MSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI-AYLHSLNPPVIHGDIKPSNILLDH----NFCAKISD-F 162 (576)
Q Consensus 91 VmE~--~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL-~yLHs~g~~IVHrDLKPeNILLd~----~g~vKLiD-F 162 (576)
|+|| +.+++|.+++.... +++. ..++.+++.++ .|||+++ |+||||||+|||++. ++.++|+| |
T Consensus 83 I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 55799999996532 3433 24577888777 8999999 999999999999974 34799999 5
Q ss_pred ccccc
Q 036407 163 GLARL 167 (576)
Q Consensus 163 GlA~~ 167 (576)
|....
T Consensus 155 G~~~~ 159 (210)
T PRK10345 155 GESTF 159 (210)
T ss_pred CCcce
Confidence 55444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=1e-15 Score=148.54 Aligned_cols=134 Identities=20% Similarity=0.319 Sum_probs=108.9
Q ss_pred ceeeccCcEEEEEEEECCceEEEEEeecCCch--------hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 21 RLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQ--------GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~--------~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
+.||+|++|.||+|...+..+++|........ ....+.+|+.++..+.+ +++.....++... ...++||
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~p~~~~~~~--~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARK-AGVNVPAVYFVDP--ENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHH-CCCCCCeEEEEeC--CCCEEEE
Confidence 57999999999999999999999987543221 12357789999999877 6666555555444 5678999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||++|++|.+.+.... . .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999886432 1 56778999999999999999 99999999999998 78899999998875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-15 Score=145.96 Aligned_cols=131 Identities=20% Similarity=0.318 Sum_probs=103.4
Q ss_pred eeeccCcEEEEEEEECCceEEEEEeecCCch--------hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEe
Q 036407 22 LLGQGGFGSVFHATLHDQSVAVKVMDSGSLQ--------GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 22 ~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~--------~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE 93 (576)
+||+|++|.||+|...+..+++|........ ...++.+|+.++..+.+ +++.....++... ...++|||
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~p~~~~~~~--~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARK-AGVNTPVVYDVDP--DNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHH-CCCCCCEEEEEEC--CCCEEEEE
Confidence 4899999999999988999999997543211 12457789999999987 4444333333333 45689999
Q ss_pred ccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 94 LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 94 ~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|++|++|.+.+.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++...
T Consensus 78 ~~~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EECCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999988765421 1 57889999999999999 99999999999998 889999999988754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=157.31 Aligned_cols=148 Identities=27% Similarity=0.398 Sum_probs=89.0
Q ss_pred CCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccC----------CceEEEEEEe-
Q 036407 17 FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQD----------DHVVSVLGFS- 80 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~----------pNIv~Llg~~- 80 (576)
+...+.||.|+++.||.+... ++.+|||++..... ...+.+.+|......+.+. ..++.+-...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 445689999999999999976 69999999964332 1223444444222222220 1111111100
Q ss_pred -------e-CCCCC-----eEEEEEeccCCCCHHHHHHh---cCC-CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecc
Q 036407 81 -------S-NPKRH-----RMLLVYELMSNGNLQDALLH---KKP-PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGD 143 (576)
Q Consensus 81 -------~-~~s~~-----~l~LVmE~~~gGsL~d~L~~---~~~-~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrD 143 (576)
. ..... ..+++|+-+ .++|.+++.. ... ...+.....+.+..|++..+++||+.| ++|+|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHgd 170 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHGD 170 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEEST
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEecc
Confidence 0 00001 336777777 5688877643 221 122444455667789999999999999 99999
Q ss_pred cCCCCeEEcCCCcEEEcccccccc
Q 036407 144 IKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 144 LKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|+|+|++++.+|.++|+||+....
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r 194 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVR 194 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEE
T ss_pred cceeeEEEcCCCCEEEcChHHHee
Confidence 999999999999999999986543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.2e-16 Score=179.02 Aligned_cols=150 Identities=25% Similarity=0.339 Sum_probs=109.6
Q ss_pred HHHHhhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCc-h--hHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 8 SVLRRAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSL-Q--GEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 8 ~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~-~--~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
.+++...+.|.+.+.||+|+||.||+|... ++.||+|+-..... . .-.+++..+. ... .+.|..+...+.+.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~---~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLK-PQM---LPSIMHISSAHVFQ 766 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhc-hhh---hcchHHHHHHHccC
Confidence 345566788999999999999999999865 89999999765321 1 1112222222 111 13444444444555
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC-------CCc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH-------NFC 156 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~-------~g~ 156 (576)
+.-+||+||.+.|+|.+++.... .+++..++.++.|++.-+.+||.++ |||+||||+|+||.. ...
T Consensus 767 --~~S~lv~ey~~~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 767 --NASVLVSEYSPYGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred --CcceeeeeccccccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccc
Confidence 45589999999999999998443 3788888999999999999999999 999999999999943 235
Q ss_pred EEEccccccccc
Q 036407 157 AKISDFGLARLK 168 (576)
Q Consensus 157 vKLiDFGlA~~~ 168 (576)
++|+|||.+..+
T Consensus 840 l~lIDfG~siDm 851 (974)
T KOG1166|consen 840 LYLIDFGRSIDM 851 (974)
T ss_pred eEEEecccceee
Confidence 677777766543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.3e-15 Score=149.61 Aligned_cols=145 Identities=21% Similarity=0.210 Sum_probs=108.6
Q ss_pred CCCccceeeccCcEEEEEEE-E--CCceEEEEEeecCCch------------------------hHHHHHHHHHHHHHhc
Q 036407 16 SFSPSRLLGQGGFGSVFHAT-L--HDQSVAVKVMDSGSLQ------------------------GEREFYNELYFASLLE 68 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~-~--~g~~VAVK~i~~~s~~------------------------~~~~~l~EI~iLs~L~ 68 (576)
.|.+.+.||+|++|.||+|. . .|+.||||++...... ....+..|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57889999999999999998 2 4899999999753210 0123568999999887
Q ss_pred cC-CceEEEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCC
Q 036407 69 QD-DHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPS 147 (576)
Q Consensus 69 h~-pNIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPe 147 (576)
+. ..+..++.+ ...++||||+.+.+|......... .....+..++.|++.+|.+||.++. |+|+||||+
T Consensus 109 ~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~LH~~g~-iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVE---PEEEEEFELYDDILEEMRKLYKEGE-LVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe------cCceEEEEEecCCcccccccccCC---cchHHHHHHHHHHHHHHHHHHhcCC-EEeCCCChh
Confidence 51 223344432 124899999998887654422221 3445567889999999999998763 999999999
Q ss_pred CeEEcCCCcEEEccccccccccCC
Q 036407 148 NILLDHNFCAKISDFGLARLKSVG 171 (576)
Q Consensus 148 NILLd~~g~vKLiDFGlA~~~~~~ 171 (576)
||+++ ++.++|+|||.+.....+
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccCCc
Confidence 99999 889999999998866554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.9e-16 Score=178.19 Aligned_cols=114 Identities=26% Similarity=0.524 Sum_probs=77.5
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
.....+|..+++|..|+||.||.++++ .+.+|+| +++... +++- ++... +..
T Consensus 79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a------------------~np 132 (1205)
T KOG0606|consen 79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFA------------------GNP 132 (1205)
T ss_pred CCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--ccccc------------------CCc
Confidence 345678999999999999999999876 6788884 432211 1110 11111 112
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++| |+-.++++..+. ++ .+++.++.|||..+ |+|||+||+|.+|..-|.+|++|||+.+..
T Consensus 133 fvv------gDc~tllk~~g~---lP--------vdmvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 133 FVV------GDCATLLKNIGP---LP--------VDMVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred cee------chhhhhcccCCC---Cc--------chhhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhh
Confidence 333 333333443222 22 12378899999999 999999999999999999999999998754
Q ss_pred c
Q 036407 169 S 169 (576)
Q Consensus 169 ~ 169 (576)
-
T Consensus 194 L 194 (1205)
T KOG0606|consen 194 L 194 (1205)
T ss_pred h
Confidence 3
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=8e-15 Score=163.59 Aligned_cols=139 Identities=19% Similarity=0.291 Sum_probs=110.7
Q ss_pred cCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCc--------hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSL--------QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~--------~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
...|...++||+|+||.||+|.+.+..+++|....... ....++.+|+.++..+.+ ++++....++...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~p~~~~~~~-- 408 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARR-AGVPTPVIYDVDP-- 408 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcc-cCCCeeEEEEEeC--
Confidence 44556789999999999999998877777765432111 112467899999999987 7777766666554
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
...++||||+++++|.+.+. ....++.+++.+|.+||+.+ ++||||||+|||+ .++.++|+|||++
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCccc
Confidence 45689999999999988774 23458899999999999999 9999999999999 6788999999999
Q ss_pred cccc
Q 036407 166 RLKS 169 (576)
Q Consensus 166 ~~~~ 169 (576)
+...
T Consensus 475 ~~~~ 478 (535)
T PRK09605 475 KYSD 478 (535)
T ss_pred ccCC
Confidence 8644
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-14 Score=143.78 Aligned_cols=135 Identities=14% Similarity=0.105 Sum_probs=108.7
Q ss_pred CccceeeccCcEEEEEEEECCceEEEEEeecCCchh----HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEe
Q 036407 18 SPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQG----EREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 18 ~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~----~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE 93 (576)
.+...|+.|.||.||.+...+.+++.+.+.....-. ...+.+|+++|..|.++++++.++++ ...+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEEe
Confidence 456889999999999888788888888876443311 22578999999999888889999886 33599999
Q ss_pred ccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeeccc-CCCCeEEcCCCcEEEccccccccccC
Q 036407 94 LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDI-KPSNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 94 ~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDL-KPeNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
|+.|.+|.+.+.. ....++.+++.+|.+||++| |+|+|| ||.|||++.++.++|+|||++.....
T Consensus 79 yI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999888654321 01236788999999999999 999999 79999999999999999999975443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3e-16 Score=169.84 Aligned_cols=79 Identities=29% Similarity=0.421 Sum_probs=69.0
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
.+++|.|++|.-.+|.+++..+......+....+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence 4689999999999999999876665556777888899999999999 77 999999999999999999999999987
Q ss_pred cccc
Q 036407 166 RLKS 169 (576)
Q Consensus 166 ~~~~ 169 (576)
....
T Consensus 404 ts~~ 407 (516)
T KOG1033|consen 404 TSQD 407 (516)
T ss_pred eecc
Confidence 5443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=6e-15 Score=155.08 Aligned_cols=91 Identities=21% Similarity=0.327 Sum_probs=72.3
Q ss_pred cCCceEEEEEEeeCC-------------------------CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHH
Q 036407 69 QDDHVVSVLGFSSNP-------------------------KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV 123 (576)
Q Consensus 69 h~pNIv~Llg~~~~~-------------------------s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~ 123 (576)
.||||+.++++|.+. .+..+|+||.-.+ .+|.+++..+. .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 479999998876532 2466899999885 49999887654 34455566889
Q ss_pred HHHHHHHHHHhCCCCeeecccCCCCeEEc--CCC--cEEEccccccc
Q 036407 124 DIAKGIAYLHSLNPPVIHGDIKPSNILLD--HNF--CAKISDFGLAR 166 (576)
Q Consensus 124 qIl~AL~yLHs~g~~IVHrDLKPeNILLd--~~g--~vKLiDFGlA~ 166 (576)
|++.|+.|||++| |.|||+|++|||+. +++ .+.|+|||.+-
T Consensus 349 QlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred HHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceee
Confidence 9999999999999 99999999999995 333 56889999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.1e-14 Score=139.23 Aligned_cols=144 Identities=20% Similarity=0.168 Sum_probs=107.8
Q ss_pred HHHhhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCch----------------------hHHHHHHHHHHHH
Q 036407 9 VLRRAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQ----------------------GEREFYNELYFAS 65 (576)
Q Consensus 9 ~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~----------------------~~~~~l~EI~iLs 65 (576)
++....-.|.+.+.||+|+||.||++... ++.||||++...... ....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 34333334888999999999999999875 899999987643210 1123567888888
Q ss_pred HhccCC--ceEEEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecc
Q 036407 66 LLEQDD--HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGD 143 (576)
Q Consensus 66 ~L~h~p--NIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrD 143 (576)
.+.+ . .+..+++. ...++||||++|++|...... .....++.+++.++.++|+.+ |+|+|
T Consensus 89 ~l~~-~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g--i~H~D 150 (198)
T cd05144 89 ALYE-EGFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG--IIHGD 150 (198)
T ss_pred HHHH-cCCCCCceeec------CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC--CCcCC
Confidence 8866 4 33333322 344899999999988764321 123457889999999999999 99999
Q ss_pred cCCCCeEEcCCCcEEEccccccccccC
Q 036407 144 IKPSNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 144 LKPeNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
|+|.||+++.++.++|+|||++.....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999865544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.3e-13 Score=123.18 Aligned_cols=136 Identities=25% Similarity=0.277 Sum_probs=109.2
Q ss_pred ccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccC-CceEEEEEEeeCCCCCeEEEEEeccCC
Q 036407 19 PSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQD-DHVVSVLGFSSNPKRHRMLLVYELMSN 97 (576)
Q Consensus 19 i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~-pNIv~Llg~~~~~s~~~l~LVmE~~~g 97 (576)
+.+.||.|.++.||++...+..+++|.+..... ...+..|+..+..+.++ .++..++.+.... +..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEEEecCC
Confidence 467899999999999998888999999865433 45788999999999875 5777777776554 678999999988
Q ss_pred CCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCC-CCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 98 GNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN-PPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 98 GsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g-~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+.+... +......++.+++.+|..||... .+++|+|++|.||+++..+.++++|||.+...
T Consensus 78 ~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 78 ETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred eecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 766543 22334557788999999999731 23999999999999999899999999988753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.4e-14 Score=152.08 Aligned_cols=97 Identities=34% Similarity=0.564 Sum_probs=82.8
Q ss_pred HhccCCceEEEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccC
Q 036407 66 LLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIK 145 (576)
Q Consensus 66 ~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLK 145 (576)
.+.| .|+++++|.+... ...++|.+||..|+|.+.+...... +++.-...++++|+.||.|||.... ..|+.++
T Consensus 3 ~l~h-~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~--~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~ 76 (484)
T KOG1023|consen 3 QLDH-DNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIK--LDYFFILSFIRDISKGLAYLHNSPI-GYHGALK 76 (484)
T ss_pred ccch-hhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccC--ccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeec
Confidence 3445 9999999999988 8899999999999999999774322 6777777788999999999997541 3899999
Q ss_pred CCCeEEcCCCcEEEccccccccc
Q 036407 146 PSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 146 PeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+.|.+++..-.+||+|||+....
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~ 99 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLL 99 (484)
T ss_pred cccceeeeeEEEEechhhhcccc
Confidence 99999999999999999987654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.7e-13 Score=130.53 Aligned_cols=137 Identities=21% Similarity=0.206 Sum_probs=96.1
Q ss_pred cceeeccCcEEEEEEEEC-CceEEEEEeecCCchh--HHH----------------------HHHHHHHHHHhccCC-ce
Q 036407 20 SRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQG--ERE----------------------FYNELYFASLLEQDD-HV 73 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~--~~~----------------------~l~EI~iLs~L~h~p-NI 73 (576)
.+.||+|+||.||+|... ++.||||++....... ... ...|+..+..+.+.. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 568999999999999877 8999999987532211 111 135555566654421 23
Q ss_pred EEEEEEeeCCCCCeEEEEEeccCCCCHHH-HHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEE
Q 036407 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQD-ALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILL 151 (576)
Q Consensus 74 v~Llg~~~~~s~~~l~LVmE~~~gGsL~d-~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILL 151 (576)
..+++. ...++||||++++.+.. .+.... .. ..+..++.+++.++.++|. .+ |+|+||||+||++
T Consensus 82 ~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL------NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILV 148 (187)
T ss_pred CceEec------CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEE
Confidence 333322 23589999998854321 111111 11 4456788999999999999 88 9999999999999
Q ss_pred cCCCcEEEccccccccccC
Q 036407 152 DHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 152 d~~g~vKLiDFGlA~~~~~ 170 (576)
+ ++.++|+|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 89999999999876554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=8.7e-13 Score=133.04 Aligned_cols=138 Identities=20% Similarity=0.233 Sum_probs=104.1
Q ss_pred ceee-ccCcEEEEEEEECCceEEEEEeecCCc-------------hhHHHHHHHHHHHHHhccCCc--eEEEEEEeeCCC
Q 036407 21 RLLG-QGGFGSVFHATLHDQSVAVKVMDSGSL-------------QGEREFYNELYFASLLEQDDH--VVSVLGFSSNPK 84 (576)
Q Consensus 21 e~LG-~GsfG~Vyka~~~g~~VAVK~i~~~s~-------------~~~~~~l~EI~iLs~L~h~pN--Iv~Llg~~~~~s 84 (576)
..|| .|+.|.||.+...+..+|||.+..... ....++.+|+.++..|.+ ++ ++..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~-~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYE-AGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHh-CCCCCceeEeeeeeec
Confidence 5687 789999999988889999998854211 123467889999999987 44 355555543322
Q ss_pred C--CeEEEEEeccCC-CCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcc
Q 036407 85 R--HRMLLVYELMSN-GNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISD 161 (576)
Q Consensus 85 ~--~~l~LVmE~~~g-GsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiD 161 (576)
. ...++|||+++| .+|.+++.... ++.. .+.+|+.+|.+||+.| |+|+||||.|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~----l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAP----LSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCC----CCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEE
Confidence 1 123599999997 68988875422 3322 3578999999999999 99999999999999989999999
Q ss_pred cccccccc
Q 036407 162 FGLARLKS 169 (576)
Q Consensus 162 FGlA~~~~ 169 (576)
||.+....
T Consensus 186 fg~~~~~~ 193 (239)
T PRK01723 186 FDRGELRT 193 (239)
T ss_pred CCCcccCC
Confidence 99887644
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.1e-13 Score=156.51 Aligned_cols=150 Identities=28% Similarity=0.354 Sum_probs=115.0
Q ss_pred cCCCCccceeeccCcEEEEEEEEC---CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH---DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~---g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
...|.+.+.||+|+|+.|-..... ...+|+|.+.... .........|..+-..+..|.|++.+++..... ...
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~--~~~ 96 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP--RSY 96 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC--ccc
Confidence 457888999999999999877643 4556777765432 222234455777767777569999998887776 778
Q ss_pred EEEEeccCCCCHHHHH-HhcCCCChhhHHHHHHHHHHHHHHHHHHH-hCCCCeeecccCCCCeEEcCCC-cEEEcccccc
Q 036407 89 LLVYELMSNGNLQDAL-LHKKPPELMEWCKRFSIAVDIAKGIAYLH-SLNPPVIHGDIKPSNILLDHNF-CAKISDFGLA 165 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L-~~~~~~~~ls~~~vl~I~~qIl~AL~yLH-s~g~~IVHrDLKPeNILLd~~g-~vKLiDFGlA 165 (576)
++++++..|+++.+.+ ..... ..+...+-.++.|+..++.|+| ..+ +.|+|+||+|.+++..+ .+++.|||+|
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred ccccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhh
Confidence 9999999999998877 33221 1333445568999999999999 888 99999999999999999 9999999998
Q ss_pred cccc
Q 036407 166 RLKS 169 (576)
Q Consensus 166 ~~~~ 169 (576)
..+.
T Consensus 173 t~~~ 176 (601)
T KOG0590|consen 173 TAYR 176 (601)
T ss_pred cccc
Confidence 7543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.21 E-value=7.7e-11 Score=128.93 Aligned_cols=142 Identities=23% Similarity=0.244 Sum_probs=97.5
Q ss_pred cceeeccCcEEEEEEEEC-CceEEEEEeecCCchh----------------------------------------HHHHH
Q 036407 20 SRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQG----------------------------------------EREFY 58 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~----------------------------------------~~~~l 58 (576)
.+.||.|++|.||+|+.. |+.||||+.+++.... +-.+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999986 8999999987642110 00234
Q ss_pred HHHHHHHHhc----cCCceEEEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHH-HHHHHH
Q 036407 59 NELYFASLLE----QDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAK-GIAYLH 133 (576)
Q Consensus 59 ~EI~iLs~L~----h~pNIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~-AL~yLH 133 (576)
+|.+.+.++. +++++.....+.... ...+|||||++|++|.+........ .+ ...++..++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~--~~~vLvmE~i~G~~L~~~~~~~~~~--~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT--SERVLTMEWIDGIPLSDIAALDEAG--LD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc--CCceEEEEeECCcccccHHHHHhcC--CC---HHHHHHHHHHHHHHHHH
Confidence 4555444443 334444333333222 3459999999999998876432111 11 2234555544 467789
Q ss_pred hCCCCeeecccCCCCeEEcCCCcEEEccccccccccC
Q 036407 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 134 s~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
..| ++|+|++|.||+++.++.++++|||++..++.
T Consensus 275 ~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 RDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred hCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999 99999999999999999999999999877654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.18 E-value=9.6e-11 Score=109.35 Aligned_cols=131 Identities=20% Similarity=0.153 Sum_probs=96.3
Q ss_pred cceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCCCC
Q 036407 20 SRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGN 99 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~gGs 99 (576)
++.|+.|.++.||++...++.|++|+...... ....+..|+.++..+.+...+..++.+.. ...++|||+++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEEEEecCCCc
Confidence 46788999999999998899999999854321 12345788888888876444455555432 22479999999987
Q ss_pred HHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCC---CCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 100 LQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN---PPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 100 L~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g---~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+.+. .. . ...++.+++.+|+.||..+ ..++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~--~~-----~----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTE--DF-----S----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc--cc-----c----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 7542 00 1 1225678999999999876 1249999999999998 67899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.4e-09 Score=121.72 Aligned_cols=147 Identities=20% Similarity=0.178 Sum_probs=93.9
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchh-------------------------------------
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG------------------------------------- 53 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~------------------------------------- 53 (576)
....|+. +.||+|++|.||+|+.+ |+.||||+.+++-...
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3445776 79999999999999975 7999999997542100
Q ss_pred ---HHHHHHHHHHHHHhcc----CCceEEEEEEeeCCCCCeEEEEEeccCCCCHHHHH--HhcC-CCChhhHHHHHHHHH
Q 036407 54 ---EREFYNELYFASLLEQ----DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDAL--LHKK-PPELMEWCKRFSIAV 123 (576)
Q Consensus 54 ---~~~~l~EI~iLs~L~h----~pNIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L--~~~~-~~~~ls~~~vl~I~~ 123 (576)
+-.+.+|...+.++.. .+.+....-+.... ...+|||||++|+++.+.. ...+ ....+....+..++.
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s--t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC--SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccC--CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 0123445555555542 12222112222222 4558999999999997743 2221 111133333333344
Q ss_pred HHHHHHHHHHhCCCCeeecccCCCCeEEcCCC----cEEEccccccccccCC
Q 036407 124 DIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF----CAKISDFGLARLKSVG 171 (576)
Q Consensus 124 qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g----~vKLiDFGlA~~~~~~ 171 (576)
|+ +..| ++|+|+||.||+++.++ .++++|||+...++..
T Consensus 275 Qi-------f~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 275 QV-------FRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HH-------HhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 43 3578 99999999999999888 9999999998776543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.1e-10 Score=117.73 Aligned_cols=96 Identities=26% Similarity=0.428 Sum_probs=77.3
Q ss_pred HHHhccCCceEEEEEEeeCC---CCCeEEEEEeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCCCCe
Q 036407 64 ASLLEQDDHVVSVLGFSSNP---KRHRMLLVYELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLNPPV 139 (576)
Q Consensus 64 Ls~L~h~pNIv~Llg~~~~~---s~~~l~LVmE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~I 139 (576)
+-.+-| .|+++++.|+.+. +.....++.||+..|+|..+|+... ....+....-.+++.||+.||.|||++.|+|
T Consensus 121 llqlvH-snlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 121 LLQLVH-SNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHH-HHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 344445 7899998888753 3356789999999999999997633 2233555566789999999999999999999
Q ss_pred eecccCCCCeEEcCCCcEEEc
Q 036407 140 IHGDIKPSNILLDHNFCAKIS 160 (576)
Q Consensus 140 VHrDLKPeNILLd~~g~vKLi 160 (576)
+|+++..+.|++..+|.+|+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred ccCCcchhheeecCCceEEec
Confidence 999999999999988888874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3e-10 Score=125.27 Aligned_cols=150 Identities=23% Similarity=0.273 Sum_probs=113.8
Q ss_pred CCCCccceeec--cCcEEEEEEEEC----CceEEEEEeec--CCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 15 DSFSPSRLLGQ--GGFGSVFHATLH----DQSVAVKVMDS--GSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 15 d~Y~i~e~LG~--GsfG~Vyka~~~----g~~VAVK~i~~--~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
..|.+.+-+|. |.+|.||.+... ...+|+|.-.. ........-.+|+....++..|+|++.....+... +
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~--~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS--G 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC--C
Confidence 34567889999 999999998762 67788887432 22233344567777667777778888865555554 8
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHH----HHHHHHhCCCCeeecccCCCCeEEcCC-CcEEEcc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAK----GIAYLHSLNPPVIHGDIKPSNILLDHN-FCAKISD 161 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~----AL~yLHs~g~~IVHrDLKPeNILLd~~-g~vKLiD 161 (576)
.+++-+|.| +.+|..+...... .++...++.++.+... ||.++|... |+|-|+||.||++..+ ..++++|
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred cceeeeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCC
Confidence 889999999 5678776654322 2555667778888888 999999999 9999999999999998 8899999
Q ss_pred ccccccccCC
Q 036407 162 FGLARLKSVG 171 (576)
Q Consensus 162 FGlA~~~~~~ 171 (576)
||+...+..+
T Consensus 267 f~~v~~i~~~ 276 (524)
T KOG0601|consen 267 FGLVSKISDG 276 (524)
T ss_pred cceeEEccCC
Confidence 9988776554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.4e-08 Score=98.37 Aligned_cols=139 Identities=14% Similarity=0.128 Sum_probs=96.0
Q ss_pred cceeeccCcEEEEEEEEC--------CceEEEEEeecCC--ch-------------------h-H----HHHHHHHHHHH
Q 036407 20 SRLLGQGGFGSVFHATLH--------DQSVAVKVMDSGS--LQ-------------------G-E----REFYNELYFAS 65 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~--------g~~VAVK~i~~~s--~~-------------------~-~----~~~l~EI~iLs 65 (576)
...||.|==+.||.|... +..+|||+.+... .+ + . ....+|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 457899999999999754 3689999885321 00 0 1 12348999998
Q ss_pred HhccC-CceEEEEEEeeCCCCCeEEEEEeccCCCCHHH-HHHhcCCCChhhHHHHHHHHHHHHHHHHHH-HhCCCCeeec
Q 036407 66 LLEQD-DHVVSVLGFSSNPKRHRMLLVYELMSNGNLQD-ALLHKKPPELMEWCKRFSIAVDIAKGIAYL-HSLNPPVIHG 142 (576)
Q Consensus 66 ~L~h~-pNIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d-~L~~~~~~~~ls~~~vl~I~~qIl~AL~yL-Hs~g~~IVHr 142 (576)
+|... -++..++++ ..-+|||||+.+..+.. .+.... ++......+..+++.+|..| |+.+ ++|+
T Consensus 82 rl~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~~----~~~~~~~~i~~~i~~~l~~l~H~~g--lVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDAK----LNDEEMKNAYYQVLSMMKQLYKECN--LVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhccc----cCHHHHHHHHHHHHHHHHHHHHhCC--eecC
Confidence 88763 244444443 23489999996543321 222211 33344556778999999988 8899 9999
Q ss_pred ccCCCCeEEcCCCcEEEccccccccccCC
Q 036407 143 DIKPSNILLDHNFCAKISDFGLARLKSVG 171 (576)
Q Consensus 143 DLKPeNILLd~~g~vKLiDFGlA~~~~~~ 171 (576)
||++.|||+. ++.+.|+|||.+-....+
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCCCC
Confidence 9999999996 578999999988766543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.9e-08 Score=96.03 Aligned_cols=144 Identities=24% Similarity=0.321 Sum_probs=100.3
Q ss_pred cceeeccCcEEEEEEEECC-ceEEEEEeecCCc-hhHHHHHHHHHHHHHhccC-CceEEEEEEeeCCC-CCeEEEEEecc
Q 036407 20 SRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSL-QGEREFYNELYFASLLEQD-DHVVSVLGFSSNPK-RHRMLLVYELM 95 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~g-~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~-pNIv~Llg~~~~~s-~~~l~LVmE~~ 95 (576)
.+.|+.|.++.||++...+ ..+++|....... .....+..|..++..+.+. ..+..++.+..... .+..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 3678999999999998875 8999999864322 1345678999999988763 23455666554321 13568999999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL---------------------------------------- 135 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~---------------------------------------- 135 (576)
+|.++.+.+.. . .++......++.+++..|..||+.
T Consensus 83 ~G~~l~~~~~~-~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLLR-P---ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCCC-C---CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 98877654321 0 134444455666666666666631
Q ss_pred --------------CCCeeecccCCCCeEEcC--CCcEEEcccccccc
Q 036407 136 --------------NPPVIHGDIKPSNILLDH--NFCAKISDFGLARL 167 (576)
Q Consensus 136 --------------g~~IVHrDLKPeNILLd~--~g~vKLiDFGlA~~ 167 (576)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 135789999999999998 56789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.3e-08 Score=94.85 Aligned_cols=132 Identities=21% Similarity=0.305 Sum_probs=96.2
Q ss_pred ceeeccCcEEEEEEEECCceEEEEEeecCCc--------hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 21 RLLGQGGFGSVFHATLHDQSVAVKVMDSGSL--------QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~--------~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
..|++|+=+.||.+.+.+.++++|.=.+... -...+..+|.+++.++... .|.....+..++ ....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~-GV~~P~v~dvD~--~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREA-GVPVPIVYDVDP--DNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHc-CCCCCeEEEEcC--CCCEEEE
Confidence 4678999999999988887777775422111 1134678899999888763 333333344444 4558999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||++|..|.+.+.... ..++..|-.-+.-||..| |+|+||.++||++...+ +.++|||++..-
T Consensus 79 e~I~G~~lkd~l~~~~----------~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 79 EYIEGELLKDALEEAR----------PDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EEeCChhHHHHHHhcc----------hHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999988888776541 235666777788899999 99999999999997665 999999998743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.1e-09 Score=115.59 Aligned_cols=147 Identities=22% Similarity=0.307 Sum_probs=112.1
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC---CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH---DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~---g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
-..+|..+..||.|.|+.|+.+... +..|++|.+..... .++..-+.|+.+...+..|.+++.+...+... .+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~--r~ 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL--RQ 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc--cc
Confidence 4567889999999999999987644 67899998865432 23334567777777777777777765555544 55
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC-CcEEEccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN-FCAKISDFGLAR 166 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~-g~vKLiDFGlA~ 166 (576)
.++-.|||+++++........ .+++..++.+..+++.++.++|+.. ++|.|++|+||++..+ +..++.|||++.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~---~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQ---MLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred ccCchhhhcCcchhhhhHHHH---hcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccccc
Confidence 678999999988865553222 2556677888999999999999998 9999999999999886 677888888764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.2e-07 Score=92.40 Aligned_cols=143 Identities=20% Similarity=0.196 Sum_probs=101.9
Q ss_pred ccceeeccCcEEEEEEEECCceEEEEEee-cC-------CchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 19 PSRLLGQGGFGSVFHATLHDQSVAVKVMD-SG-------SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 19 i~e~LG~GsfG~Vyka~~~g~~VAVK~i~-~~-------s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.+.+|-+|+=+.|+++.+.|+.++||.=- +. ..-...+..+|.+.+.++.-. .|.-...++.+. ..-+|
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~-GI~~P~l~~~D~--~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL-GIPAPRLIFIDT--YGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh-CCCCceEEEEec--CCCeE
Confidence 67899999999999999999998888532 11 112235678999998888663 222223334343 33478
Q ss_pred EEeccCC-CCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC---cEEEccccccc
Q 036407 91 VYELMSN-GNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF---CAKISDFGLAR 166 (576)
Q Consensus 91 VmE~~~g-GsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g---~vKLiDFGlA~ 166 (576)
+|||++| .++.+++.........+. ....++..|-..+.-||.++ |+|+||..+||+|..++ .+.++|||++.
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~-~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDE-GLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccch-hHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchh
Confidence 9999976 377777765443222222 22467788888999999999 99999999999997665 45899999875
Q ss_pred c
Q 036407 167 L 167 (576)
Q Consensus 167 ~ 167 (576)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.8e-09 Score=123.58 Aligned_cols=147 Identities=20% Similarity=0.196 Sum_probs=95.5
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch---hHHHHHHHHHHHHHhccCCceEEEEEEe-eCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLLEQDDHVVSVLGFS-SNPKR 85 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~---~~~~~l~EI~iLs~L~h~pNIv~Llg~~-~~~s~ 85 (576)
...+.+.+.+-+.+|+++.++.+.-. +...++|+......- +.+....+ +.+.++++...+...+ .+...
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~----s~~~i~p~~P~v~~~~~s~~~r 876 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSK----SNILITPRSPAVVRSFPSFPCR 876 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCc----cCccccCCCCceecccCCCCCC
Confidence 34567778888889999999877533 444444444321111 11111111 1111112222222222 23445
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
..++|+++|+.+++|...++..+. .+.....-++..+++++++||... ++|+|++|.|+|+..++..++.||++.
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTL 951 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCccccc
Confidence 778999999999999988876542 344444556677899999999877 899999999999999999999999965
Q ss_pred cc
Q 036407 166 RL 167 (576)
Q Consensus 166 ~~ 167 (576)
..
T Consensus 952 ~~ 953 (1205)
T KOG0606|consen 952 SK 953 (1205)
T ss_pred cc
Confidence 43
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=7.2e-07 Score=91.93 Aligned_cols=144 Identities=13% Similarity=0.081 Sum_probs=98.0
Q ss_pred ceeeccCcEEEEEEEECCceEEEEEeecCCchh-----------HHHHHHHHHHHHHhccCC-ceEEEEEEeeC---CCC
Q 036407 21 RLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQG-----------EREFYNELYFASLLEQDD-HVVSVLGFSSN---PKR 85 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~-----------~~~~l~EI~iLs~L~h~p-NIv~Llg~~~~---~s~ 85 (576)
+.+-.-....|.++.+.|+.|.||......... ...+.+|+..+.+|.... ....+.++... ...
T Consensus 28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 444444445567788889999999775433110 114778888888885421 11222333322 112
Q ss_pred CeEEEEEeccCCC-CHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC-------CCcE
Q 036407 86 HRMLLVYELMSNG-NLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH-------NFCA 157 (576)
Q Consensus 86 ~~l~LVmE~~~gG-sL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~-------~g~v 157 (576)
..-+||||++++. +|.+++..... ...+......++.+++..+.-||..| |+|+|+++.|||++. ++.+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceE
Confidence 4568999999875 78888754221 11344556678999999999999999 999999999999975 4688
Q ss_pred EEcccccccc
Q 036407 158 KISDFGLARL 167 (576)
Q Consensus 158 KLiDFGlA~~ 167 (576)
.++||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999997753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.57 E-value=5.6e-07 Score=88.15 Aligned_cols=127 Identities=25% Similarity=0.273 Sum_probs=80.5
Q ss_pred EEEEEEEC-CceEEEEEeecCC--ch------------------------hHHHHHHHHHHHHHhccCC-ceEEEEEEee
Q 036407 30 SVFHATLH-DQSVAVKVMDSGS--LQ------------------------GEREFYNELYFASLLEQDD-HVVSVLGFSS 81 (576)
Q Consensus 30 ~Vyka~~~-g~~VAVK~i~~~s--~~------------------------~~~~~l~EI~iLs~L~h~p-NIv~Llg~~~ 81 (576)
.||.|... +..+|||+..... .. ......+|++.|.++.... ++..++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999875 7899999886421 00 0235689999999998753 566666553
Q ss_pred CCCCCeEEEEEeccC--CCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHH-HHhCCCCeeecccCCCCeEEcCCCcEE
Q 036407 82 NPKRHRMLLVYELMS--NGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAY-LHSLNPPVIHGDIKPSNILLDHNFCAK 158 (576)
Q Consensus 82 ~~s~~~l~LVmE~~~--gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~y-LHs~g~~IVHrDLKPeNILLd~~g~vK 158 (576)
.-+|||||+. |..+..+.... ++......++.+++..+.. +|..| |+|+||++.|||++.+ .+.
T Consensus 80 -----~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 -----RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp -----TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEE
T ss_pred -----CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEE
Confidence 2279999997 65555433322 1112234466777775555 57899 9999999999999877 899
Q ss_pred EccccccccccC
Q 036407 159 ISDFGLARLKSV 170 (576)
Q Consensus 159 LiDFGlA~~~~~ 170 (576)
|+|||.+.....
T Consensus 147 iIDf~qav~~~~ 158 (188)
T PF01163_consen 147 IIDFGQAVDSSH 158 (188)
T ss_dssp E--GTTEEETTS
T ss_pred EEecCcceecCC
Confidence 999998765543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.1e-06 Score=96.49 Aligned_cols=116 Identities=16% Similarity=0.163 Sum_probs=93.8
Q ss_pred CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHH
Q 036407 38 DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCK 117 (576)
Q Consensus 38 g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~ 117 (576)
+.+|.|...............+.+..++.++| |||+.++..+... +.+|||+|-+. .|...+...+ ...
T Consensus 37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRH-P~Il~yL~t~e~~--~~~ylvTErV~--Pl~~~lk~l~------~~~ 105 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRH-PNILSYLDTTEEE--GTLYLVTERVR--PLETVLKELG------KEE 105 (690)
T ss_pred CCceEEEEEeCCCchhhHHHHHHHHHhhhccC-chhhhhhhhhccc--CceEEEeeccc--cHHHHHHHhH------HHH
Confidence 77888888765444334456778888999988 9999999888766 78999999984 6777776633 344
Q ss_pred HHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 118 RFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 118 vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
+...+.||+.||.|||. ++ ++|++|....|+++..|.-||++|.++.
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~ 153 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVS 153 (690)
T ss_pred HHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEe
Confidence 55577899999999985 77 9999999999999999999999998764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.1e-06 Score=81.90 Aligned_cols=111 Identities=23% Similarity=0.314 Sum_probs=80.3
Q ss_pred HHHHHHHHHHHHHhccCC-ceEEEEEEeeCCC--CCeEEEEEeccCCC-CHHHHHHhcCCCChhhHHHHHHHHHHHHHHH
Q 036407 54 EREFYNELYFASLLEQDD-HVVSVLGFSSNPK--RHRMLLVYELMSNG-NLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129 (576)
Q Consensus 54 ~~~~l~EI~iLs~L~h~p-NIv~Llg~~~~~s--~~~l~LVmE~~~gG-sL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL 129 (576)
..+..+|+..+..|.... .+...+++..... ....+||+|++++. +|.+++..... .+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 456788888877776521 2233344433321 13458999999874 78888876322 23445567889999999
Q ss_pred HHHHhCCCCeeecccCCCCeEEcCCC---cEEEcccccccccc
Q 036407 130 AYLHSLNPPVIHGDIKPSNILLDHNF---CAKISDFGLARLKS 169 (576)
Q Consensus 130 ~yLHs~g~~IVHrDLKPeNILLd~~g---~vKLiDFGlA~~~~ 169 (576)
.-||..| |+|+|+++.|||++.++ .+.++||+-++...
T Consensus 132 ~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999999 99999999999999887 89999999776543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.2e-05 Score=78.43 Aligned_cols=141 Identities=21% Similarity=0.177 Sum_probs=101.2
Q ss_pred eccCcEEEEEEEECCceEEEEEeec---CC---chhHHHHHHHHHHHHHhccCC-ceEEEEEEee---CCCCCeEEEEEe
Q 036407 24 GQGGFGSVFHATLHDQSVAVKVMDS---GS---LQGEREFYNELYFASLLEQDD-HVVSVLGFSS---NPKRHRMLLVYE 93 (576)
Q Consensus 24 G~GsfG~Vyka~~~g~~VAVK~i~~---~s---~~~~~~~l~EI~iLs~L~h~p-NIv~Llg~~~---~~s~~~l~LVmE 93 (576)
|.|+-+-|++..+.|..|-+|.-.. .+ ...+..|.+|+..+..|.... .+..+. ++. ....-.-+||+|
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEE
Confidence 4588888999888888888887641 11 234678999999999887631 122232 221 222345689999
Q ss_pred ccCC-CCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc--EEEccccccccc
Q 036407 94 LMSN-GNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC--AKISDFGLARLK 168 (576)
Q Consensus 94 ~~~g-GsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~--vKLiDFGlA~~~ 168 (576)
-+.+ -+|.+++...... ..+......++.+|+..++-||+.| +.|+|+.+.|||++.++. +.++||.-++..
T Consensus 106 ~L~g~~~L~~~l~~~~~~-~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 106 DMAGFISIADWYAQHAVS-PYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred eCCCCccHHHHHhcCCcC-CcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 7753 5888887553221 1455566778999999999999999 999999999999986676 999999876543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=6e-06 Score=80.23 Aligned_cols=136 Identities=18% Similarity=0.209 Sum_probs=99.6
Q ss_pred CCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc
Q 036407 16 SFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
..+..+.|++|.+|.||+|.+.+..+|+|+-..++ .+..+..|.+++..+....--..++.|.. -++.|||+
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~------~~i~me~i 94 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE------DFIRMEYI 94 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech------hhhhhhhh
Confidence 34467899999999999999999999999976543 34578899999999988555556666533 24669999
Q ss_pred CCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccC-CCCeEEcCCCcEEEccccccccccCC
Q 036407 96 SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIK-PSNILLDHNFCAKISDFGLARLKSVG 171 (576)
Q Consensus 96 ~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLK-PeNILLd~~g~vKLiDFGlA~~~~~~ 171 (576)
.|..|.+..... +.. -+..++..-.-|-..| |-|..|+ |..++|..++.+.|+||..|+....+
T Consensus 95 ~G~~L~~~~~~~------~rk----~l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p 159 (201)
T COG2112 95 DGRPLGKLEIGG------DRK----HLLRVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKP 159 (201)
T ss_pred cCcchhhhhhcc------cHH----HHHHHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhhccCC
Confidence 998887755421 111 2234555544455678 9999998 77777777779999999988855443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.1e-05 Score=79.03 Aligned_cols=141 Identities=17% Similarity=0.168 Sum_probs=94.5
Q ss_pred hhcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHH---------HHHHHHHHHhcc--CCceEEEEEEe
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREF---------YNELYFASLLEQ--DDHVVSVLGFS 80 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~---------l~EI~iLs~L~h--~pNIv~Llg~~ 80 (576)
...++|.+.+.+-......|.+...+++.+++|..+......+..+ .+.+..+..+.. ...++.++...
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 5678899999999999999999999999999999875433222222 233333333322 22333322222
Q ss_pred eCC---CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcE
Q 036407 81 SNP---KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA 157 (576)
Q Consensus 81 ~~~---s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~v 157 (576)
.-. -....+|||||++|..|.+... ++. .+...|+.++.-||+.| ++|+|++|.|+++..++ +
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-E
Confidence 211 1144578999999987765432 221 14456777889999999 99999999999998554 9
Q ss_pred EEccccccc
Q 036407 158 KISDFGLAR 166 (576)
Q Consensus 158 KLiDFGlA~ 166 (576)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.11 E-value=3.6e-05 Score=74.40 Aligned_cols=147 Identities=26% Similarity=0.327 Sum_probs=85.2
Q ss_pred cceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCC-ceEEEEEEeeCC-CCCeEEEEEeccCC
Q 036407 20 SRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDD-HVVSVLGFSSNP-KRHRMLLVYELMSN 97 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~p-NIv~Llg~~~~~-s~~~l~LVmE~~~g 97 (576)
++.|+.|..+.||++...+..+++|..... .....+..|..++..|..+. .+..++.+.... .....+++|++++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 468999999999999998889999997543 34567788888888887642 245565544322 22457999999988
Q ss_pred CCHHH----------------HHHh---c-CC-CChhhHH--------HHHHH------------HHHHHH-HHHHHHh-
Q 036407 98 GNLQD----------------ALLH---K-KP-PELMEWC--------KRFSI------------AVDIAK-GIAYLHS- 134 (576)
Q Consensus 98 GsL~d----------------~L~~---~-~~-~~~ls~~--------~vl~I------------~~qIl~-AL~yLHs- 134 (576)
..+.. .+.. . .. ....... ..... ...+.. .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 77766 1111 1 00 0000000 00000 011112 2333332
Q ss_pred ----CCCCeeecccCCCCeEEc-CCCcEEEccccccccc
Q 036407 135 ----LNPPVIHGDIKPSNILLD-HNFCAKISDFGLARLK 168 (576)
Q Consensus 135 ----~g~~IVHrDLKPeNILLd-~~g~vKLiDFGlA~~~ 168 (576)
....++|+|+.|.|||++ .++.+.|+||+.+...
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 223589999999999999 5566689999987543
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.8e-05 Score=81.44 Aligned_cols=137 Identities=20% Similarity=0.152 Sum_probs=94.0
Q ss_pred CccceeeccCcEEEEEEEEC-CceEEEEEeecCCc----------------------hhHHHHHHHHHHHHHhccC-Cce
Q 036407 18 SPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSL----------------------QGEREFYNELYFASLLEQD-DHV 73 (576)
Q Consensus 18 ~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~----------------------~~~~~~l~EI~iLs~L~h~-pNI 73 (576)
.+...||-|-=+.||.|... +.++|||.=+.+.. ..+....+|+.+|.+|... -.+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 45689999999999999987 89999997543211 1123568899999998763 244
Q ss_pred EEEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC
Q 036407 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH 153 (576)
Q Consensus 74 v~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~ 153 (576)
...+++ +.-.+|||+++|-.|...-. +....-.++..|+.-+..+-..| ++|+|+++-||+++.
T Consensus 174 P~P~~~------nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIAW------NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTE 237 (304)
T ss_pred CCcccc------ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEec
Confidence 444443 55689999999866643211 01112223444444444444677 999999999999999
Q ss_pred CCcEEEccccccccccC
Q 036407 154 NFCAKISDFGLARLKSV 170 (576)
Q Consensus 154 ~g~vKLiDFGlA~~~~~ 170 (576)
+|.+.++||--+.....
T Consensus 238 dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 238 DGDIVVIDWPQAVPISH 254 (304)
T ss_pred CCCEEEEeCcccccCCC
Confidence 99999999976654443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.2e-05 Score=89.94 Aligned_cols=142 Identities=21% Similarity=0.244 Sum_probs=92.4
Q ss_pred ceeeccCcEEEEEEEEC-CceEEEEEeecCCchh----------------------------------------HHHHHH
Q 036407 21 RLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQG----------------------------------------EREFYN 59 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~----------------------------------------~~~~l~ 59 (576)
+.|+.++-|.||+|++. |+.||||+.+++-... +-.+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 78889999999999998 8999999987642110 001234
Q ss_pred HHHHHHHhcc----CCceEEEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHH-HHHHHh
Q 036407 60 ELYFASLLEQ----DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKG-IAYLHS 134 (576)
Q Consensus 60 EI~iLs~L~h----~pNIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~A-L~yLHs 134 (576)
|...+..+.+ .+++..-.-++... +.-.|+|||++|-.+.+.......+ .+... ++..++.+ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t--~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~---ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYT--TRRVLTMEWIDGIKISDIAALKSAG--IDRKE---LAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhcc--CCcEEEEEeeCCEecccHHHHHhcC--CCHHH---HHHHHHHHHHHHHHh
Confidence 4444444433 34444444444433 4458999999998888764322211 23221 22222221 222333
Q ss_pred CCCCeeecccCCCCeEEcCCCcEEEccccccccccCC
Q 036407 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVG 171 (576)
Q Consensus 135 ~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~~~ 171 (576)
.| +.|+|.+|.||++..+|.+.+.|||+...++..
T Consensus 284 dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 284 DG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cC--ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 67 999999999999999999999999998776654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.06 E-value=6.9e-05 Score=75.22 Aligned_cols=140 Identities=15% Similarity=0.209 Sum_probs=84.0
Q ss_pred ceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCc-eEEEEEEeeCCCCCeEEEEEeccCCCC
Q 036407 21 RLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH-VVSVLGFSSNPKRHRMLLVYELMSNGN 99 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pN-Iv~Llg~~~~~s~~~l~LVmE~~~gGs 99 (576)
..||.|..+.||+. .+..+++|...... ......+|.+.+..+....- +..++.+.... +...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~--~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDG--GRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecC--CeeeeeeeecCCcc
Confidence 68899999999984 35678899986533 33457889999988876433 45566666544 55788999998853
Q ss_pred -HH--------------HHHHh-----cC---CCChhhHHHHHHHHH----------HHHHH-HHHHH--hCCCCeeecc
Q 036407 100 -LQ--------------DALLH-----KK---PPELMEWCKRFSIAV----------DIAKG-IAYLH--SLNPPVIHGD 143 (576)
Q Consensus 100 -L~--------------d~L~~-----~~---~~~~ls~~~vl~I~~----------qIl~A-L~yLH--s~g~~IVHrD 143 (576)
+. ..+.. +. ....+... ...+.. .+... ..+|. ...+.++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 11 11100 00 00001100 000100 01111 11222 2233578999
Q ss_pred cCCCCeEEcCCCcEEEccccccccc
Q 036407 144 IKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 144 LKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+.|.||+++.++ +.++||+.+..-
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCcC
Confidence 999999999888 999999987643
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.1e-06 Score=95.56 Aligned_cols=92 Identities=22% Similarity=0.326 Sum_probs=59.0
Q ss_pred ccccccccccCCCCcccccceeehhHHHHHHH-hCCCCccccCCCchhhhhhhHHHHHHHhccccchhhhhhhHHhhhcC
Q 036407 433 TVCYVAPEYGAGGDISEKCDVYSYGVLLLVLI-AGRRPLQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLD 511 (576)
Q Consensus 433 t~~y~aPE~~~~~~~~~~~DiwS~G~~l~eli-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (576)
...|.|||++.+..-+..+|+||+||++|.+. .|+.-+...+......+..++.+-.. . ...
T Consensus 172 ~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~-------------~----~~s 234 (700)
T KOG2137|consen 172 HLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGA-------------F----GYS 234 (700)
T ss_pred CcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccc-------------c----ccc
Confidence 46799999999888899999999999999999 56666665543222111111110000 0 011
Q ss_pred HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 036407 512 REQALLCITVALLCLQKSPALRPSMEEVVG 541 (576)
Q Consensus 512 ~~~~~~~~~~~~~cl~~dP~~Rps~~~v~~ 541 (576)
.+-+..+.+-+.++|..++.-||++.++..
T Consensus 235 ~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 235 NNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred ccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 223344566667789999999997776653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00011 Score=79.54 Aligned_cols=139 Identities=14% Similarity=0.193 Sum_probs=84.9
Q ss_pred CccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEE----eeC-CCCCeEEEEE
Q 036407 18 SPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGF----SSN-PKRHRMLLVY 92 (576)
Q Consensus 18 ~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~----~~~-~s~~~l~LVm 92 (576)
.....||+|+-+.+|-.-.- ...+.|+.......... +.+.+|.....+|-+..-+.+ ... .......++|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchh-hchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 35678999999999854221 23456777544332222 222333333333332220111 111 1123366778
Q ss_pred eccCCC-CHHHHHHh---cCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccc
Q 036407 93 ELMSNG-NLQDALLH---KKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDF 162 (576)
Q Consensus 93 E~~~gG-sL~d~L~~---~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDF 162 (576)
..+.+- .+..++.- ++......|...+++++.++.+-+.||..| .+-+|+.++|+|+++++.+.|+|-
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcc
Confidence 877653 22333321 222223567788889999999999999999 889999999999999999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00011 Score=81.18 Aligned_cols=140 Identities=15% Similarity=0.116 Sum_probs=105.6
Q ss_pred cEEEEEEEE--CCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeC--CCCCeEEEEEeccCC-CCHHH
Q 036407 28 FGSVFHATL--HDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN--PKRHRMLLVYELMSN-GNLQD 102 (576)
Q Consensus 28 fG~Vyka~~--~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~--~s~~~l~LVmE~~~g-GsL~d 102 (576)
..+.|++.. +|..|++|+++............-++.++++.| .|+|.++..+.. .....+++|++|.++ ++|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h-~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCH-TNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhcc-CceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 456688764 488999999965555555555666778889988 999999887652 234678999999875 57877
Q ss_pred HHHhcCC------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccccC
Q 036407 103 ALLHKKP------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 103 ~L~~~~~------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
+.-.... +...++..+|.|+.|+..||.++|+.| ..-+-|.|.+||+..+..++|..-|+...+..
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 6533211 123677899999999999999999999 77799999999999988888877666554433
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00019 Score=71.71 Aligned_cols=76 Identities=17% Similarity=0.176 Sum_probs=52.6
Q ss_pred eeeccCc-EEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCCCCH
Q 036407 22 LLGQGGF-GSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNL 100 (576)
Q Consensus 22 ~LG~Gsf-G~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~gGsL 100 (576)
.|..|.+ +.||+....+..++||+..... ...+..|+.++..+..+--+..++++.... +..++|||+++|.+|
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCCccH
Confidence 3445554 7889988777788899886432 235677888888876543455666665543 567899999998776
Q ss_pred HH
Q 036407 101 QD 102 (576)
Q Consensus 101 ~d 102 (576)
.+
T Consensus 80 ~~ 81 (244)
T cd05150 80 AA 81 (244)
T ss_pred hH
Confidence 54
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00028 Score=72.06 Aligned_cols=153 Identities=20% Similarity=0.163 Sum_probs=98.4
Q ss_pred ChHHHHhhcCCCCccceeec---cCcEEEEEEEEC-CceEEEEEeecCCchh------------------------HHHH
Q 036407 6 SYSVLRRAADSFSPSRLLGQ---GGFGSVFHATLH-DQSVAVKVMDSGSLQG------------------------EREF 57 (576)
Q Consensus 6 s~~~lk~~~d~Y~i~e~LG~---GsfG~Vyka~~~-g~~VAVK~i~~~s~~~------------------------~~~~ 57 (576)
|+..|.....+..+..+.|. |-=+.||+|... +..+|||++....... ....
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 55667777777777766665 556678888754 7899999986432111 1134
Q ss_pred HHHHHHHHHhccC-CceEEEEEEeeCCCCCeEEEEEeccCCC-CHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-
Q 036407 58 YNELYFASLLEQD-DHVVSVLGFSSNPKRHRMLLVYELMSNG-NLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS- 134 (576)
Q Consensus 58 l~EI~iLs~L~h~-pNIv~Llg~~~~~s~~~l~LVmE~~~gG-sL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs- 134 (576)
..|++.|.++..- -.+..-+++ ....|||||+... .-.-.|+.-. +.......+..+++..+.-|-.
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~------~~nVLvMEfIg~~g~pAP~LkDv~----~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAF------RNNVLVMEFIGDDGLPAPRLKDVP----LELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceee------cCCeEEEEeccCCCCCCCCcccCC----cCchhHHHHHHHHHHHHHHHHHh
Confidence 6777777777541 122222222 2337999998432 1111112111 1112455677788888887766
Q ss_pred CCCCeeecccCCCCeEEcCCCcEEEccccccccccCC
Q 036407 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVG 171 (576)
Q Consensus 135 ~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~~~ 171 (576)
.+ +||+||+.=|||+. ++.+.|+||+-|-....+
T Consensus 186 a~--LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 186 AG--LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred cC--cccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 78 99999999999998 889999999988766544
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00024 Score=79.70 Aligned_cols=138 Identities=21% Similarity=0.215 Sum_probs=86.1
Q ss_pred cceeeccCcEEEEEEEEC-CceEEEEEeecCCchh-------------------------------------HHHHHHHH
Q 036407 20 SRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQG-------------------------------------EREFYNEL 61 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~-------------------------------------~~~~l~EI 61 (576)
.+.||..+.|.||+|+.+ |+.||||+-+++-... +-.|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 478999999999999988 7889999876542211 01234444
Q ss_pred HHHH----HhccCCc-----eEEEEEEeeCCCCCeEEEEEeccCCCCHHHHH--HhcCCCChhhHHHHHHHHHHHHHHHH
Q 036407 62 YFAS----LLEQDDH-----VVSVLGFSSNPKRHRMLLVYELMSNGNLQDAL--LHKKPPELMEWCKRFSIAVDIAKGIA 130 (576)
Q Consensus 62 ~iLs----~L~h~pN-----Iv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L--~~~~~~~~ls~~~vl~I~~qIl~AL~ 130 (576)
+... .+.+.+. |..+ |+... ..-.|+||||+|..+.++- ...+ ++... ++..+.++..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~V--y~~~s--t~RVLtME~~~G~~i~Dl~~i~~~g----i~~~~---i~~~l~~~~~ 314 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKV--YWDLS--TKRVLTMEYVDGIKINDLDAIDKRG----ISPHD---ILNKLVEAYL 314 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCee--hhhcC--cceEEEEEecCCccCCCHHHHHHcC----CCHHH---HHHHHHHHHH
Confidence 3332 3333221 2233 22222 4568999999998665543 3332 33332 3333333322
Q ss_pred H-HHhCCCCeeecccCCCCeEEcC----CCcEEEccccccccccC
Q 036407 131 Y-LHSLNPPVIHGDIKPSNILLDH----NFCAKISDFGLARLKSV 170 (576)
Q Consensus 131 y-LHs~g~~IVHrDLKPeNILLd~----~g~vKLiDFGlA~~~~~ 170 (576)
. |-..| ++|+|-+|.||++.. ++.+.+.|||+...+..
T Consensus 315 ~qIf~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 315 EQIFKTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHhcC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2 23467 999999999999983 67899999999876654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0017 Score=64.41 Aligned_cols=138 Identities=23% Similarity=0.283 Sum_probs=91.1
Q ss_pred ccceeeccCcEEEEEEEECCceEEEEEeecCC----------------chhHHHHHHHHHHHHHhc-c----CCceEEEE
Q 036407 19 PSRLLGQGGFGSVFHATLHDQSVAVKVMDSGS----------------LQGEREFYNELYFASLLE-Q----DDHVVSVL 77 (576)
Q Consensus 19 i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s----------------~~~~~~~l~EI~iLs~L~-h----~pNIv~Ll 77 (576)
-...||+|+.-.||..-. +....||++.... .....+..+|+.....+. . ..+|..++
T Consensus 5 ~~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CCcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 457899999999995432 3446789887654 122345677776665555 2 36788899
Q ss_pred EEeeCCCCCeEEEEEeccC------CCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE
Q 036407 78 GFSSNPKRHRMLLVYELMS------NGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL 151 (576)
Q Consensus 78 g~~~~~s~~~l~LVmE~~~------gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL 151 (576)
|+.... .-+.+|+|.+. ..+|.+++.... ++. .....+.+ -..||-++. |+.+|++|.||++
T Consensus 84 G~veT~--~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~~L~~---f~~~l~~~~--Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETN--LGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQALDE---FKRYLLDHH--IVIRDLNPHNIVV 151 (199)
T ss_pred EEEecC--CceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHHHHHH---HHHHHHHcC--CeecCCCcccEEE
Confidence 988765 55678888862 237777775433 333 22223333 334666677 9999999999999
Q ss_pred cCC--C--cEEEcc-cccccccc
Q 036407 152 DHN--F--CAKISD-FGLARLKS 169 (576)
Q Consensus 152 d~~--g--~vKLiD-FGlA~~~~ 169 (576)
... + .+.|+| ||....++
T Consensus 152 ~~~~~~~~~lvlIDG~G~~~~ip 174 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEKELIP 174 (199)
T ss_pred EecCCCceEEEEEeCCCCccccc
Confidence 643 2 588898 77665544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0014 Score=65.29 Aligned_cols=130 Identities=20% Similarity=0.306 Sum_probs=92.3
Q ss_pred hcCCCCccceeeccCc-EEEEEEEECCceEEEEEeec---CC-------chh-----------HHHHHHHHHHHHHhccC
Q 036407 13 AADSFSPSRLLGQGGF-GSVFHATLHDQSVAVKVMDS---GS-------LQG-----------EREFYNELYFASLLEQD 70 (576)
Q Consensus 13 ~~d~Y~i~e~LG~Gsf-G~Vyka~~~g~~VAVK~i~~---~s-------~~~-----------~~~~l~EI~iLs~L~h~ 70 (576)
.+.+++.++.||.|.- |.||+++..|+.||+|++.. .. ... ..-|..|.+...+|+.+
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 3478999999999999 99999999999999999431 00 000 12367888888888765
Q ss_pred Cc----eEEEEEEeeCC----------------CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHH
Q 036407 71 DH----VVSVLGFSSNP----------------KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIA 130 (576)
Q Consensus 71 pN----Iv~Llg~~~~~----------------s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~ 130 (576)
.. .++++||.... ......||.||.+... .+... -+.+|..-+.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~ 178 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLK 178 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHH
Confidence 33 48888886432 1233467888876533 01222 2345666778
Q ss_pred HHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 131 YLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 131 yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
.+|..| |+-+|+++.|.. .-+|+|||.+
T Consensus 179 ~~~k~g--I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLG--IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHCC--eeeccCcccccc-----CCEEEecccC
Confidence 899999 999999999987 3588999854
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0004 Score=68.03 Aligned_cols=102 Identities=22% Similarity=0.270 Sum_probs=79.4
Q ss_pred HHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCCCCHHHH---HHhcCCCChhhHHHHHHHHHHHHHHHHHHHh
Q 036407 58 YNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDA---LLHKKPPELMEWCKRFSIAVDIAKGIAYLHS 134 (576)
Q Consensus 58 l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~---L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs 134 (576)
.+|.-++..+.+.+++.+++|+|-. ++|.|+...+++... +.... ..+|..+.+|+.+++..+.+++.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~~---~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQFL---QSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCcccccccccccccc---ccCHHHHHHHHHHHHHHHHHHhc
Confidence 4678888999888899999999943 568899976655421 11111 15788999999999999999986
Q ss_pred --CCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 135 --LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 135 --~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
.+. +.-+|++++|+-++.+|.+|++|........
T Consensus 78 ~~~~~-~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 78 GPLGF-FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred CCCCc-EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 232 7789999999999999999999998665443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00094 Score=67.45 Aligned_cols=139 Identities=12% Similarity=0.006 Sum_probs=77.2
Q ss_pred eeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCCCCHHH
Q 036407 23 LGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQD 102 (576)
Q Consensus 23 LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d 102 (576)
+..|-...+|+....+..+++|........-.....+|..++..+....-...++.... -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE------HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEeccCccccc
Confidence 45678889999887788899998643321110124677778887765433344444331 268999998755421
Q ss_pred --------------HHH---hcCC-CChhhH-HHHHHHHHHH---------HHHHHHHHhC------CCCeeecccCCCC
Q 036407 103 --------------ALL---HKKP-PELMEW-CKRFSIAVDI---------AKGIAYLHSL------NPPVIHGDIKPSN 148 (576)
Q Consensus 103 --------------~L~---~~~~-~~~ls~-~~vl~I~~qI---------l~AL~yLHs~------g~~IVHrDLKPeN 148 (576)
.+. .... ...++. ..+..+..++ ...+..+... ...++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 111 1110 000111 1111111111 1111112111 2358999999999
Q ss_pred eEEcCCCcEEEccccccccc
Q 036407 149 ILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 149 ILLd~~g~vKLiDFGlA~~~ 168 (576)
|+++.++ +.|+||+.+..-
T Consensus 158 il~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred EEEeCCC-CEEEeccccCcC
Confidence 9998877 789999987643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0028 Score=62.76 Aligned_cols=74 Identities=16% Similarity=0.171 Sum_probs=48.1
Q ss_pred cceeeccCcEEEEEEEEC---CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccC
Q 036407 20 SRLLGQGGFGSVFHATLH---DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMS 96 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~---g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~ 96 (576)
++.|..|-...+|+.... ++.|++|+....... .....+|+.++..+........++.... . .+||||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~--~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----N--GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----C--cEEEEeeC
Confidence 356777888899998865 478999977543211 1123467878887765444555654432 1 47999998
Q ss_pred CCCH
Q 036407 97 NGNL 100 (576)
Q Consensus 97 gGsL 100 (576)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0022 Score=63.98 Aligned_cols=75 Identities=15% Similarity=0.176 Sum_probs=45.4
Q ss_pred ceeeccCcE-EEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccC-C-ceEEEEEEeeCCCC-CeEEEEEeccC
Q 036407 21 RLLGQGGFG-SVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQD-D-HVVSVLGFSSNPKR-HRMLLVYELMS 96 (576)
Q Consensus 21 e~LG~GsfG-~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~-p-NIv~Llg~~~~~s~-~~l~LVmE~~~ 96 (576)
+.|+.|+.. .||+. +..+++|+.... .....+..|...+..|... + -+..++......+. ...|++|++++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 467766655 58875 345788876532 2234688899888888652 1 23334443332211 24588999998
Q ss_pred CCCH
Q 036407 97 NGNL 100 (576)
Q Consensus 97 gGsL 100 (576)
|.++
T Consensus 78 G~~l 81 (235)
T cd05155 78 GETA 81 (235)
T ss_pred CCCC
Confidence 8655
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0032 Score=74.60 Aligned_cols=80 Identities=14% Similarity=0.203 Sum_probs=56.0
Q ss_pred cceeeccCcEEEEEEEECC----ceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCce--EEEEEEeeCCC-CCeEEEE
Q 036407 20 SRLLGQGGFGSVFHATLHD----QSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHV--VSVLGFSSNPK-RHRMLLV 91 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~g----~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNI--v~Llg~~~~~s-~~~l~LV 91 (576)
.+.|+.|.+..+|+....+ ..+++|+..... ......+.+|++++..|..+.++ ..++.+|.+.. .+..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 6778999999999987664 468888765432 22345688999999998643443 66667765432 2457899
Q ss_pred EeccCCCC
Q 036407 92 YELMSNGN 99 (576)
Q Consensus 92 mE~~~gGs 99 (576)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998753
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0027 Score=65.15 Aligned_cols=145 Identities=17% Similarity=0.170 Sum_probs=83.2
Q ss_pred cceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCC-ceEEEEEEee----CCCCCeEEEEEec
Q 036407 20 SRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDD-HVVSVLGFSS----NPKRHRMLLVYEL 94 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~p-NIv~Llg~~~----~~s~~~l~LVmE~ 94 (576)
.+.|..|....+|+....+..+++|+... .....+..|+.++..|..+. .+..++.... ....+..++|+++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 56777788889999887778899999864 23345677787777775532 2333333210 0112456899999
Q ss_pred cCCCCHHH-----------HH---Hhc----CCC----ChhhHHHHH----------HHHHHHHHHHHHHHh-----CCC
Q 036407 95 MSNGNLQD-----------AL---LHK----KPP----ELMEWCKRF----------SIAVDIAKGIAYLHS-----LNP 137 (576)
Q Consensus 95 ~~gGsL~d-----------~L---~~~----~~~----~~ls~~~vl----------~I~~qIl~AL~yLHs-----~g~ 137 (576)
++|..+.. .+ +.. ... ....+.... .....+..++.++.+ ...
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 98755321 11 000 000 001111100 001112223334332 112
Q ss_pred CeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 138 PVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 138 ~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
.++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 389999999999999887778999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0078 Score=62.87 Aligned_cols=82 Identities=11% Similarity=0.113 Sum_probs=59.0
Q ss_pred CCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccC--CceEEEEEEeeCC-CCCeEEEEEe
Q 036407 17 FSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQD--DHVVSVLGFSSNP-KRHRMLLVYE 93 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~--pNIv~Llg~~~~~-s~~~l~LVmE 93 (576)
..-.+.||.|..+.||.....+..+++|..+. ......+..|...+..|... -.+.++++.+... ..+..+||||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGNPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCCEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 33457899999999999877666677888532 11235788999999888763 2577788776542 2356799999
Q ss_pred ccCCCCH
Q 036407 94 LMSNGNL 100 (576)
Q Consensus 94 ~~~gGsL 100 (576)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9988654
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0075 Score=62.76 Aligned_cols=91 Identities=10% Similarity=0.029 Sum_probs=53.4
Q ss_pred CChHHHHhhcCCCCc-----cceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCC-ceEEEEE
Q 036407 5 FSYSVLRRAADSFSP-----SRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDD-HVVSVLG 78 (576)
Q Consensus 5 fs~~~lk~~~d~Y~i-----~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~p-NIv~Llg 78 (576)
.+.+++......|.+ .+.|+.|....+|+....+..+++|++.. .....+..|+..+..|.... .+..++.
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQGEYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCCcEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCccee
Confidence 455666665566755 35566777788999887777899998862 12234445555555554311 1223322
Q ss_pred E----eeCCCCCeEEEEEeccCCC
Q 036407 79 F----SSNPKRHRMLLVYELMSNG 98 (576)
Q Consensus 79 ~----~~~~s~~~l~LVmE~~~gG 98 (576)
. ....-.+..+++++|++|.
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~ 107 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGK 107 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCC
Confidence 1 1111125678999999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0083 Score=62.38 Aligned_cols=157 Identities=17% Similarity=0.206 Sum_probs=87.3
Q ss_pred HHHHhhcCCCCc-----cceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCC-ceEEEEEEee
Q 036407 8 SVLRRAADSFSP-----SRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDD-HVVSVLGFSS 81 (576)
Q Consensus 8 ~~lk~~~d~Y~i-----~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~p-NIv~Llg~~~ 81 (576)
+.|....+.|.+ ++.|+.|....+|+....+..+++|+..... ....+..|+.++..|.... .+..++....
T Consensus 10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~ 87 (307)
T TIGR00938 10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRD 87 (307)
T ss_pred HHHHHHHHhcCCCCceeccccCCccccceEEEEeCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCC
Confidence 455555555644 4667777778999988777788999875422 1234556666676665321 1333333211
Q ss_pred ----CCCCCeEEEEEeccCCCCHH-----------HHH---HhcCC----C-----ChhhHHHHH------------HHH
Q 036407 82 ----NPKRHRMLLVYELMSNGNLQ-----------DAL---LHKKP----P-----ELMEWCKRF------------SIA 122 (576)
Q Consensus 82 ----~~s~~~l~LVmE~~~gGsL~-----------d~L---~~~~~----~-----~~ls~~~vl------------~I~ 122 (576)
....+..+++++|++|..+. ..+ +.... . ....|.... ...
T Consensus 88 g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~ 167 (307)
T TIGR00938 88 GRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMG 167 (307)
T ss_pred CCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHH
Confidence 11135678999999874321 111 11000 0 001111100 001
Q ss_pred HHHHHHHHHHHh-----CCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 123 VDIAKGIAYLHS-----LNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 123 ~qIl~AL~yLHs-----~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
..+...+.++.. ....++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 168 ~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 168 AELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 112234444432 12349999999999999988877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0092 Score=61.60 Aligned_cols=73 Identities=16% Similarity=0.168 Sum_probs=46.7
Q ss_pred ceeeccCcEEEEEEEEC--------CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 21 RLLGQGGFGSVFHATLH--------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~--------g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
+.|..|-...||+.... ++.+++|+..... .......+|..++..+....-...+++++.. .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~------~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN------GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC------Cchh
Confidence 45566777789988765 3789999976432 1223456777777777664434455555431 3588
Q ss_pred eccCCCCH
Q 036407 93 ELMSNGNL 100 (576)
Q Consensus 93 E~~~gGsL 100 (576)
||++|..+
T Consensus 77 e~i~G~~l 84 (302)
T cd05156 77 EFIPSRTL 84 (302)
T ss_pred heeCCCcC
Confidence 99887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.00084 Score=75.92 Aligned_cols=138 Identities=14% Similarity=0.036 Sum_probs=83.0
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCc-eEEEEEEeeCCCCCeEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH-VVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pN-Iv~Llg~~~~~s~~~l~LV 91 (576)
+.-|...+-+++|+++++++.+-. .+....+.+... .....++++|.++++ || .+..++-+ +...+.+++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~-P~~~v~~~~d~--~~E~~~~i~ 312 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNN-PNPVVRYLEDY--DGEDYLWIP 312 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccC-CCCcccccccC--Ccccccchh
Confidence 344556677889999999988754 233334444321 345667788899988 78 33333333 334788999
Q ss_pred EeccCCC-CHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNG-NLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gG-sL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++++.++ +-...... ....+...+...+.+.-..+|+++|+.- -+|+| ||+... +..+..+|++...+
T Consensus 313 ~~i~s~~rs~~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTV--SEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred hhhhcCCccccccCCh--hhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCccc
Confidence 9999776 22111100 0001222333445566677899999754 47887 777644 66778888765433
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.12 Score=56.66 Aligned_cols=75 Identities=23% Similarity=0.182 Sum_probs=51.1
Q ss_pred cceeeccCcEEEEEEEECC--ceEEEEEeec------CC-chhHHHHHHHHHHHHHhccC--CceEEEEEEeeCCCCCeE
Q 036407 20 SRLLGQGGFGSVFHATLHD--QSVAVKVMDS------GS-LQGEREFYNELYFASLLEQD--DHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~g--~~VAVK~i~~------~s-~~~~~~~l~EI~iLs~L~h~--pNIv~Llg~~~~~s~~~l 88 (576)
.+.||.|.+..||++...+ +.++||.-.. .. .....+...|.+.|..+... .+++.++.+.. ...
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~----~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE----ELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC----CCC
Confidence 4689999999999999874 3899998531 11 12345667777777765432 35667766633 446
Q ss_pred EEEEeccCCC
Q 036407 89 LLVYELMSNG 98 (576)
Q Consensus 89 ~LVmE~~~gG 98 (576)
++|||++++.
T Consensus 107 ~lVME~L~~~ 116 (401)
T PRK09550 107 VTVMEDLSDH 116 (401)
T ss_pred EEEEecCCCc
Confidence 8999999753
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.052 Score=57.91 Aligned_cols=143 Identities=19% Similarity=0.197 Sum_probs=80.0
Q ss_pred cceeeccCcEEEEEEEEC------CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEe
Q 036407 20 SRLLGQGGFGSVFHATLH------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~------g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE 93 (576)
+..|-.|-...+|++... ++.|++|+......... .-.+|+.++..+....--..+++.+.. ..|.+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~------g~v~e 113 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN------GRVEE 113 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECC------ceEEE
Confidence 345555888889998753 25788998754322111 226778787777765555556665422 25789
Q ss_pred ccCCCCHHHH--------------H---HhcC-C--CChhhHHHHHHHHHHH-----------------HHHHHHH----
Q 036407 94 LMSNGNLQDA--------------L---LHKK-P--PELMEWCKRFSIAVDI-----------------AKGIAYL---- 132 (576)
Q Consensus 94 ~~~gGsL~d~--------------L---~~~~-~--~~~ls~~~vl~I~~qI-----------------l~AL~yL---- 132 (576)
|+++.+|... + +... . .....+.++..++.++ ...+..|
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 9877555311 1 1101 0 0011122222222111 1111112
Q ss_pred Hh--CCCCeeecccCCCCeEEcC-CCcEEEcccccccccc
Q 036407 133 HS--LNPPVIHGDIKPSNILLDH-NFCAKISDFGLARLKS 169 (576)
Q Consensus 133 Hs--~g~~IVHrDLKPeNILLd~-~g~vKLiDFGlA~~~~ 169 (576)
.. ....++|+|+++.|||++. ++.+.++||..+....
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~ 233 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP 233 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence 11 1224899999999999986 4689999999886543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.041 Score=55.92 Aligned_cols=114 Identities=18% Similarity=0.165 Sum_probs=71.6
Q ss_pred CcEEEEEEEECCceEEEEEeecCCch-hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCCCCHHHHHH
Q 036407 27 GFGSVFHATLHDQSVAVKVMDSGSLQ-GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALL 105 (576)
Q Consensus 27 sfG~Vyka~~~g~~VAVK~i~~~s~~-~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~ 105 (576)
+.++.-.++.+-.+..+|.+..-... ...-+.++.++++++ ..|++++ .+....+.++.|.|.-...
T Consensus 74 gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Arm---hGilrL~----NDn~~~yGvIlE~Cy~~~i----- 141 (308)
T PF07387_consen 74 GNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARM---HGILRLK----NDNNYKYGVILERCYKIKI----- 141 (308)
T ss_pred CceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHh---hheeEee----cCCCceeEEEEeeccCccc-----
Confidence 33344334333244556666432222 445567888888887 3566665 2344667899999953211
Q ss_pred hcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 106 HKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 106 ~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
.. .-.|.. -+.+|...|+..+..+|+|..|+||+.|..|.+||.|=+
T Consensus 142 -------~~---~N~i~a-gi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 142 -------NF---SNFITA-GIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred -------ch---hHHHHH-hHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChh
Confidence 00 111222 246778889644559999999999999999999999965
|
The function of this family is unknown. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.0097 Score=63.28 Aligned_cols=133 Identities=19% Similarity=0.195 Sum_probs=89.5
Q ss_pred CCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCc----------------------hhHHHHHHHHHHHHHhccCCc
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSL----------------------QGEREFYNELYFASLLEQDDH 72 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~----------------------~~~~~~l~EI~iLs~L~h~pN 72 (576)
-+.+.+.||=|-=+.||.+... |+++++|+=+.+.. -++-...+|+..|+.|..+..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4567789999999999999876 88888885432111 112346788888988876433
Q ss_pred eE-EEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE
Q 036407 73 VV-SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL 151 (576)
Q Consensus 73 Iv-~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL 151 (576)
.| ..++ .+.-|+|||++.|-.|...-+... ..++. ..+..-+.-|-.+| +||+|..--||++
T Consensus 173 pVPkpiD------~~RH~Vvmelv~g~Pl~~v~~v~d------~~~ly---~~lm~~Iv~la~~G--lIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPID------HNRHCVVMELVDGYPLRQVRHVED------PPTLY---DDLMGLIVRLANHG--LIHGDFNEFNIMV 235 (465)
T ss_pred CCCCccc------ccceeeHHHhhcccceeeeeecCC------hHHHH---HHHHHHHHHHHHcC--ceecccchheeEE
Confidence 22 2222 256689999998877765332222 22222 22222233455678 9999999999999
Q ss_pred cCCCcEEEcccccc
Q 036407 152 DHNFCAKISDFGLA 165 (576)
Q Consensus 152 d~~g~vKLiDFGlA 165 (576)
..++.++++||--.
T Consensus 236 ~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQM 249 (465)
T ss_pred ecCCCEEEeechHh
Confidence 99999999999643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.074 Score=57.63 Aligned_cols=139 Identities=17% Similarity=0.150 Sum_probs=88.7
Q ss_pred ccceeeccCcEEEEEEEEC-CceEEEEEeecCC--chh------------------------HHHHHHHHHHHHHhccC-
Q 036407 19 PSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGS--LQG------------------------EREFYNELYFASLLEQD- 70 (576)
Q Consensus 19 i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s--~~~------------------------~~~~l~EI~iLs~L~h~- 70 (576)
+..+|..|-=+-||.+... |..+|||+++-.- +.+ ......|++.|.+|...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 4567888888899998765 7889999875310 000 12457888888888652
Q ss_pred -CceEEEEEEeeCCCCCeEEEEEeccCCCCHH--HHHHhcCCCChhhHHHHHHHHHHHHHHHHHHH-hCCCCeeecccCC
Q 036407 71 -DHVVSVLGFSSNPKRHRMLLVYELMSNGNLQ--DALLHKKPPELMEWCKRFSIAVDIAKGIAYLH-SLNPPVIHGDIKP 146 (576)
Q Consensus 71 -pNIv~Llg~~~~~s~~~l~LVmE~~~gGsL~--d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLH-s~g~~IVHrDLKP 146 (576)
|+.-.++. ..-.|||+|+- .+=+ -.|+... ++...+..+-.+++.-+.-|. .++ .||.||+-
T Consensus 228 IP~PePIlL-------k~hVLVM~FlG-rdgw~aPkLKd~~----ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSE 293 (520)
T KOG2270|consen 228 IPCPEPILL-------KNHVLVMEFLG-RDGWAAPKLKDAS----LSTSKARELYQQCVRIMRRLYQKCR--LVHADLSE 293 (520)
T ss_pred CCCCCceee-------ecceEeeeecc-CCCCcCccccccc----CChHHHHHHHHHHHHHHHHHHHHhc--eeccchhh
Confidence 22211211 22368999993 2211 1122211 344455556667777666664 488 99999999
Q ss_pred CCeEEcCCCcEEEccccccccccCCC
Q 036407 147 SNILLDHNFCAKISDFGLARLKSVGE 172 (576)
Q Consensus 147 eNILLd~~g~vKLiDFGlA~~~~~~~ 172 (576)
-|+|+ .+|.+.|+|.+-+-..+.+.
T Consensus 294 fN~Ly-hdG~lyiIDVSQSVE~DHP~ 318 (520)
T KOG2270|consen 294 FNLLY-HDGKLYIIDVSQSVEHDHPH 318 (520)
T ss_pred hhheE-ECCEEEEEEccccccCCChh
Confidence 99998 56889999998776665553
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.11 Score=55.16 Aligned_cols=153 Identities=16% Similarity=0.187 Sum_probs=83.0
Q ss_pred CCccceeeccCcEEEEEEEECCceEEEEEeec--CCchhHHHHHHHHHHHHHhccCCc-eEEEEEEeeCCCCCeEEEEEe
Q 036407 17 FSPSRLLGQGGFGSVFHATLHDQSVAVKVMDS--GSLQGEREFYNELYFASLLEQDDH-VVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~--~s~~~~~~~l~EI~iLs~L~h~pN-Iv~Llg~~~~~s~~~l~LVmE 93 (576)
..+.+.+..|-...+|....+++.+++. ... ..........+|+.++..+...+- +...++.|.....+..|.||+
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred CceeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 3344555455555566666667888888 331 122333456777777777755321 223355555443356799999
Q ss_pred ccCCCCHHH------------------HHHh-cC--------CC--ChhhHHHHHHHHHH--------------HHHHHH
Q 036407 94 LMSNGNLQD------------------ALLH-KK--------PP--ELMEWCKRFSIAVD--------------IAKGIA 130 (576)
Q Consensus 94 ~~~gGsL~d------------------~L~~-~~--------~~--~~ls~~~vl~I~~q--------------Il~AL~ 130 (576)
|++|..+.. .|.. +. .+ ......++..+..+ ...-..
T Consensus 106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 998732211 1110 00 00 00000011111111 111223
Q ss_pred HHHhCC------CCeeecccCCCCeEEcCCCcEEEccccccccccC
Q 036407 131 YLHSLN------PPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 131 yLHs~g------~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
+++++. ++++|+|+.+.||+++..+.+-++||+.+..-++
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 343322 3689999999999999988899999999875544
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.13 Score=53.84 Aligned_cols=77 Identities=18% Similarity=0.219 Sum_probs=47.3
Q ss_pred CCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhcc--CCceEEEEEEeeCCCCCeEEEEEec
Q 036407 17 FSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQ--DDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h--~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
....+.|+-|....+|+....++.+.||+-. ......+..|..-|+.|.. .-.+.+++++.... +.-+|||||
T Consensus 19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fLlle~ 93 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFLLLEF 93 (288)
T ss_dssp --EEEEE--SSSSEEEEEETTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEEEEE-
T ss_pred eeeeEecCCCChhheEEEECCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceEEEEe
Confidence 3445788889999999998778999999976 2233467888888887743 24567777776655 344999999
Q ss_pred cCCC
Q 036407 95 MSNG 98 (576)
Q Consensus 95 ~~gG 98 (576)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 8755
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.19 Score=55.19 Aligned_cols=75 Identities=17% Similarity=0.130 Sum_probs=49.8
Q ss_pred ccceeeccCcEEEEEEEECCceEEEEEeecCCc-------hhHHHHHHHHHHHHHhccC--CceEEEEEEeeCCCCCeEE
Q 036407 19 PSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSL-------QGEREFYNELYFASLLEQD--DHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 19 i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~-------~~~~~~l~EI~iLs~L~h~--pNIv~Llg~~~~~s~~~l~ 89 (576)
..+.||.|....||+....++.++||.-..... ....+...|...|..+... .++..++.++.. ..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----CCE
Confidence 367889999999999987777899998652110 1223344445555554321 367778888763 347
Q ss_pred EEEeccCC
Q 036407 90 LVYELMSN 97 (576)
Q Consensus 90 LVmE~~~g 97 (576)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999966
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.2 Score=53.08 Aligned_cols=74 Identities=14% Similarity=0.175 Sum_probs=45.0
Q ss_pred cceeeccCcEEEEEEEECC-----ceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEec
Q 036407 20 SRLLGQGGFGSVFHATLHD-----QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~g-----~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
++.|..|-...+|+....+ ..|++|+....... -..-.+|+.++..+....--..+++++. . + +|.+|
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~--~-G---~i~~f 91 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG--N-G---MIQSF 91 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC--C-c---Eeehh
Confidence 3455557788899887553 27889987543221 1123567777777776544455665542 1 2 58888
Q ss_pred cCCCCH
Q 036407 95 MSNGNL 100 (576)
Q Consensus 95 ~~gGsL 100 (576)
+++..|
T Consensus 92 i~g~~l 97 (330)
T PLN02421 92 INARTL 97 (330)
T ss_pred hcCCCC
Confidence 876544
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.25 Score=51.18 Aligned_cols=33 Identities=27% Similarity=0.585 Sum_probs=26.6
Q ss_pred CCeeecccCCCCeEEcCCCc-EEEcccccccccc
Q 036407 137 PPVIHGDIKPSNILLDHNFC-AKISDFGLARLKS 169 (576)
Q Consensus 137 ~~IVHrDLKPeNILLd~~g~-vKLiDFGlA~~~~ 169 (576)
+.++|+|++|.|||++.++. .-|+||+.+..-+
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 35899999999999987555 5699999876543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.12 Score=62.47 Aligned_cols=75 Identities=20% Similarity=0.178 Sum_probs=52.7
Q ss_pred HHHHHHHHHhccCCceEEEEEEeeCCCC-C-eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhC
Q 036407 58 YNELYFASLLEQDDHVVSVLGFSSNPKR-H-RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL 135 (576)
Q Consensus 58 l~EI~iLs~L~h~pNIv~Llg~~~~~s~-~-~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~ 135 (576)
.-|+..+.++.| +|++.++.|...... + ...+..++|..-++...+..-+. ++..+.+.+..+++.||.++|+.
T Consensus 230 E~e~~~l~k~~~-~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 230 EIELESLSKIAH-DNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---IPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHhhcc-ccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---cCHHHHHHHHHHHhhhHHHHHHh
Confidence 445556677777 899998887654322 1 12244577877788777766543 66777888889999999999986
Q ss_pred C
Q 036407 136 N 136 (576)
Q Consensus 136 g 136 (576)
.
T Consensus 306 ~ 306 (1351)
T KOG1035|consen 306 S 306 (1351)
T ss_pred c
Confidence 5
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.0068 Score=74.37 Aligned_cols=102 Identities=9% Similarity=0.004 Sum_probs=66.9
Q ss_pred HHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCC-CChhhHHHHHHHHHHH-HHHHHHHHh---CCC
Q 036407 63 FASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP-PELMEWCKRFSIAVDI-AKGIAYLHS---LNP 137 (576)
Q Consensus 63 iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~-~~~ls~~~vl~I~~qI-l~AL~yLHs---~g~ 137 (576)
.++.+.| +++.....-....+....+.+++++.+|.+.+.+-.... ....+..-+. ...++ +.+..-+|. .|-
T Consensus 1282 e~~~~~h-~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~-~~~kvsvl~~~~~ls~tnlg~ 1359 (2724)
T KOG1826|consen 1282 ELREAKH-YLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVH-LRHKVSVLNRNVILSLTNLGN 1359 (2724)
T ss_pred hhhhhhc-eeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHH-HHHHHHHhccchhhhcccCCc
Confidence 3444555 666655554444445667899999999999987754221 1112222222 33333 555566664 223
Q ss_pred CeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 138 PVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 138 ~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
..+|+++|+-|.+|..+..+++.++|+.+
T Consensus 1360 T~v~~~Lkf~lpmIVtny~v~~gk~gLdK 1388 (2724)
T KOG1826|consen 1360 TNVSKSLKFTLPMIVTNYNVKLGKGGLDK 1388 (2724)
T ss_pred cchhhhhhhhccceecCCccccccccccc
Confidence 46899999999999999999999999987
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.57 E-value=0.12 Score=50.76 Aligned_cols=30 Identities=33% Similarity=0.533 Sum_probs=21.2
Q ss_pred CeeecccCCCCeEE-cCCCcEEEcccccccc
Q 036407 138 PVIHGDIKPSNILL-DHNFCAKISDFGLARL 167 (576)
Q Consensus 138 ~IVHrDLKPeNILL-d~~g~vKLiDFGlA~~ 167 (576)
.+.|.|+.|.|||+ ..++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47899999999999 7889999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.18 E-value=0.71 Score=47.49 Aligned_cols=28 Identities=29% Similarity=0.296 Sum_probs=24.3
Q ss_pred CeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 138 PVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 138 ~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 3899999999999987 678899999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.14 E-value=0.31 Score=50.80 Aligned_cols=30 Identities=23% Similarity=0.376 Sum_probs=26.9
Q ss_pred CeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 138 PVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 138 ~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
.++|+|+.+.|+|++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999987653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.64 E-value=0.42 Score=51.07 Aligned_cols=143 Identities=22% Similarity=0.249 Sum_probs=78.9
Q ss_pred ceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCC--ceEE---EEEEeeCCCCC--eEEEEEe
Q 036407 21 RLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDD--HVVS---VLGFSSNPKRH--RMLLVYE 93 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~p--NIv~---Llg~~~~~s~~--~l~LVmE 93 (576)
..|.+ .-..||+....++.+++|+.+.. .....+.-|+..+..|..+. -.+. +-|-....-.. +.+-+++
T Consensus 32 ~~l~s-~eN~~f~~~~~~g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 32 RGLNS-EENSNFRVQTEDGRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccccc-ccCceEEEEecCCCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 34444 45568888888777799998765 33445566666666665421 1111 11111111113 7788999
Q ss_pred ccCCCCHHH-----HH----------H----hcC--CC---ChhhHHH-------------HHHHHHHHHHHHHHHHhCC
Q 036407 94 LMSNGNLQD-----AL----------L----HKK--PP---ELMEWCK-------------RFSIAVDIAKGIAYLHSLN 136 (576)
Q Consensus 94 ~~~gGsL~d-----~L----------~----~~~--~~---~~ls~~~-------------vl~I~~qIl~AL~yLHs~g 136 (576)
|++|..+.. .+ + ... .+ ....|.. ......++...+..+.+.-
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 998866551 00 0 000 00 0111110 0012233334444444311
Q ss_pred ------CC--eeecccCCCCeEEcCCCc-EEEccccccc
Q 036407 137 ------PP--VIHGDIKPSNILLDHNFC-AKISDFGLAR 166 (576)
Q Consensus 137 ------~~--IVHrDLKPeNILLd~~g~-vKLiDFGlA~ 166 (576)
.+ +||+|+.|.||+++.+.. +.++||+.+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 12 899999999999998874 8999999765
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=93.62 E-value=0.75 Score=49.87 Aligned_cols=72 Identities=19% Similarity=0.119 Sum_probs=45.2
Q ss_pred eeeccCcEEEEEEEECC--ceEEEEEeec------CC-chhHHHHHHHHHHHHHhcc-CC-ceEEEEEEeeCCCCCeEEE
Q 036407 22 LLGQGGFGSVFHATLHD--QSVAVKVMDS------GS-LQGEREFYNELYFASLLEQ-DD-HVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 22 ~LG~GsfG~Vyka~~~g--~~VAVK~i~~------~s-~~~~~~~l~EI~iLs~L~h-~p-NIv~Llg~~~~~s~~~l~L 90 (576)
.||.|....||++...+ +.++||.-.. .+ .-...+..-|...|..... .| .+..++.+.. ....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~----e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDT----EMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcc----cccee
Confidence 57999999999998764 5899997632 11 1223445566666655433 23 4555655532 44578
Q ss_pred EEeccCC
Q 036407 91 VYELMSN 97 (576)
Q Consensus 91 VmE~~~g 97 (576)
|||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 9999853
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.19 E-value=0.77 Score=50.40 Aligned_cols=74 Identities=24% Similarity=0.177 Sum_probs=48.1
Q ss_pred cceeeccCcEEEEEEEEC--CceEEEEEeec-----CC-chhHHHHHHHHHHHHHhcc-CC-ceEEEEEEeeCCCCCeEE
Q 036407 20 SRLLGQGGFGSVFHATLH--DQSVAVKVMDS-----GS-LQGEREFYNELYFASLLEQ-DD-HVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~-----~s-~~~~~~~l~EI~iLs~L~h-~p-NIv~Llg~~~~~s~~~l~ 89 (576)
.+.||.|....||++... ++.++||.-.. .+ .-...+..-|...|..+.. .| ++..++.+.. ....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~----e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS----VMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc----HHhh
Confidence 568999999999999975 67899987532 11 1223455666666665543 23 5666655533 4457
Q ss_pred EEEeccCC
Q 036407 90 LVYELMSN 97 (576)
Q Consensus 90 LVmE~~~g 97 (576)
+|||+++.
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 89999853
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.19 E-value=1.5 Score=53.55 Aligned_cols=96 Identities=17% Similarity=0.166 Sum_probs=51.1
Q ss_pred CCChHHHH-hhcCCCCcc---ceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhcc------CCc
Q 036407 4 RFSYSVLR-RAADSFSPS---RLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQ------DDH 72 (576)
Q Consensus 4 ~fs~~~lk-~~~d~Y~i~---e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h------~pN 72 (576)
.++..++. .+...|-+. +.|+ |..-.+|+.... +..+++|+.+... .......|...+..|.. +|.
T Consensus 10 ~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~ 86 (1013)
T PRK06148 10 EFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPR 86 (1013)
T ss_pred CCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCe
Confidence 35555553 444445443 4554 455778888765 5689999997542 22334444455554433 122
Q ss_pred eEEEE-E----EeeC-CCCCeEEEEEeccCCCCHHH
Q 036407 73 VVSVL-G----FSSN-PKRHRMLLVYELMSNGNLQD 102 (576)
Q Consensus 73 Iv~Ll-g----~~~~-~s~~~l~LVmE~~~gGsL~d 102 (576)
++.-. + .... ....+.+-+++|++|..|.+
T Consensus 87 ~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 87 LIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAE 122 (1013)
T ss_pred eeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHh
Confidence 22211 1 1111 11125677899998866644
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.09 E-value=0.58 Score=51.53 Aligned_cols=62 Identities=16% Similarity=0.144 Sum_probs=41.6
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHH-hCCCCeeecccCCCCeEEcC
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLH-SLNPPVIHGDIKPSNILLDH 153 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLH-s~g~~IVHrDLKPeNILLd~ 153 (576)
....|+-+|..|.++..+++.... ++..+..++.--+.|+.-|- -.+ ++|.|++|.||++--
T Consensus 318 ~~~vl~E~~~~Gl~v~~~v~~~~~----pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 318 TDLVLVETYERGLSVLRFVKWKSQ----PEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRF 380 (565)
T ss_pred ccceeeeeccccccHHhhhhcccC----hHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEe
Confidence 344677778888888888876553 33344445554455555443 256 999999999999843
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.40 E-value=2.2 Score=46.43 Aligned_cols=75 Identities=17% Similarity=0.214 Sum_probs=45.1
Q ss_pred ccceeeccCcEEEEEEEECC---ce-----EEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 19 PSRLLGQGGFGSVFHATLHD---QS-----VAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 19 i~e~LG~GsfG~Vyka~~~g---~~-----VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.++.|..|-...+|++...+ .. |.++........ --.-.+|+.++..|..+..-.++++.+.. ++
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l-~IdR~~E~~i~~~Ls~~glgP~l~~~f~~------g~ 126 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSL-VIDNDLQYNIAKLLGDNNFGPKIIGRFGD------FT 126 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCce-EeccHHHHHHHHHHHhCCCCCeEEEecCC------EE
Confidence 34566568888999987542 12 333332111100 01225678888888886666777666531 68
Q ss_pred EEeccCCCCH
Q 036407 91 VYELMSNGNL 100 (576)
Q Consensus 91 VmE~~~gGsL 100 (576)
|.||++|..|
T Consensus 127 l~efIeGr~l 136 (383)
T PTZ00384 127 IQEWVEGNTM 136 (383)
T ss_pred EEEEeccccC
Confidence 9999987655
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=90.07 E-value=0.14 Score=53.20 Aligned_cols=114 Identities=18% Similarity=0.267 Sum_probs=85.1
Q ss_pred hhccccCccccCCCCCCCcceeeccccCccccccccccC------CCCcccccceeehhHHHHHHHhCCCCccccCCCch
Q 036407 405 ARHNSYDSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGA------GGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMS 478 (576)
Q Consensus 405 ~~~~~~d~~~~~~i~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwS~G~~l~eli~g~~pf~~~~~~~~ 478 (576)
-++.+.|||.+.-++.++.+. ..||||+|.|||.+. ...|+.-+|+|++||+||.|+.|.+||.-
T Consensus 160 ~~i~isDFGFa~~l~~GekLr---elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH------ 230 (411)
T KOG0599|consen 160 MNIKISDFGFACQLEPGEKLR---ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH------ 230 (411)
T ss_pred cceEEeccceeeccCCchhHH---HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH------
Confidence 368889999999888887766 689999999999884 13688889999999999999999999952
Q ss_pred hhhhhhHHHHHHHhccccchhhhhhhHHhhhcC---HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 036407 479 EFQRANLMSWARHLARNGKLIELVDQAVVKSLD---REQALLCITVALLCLQKSPALRPSMEEVVG 541 (576)
Q Consensus 479 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~cl~~dP~~Rps~~~v~~ 541 (576)
+..++ ++.++-...-.... ...+...++|+.+||++||.+|.|++|+|+
T Consensus 231 ---RkQml-----------MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 231 ---RKQML-----------MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ---HHHHH-----------HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11111 22222221111111 134556789999999999999999999986
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.98 E-value=2.7 Score=46.73 Aligned_cols=75 Identities=12% Similarity=0.029 Sum_probs=43.7
Q ss_pred ccceeeccCcEEEEEEEEC----------CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 19 PSRLLGQGGFGSVFHATLH----------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 19 i~e~LG~GsfG~Vyka~~~----------g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
.++.|..|-.-.+|++... ++.|++++.-.....-. .-..|..++..+....--.++++.+. -
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~------g 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS------G 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC------C
Confidence 4566666777788888754 35788888744321111 22456666666665444445555442 1
Q ss_pred EEEEeccCCCCH
Q 036407 89 LLVYELMSNGNL 100 (576)
Q Consensus 89 ~LVmE~~~gGsL 100 (576)
+.|.+|++|..|
T Consensus 182 g~I~efi~g~~l 193 (442)
T PTZ00296 182 GRIEEWLYGDPL 193 (442)
T ss_pred CEEEEeeCCccC
Confidence 467899987533
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.01 E-value=4.3 Score=42.90 Aligned_cols=69 Identities=13% Similarity=0.114 Sum_probs=39.6
Q ss_pred CcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccC--CceEEE--EE--EeeCCCCCeEEEEEeccCCC
Q 036407 27 GFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQD--DHVVSV--LG--FSSNPKRHRMLLVYELMSNG 98 (576)
Q Consensus 27 sfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~--pNIv~L--lg--~~~~~s~~~l~LVmE~~~gG 98 (576)
.-..||+.... +..+++|+.+... .....+..|+..+..|... |-+..+ -+ .... .+..+.++++++|.
T Consensus 37 ~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~--~g~~~~l~~~~~G~ 112 (325)
T PRK11768 37 YENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEH--QGFRFALFPRRGGR 112 (325)
T ss_pred ccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEE--CCEEEEEEeeeCCC
Confidence 34558888765 5679999886433 2344566777777666542 211111 11 1111 25677899998764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=88.71 E-value=0.62 Score=50.66 Aligned_cols=75 Identities=19% Similarity=0.192 Sum_probs=53.8
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
+..++|++|++- |++|.- +. ...+.++..++.+++.-++-+-. ..+.-||++...||||+ .|.+.|+||-
T Consensus 297 e~~y~yl~~kdh-gt~is~-ik------~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISI-IK------ADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred CceEEEEEEecC-Cceeee-ee------cccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEee
Confidence 346667778776 555531 11 13466777788877665555544 34589999999999999 9999999999
Q ss_pred ccccc
Q 036407 164 LARLK 168 (576)
Q Consensus 164 lA~~~ 168 (576)
+++..
T Consensus 367 lsRl~ 371 (488)
T COG5072 367 LSRLS 371 (488)
T ss_pred eeecc
Confidence 99854
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 576 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-23 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-17 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-23 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-20 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-19 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-05 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-05 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-05 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-05 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-05 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-05 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-05 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-05 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-05 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-05 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-05 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-05 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-05 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-05 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-05 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-05 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-05 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-05 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-05 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-05 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-05 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-05 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-05 | ||
| 3e7e_A | 365 | Structure And Substrate Recruitment Of The Human Sp | 8e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3E7E|A Chain A, Structure And Substrate Recruitment Of The Human Spindle Checkpoint Kinase Bub Length = 365 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-62
Identities = 63/173 (36%), Positives = 92/173 (53%), Gaps = 7/173 (4%)
Query: 3 HRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQGEREFYNEL 61
+R L A ++F L+G G FG V+ L D VA+K S QG EF E+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 62 YFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPEL-MEWCKRFS 120
S + H+VS++GF R+ M+L+Y+ M NGNL+ L P + M W +R
Sbjct: 87 ETLSFC-RHPHLVSLIGFCDE--RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 121 IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGEN 173
I + A+G+ YLH +IH D+K NILLD NF KI+DFG+++ + +
Sbjct: 144 ICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 40/123 (32%), Positives = 58/123 (47%), Gaps = 5/123 (4%)
Query: 426 STPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANL 485
ST GT+ Y+ PEY G ++EK DVYS+GV+L ++ R + + NL
Sbjct: 198 STVVK-GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV----NL 252
Query: 486 MSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGMLTG 545
WA NG+L ++VD + + E A+ CL S RPSM +V+ L
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
Query: 546 KLE 548
L
Sbjct: 313 ALR 315
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 1e-61
Identities = 63/183 (34%), Positives = 92/183 (50%), Gaps = 15/183 (8%)
Query: 2 PHRFSYSVLRRAADSFSP------SRLLGQGGFGSVFHATLHDQSVAVKVMDSG----SL 51
H FS+ L+ ++F +G+GGFG V+ +++ +VAVK + + +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 71
Query: 52 QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPE 111
+ +++F E+ + Q +++V +LGFSS+ LVY M NG+L D L
Sbjct: 72 ELKQQFDQEIKVMAKC-QHENLVELLGFSSDGD-DL-CLVYVYMPNGSLLDRLSCLDGTP 128
Query: 112 LMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVG 171
+ W R IA A GI +LH IH DIK +NILLD F AKISDFGLAR
Sbjct: 129 PLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 172 ENQ 174
Sbjct: 187 AQT 189
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 30/119 (25%), Positives = 51/119 (42%), Gaps = 9/119 (7%)
Query: 432 GTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSWAR- 490
GT Y+APE G+I+ K D+YS+GV+LL +I G + P L+
Sbjct: 197 GTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ------LLLDIKEE 249
Query: 491 HLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGMLTGKLEA 549
+ + +D+ + D +VA CL + RP +++V +L +
Sbjct: 250 IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-60
Identities = 68/175 (38%), Positives = 99/175 (56%), Gaps = 7/175 (4%)
Query: 2 PHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQG-EREFYN 59
RFS L+ A+D+FS +LG+GGFG V+ L D VAVK + QG E +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 60 ELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPEL-MEWCKR 118
E+ S+ +++ + GF P R LLVY M+NG++ L + + ++W KR
Sbjct: 77 EVEMISMA-VHRNLLRLRGFCMTPT-ER-LLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 119 FSIAVDIAKGIAYLH-SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGE 172
IA+ A+G+AYLH +P +IH D+K +NILLD F A + DFGLA+L +
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 49/115 (42%), Positives = 64/115 (55%), Gaps = 2/115 (1%)
Query: 431 RGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSWAR 490
RGT+ ++APEY + G SEK DV+ YGV+LL LI G+R + + L+ W +
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD--VMLLDWVK 253
Query: 491 HLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGMLTG 545
L + KL LVD + + E+ I VALLC Q SP RP M EVV ML G
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-44
Identities = 34/151 (22%), Positives = 66/151 (43%), Gaps = 8/151 (5%)
Query: 23 LGQGGFGSVFHATLHDQSVAVKVMDSGSLQGE--REFYNELYFASLLEQDDH--VVSVLG 78
L + G ++ + VKV+ R+F E L H V+ VLG
Sbjct: 18 LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEE---CPRLRIFSHPNVLPVLG 74
Query: 79 FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPP 138
+P L+ M G+L + +LH+ +++ + A+D+A+G+A+LH+L P
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYN-VLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 139 VIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
+ + ++++D + A+IS +
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQ 164
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 25/126 (19%), Positives = 41/126 (32%), Gaps = 28/126 (22%)
Query: 424 VTSTPSMRGTVCYVAPE---YGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEF 480
+P +VAPE D++S+ VLL L+ P F
Sbjct: 162 SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP----------F 211
Query: 481 QRANLMSWARHLARNGKLIEL---VDQAVVKSLDREQALLCITVALLCLQKSPALRPSME 537
+ M +A G + + V K + C+ + PA RP +
Sbjct: 212 ADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKI------------CMNEDPAKRPKFD 259
Query: 538 EVVGML 543
+V +L
Sbjct: 260 MIVPIL 265
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 47/186 (25%), Positives = 78/186 (41%), Gaps = 16/186 (8%)
Query: 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFA 64
L + + +G FG V+ A L ++ VAVK+ Q + E+Y
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSW-QNEYEVYSL 72
Query: 65 SLLEQDDHVVSVLGFSSNPKRHR--MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIA 122
+ + ++++ +G + L+ G+L D L + W + IA
Sbjct: 73 PGM-KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD-FLKANV---VSWNELCHIA 127
Query: 123 VDIAKGIAYLHS--------LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQ 174
+A+G+AYLH P + H DIK N+LL +N A I+DFGLA G++
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 175 NQADGE 180
G+
Sbjct: 188 GDTHGQ 193
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 23/140 (16%), Positives = 47/140 (33%), Gaps = 23/140 (16%)
Query: 420 KSGGVTSTPSMR--GTVCYVAPEYGAGG-----DISEKCDVYSYGVLLLVLIAGRRPLQV 472
G ++ + GT Y+APE G D + D+Y+ G++L L +
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA--- 237
Query: 473 TGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLD--------REQALLCIT-VAL 523
P+ E+ + + + ++ L ++ + V K + + +
Sbjct: 238 ADGPVDEYM----LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE 293
Query: 524 LCLQKSPALRPSMEEVVGML 543
C R S V +
Sbjct: 294 ECWDHDAEARLSAGCVGERI 313
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-43
Identities = 52/151 (34%), Positives = 85/151 (56%), Gaps = 9/151 (5%)
Query: 23 LGQGGFGSVFHATLHDQSVAVKVMDSGSLQGE--REFYNELYFASLLEQDDH--VVSVLG 78
+G G FG+V A H VAVK++ E EF E +++++ H +V +G
Sbjct: 45 IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLRE---VAIMKRLRHPNIVLFMG 101
Query: 79 FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPP 138
+ P + +V E +S G+L L E ++ +R S+A D+AKG+ YLH+ NPP
Sbjct: 102 AVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 139 VIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
++H ++K N+L+D + K+ DFGL+RLK+
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 30/142 (21%), Positives = 52/142 (36%), Gaps = 25/142 (17%)
Query: 420 KSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSE 479
K+ S+ S GT ++APE +EK DVYS+GV+L L ++P
Sbjct: 189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP---------- 238
Query: 480 FQRANLMSWARHLARNGK---LIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSM 536
+ N + K + ++ V ++ C P RPS
Sbjct: 239 WGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG------------CWTNEPWKRPSF 286
Query: 537 EEVVGMLTGKLEAPKLPAEFSP 558
++ +L +++ P S
Sbjct: 287 ATIMDLLRPLIKSAVPPPNRSD 308
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-42
Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 23 LGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSVLGFS 80
+G+G FG V A + VA+K ++S S + F E L + +H +V + G
Sbjct: 16 VGRGAFGVVCKAKWRAKDVAIKQIESESE--RKAFIVE---LRQLSRVNHPNIVKLYGAC 70
Query: 81 SNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNP-PV 139
NP + LV E G+L + L +P S + ++G+AYLHS+ P +
Sbjct: 71 LNP----VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 140 IHGDIKPSNILLDHNF-CAKISDFGLARLKS 169
IH D+KP N+LL KI DFG A
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 35/120 (29%), Positives = 58/120 (48%), Gaps = 26/120 (21%)
Query: 429 SMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSW 488
+ +G+ ++APE G + SEKCDV+S+G++L +I R+P F ++
Sbjct: 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP----------FDEIGGPAF 211
Query: 489 ARHLA-RNGK---LIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGMLT 544
A NG LI+ + + + + R C K P+ RPSMEE+V ++T
Sbjct: 212 RIMWAVHNGTRPPLIKNLPKPIESLMTR------------CWSKDPSQRPSMEEIVKIMT 259
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-41
Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 25/165 (15%)
Query: 21 RLLGQGGFGSVFHATL--HDQSVAVKVMDSGSLQGE-------REFYNELYFASLLEQDD 71
+ +G+GGFG V L VA+K + G +GE +EF E ++ +
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE---VFIMSNLN 81
Query: 72 H--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
H +V + G NP +V E + G+L L K + +W + + +DIA GI
Sbjct: 82 HPNIVKLYGLMHNP----PRMVMEFVPCGDLYH-RLLDKAHPI-KWSVKLRLMLDIALGI 135
Query: 130 AYLHSLNPPVIHGDIKPSNILLD-----HNFCAKISDFGLARLKS 169
Y+ + NPP++H D++ NI L CAK++DFGL++
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV 180
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 21/125 (16%), Positives = 42/125 (33%), Gaps = 26/125 (20%)
Query: 425 TSTPSMRGTVCYVAPE--YGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQR 482
+ + + G ++APE +EK D YS+ ++L ++ G P S +
Sbjct: 182 SVS-GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF----DEYSYGK- 235
Query: 483 ANLMSWARHLARNGK---LIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEV 539
+ + + G + E + ++ C P RP +
Sbjct: 236 ---IKFINMIREEGLRPTIPEDCPPRLRNVIEL------------CWSGDPKKRPHFSYI 280
Query: 540 VGMLT 544
V L+
Sbjct: 281 VKELS 285
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-41
Identities = 47/193 (24%), Positives = 83/193 (43%), Gaps = 20/193 (10%)
Query: 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNEL--Y 62
+ S D+ L+G+G +G+V+ +L ++ VAVKV + + F NE Y
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---RQNFINEKNIY 59
Query: 63 FASLLEQDDHVVSVLGFS---SNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF 119
L+ + D++ + + R LLV E NG+L L +W
Sbjct: 60 RVPLM-EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114
Query: 120 SIAVDIAKGIAYLHS-------LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGE 172
+A + +G+AYLH+ P + H D+ N+L+ ++ ISDFGL+ +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 173 NQNQADGENKNKA 185
+ +N +
Sbjct: 175 LVRPGEEDNAAIS 187
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 19/155 (12%), Positives = 46/155 (29%), Gaps = 22/155 (14%)
Query: 425 TSTPSMRGTVCYVAPEY-------GAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPM 477
+ S GT+ Y+APE ++ D+Y+ G++ + R G +
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-RCTDLFPGESV 241
Query: 478 SEFQRANLMSWARHLARNGKLIELVDQAVVKSL--------DREQALLCITVALL--CLQ 527
E+Q A + + + ++ + + + C
Sbjct: 242 PEYQMA----FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297
Query: 528 KSPALRPSMEEVVGMLTGKLEAPKLPAEFSPSPPS 562
+ R + + + + + SP+
Sbjct: 298 QDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-39
Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 8 SVLRRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNE--LYFAS 65
S+ R A + +G+G +G V+ + ++VAVK+ S + E+ ++ E LY
Sbjct: 1 SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSS---RDEKSWFRETELYNTV 57
Query: 66 LLEQDDHVVSVLG--FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV 123
+L + ++++ + +S ++ L+ G+L D L ++ I +
Sbjct: 58 ML-RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTT---LDTVSCLRIVL 112
Query: 124 DIAKGIAYLHSL------NPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGEN 173
IA G+A+LH P + H D+K NIL+ N I+D GLA + S N
Sbjct: 113 SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 20/133 (15%), Positives = 48/133 (36%), Gaps = 26/133 (19%)
Query: 432 GTVCYVAPE------YGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANL 485
GT Y+APE D ++ D++++G++L + + +++
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS----NGIVEDYKPP-- 232
Query: 486 MSWARHLARNGKLIELVDQAVVKSLDR----EQALLCITVALL------CLQKSPALRPS 535
+ + + ++ V R + T+ L C ++P+ R +
Sbjct: 233 --FYDVVPNDPSFEDMRKVVCVDQQ-RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 536 MEEVVGMLTGKLE 548
+ LT K++
Sbjct: 290 ALRIKKTLT-KID 301
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-38
Identities = 35/163 (21%), Positives = 67/163 (41%), Gaps = 16/163 (9%)
Query: 21 RLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLE-QDDHVVSVLG- 78
+ +G+G +G V+ + VAVKV + E ++ E + + ++++ +
Sbjct: 43 KQIGKGRYGEVWMGKWRGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 79 -FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL-- 135
++ L+ + NG+L D L ++ +A G+ +LH+
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYD-YLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 136 ----NPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQ 174
P + H D+K NIL+ N I+D GLA N+
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 27/132 (20%), Positives = 47/132 (35%), Gaps = 27/132 (20%)
Query: 429 SMRGTVCYVAPE------YGAGGDISEKCDVYSYGVLLLVL--IAGRRPLQVTGSPMSEF 480
+ GT Y+ PE D+YS+G L+L +A R V+G + E+
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG---LILWEVARR---CVSGGIVEEY 258
Query: 481 QRANLMSWARHLARNGKLIELVDQAVVKSL-------DREQALLCITVALL--CLQKSPA 531
Q + + + + ++ + +K L L L+ C +PA
Sbjct: 259 Q----LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPA 314
Query: 532 LRPSMEEVVGML 543
R + V L
Sbjct: 315 SRLTALRVKKTL 326
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-37
Identities = 49/164 (29%), Positives = 67/164 (40%), Gaps = 24/164 (14%)
Query: 21 RLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQ----GEREFYNELYFASLLEQDDH--VV 74
++G GGFG V+ A VAVK + E A L H ++
Sbjct: 13 EIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQE---AKLFAMLKHPNII 69
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS 134
++ G + LV E G L +L K + + AV IA+G+ YLH
Sbjct: 70 ALRGVCLKEP--NLCLVMEFARGGPLNR-VLSGKR---IPPDILVNWAVQIARGMNYLHD 123
Query: 135 LNP-PVIHGDIKPSNILLD--------HNFCAKISDFGLARLKS 169
P+IH D+K SNIL+ N KI+DFGLAR
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH 167
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 29/122 (23%), Positives = 46/122 (37%), Gaps = 25/122 (20%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRAN 484
T+ S G ++APE S+ DV+SYGVLL L+ G P F+ +
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP----------FRGID 218
Query: 485 LMSWARHLARNGK---LIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVG 541
++ A +A N + + K ++ C P RPS ++
Sbjct: 219 GLAVAYGVAMNKLALPIPSTCPEPFAKLMED------------CWNPDPHSRPSFTNILD 266
Query: 542 ML 543
L
Sbjct: 267 QL 268
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 39/161 (24%), Positives = 71/161 (44%), Gaps = 16/161 (9%)
Query: 22 LLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLE-QDDHVVSVLG-- 78
+G+G FG V+ + VAVK+ S + ER ++ E + + ++++ +
Sbjct: 49 SIGKGRFGEVWRGKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 79 FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS---- 134
N ++ LV + +G+L D L++ + +A+ A G+A+LH
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFD-YLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 135 --LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGEN 173
P + H D+K NIL+ N I+D GLA +
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 19/128 (14%), Positives = 43/128 (33%), Gaps = 25/128 (19%)
Query: 432 GTVCYVAPE------YGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANL 485
GT Y+APE + ++ D+Y+ G++ + G ++Q
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI----GGIHEDYQLP-- 266
Query: 486 MSWARHLARNGKLIELVDQAVVKSLDR----EQALLCITVALL------CLQKSPALRPS 535
+ + + + E+ + L R + C + ++ C + A R +
Sbjct: 267 --YYDLVPSDPSVEEMRKVVCEQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323
Query: 536 MEEVVGML 543
+ L
Sbjct: 324 ALRIKKTL 331
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-36
Identities = 48/164 (29%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 21 RLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGE--REFYNELYFASLLEQDDH--VVSV 76
+ +G G FG+V+ H VAVK+++ + + + F NE +L + H ++
Sbjct: 30 QRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNE---VGVLRKTRHVNILLF 85
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN 136
+G+S+ P ++ +V + +L LH + E K IA A+G+ YLH+ +
Sbjct: 86 MGYSTAP---QLAIVTQWCEGSSLYH-HLHASETKF-EMKKLIDIARQTARGMDYLHAKS 140
Query: 137 PPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGE 180
+IH D+K +NI L + KI DFGLA KS +Q +
Sbjct: 141 --IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL 182
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 27/132 (20%), Positives = 52/132 (39%), Gaps = 18/132 (13%)
Query: 415 SGEIPKSGGVTSTPSMRGTVCYVAPE---YGAGGDISEKCDVYSYGVLLLVLIAGRRPLQ 471
+ E + G + G++ ++APE S + DVY++G++L L+ G+ P
Sbjct: 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY- 225
Query: 472 VTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPA 531
S ++ + M + R +L V + + L CL+K
Sbjct: 226 ---SNINNRDQIIEM-----VGRGSLSPDLSK--VRSNCPKRMKRLM----AECLKKKRD 271
Query: 532 LRPSMEEVVGML 543
RPS ++ +
Sbjct: 272 ERPSFPRILAEI 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 13/168 (7%)
Query: 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSV 76
+LG+G FG T + + +K + + +R F E ++ +H V+
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKE---VKVMRCLEHPNVLKF 72
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN 136
+G KR + + E + G L+ ++ + W +R S A DIA G+AYLHS+N
Sbjct: 73 IGVLYKDKR--LNFITEYIKGGTLRG-IIKSMDSQY-PWSQRVSFAKDIASGMAYLHSMN 128
Query: 137 PPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGENKNK 184
+IH D+ N L+ N ++DFGLARL + Q + K
Sbjct: 129 --IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 30/176 (17%), Positives = 50/176 (28%), Gaps = 28/176 (15%)
Query: 404 RARHNSYDSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVL 463
R + K ++ G ++APE G EK DV+S+G++L +
Sbjct: 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215
Query: 464 IAGRRPLQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLC----I 519
I +L R V LDR C
Sbjct: 216 IGRVNA------------------DPDYLPRT----MDFGLNVRGFLDRYCPPNCPPSFF 253
Query: 520 TVALLCLQKSPALRPSMEEVVGMLTGKLEAPKLPAEFSPSPPSRIP--FKSRKKGP 573
+ + C P RPS ++ L P +++ ++G
Sbjct: 254 PITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRRGE 309
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 15/163 (9%)
Query: 21 RLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGE--REFYNELYFASLLEQDDH--VVSV 76
L+G+G FG V+H H + VA++++D + + F E Q H VV
Sbjct: 39 ELIGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKRE---VMAYRQTRHENVVLF 94
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN 136
+G +P + ++ L L ++ L + K IA +I KG+ YLH+
Sbjct: 95 MGACMSP--PHLAIITSLCKGRTLYS-VVRDAKIVL-DVNKTRQIAQEIVKGMGYLHA-- 148
Query: 137 PPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADG 179
++H D+K N+ D+ I+DFGL + V + + D
Sbjct: 149 KGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDK 190
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 27/141 (19%), Positives = 44/141 (31%), Gaps = 33/141 (23%)
Query: 431 RGTVCYVAPE---------YGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQ 481
G +C++APE S+ DV++ G + L A P F+
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP----------FK 244
Query: 482 RANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVG 541
+ G L + K + +L L C RP+ +++
Sbjct: 245 TQPAEA-IIWQMGTGMKPNLSQIGMGKEI---SDIL-----LFCWAFEQEERPTFTKLMD 295
Query: 542 MLTGKLEAPKLPAEFSPSPPS 562
ML + PK S P
Sbjct: 296 MLE---KLPKRNR--RLSHPG 311
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 51/169 (30%), Positives = 74/169 (43%), Gaps = 27/169 (15%)
Query: 21 RLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSLQGER-EFYNELYFASLLEQDDH 72
+ LG G FG V AT + +VAVK++ + ER +EL S L +
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR-------------- 118
+V++LG + L++ E G+L + L K+ +
Sbjct: 89 IVNLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 119 -FSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
S + +AKG+A+L S N IH D+ NILL H KI DFGLAR
Sbjct: 147 LLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 48/167 (28%), Positives = 70/167 (41%), Gaps = 24/167 (14%)
Query: 21 RLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSLQGER-EFYNELYFASLLEQDDH 72
+ LG+G FG V A ++VAVK++ G+ E +EL + +
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF------------- 119
VV++LG + P M++V E GNL L K+ +
Sbjct: 93 VVNLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ +AKG+ +L S IH D+ NILL KI DFGLAR
Sbjct: 152 CYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 48/172 (27%), Positives = 76/172 (44%), Gaps = 27/172 (15%)
Query: 21 RLLGQGGFGSVFHATLHDQS------VAVKVMDSGSLQGER-EFYNELYFASLLEQDDH- 72
++LG G FG+V+ + VA+K + + E +E A ++ D+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE---AYVMASVDNP 77
Query: 73 -VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK----PPELMEWCKRFSIAVDIAK 127
V +LG + L+ +LM G L D + K L+ WC V IAK
Sbjct: 78 HVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAK 128
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADG 179
G+ YL ++H D+ N+L+ KI+DFGLA+L E + A+G
Sbjct: 129 GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 23/165 (13%)
Query: 21 RLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSLQGER-EFYNELYFASLLEQDDH 72
+ LG G FG V AT VAVK++ S + E+ +EL S L Q ++
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR-----------FSI 121
+V++LG + +L++ E G+L + L K +
Sbjct: 112 IVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ +A+G+A+L S N IH D+ N+LL + AKI DFGLAR
Sbjct: 170 SSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 23/165 (13%)
Query: 21 RLLGQGGFGSVFHATLHDQS------VAVKVMDSGSLQGEREFYNELYFASLLEQDDH-- 72
LG+G FGSV VAVK + +R+F E +L+
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQRE---IQILKALHSDF 85
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIAKG 128
+V G S P R + LV E + +G L+D L + L+ + + I KG
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY------SSQICKG 139
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGEN 173
+ YL S +H D+ NIL++ KI+DFGLA+L + ++
Sbjct: 140 MEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-27
Identities = 42/158 (26%), Positives = 68/158 (43%), Gaps = 14/158 (8%)
Query: 15 DSFSPSRLLGQGGFGSVFHATL--HDQSVAVKVMDSGSLQGER-EFYNELYFASLLEQDD 71
+ +G+G FG VF L + VAVK + +F E A +L+Q
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQE---ARILKQYS 170
Query: 72 H--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
H +V ++G + ++ + +V EL+ G+ L + + + D A G+
Sbjct: 171 HPNIVRLIGVCT--QKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGM 226
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
YL S IH D+ N L+ KISDFG++R
Sbjct: 227 EYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSRE 262
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 21 RLLGQGGFGSVFHATLH------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH-- 72
+ LG+G FGSV + VAVK + + + R+F E +L+ H
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE---IEILKSLQHDN 72
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIAKG 128
+V G + R + L+ E + G+L+D L K +L+++ I KG
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT------SQICKG 126
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+ YL + IH D+ NIL+++ KI DFGL ++
Sbjct: 127 MEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKV 163
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 42/169 (24%), Positives = 78/169 (46%), Gaps = 27/169 (15%)
Query: 21 RLLGQGGFGSVFHATLHD---------QSVAVKVMDSGSLQGER-EFYNELYFASLLEQD 70
+ LG+G FG V A +VAVK++ + + + + +E+ ++ +
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 71 DHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR------------ 118
+++++LG + + + ++ E S GNL++ L ++PP +
Sbjct: 101 KNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 119 -FSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
S +A+G+ YL S IH D+ N+L+ N KI+DFGLAR
Sbjct: 159 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 23/159 (14%)
Query: 21 RLLGQGGFGSVFHATLH------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH-- 72
+ LG+G FGSV + VAVK + + + R+F E +L+ H
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE---IEILKSLQHDN 103
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIAKG 128
+V G + R + L+ E + G+L+D L K +L+++ I KG
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------TSQICKG 157
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+ YL + IH D+ NIL+++ KI DFGL ++
Sbjct: 158 MEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKV 194
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 42/169 (24%), Positives = 78/169 (46%), Gaps = 27/169 (15%)
Query: 21 RLLGQGGFGSVFHATLHD---------QSVAVKVMDSGSLQGER-EFYNELYFASLLEQD 70
+ LG+G FG V A +VAVK++ + + + + +E+ ++ +
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 71 DHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR------------ 118
+++++LG + + + ++ E S GNL++ L ++PP +
Sbjct: 147 KNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 119 -FSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
S +A+G+ YL S IH D+ N+L+ N KI+DFGLAR
Sbjct: 205 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 40/179 (22%), Positives = 69/179 (38%), Gaps = 7/179 (3%)
Query: 21 RLLGQGGFGSVFHAT-LHD-QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLG 78
R+L +GGF V+ A + + A+K + S + R E+ F L ++V
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 79 FSSNPKRHRMLLVYELM-----SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLH 133
+S K E + G L + L + + I + + ++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGENKNKAAELESNC 192
PP+IH D+K N+LL + K+ DFG A S + + + E+ N
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 34/184 (18%), Positives = 53/184 (28%), Gaps = 46/184 (25%)
Query: 405 ARHNSYDSAASGEIPKSGGVTSTPSMRGTVCYVAPE----YGAGGDISEKCDVYSYGVLL 460
A S+ S + V + T Y PE Y I EK D+++ G +L
Sbjct: 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCIL 243
Query: 461 LVLIAGRRPLQVTGSPMSEFQRANLM-------SWARHLARNGKLIELVDQAVVKSLDRE 513
+L + P F+ + S H + L+
Sbjct: 244 YLLCFRQHP----------FEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRA--------- 284
Query: 514 QALLCITVALLCLQKSPALRPSMEEVV----GMLTGKLEAPKLPAEFSPSPPSRIPFKSR 569
LQ +P R S+ EVV + + PK P +
Sbjct: 285 -----------MLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATL 333
Query: 570 KKGP 573
+GP
Sbjct: 334 SRGP 337
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 45/165 (27%), Positives = 71/165 (43%), Gaps = 26/165 (15%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS-----VAVKVMDSGSLQGER-EFYNELYFASLLE 68
+ +R+LG+G FG V+ + VAVK + +F +E A +++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE---AVIMK 68
Query: 69 QDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIA 122
DH +V ++G ++ EL G L L K L+ +
Sbjct: 69 NLDHPHIVKLIGIIE---EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS------ 119
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+ I K +AYL S+N +H DI NIL+ C K+ DFGL+R
Sbjct: 120 LQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 24/163 (14%)
Query: 21 RLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSLQGER-EFYNELYFASLLEQDDH 72
R LGQG FG V+ VA+K ++ + ER EF NE AS++++ +
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE---ASVMKEFNC 87
Query: 73 --VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR-------FSIAV 123
VV +LG S + L++ ELM+ G+L+ L +P +A
Sbjct: 88 HHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 124 DIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+IA G+AYL++ +H D+ N ++ +F KI DFG+ R
Sbjct: 146 EIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 27/169 (15%)
Query: 21 RLLGQGGFGSVFHATLHD---------QSVAVKVMDSGSLQGER-EFYNELYFASLLEQD 70
+ LG+G FG V A VAVK++ S + + + + +E+ ++ +
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 71 DHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR------------ 118
+++++LG + + + ++ E S GNL++ L ++PP L
Sbjct: 135 KNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 119 -FSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
S A +A+G+ YL S IH D+ N+L+ + KI+DFGLAR
Sbjct: 193 LVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 44/174 (25%), Positives = 75/174 (43%), Gaps = 32/174 (18%)
Query: 21 RLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSLQGER-EFYNELYFASLLEQDDH 72
++LG G FG V +AT + VAVK++ + ER +EL + L ++
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR-------------- 118
+V++LG + + L++E G+L + L K+ + +
Sbjct: 111 IVNLLGACT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 119 ------FSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
A +AKG+ +L + +H D+ N+L+ H KI DFGLAR
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 21 RLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSVLG 78
+ +G+G FG V VAVK + + + + F E AS++ Q H +V +LG
Sbjct: 27 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAE---ASVMTQLRHSNLVQLLG 81
Query: 79 FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPP 138
++ + +V E M+ G+L D L + ++ ++D+ + + YL N
Sbjct: 82 VIVE-EKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-- 137
Query: 139 VIHGDIKPSNILLDHNFCAKISDFGLAR 166
+H D+ N+L+ + AK+SDFGL +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 22/158 (13%)
Query: 21 RLLGQGGFGSVFHATLHD------QSVAVKVMDSGSLQGER-EFYNELYFASLLEQDDH- 72
R LG+G FG V + VAVK + + + R + E +L H
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQE---IDILRTLYHE 93
Query: 73 -VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP--PELMEWCKRFSIAVDIAKGI 129
++ G + + LV E + G+L+D L +L+ + A I +G+
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGM 147
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
AYLH+ + IH D+ N+LLD++ KI DFGLA+
Sbjct: 148 AYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 48/160 (30%), Positives = 71/160 (44%), Gaps = 21/160 (13%)
Query: 22 LLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGE--REFYNELYFASLLEQDDH--VVS 75
+G+G F +V+ T VA + L + F E A +L+ H +V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEE---AEMLKGLQHPNIVR 89
Query: 76 VLG--FSSNPKRHRMLLVYELMSNGNLQDALL-HKKPPE--LMEWCKRFSIAVDIAKGIA 130
S+ + ++LV ELM++G L+ L K L WC+ I KG+
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR------QILKGLQ 143
Query: 131 YLHSLNPPVIHGDIKPSNILLDH-NFCAKISDFGLARLKS 169
+LH+ PP+IH D+K NI + KI D GLA LK
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 20/115 (17%), Positives = 44/115 (38%), Gaps = 21/115 (18%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRAN 484
+ ++ GT ++APE E DVY++G+ +L + P + ++R
Sbjct: 185 SFAKAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 243
Query: 485 LMSWARHLARNGKLIELVDQAVVKSLDRE-QALLCITVALLCLQKSPALRPSMEE 538
+G D K E + ++ C++++ R S+++
Sbjct: 244 ----------SGVKPASFD----KVAIPEVKEII-----EGCIRQNKDERYSIKD 279
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 41/160 (25%), Positives = 67/160 (41%), Gaps = 24/160 (15%)
Query: 21 RLLGQGGFGSVFHATLH------DQSVAVKVMDSGSLQGER-EFYNELYFASLLEQDDH- 72
R LG+G FG V + VAVK + S + E +L H
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKE---IEILRNLYHE 83
Query: 73 -VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIAK 127
+V G + + + L+ E + +G+L++ L K + +++ AV I K
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY------AVQICK 137
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
G+ YL S +H D+ N+L++ KI DFGL +
Sbjct: 138 GMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKA 175
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 48/172 (27%), Positives = 76/172 (44%), Gaps = 27/172 (15%)
Query: 21 RLLGQGGFGSVFHATLHDQS------VAVKVMDSGSLQGER-EFYNELYFASLLEQDDH- 72
++LG G FG+V+ + VA+K + + E +E A ++ D+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE---AYVMASVDNP 77
Query: 73 -VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK----PPELMEWCKRFSIAVDIAK 127
V +LG + L+ +LM G L D + K L+ WC V IAK
Sbjct: 78 HVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAK 128
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADG 179
G+ YL ++H D+ N+L+ KI+DFGLA+L E + A+G
Sbjct: 129 GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 45/164 (27%), Positives = 70/164 (42%), Gaps = 22/164 (13%)
Query: 21 RLLGQGGFGSVFHATLHD----QSVAVKVMDSGSLQGER-EFYNELYFASLLEQDDHVVS 75
++G+G FG V A + A+K M + + + +F EL L ++++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF-------------SIA 122
+LG R + L E +GNL D L + E A
Sbjct: 91 LLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
D+A+G+ YL IH D+ NIL+ N+ AKI+DFGL+R
Sbjct: 149 ADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 24/158 (15%)
Query: 21 RLLGQGGFGSVFHATLHD-----QSVAVKVMDSGSLQGER-EFYNELYFASLLEQDDH-- 72
++G+G FG V+H TL D AVK ++ + GE +F E +++ H
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE---GIIMKDFSHPN 87
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIAKG 128
V+S+LG L+V M +G+L++ + ++ +L+ + +AKG
Sbjct: 88 VLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GFGLQVAKG 140
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ YL S +H D+ N +LD F K++DFGLAR
Sbjct: 141 MKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 49/162 (30%), Positives = 74/162 (45%), Gaps = 21/162 (12%)
Query: 21 RLLGQGGFGSVFHATLHD-----QSVAVKVM--DSGSLQGEREFYNELYFASLLEQDDH- 72
R+LG+G FGSV A L VAVK++ D + EF E A+ +++ DH
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE---AACMKEFDHP 85
Query: 73 -VVSVLGFSS----NPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR---FSIAVD 124
V ++G S + +++ M +G+L LL + E VD
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145
Query: 125 IAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
IA G+ YL S N IH D+ N +L + ++DFGL+R
Sbjct: 146 IACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 38/170 (22%), Positives = 61/170 (35%), Gaps = 36/170 (21%)
Query: 21 RLLGQGGFGSVFHATLHDQS---------VAVKVMDSGSLQGEREFYNELYFASLLEQDD 71
LGQG F +F + V +KV+D F+ AS++ +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA---ASMMSKLS 70
Query: 72 H--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDI 125
H +V G +LV E + G+L L K +E K +
Sbjct: 71 HKHLVLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK------QL 122
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLD--------HNFCAKISDFGLARL 167
A + +L +IHG++ NILL + K+SD G++
Sbjct: 123 AAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 20/161 (12%)
Query: 21 RLLGQGGFGSVFHATLHD-----QSVAVKVM--DSGSLQGEREFYNELYFASLLEQDDH- 72
++LG+G FGSV L VAVK M D+ S + EF +E A+ ++ H
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE---AACMKDFSHP 96
Query: 73 -VVSVLG--FSSNPKRH-RMLLVYELMSNGNLQDALLHKKPPELMEWCKR---FSIAVDI 125
V+ +LG + + + +++ M G+L LL+ + + VDI
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
A G+ YL + N +H D+ N +L + ++DFGL++
Sbjct: 157 ALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 45/177 (25%), Positives = 74/177 (41%), Gaps = 38/177 (21%)
Query: 21 RLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSLQGER-EFYNELYFASLLEQDDH 72
+ LG+G FG V AT +VAVK++ + E + +E ++L+Q +H
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSE---FNVLKQVNH 85
Query: 73 --VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF----------- 119
V+ + G S + +LL+ E G+L+ L +
Sbjct: 86 PHVIKLYGACS--QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 120 ----------SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
S A I++G+ YL + ++H D+ NIL+ KISDFGL+R
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 21 RLLGQGGFGSVFHATLHDQS----VAVKVM--DSGSLQGEREFYNELYFASLLEQDDH-- 72
+ LG G FG+V + VAVK++ ++ + E E A++++Q D+
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE---ANVMQQLDNPY 79
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK---PPELMEWCKRFSIAVDIAKGI 129
+V ++G +LV E+ G L L + ++E ++ G+
Sbjct: 80 IVRMIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV------HQVSMGM 130
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGENK 182
YL N +H D+ N+LL AKISDFGL++ EN +A K
Sbjct: 131 KYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 26/159 (16%)
Query: 21 RLLGQGGFGSVFHATLHDQS-----VAVKVMDSGSLQGER-EFYNELYFASLLEQDDH-- 72
R +G+G FG V VA+K + + R +F E A + Q DH
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE---ALTMRQFDHPH 77
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIAKG 128
+V ++G + + + ++ EL + G L+ L +K L+ + ++
Sbjct: 78 IVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA------YQLSTA 128
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+AYL S +H DI N+L+ N C K+ DFGL+R
Sbjct: 129 LAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 47/176 (26%), Positives = 65/176 (36%), Gaps = 28/176 (15%)
Query: 21 RLLGQGGFGSVFHATLHDQS-----VAVKVMDSGSLQGE---REFYNELYFASLLEQDDH 72
LG G FG V S VAVK + L +F E + + DH
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE---VNAMHSLDH 80
Query: 73 --VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK----PPELMEWCKRFSIAVDIA 126
++ + G P M +V EL G+L D L + L + V +A
Sbjct: 81 RNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA------VQVA 131
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGENK 182
+G+ YL S IH D+ N+LL KI DFGL R ++ K
Sbjct: 132 EGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 48/168 (28%), Positives = 72/168 (42%), Gaps = 29/168 (17%)
Query: 21 RLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH- 72
R LG+G FG VF A ++ VAVK + +L ++F E A LL H
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQRE---AELLTNLQHE 77
Query: 73 -VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR------------- 118
+V G +++V+E M +G+L L P ++ +
Sbjct: 78 HIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 119 FSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
IA IA G+ YL S + +H D+ N L+ N KI DFG++R
Sbjct: 136 LHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 24/159 (15%)
Query: 21 RLLGQGGFGSVFHATLHDQS-----VAVKVMDSGSLQGER-EFYNELYFASLLEQDDH-- 72
R++G+G FG V+H DQ+ A+K + + + F E L+ +H
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE---GLLMRGLNHPN 83
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIAKG 128
V++++G P+ +L+ M +G+L + + +L+ S + +A+G
Sbjct: 84 VLALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDLI------SFGLQVARG 136
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+ YL +H D+ N +LD +F K++DFGLAR
Sbjct: 137 MEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARD 173
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 43/159 (27%), Positives = 76/159 (47%), Gaps = 25/159 (15%)
Query: 21 RLLGQGGFGSVFHATLHDQS-----VAVKVMDSGSLQGER-EFYNELYFASLLEQDDH-- 72
+++G G G V + L VA+K + +G + +R +F +E AS++ Q DH
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSE---ASIMGQFDHPN 111
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK----PPELMEWCKRFSIAVDIAKG 128
++ + G + + ++V E M NG+L L +L+ + + G
Sbjct: 112 IIRLEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR------GVGAG 163
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+ YL L +H D+ N+L+D N K+SDFGL+R+
Sbjct: 164 MRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 11/148 (7%)
Query: 21 RLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSVLG 78
+ +G+G FG V VAVK + + + + F E AS++ Q H +V +LG
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAE---ASVMTQLRHSNLVQLLG 253
Query: 79 FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPP 138
++ + +V E M+ G+L D L + ++ ++D+ + + YL N
Sbjct: 254 VIVE-EKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-- 309
Query: 139 VIHGDIKPSNILLDHNFCAKISDFGLAR 166
+H D+ N+L+ + AK+SDFGL +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 46/172 (26%), Positives = 76/172 (44%), Gaps = 27/172 (15%)
Query: 23 LGQGGFGSVFHATLHDQS----VAVKVMDSGSLQGER-EFYNELYFASLLEQDDH--VVS 75
LG G FGSV + VA+KV+ G+ + + E E A ++ Q D+ +V
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE---AQIMHQLDNPYIVR 74
Query: 76 VLGF-SSNPKRHRMLLVYELMSNGNLQDALLHKK----PPELMEWCKRFSIAVDIAKGIA 130
++G + ++LV E+ G L L+ K+ + E ++ G+
Sbjct: 75 LIGVCQAEA----LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL------HQVSMGMK 124
Query: 131 YLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGENK 182
YL N +H D+ N+LL + AKISDFGL++ ++ A K
Sbjct: 125 YLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 24/158 (15%)
Query: 21 RLLGQGGFGSVFHATLHD-----QSVAVKVMDSGSLQGER-EFYNELYFASLLEQDDH-- 72
++G+G FG V+H TL D AVK ++ + GE +F E +++ H
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE---GIIMKDFSHPN 151
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIAKG 128
V+S+LG L+V M +G+L++ + ++ +L+ + +AKG
Sbjct: 152 VLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GFGLQVAKG 204
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ +L S +H D+ N +LD F K++DFGLAR
Sbjct: 205 MKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 41/172 (23%), Positives = 70/172 (40%), Gaps = 27/172 (15%)
Query: 21 RLLGQGGFGSVFHATLHDQS------VAVKVM-DSGSLQGEREFYNELYFASLLEQDDH- 72
++LG G FG+V + V +KV+ D Q + + + DH
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDH---MLAIGSLDHA 75
Query: 73 -VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK----PPELMEWCKRFSIAVDIAK 127
+V +LG + LV + + G+L D + + P L+ W V IAK
Sbjct: 76 HIVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG------VQIAK 126
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADG 179
G+ YL ++H ++ N+LL +++DFG+A L + Q
Sbjct: 127 GMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 46/167 (27%), Positives = 70/167 (41%), Gaps = 28/167 (16%)
Query: 21 RLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH- 72
LG+G FG VF A H+ VAVK + S ++F E A LL H
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQRE---AELLTMLQHQ 103
Query: 73 -VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR------------F 119
+V G + + +L+V+E M +G+L L P +
Sbjct: 104 HIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
++A +A G+ YL L+ +H D+ N L+ KI DFG++R
Sbjct: 162 AVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 51/160 (31%), Positives = 77/160 (48%), Gaps = 21/160 (13%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQ-SVAVKVMDSGSLQGEREFYNELYFASLLEQDDH- 72
+ + + LG G FG V Q VAVK++ GS+ E EF+ E A + + H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQE---AQTMMKLSHP 63
Query: 73 -VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIAK 127
+V G S K + + +V E +SNG L + L +L+E C D+ +
Sbjct: 64 KLVKFYGVCS--KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCY------DVCE 115
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
G+A+L S IH D+ N L+D + C K+SDFG+ R
Sbjct: 116 GMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRY 153
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS------VAVKVMDSGSLQGER-EFYNELYFASLL 67
+ +++G G FG V+ L S VA+K + +G + +R +F E A ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE---AGIM 100
Query: 68 EQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSI 121
Q H ++ + G S K M+++ E M NG L L K +L+
Sbjct: 101 GQFSHHNIIRLEGVIS--KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML----- 153
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
IA G+ YL ++N +H D+ NIL++ N K+SDFGL+R+
Sbjct: 154 -RGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV 196
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 13/156 (8%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQ-SVAVKVMDSGSLQGEREFYNELYFASLLEQDDH- 72
++ LG G FG V+ + VAVK + GS+ + F E A+L++Q H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAE---ANLMKQLQHQ 68
Query: 73 -VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAY 131
+V + + + + ++ E M NG+L D L +L K +A IA+G+A+
Sbjct: 69 RLVRLYAVVT---QEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAF 124
Query: 132 LHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+ N IH D++ +NIL+ KI+DFGLARL
Sbjct: 125 IEERN--YIHRDLRAANILVSDTLSCKIADFGLARL 158
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 21/154 (13%)
Query: 21 RLLGQGGFGSVFHATLHDQ-SVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSVL 77
+ LG G FG V + Q VA+K++ GS+ E EF E A ++ H +V +
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEE---AKVMMNLSHEKLVQLY 85
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIAKGIAYLH 133
G + K+ + ++ E M+NG L + L + +L+ + D+ + + YL
Sbjct: 86 GVCT--KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL------EMCKDVCEAMEYLE 137
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
S +H D+ N L++ K+SDFGL+R
Sbjct: 138 SKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 13/151 (8%)
Query: 21 RLLGQGGFGSVFHATLHDQS--VAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSV 76
LG G +G V+ S VAVK + +++ E EF E A+++++ H +V +
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE---AAVMKEIKHPNLVQL 74
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN 136
LG + + ++ E M+ GNL D L E+ +A I+ + YL N
Sbjct: 75 LGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN 131
Query: 137 PPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
IH D+ N L+ N K++DFGL+RL
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRL 160
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 21/154 (13%)
Query: 21 RLLGQGGFGSVFHATLHDQS-VAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSVL 77
+ +G G FG V ++ VA+K + G++ E +F E A ++ + H +V +
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEE---AEVMMKLSHPKLVQLY 69
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIAKGIAYLH 133
G ++ + LV E M +G L D L ++ L+ C D+ +G+AYL
Sbjct: 70 GVCL--EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL------DVCEGMAYLE 121
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
VIH D+ N L+ N K+SDFG+ R
Sbjct: 122 EAC--VIHRDLAARNCLVGENQVIKVSDFGMTRF 153
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQ-SVAVKVMDSGSLQGEREFYNELYFASLLEQDDH- 72
+S LGQG FG V+ T + VA+K + G++ E F E A ++++ H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQE---AQVMKKLRHE 239
Query: 73 -VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIA 130
+V + S P + +V E MS G+L D L + L + +A IA G+A
Sbjct: 240 KLVQLYAVVSEEP----IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMA 294
Query: 131 YLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
Y+ +N +H D++ +NIL+ N K++DFGLARL
Sbjct: 295 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARL 329
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-24
Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 13/151 (8%)
Query: 21 RLLGQGGFGSVFHATL--HDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSV 76
LG G +G V+ + +VAVK + +++ E EF E A+++++ H +V +
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE---AAVMKEIKHPNLVQL 281
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN 136
LG + + ++ E M+ GNL D L + + + +A I+ + YL N
Sbjct: 282 LGVCT--REPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 137 PPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
IH ++ N L+ N K++DFGL+RL
Sbjct: 339 --FIHRNLAARNCLVGENHLVKVADFGLSRL 367
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 25/171 (14%)
Query: 23 LGQGGFGSVFHATLHDQS----VAVKVMDSGSLQGER-EFYNELYFASLLEQDDH--VVS 75
LG G FGSV + VA+KV+ G+ + + E E A ++ Q D+ +V
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE---AQIMHQLDNPYIVR 400
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK----PPELMEWCKRFSIAVDIAKGIAY 131
++G ++LV E+ G L L+ K+ + E ++ G+ Y
Sbjct: 401 LIGVCQ---AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL------HQVSMGMKY 451
Query: 132 LHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGENK 182
L N +H ++ N+LL + AKISDFGL++ ++ A K
Sbjct: 452 LEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 28/160 (17%)
Query: 21 RLLGQGGFGSVFHATLHDQS-----VAVKVMDSGSLQGER-EFYNELYFASLLEQDDH-- 72
R +G+G FG V VA+K + + R +F E A + Q DH
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE---ALTMRQFDHPH 452
Query: 73 VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIAK 127
+V ++G + NP + ++ EL + G L+ L +K L+ + ++
Sbjct: 453 IVKLIGVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYA------YQLST 502
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+AYL S +H DI N+L+ N C K+ DFGL+R
Sbjct: 503 ALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 49/166 (29%), Positives = 80/166 (48%), Gaps = 25/166 (15%)
Query: 14 ADSFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGSLQGER-EFYNELYFASLL 67
A + S +++G G FG V L + SVA+K + G + +R +F E AS++
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE---ASIM 100
Query: 68 EQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSI 121
Q DH ++ + G + K +++V E M NG+L L +L+ +
Sbjct: 101 GQFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---- 154
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
IA G+ YL + +H D+ NIL++ N K+SDFGL R+
Sbjct: 155 --GIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRV 196
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 48/163 (29%), Positives = 71/163 (43%), Gaps = 24/163 (14%)
Query: 21 RLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSLQGER-EFYNELYFASLLEQDDH 72
R LG G FG V+ + VAVK + + + +F E A ++ + +H
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME---ALIISKFNH 92
Query: 73 --VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIA 126
+V +G S + ++ ELM+ G+L+ L +P P + +A DIA
Sbjct: 93 QNIVRCIGVSL--QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLD---HNFCAKISDFGLAR 166
G YL + IH DI N LL AKI DFG+AR
Sbjct: 151 CGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQ-SVAVKVMDSGSLQGEREFYNELYFASLLEQDDH- 72
+S + LG G FG V+ AT + VAVK M GS+ F E A++++ H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAE---ANVMKTLQHD 243
Query: 73 -VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIA 130
+V + + P + ++ E M+ G+L D L K + IA+G+A
Sbjct: 244 KLVKLHAVVTKEP----IYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 131 YLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
++ N IH D++ +NIL+ + KI+DFGLAR+
Sbjct: 299 FIEQRN--YIHRDLRAANILVSASLVCKIADFGLARV 333
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 45/169 (26%), Positives = 71/169 (42%), Gaps = 30/169 (17%)
Query: 21 RLLGQGGFGSVFHATLHD-------QSVAVKVM-DSGSLQGEREFYNELYFASLLEQDDH 72
LG+ FG V+ L Q+VA+K + D EF +E A L + H
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE---AMLRARLQH 71
Query: 73 --VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR------------ 118
VV +LG + K + +++ S+G+L + L+ + P +
Sbjct: 72 PNVVCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 119 -FSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ IA G+ YL S + V+H D+ N+L+ KISD GL R
Sbjct: 130 FVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 47/177 (26%), Positives = 74/177 (41%), Gaps = 38/177 (21%)
Query: 21 RLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSLQGER-EFYNELYFASLLEQDDH 72
R +G+G FG VF A VAVK++ + + +F E A+L+ + D+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE---AALMAEFDN 109
Query: 73 --VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF----------- 119
+V +LG + M L++E M+ G+L + L P +
Sbjct: 110 PNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 120 ----------SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
IA +A G+AYL +H D+ N L+ N KI+DFGL+R
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 51/162 (31%), Positives = 82/162 (50%), Gaps = 25/162 (15%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQ-SVAVKVMDSGSLQGEREFYNELYFASLLEQDDH- 72
+S LGQG FG V+ T + VA+K + G++ E F E A ++++ H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQE---AQVMKKLRHE 322
Query: 73 -VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDAL-----LHKKPPELMEWCKRFSIAVDI 125
+V + S P + +V E MS G+L D L + + P+L++ I
Sbjct: 323 KLVQLYAVVSEEP----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA------AQI 372
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
A G+AY+ +N +H D++ +NIL+ N K++DFGLARL
Sbjct: 373 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL 412
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 37/167 (22%), Positives = 65/167 (38%), Gaps = 14/167 (8%)
Query: 15 DSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGERE-FYNELYFASLLEQDD 71
+ S +LGQG +VF A+KV ++ S + E +L++ +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREF---EVLKKLN 65
Query: 72 H--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
H +V + +L+ E G+L L + + + D+ G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 130 AYLHSLNPPVIHGDIKPSNILL----DHNFCAKISDFGLARLKSVGE 172
+L ++H +IKP NI+ D K++DFG AR E
Sbjct: 126 NHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 23/127 (18%), Positives = 38/127 (29%), Gaps = 16/127 (12%)
Query: 429 SMRGTVCYVAPEYGAGGDI--------SEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEF 480
S+ GT Y+ P+ + D++S GV G P + P
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
Query: 481 Q--------RANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPAL 532
+ + + A NG + D V SL R +L V L+
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
Query: 533 RPSMEEV 539
++
Sbjct: 294 CWGFDQF 300
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 5e-23
Identities = 34/168 (20%), Positives = 63/168 (37%), Gaps = 22/168 (13%)
Query: 21 RLLGQGGFGSVFHAT-LHD-QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSV 76
+ LG+GGF V LHD A+K + Q E E L +H ++ +
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF---NHPNILRL 91
Query: 77 LGFSSNPK--RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IAVDIAKG 128
+ + + +H L+ G L + + K + + + + I +G
Sbjct: 92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLK-----DKGNFLTEDQILWLLLGICRG 146
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQ 176
+ +H+ H D+KP+NILL + D G + ++
Sbjct: 147 LEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 24/114 (21%), Positives = 39/114 (34%), Gaps = 21/114 (18%)
Query: 429 SMRGTVCYVAPE---YGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANL 485
+ R T+ Y APE + I E+ DV+S G +L ++ G P +
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP----------YDMVFQ 251
Query: 486 MSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEV 539
+ LA +L +L LL + P RP + +
Sbjct: 252 KGDSVALAVQNQLSIPQSPRHSSAL---WQLLNS-----MMTVDPHQRPHIPLL 297
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-23
Identities = 49/197 (24%), Positives = 77/197 (39%), Gaps = 21/197 (10%)
Query: 12 RAADSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGERE-FYNELYFASLLE 68
R F P + LG+GGFG VF A + D + A+K + + + RE E L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMRE---VKALA 58
Query: 69 QDDH--VVSVLG-------FSSNPKRHRMLLVY---ELMSNGNLQDALLHKKPPELMEWC 116
+ +H +V + +Y +L NL+D + + E E
Sbjct: 59 KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 117 KRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQ 176
I + IA+ + +LHS ++H D+KPSNI + K+ DFGL + + Q
Sbjct: 119 VCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD-QDEEEQ 175
Query: 177 ADGENKNKAAELESNCG 193
A G
Sbjct: 176 TVLTPMPAYARHTGQVG 192
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 31/167 (18%), Positives = 46/167 (27%), Gaps = 32/167 (19%)
Query: 405 ARHNSYDSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLI 464
D + GT Y++PE G S K D++S G++L L+
Sbjct: 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
Query: 465 AGRRPLQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALL 524
P F RN K L Q K E ++
Sbjct: 225 ---YP----------FSTQMERVRTLTDVRNLKFPPLFTQ---KYPC-EYVMVQ-----D 262
Query: 525 CLQKSPALRPSMEEVVGMLTGKLEAPKLPAEFSPSPPSRIPFKSRKK 571
L SP RP + +E P + + R +
Sbjct: 263 MLSPSPMERPEAINI-------IENAVF---EDLDFPGKTVLRQRSR 299
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 8e-23
Identities = 38/162 (23%), Positives = 64/162 (39%), Gaps = 16/162 (9%)
Query: 15 DSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGERE-FYNELYFASLLEQDD 71
+ S +LGQG +VF A+KV ++ S + E +L++ +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREF---EVLKKLN 65
Query: 72 H--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALL-HKKPPELMEWCKRFSIAVDIAKG 128
H +V + +L+ E G+L L L E + D+ G
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGG 124
Query: 129 IAYLHSLNPPVIHGDIKPSNILL----DHNFCAKISDFGLAR 166
+ +L ++H +IKP NI+ D K++DFG AR
Sbjct: 125 MNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 23/133 (17%), Positives = 38/133 (28%), Gaps = 16/133 (12%)
Query: 432 GTVCYVAPEYGAGGDI--------SEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQ-- 481
GT Y+ P+ + D++S GV G P + P +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 482 ------RANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPS 535
+ + A NG + D V SL R +L V L+
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
Query: 536 MEEVVGMLTGKLE 548
++ + L
Sbjct: 297 FDQFFAETSDILH 309
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 48/163 (29%), Positives = 71/163 (43%), Gaps = 24/163 (14%)
Query: 21 RLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSLQGER-EFYNELYFASLLEQDDH 72
R LG G FG V+ + VAVK + + + +F E A ++ + +H
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME---ALIISKFNH 133
Query: 73 --VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIA 126
+V +G S + ++ ELM+ G+L+ L +P P + +A DIA
Sbjct: 134 QNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLD---HNFCAKISDFGLAR 166
G YL + IH DI N LL AKI DFG+AR
Sbjct: 192 CGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 24/177 (13%)
Query: 6 SYSVLRRAADSFSPSRLLGQGGFGSVFHAT-LHD-QSVAVKVMDSGSLQGEREFYNEL-- 61
+++V +R F L+G GGFG VF A D ++ +K + + + ERE +
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREV--KALA 59
Query: 62 ---------YFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP--- 109
Y D + SS K + + E G L+ + ++
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 110 PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+++ + I KG+ Y+HS +I+ D+KPSNI L KI DFGL
Sbjct: 120 DKVLAL----ELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVT 170
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 24/111 (21%), Positives = 47/111 (42%), Gaps = 25/111 (22%)
Query: 429 SMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSW 488
+GT+ Y++PE + D ++ D+Y+ G++L L+ F+ + +
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA---------FETSKFFT- 229
Query: 489 ARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEV 539
R+G + ++ D+ E+ LL L K P RP+ E+
Sbjct: 230 ---DLRDGIISDIFDKK-------EKTLLQ-----KLLSKKPEDRPNTSEI 265
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 22/197 (11%)
Query: 12 RAADSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVM-----DSGSLQGEREFYNEL--- 61
R A F +LGQG FG V A L + A+K + ++ E L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 62 ----YFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCK 117
Y+A+ LE+ + V + ++ K+ + + E NG L D + + + +
Sbjct: 63 YVVRYYAAWLERRNFVKPM---TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 118 RFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR-LKSVGENQNQ 176
R + I + ++Y+HS +IH D+KP NI +D + KI DFGLA+ + +
Sbjct: 120 R--LFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 177 ADGENKNKAAELESNCG 193
+ L S G
Sbjct: 176 DSQNLPGSSDNLTSAIG 192
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 31/144 (21%), Positives = 50/144 (34%), Gaps = 24/144 (16%)
Query: 397 GFSGELYRARHNSYDSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAG-GDISEKCDVYS 455
G + + H S D G + S GT YVA E G G +EK D+YS
Sbjct: 161 GLAKNV----HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYS 216
Query: 456 YGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQA 515
G++ +I + +R N++ R+ IE + E+
Sbjct: 217 LGIIFFEMIYP---------FSTGMERVNILK----KLRSVS-IEFPPDFDDNKMKVEKK 262
Query: 516 LLCITVALLCLQKSPALRPSMEEV 539
++ L + P RP +
Sbjct: 263 IIR-----LLIDHDPNKRPGARTL 281
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 9e-22
Identities = 48/165 (29%), Positives = 68/165 (41%), Gaps = 20/165 (12%)
Query: 21 RLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGER---EFYNELYFASLLEQDDHVVS 75
R LG+GGF F + D + A K++ L + E+ L HVV
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-HVVG 79
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL 135
GF + ++L EL +L + +K L E R+ I G YLH
Sbjct: 80 FHGFFEDNDFVFVVL--ELCRRRSLLELHKRRKA--LTEPEARY-YLRQIVLGCQYLHRN 134
Query: 136 NPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGE 180
VIH D+K N+ L+ + KI DFGLA + + DGE
Sbjct: 135 R--VIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGE 170
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 32/135 (23%), Positives = 53/135 (39%), Gaps = 29/135 (21%)
Query: 432 GTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQR--ANLMSWA 489
GT Y+APE + S + DV+S G ++ L+ G+ P + T + R N S
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIP 235
Query: 490 RHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVG---MLTGK 546
+H+ L+ + LQ P RP++ E++ +G
Sbjct: 236 KHINPVAA--SLIQK--------------------MLQTDPTARPTINELLNDEFFTSGY 273
Query: 547 LEAPKLPAEFSPSPP 561
+ A +LP PP
Sbjct: 274 IPA-RLPITCLTIPP 287
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 25/178 (14%), Positives = 53/178 (29%), Gaps = 34/178 (19%)
Query: 21 RLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGERE---------------------- 56
+LGQ + AT +S V V
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 57 ---FYNELYFASLLEQDDH--VVSVLGFSSNPKRHRMLLVYELM--SNGNLQDALL-HKK 108
++ L++ ++ V + +Y M + + LL H
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 109 PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ + R + + + + +A LH ++H ++P +I+LD ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 18/151 (11%), Positives = 43/151 (28%), Gaps = 48/151 (31%)
Query: 426 STPSMRGTVCYVAPEY-----------GAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTG 474
+ + + PE ++ D ++ G+++ + P
Sbjct: 258 ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP----- 312
Query: 475 SPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDRE-QALLCITVALLCLQKSPALR 533
+ + + + R+ K++ + +ALL L+ R
Sbjct: 313 -----ITKDAALGGSEWIFRS-----------CKNIPQPVRALLE-----GFLRYPKEDR 351
Query: 534 PSMEEVVGMLTGKLEAP---KLPAEFSPSPP 561
+ +E P +L E S + P
Sbjct: 352 LLPLQA-------METPEYEQLRTELSAALP 375
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 1e-21
Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 19/165 (11%)
Query: 21 RLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQG---EREFYNELYFASLLEQDDHVVS 75
LLG+G F V+ A VA+K++D ++ + NE+ L+ ++
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP-SILE 75
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL 135
+ + + ++L E+ NG + L + E R + I G+ YLHS
Sbjct: 76 LYNYFEDSNYVYLVL--EMCHNGEMNR-YLKNRVKPFSENEARHFMH-QIITGMLYLHSH 131
Query: 136 NPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGE 180
++H D+ SN+LL N KI+DFGLA Q + E
Sbjct: 132 G--ILHRDLTLSNLLLTRNMNIKIADFGLA-------TQLKMPHE 167
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 48/165 (29%), Positives = 68/165 (41%), Gaps = 20/165 (12%)
Query: 21 RLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGER---EFYNELYFASLLEQDDHVVS 75
R LG+GGF F + D + A K++ L + E+ L HVV
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-HVVG 105
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL 135
GF + ++L EL +L + +K L E R+ I G YLH
Sbjct: 106 FHGFFEDNDFVFVVL--ELCRRRSLLELHKRRKA--LTEPEARY-YLRQIVLGCQYLHRN 160
Query: 136 NPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGE 180
VIH D+K N+ L+ + KI DFGLA + + DGE
Sbjct: 161 R--VIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGE 196
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 32/135 (23%), Positives = 53/135 (39%), Gaps = 29/135 (21%)
Query: 432 GTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQR--ANLMSWA 489
GT Y+APE + S + DV+S G ++ L+ G+ P + T + R N S
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIP 261
Query: 490 RHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVG---MLTGK 546
+H+ L+ + LQ P RP++ E++ +G
Sbjct: 262 KHINPVAA--SLIQK--------------------MLQTDPTARPTINELLNDEFFTSGY 299
Query: 547 LEAPKLPAEFSPSPP 561
+ A +LP PP
Sbjct: 300 IPA-RLPITCLTIPP 313
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 95.1 bits (236), Expect = 3e-21
Identities = 26/191 (13%), Positives = 50/191 (26%), Gaps = 35/191 (18%)
Query: 8 SVLRRAADSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGERE---FYNELY 62
S+L + L G VF + A+KV G+ E + +
Sbjct: 55 SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATF 114
Query: 63 FASLL-----------------------EQDDHVVSVLGFSSNPKRHRMLLVYELMSNGN 99
A+ L + + + LL+ S +
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VD 173
Query: 100 LQD--ALLHKKP--PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF 155
L+ + L + + + A L S ++HG P N+ + +
Sbjct: 174 LELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDG 231
Query: 156 CAKISDFGLAR 166
+ D
Sbjct: 232 RLMLGDVSALW 242
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 12/118 (10%), Positives = 30/118 (25%), Gaps = 14/118 (11%)
Query: 425 TSTPSMRGTVCYVAPEY--GAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQR 482
T P+ V Y E+ + + + + G+ + + P + + +
Sbjct: 246 TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK 305
Query: 483 ANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVV 540
+ + + V + L+ L R E +
Sbjct: 306 RPSLRVPGTDSLAFGSCTPLPDFV-------KTLIG-----RFLNFDRRRRLLPLEAM 351
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 46/161 (28%), Positives = 73/161 (45%), Gaps = 24/161 (14%)
Query: 16 SFSPSRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQG-EREFYNELYFASLLEQ-DDH 72
SF P +LG G G++ + + D + VAVK + +RE LL + D+H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE-------VQLLRESDEH 77
Query: 73 --VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIA 130
V+ + + + EL + LQ+ + K L + ++ G+A
Sbjct: 78 PNVIRYFCTEKDRQFQ--YIAIELCA-ATLQEYVEQKDFAHLGL--EPITLLQQTTSGLA 132
Query: 131 YLHSLNPPVIHGDIKPSNILL-----DHNFCAKISDFGLAR 166
+LHSLN ++H D+KP NIL+ A ISDFGL +
Sbjct: 133 HLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 22/118 (18%), Positives = 38/118 (32%), Gaps = 20/118 (16%)
Query: 425 TSTPSMRGTVCYVAPEY---GAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQ 481
+ + GT ++APE + + D++S G + +I+ P F
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH------P---FG 231
Query: 482 RANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEV 539
++ A L L L + A I + P RPS + V
Sbjct: 232 KSLQRQ-ANILLGACSLDCLHPEKHED----VIARELIE---KMIAMDPQKRPSAKHV 281
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 41/166 (24%), Positives = 72/166 (43%), Gaps = 15/166 (9%)
Query: 21 RLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSV 76
+LG+G +G V+ +A+K + + + + E+ +L + H +V
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEI---ALHKHLKHKNIVQY 84
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHK-KPPELMEWCKRFSIAVDIAKGIAYLHSL 135
LG S + + + E + G+L L K P + E I +G+ YLH
Sbjct: 85 LGSFS--ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHDN 141
Query: 136 NPPVIHGDIKPSNILLD-HNFCAKISDFGLA-RLKSVGENQNQADG 179
++H DIK N+L++ ++ KISDFG + RL + G
Sbjct: 142 Q--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTG 185
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 1e-20
Identities = 26/178 (14%), Positives = 54/178 (30%), Gaps = 34/178 (19%)
Query: 21 RLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGE---REFYNELYFASLLEQDDH--- 72
+LGQ + AT +S V V ++ E+ LL +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 73 ---------------------VVSVLGFSSNPKRHRMLLVYELM--SNGNLQDALLHKKP 109
++ V + +Y M + + LL
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 110 -PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ + R + + + + +A LH ++H ++P +I+LD ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 12/155 (7%), Positives = 33/155 (21%), Gaps = 36/155 (23%)
Query: 421 SGGVTSTPSMRGTVCYVAPEYGAG-----GDISEKCDVYSYGVLLLVLIAGRRPLQVTGS 475
+ V+ A ++ D ++ G+ + + P
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP------ 316
Query: 476 PMSEFQRANLMSWAR-HLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRP 534
+ + + + V + L+ R
Sbjct: 317 ----NTDDAALGGSEWIFRSCKNIPQPVRALLEG----------------FLRYPKEDRL 356
Query: 535 SMEEVVGMLTGK----LEAPKLPAEFSPSPPSRIP 565
+ + + + LP + P+R
Sbjct: 357 LPLQAMETPEYEQLRTELSAALPLYQTDGEPTREG 391
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 40/175 (22%), Positives = 66/175 (37%), Gaps = 35/175 (20%)
Query: 21 RLLGQGGFGSVFHATLH---DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVL 77
+G+G +G V A + + A+KV+ L + F +
Sbjct: 19 DEIGKGSYGVVKLAY-NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 78 GFSSNPKRH----RML---------------------LVYELMSNGNLQDALLHKKPPEL 112
G + + L +V+EL++ G + + K E
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE- 136
Query: 113 MEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+ F D+ KGI YLH +IH DIKPSN+L+ + KI+DFG++
Sbjct: 137 DQARFYFQ---DLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 35/167 (20%), Positives = 64/167 (38%), Gaps = 26/167 (15%)
Query: 21 RLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDD--------- 71
R L QG F + ++ A+K + L+ +R+F ++
Sbjct: 37 RTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 72 -------HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV- 123
+ ++ G +N + ++YE M N ++ + I V
Sbjct: 97 ITDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILK-FDEYFFVLDKNYTCFIPIQVI 153
Query: 124 -----DIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+ +Y+H+ + H D+KPSNIL+D N K+SDFG +
Sbjct: 154 KCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKNGRVKLSDFGES 199
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 13/53 (24%), Positives = 21/53 (39%), Gaps = 2/53 (3%)
Query: 432 GTVCYVAPE--YGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQR 482
GT ++ PE K D++S G+ L V+ P + S + F
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 90.8 bits (225), Expect = 7e-20
Identities = 41/184 (22%), Positives = 62/184 (33%), Gaps = 32/184 (17%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSLQGEREFYNELYFASLL 67
LLG+G F V+ AT D Q +KV + EFY L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERL 121
Query: 68 EQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPE---LMEWCKRFSIA 122
+ + +LV EL S G L +A+ K + + A
Sbjct: 122 KPSMQHMFMKFYSAHLFQNG--SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS-FA 178
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA-----------KISDFGLAR-LKSV 170
+ + I +H +IHGDIKP N +L + F + D G + +K
Sbjct: 179 MRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236
Query: 171 GENQ 174
+
Sbjct: 237 PKGT 240
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 33/163 (20%), Positives = 65/163 (39%), Gaps = 15/163 (9%)
Query: 21 RLLGQGGFGSVFHAT-LHDQSVAVKVMDSGSLQGE--REFYNELYFASLLE-QDDHVVSV 76
+ +G GG VF Q A+K ++ + + NE+ + + L+ D ++ +
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP-PELMEWCKRFSIAVDIAKGIAYLHSL 135
+ + + +V E N +L L KK K + ++ + + +H
Sbjct: 94 YDYEITDQY--IYMVMEC-GNIDLNSWLKKKKSIDP--WERKSY--WKNMLEAVHTIHQH 146
Query: 136 NPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQAD 178
++H D+KP+N L+ K+ DFG+A D
Sbjct: 147 G--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 186
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 30/122 (24%), Positives = 44/122 (36%), Gaps = 29/122 (23%)
Query: 429 SMRGTVCYVAPE-----------YGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPM 477
S GTV Y+ PE + IS K DV+S G +L + G+ P Q + +
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246
Query: 478 SEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSME 537
S+ + IE D D V CL++ P R S+
Sbjct: 247 SKLHA---------IIDPNHEIEFPDIP---EKD------LQDVLKCCLKRDPKQRISIP 288
Query: 538 EV 539
E+
Sbjct: 289 EL 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 34/164 (20%), Positives = 68/164 (41%), Gaps = 17/164 (10%)
Query: 21 RLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGE--REFYNELYFASLLEQ-DDHVVS 75
+ +G GG VF L++ Q A+K ++ + + NE+ + + L+Q D ++
Sbjct: 15 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP-PELMEWCKRFSIAVDIAKGIAYLHS 134
+ + + M++ N +L L KK K + ++ + + +H
Sbjct: 74 LYDYEITDQYIYMVMECG---NIDLNSWLKKKKSIDP--WERKSY--WKNMLEAVHTIHQ 126
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQAD 178
++H D+KP+N L+ K+ DFG+A D
Sbjct: 127 HG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 167
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 30/122 (24%), Positives = 44/122 (36%), Gaps = 29/122 (23%)
Query: 429 SMRGTVCYVAPE-----------YGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPM 477
S GTV Y+ PE + IS K DV+S G +L + G+ P Q + +
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227
Query: 478 SEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSME 537
S+ + IE D D V CL++ P R S+
Sbjct: 228 SKLHA---------IIDPNHEIEFPDIP---EKD------LQDVLKCCLKRDPKQRISIP 269
Query: 538 EV 539
E+
Sbjct: 270 EL 271
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 21/158 (13%)
Query: 15 DSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
++ +GQG G+V+ A Q VA++ M+ + NE+ ++ ++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI---LVMRENKN 76
Query: 73 --VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV---DIAK 127
+V+ L S + +V E ++ G+L D + E IA + +
Sbjct: 77 PNIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-------IAAVCRECLQ 127
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+ +LHS VIH DIK NILL + K++DFG
Sbjct: 128 ALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 13/150 (8%)
Query: 21 RLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQG---EREFYNELYFASLLEQDDHVVS 75
R LG+G FG+V+ A +A+KV+ L+ E + E+ S L +++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP-NILR 73
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL 135
+ G+ + R + L+ E G + L E I ++A ++Y HS
Sbjct: 74 LYGYFHDATR--VYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANALSYCHSK 128
Query: 136 NPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
VIH DIKP N+LL KI+DFG +
Sbjct: 129 R--VIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 33/153 (21%), Positives = 56/153 (36%), Gaps = 26/153 (16%)
Query: 22 LLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSVL 77
+G+G FG V AVK + + E EL +V +
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----EL---VACAGLSSPRIVPLY 116
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKP---PELMEWCKRFSIAVDIAKGIAYLHS 134
G + + + EL+ G+L + + + +G+ YLH+
Sbjct: 117 GAVR--EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG------QALEGLEYLHT 168
Query: 135 LNPPVIHGDIKPSNILLDHN-FCAKISDFGLAR 166
++HGD+K N+LL + A + DFG A
Sbjct: 169 RR--ILHGDVKADNVLLSSDGSRAALCDFGHAL 199
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 46/182 (25%), Positives = 73/182 (40%), Gaps = 28/182 (15%)
Query: 12 RAADSFSPSRLLGQGGFGSVFHAT-LHD-QSVAVKVMD--SGSLQGEREFYNELYFASLL 67
R F +G G FGSVF D A+K E+ E+Y ++L
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 68 EQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALL-HKKPPELMEWCKRFSIAVDIA 126
Q HVV FS+ + ML+ E + G+L DA+ + + + + + + +
Sbjct: 68 GQHSHVVRY--FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHN-------------------FCAKISDFGLARL 167
+G+ Y+HS++ ++H DIKPSNI + KI D G
Sbjct: 126 RGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 168 KS 169
S
Sbjct: 184 IS 185
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 19/125 (15%), Positives = 37/125 (29%), Gaps = 34/125 (27%)
Query: 421 SGGVTSTPSMRGTVCYVAPE-----YGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGS 475
++S G ++A E Y K D+++ + ++
Sbjct: 181 VTRISSPQVEEGDSRFLANEVLQENYTH----LPKADIFALALTVVCAAGAEPL------ 230
Query: 476 PMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDRE-QALLCITVALLCLQKSPALRP 534
+ + H R G+L + L +E LL + + P RP
Sbjct: 231 ----PRNGDQW----HEIRQGRLPRIPQV-----LSQEFTELL-----KVMIHPDPERRP 272
Query: 535 SMEEV 539
S +
Sbjct: 273 SAMAL 277
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 30/161 (18%), Positives = 53/161 (32%), Gaps = 3/161 (1%)
Query: 33 HATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92
D+ L ++ +V + + + +
Sbjct: 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140
Query: 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLD 152
+L NL+D + + E E I + IA+ + +LHS ++H D+KPSNI
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT 198
Query: 153 HNFCAKISDFGLARLKSVGENQNQADGENKNKAAELESNCG 193
+ K+ DFGL + + Q A G
Sbjct: 199 MDDVVKVGDFGLVT-AMDQDEEEQTVLTPMPAYATHTGQVG 238
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 26/135 (19%), Positives = 47/135 (34%), Gaps = 22/135 (16%)
Query: 405 ARHNSYDSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLI 464
D + + GT Y++PE G + S K D++S G++L L+
Sbjct: 211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
Query: 465 AGRRPLQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALL 524
++ +R +++ RN K L Q +E ++
Sbjct: 271 YS---------FSTQMERVRIIT----DVRNLKFPLLFTQ----KYPQEHMMV-----QD 308
Query: 525 CLQKSPALRPSMEEV 539
L SP RP ++
Sbjct: 309 MLSPSPTERPEATDI 323
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 16/161 (9%)
Query: 14 ADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDD 71
A F L+G G +G V+ Q A+KVMD E E E+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81
Query: 72 HVV----SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV---D 124
++ + + + ++ LV E G++ D + + K L E IA +
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW----IAYICRE 137
Query: 125 IAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
I +G+++LH VIH DIK N+LL N K+ DFG++
Sbjct: 138 ILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 43/150 (28%), Positives = 65/150 (43%), Gaps = 21/150 (14%)
Query: 23 LGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSVLG 78
+G+G G V A + VAVK+MD Q +NE+ ++ H VV +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEV---VIMRDYQHFNVVEMYK 109
Query: 79 FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV---DIAKGIAYLHSL 135
S + ++ E + G L D + + E IA + + +AYLH+
Sbjct: 110 --SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ-------IATVCEAVLQALAYLHAQ 160
Query: 136 NPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
VIH DIK +ILL + K+SDFG
Sbjct: 161 G--VIHRDIKSDSILLTLDGRVKLSDFGFC 188
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-19
Identities = 37/159 (23%), Positives = 70/159 (44%), Gaps = 19/159 (11%)
Query: 14 ADSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDD 71
+ + LG G FG V+ A A KV+++ S + ++ E+ +L D
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI---EILATCD 74
Query: 72 H--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV---DIA 126
H +V +LG + ++ ++ E G + +L L E I V +
Sbjct: 75 HPYIVKLLG--AYYHDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQ----IQVVCRQML 127
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+ + +LHS +IH D+K N+L+ +++DFG++
Sbjct: 128 EALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 42/172 (24%), Positives = 59/172 (34%), Gaps = 15/172 (8%)
Query: 1 PPHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHAT-LHD-QSVAVKVMDSGSL--QGERE 56
P SF LG G +G VF D + AVK S +
Sbjct: 43 SPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRAR 102
Query: 57 FYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP--PELME 114
E+ + Q V + + + + L EL +LQ PE
Sbjct: 103 KLAEVGSHEKVGQHPCCVRL--EQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQV 159
Query: 115 WCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
W D +A+LHS ++H D+KP+NI L K+ DFGL
Sbjct: 160 W----GYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLV 205
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 33/163 (20%), Positives = 65/163 (39%), Gaps = 15/163 (9%)
Query: 21 RLLGQGGFGSVFHAT-LHDQSVAVKVMDSGSLQGE--REFYNELYFASLLEQ-DDHVVSV 76
+ +G GG VF Q A+K ++ + + NE+ + + L+Q D ++ +
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP-PELMEWCKRFSIAVDIAKGIAYLHSL 135
+ + M++ N +L L KK K + ++ + + +H
Sbjct: 122 YDYEITDQYIYMVMECG---NIDLNSWLKKKKSIDP--WERKSY--WKNMLEAVHTIHQH 174
Query: 136 NPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQAD 178
++H D+KP+N L+ K+ DFG+A D
Sbjct: 175 G--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 214
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 29/122 (23%), Positives = 43/122 (35%), Gaps = 29/122 (23%)
Query: 429 SMRGTVCYVAPE-----------YGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPM 477
S G V Y+ PE + IS K DV+S G +L + G+ P Q + +
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 478 SEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSME 537
S+ + IE D D V CL++ P R S+
Sbjct: 275 SKLHA---------IIDPNHEIEFPDIP---EKD------LQDVLKCCLKRDPKQRISIP 316
Query: 538 EV 539
E+
Sbjct: 317 EL 318
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 39/163 (23%), Positives = 68/163 (41%), Gaps = 19/163 (11%)
Query: 14 ADSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGERE-FYNELYFASLLEQD 70
D + ++G G V A + VA+K ++ Q + E + Q
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKE---IQAMSQC 70
Query: 71 DH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS---IAV-- 123
H +VS S + + LV +L+S G++ D ++ + IA
Sbjct: 71 HHPNIVSYYT--SFVVKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATIL 127
Query: 124 -DIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
++ +G+ YLH IH D+K NILL + +I+DFG++
Sbjct: 128 REVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVS 168
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 44/164 (26%), Positives = 65/164 (39%), Gaps = 33/164 (20%)
Query: 21 RLLGQGGFGSVFHAT--LHDQSVAVKVMD--------SGSLQGEREFYNELYFASLLEQD 70
LLG+G +G V AVK++ +G ++E LL +
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEI-------QLLRRL 63
Query: 71 DH--VVS---VLGFSSNPKRHRMLLVYELMSNGN--LQDALLHKKPPELMEWCKRFSIAV 123
H V+ VL K M +V E G + D++ K+ P + F
Sbjct: 64 RHKNVIQLVDVLYNEEKQK---MYMVMEYCVCGMQEMLDSVPEKRFPV-CQAHGYF---C 116
Query: 124 DIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+ G+ YLHS ++H DIKP N+LL KIS G+A
Sbjct: 117 QLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEA 158
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 34/167 (20%), Positives = 64/167 (38%), Gaps = 21/167 (12%)
Query: 15 DSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSL-QGEREF-YNELYFASLLEQD 70
+ + +G G +G + + K +D GS+ + E++ +E +LL +
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSE---VNLLREL 62
Query: 71 DH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP-----PELMEWCKRFSIAV 123
H +V + + +V E G+L + E +
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL----RVMT 118
Query: 124 DIAKGIAYLHSLNPP---VIHGDIKPSNILLDHNFCAKISDFGLARL 167
+ + H + V+H D+KP+N+ LD K+ DFGLAR+
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 23/108 (21%), Positives = 37/108 (34%), Gaps = 20/108 (18%)
Query: 432 GTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSWARH 491
GT Y++PE +EK D++S G LL L A P F +
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----------FTAFSQKE---- 223
Query: 492 LARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEV 539
L + + + + + + L RPS+EE+
Sbjct: 224 ------LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 4e-18
Identities = 33/153 (21%), Positives = 66/153 (43%), Gaps = 16/153 (10%)
Query: 21 RLLGQGGFGSVFHAT---LHDQSVAVKVM-DSGSLQGEREFYNELYFASLLEQDDHVVSV 76
+ GG G ++ A ++ + V +K + SG + + E F + + +V +
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQI 144
Query: 77 LGFSSNPKRHRMLLVY---ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLH 133
F + RH + Y E + +L+ + K P + + ++I ++YLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVA-----EAIAYLLEILPALSYLH 199
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
S+ +++ D+KP NI+L K+ D G
Sbjct: 200 SIG--LVYNDLKPENIMLTEEQ-LKLIDLGAVS 229
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 25/144 (17%), Positives = 37/144 (25%), Gaps = 29/144 (20%)
Query: 424 VTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRA 483
+ S + GT + APE + D+Y+ G L L G +
Sbjct: 231 INSFGYLYGTPGFQAPEI-VRTGPTVATDIYTVGRTLAALTLDLPTR--NGRYVDGLPE- 286
Query: 484 NLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRP-SMEEVVGM 542
+ S R + + P R + EE+
Sbjct: 287 ----------------DDPVLKTYDSYGR--------LLRRAIDPDPRQRFTTAEEMSAQ 322
Query: 543 LTGKLEAPKLPAEFSPSPPSRIPF 566
LTG L P P F
Sbjct: 323 LTGVLREVVAQDTGVPRPGLSTIF 346
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 86.3 bits (213), Expect = 8e-18
Identities = 45/159 (28%), Positives = 65/159 (40%), Gaps = 19/159 (11%)
Query: 21 RLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGERE-FYNELYFASLLEQDDH--VVS 75
LG GGFG V + VA+K RE + E+ ++++ +H VVS
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEI---QIMKKLNHPNVVS 76
Query: 76 VL----GFSSNPKRHRMLLVYELMSNGNLQDALL-HKKPPELMEWCKRFSIAVDIAKGIA 130
G LL E G+L+ L + L E R ++ DI+ +
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALR 135
Query: 131 YLHSLNPPVIHGDIKPSNILLD---HNFCAKISDFGLAR 166
YLH +IH D+KP NI+L KI D G A+
Sbjct: 136 YLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 7e-05
Identities = 15/46 (32%), Positives = 21/46 (45%)
Query: 432 GTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPM 477
GT+ Y+APE + D +S+G L I G RP P+
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV 230
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 9e-18
Identities = 48/172 (27%), Positives = 69/172 (40%), Gaps = 30/172 (17%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH- 72
+ ++LG G G+V + VAVK M E+ L E DDH
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL---MEI--KLLTESDDHP 69
Query: 73 -VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV----DIAK 127
V+ + + + EL N NLQD + K + ++ + IA
Sbjct: 70 NVIRYYCSETTDRFL--YIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDH-------------NFCAKISDFGLAR 166
G+A+LHSL +IH D+KP NIL+ N ISDFGL +
Sbjct: 127 GVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 18/158 (11%)
Query: 14 ADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFY-NELYFASLLEQD 70
+ F+ +G+G FG VF + VA+K++D + E E E+ S +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 71 DHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV---DIAK 127
+V G S K ++ ++ E + G+ D L E IA +I K
Sbjct: 81 -YVTKYYG--SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-------IATILREILK 130
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
G+ YLHS IH DIK +N+LL + K++DFG+A
Sbjct: 131 GLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVA 166
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 13/150 (8%)
Query: 21 RLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQG---EREFYNELYFASLLEQDDHVVS 75
R LG+G FG+V+ A + +A+KV+ L+ E + E+ S L +++
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP-NILR 78
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL 135
+ + + KR + L+ E G L L E + ++A + Y H
Sbjct: 79 MYNYFHDRKR--IYLMLEFAPRGELYKELQKHGR--FDEQRSATFME-ELADALHYCHER 133
Query: 136 NPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
VIH DIKP N+L+ + KI+DFG +
Sbjct: 134 K--VIHRDIKPENLLMGYKGELKIADFGWS 161
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 50/159 (31%), Positives = 77/159 (48%), Gaps = 23/159 (14%)
Query: 15 DSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGE-REFYNELYFASLLEQDD 71
+ F LG+G +GSV+ A Q VA+K + ++ + +E E+ S+++Q D
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQEIIKEI---SIMQQCD 82
Query: 72 H--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV---DIA 126
VV G S K + +V E G++ D ++ + L E IA
Sbjct: 83 SPHVVKYYG--SYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDE----IATILQSTL 135
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
KG+ YLH + IH DIK NILL+ AK++DFG+A
Sbjct: 136 KGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVA 172
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 48/181 (26%), Positives = 83/181 (45%), Gaps = 38/181 (20%)
Query: 11 RRAADSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLE 68
R S++ ++++G G FG V+ A L D + VA+K + LQ +R EL ++
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNREL---QIMR 102
Query: 69 QDDH--VVSVLGF--SSNPKRHRMLL--VYELMSNGNLQDALLHKKPPELMEWCKRFSIA 122
+ DH +V + F SS K+ + L V + + + +++ + R
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ET--VYR----VARHYSRAKQT 152
Query: 123 VD----------IAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA-KISDFGLARLKSVG 171
+ + + +AY+HS + H DIKP N+LLD + K+ DFG A+ G
Sbjct: 153 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210
Query: 172 E 172
E
Sbjct: 211 E 211
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 43/204 (21%), Positives = 77/204 (37%), Gaps = 41/204 (20%)
Query: 13 AADSFSPS---------RLLGQGGFGSVFHATLH---DQSVAVKVMDSGSLQGEREFYNE 60
+ DSFS +LG+G V + Q AVK+++ + E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCI-NLITSQEYAVKIIEKQPGHIRSRVFRE 60
Query: 61 LYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS 120
+ + +V+ ++ F R LV+E M G++ + ++ F+
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRF--YLVFEKMRGGSILSHIHKRR---------HFN 109
Query: 121 ------IAVDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLARLKSVG 171
+ D+A + +LH+ + H D+KP NIL + KI DF L +
Sbjct: 110 ELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 172 ENQNQADGENKNKAAELESNCGAA 195
+ + EL + CG+A
Sbjct: 168 GDCSPISTP------ELLTPCGSA 185
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 27/161 (16%), Positives = 60/161 (37%), Gaps = 18/161 (11%)
Query: 14 ADSFSPSRLLGQG--GFGSVFHA--TLHDQSVAVKVMDSGSLQGER--EFYNELYFASLL 67
+ ++G+G +V A + V V+ ++ + E EL+ + L
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 68 EQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV---D 124
++V + + + +V M+ G+ +D + + E IA
Sbjct: 84 -NHPNIVPYRA--TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA----IAYILQG 136
Query: 125 IAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+ K + Y+H + +H +K S+IL+ + +S
Sbjct: 137 VLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSN 175
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 46/182 (25%), Positives = 73/182 (40%), Gaps = 24/182 (13%)
Query: 6 SYSVLRRAADSFSPSRLLGQGGFGSVFHATLHD--QSVAVK-VMDSGSLQGEREFYN-EL 61
+ R+ D F R+ GQG FG+V SVA+K V+ + F N EL
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ------DPRFRNREL 67
Query: 62 YFASLLEQDDH--VVSVLGF--SSNPKRHR---MLLVYELMSNGNLQDALLHKKPPEL-- 112
L H +V + + + + R + +V E + + L + ++
Sbjct: 68 QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAP 126
Query: 113 -MEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA-KISDFGLARLKSV 170
K F + + I LH + V H DIKP N+L++ K+ DFG A+ S
Sbjct: 127 PPILIKVFL--FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 171 GE 172
E
Sbjct: 185 SE 186
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 51/162 (31%), Positives = 70/162 (43%), Gaps = 23/162 (14%)
Query: 14 ADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFY---NELYFASLLE 68
FS R +G G FG+V+ A + + VA+K M Q ++ E+ F L+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF---LQ 109
Query: 69 QDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV--- 123
+ H + G + H LV E +HKKP L E IA
Sbjct: 110 KLRHPNTIQYRG--CYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVE----IAAVTH 161
Query: 124 DIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+G+AYLHS N +IH D+K NILL K+ DFG A
Sbjct: 162 GALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 43/167 (25%), Positives = 65/167 (38%), Gaps = 35/167 (20%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLH---DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDD 71
D + +G G + H + AVK++D E LL
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCI-HKATNMEFAVKIIDKSKRDPTEEI------EILLRYGQ 74
Query: 72 H--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IAV 123
H ++++ + K +V ELM G L D +L +K FS +
Sbjct: 75 HPNIITLKDVYDDGKYV--YVVTELMKGGELLDKILRQK---------FFSEREASAVLF 123
Query: 124 DIAKGIAYLHSLNPPVIHGDIKPSNILL----DHNFCAKISDFGLAR 166
I K + YLH+ V+H D+KPSNIL + +I DFG A+
Sbjct: 124 TITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 42/168 (25%), Positives = 72/168 (42%), Gaps = 29/168 (17%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQD-- 70
+ P ++G+G V AVK+M+ + + E E+ A+ E
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 71 ----DH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS---- 120
H +++++ + M LV++LM G L D L K S
Sbjct: 154 RQVAGHPHIITLIDSYESS--SFMFLVFDLMRKGELFDYLTEKV---------ALSEKET 202
Query: 121 --IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
I + + +++LH+ N ++H D+KP NILLD N ++SDFG +
Sbjct: 203 RSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSC 248
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 9e-17
Identities = 42/169 (24%), Positives = 69/169 (40%), Gaps = 30/169 (17%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMD--------SGSLQGERE-FYNELYF 63
+++ P +LG+G V + AVK++D + +Q RE E+
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS--- 120
+ +++ + LV++LM G L D L K S
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFF--FLVFDLMKKGELFDYLTEK---------VTLSEKE 125
Query: 121 ---IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
I + + I LH LN ++H D+KP NILLD + K++DFG +
Sbjct: 126 TRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC 172
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 15/154 (9%)
Query: 21 RLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFY----NELYFASLLEQDDHVV 74
+LG GG V A + VAVKV+ + L + FY E A+ L +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAAL-NHPAIV 75
Query: 75 SVL--GFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYL 132
+V G + P +V E + L+D ++H + P M + + D + + +
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGP--MTPKRAIEVIADACQALNFS 132
Query: 133 HSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
H +IH D+KP+NI++ K+ DFG+AR
Sbjct: 133 HQNG--IIHRDVKPANIMISATNAVKVMDFGIAR 164
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 36/157 (22%), Positives = 57/157 (36%), Gaps = 20/157 (12%)
Query: 421 SGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEF 480
VT T ++ GT Y++PE G + + DVYS G +L ++ G P F
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----------F 219
Query: 481 QRANLMSWA-RHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRP-SMEE 538
+ +S A +H+ + + + LD V L L K+P R + E
Sbjct: 220 TGDSPVSVAYQHVREDPIPPSARHEGLSADLDA--------VVLKALAKNPENRYQTAAE 271
Query: 539 VVGMLTGKLEAPKLPAEFSPSPPSRIPFKSRKKGPVS 575
+ L A + R S G +S
Sbjct: 272 MRADLVRVHNGEPPEAPKVLTDAERTSLLSSAAGNLS 308
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 15/152 (9%)
Query: 21 RLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGERE----FYNELYFASLLEQDDHVV 74
LG GG +V+ A T+ + VA+K + + + E F E++ +S L ++V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFI-PPREKEETLKRFEREVHNSSQL-SHQNIV 74
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS 134
S++ + LV E + L + + P + + I GI + H
Sbjct: 75 SMIDVDEEDDCY--YLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHD 129
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ ++H DIKP NIL+D N KI DFG+A+
Sbjct: 130 MR--IVHRDIKPQNILIDSNKTLKIFDFGIAK 159
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 32/138 (23%), Positives = 56/138 (40%), Gaps = 21/138 (15%)
Query: 421 SGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEF 480
+T T + GTV Y +PE G E D+YS G++L ++ G P F
Sbjct: 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP----------F 212
Query: 481 QRANLMSWA-RHLARNG-KLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRP-SME 537
+S A +H+ + + V + + +SL V L +K A R +++
Sbjct: 213 NGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN--------VILRATEKDKANRYKTIQ 264
Query: 538 EVVGMLTGKLEAPKLPAE 555
E+ L+ L + +
Sbjct: 265 EMKDDLSSVLHENRANED 282
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 15/152 (9%)
Query: 21 RLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFY----NELYFASLLEQDDHVV 74
RL+G+GG G V+ A T+ ++ VA+K+M +L + F E A L Q+ HVV
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSE-TLSSDPVFRTRMQREARTAGRL-QEPHVV 97
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS 134
+ F + + L++ +L L + P + + +I I + H+
Sbjct: 98 PIHDFGEIDGQL--YVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHA 152
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
H D+KP NIL+ + A + DFG+A
Sbjct: 153 AG--ATHRDVKPENILVSADDFAYLVDFGIAS 182
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 23/144 (15%), Positives = 46/144 (31%), Gaps = 21/144 (14%)
Query: 421 SGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEF 480
+T + GT+ Y+APE + + + D+Y+ +L + G P +
Sbjct: 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP----------Y 235
Query: 481 QRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALR-PSMEEV 539
Q L H+ + V + + D V + K+P R + ++
Sbjct: 236 QGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA--------VIARGMAKNPEDRYVTCGDL 287
Query: 540 VGMLTGKLEAPKLPAEFSPSPPSR 563
L + + R
Sbjct: 288 SAAAHAALATA--DQDRATDILRR 309
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 15 DSFSPSRLLGQGGFGSVFHATL-HDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH- 72
+++ +++G G FG VF A L VA+K + LQ +R EL ++ H
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV----LQDKRFKNREL---QIMRIVKHP 92
Query: 73 -VVSVLGF---SSNPKRHRML-LVYELMSNGNLQDALLH-KKPPELM--EWCKRFSIAVD 124
VV + F + + K L LV E + + A H K + M K +
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYM--YQ 149
Query: 125 IAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA--KISDFGLAR 166
+ + +AY+HS+ + H DIKP N+LLD K+ DFG A+
Sbjct: 150 LLRSLAYIHSIG--ICHRDIKPQNLLLDPP-SGVLKLIDFGSAK 190
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 43/164 (26%), Positives = 69/164 (42%), Gaps = 23/164 (14%)
Query: 15 DSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGERE---FYNELYFASLLEQ 69
+F + +G+G F V+ A L VA+K + L + E LL+Q
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKE---IDLLKQ 88
Query: 70 DDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP-----PELMEWCKRFSIA 122
+H V+ S + + + +V EL G+L + H K PE W
Sbjct: 89 LNHPNVIKYYA--SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYF 142
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
V + + ++HS V+H DIKP+N+ + K+ D GL R
Sbjct: 143 VQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGR 184
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 26/114 (22%), Positives = 44/114 (38%), Gaps = 23/114 (20%)
Query: 429 SMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSW 488
S+ GT Y++PE + K D++S G LL + A + P + NL S
Sbjct: 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY--------GDKMNLYS- 245
Query: 489 ARHLARNGKLIELVDQAVVKSLDRE---QALLCITVALLCLQKSPALRPSMEEV 539
L + ++Q L + + L + +C+ P RP + V
Sbjct: 246 ---------LCKKIEQCDYPPLPSDHYSEEL--RQLVNMCINPDPEKRPDVTYV 288
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 37/161 (22%), Positives = 70/161 (43%), Gaps = 31/161 (19%)
Query: 21 RLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSV 76
+LG G F VF + A+K + + NE+ ++L++ H +V++
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEI---AVLKKIKHENIVTL 71
Query: 77 LG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IAVDIAKGI 129
+ S + LV +L+S G L D +L + ++ + + +
Sbjct: 72 EDIYESTTHYY---LVMQLVSGGELFDRILERG---------VYTEKDASLVIQQVLSAV 119
Query: 130 AYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLARL 167
YLH ++H D+KP N+L + N I+DFGL+++
Sbjct: 120 KYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 24/177 (13%)
Query: 21 RLLGQGGFGSVFHATLH---DQSVAVKVMDSGSLQGERE-FYNELYFASLLEQDDHVVSV 76
+ LG+G +G V A + +++VAVK++D E E+ +L ++VV
Sbjct: 13 QTLGEGAYGEVQLAV-NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKF 70
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN 136
G L E S G L D + + + F + G+ YLH +
Sbjct: 71 YGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHGIG 125
Query: 137 PPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGENKNKAAELESNCG 193
+ H DIKP N+LLD KISDFGLA + N+ L CG
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVF-----------RYNNRERLLNKMCG 169
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 34/162 (20%), Positives = 64/162 (39%), Gaps = 20/162 (12%)
Query: 15 DSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSL-QGEREF-YNELYFASLLEQD 70
+ + + +G+G FG T + +K ++ + ERE E ++L
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRRE---VAVLANM 80
Query: 71 DH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP---PELMEWCKRFSIAVDI 125
H +V S + + +V + G+L + +K E V I
Sbjct: 81 KHPNIVQYRE--SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL----DWFVQI 134
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+ ++H ++H DIK NI L + ++ DFG+AR+
Sbjct: 135 CLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARV 174
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 16/111 (14%), Positives = 40/111 (36%), Gaps = 20/111 (18%)
Query: 429 SMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSW 488
+ GT Y++PE + K D+++ G +L L + F+ ++ +
Sbjct: 184 ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA----------FEAGSMKN- 232
Query: 489 ARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEV 539
L+ + + + ++ +++P RPS+ +
Sbjct: 233 ---------LVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 41/181 (22%), Positives = 75/181 (41%), Gaps = 33/181 (18%)
Query: 15 DSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGERE--FYNELYFASLLEQD 70
+ + + LG G +G V + A+K++ S+ E+ ++L+
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV---AVLKLL 93
Query: 71 DH--VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------I 121
DH ++ + F + LV E G L D ++H+ +F+ I
Sbjct: 94 DHPNIMKLYDFFEDKRNYY---LVMECYKGGELFDEIIHRM---------KFNEVDAAVI 141
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLARLKSVGENQNQAD 178
+ G+ YLH N ++H D+KP N+LL + + KI DFGL+ + + +
Sbjct: 142 IKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL 199
Query: 179 G 179
G
Sbjct: 200 G 200
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 19/38 (50%), Positives = 24/38 (63%), Gaps = 1/38 (2%)
Query: 432 GTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRP 469
GT Y+APE EKCDV+S GV+L +L+AG P
Sbjct: 200 GTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 40/171 (23%), Positives = 67/171 (39%), Gaps = 19/171 (11%)
Query: 17 FSPSRLLGQGGFGSVFHAT-LHDQSVAVK-VMDSGSLQGEREFYNELYFA-------SLL 67
++ R + G +G+V VA+K V ++ S ++ + LL
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 68 EQDDH--VVSVLGFSSNPKRHRML---LVYELMSNGNLQDALLHKKPPELMEWCKRFSIA 122
H ++ + + + M LV ELM +L ++H + + ++
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLA-QVIHDQRIVISPQHIQY-FM 140
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGEN 173
I G+ LH V+H D+ P NILL N I DF LAR + N
Sbjct: 141 YHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 28/180 (15%)
Query: 15 DSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGERE-FYNELYFASLLEQDD 71
D F R LG G FG V +K ++ Q E E+ +L+ D
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEI---EVLKSLD 78
Query: 72 H--VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IA 122
H ++ + F + +V E G L + ++ + K S +
Sbjct: 79 HPNIIKIFEVFEDYHNMY---IVMETCEGGELLERIVSAQARG-----KALSEGYVAELM 130
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLARLKSVGENQNQADG 179
+ +AY HS + V+H D+KP NIL + KI DFGLA L E+ A G
Sbjct: 131 KQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAG 188
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 15/43 (34%), Positives = 21/43 (48%), Gaps = 11/43 (25%)
Query: 432 GTVCYVAPE-----YGAGGDISEKCDVYSYGVLLLVLIAGRRP 469
GT Y+APE KCD++S GV++ L+ G P
Sbjct: 188 GTALYMAPEVFKRDVT------FKCDIWSAGVVMYFLLTGCLP 224
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-16
Identities = 48/182 (26%), Positives = 77/182 (42%), Gaps = 34/182 (18%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGERE---FYNELYFASLLEQ 69
D + R+LG+G FG V Q AVKV+ ++ + + E+ LL+Q
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREV---QLLKQ 82
Query: 70 DDH--VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------ 120
DH ++ + F + LV E+ + G L D ++ +K RFS
Sbjct: 83 LDHPNIMKLYEFFEDKGYFY---LVGEVYTGGELFDEIISRK---------RFSEVDAAR 130
Query: 121 IAVDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLARLKSVGENQNQA 177
I + GI Y+H ++H D+KP N+LL + +I DFGL+ +
Sbjct: 131 IIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 188
Query: 178 DG 179
G
Sbjct: 189 IG 190
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 48/181 (26%), Positives = 78/181 (43%), Gaps = 33/181 (18%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGE--REFYNELYFASLLEQD 70
+ ++ +LG+G FG V Q AVKV++ S + + E+ LL++
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV---ELLKKL 78
Query: 71 DH--VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------I 121
DH ++ + + + +V EL + G L D ++ +K RFS I
Sbjct: 79 DHPNIMKLFEILEDSSSFY---IVGELYTGGELFDEIIKRK---------RFSEHDAARI 126
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLARLKSVGENQNQAD 178
+ GI Y+H N ++H D+KP NILL + + KI DFGL+
Sbjct: 127 IKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI 184
Query: 179 G 179
G
Sbjct: 185 G 185
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 19/43 (44%), Positives = 25/43 (58%), Gaps = 11/43 (25%)
Query: 432 GTVCYVAPE-----YGAGGDISEKCDVYSYGVLLLVLIAGRRP 469
GT Y+APE Y EKCDV+S GV+L +L++G P
Sbjct: 185 GTAYYIAPEVLRGTYD------EKCDVWSAGVILYILLSGTPP 221
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 26/163 (15%)
Query: 21 RLLGQGGFGSVFHATLH---DQSVAVKVMDSGSLQG------EREFYNELYFASLLEQDD 71
+ +G+G F V A H + VA+K++D L RE +++ +
Sbjct: 21 KTIGKGNFAKVKLAR-HILTGREVAIKIIDKTQLNPTSLQKLFRE-------VRIMKILN 72
Query: 72 H--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
H +V + K + L+ E S G + D L+ + E +F I +
Sbjct: 73 HPNIVKLFEVIETEKT--LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAV 127
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGE 172
Y H ++H D+K N+LLD + KI+DFG + +VG
Sbjct: 128 QYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 7e-16
Identities = 48/158 (30%), Positives = 69/158 (43%), Gaps = 15/158 (9%)
Query: 21 RLLGQGGFGSVFHATLH---DQSVAVKVMDSGSLQGEREF---YNELYFASLLEQDDHVV 74
LG G FG V H VAVK+++ ++ E+ L H++
Sbjct: 17 DTLGVGTFGKVKIGE-HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP-HII 74
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS 134
+ S P +V E +S G L D + E ME + F I + Y H
Sbjct: 75 KLYQVISTPTD--FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSAVDYCHR 129
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGE 172
V+H D+KP N+LLD + AKI+DFGL+ + S GE
Sbjct: 130 HM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 21/195 (10%)
Query: 4 RFSYSVLRRAADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVK-VMD--SGSLQGEREFY 58
R VLR+ + + LG+G +G V+ + + VAVK + D S +R +
Sbjct: 2 RVDRHVLRK----YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT-F 56
Query: 59 NELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHK--KPPELMEWC 116
E+ + L +++V++L + LV++ M + LH + L
Sbjct: 57 REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM------ETDLHAVIRANILEPVH 110
Query: 117 KRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQ 176
K++ + + K I YLHS ++H D+KPSNILL+ K++DFGL+R
Sbjct: 111 KQY-VVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 177 ADGENKNKAAELESN 191
+ N+ E +
Sbjct: 168 NIPLSINENTENFDD 182
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 9e-16
Identities = 51/192 (26%), Positives = 73/192 (38%), Gaps = 44/192 (22%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMD-------------SGSLQGEREFYN 59
+S+ R LG G +G V A+KV+ + E YN
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 60 ELYFASLLEQDDH--VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWC 116
E+ SLL+ DH ++ + F + LV E G L + ++++
Sbjct: 96 EI---SLLKSLDHPNIIKLFDVFEDKKYFY---LVTEFYEGGELFEQIINRH-------- 141
Query: 117 KRFS------IAVDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLARL 167
+F I I GI YLH N ++H DIKP NILL + KI DFGL+
Sbjct: 142 -KFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 168 KSVGENQNQADG 179
S G
Sbjct: 199 FSKDYKLRDRLG 210
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 18/43 (41%), Positives = 24/43 (55%), Gaps = 11/43 (25%)
Query: 432 GTVCYVAPE-----YGAGGDISEKCDVYSYGVLLLVLIAGRRP 469
GT Y+APE Y EKCDV+S GV++ +L+ G P
Sbjct: 210 GTAYYIAPEVLKKKYN------EKCDVWSCGVIMYILLCGYPP 246
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 44/173 (25%), Positives = 69/173 (39%), Gaps = 31/173 (17%)
Query: 21 RLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSV 76
+G+G +G V A A K + ++ F E+ +++ DH ++ +
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEI---EIMKSLDHPNIIRL 71
Query: 77 LG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IAVDIAKGI 129
F N + LV EL + G L + ++HK+ F I D+ +
Sbjct: 72 YETFEDNTDIY---LVMELCTGGELFERVVHKR---------VFRESDAARIMKDVLSAV 119
Query: 130 AYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLARLKSVGENQNQADG 179
AY H LN V H D+KP N L + K+ DFGLA G+ G
Sbjct: 120 AYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG 170
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 47/198 (23%), Positives = 77/198 (38%), Gaps = 38/198 (19%)
Query: 2 PHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYN 59
P R Y++ F LLG+G +G V A + VA+K ++ F
Sbjct: 2 PKRIVYNISSD----FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDK 49
Query: 60 ELYFA-------SLLEQDDH--VVSVLGFSSNPKRHRML---LVYELMSNGNLQDALLHK 107
L FA +L+ H ++++ ++ ELM LH+
Sbjct: 50 PL-FALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM------QTDLHR 102
Query: 108 --KPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
L + ++ + + LH N VIH D+KPSN+L++ N K+ DFGLA
Sbjct: 103 VISTQMLSDDHIQY-FIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLA 159
Query: 166 RLKSVGENQNQADGENKN 183
R+ N ++
Sbjct: 160 RIIDESAADNSEPTGQQS 177
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 24/177 (13%)
Query: 21 RLLGQGGFGSVFHATLH---DQSVAVKVMDSGSLQGERE-FYNELYFASLLEQDDHVVSV 76
+ LG+G +G V A + +++VAVK++D E E+ +L ++VV
Sbjct: 13 QTLGEGAYGEVQLAV-NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKF 70
Query: 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN 136
G L E S G L D + + + F + G+ YLH +
Sbjct: 71 YGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHGIG 125
Query: 137 PPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGENKNKAAELESNCG 193
+ H DIKP N+LLD KISDFGLA + N+ L CG
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVF-----------RYNNRERLLNKMCG 169
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 38/163 (23%), Positives = 61/163 (37%), Gaps = 19/163 (11%)
Query: 21 RLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGEREF--------YNELYFASLLEQD 70
LG G FG V+ A ++ V VK + + + E+ S +E
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 71 DHVVSVLGFSSNPKRHRMLLVYELMSNGN-LQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
+++ VL N LV E +G L + + F + +
Sbjct: 90 -NIIKVLDIFENQGF--FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF---RQLVSAV 143
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGE 172
YL + +IH DIK NI++ +F K+ DFG A G+
Sbjct: 144 GYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 48/180 (26%), Positives = 77/180 (42%), Gaps = 31/180 (17%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGERE--FYNELYFASLLEQD 70
+ ++ +LG+G FG V Q AVKV++ S + + E+ LL++
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV---ELLKKL 78
Query: 71 DH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IA 122
DH ++ + + +V EL + G L D ++ +K RFS I
Sbjct: 79 DHPNIMKLFEILEDSSSFY--IVGELYTGGELFDEIIKRK---------RFSEHDAARII 127
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLARLKSVGENQNQADG 179
+ GI Y+H N ++H D+KP NILL + + KI DFGL+ G
Sbjct: 128 KQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 46/219 (21%), Positives = 82/219 (37%), Gaps = 48/219 (21%)
Query: 15 DSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFA-------S 65
D + L+G G +G V A L + VA+K + R F + + +
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLI-DCKRILREIA 104
Query: 66 LLEQDDH--VVSVLGFSSNPKRHRML---LVYELM---------SNGNLQDALLHKKPPE 111
+L + +H VV VL + +V E+ + L + H K
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTEL--HIK--- 159
Query: 112 LMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVG 171
++ ++ G+ Y+HS ++H D+KP+N L++ + K+ DFGLAR +V
Sbjct: 160 --------TLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLAR--TVD 207
Query: 172 ENQNQADGENKNKAAELESNCGAAVEDCGSVVETESVNT 210
+N + + + T V T
Sbjct: 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVT 246
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 34/172 (19%), Positives = 69/172 (40%), Gaps = 39/172 (22%)
Query: 21 RLLGQGGFGSVFHAT--LHDQSVAVKVM-----DSGSLQGEREFYNELYFASLLEQ--DD 71
+ +G GGFG ++ A + A V+ ++G L E +FY + +++ +
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 72 HVVSVLGF---------SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS-- 120
+ LG + +R + V E + +LQ + F
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFM-VMERLGI-DLQK---------ISGQNGTFKKS 151
Query: 121 ----IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKI--SDFGLAR 166
+ + + + Y+H +HGDIK +N+LL + ++ +D+GL+
Sbjct: 152 TVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 12 RAADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFASL--- 66
A + P +G G +G+V+ A VA+K + + L +++
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVREV 62
Query: 67 -----LEQDDH--VVS---VLGFSSNPKRHRMLLVYELMSNGNLQD--ALLHKKPPELME 114
LE +H VV V S + ++ LV+E + QD L K PP +
Sbjct: 63 ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLP 118
Query: 115 WCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
+ +G+ +LH+ ++H D+KP NIL+ K++DFGLAR+ S
Sbjct: 119 AETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSY 172
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 40/158 (25%), Positives = 65/158 (41%), Gaps = 18/158 (11%)
Query: 21 RLLGQGGFGSVFHAT-LHD-QSVAVKVMDSGSLQGEREFYN------ELYFASLLE-QDD 71
LLG GGFGSV+ + D VA+K ++ + E N E+ +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 72 HVVSVLGFSSNPKRHRMLLVYELMSN-GNLQDALLHKKPPELMEWCKRFSIAVDIAKGIA 130
V+ +L + P +L+ E +L D + + + F + + +
Sbjct: 109 GVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFF---WQVLEAVR 163
Query: 131 YLHSLNPPVIHGDIKPSNILLDHNFC-AKISDFGLARL 167
+ H+ V+H DIK NIL+D N K+ DFG L
Sbjct: 164 HCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL 199
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 23/179 (12%)
Query: 1 PPHRFSYSVLRRAADSFS------PSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQ 52
PP F + ++ + + + +LG G FG V +A K++ + ++
Sbjct: 69 PPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK 128
Query: 53 GEREFYNELYFASLLEQDDH--VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKP 109
+ E NE+ S++ Q DH ++ + F S ++ ++LV E + G L D ++ +
Sbjct: 129 DKEEVKNEI---SVMNQLDHANLIQLYDAFES---KNDIVLVMEYVDGGELFDRIIDESY 182
Query: 110 PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA--KISDFGLAR 166
L E I +GI ++H + ++H D+KP NIL + KI DFGLAR
Sbjct: 183 -NLTELDTI-LFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLAR 237
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 45/193 (23%), Positives = 75/193 (38%), Gaps = 35/193 (18%)
Query: 3 HRFSYSVLRRAADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNE 60
+ + + R + + LG GG G VF A D+ VA+K + Q + E
Sbjct: 3 NIHGFDLGSR----YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE 58
Query: 61 LYFASLLEQDDH--VVSVLGFSSNPKRHRML------------LVYELMSNGNLQDALLH 106
+ ++ + DH +V V +V E M + L
Sbjct: 59 I---KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM------ETDLA 109
Query: 107 K--KPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA-KISDFG 163
+ L+E R + +G+ Y+HS N V+H D+KP+N+ ++ KI DFG
Sbjct: 110 NVLEQGPLLEEHARL-FMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFG 166
Query: 164 LARLKSVGENQNQ 176
LAR+ +
Sbjct: 167 LARIMDPHYSHKG 179
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 45/161 (27%), Positives = 63/161 (39%), Gaps = 22/161 (13%)
Query: 21 RLLGQGGFGSVFHAT-LHD-QSVAVKVMD------SGSLQGEREFYNELYFASLLEQDD- 71
LLG+GGFG+VF L D VA+KV+ L E+ +
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 72 --HVVSVLGFSSNPKRHRMLLVYELMSNGN-LQDAL-LHKKPPELMEWCKRFSIAVDIAK 127
V+ +L + + +LV E L D + E + F +
Sbjct: 97 HPGVIRLLDWFETQEG--FMLVLERPLPAQDLFDYITEKGPLGEGP--SRCF--FGQVVA 150
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLD-HNFCAKISDFGLARL 167
I + HS V+H DIK NIL+D CAK+ DFG L
Sbjct: 151 AIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGAL 189
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 21 RLLGQGGFGSVFHATLH---DQSVAVKVMDSGSLQGEREF---YNELYFASLLEQDDHVV 74
LG G FG V H VAVK+++ ++ E+ L H++
Sbjct: 22 DTLGVGTFGKVKVGK-HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP-HII 79
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS 134
+ S P + +V E +S G L D + + E + F I G+ Y H
Sbjct: 80 KLYQVISTPSD--IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ---QILSGVDYCHR 134
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGE 172
V+H D+KP N+LLD + AKI+DFGL+ + S GE
Sbjct: 135 HM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 38/168 (22%), Positives = 68/168 (40%), Gaps = 26/168 (15%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYF--ASLLEQD 70
D + ++G+G F V + Q AVK++D E AS+
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 71 DH--VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------I 121
H +V +L +SS+ + +V+E M +L ++ + +S
Sbjct: 84 KHPHIVELLETYSSDGMLY---MVFEFMDGADLCFEIVKRADAG-----FVYSEAVASHY 135
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLAR 166
I + + Y H N +IH D+KP +LL +++ K+ FG+A
Sbjct: 136 MRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 6e-15
Identities = 39/173 (22%), Positives = 69/173 (39%), Gaps = 31/173 (17%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGERE--FYNELYFASLLEQD 70
D++ LG+G F V A K++++ L E A + +
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE---ARICRKL 62
Query: 71 DH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IA 122
H +V + H LV++L++ G L + ++ ++ +S
Sbjct: 63 QHPNIVRLHDSIQEESFHY--LVFDLVTGGELFEDIVARE---------FYSEADASHCI 111
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLARLKSVGE 172
I + IAY HS ++H ++KP N+LL K++DFGLA + E
Sbjct: 112 QQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 39/173 (22%), Positives = 68/173 (39%), Gaps = 38/173 (21%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGERE--------FYNELYFA 64
D + S+ LG G G V A + VA++++ E+
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI--- 191
Query: 65 SLLEQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS-- 120
+L++ +H ++ + F + +V ELM G L D ++ K R
Sbjct: 192 EILKKLNHPCIIKIKNFFDAEDYY---IVLELMEGGELFDKVVGNK---------RLKEA 239
Query: 121 ----IAVDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLAR 166
+ + YLH +IH D+KP N+LL + + KI+DFG ++
Sbjct: 240 TCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 34/156 (21%), Positives = 70/156 (44%), Gaps = 16/156 (10%)
Query: 15 DSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
D + R LG+G + VF A +++ V VK++ +++ E+ L +
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPN 92
Query: 73 VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAY 131
++++ R L+ + + + L ++ RF + +I K + Y
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVN------NTDFKQLYQTLTDYDIRFYM-YEILKALDY 145
Query: 132 LHSLNPPVIHGDIKPSNILLDHNFCA-KISDFGLAR 166
HS+ ++H D+KP N+++DH ++ D+GLA
Sbjct: 146 CHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 37/160 (23%), Positives = 62/160 (38%), Gaps = 31/160 (19%)
Query: 21 RLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSV 76
++LG G G V + A+K++ + RE +V +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREV------ELHWRASQCPHIVRI 76
Query: 77 LGF--SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IAVDIAKG 128
+ + R +L+V E + G L + + + F+ I I +
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEA 129
Query: 129 IAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLA 165
I YLHS+N + H D+KP N+L N K++DFG A
Sbjct: 130 IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 38/165 (23%), Positives = 66/165 (40%), Gaps = 29/165 (17%)
Query: 22 LLGQGGFGSVFHATLH---DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLG 78
+LG G G V H Q A+K++ +E + H+V +L
Sbjct: 36 VLGLGVNGKVLECF-HRRTGQKCALKLLYDSPKAR-QEVDHHWQ----ASGGPHIVCILD 89
Query: 79 F--SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IAVDIAKGIA 130
+ + + +L++ E M G L + + + F+ I DI I
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGD-------QAFTEREAAEIMRDIGTAIQ 142
Query: 131 YLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLARLKSVGE 172
+LHS N + H D+KP N+L + + K++DFG A+ +
Sbjct: 143 FLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 42/181 (23%), Positives = 72/181 (39%), Gaps = 40/181 (22%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGERE--------FYNELYFA 64
D + S+ LG G G V A + VA+K++ E+
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI--- 66
Query: 65 SLLEQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS-- 120
+L++ +H ++ + F + +V ELM G L D ++ K R
Sbjct: 67 EILKKLNHPCIIKIKNFFDAEDYY---IVLELMEGGELFDKVVGNK---------RLKEA 114
Query: 121 ----IAVDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLARLKSVGEN 173
+ + YLH +IH D+KP N+LL + + KI+DFG +++ +GE
Sbjct: 115 TCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGET 170
Query: 174 Q 174
Sbjct: 171 S 171
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 36/158 (22%), Positives = 65/158 (41%), Gaps = 15/158 (9%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
D + LG G FG V T + A K + + + E+ + H
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEI---QTMSVLRH 213
Query: 73 --VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIA 130
+V++ + + M+++YE MS G L + + + ++ E + + KG+
Sbjct: 214 PTLVNLHDAFEDD--NEMVMIYEFMSGGELFEKVADEHN-KMSE-DEAVEYMRQVCKGLC 269
Query: 131 YLHSLNPPVIHGDIKPSNILLDHNFCA--KISDFGLAR 166
++H N +H D+KP NI+ K+ DFGL
Sbjct: 270 HMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA 305
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 43/166 (25%), Positives = 69/166 (41%), Gaps = 29/166 (17%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLH---DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDD 71
D + LG+G F H +Q+ AVK++ + E+ L E
Sbjct: 11 DLDLKDKPLGEGSFSICRKCV-HKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHP 66
Query: 72 HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IAVDI 125
++V + + LV EL++ G L + + KK FS I +
Sbjct: 67 NIVKLHEVFHDQLHT--FLVMELLNGGELFERIKKKK---------HFSETEASYIMRKL 115
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLARLK 168
++++H + V+H D+KP N+L + N KI DFG ARLK
Sbjct: 116 VSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 39/167 (23%), Positives = 68/167 (40%), Gaps = 29/167 (17%)
Query: 20 SRLLGQGGFGSVFHATLH---DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSV 76
S++LG G G V + + A+K++ + E+ Q H+V +
Sbjct: 67 SQVLGLGINGKVLQIF-NKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRI 120
Query: 77 LGF--SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IAVDIAKG 128
+ + R +L+V E + G L + + + F+ I I +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEA 173
Query: 129 IAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLARLKSVGE 172
I YLHS+N + H D+KP N+L N K++DFG A+ +
Sbjct: 174 IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 40/192 (20%), Positives = 80/192 (41%), Gaps = 34/192 (17%)
Query: 17 FSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFA-------SLL 67
+ L+G+G +G V+ A +++VA+K + R F + + ++L
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-------NRMFEDLI-DCKRILREITIL 79
Query: 68 EQDDH--VVSVLGFSSNPKRHRML---LVYELMSNGNLQDALLH---KKPPELMEWCKRF 119
+ ++ + + +V E+ D+ L K P L E +
Sbjct: 80 NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA------DSDLKKLFKTPIFLTEEHIKT 133
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADG 179
I ++ G ++H +IH D+KP+N LL+ + K+ DFGLAR + ++ N +
Sbjct: 134 -ILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 180 ENKNKAAELESN 191
+N+ +
Sbjct: 191 LEENEEPGPHNK 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 27/175 (15%), Positives = 61/175 (34%), Gaps = 42/175 (24%)
Query: 21 RLLGQGGFGSVFHAT----------LHDQSVAVKV-MDSGSLQGEREFYN------ELYF 63
+ G ++ A Q ++K+ G L E+ F+ ++
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 64 ASLLEQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR--F 119
L + + +GF + ++R L V + +LQ ++ +
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFL-VLPSLGR-SLQS---------ALDVSPKHVL 156
Query: 120 S------IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKI--SDFGLAR 166
S +A + + +LH +HG++ NI +D +++ + +G A
Sbjct: 157 SERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 46/170 (27%), Positives = 67/170 (39%), Gaps = 32/170 (18%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGER------EFYNELYFASL 66
D + LG G F V A K + + R E E S+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE---VSI 68
Query: 67 LEQDDH--VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKP---PELMEWCKRFS 120
L Q H V+++ + + R ++L+ EL+S G L D L K+ E + K
Sbjct: 69 LRQVLHHNVITLHDVYEN---RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK--- 122
Query: 121 IAVDIAKGIAYLHSLNPPVIHGDIKPSNILL----DHNFCAKISDFGLAR 166
I G+ YLH+ + H D+KP NI+L K+ DFGLA
Sbjct: 123 ---QILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 39/166 (23%), Positives = 66/166 (39%), Gaps = 24/166 (14%)
Query: 15 DSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYN-----ELYFASLL 67
+ + +G+G +G VF Q VA+K + E+ +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF---LESEDDPVIKKIALREI---RML 56
Query: 68 EQDDH--VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVD 124
+Q H +V++L F + H LV+E + + L + K +
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLH---LVFEYCDH-TVLHELDRYQRGVPEHLVKSITW--Q 110
Query: 125 IAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
+ + + H N IH D+KP NIL+ + K+ DFG ARL +
Sbjct: 111 TLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 34/176 (19%)
Query: 17 FSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFA-------SLL 67
++ +G+G +G V A L+ VA+K + F ++ + +L
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQT-YCQRTLREIKIL 79
Query: 68 EQDDH--VVSVLGFSSNPKRHRML---LVYELMSNGNLQDALLHK--KPPELMEWCKRFS 120
+ H ++ + P +M +V +LM + L+K K L +
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM------ETDLYKLLKTQHLSNDHICY- 132
Query: 121 IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQ 176
I +G+ Y+HS N V+H D+KPSN+LL+ KI DFGLAR+ +
Sbjct: 133 FLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 41/148 (27%), Positives = 65/148 (43%), Gaps = 13/148 (8%)
Query: 23 LGQGGFGSVFHATLHDQS---VAVKVMD-SGSLQGEREFYNELYFASLLEQDDHVVSVLG 78
+G G G V+ ++ +AVK M SG+ + + +L ++V G
Sbjct: 33 MGSGTCGQVWKM-RFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 79 -FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNP 137
F +N + + ELM + L + + E + V I K + YL +
Sbjct: 92 TFITN---TDVFIAMELMGTCA--EKLKKRMQGPIPERILG-KMTVAIVKALYYLKEKHG 145
Query: 138 PVIHGDIKPSNILLDHNFCAKISDFGLA 165
VIH D+KPSNILLD K+ DFG++
Sbjct: 146 -VIHRDVKPSNILLDERGQIKLCDFGIS 172
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 37/162 (22%), Positives = 72/162 (44%), Gaps = 23/162 (14%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
D + LG G FG V + K +++ + NE+ S++ Q H
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEI---SIMNQLHH 107
Query: 73 --VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAK--- 127
++++ + + M+L+ E +S G L D + + ++ E + ++ +
Sbjct: 108 PKLINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDY-KMSE-----AEVINYMRQAC 159
Query: 128 -GIAYLHSLNPPVIHGDIKPSNILLDHNFCA--KISDFGLAR 166
G+ ++H + ++H DIKP NI+ + + KI DFGLA
Sbjct: 160 EGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLAT 199
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 41/183 (22%), Positives = 67/183 (36%), Gaps = 29/183 (15%)
Query: 8 SVLRRAADSFSPSRLLGQGGFGSVFHATLHDQS---VAVKVMDSGSLQGERE-FYNELYF 63
A+ +G+G +GSV +H S +AVK + S + E++ +L
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKM-VHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDV 73
Query: 64 ASLLEQDDHVVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS-- 120
++V G + ELM + + +
Sbjct: 74 VMRSSDCPYIVQFYGALFRE---GDCWICMELM-STSFDKFYKYVYSVL----DDVIPEE 125
Query: 121 ----IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG--------LARLK 168
I + K + +L N +IH DIKPSNILLD + K+ DFG +A+ +
Sbjct: 126 ILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR 184
Query: 169 SVG 171
G
Sbjct: 185 DAG 187
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 38/167 (22%), Positives = 67/167 (40%), Gaps = 31/167 (18%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGERE--FYNELYFASLLEQD 70
D++ LG+G F V A K++++ L E A + +
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE---ARICRKL 85
Query: 71 DH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IA 122
H +V + H LV++L++ G L + ++ ++ +S
Sbjct: 86 QHPNIVRLHDSIQEESFHY--LVFDLVTGGELFEDIVARE---------FYSEADASHCI 134
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLAR 166
I + IAY HS ++H ++KP N+LL K++DFGLA
Sbjct: 135 QQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 40/175 (22%), Positives = 73/175 (41%), Gaps = 25/175 (14%)
Query: 8 SVLRRAADSFS-----PSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGE--REFY 58
++ ++ ++F+ S+ LG+G F V Q A K + + E
Sbjct: 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL 76
Query: 59 NELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR 118
+E+ L + V+++ N ++L+ E + G + L + + E
Sbjct: 77 HEIAVLELAKSCPRVINLHEVYENT--SEIILILEYAAGGEIFSLCLPELAEMVSE---- 130
Query: 119 FSIAVDIAK----GIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLAR 166
+ + + K G+ YLH N ++H D+KP NILL KI DFG++R
Sbjct: 131 -NDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 8e-14
Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 13/162 (8%)
Query: 11 RRAADSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLE 68
++ + F ++LG+G F +V A + A+K+++ + E + ++
Sbjct: 26 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 69 QDDH--VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDI 125
+ DH V + F + ++ NG L + +K E C RF A +I
Sbjct: 86 RLDHPFFVKLYFTFQDD---EKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTA-EI 139
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+ YLH +IH D+KP NILL+ + +I+DFG A++
Sbjct: 140 VSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKV 179
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 48/158 (30%), Positives = 72/158 (45%), Gaps = 16/158 (10%)
Query: 21 RLLGQGGFGSVFHATLH---DQSVAVKVMDSGSLQGEREFYN---ELYFASLLEQDDHVV 74
LG+G FG V AT H Q VA+K + L+ E+ + LL H++
Sbjct: 15 ETLGEGSFGKVKLAT-HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP-HII 72
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS 134
+ + P M++ Y + G L D ++ KK E + F I I Y H
Sbjct: 73 KLYDVITTPTDIVMVIEY---AGGELFDYIVEKKRMTEDEGRRFFQ---QIICAIEYCHR 126
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGE 172
++H D+KP N+LLD N KI+DFGL+ + + G
Sbjct: 127 HK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 31/196 (15%), Positives = 61/196 (31%), Gaps = 42/196 (21%)
Query: 14 ADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVK--------------------------- 44
+ +S + LG G FG V + A+K
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKL 65
Query: 45 --VMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML--LVYELMSNGNL 100
+ + + L +++ V + ++ E + + L
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TL 124
Query: 101 QDALLH--KKPPEL-MEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA 157
L + + M + + + + ++HSL + H DIKP N+L++
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYI--YQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNT 180
Query: 158 -KISDFGLARLKSVGE 172
K+ DFG A+ E
Sbjct: 181 LKLCDFGSAKKLIPSE 196
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 47/180 (26%), Positives = 75/180 (41%), Gaps = 36/180 (20%)
Query: 12 RAADSFSPSRLLGQGGFGSVF---HATLHDQSVAVKVMDSGSLQGEREFYN-----ELYF 63
RA + +G+G +G VF + VA+K + +Q E E+
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAV 64
Query: 64 ASLLEQDDH--VVS---VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR 118
LE +H VV V S + ++ LV+E + QD L ++
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QD--LTT----YLDKVPE 114
Query: 119 FSIAVDIAK--------GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
+ + K G+ +LHS V+H D+KP NIL+ + K++DFGLAR+ S
Sbjct: 115 PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 42/175 (24%)
Query: 21 RLLGQGGFGSVFHATLH-------DQSVAVKVM--DSGSLQGEREFYNELYFASLLEQ-- 69
+GQGGFG ++ A ++ D VKV D+G L E +FY +++
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 70 DDHVVSVLGF---------SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWC-KRF 119
+ LG N K +R + + + + +LQ + E KRF
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFM-IMDRFGS-DLQK---------IYEANAKRF 149
Query: 120 S------IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKI--SDFGLAR 166
S +++ I + Y+H +HGDIK SN+LL++ ++ D+GLA
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 34/168 (20%), Positives = 66/168 (39%), Gaps = 33/168 (19%)
Query: 15 DSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGERE--FYNELYFASLLEQD 70
+ + LG+G F V L Q A ++++ L E A +
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE---ARICRLL 67
Query: 71 DH--VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------I 121
H +V + S + L+++L++ G L + ++ ++ +S
Sbjct: 68 KHPNIVRLHDSISEEGHHY---LIFDLVTGGELFEDIVARE---------YYSEADASHC 115
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLAR 166
I + + + H + V+H ++KP N+LL K++DFGLA
Sbjct: 116 IQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 44/172 (25%), Positives = 63/172 (36%), Gaps = 36/172 (20%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGER------EFYNELYFASL 66
D + LG G F V A K + + R E E S+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE---VSI 68
Query: 67 LEQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS---- 120
L Q H ++++ N ++L+ EL+S G L D L K+ S
Sbjct: 69 LRQVLHPNIITLHDVYENR--TDVVLILELVSGGELFDFLAQKE---------SLSEEEA 117
Query: 121 --IAVDIAKGIAYLHSLNPPVIHGDIKPSNILL----DHNFCAKISDFGLAR 166
I G+ YLH+ + H D+KP NI+L K+ DFGLA
Sbjct: 118 TSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 33/168 (19%)
Query: 15 DSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFA-------S 65
++ +G G +GSV A + VA+K + R F +E+ FA
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-------SRPFQSEI-FAKRAYRELL 75
Query: 66 LLEQDDH--VVSVLGFSSNPKRHRML----LVYELMSNGNLQDALLHK-KPPELMEWCKR 118
LL+ H V+ +L + R LV M L K + E +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM------QTDLQKIMGLKFSEEKIQ 129
Query: 119 FSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ + + KG+ Y+HS V+H D+KP N+ ++ + KI DFGLAR
Sbjct: 130 Y-LVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR 174
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 42/172 (24%), Positives = 64/172 (37%), Gaps = 36/172 (20%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGER------EFYNELYFASL 66
D + LG G F V + A K + L R E E ++
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIERE---VNI 61
Query: 67 LEQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS---- 120
L + H ++++ N ++L+ EL+S G L D L K+ +
Sbjct: 62 LREIRHPNIITLHDIFENK--TDVVLILELVSGGELFDFLAEKE---------SLTEDEA 110
Query: 121 --IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA----KISDFGLAR 166
I G+ YLHS + H D+KP NI+L K+ DFG+A
Sbjct: 111 TQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 30/177 (16%)
Query: 14 ADSFSPSRLLGQGGFGSVFHATLHDQS---VAVKVMD-SGSLQGEREFYNELYFASLLEQ 69
AD P LG+G +G V H S +AVK + + + Q ++ +L +
Sbjct: 6 ADDLEPIMELGRGAYGVVEKM-RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64
Query: 70 DDHVVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IA 122
V+ G + + ELM + +L ++++ + IA
Sbjct: 65 CPFTVTFYGALFREGD---VWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIA 115
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG--------LARLKSVG 171
V I K + +LHS VIH D+KPSN+L++ K+ DFG +A+ G
Sbjct: 116 VSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAG 171
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 34/167 (20%)
Query: 17 FSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFA-------SLL 67
+ + +G G +G+V A VA+K + R F +EL FA LL
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-------YRPFQSEL-FAKRAYRELRLL 78
Query: 68 EQDDH--VVSVLGFSSNPKRHRML----LVYELMSNGNLQDALLHK--KPPELMEWCKRF 119
+ H V+ +L + + LV M L K K +L E +F
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM------GTDLGKLMKHEKLGEDRIQF 132
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ + KG+ Y+H+ +IH D+KP N+ ++ + KI DFGLAR
Sbjct: 133 -LVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 176
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 29/175 (16%)
Query: 10 LRRAADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKV--MDSGSLQGE-------REFY 58
++ A + LG+G F +V+ A +Q VA+K + S + RE
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE-- 62
Query: 59 NELYFASLLEQDDH--VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEW 115
LL++ H ++ +L F + LV++ M +L+ +
Sbjct: 63 -----IKLLQELSHPNIIGLLDAFGHKSN---ISLVFDFMET-DLEVIIKDNSLVLTPSH 113
Query: 116 CKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
K + + +G+ YLH ++H D+KP+N+LLD N K++DFGLA+
Sbjct: 114 IKAYML--MTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 41/184 (22%), Positives = 76/184 (41%), Gaps = 30/184 (16%)
Query: 12 RAADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVK--VMDSGSLQGEREFYN-----ELY 62
+ +GQG FG VF A Q VA+K +M++ E+E + E+
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-----EKEGFPITALREI- 67
Query: 63 FASLLEQDDH--------VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELME 114
+L+ H + N + + LV++ + +L L + +
Sbjct: 68 --KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124
Query: 115 WCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQ 174
K + + G+ Y+H ++H D+K +N+L+ + K++DFGLAR S+ +N
Sbjct: 125 EIK--RVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 175 NQAD 178
Sbjct: 181 QPNR 184
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 7/162 (4%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
++F R+LG+GGFG V + + A K ++ ++ + L +LE+ +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYL 132
V + + + LV LM+ G+L+ + H E F A +I G+ L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLEDL 302
Query: 133 HSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQ 174
H +++ D+KP NILLD + +ISD GLA V E Q
Sbjct: 303 HRER--IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQ 340
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 44/158 (27%), Positives = 70/158 (44%), Gaps = 16/158 (10%)
Query: 14 ADSFSPSRLLGQGGFGSVFHATLHDQS---VAVKVMDSGSLQGEREF-YNELYFASLLEQ 69
D F LG G G VF H S +A K++ R EL L E
Sbjct: 32 DDDFEKISELGAGNGGVVFKV-SHKPSGLVMARKLIHLEIKPAIRNQIIRELQV--LHEC 88
Query: 70 D-DHVVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAK 127
+ ++V G F S+ + + + E M G+L + KK + E +++ + K
Sbjct: 89 NSPYIVGFYGAFYSDGE---ISICMEHMDGGSLDQ--VLKKAGRIPEQILG-KVSIAVIK 142
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
G+ YL ++H D+KPSNIL++ K+ DFG++
Sbjct: 143 GLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 39/162 (24%), Positives = 66/162 (40%), Gaps = 28/162 (17%)
Query: 23 LGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGE--------REFYNELYFASLLEQDDH 72
LG G + +V+ VA+K + L E RE SL+++ H
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIRE-------ISLMKELKH 62
Query: 73 --VVSVLGFSSNPKRHRMLLVYELMSN--GNLQDALLHKKPPELMEWCKRFSIAVDIAKG 128
+V + + + LV+E M N D+ P +E + +G
Sbjct: 63 ENIVRLYDVIHTENK--LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
+A+ H ++H D+KP N+L++ K+ DFGLAR +
Sbjct: 121 LAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 49/185 (26%), Positives = 79/185 (42%), Gaps = 37/185 (20%)
Query: 2 PHRFSYSVLRRA---ADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGERE 56
P + + + + + +G G +GSV A T VAVK + R
Sbjct: 13 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK-------KLSRP 65
Query: 57 FYNELYFA-------SLLEQDDH--VVSVLGFSSNPKRHRML----LVYELMSNGNLQDA 103
F + + A LL+ H V+ +L + + LV LM A
Sbjct: 66 FQSII-HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM------GA 118
Query: 104 LLHK--KPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISD 161
L+ K +L + +F + I +G+ Y+HS + +IH D+KPSN+ ++ + KI D
Sbjct: 119 DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILD 175
Query: 162 FGLAR 166
FGLAR
Sbjct: 176 FGLAR 180
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 41/169 (24%), Positives = 73/169 (43%), Gaps = 24/169 (14%)
Query: 12 RAADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYN-----ELYFA 64
++ + + L+G+G +G V + VA+K + + E+
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF---LESDDDKMVKKIAMREI--- 75
Query: 65 SLLEQDDH--VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSI 121
LL+Q H +V++L + + LV+E + + + D L + +++
Sbjct: 76 KLLKQLRHENLVNLLEVCKKKKRWY---LVFEFVDH-TILDDLELFPNGLDYQVVQKYLF 131
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
I GI + HS N +IH DIKP NIL+ + K+ DFG AR +
Sbjct: 132 --QIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 29/168 (17%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGE--------REFYNELYFA 64
+++ LG+G + +V+ D VA+K + L+ E RE
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIRE-------V 51
Query: 65 SLLEQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIA 122
SLL+ H +V++ K + LV+E + +L+ L M K F
Sbjct: 52 SLLKDLKHANIVTLHDIIHTEKS--LTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLF- 107
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
+ +G+AY H V+H D+KP N+L++ K++DFGLAR KS+
Sbjct: 108 -QLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSI 152
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 46/170 (27%), Positives = 70/170 (41%), Gaps = 30/170 (17%)
Query: 10 LRRAADSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSL--QGEREFYNELYFAS 65
+R D F +++G+G F V + Q A+K+M+ + +GE + E
Sbjct: 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE----- 110
Query: 66 LLEQDDHVVSVLGFSSNP----------KRHRMLLVYELMSNGNLQDALLHKKPPELMEW 115
E+D VL + + LV E G+L LL K +
Sbjct: 111 --ERD-----VLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL-TLLSKFGERIPAE 162
Query: 116 CKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
RF +A +I I +H L +H DIKP NILLD +++DFG
Sbjct: 163 MARFYLA-EIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSC 209
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 38/200 (19%), Positives = 63/200 (31%), Gaps = 55/200 (27%)
Query: 15 DSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMD-----SGSLQGEREFYNELYFASLL 67
+ +GQG +G V A A+K+M+ + + E+ L+
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEV---RLM 82
Query: 68 EQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK----------------- 108
++ H + + + + LV EL G+L D L
Sbjct: 83 KKLHHPNIARLYEVYED--EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 109 --------------PPELMEWCKRFS------IAVDIAKGIAYLHSLNPPVIHGDIKPSN 148
I I + YLH+ + H DIKP N
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPEN 198
Query: 149 ILL--DHNFCAKISDFGLAR 166
L + +F K+ DFGL++
Sbjct: 199 FLFSTNKSFEIKLVDFGLSK 218
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 17/40 (42%), Positives = 21/40 (52%), Gaps = 2/40 (5%)
Query: 432 GTVCYVAPE--YGAGGDISEKCDVYSYGVLLLVLIAGRRP 469
GT +VAPE KCD +S GVLL +L+ G P
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 34/188 (18%)
Query: 1 PPHRFSYSVL--RRAADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGERE 56
P S S + D + LG+G +G V+ A T+ +++VA+K + L+ E E
Sbjct: 18 GPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEE 74
Query: 57 FYN-----ELYFASLLEQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQD--ALLHK 107
E+ SLL++ H ++ + + HR+ L++E D + K
Sbjct: 75 GVPGTAIREV---SLLKELQHRNIIELKSVIHH--NHRLHLIFEYAE----NDLKKYMDK 125
Query: 108 KPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA-----KISDF 162
P M K F + G+ + HS +H D+KP N+LL + + KI DF
Sbjct: 126 NPDVSMRVIKSFLY--QLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDF 181
Query: 163 GLARLKSV 170
GLAR +
Sbjct: 182 GLARAFGI 189
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 44/172 (25%), Positives = 65/172 (37%), Gaps = 36/172 (20%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGER------EFYNELYFASL 66
D + LG G F V A K + + R + E S+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE---VSI 67
Query: 67 LEQDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS---- 120
L++ H V+++ N ++L+ EL++ G L D L K+ +
Sbjct: 68 LKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKE---------SLTEEEA 116
Query: 121 --IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA----KISDFGLAR 166
I G+ YLHSL + H D+KP NI+L KI DFGLA
Sbjct: 117 TEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 1e-12
Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 35/172 (20%)
Query: 15 DSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGE---------REFYNELYF 63
++F +G+G +G V+ A L + VA+K + L E RE
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI---RLDTETEGVPSTAIRE------- 52
Query: 64 ASLLEQDDH--VVSVLG-FSSNPKRHRMLLVYELMSNGNLQD--ALLHKKPPELMEWCKR 118
SLL++ +H +V +L + +++ LV+E + QD + +
Sbjct: 53 ISLLKELNHPNIVKLLDVIHTE---NKLYLVFEFLH----QDLKKFMDASALTGIPLPLI 105
Query: 119 FSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
S + +G+A+ HS V+H D+KP N+L++ K++DFGLAR V
Sbjct: 106 KSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 25/151 (16%), Positives = 44/151 (29%), Gaps = 15/151 (9%)
Query: 21 RLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGE---REFYNELYFASLLEQDDHVVS 75
G + A T D+ VA+ +D + + +E + S + V
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVAR 95
Query: 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL 135
VL R L+V E + G+LQ+ P +A H
Sbjct: 96 VLDVVHT--RAGGLVVAEWIRGGSLQEVADTSPSPV-----GAIRAMQSLAAAADAAHRA 148
Query: 136 NPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
V PS + + + ++
Sbjct: 149 G--VALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 23/136 (16%), Positives = 42/136 (30%), Gaps = 18/136 (13%)
Query: 432 GTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSWARH 491
G V P + + D+ G L L+ R PL G + L R
Sbjct: 166 GDVVLAYPATMPDAN--PQDDIRGIGASLYALLVNRWPLPEAGVR------SGLAPAERD 217
Query: 492 LARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPS--MEEVVGMLTGKLEA 549
A +D+ + + VA +Q +R + + ++ T +
Sbjct: 218 TAGQPIEPADIDRDIPFQIS--------AVAARSVQGDGGIRSASTLLNLMQQATAVADR 269
Query: 550 PKLPAEFSPSPPSRIP 565
++ +P S P
Sbjct: 270 TEVLGPIDEAPVSAAP 285
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 23/169 (13%)
Query: 11 RRAADSFSPSRLLGQGGFGSVFHAT-LHDQSVAVKVMDSGSLQGEREFYN-----ELYFA 64
+ + + +G+G +G V+ A + VA+K + L E E E
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIRE---I 70
Query: 65 SLLEQDDH--VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSI 121
SLL++ H +VS++ S + LV+E M +L+ L K K
Sbjct: 71 SLLKELHHPNIVSLIDVIHSE---RCLTLVFEFMEK-DLKKVLDENKTGLQDSQIK--IY 124
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
+ +G+A+ H ++H D+KP N+L++ + K++DFGLAR +
Sbjct: 125 LYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 3e-12
Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 36/164 (21%)
Query: 23 LGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGE---------REFYNELYFASLLEQDD 71
+G+G +G+VF A + VA+K + L + RE LL++
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALRE-------ICLLKELK 59
Query: 72 H--VVSVLG-FSSNPKRHRMLLVYELMSNGNLQD--ALLHKKPPELMEWCKRFSIAVDIA 126
H +V + S+ ++ LV+E QD +L + S +
Sbjct: 60 HKNIVRLHDVLHSD---KKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVK-SFLFQLL 111
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
KG+ + HS N V+H D+KP N+L++ N K+++FGLAR +
Sbjct: 112 KGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
D F R+LG+GGFG VF + + A K ++ L+ + + + +L +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 73 --VVSVLGFSSNPKRHRMLLVYELMSNGNL--QDALLHKKPPELMEWCKRFSIAVDIAKG 128
+VS+ + + + LV +M+ G++ + + P E F A I G
Sbjct: 245 RFIVSL--AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSG 301
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+ +LH N +I+ D+KP N+LLD + +ISD GLA
Sbjct: 302 LEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLA 336
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 36/157 (22%), Positives = 61/157 (38%), Gaps = 15/157 (9%)
Query: 21 RLLGQGGFGSVFHATLH---DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVL 77
+ +G G FG + VAVK ++ G+ E E+ L ++V
Sbjct: 26 KDIGSGNFGVARLMR-DKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHP-NIVRFK 82
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNP 137
P + ++ E S G L + + + E F + G++Y HS+
Sbjct: 83 EVILTPTH--LAIIMEYASGGELYERICNAGRFSEDEARFFFQ---QLLSGVSYCHSMQ- 136
Query: 138 PVIHGDIKPSNILLDHNFCA--KISDFGLARLKSVGE 172
+ H D+K N LLD + KI DFG ++ +
Sbjct: 137 -ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 35/159 (22%), Positives = 68/159 (42%), Gaps = 18/159 (11%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
+ + + LG+G FG V ++ K + + E+ S+L H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEI---SILNIARH 60
Query: 73 --VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
++ + F S +++++E +S ++ + + EL E + S + + +
Sbjct: 61 RNILHLHESFES---MEELVMIFEFISGLDIFERINTSAF-ELNE-REIVSYVHQVCEAL 115
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCA--KISDFGLAR 166
+LHS N + H DI+P NI+ + KI +FG AR
Sbjct: 116 QFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 50/173 (28%), Positives = 79/173 (45%), Gaps = 35/173 (20%)
Query: 9 VLRRAADSFSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFA-- 64
VL+R + + +G G G V A + D++VA+K + R F N+ A
Sbjct: 60 VLKR----YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-------SRPFQNQT-HAKR 107
Query: 65 -----SLLEQDDH--VVSVLG-FSSNPKRHRM---LLVYELMSNGNLQDALLHKKPPELM 113
L++ +H ++S+L F+ LV ELM DA L + +
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM------DANLCQVIQMEL 161
Query: 114 EWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ + + + GI +LHS +IH D+KPSNI++ + KI DFGLAR
Sbjct: 162 DHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 212
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 39/172 (22%), Positives = 70/172 (40%), Gaps = 33/172 (19%)
Query: 15 DSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
D F LG+G V+ + A+KV+ ++ E+ +L + H
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEI---GVLLRLSH 107
Query: 73 --VVSVLG-FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS------IAV 123
++ + F + + LV EL++ G L D ++ K +S
Sbjct: 108 PNIIKLKEIFETPTEIS---LVLELVTGGELFDRIVEKG---------YYSERDAADAVK 155
Query: 124 DIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLARLKSVGE 172
I + +AYLH ++H D+KP N+L + KI+DFGL+++
Sbjct: 156 QILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 5e-12
Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 33/162 (20%)
Query: 23 LGQGGFGSVFHAT-LHDQSVAVKVMDSGSLQGE---------REFYNELYFASLLEQDDH 72
+G+G +G V+ A + ++ A+K + L+ E RE S+L++ H
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKI---RLEKEDEGIPSTTIRE-------ISILKELKH 59
Query: 73 --VVSVLGFSSNPKRHRMLLVYELMSNGNLQD--ALLHKKPPELMEWCKRFSIAVDIAKG 128
+V + KR ++LV+E + QD LL L + S + + G
Sbjct: 60 SNIVKLYDVIHTKKR--LVLVFEHLD----QDLKKLLDVCEGGLESVTAK-SFLLQLLNG 112
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170
IAY H V+H D+KP N+L++ KI+DFGLAR +
Sbjct: 113 IAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGI 152
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.1 bits (160), Expect = 6e-12
Identities = 33/214 (15%), Positives = 60/214 (28%), Gaps = 52/214 (24%)
Query: 2 PHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVM--------DSGSLQG 53
P FS+ + + +G+G FG VF VA+K++ + +
Sbjct: 10 PVPFSHCL---PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKT 66
Query: 54 EREFYNELYFASLLEQ----------------DDHVV--------------------SVL 77
E E+ + L H V S
Sbjct: 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNP 137
K ++ +V E G L + +L SI + +A + +
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGI----DLEQMRTKLSSLATAKSILHQLTASLAVAEA-SL 181
Query: 138 PVIHGDIKPSNILLDHNFCAKISDFGLARLKSVG 171
H D+ N+LL K+ + ++
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIP 215
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 30/170 (17%)
Query: 10 LRRAADSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSL--QGEREFYNELYFAS 65
+R + F +++G+G FG V L + + A+K+++ + + E + E
Sbjct: 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE----- 123
Query: 66 LLEQDDHVVSVLGFSSNP----------KRHRMLLVYELMSNGNLQDALLHKKPPELMEW 115
E+D VL + + + LV + G+L LL K L E
Sbjct: 124 --ERD-----VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL-TLLSKFEDRLPEE 175
Query: 116 CKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
RF +A ++ I +H L+ +H DIKP NIL+D N +++DFG
Sbjct: 176 MARFYLA-EMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSC 222
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 15/158 (9%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
D F R +G+G FG V +D + A+K M+ E N +++ +H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 73 --VVSVLGFS-SNPKRHRMLLVYELMSNGNLQDALLH-KKPPELMEWCKRFSIAVDIAKG 128
+V+ L +S + + M +V +L+ G+L H ++ E + I ++
Sbjct: 75 PFLVN-LWYSFQDEED--MFMVVDLLLGGDL---RYHLQQNVHFKEETVKLFIC-ELVMA 127
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ YL + +IH D+KP NILLD + I+DF +A
Sbjct: 128 LDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAA 163
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 16/159 (10%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSL---QGEREFYNELYFASLLEQ 69
+ FS R++G+GGFG V+ D + A+K +D + QGE NE SL+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 70 DDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLH-KKPPELMEWCKRFSIAVDIA 126
D +V + + ++ + +LM+ G D H + E RF A +I
Sbjct: 249 GDCPFIVCM--SYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEADMRFYAA-EII 302
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
G+ ++H+ V++ D+KP+NILLD + +ISD GLA
Sbjct: 303 LGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLA 339
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 17 FSPSRLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFA-------SLL 67
+ + +G G G V A + +++VA+K + R F N+ A L+
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-------SRPFQNQT-HAKRAYRELVLM 78
Query: 68 EQDDH--VVSVLGFSSNPKRHRML----LVYELMSNGNLQDALLHKK-PPELMEWCKRFS 120
+ +H ++ +L + K +V ELM DA L + EL +
Sbjct: 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM------DANLCQVIQMELDHERMSY- 131
Query: 121 IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ + GI +LHS +IH D+KPSNI++ + KI DFGLAR
Sbjct: 132 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 175
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 37/166 (22%), Positives = 75/166 (45%), Gaps = 26/166 (15%)
Query: 21 RLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSL-----QGEREFYNELYFASLLEQDD-- 71
R LG G F +V+ A +++ VA+K++ + + E + + A ++D
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 72 --HVVSVLG---FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPEL-MEWCKRFSIAVDI 125
H++ +L H +++V+E++ NL + + + + + K+ + +
Sbjct: 85 ANHILKLLDHFNHKGPNGVH-VVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQI--SKQL 140
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDH------NFCAKISDFGLA 165
G+ Y+H +IH DIKP N+L++ KI+D G A
Sbjct: 141 LLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 41/170 (24%), Positives = 77/170 (45%), Gaps = 32/170 (18%)
Query: 10 LRRAADSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSL--QGEREFYNELYFAS 65
LR A+ + +++G+G FG V + A+K++ + + + F+ E
Sbjct: 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE----- 118
Query: 66 LLEQDDHVVSVLGFSSNP----------KRHRMLLVYELMSNGNLQDALLHKKPPELMEW 115
E+D ++ F+++P + +V E M G+L + + + PE
Sbjct: 119 --ERD-----IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW-- 169
Query: 116 CKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
RF A ++ + +HS+ IH D+KP N+LLD + K++DFG
Sbjct: 170 -ARFYTA-EVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTC 215
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 39/163 (23%), Positives = 71/163 (43%), Gaps = 28/163 (17%)
Query: 23 LGQGGFGSVFHATLHD----QSVAVKVM--DSGSLQGEREFYNELYFASLLEQDDH--VV 74
+G+G +G V+ A D + A+K + S+ RE +LL + H V+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE-------IALLRELKHPNVI 81
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV------DIAKG 128
S+ + ++ L+++ + +L + + + + + + I G
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 129 IAYLHSLNPPVIHGDIKPSNILL----DHNFCAKISDFGLARL 167
I YLH+ V+H D+KP+NIL+ KI+D G ARL
Sbjct: 141 IHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 32/162 (19%)
Query: 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYN----ELYFASLLEQDD--- 71
+++G+G FG V A H Q VA+K++ + E+ F+ E+ L + D
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 72 --HVVSVLG-FSSNPKRHR--MLLVYELMSNGNLQDAL-LHKKPPELMEWCKRFSIAVDI 125
+V+ +L F+ R + + +EL+S NL + + +K + ++F A I
Sbjct: 158 TMNVIHMLENFT-----FRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKF--AHSI 209
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA--KISDFGLA 165
+ + LH +IH D+KP NILL + K+ DFG +
Sbjct: 210 LQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 40/165 (24%), Positives = 68/165 (41%), Gaps = 31/165 (18%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
D F + LG G FG V + A+K++D + ++ + L +L+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 73 --VVSVLGFSSNPKRHRMLLVY----ELMSNGNLQDALLHKKPPELMEWCKRFS------ 120
+V + + M++ Y E+ S L + RFS
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFS-------HLRR--------IGRFSEPHARF 145
Query: 121 IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
A I YLHSL+ +I+ D+KP N+L+D +++DFG A
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 3e-10
Identities = 47/174 (27%), Positives = 69/174 (39%), Gaps = 49/174 (28%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSL---------QGEREFYNELYF 63
F R LG G FG V + A+KV+ + ER
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER-------- 57
Query: 64 ASLLEQDDH--VVSVLGFSSNPKRHRMLLVY----ELMSNGNLQDALLHKKPPELMEWCK 117
+L H ++ + G + ++ M++ Y EL S LL K +
Sbjct: 58 -LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-------LLRK--------SQ 101
Query: 118 RFSIAV------DIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
RF V ++ + YLHS + +I+ D+KP NILLD N KI+DFG A
Sbjct: 102 RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 44/161 (27%), Positives = 68/161 (42%), Gaps = 32/161 (19%)
Query: 21 RLLGQGGFGSVFHAT-LHD-QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLG 78
+ +G G FG + L+ + VA+K+ S + + E F L D + V
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYY 72
Query: 79 FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR-FS------IAVDIAKGIAY 131
F K + M V EL+ +L+D L + C R FS IA+ + + Y
Sbjct: 73 FGPCGKYNAM--VLELLGP-SLED---------LFDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 132 LHSLNPPVIHGDIKPSNILL------DHNFCAKISDFGLAR 166
+HS N +I+ D+KP N L+ I DF LA+
Sbjct: 121 VHSKN--LIYRDVKPENFLIGRPGNKTQQVIHII-DFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 41/164 (25%), Positives = 70/164 (42%), Gaps = 38/164 (23%)
Query: 21 RLLGQGGFGSVFHAT--LHDQSVAVKV----MDSGSLQGEREFYNELYFASLLEQDDHVV 74
R +G+G FG +F T L++Q VA+K D+ L+ E Y LL +
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYK------LLAGCTGIP 69
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR-FS------IAVDIAK 127
+V F + +LV +L+ +L+D L++ C R FS A +
Sbjct: 70 NVYYFGQEGLHN--VLVIDLLGP-SLED---------LLDLCGRKFSVKTVAMAAKQMLA 117
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAK-----ISDFGLAR 166
+ +H + +++ DIKP N L+ + DFG+ +
Sbjct: 118 RVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 6e-10
Identities = 38/168 (22%), Positives = 62/168 (36%), Gaps = 37/168 (22%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS--VAVKVM---------DSGSLQGEREFYNELYF 63
+ F +LLG+G FG V A+K++ + E
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES-------- 56
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSI-- 121
+L+ H + R+ V E + G L H + + F+
Sbjct: 57 -RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFH------LSRERVFTEER 106
Query: 122 ----AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+I + YLHS + V++ DIK N++LD + KI+DFGL
Sbjct: 107 ARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 42/175 (24%), Positives = 74/175 (42%), Gaps = 36/175 (20%)
Query: 8 SVLRRAADSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVM----DSGSLQGEREFYNEL 61
S+ R + + R +G G FG ++ T + VA+K+ L E + Y
Sbjct: 2 SMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYK-- 59
Query: 62 YFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWC-KRFS 120
+++ + ++ + + ++V EL+ +L+D L +C ++FS
Sbjct: 60 ----MMQGGVGIPTIRWCGAEGDYN--VMVMELLGP-SLED---------LFNFCSRKFS 103
Query: 121 ------IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAK---ISDFGLAR 166
+A + I Y+HS N IH D+KP N L+ I DFGLA+
Sbjct: 104 LKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 30/162 (18%)
Query: 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYN----ELYFASLLEQDD--- 71
L+G+G FG V A + VA+K++ + ++ F N E+ L+ + D
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-----KKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 72 --HVVSVLG-FSSNPKRHR--MLLVYELMSNGNLQDAL-LHKKPPELMEWCKRFSIAVDI 125
++V + F R + LV+E++S NL D L + ++F A +
Sbjct: 115 KYYIVHLKRHFM-----FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKF--AQQM 166
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA--KISDFGLA 165
+ +L + +IH D+KP NILL + + KI DFG +
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 36/172 (20%), Positives = 66/172 (38%), Gaps = 29/172 (16%)
Query: 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYN----ELYFASLLEQDD--- 71
R +G G FG V + AVKV+ + +++ E ++ DD
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINN 95
Query: 72 -HVVSVLG-FSSNPKRHR--MLLVYELMSNGNLQDAL-LHKKPPELMEWCKRFSIAVDIA 126
++V G F + M L++E + +L + + + +E K + ++I
Sbjct: 96 NNIVKYHGKFM-----YYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLY--CIEIL 147
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQAD 178
K + YL ++ + H D+KP NILLD + K +
Sbjct: 148 KALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 20/47 (42%), Positives = 25/47 (53%), Gaps = 2/47 (4%)
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+ +AKG+ +L S IH D+ NILL KI DFGLAR
Sbjct: 197 CYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 38/164 (23%), Positives = 65/164 (39%), Gaps = 18/164 (10%)
Query: 21 RLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSLQGER-EFYNELYFASLLEQDDH 72
+ LG+G FG V A ++VAVK++ G+ E +EL + +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYL 132
VV++LG + P M++V E GNL L K+ E+ + +G Y+
Sbjct: 88 VVNLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRN----EFVPYKTKGARFRQGKDYV 142
Query: 133 HSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQ 176
+ I D+K + + + S F + S E +
Sbjct: 143 GA-----IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 46/230 (20%), Positives = 77/230 (33%), Gaps = 20/230 (8%)
Query: 21 RLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDD------- 71
R LG G F +V+ + + VA+KV+ S E +E+ + D
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNRE 101
Query: 72 HVVSVLG-FS-SNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
VV +L F S + +V+E++ + +L + K + + I + +G+
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGH-HLLK-WIIKSNYQGLPLPCVKKIIQQVLQGL 159
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGENKNKAAELE 189
YLH+ +IH DIKP NILL N A + A
Sbjct: 160 DYLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 190 SNCGAAVEDCGSVVETESVNTTTTATAFEDLSVGIDQ-----SPETFLKM 234
+ +E + + A Q S E +
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS 268
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 6e-09
Identities = 41/173 (23%), Positives = 71/173 (41%), Gaps = 43/173 (24%)
Query: 15 DSFSPSRLLGQGGFGSVF---HATLHDQSV--AVKVMDSGSLQGEREFYNELYFASLLEQ 69
+ F R+LG+GG+G VF T + A+KV+ A ++
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK---------------AMIVRN 61
Query: 70 DDHVVS------VLGFSSNP----------KRHRMLLVYELMSNGNLQDALLH-KKPPEL 112
+L +P ++ L+ E +S G L + ++
Sbjct: 62 AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIF 118
Query: 113 MEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
ME F +A +I+ + +LH +I+ D+KP NI+L+H K++DFGL
Sbjct: 119 MEDTACFYLA-EISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 41/163 (25%), Positives = 62/163 (38%), Gaps = 26/163 (15%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQSV--AVKVM---------DSGSLQGEREFYNELYF 63
+ F +LLG+G FG V A+K++ + E
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN-------- 199
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLH-KKPPELMEWCKRFSIA 122
+L+ H S R+ V E + G L H + E RF A
Sbjct: 200 -RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGA 255
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+I + YLHS V++ D+K N++LD + KI+DFGL
Sbjct: 256 -EIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLC 296
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 37/169 (21%), Positives = 65/169 (38%), Gaps = 31/169 (18%)
Query: 21 RLLGQGGFGSVFHAT---LHDQSVAVKVMDSGSLQGEREFYN----ELYFASLLEQDD-- 71
LG+G FG V + VAVK+ ++ + E+ L D
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKI-----VKNVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 72 ---HVVSVLG-FSSNPKRHR--MLLVYELMSNGNLQDAL-LHKKPPELMEWCKRFSIAVD 124
V +L F H + +V+EL+ + D + + P ++ ++ A
Sbjct: 75 STFRCVQMLEWFE-----HHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKM--AYQ 126
Query: 125 IAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGEN 173
I K + +LHS + H D+KP NIL + + + + R + N
Sbjct: 127 ICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 39/163 (23%), Positives = 64/163 (39%), Gaps = 26/163 (15%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVM---------DSGSLQGEREFYNELYF 63
F+ +LG+G FG V + + AVK++ D E+
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV------ 394
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLH-KKPPELMEWCKRFSIA 122
L S R+ V E ++ G+L + H ++ E F A
Sbjct: 395 --LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAA 449
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+IA G+ +L S +I+ D+K N++LD KI+DFG+
Sbjct: 450 -EIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMC 489
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 39/163 (23%), Positives = 63/163 (38%), Gaps = 26/163 (15%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS--VAVKVM---------DSGSLQGEREFYNELYF 63
F+ +LG+G FG V + AVK++ D E+
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV------ 73
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLH-KKPPELMEWCKRFSIA 122
L S R+ V E ++ G+L + H ++ E F A
Sbjct: 74 --LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAA 128
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+IA G+ +L S +I+ D+K N++LD KI+DFG+
Sbjct: 129 -EIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 40/183 (21%), Positives = 72/183 (39%), Gaps = 44/183 (24%)
Query: 15 DSFSPSRLLGQGGFGSVF---HATLHDQSV--AVKVMDSGSLQGEREFYNELYFASLLEQ 69
++F ++LG G +G VF + HD A+KV+ A+++++
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK---------------ATIVQK 98
Query: 70 DDHVVS------VLGFSSNP----KRH-------RMLLVYELMSNGNLQDALLH-KKPPE 111
VL H ++ L+ + ++ G L H +
Sbjct: 99 AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL---FTHLSQRER 155
Query: 112 LMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVG 171
E + + +I + +LH L +I+ DIK NILLD N ++DFGL++
Sbjct: 156 FTEHEVQIYVG-EIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212
Query: 172 ENQ 174
E +
Sbjct: 213 ETE 215
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 2e-08
Identities = 46/171 (26%), Positives = 74/171 (43%), Gaps = 41/171 (23%)
Query: 15 DSFSPSRLLGQGGFGSVF---HATLHDQSV--AVKVMDSGSLQGEREFYNELYFASLLEQ 69
F ++LGQG FG VF + D A+KV+ A+L +
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK---------------ATLKVR 68
Query: 70 DD-HVVS---VLGFSSNP---KRH-------RMLLVYELMSNGNLQDALLH-KKPPELME 114
D +L ++P K H ++ L+ + + G+L K E
Sbjct: 69 DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTE 125
Query: 115 WCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+F +A ++A + +LHSL +I+ D+KP NILLD K++DFGL+
Sbjct: 126 EDVKFYLA-ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 40/163 (24%), Positives = 69/163 (42%), Gaps = 26/163 (15%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQSV--AVKVM---------DSGSLQGEREFYNELYF 63
F R++G+G + V L A+KV+ D +Q E+
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV------ 62
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLH-KKPPELMEWCKRFSIA 122
+ +H V S R+ V E ++ G+L + H ++ +L E RF A
Sbjct: 63 --FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSA 117
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+I+ + YLH +I+ D+K N+LLD K++D+G+
Sbjct: 118 -EISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 47/163 (28%), Positives = 72/163 (44%), Gaps = 26/163 (15%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQSV--AVKVM---------DSGSLQGEREFYNELYF 63
F +++G+G FG V A + V AVKV+ + + ER
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV------ 91
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLH-KKPPELMEWCKRFSIA 122
LL+ H V S ++ V + ++ G L H ++ +E RF A
Sbjct: 92 --LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAA 146
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+IA + YLHSLN +++ D+KP NILLD ++DFGL
Sbjct: 147 -EIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLC 186
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 31/169 (18%), Positives = 64/169 (37%), Gaps = 31/169 (18%)
Query: 21 RLLGQGGFGSVFHATLHDQS---VAVKVMDSGSLQGEREFYN----ELYFASLLEQDD-- 71
LG+G FG V H + VA+K++ + ++ E+ +++ D
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKE 79
Query: 72 ---HVVSVLG-FSSNPKRHR--MLLVYELMSNGNLQDAL-LHKKPPELMEWCKRFSIAVD 124
V + F+ M + +EL+ N + L + P + + A
Sbjct: 80 NKFLCVLMSDWFN-----FHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHM--AYQ 131
Query: 125 IAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGEN 173
+ + +LH + H D+KP NIL ++ + + + + +N
Sbjct: 132 LCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN 178
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 41/162 (25%), Positives = 69/162 (42%), Gaps = 36/162 (22%)
Query: 21 RLLGQGGFGSVFHAT--LHDQSVAVKVM----DSGSLQGEREFYNELYFASLLEQDDHVV 74
R +G G FG ++ T ++ VA+K+ L E + Y +L+ +
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYR------ILQGGTGIP 66
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKR-FS------IAVDIAK 127
+V F + +LV +L+ +L+D L +C R S +A +
Sbjct: 67 NVRWFGVEGDYN--VLVMDLLGP-SLED---------LFNFCSRKLSLKTVLMLADQMIN 114
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAK---ISDFGLAR 166
+ ++HS + +H DIKP N L+ A I DFGLA+
Sbjct: 115 RVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 4e-08
Identities = 43/168 (25%), Positives = 69/168 (41%), Gaps = 36/168 (21%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS--VAVKVM---------DSGSLQGEREFYNELYF 63
D+F R+LG+G FG V A + + AVKV+ D E+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRI------ 76
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFS--- 120
L +H F R+ V E ++ G+L + H ++ +RF
Sbjct: 77 --LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFH------IQKSRRFDEAR 125
Query: 121 ---IAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
A +I + +LH +I+ D+K N+LLDH K++DFG+
Sbjct: 126 ARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 39/163 (23%), Positives = 69/163 (42%), Gaps = 26/163 (15%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQSV--AVKVM---------DSGSLQGEREFYNELYF 63
F R++G+G + V L A++V+ D +Q E+
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV------ 105
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLH-KKPPELMEWCKRFSIA 122
+ +H V S R+ V E ++ G+L + H ++ +L E RF A
Sbjct: 106 --FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSA 160
Query: 123 VDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+I+ + YLH +I+ D+K N+LLD K++D+G+
Sbjct: 161 -EISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMC 200
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 41/168 (24%), Positives = 71/168 (42%), Gaps = 36/168 (21%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS--VAVKVM---------DSGSLQGEREFYNELYF 63
+ F ++LG+G FG VF A + A+K + D E+
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV------ 70
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSI-- 121
L +H F + + + V E ++ G+L + H ++ C +F +
Sbjct: 71 --LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYH------IQSCHKFDLSR 119
Query: 122 ----AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
A +I G+ +LHS +++ D+K NILLD + KI+DFG+
Sbjct: 120 ATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMC 165
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 3e-07
Identities = 83/569 (14%), Positives = 163/569 (28%), Gaps = 156/569 (27%)
Query: 68 EQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQ-----DALLHKKPPELME-WCKRFSI 121
E+ DH++ S + + L + L+S + +L LM
Sbjct: 49 EEIDHIIM----SKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQ 104
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGEN 181
+ + Y+ + ++ D + + + ++RL+ +
Sbjct: 105 PSMMTR--MYIEQRDR--LYNDNQV------------FAKYNVSRLQPYLKL-------- 140
Query: 182 KNKAAELESNCGAAVED---CG-SVVETESVNTTTTATAFED----LSVGIDQSPETFLK 233
+ EL ++ G + V + + + L++ SPET L+
Sbjct: 141 RQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE 200
Query: 234 MTQK-QTQSTEALEKKASVDENVKEDVKVKEYVIEWIGTAIGNER-PKS----D--W--- 282
M QK Q ++ N+K + + + + ++
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRI---HSIQAELRRLLKSKPYENCLLVLLNVQNAK 257
Query: 283 ------IG-------RDTGSSSSVGGKVDRKKSRKRLDWWVSLDEDKE-------ENVKN 322
+ R + + S ++ DE K ++
Sbjct: 258 AWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD 317
Query: 323 LKRE---------------RRRRPAREW--WKEEYCEELAKKKKKKKRALGTNS------ 359
L RE R A W WK C++L + L
Sbjct: 318 LPREVLTTNPRRLSIIAESIRDGLAT-WDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFD 376
Query: 360 -----DDD-----------WW---PRDEELYVER-KKKS---KTRSRSRSSIGSLDWWLE 396
W+ D + V + K S K S SI S+ L+
Sbjct: 377 RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK 436
Query: 397 GFSGELYRARH----NSYDSAASGEIPKS--GGVTSTPSMRGTVCYVAPEYG---AGGDI 447
Y A H + Y IPK+ P + Y G +
Sbjct: 437 VKLENEY-ALHRSIVDHY------NIPKTFDSDDLIPPYLDQ---YFYSHIGHHLKNIEH 486
Query: 448 SEKCD----VY-SYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSWARHLARNGKLIELV 502
E+ V+ + L + +GS ++ Q+ L + ++ N E +
Sbjct: 487 PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQ--LKFYKPYICDNDPKYERL 544
Query: 503 DQAVVKSLDR-EQALLC------ITVALL 524
A++ L + E+ L+C + +AL+
Sbjct: 545 VNAILDFLPKIEENLICSKYTDLLRIALM 573
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 2e-04
Identities = 30/205 (14%), Positives = 53/205 (25%), Gaps = 38/205 (18%)
Query: 54 EREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKK----- 108
N+L+ SL+E+ + +Y + + LH+
Sbjct: 404 VMVVVNKLHKYSLVEKQ----------PKESTISIPSIYLELKVKLENEYALHRSIVDHY 453
Query: 109 -PPELMEWCKRFSIAVD--IAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC-AKISDFGL 164
P+ + +D I + H N + LD F KI
Sbjct: 454 NIPKTFDSDDLIPPYLDQYFYSHIGH-HLKNIEHPERMTLFRMVFLDFRFLEQKIRHDST 512
Query: 165 ARLKSVGENQNQAD--------GENKNKAAELESNCGAAVEDCGS-VVETESVNTTTTAT 215
A S +N K L + + ++ ++ + A
Sbjct: 513 AWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIAL 572
Query: 216 AFEDLSVGIDQSPETFLKMTQKQTQ 240
ED E + KQ Q
Sbjct: 573 MAED---------EAIFEEAHKQVQ 588
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 2e-05
Identities = 13/59 (22%), Positives = 25/59 (42%), Gaps = 11/59 (18%)
Query: 331 PAREWWKEEYCEELAKK----KKKKK--RALGTNSDDDWWPRDEELYVERKKKSKTRSR 383
R+W +EE + L + K ++ R ++W R E+ +K+K +R
Sbjct: 86 SIRKW-REEQRKRLQELDAASKVMEQEWREKAKKDLEEWNQR----QSEQVEKNKINNR 139
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 2e-05
Identities = 15/79 (18%), Positives = 32/79 (40%), Gaps = 21/79 (26%)
Query: 299 RKKSRKRLDWWVSLDEDKEENVKNLKRERRRRPAREW--WKEEYCEELAKKKKKKKRALG 356
R++ RKRL ++ + K +++E R + ++ W + E++ K K + A
Sbjct: 91 REEQRKRL-------QELDAASKVMEQEWREKAKKDLEEWNQRQSEQVEKNKINNRIA-- 141
Query: 357 TNSDDDWWPRDEELYVERK 375
D+ Y +
Sbjct: 142 ----------DKAFYQQPD 150
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 576 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.49 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.92 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.8 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.35 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.25 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.16 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.13 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.13 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.86 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.83 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.58 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.55 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.31 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.28 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.15 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.06 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.99 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.72 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.4 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.24 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.15 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.12 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.79 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.43 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.33 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.92 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.06 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.54 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=417.72 Aligned_cols=149 Identities=30% Similarity=0.550 Sum_probs=128.8
Q ss_pred CCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
++|.+.++||+|+||.||+|++. +..||||+++.......+.|.+|+.+++.|+| |||++++++|... ..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-pnIV~l~g~~~~~--~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH-QHIVRFFGVCTEG--RP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSS--SS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEEC--CE
Confidence 46777899999999999999864 57899999987666667789999999999977 9999999999876 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCC------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC
Q 036407 88 MLLVYELMSNGNLQDALLHKKP------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF 155 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g 155 (576)
+|||||||++|+|.+++..... ...+++.+++.|+.||+.||.|||+++ |+||||||+||||+.++
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCCC
Confidence 9999999999999999976431 124788999999999999999999999 99999999999999999
Q ss_pred cEEEccccccccc
Q 036407 156 CAKISDFGLARLK 168 (576)
Q Consensus 156 ~vKLiDFGlA~~~ 168 (576)
.+||+|||+++..
T Consensus 196 ~~Ki~DFGla~~~ 208 (329)
T 4aoj_A 196 VVKIGDFGMSRDI 208 (329)
T ss_dssp EEEECCCC-----
T ss_pred cEEEcccccceec
Confidence 9999999999754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=415.04 Aligned_cols=150 Identities=31% Similarity=0.520 Sum_probs=131.4
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
.++|.+.+.||+|+||.||+|++. +..||||+++.......+.|.+|+.+++.|+| |||++++++|... +
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-pnIV~l~g~~~~~--~ 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH-EHIVKFYGVCVEG--D 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSS--S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCC-CCCccEEEEEeeC--C
Confidence 357888999999999999999863 57899999987666667789999999999976 9999999999876 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcC----------CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc
Q 036407 87 RMLLVYELMSNGNLQDALLHKK----------PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC 156 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~----------~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~ 156 (576)
.+|||||||++|+|.+++.... ....+++.+++.|+.||+.||.|||+++ |+||||||+||||+.++.
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCCCc
Confidence 8999999999999999997642 1234789999999999999999999999 999999999999999999
Q ss_pred EEEccccccccc
Q 036407 157 AKISDFGLARLK 168 (576)
Q Consensus 157 vKLiDFGlA~~~ 168 (576)
+||+|||+|+..
T Consensus 167 ~Ki~DFGla~~~ 178 (299)
T 4asz_A 167 VKIGDFGMSRDV 178 (299)
T ss_dssp EEECCCSCHHHH
T ss_pred EEECCcccceec
Confidence 999999999754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=416.90 Aligned_cols=149 Identities=19% Similarity=0.326 Sum_probs=126.9
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
.++|++++.||+|+||.||+|+.. ++.||||++..... ...+.+.+|+.+++.|.| |||+++++++... +.+|
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIV~~~~~~~~~--~~~y 99 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH-PNIVQYRESFEEN--GSLY 99 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEET--TEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCC-CCCCcEEEEEEEC--CEEE
Confidence 478999999999999999999976 89999999976543 334678999999999987 9999999999876 8899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||||||+||+|.+++..... ..+++..++.|+.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+|+..
T Consensus 100 iVmEy~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred EEEeCCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceee
Confidence 99999999999999976543 23678889999999999999999999 999999999999999999999999999754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=408.38 Aligned_cols=149 Identities=28% Similarity=0.466 Sum_probs=128.7
Q ss_pred CCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
+++++.+.||+|+||.||+|++. ++.||||+++... ....+.|.+|+.++++|+| |||++++++|... .
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~H-pNIV~l~g~~~~~--~ 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH-PNVVCLLGVVTKD--Q 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCC-TTBCCEEEEECSS--S
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCC-CCCCCcceEEEEC--C
Confidence 45678899999999999999863 5789999997533 2335689999999999977 9999999999876 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCC-------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC
Q 036407 87 RMLLVYELMSNGNLQDALLHKKP-------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH 153 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~-------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~ 153 (576)
.++||||||++|+|.+++..... ...+++..++.|+.||+.||.|||+++ |+||||||+||||+.
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYD 180 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECG
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEECC
Confidence 78999999999999999965321 123788899999999999999999999 999999999999999
Q ss_pred CCcEEEccccccccc
Q 036407 154 NFCAKISDFGLARLK 168 (576)
Q Consensus 154 ~g~vKLiDFGlA~~~ 168 (576)
++.+||+|||+++..
T Consensus 181 ~~~~Ki~DFGlar~~ 195 (308)
T 4gt4_A 181 KLNVKISDLGLFREV 195 (308)
T ss_dssp GGCEEECCSCCBCGG
T ss_pred CCCEEECCcccceec
Confidence 999999999998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=403.52 Aligned_cols=150 Identities=29% Similarity=0.474 Sum_probs=129.2
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
+...++|.+.+.||+|+||+||+|++.+ .||||+++... ....+.|.+|+.+++.|+| |||+.+++++.. +.+
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~H-pNIV~l~g~~~~---~~~ 106 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRH-VNILLFMGYMTK---DNL 106 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECS---SSC
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEC---CeE
Confidence 3445788899999999999999998765 58999997533 2334679999999999977 999999998854 457
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||||||++|+|.+++..... .+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEEEcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 999999999999999976443 2788999999999999999999999 999999999999999999999999999754
Q ss_pred c
Q 036407 169 S 169 (576)
Q Consensus 169 ~ 169 (576)
.
T Consensus 183 ~ 183 (307)
T 3omv_A 183 S 183 (307)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=412.06 Aligned_cols=146 Identities=29% Similarity=0.404 Sum_probs=132.5
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
+.|++++.||+|+||.||+|+.. |+.||||++........+.+.+|+.+++.|.| |||+++++++... +.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~~--~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVG--DELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCC-TTBCCEEEEEEET--TEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEEC--CEEEEEE
Confidence 46999999999999999999986 78999999986555556678999999999977 9999999999877 8899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|||+||+|.+++.... +++..+..|+.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+|+.+.
T Consensus 151 Ey~~gg~L~~~l~~~~----l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 151 EFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 221 (346)
T ss_dssp CCCTTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eCCCCCcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecC
Confidence 9999999999887532 788899999999999999999999 9999999999999999999999999997653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=409.15 Aligned_cols=145 Identities=23% Similarity=0.314 Sum_probs=127.5
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
..+.|++.++||+|+||.||+|+.. ++.||||+++.... ..+|+.+++.|.| |||+++++++... ..+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~H-pnIV~l~~~~~~~--~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSS-PRIVPLYGAVREG--PWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCC-TTBCCEEEEEEET--TEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCC-CCCCcEEEEEEEC--CEEEE
Confidence 3456788899999999999999976 78999999976433 2468999999977 9999999999876 88999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC-cEEEcccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF-CAKISDFGLARLKS 169 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g-~vKLiDFGlA~~~~ 169 (576)
|||||+||+|.+++...+. +++..+..|+.||+.||.|||+++ |+||||||+||||+.+| .+||+|||+|+...
T Consensus 128 vmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGC---LPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp EECCCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred EEeccCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 9999999999999987654 788999999999999999999999 99999999999999988 69999999998654
Q ss_pred C
Q 036407 170 V 170 (576)
Q Consensus 170 ~ 170 (576)
.
T Consensus 203 ~ 203 (336)
T 4g3f_A 203 P 203 (336)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=412.28 Aligned_cols=159 Identities=30% Similarity=0.467 Sum_probs=135.6
Q ss_pred HHHHhhcCCCCccceeeccCcEEEEEEEECC-------ceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEE
Q 036407 8 SVLRRAADSFSPSRLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGF 79 (576)
Q Consensus 8 ~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~g-------~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~ 79 (576)
+.++...++|++.+.||+|+||.||+|.+.+ +.||||.+..... .....+.+|+.++..+.|||||++++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3455566889999999999999999998652 5799999976543 3346799999999999999999999999
Q ss_pred eeCCCCCeEEEEEeccCCCCHHHHHHhcCC-------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCC
Q 036407 80 SSNPKRHRMLLVYELMSNGNLQDALLHKKP-------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKP 146 (576)
Q Consensus 80 ~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~-------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKP 146 (576)
|..+ ...+|||||||++|+|.+++..... ...+++..++.|+.||+.||.|||+++ ||||||||
T Consensus 137 ~~~~-~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~ 213 (353)
T 4ase_A 137 CTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 213 (353)
T ss_dssp ECCT-TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EEec-CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCc
Confidence 8754 2568999999999999999975321 234788899999999999999999999 99999999
Q ss_pred CCeEEcCCCcEEEcccccccccc
Q 036407 147 SNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 147 eNILLd~~g~vKLiDFGlA~~~~ 169 (576)
+|||++.++.+||+|||+|+...
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~ 236 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIY 236 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTT
T ss_pred cceeeCCCCCEEECcchhhhhcc
Confidence 99999999999999999998543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=404.79 Aligned_cols=149 Identities=23% Similarity=0.376 Sum_probs=133.4
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
..++|++.+.||+|+||+||+|+.. ++.||||++.+... .....+.+|+.+++.|.| |||+++++++... ..
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~--~~ 106 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLYFTFQDD--EK 106 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECS--SE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeC--CE
Confidence 3467999999999999999999976 78999999975322 234678999999999976 9999999999876 88
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+|||||||+||+|.+++...+. +++..+..|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~---l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~ 181 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKV 181 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence 9999999999999999987554 788999999999999999999999 99999999999999999999999999986
Q ss_pred cc
Q 036407 168 KS 169 (576)
Q Consensus 168 ~~ 169 (576)
+.
T Consensus 182 ~~ 183 (311)
T 4aw0_A 182 LS 183 (311)
T ss_dssp CC
T ss_pred cC
Confidence 54
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=395.71 Aligned_cols=146 Identities=28% Similarity=0.373 Sum_probs=126.7
Q ss_pred CccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeC--CCCCeEEEE
Q 036407 18 SPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSN--PKRHRMLLV 91 (576)
Q Consensus 18 ~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~--~s~~~l~LV 91 (576)
++.+.||+|+||.||+|+.. +..||||.+.... ....+.+.+|+.+++.|.| |||+++++++.. .....+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEeeccCCCcEEEEE
Confidence 66778999999999999976 7889999997533 2335678999999999987 999999998864 234678999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC-CCcEEEcccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH-NFCAKISDFGLARL 167 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~-~g~vKLiDFGlA~~ 167 (576)
||||++|+|.+++..... +++..+..|+.||+.||.|||+++++|+||||||+||||+. +|.+||+|||+|+.
T Consensus 108 mEy~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 999999999999987543 78888999999999999999998877999999999999984 79999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=414.55 Aligned_cols=146 Identities=29% Similarity=0.404 Sum_probs=133.2
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
+.|++++.||+|+||.||+|+.. |+.||||++........+.+.+|+.+|+.|.| |||+++++++... +.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~~--~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVG--DELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCC-TTBCCEEEEEEET--TEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCC-CCCCceEEEEEEC--CEEEEEE
Confidence 56999999999999999999976 79999999987666666778999999999977 9999999999876 7899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|||+||+|.+++.... +++..+..|+.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+|+.+.
T Consensus 228 Ey~~gG~L~~~i~~~~----l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 228 EFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp ECCTTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred eCCCCCcHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 9999999999887543 788899999999999999999999 9999999999999999999999999997653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=394.08 Aligned_cols=151 Identities=26% Similarity=0.388 Sum_probs=124.3
Q ss_pred cCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC--CeEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR--HRMLLV 91 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~--~~l~LV 91 (576)
..+|.+.+.||+|+||.||+|+++|+.||||+++.... ....+..|+..+..++| |||+.+++++..... ..+|||
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~H-pNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-RSWFREAEIYQTVMLRH-ENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch-hhHHHHHHHHHHhcCCC-CCCCcEEEEEEecCCCceEEEEE
Confidence 34678899999999999999999999999999964322 12223445555566766 999999999976432 468999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhC------CCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL------NPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~------g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
||||++|+|.+++.... +++..+..++.|++.||.|||++ .++|+||||||+||||+.++.+||+|||++
T Consensus 80 ~Ey~~~gsL~~~l~~~~----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCcHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999997643 67888899999999999999976 123999999999999999999999999999
Q ss_pred ccccC
Q 036407 166 RLKSV 170 (576)
Q Consensus 166 ~~~~~ 170 (576)
+....
T Consensus 156 ~~~~~ 160 (303)
T 3hmm_A 156 VRHDS 160 (303)
T ss_dssp EEEET
T ss_pred ccccC
Confidence 86543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=387.78 Aligned_cols=146 Identities=26% Similarity=0.474 Sum_probs=123.9
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
.++|++.+.||+|+||.||+|+.. ++.||||++++... .....+.+|+.+++.+.| |||+++++++... +.+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~--~~~ 88 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH-PHIIKLYDVIKSK--DEI 88 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCC-TTBCCEEEEEECS--SEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEEC--CEE
Confidence 378999999999999999999875 89999999976432 234578999999999976 9999999999876 889
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||||||| +|+|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~~---l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSCS---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred EEEEeCC-CCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeec
Confidence 9999999 6799999877554 788999999999999999999999 999999999999999999999999998743
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=393.43 Aligned_cols=147 Identities=27% Similarity=0.362 Sum_probs=124.4
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-----CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
.++|++++.||+|+||+||+|+.. ++.||||++++... .....+.+|+.++..|.| |||+++++++... +
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~--~ 99 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH-PFIVKLHYAFQTE--G 99 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCC-TTEECEEEEEEET--T
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEEC--C
Confidence 357999999999999999999862 57899999975432 223467889999999977 9999999999876 8
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+|||||||+||+|.+++..... +++..+..|+.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVM---FTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccce
Confidence 89999999999999999987654 788899999999999999999999 9999999999999999999999999997
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 175 ~~ 176 (304)
T 3ubd_A 175 ES 176 (304)
T ss_dssp C-
T ss_pred ec
Confidence 43
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=384.84 Aligned_cols=153 Identities=27% Similarity=0.400 Sum_probs=126.0
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC-------
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPK------- 84 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s------- 84 (576)
++|++++.||+|+||.||+|+.. ++.||||+++.... ...+.+.+|+.+++.|.| |||+++++++...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~H-pnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-PGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEecCccccccc
Confidence 46899999999999999999976 88999999975443 334678999999999976 99999999886432
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcc
Q 036407 85 ---RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISD 161 (576)
Q Consensus 85 ---~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiD 161 (576)
..++|||||||++|+|.+++.........++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEcc
Confidence 2358999999999999999987654333455668889999999999999999 99999999999999999999999
Q ss_pred ccccccccC
Q 036407 162 FGLARLKSV 170 (576)
Q Consensus 162 FGlA~~~~~ 170 (576)
||+|+....
T Consensus 162 FGla~~~~~ 170 (299)
T 4g31_A 162 FGLVTAMDQ 170 (299)
T ss_dssp CCCC-----
T ss_pred CccceecCC
Confidence 999986654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=376.84 Aligned_cols=151 Identities=21% Similarity=0.338 Sum_probs=131.9
Q ss_pred HHHHhhcCCCCccceeeccCcEEEEEEEEC-----CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 8 SVLRRAADSFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 8 ~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
+.+..+.+.|++.+.||+|+||.||+|+.+ ++.||||.+.... ...++.+|+.++..+.+||||+.+++++..
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 334567789999999999999999999753 5789999986543 345788999999999878999999999887
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC-CcEEEcc
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN-FCAKISD 161 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~-g~vKLiD 161 (576)
. +++|||||||++|+|.+++.. +++..+..|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|
T Consensus 92 ~--~~~~lvmE~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 92 N--DHVVIAMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp T--TEEEEEEECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECC
T ss_pred C--CEEEEEEeCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECc
Confidence 6 899999999999999998842 678889999999999999999999 9999999999999876 7999999
Q ss_pred ccccccccC
Q 036407 162 FGLARLKSV 170 (576)
Q Consensus 162 FGlA~~~~~ 170 (576)
||+|+....
T Consensus 162 FGla~~~~~ 170 (361)
T 4f9c_A 162 FGLAQGTHD 170 (361)
T ss_dssp CTTCEECTT
T ss_pred CCCCcccCC
Confidence 999986554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=380.71 Aligned_cols=150 Identities=26% Similarity=0.458 Sum_probs=129.7
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCC----C
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNP----K 84 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~----s 84 (576)
+.++|++++.||+|+||.||+|+.. |+.||||++.... ......+.+|+.+|+.|.| |||+.+++++... .
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH-DNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCC-CCcceEeeeeeccccccc
Confidence 3468999999999999999999976 8999999996543 2334578899999999976 9999999987642 3
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
...+|||||||+ |+|.+++..... +++..+..|+.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~---l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQP---LTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSC---CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecce
Confidence 478999999995 689998876543 788899999999999999999999 99999999999999999999999999
Q ss_pred ccccc
Q 036407 165 ARLKS 169 (576)
Q Consensus 165 A~~~~ 169 (576)
|+.+.
T Consensus 205 a~~~~ 209 (398)
T 4b99_A 205 ARGLC 209 (398)
T ss_dssp CBCC-
T ss_pred eeecc
Confidence 97543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=387.72 Aligned_cols=150 Identities=25% Similarity=0.381 Sum_probs=134.2
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
+.++|++.+.||+|+||.||+|+.. |+.||||++........+.+.+|+.+|+.|.| |||+++++++... ..+||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~--~~~~i 231 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PTLVNLHDAFEDD--NEMVM 231 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCC-TTBCCEEEEEECS--SEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCC-CCCCeEEEEEEEC--CEEEE
Confidence 4578999999999999999999976 78999999987766667789999999999977 9999999999876 89999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC--CcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN--FCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~--g~vKLiDFGlA~~~ 168 (576)
|||||+||+|.+++..... .+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 232 v~E~~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EEECCCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EEeecCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 9999999999998865432 2888999999999999999999999 9999999999999854 89999999999865
Q ss_pred c
Q 036407 169 S 169 (576)
Q Consensus 169 ~ 169 (576)
.
T Consensus 308 ~ 308 (573)
T 3uto_A 308 D 308 (573)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=357.53 Aligned_cols=287 Identities=34% Similarity=0.563 Sum_probs=237.6
Q ss_pred CCCChHHHHhhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEee
Q 036407 3 HRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSS 81 (576)
Q Consensus 3 ~~fs~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~ 81 (576)
.++++.++...+++|++.+.||+|+||.||+|+.. ++.||||.+..........+.+|+.++..+.| +||+.+++++.
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~ 105 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRH-PHLVSLIGFCD 105 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCC-TTBCCEEEECC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCC-CCEeeEEEEEc
Confidence 35677778889999999999999999999999976 78999999976665666789999999999976 99999999987
Q ss_pred CCCCCeEEEEEeccCCCCHHHHHHhcCC-CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEc
Q 036407 82 NPKRHRMLLVYELMSNGNLQDALLHKKP-PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKIS 160 (576)
Q Consensus 82 ~~s~~~l~LVmE~~~gGsL~d~L~~~~~-~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLi 160 (576)
.. ..+++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+
T Consensus 106 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 106 ER--NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp CT--TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEEC
T ss_pred CC--CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEe
Confidence 65 788999999999999998865432 223788899999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCcCcCCCCccccchhhhccCCCCCCCCcceecccccccccccccccccccccCcchhHhhhhcccch
Q 036407 161 DFGLARLKSVGENQNQADGENKNKAAELESNCGAAVEDCGSVVETESVNTTTTATAFEDLSVGIDQSPETFLKMTQKQTQ 240 (576)
Q Consensus 161 DFGlA~~~~~~~~~~~~~gt~~y~APEl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (576)
|||++........
T Consensus 182 Dfg~~~~~~~~~~------------------------------------------------------------------- 194 (321)
T 2qkw_B 182 DFGISKKGTELDQ------------------------------------------------------------------- 194 (321)
T ss_dssp CCTTCEECSSSSC-------------------------------------------------------------------
T ss_pred ecccccccccccc-------------------------------------------------------------------
Confidence 9999875332100
Q ss_pred hHHHHhhhcccccccchhhhhHHHHHHHHhhhcCCCCCCCCcccCCCCCcccccccccccccccccccccccchhHHHHH
Q 036407 241 STEALEKKASVDENVKEDVKVKEYVIEWIGTAIGNERPKSDWIGRDTGSSSSVGGKVDRKKSRKRLDWWVSLDEDKEENV 320 (576)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (576)
T Consensus 195 -------------------------------------------------------------------------------- 194 (321)
T 2qkw_B 195 -------------------------------------------------------------------------------- 194 (321)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred HhhhhhhccccccchhhhHHHHHHHHHHHhhhhccCCCCCCCCCCCChhhHHHHhccccccccccCCCCCcccccccccc
Q 036407 321 KNLKRERRRRPAREWWKEEYCEELAKKKKKKKRALGTNSDDDWWPRDEELYVERKKKSKTRSRSRSSIGSLDWWLEGFSG 400 (576)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (576)
T Consensus 195 -------------------------------------------------------------------------------- 194 (321)
T 2qkw_B 195 -------------------------------------------------------------------------------- 194 (321)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred hhhhhhccccCccccCCCCCCCcceeeccccCccccccccccCCCCcccccceeehhHHHHHHHhCCCCccccCCCchhh
Q 036407 401 ELYRARHNSYDSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEF 480 (576)
Q Consensus 401 ~~~~~~~~~~d~~~~~~i~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~G~~l~eli~g~~pf~~~~~~~~~~ 480 (576)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 195 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~---- 247 (321)
T 2qkw_B 195 -----------------------THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR---- 247 (321)
T ss_dssp -----------------------CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS----
T ss_pred -----------------------cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH----
Confidence 00012346899999999998899999999999999999999999999764432
Q ss_pred hhhhHHHHHHHhccccchhhhhhhHHhhhcCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhccccC
Q 036407 481 QRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGMLTGKLE 548 (576)
Q Consensus 481 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~Rps~~~v~~~l~~~~e 548 (576)
...+...|.........+...+++.+.......++..+.+++.+||+.||.+|||+.||++.|+.++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 248 EMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 23345666665556666667777766667778899999999999999999999999999999987754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=354.95 Aligned_cols=286 Identities=40% Similarity=0.657 Sum_probs=237.9
Q ss_pred CCCChHHHHhhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCch-hHHHHHHHHHHHHHhccCCceEEEEEEe
Q 036407 3 HRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQ-GEREFYNELYFASLLEQDDHVVSVLGFS 80 (576)
Q Consensus 3 ~~fs~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~-~~~~~l~EI~iLs~L~h~pNIv~Llg~~ 80 (576)
..|++.++....++|++.+.||+|+||.||+|+.. ++.||||++...... ....+.+|+.++..+.| +||+.+++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~ 96 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGFC 96 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCC-TTBCCCCEEE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccC-CCccceEEEE
Confidence 36899999999999999999999999999999865 789999999754322 23368899999999976 9999999999
Q ss_pred eCCCCCeEEEEEeccCCCCHHHHHHhcCC-CChhhHHHHHHHHHHHHHHHHHHHhC---CCCeeecccCCCCeEEcCCCc
Q 036407 81 SNPKRHRMLLVYELMSNGNLQDALLHKKP-PELMEWCKRFSIAVDIAKGIAYLHSL---NPPVIHGDIKPSNILLDHNFC 156 (576)
Q Consensus 81 ~~~s~~~l~LVmE~~~gGsL~d~L~~~~~-~~~ls~~~vl~I~~qIl~AL~yLHs~---g~~IVHrDLKPeNILLd~~g~ 156 (576)
... ...++||||+++++|.+++..... ...+++..++.++.|++.||.|||++ + |+|+||||+|||++.++.
T Consensus 97 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 97 MTP--TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFE 172 (326)
T ss_dssp CCS--SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCC
T ss_pred ecC--CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCC
Confidence 876 678999999999999999976432 23478888999999999999999998 8 999999999999999999
Q ss_pred EEEccccccccccCCCCCcCcCCCCccccchhhhccCCCCCCCCcceecccccccccccccccccccccCcchhHhhhhc
Q 036407 157 AKISDFGLARLKSVGENQNQADGENKNKAAELESNCGAAVEDCGSVVETESVNTTTTATAFEDLSVGIDQSPETFLKMTQ 236 (576)
Q Consensus 157 vKLiDFGlA~~~~~~~~~~~~~gt~~y~APEl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (576)
++|+|||++.......
T Consensus 173 ~kl~Dfg~~~~~~~~~---------------------------------------------------------------- 188 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKD---------------------------------------------------------------- 188 (326)
T ss_dssp EEECCCSSCEECCSSS----------------------------------------------------------------
T ss_pred EEeccCccccccCccc----------------------------------------------------------------
Confidence 9999999987553221
Q ss_pred ccchhHHHHhhhcccccccchhhhhHHHHHHHHhhhcCCCCCCCCcccCCCCCcccccccccccccccccccccccchhH
Q 036407 237 KQTQSTEALEKKASVDENVKEDVKVKEYVIEWIGTAIGNERPKSDWIGRDTGSSSSVGGKVDRKKSRKRLDWWVSLDEDK 316 (576)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (576)
T Consensus 189 -------------------------------------------------------------------------------- 188 (326)
T 3uim_A 189 -------------------------------------------------------------------------------- 188 (326)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred HHHHHhhhhhhccccccchhhhHHHHHHHHHHHhhhhccCCCCCCCCCCCChhhHHHHhccccccccccCCCCCcccccc
Q 036407 317 EENVKNLKRERRRRPAREWWKEEYCEELAKKKKKKKRALGTNSDDDWWPRDEELYVERKKKSKTRSRSRSSIGSLDWWLE 396 (576)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (576)
T Consensus 189 -------------------------------------------------------------------------------- 188 (326)
T 3uim_A 189 -------------------------------------------------------------------------------- 188 (326)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccchhhhhhccccCccccCCCCCCCcceeeccccCccccccccccCCCCcccccceeehhHHHHHHHhCCCCccccCCC
Q 036407 397 GFSGELYRARHNSYDSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSP 476 (576)
Q Consensus 397 ~~~~~~~~~~~~~~d~~~~~~i~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~G~~l~eli~g~~pf~~~~~~ 476 (576)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 189 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 241 (326)
T 3uim_A 189 ---------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241 (326)
T ss_dssp ---------------------------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHT
T ss_pred ---------------------------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccc
Confidence 00112346999999999998889999999999999999999999999632210
Q ss_pred chhhhhhhHHHHHHHhccccchhhhhhhHHhhhcCHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhccc
Q 036407 477 MSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGMLTGK 546 (576)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~Rps~~~v~~~l~~~ 546 (576)
.........|.........+..+.+..+...+...++..+.+++..||+.||.+|||+.||+++|++.
T Consensus 242 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 242 --NDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp --TTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred --cccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 11223466777777777777777787777778889999999999999999999999999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=387.38 Aligned_cols=148 Identities=30% Similarity=0.440 Sum_probs=126.4
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhc--cCCceEEEEEEeeCCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLE--QDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~--h~pNIv~Llg~~~~~s~~ 86 (576)
.++|++++.||+|+||.||+|+.. |+.||||++.+... .....+..|..++..+. +||||+.+++.+... .
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~--~ 265 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--D 265 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--S
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC--C
Confidence 578999999999999999999976 79999999975322 22334555554444443 359999999999877 8
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+|||||||+||+|.+++...+. +++..+..|+.||+.||.|||++| |+||||||+||||+.+|.+||+|||+|+
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~---l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999999987654 788999999999999999999999 9999999999999999999999999997
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 341 ~~ 342 (689)
T 3v5w_A 341 DF 342 (689)
T ss_dssp EC
T ss_pred ec
Confidence 54
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=356.20 Aligned_cols=160 Identities=31% Similarity=0.554 Sum_probs=133.5
Q ss_pred CChHHHHhhcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 5 fs~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
++...+....++|++.+.||+|+||.||+|+..++.||||++..... .....+.+|+.++..+.| +||+.+++++..
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~ 105 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH-PNIVLFMGAVTQ 105 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECS
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEE
Confidence 44455566678899999999999999999999999999999975443 234578899999999986 999999999977
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccc
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDF 162 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDF 162 (576)
. ..+++||||+++++|.+++........+++..++.++.||+.||.|||+++++|+||||||+|||++.++.+||+||
T Consensus 106 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 106 P--PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp T--TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred C--CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence 6 67899999999999999997654333477888999999999999999998877999999999999999999999999
Q ss_pred ccccc
Q 036407 163 GLARL 167 (576)
Q Consensus 163 GlA~~ 167 (576)
|+++.
T Consensus 184 g~a~~ 188 (309)
T 3p86_A 184 GLSRL 188 (309)
T ss_dssp C----
T ss_pred CCCcc
Confidence 98864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=336.52 Aligned_cols=162 Identities=38% Similarity=0.626 Sum_probs=142.3
Q ss_pred CCCChHHHHhhcCCCCcc------ceeeccCcEEEEEEEECCceEEEEEeecCC----chhHHHHHHHHHHHHHhccCCc
Q 036407 3 HRFSYSVLRRAADSFSPS------RLLGQGGFGSVFHATLHDQSVAVKVMDSGS----LQGEREFYNELYFASLLEQDDH 72 (576)
Q Consensus 3 ~~fs~~~lk~~~d~Y~i~------e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s----~~~~~~~l~EI~iLs~L~h~pN 72 (576)
+.|++.++..++++|... +.||+|+||.||+|...++.||||.+.... ....+.+.+|+.++..+.| +|
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH-EN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC-TT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC-CC
Confidence 569999999999999877 999999999999999999999999996432 2335678999999999976 99
Q ss_pred eEEEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEc
Q 036407 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLD 152 (576)
Q Consensus 73 Iv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd 152 (576)
|+.+++++... ..+++||||+++++|.+++........+++..++.++.||+.||.|||+++ |+|+||||+|||++
T Consensus 92 i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~ 167 (307)
T 2nru_A 92 LVELLGFSSDG--DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLD 167 (307)
T ss_dssp BCCEEEEECSS--SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC
T ss_pred eEEEEEEEecC--CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEc
Confidence 99999998776 678999999999999999875433334788889999999999999999999 99999999999999
Q ss_pred CCCcEEEcccccccccc
Q 036407 153 HNFCAKISDFGLARLKS 169 (576)
Q Consensus 153 ~~g~vKLiDFGlA~~~~ 169 (576)
.++.++|+|||++....
T Consensus 168 ~~~~~kl~Dfg~~~~~~ 184 (307)
T 2nru_A 168 EAFTAKISDFGLARASE 184 (307)
T ss_dssp TTCCEEECCCTTCEECC
T ss_pred CCCcEEEeecccccccc
Confidence 99999999999987543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=338.38 Aligned_cols=150 Identities=30% Similarity=0.503 Sum_probs=133.9
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
.++|.+.+.||+|+||.||+|... ++.||+|.+..........+.+|+.++..+.| +||+.+++++... ..+++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~--~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH-PNVLKFIGVLYKD--KRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEET--TEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-cCcccEEEEEecC--CeeEEE
Confidence 467889999999999999999976 78999999876556666789999999999976 9999999999876 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccccC
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
|||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.....
T Consensus 86 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EECCTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 999999999999987433 2788899999999999999999999 99999999999999999999999999886543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=348.09 Aligned_cols=162 Identities=30% Similarity=0.460 Sum_probs=138.8
Q ss_pred CCChHHHHhhcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEE
Q 036407 4 RFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVS 75 (576)
Q Consensus 4 ~fs~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~ 75 (576)
.++.+.+....++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.+|+||+.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3667778888899999999999999999999842 47899999975433 334578999999999988899999
Q ss_pred EEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCC----------------------------------------------
Q 036407 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP---------------------------------------------- 109 (576)
Q Consensus 76 Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~---------------------------------------------- 109 (576)
+++++.... ..+++|||||++|+|.+++.....
T Consensus 91 ~~~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 91 LLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp EEEEECSTT-SCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeecCC-CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 999987653 568999999999999999976432
Q ss_pred -----------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 110 -----------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 110 -----------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 112778889999999999999999999 999999999999999999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=338.36 Aligned_cols=148 Identities=25% Similarity=0.366 Sum_probs=132.4
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
..++|++.+.||+|+||.||+|... ++.||||.+........+.+.+|+.++..+.| |||+++++++... ..+|+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~--~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVG--DELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEEET--TEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCC-CCCCeEeEEEEEC--CEEEE
Confidence 4568999999999999999999864 78999999976555566788999999999977 9999999998876 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
||||+++++|.+++.... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 95 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEECCTTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEECCCCCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 999999999999987643 678889999999999999999999 9999999999999999999999999987543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=338.27 Aligned_cols=152 Identities=29% Similarity=0.457 Sum_probs=132.2
Q ss_pred hcCCCCccceeeccCcEEEEEEEE------CCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATL------HDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~------~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
..++|++.+.||+|+||.||+|++ .++.||||++..........+.+|+.++..+.| +||+.+++++......
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECHHHHT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCCC
Confidence 457899999999999999999985 378999999986665556788999999999986 9999999998765556
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred ceEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 78999999999999999976432 2778889999999999999999999 9999999999999999999999999987
Q ss_pred ccc
Q 036407 167 LKS 169 (576)
Q Consensus 167 ~~~ 169 (576)
...
T Consensus 163 ~~~ 165 (295)
T 3ugc_A 163 VLP 165 (295)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=334.44 Aligned_cols=149 Identities=27% Similarity=0.405 Sum_probs=131.7
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
...++|++.+.||+|+||.||+|+.. ++.||+|.+..... .....+.+|+.++..+.| |||+.+++++... .
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~--~ 84 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH-QNIVSMIDVDEED--D 84 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCB-TTBCCEEEEEECS--S
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCC-CCCceEEEeeeeC--C
Confidence 35678999999999999999999865 78999999865332 234578899999999987 9999999998766 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+|+||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 159 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAK 159 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSST
T ss_pred eEEEEEeCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCcc
Confidence 89999999999999999977553 778889999999999999999999 9999999999999999999999999986
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 160 ~~ 161 (294)
T 4eqm_A 160 AL 161 (294)
T ss_dssp TC
T ss_pred cc
Confidence 54
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.73 Aligned_cols=151 Identities=28% Similarity=0.427 Sum_probs=130.1
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC--CCeE
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK--RHRM 88 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s--~~~l 88 (576)
....++|++.+.||+|+||.||+|+..++.||||++.... ........|+.++..+.| +||+++++++.... ...+
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKH-ENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECSSSEEE
T ss_pred ccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCC-CCchhhcceeccCCCCCceE
Confidence 3445789999999999999999999999999999996433 233455678888888876 99999999987643 3568
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhC----------CCCeeecccCCCCeEEcCCCcEE
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL----------NPPVIHGDIKPSNILLDHNFCAK 158 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~----------g~~IVHrDLKPeNILLd~~g~vK 158 (576)
++||||+++|+|.+++.... +++..++.++.||+.||.|||+. + |+|+||||+|||++.++.+|
T Consensus 98 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTTCCEE
T ss_pred EEEEecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCCCeEE
Confidence 99999999999999997643 77888999999999999999998 8 99999999999999999999
Q ss_pred Ecccccccccc
Q 036407 159 ISDFGLARLKS 169 (576)
Q Consensus 159 LiDFGlA~~~~ 169 (576)
|+|||+++...
T Consensus 172 L~DFg~a~~~~ 182 (322)
T 3soc_A 172 IADFGLALKFE 182 (322)
T ss_dssp ECCCTTCEEEC
T ss_pred EccCCcccccc
Confidence 99999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=343.26 Aligned_cols=150 Identities=26% Similarity=0.476 Sum_probs=130.2
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC-----CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
..++|++.+.||+|+||.||+|+.. +..||||.+.... ......+.+|+.++..+.| +||+.+++++... .
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~ 123 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH-PNIIRLEGVVTRG--R 123 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECGG--G
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeC--C
Confidence 3567889999999999999999974 3469999997543 3345678999999999976 9999999998765 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||+++
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred ccEEEeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCccc
Confidence 78999999999999999976432 2788889999999999999999999 9999999999999999999999999987
Q ss_pred ccc
Q 036407 167 LKS 169 (576)
Q Consensus 167 ~~~ 169 (576)
...
T Consensus 200 ~~~ 202 (325)
T 3kul_A 200 VLE 202 (325)
T ss_dssp ECC
T ss_pred ccc
Confidence 654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=340.86 Aligned_cols=153 Identities=23% Similarity=0.382 Sum_probs=133.2
Q ss_pred HHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 8 SVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 8 ~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
++.....++|++.+.||+|+||.||+|+.. ++.||||++.... ......+.+|+.++..+.| +||+++++++...
T Consensus 8 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~ 86 (328)
T 3fe3_A 8 ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-PNIVKLFEVIETE 86 (328)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECS
T ss_pred cccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEEC
Confidence 344556789999999999999999999974 8999999997542 2334578899999999986 9999999998876
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
..+|+||||+++++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 87 --~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG 159 (328)
T 3fe3_A 87 --KTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFG 159 (328)
T ss_dssp --SEEEEEECCCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTT
T ss_pred --CEEEEEEECCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeecc
Confidence 789999999999999999876554 778889999999999999999999 9999999999999999999999999
Q ss_pred ccccc
Q 036407 164 LARLK 168 (576)
Q Consensus 164 lA~~~ 168 (576)
++...
T Consensus 160 ~a~~~ 164 (328)
T 3fe3_A 160 FSNEF 164 (328)
T ss_dssp CCGGG
T ss_pred Cceec
Confidence 98654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=328.23 Aligned_cols=152 Identities=20% Similarity=0.359 Sum_probs=133.2
Q ss_pred hcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
..++|++.+.||+|+||.||+|+.+++.||||++.... ......+.+|+.++..+.| +||+++++++.......+++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH-PNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSC-TTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCC-CchhheEEEEccCCCCCeEe
Confidence 45689999999999999999999999999999997543 2334578999999999976 99999999998776678899
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
||||+++++|.+++..... ..+++..++.++.||+.||.|||+++++|+|+||||+|||++.++.++|+|||++.
T Consensus 87 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EEECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred eecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 9999999999999976442 23788899999999999999999988789999999999999999999999988754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=342.38 Aligned_cols=151 Identities=31% Similarity=0.482 Sum_probs=134.0
Q ss_pred cCCCCccceeeccCcEEEEEEEE------CCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATL------HDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~------~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.++|++.+.||+|+||.||+|++ .++.||||++..........+.+|+.++..+.| +||+.+++++.......
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-DFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCC-CceeEEEEEEecCCCce
Confidence 36889999999999999999985 368899999987666666779999999999966 99999999988766688
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++..
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999999976432 2788889999999999999999999 99999999999999999999999999876
Q ss_pred cc
Q 036407 168 KS 169 (576)
Q Consensus 168 ~~ 169 (576)
..
T Consensus 177 ~~ 178 (327)
T 3lxl_A 177 LP 178 (327)
T ss_dssp CC
T ss_pred cc
Confidence 54
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=329.30 Aligned_cols=148 Identities=26% Similarity=0.430 Sum_probs=125.9
Q ss_pred hhcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHH--hccCCceEEEEEEeeC--CCCCe
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASL--LEQDDHVVSVLGFSSN--PKRHR 87 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~--L~h~pNIv~Llg~~~~--~s~~~ 87 (576)
...++|++.+.||+|+||.||+|+.+++.||||++... ....+..|..++.. +. |+||+.+++++.. .....
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~-h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLR-HENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCC-CTTBCCEEEEEEEEETTEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhcc-CcCeeeEEEeeccccCCCce
Confidence 45689999999999999999999999999999999643 34455667666666 44 4999999988653 23467
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHH--------hCCCCeeecccCCCCeEEcCCCcEEE
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLH--------SLNPPVIHGDIKPSNILLDHNFCAKI 159 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLH--------s~g~~IVHrDLKPeNILLd~~g~vKL 159 (576)
+++||||+++|+|.+++... .+++..++.++.||+.||.||| +++ |+||||||+|||++.++.+||
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEE
T ss_pred eEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEE
Confidence 89999999999999999543 2788889999999999999999 888 999999999999999999999
Q ss_pred cccccccccc
Q 036407 160 SDFGLARLKS 169 (576)
Q Consensus 160 iDFGlA~~~~ 169 (576)
+|||++....
T Consensus 155 ~Dfg~a~~~~ 164 (301)
T 3q4u_A 155 ADLGLAVMHS 164 (301)
T ss_dssp CCCTTCEEEE
T ss_pred eeCCCeeecc
Confidence 9999987544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=347.67 Aligned_cols=153 Identities=29% Similarity=0.500 Sum_probs=130.6
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC---------CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH---------DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~---------g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
..++|++.+.||+|+||.||+|+.. +..||||++..... .....+.+|+.++..+.+||||+.+++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3468899999999999999999852 35699999975432 3346789999999999666999999999876
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCC-------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCe
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKP-------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNI 149 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~-------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNI 149 (576)
. ..+|+||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 159 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NI 234 (370)
T 2psq_A 159 D--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNV 234 (370)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGE
T ss_pred C--CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhE
Confidence 6 778999999999999999976432 123677888999999999999999999 99999999999
Q ss_pred EEcCCCcEEEcccccccccc
Q 036407 150 LLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 150 LLd~~g~vKLiDFGlA~~~~ 169 (576)
|++.++.+||+|||+++...
T Consensus 235 ll~~~~~~kl~DFG~a~~~~ 254 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDIN 254 (370)
T ss_dssp EECTTCCEEECCCSSCEETT
T ss_pred EECCCCCEEEccccCCcccC
Confidence 99999999999999987543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=325.50 Aligned_cols=150 Identities=31% Similarity=0.492 Sum_probs=131.3
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
...++|++.+.||+|+||.||+|... +..||||++..... ....+.+|+.++..+.| +||+++++++... ..+++
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~--~~~~l 80 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSH-PKLVKFYGVCSKE--YPIYI 80 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCC-TTBCCEEEEECSS--SSEEE
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCC-CCEeeEEEEEccC--CceEE
Confidence 34578999999999999999999887 45799999975443 34578999999999986 9999999998765 77999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
||||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp EEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred EEEccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecc
Confidence 9999999999999976432 2778889999999999999999999 9999999999999999999999999987543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=339.51 Aligned_cols=154 Identities=27% Similarity=0.471 Sum_probs=129.5
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEE-------CCceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATL-------HDQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~-------~g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
....++|.+.+.||+|+||.||+|+. .+..||||++.... ......+.+|+.++..+..||||+.+++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 44567899999999999999999986 24679999997432 23346789999999999666999999999887
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCCC--------------------ChhhHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKPP--------------------ELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHG 142 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~~--------------------~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHr 142 (576)
. ..+++||||+++|+|.+++...... ..+++..++.++.||+.||.|||+++ |+|+
T Consensus 121 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~ 196 (344)
T 1rjb_A 121 S--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHR 196 (344)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred C--CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccC
Confidence 6 7789999999999999999764321 23678889999999999999999999 9999
Q ss_pred ccCCCCeEEcCCCcEEEccccccccc
Q 036407 143 DIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 143 DLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||||+|||++.++.++|+|||++...
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~ 222 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDI 222 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCG
T ss_pred CCChhhEEEcCCCcEEeCCCccCccc
Confidence 99999999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=329.06 Aligned_cols=154 Identities=23% Similarity=0.335 Sum_probs=133.9
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
..++|++.+.||+|+||.||+|+.. ++.||||++.... ......+.+|+.++..+.| +||+.+++++.......++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-KNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECTTTCCEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC-CCcceEEEEeecCCCceEE
Confidence 3568999999999999999999987 7899999997533 2334678899999999986 9999999999887667899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE----cCCCcEEEcccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL----DHNFCAKISDFGLA 165 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL----d~~g~vKLiDFGlA 165 (576)
+||||+++++|.+++........+++..++.++.||+.||.|||+++ |+|+||||+|||+ +.++.+||+|||++
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999999987543333788899999999999999999999 9999999999999 77888999999998
Q ss_pred cccc
Q 036407 166 RLKS 169 (576)
Q Consensus 166 ~~~~ 169 (576)
+...
T Consensus 164 ~~~~ 167 (319)
T 4euu_A 164 RELE 167 (319)
T ss_dssp EECC
T ss_pred eecC
Confidence 7543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=331.41 Aligned_cols=157 Identities=25% Similarity=0.329 Sum_probs=138.5
Q ss_pred CCCChHHHHhhcCC----------CCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccC
Q 036407 3 HRFSYSVLRRAADS----------FSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQD 70 (576)
Q Consensus 3 ~~fs~~~lk~~~d~----------Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~ 70 (576)
..|++++++.+++. |...+.||+|+||.||+|+.. ++.||||++........+.+.+|+.++..+.|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h- 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH- 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC-
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC-
Confidence 46888998877764 777889999999999999875 79999999987666666789999999999977
Q ss_pred CceEEEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeE
Q 036407 71 DHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNIL 150 (576)
Q Consensus 71 pNIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNIL 150 (576)
+||+.+++++... ..+++||||+++++|.+++.... +++..+..++.||+.||.|||+.+ |+|+||||+|||
T Consensus 102 ~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~----l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVG--EELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEET--TEEEEEECCCCSCBHHHHHTTCC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEE
T ss_pred CCcceEEEEEEEC--CEEEEEEecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEE
Confidence 9999999998876 78999999999999999886532 778889999999999999999999 999999999999
Q ss_pred EcCCCcEEEccccccccc
Q 036407 151 LDHNFCAKISDFGLARLK 168 (576)
Q Consensus 151 Ld~~g~vKLiDFGlA~~~ 168 (576)
++.++.+||+|||++...
T Consensus 174 l~~~~~~kl~Dfg~~~~~ 191 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQI 191 (321)
T ss_dssp ECTTCCEEECCCTTCEEC
T ss_pred ECCCCcEEEeeeeeeeec
Confidence 999999999999998654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=327.40 Aligned_cols=150 Identities=23% Similarity=0.298 Sum_probs=130.0
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++.... ....+.+|+.++..+.+|+|++.+++++... ...+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~ 82 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LHNV 82 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET--TEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCC--ceeE
Confidence 45678999999999999999999954 8999999986443 2345788999999998889999999998766 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc-----EEEccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC-----AKISDFGL 164 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~-----vKLiDFGl 164 (576)
+||||+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++. ++|+|||+
T Consensus 83 lv~e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEEec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 999999 9999999976543 2788899999999999999999999 999999999999987765 99999999
Q ss_pred cccccC
Q 036407 165 ARLKSV 170 (576)
Q Consensus 165 A~~~~~ 170 (576)
+.....
T Consensus 158 ~~~~~~ 163 (298)
T 1csn_A 158 VKFYRD 163 (298)
T ss_dssp CEESBC
T ss_pred cccccc
Confidence 876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=328.01 Aligned_cols=149 Identities=28% Similarity=0.474 Sum_probs=130.9
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++..... ..+.+.+|+.++..+.| +||+++++++... ..+++
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~--~~~~l 82 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQ--APICL 82 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCC-TTBCCEEEEECSS--SSEEE
T ss_pred eChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCC-CCEeeEEEEEecC--CceEE
Confidence 34568999999999999999999985 78899999975443 34678999999999986 9999999998776 77999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV 156 (269)
T ss_dssp EEECCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred EEEeCCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccccccc
Confidence 9999999999999976443 2778889999999999999999999 999999999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=332.59 Aligned_cols=149 Identities=25% Similarity=0.304 Sum_probs=129.2
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
..++|++.+.||+|+||.||+|+.. ++.||||++..... ...+.+|+.++..|.+|+||+.+++++... ...++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~l 82 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCG--KYNAM 82 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEET--TEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecC--CccEE
Confidence 4578999999999999999999964 88999999975432 235789999999997779999999998876 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc-----EEEcccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC-----AKISDFGLA 165 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~-----vKLiDFGlA 165 (576)
||||+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 83 v~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EEEeC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 99999 9999999986432 3788899999999999999999999 999999999999998887 999999999
Q ss_pred ccccC
Q 036407 166 RLKSV 170 (576)
Q Consensus 166 ~~~~~ 170 (576)
+....
T Consensus 158 ~~~~~ 162 (330)
T 2izr_A 158 KEYID 162 (330)
T ss_dssp EESBC
T ss_pred eeeec
Confidence 86543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=330.84 Aligned_cols=156 Identities=32% Similarity=0.443 Sum_probs=133.3
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEE-------CCceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEee
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATL-------HDQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSS 81 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~-------~g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~ 81 (576)
+....++|++.+.||+|+||.||+|+. .++.||||++..... ...+.+.+|+.++..+.+|+||+.+++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 345567899999999999999999985 257899999975433 345678999999999966699999999997
Q ss_pred CCCCCeEEEEEeccCCCCHHHHHHhcCCC---------------ChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCC
Q 036407 82 NPKRHRMLLVYELMSNGNLQDALLHKKPP---------------ELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKP 146 (576)
Q Consensus 82 ~~s~~~l~LVmE~~~gGsL~d~L~~~~~~---------------~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKP 146 (576)
.. ...++||||+++|+|.+++...... ..+++..++.++.||+.||.|||+++ |+|+||||
T Consensus 98 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp 173 (313)
T 1t46_A 98 IG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA 173 (313)
T ss_dssp SS--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred cC--CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCcc
Confidence 76 6789999999999999999764321 12678889999999999999999999 99999999
Q ss_pred CCeEEcCCCcEEEcccccccccc
Q 036407 147 SNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 147 eNILLd~~g~vKLiDFGlA~~~~ 169 (576)
+|||++.++.+||+|||++....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~ 196 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIK 196 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTT
T ss_pred ceEEEcCCCCEEEcccccccccc
Confidence 99999999999999999987543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=334.96 Aligned_cols=146 Identities=24% Similarity=0.312 Sum_probs=129.2
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
.++|++.+.||+|+||.||+|+.. ++.||||++.+.. ......+.+|+.++..+.| |||+.+++++... ..+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~~~--~~~ 80 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTH--DRL 80 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC-TTBCCEEEEEECS--SEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCC-CcCcceEEEEEeC--CEE
Confidence 468999999999999999999976 7899999997532 2234568899999999876 9999999999876 789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|+||||+++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++.
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 154 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhh
Confidence 999999999999998876543 778889999999999999999999 99999999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=330.59 Aligned_cols=162 Identities=30% Similarity=0.460 Sum_probs=137.8
Q ss_pred CCChHHHHhhcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEE
Q 036407 4 RFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVS 75 (576)
Q Consensus 4 ~fs~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~ 75 (576)
.++.+.+....++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.+|+||+.
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 3556677778899999999999999999999842 47899999975433 334578999999999988899999
Q ss_pred EEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCC-------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeec
Q 036407 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP-------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHG 142 (576)
Q Consensus 76 Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~-------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHr 142 (576)
+++++... ...+++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+|+
T Consensus 96 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~ 172 (316)
T 2xir_A 96 LLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHR 172 (316)
T ss_dssp EEEEECCT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred EEEEEecC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccc
Confidence 99998764 2568999999999999999976542 112678889999999999999999999 9999
Q ss_pred ccCCCCeEEcCCCcEEEccccccccc
Q 036407 143 DIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 143 DLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||||+|||++.++.+||+|||++...
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~ 198 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDI 198 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred cCccceEEECCCCCEEECCCcccccc
Confidence 99999999999999999999998654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=336.84 Aligned_cols=155 Identities=30% Similarity=0.510 Sum_probs=133.3
Q ss_pred HHHhhcCCCCccceeeccCcEEEEEEEECC-------ceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEe
Q 036407 9 VLRRAADSFSPSRLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFS 80 (576)
Q Consensus 9 ~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~g-------~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~ 80 (576)
.+....++|++.+.||+|+||.||+|+..+ +.||||++..... .....+.+|+.++..+.| +||+.+++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN-PNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEE
Confidence 344567899999999999999999998753 7899999975432 334678999999999976 9999999998
Q ss_pred eCCCCCeEEEEEeccCCCCHHHHHHhcCC---------------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCe
Q 036407 81 SNPKRHRMLLVYELMSNGNLQDALLHKKP---------------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPV 139 (576)
Q Consensus 81 ~~~s~~~l~LVmE~~~gGsL~d~L~~~~~---------------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~I 139 (576)
... ..+++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |
T Consensus 120 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--i 195 (343)
T 1luf_A 120 AVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--F 195 (343)
T ss_dssp CSS--SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred ccC--CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 775 778999999999999999976421 123778889999999999999999999 9
Q ss_pred eecccCCCCeEEcCCCcEEEccccccccc
Q 036407 140 IHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 140 VHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+|+||||+|||++.++.+||+|||++...
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 224 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNI 224 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHH
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCccc
Confidence 99999999999999999999999998654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=322.83 Aligned_cols=150 Identities=23% Similarity=0.341 Sum_probs=122.4
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++..... ...+..|+.++..+.|++++..+..+.... ...+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG--DYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEET--TEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCC--CceE
Confidence 45689999999999999999999964 78999998764332 235788999999999977777666665554 7889
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE---cCCCcEEEccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLAR 166 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL---d~~g~vKLiDFGlA~ 166 (576)
+||||+ +++|.+++...... +++..++.++.||+.||.|||+++ |+|+||||+|||+ +.++.+||+|||++.
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSC--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEEcc-CCCHHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 999999 99999998754322 788899999999999999999999 9999999999999 788999999999987
Q ss_pred cccC
Q 036407 167 LKSV 170 (576)
Q Consensus 167 ~~~~ 170 (576)
....
T Consensus 157 ~~~~ 160 (296)
T 4hgt_A 157 KYRD 160 (296)
T ss_dssp ECBC
T ss_pred eccC
Confidence 6543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=334.59 Aligned_cols=165 Identities=25% Similarity=0.343 Sum_probs=138.0
Q ss_pred CChHHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 5 FSYSVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 5 fs~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
|..+.+.....+|++.+.||+|+||.||+|+.. ++.||||++..........+.+|+.++..+..|+||+.+++++..
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp STTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred hhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 334445555668999999999999999999984 789999999766656667889999999999866999999998842
Q ss_pred ------CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc
Q 036407 83 ------PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC 156 (576)
Q Consensus 83 ------~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~ 156 (576)
.....+++||||+. |+|.+++........+++..++.++.||+.||.|||+++++|+|+||||+|||++.++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence 33466899999995 69998886533223478889999999999999999998777999999999999999999
Q ss_pred EEEccccccccccC
Q 036407 157 AKISDFGLARLKSV 170 (576)
Q Consensus 157 vKLiDFGlA~~~~~ 170 (576)
+||+|||++.....
T Consensus 177 ~kl~Dfg~~~~~~~ 190 (337)
T 3ll6_A 177 IKLCDFGSATTISH 190 (337)
T ss_dssp EEBCCCTTCBCCSS
T ss_pred EEEecCccceeccc
Confidence 99999999876543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=330.26 Aligned_cols=150 Identities=29% Similarity=0.511 Sum_probs=122.7
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHH--HHHhccCCceEEEEEEee---CCCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYF--ASLLEQDDHVVSVLGFSS---NPKR 85 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~i--Ls~L~h~pNIv~Llg~~~---~~s~ 85 (576)
....++|++.+.||+|+||.||+|+..++.||||++.... ...+..|..+ +..+.| +||+.+++.+. ....
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h-~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---RQNFINEKNIYRVPLMEH-DNIARFIVGDERVTADGR 84 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECTTSC
T ss_pred CcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc---hhhHHHHHHHHHHHhccC-cchhhheecccccccCCC
Confidence 3456899999999999999999999999999999996432 2334444443 334555 99999987543 3334
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhC---------CCCeeecccCCCCeEEcCCCc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL---------NPPVIHGDIKPSNILLDHNFC 156 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~---------g~~IVHrDLKPeNILLd~~g~ 156 (576)
..+++||||+++|+|.+++.... .++..++.++.||+.||.|||+. + |+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTTSC
T ss_pred ceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCCCc
Confidence 57899999999999999997654 46777888999999999999998 8 999999999999999999
Q ss_pred EEEccccccccccC
Q 036407 157 AKISDFGLARLKSV 170 (576)
Q Consensus 157 vKLiDFGlA~~~~~ 170 (576)
+||+|||++.....
T Consensus 159 ~kL~DFG~a~~~~~ 172 (336)
T 3g2f_A 159 CVISDFGLSMRLTG 172 (336)
T ss_dssp EEECCCTTCEECSS
T ss_pred EEEeeccceeeccc
Confidence 99999999976543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=325.53 Aligned_cols=148 Identities=32% Similarity=0.457 Sum_probs=122.3
Q ss_pred hcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCc----hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSL----QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~----~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
..++|++.+.||+|+||.||+|...++.||||++..... ...+.+.+|+.++..+.| +||+++++++... ..+
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~ 81 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH-PNIIALRGVCLKE--PNL 81 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCC-TTBCCEEEEECCC----C
T ss_pred chhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCC-CCEeeEEEEEecC--Cce
Confidence 457899999999999999999999999999999865332 223578899999999986 9999999999876 678
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCC-CeeecccCCCCeEEcC--------CCcEEE
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNP-PVIHGDIKPSNILLDH--------NFCAKI 159 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~-~IVHrDLKPeNILLd~--------~g~vKL 159 (576)
++||||+++++|.+++... .+++..++.++.|++.||.|||+++. +|+|+||||+|||++. ++.++|
T Consensus 82 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EEEEECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEEEEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999999988543 27788899999999999999999873 3889999999999986 678999
Q ss_pred cccccccc
Q 036407 160 SDFGLARL 167 (576)
Q Consensus 160 iDFGlA~~ 167 (576)
+|||++..
T Consensus 158 ~Dfg~~~~ 165 (271)
T 3dtc_A 158 TDFGLARE 165 (271)
T ss_dssp CCCCC---
T ss_pred ccCCcccc
Confidence 99998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=342.97 Aligned_cols=155 Identities=28% Similarity=0.468 Sum_probs=132.4
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC---------CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEe
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH---------DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFS 80 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~---------g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~ 80 (576)
....++|.+.+.||+|+||.||+|+.. +..||||++..... .....+.+|+.++..+..|+||+.+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 344578899999999999999999853 25799999975432 33467899999999996669999999999
Q ss_pred eCCCCCeEEEEEeccCCCCHHHHHHhcCC-------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCC
Q 036407 81 SNPKRHRMLLVYELMSNGNLQDALLHKKP-------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPS 147 (576)
Q Consensus 81 ~~~s~~~l~LVmE~~~gGsL~d~L~~~~~-------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPe 147 (576)
... ..+++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 145 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~ 220 (382)
T 3tt0_A 145 TQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAAR 220 (382)
T ss_dssp CSS--SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred ccC--CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcc
Confidence 776 778999999999999999977542 123788899999999999999999999 999999999
Q ss_pred CeEEcCCCcEEEcccccccccc
Q 036407 148 NILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 148 NILLd~~g~vKLiDFGlA~~~~ 169 (576)
|||++.++.+||+|||+++...
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~ 242 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIH 242 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSS
T ss_pred eEEEcCCCcEEEcccCcccccc
Confidence 9999999999999999987543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=332.93 Aligned_cols=145 Identities=31% Similarity=0.455 Sum_probs=123.9
Q ss_pred cCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEe
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE 93 (576)
.++|++.+.||+|+||.||+|+..++.||||.+... .....+.+|+.++..+.| +||+++++++.. ..++|||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~----~~~lv~e 79 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNH-PNIVKLYGACLN----PVCLVME 79 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHCCC-TTBCCEEEBCTT----TTEEEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCC-CCcCeEEEEEcC----CcEEEEE
Confidence 357889999999999999999999999999999643 345678999999999976 999999998763 3699999
Q ss_pred ccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh---CCCCeeecccCCCCeEEcCCCc-EEEcccccccc
Q 036407 94 LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS---LNPPVIHGDIKPSNILLDHNFC-AKISDFGLARL 167 (576)
Q Consensus 94 ~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs---~g~~IVHrDLKPeNILLd~~g~-vKLiDFGlA~~ 167 (576)
|+++++|.+++........++...++.++.||+.||.|||+ ++ |+|+||||+|||++.++. +||+|||++..
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999999999865543336678888999999999999999 77 999999999999998886 79999998753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.79 Aligned_cols=147 Identities=25% Similarity=0.230 Sum_probs=126.5
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
++|++.++||+|+||.||+|+.. ++.||||++.... .........|+..+..+.+|+||+.+++++... ..+|+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--GILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--CEEEE
Confidence 67999999999999999999986 7899999986432 233445677777777776779999999999866 88999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||||+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 7799998876543 2788999999999999999999999 999999999999999999999999997644
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.59 Aligned_cols=149 Identities=26% Similarity=0.416 Sum_probs=130.1
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++.+.. ......+..|..++..+.+|+||+.+++++... .
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~ 97 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP--D 97 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--S
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--C
Confidence 44688999999999999999999976 7899999997532 123456788999999987779999999999876 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+||||||+++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRR---FDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEcccccee
Confidence 89999999999999999977543 788889999999999999999999 9999999999999999999999999986
Q ss_pred c
Q 036407 167 L 167 (576)
Q Consensus 167 ~ 167 (576)
.
T Consensus 173 ~ 173 (353)
T 3txo_A 173 E 173 (353)
T ss_dssp C
T ss_pred e
Confidence 4
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=353.87 Aligned_cols=155 Identities=30% Similarity=0.487 Sum_probs=133.3
Q ss_pred ChHHHHhhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC
Q 036407 6 SYSVLRRAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK 84 (576)
Q Consensus 6 s~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s 84 (576)
....+....++|++.+.||+|+||.||+|... +..||||.+.... ...+.+.+|+.++..+.| +||+++++++..
T Consensus 179 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~~-- 254 (454)
T 1qcf_A 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQH-DKLVKLHAVVTK-- 254 (454)
T ss_dssp CTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCC-TTBCCEEEEECS--
T ss_pred cccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCC-CCEeeEEEEEeC--
Confidence 34455667788999999999999999999987 6789999997644 346689999999999976 999999999862
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
..+++||||+++|+|.+++..... ..++...++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 255 -~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 255 -EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp -SSCEEEECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred -CccEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 568999999999999999975321 12567788899999999999999999 99999999999999999999999999
Q ss_pred cccc
Q 036407 165 ARLK 168 (576)
Q Consensus 165 A~~~ 168 (576)
++..
T Consensus 331 a~~~ 334 (454)
T 1qcf_A 331 ARVI 334 (454)
T ss_dssp GGGB
T ss_pred ceEc
Confidence 8754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=325.59 Aligned_cols=153 Identities=24% Similarity=0.361 Sum_probs=127.4
Q ss_pred HHHHhhcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHh-ccCCceEEEEEEeeCCCC-
Q 036407 8 SVLRRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLL-EQDDHVVSVLGFSSNPKR- 85 (576)
Q Consensus 8 ~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L-~h~pNIv~Llg~~~~~s~- 85 (576)
..-....++|++.+.||+|+||.||+|+..++.||||++... .......|..++..+ .+|+||+.+++++.....
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 334456689999999999999999999999999999999643 233445555555443 245999999998876533
Q ss_pred -CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhC--------CCCeeecccCCCCeEEcCCCc
Q 036407 86 -HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL--------NPPVIHGDIKPSNILLDHNFC 156 (576)
Q Consensus 86 -~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~--------g~~IVHrDLKPeNILLd~~g~ 156 (576)
..+++||||+++|+|.+++.... +++..++.++.|++.||.|||+. + |+||||||+|||++.++.
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSC
T ss_pred CCceEEEEeccCCCcHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCC
Confidence 67899999999999999997643 77888999999999999999988 7 999999999999999999
Q ss_pred EEEcccccccccc
Q 036407 157 AKISDFGLARLKS 169 (576)
Q Consensus 157 vKLiDFGlA~~~~ 169 (576)
+||+|||++....
T Consensus 181 ~kl~Dfg~a~~~~ 193 (337)
T 3mdy_A 181 CCIADLGLAVKFI 193 (337)
T ss_dssp EEECCCTTCEECC
T ss_pred EEEEeCCCceeec
Confidence 9999999987543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=330.86 Aligned_cols=150 Identities=27% Similarity=0.421 Sum_probs=127.4
Q ss_pred CCCCccceeeccCcEEEEEEEE------CCceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATL------HDQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~------~g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
..|++.+.||+|+||.||+|++ .++.||||++.... ......+.+|+.++..+.| +||+.+++++.......
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH-ENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCC-TTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCC-CCeeeeeeEEecCCCce
Confidence 4588999999999999999984 37899999997543 2334678999999999976 99999999998876678
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++||||+++++|.+++...... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++..
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTT--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHhcccc--CCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECccccccc
Confidence 99999999999999999654322 778889999999999999999999 99999999999999999999999999875
Q ss_pred cc
Q 036407 168 KS 169 (576)
Q Consensus 168 ~~ 169 (576)
..
T Consensus 176 ~~ 177 (302)
T 4e5w_A 176 IE 177 (302)
T ss_dssp CC
T ss_pred cc
Confidence 54
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=337.09 Aligned_cols=149 Identities=30% Similarity=0.457 Sum_probs=130.7
Q ss_pred cCCC-CccceeeccCcEEEEEEEE------CCceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 14 ADSF-SPSRLLGQGGFGSVFHATL------HDQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 14 ~d~Y-~i~e~LG~GsfG~Vyka~~------~g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
.++| ++.+.||+|+||.||++.+ .++.||||++..... .....+.+|+.++..+.| +||+.+++++.....
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH-EHIIKYKGCCEDAGA 107 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCC-cchhhEEEEEecCCC
Confidence 3455 8999999999999999875 368899999975432 335678999999999986 999999999988766
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
..+++||||+++++|.+++.... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred ceEEEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCcccc
Confidence 88999999999999999987643 678889999999999999999999 999999999999999999999999998
Q ss_pred cccc
Q 036407 166 RLKS 169 (576)
Q Consensus 166 ~~~~ 169 (576)
....
T Consensus 182 ~~~~ 185 (318)
T 3lxp_A 182 KAVP 185 (318)
T ss_dssp EECC
T ss_pred cccc
Confidence 7654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=329.42 Aligned_cols=154 Identities=27% Similarity=0.385 Sum_probs=131.1
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC-----
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR----- 85 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~----- 85 (576)
.++|++.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|+.++..+.| |||+++++++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-PGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCC-TTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCC-CCEeeEEEEEEEeccchhhh
Confidence 467999999999999999999986 7899999997543 2345678999999999976 999999998754321
Q ss_pred --------------------------------------------------CeEEEEEeccCCCCHHHHHHhcCCCChhhH
Q 036407 86 --------------------------------------------------HRMLLVYELMSNGNLQDALLHKKPPELMEW 115 (576)
Q Consensus 86 --------------------------------------------------~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~ 115 (576)
..+++|||||++++|.+++.........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 248999999999999999987665444556
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccccC
Q 036407 116 CKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 116 ~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 216 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSC
T ss_pred HHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCccccccc
Confidence 678889999999999999999 99999999999999999999999999986654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=335.69 Aligned_cols=160 Identities=31% Similarity=0.488 Sum_probs=135.1
Q ss_pred CCChHHHHhhcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEE
Q 036407 4 RFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVS 75 (576)
Q Consensus 4 ~fs~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~ 75 (576)
.+..+++....++|++.+.||+|+||.||+|+.. ++.||||.+..... .....+.+|+.++..+.| +||+.
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~ 92 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVR 92 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCC-TTBCC
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCC-CCEee
Confidence 3455666778889999999999999999999754 57899999975432 334568899999999976 99999
Q ss_pred EEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCC-------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCC
Q 036407 76 VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP-------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSN 148 (576)
Q Consensus 76 Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~-------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeN 148 (576)
+++++... ...++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+|+||||+|
T Consensus 93 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~N 168 (322)
T 1p4o_A 93 LLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARN 168 (322)
T ss_dssp EEEEECSS--SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGG
T ss_pred eEEEEccC--CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccce
Confidence 99998765 678999999999999998865321 112577888999999999999999999 9999999999
Q ss_pred eEEcCCCcEEEccccccccc
Q 036407 149 ILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 149 ILLd~~g~vKLiDFGlA~~~ 168 (576)
||++.++.+||+|||++...
T Consensus 169 Ili~~~~~~kl~Dfg~~~~~ 188 (322)
T 1p4o_A 169 CMVAEDFTVKIGDFGMTRDI 188 (322)
T ss_dssp EEECTTCCEEECCTTCCCGG
T ss_pred EEEcCCCeEEECcCcccccc
Confidence 99999999999999988643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=331.17 Aligned_cols=150 Identities=18% Similarity=0.292 Sum_probs=131.4
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
.+.++|++.+.||+|+||.||+|+.. ++.||+|.+.... .....+.+|+.++..+.| |||+.+++++... ..++
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~--~~~~ 77 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARH-RNILHLHESFESM--EELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCC-TTBCCEEEEEEET--TEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCC-CCCCeEeEEEecC--CEEE
Confidence 35689999999999999999999876 7889999997543 345578899999999976 9999999999876 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC--CCcEEEcccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH--NFCAKISDFGLARL 167 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~--~g~vKLiDFGlA~~ 167 (576)
+|||||++++|.+.+..... .+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++..
T Consensus 78 lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 99999999999999865432 2788899999999999999999999 999999999999987 78999999999875
Q ss_pred cc
Q 036407 168 KS 169 (576)
Q Consensus 168 ~~ 169 (576)
..
T Consensus 154 ~~ 155 (321)
T 1tki_A 154 LK 155 (321)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=323.79 Aligned_cols=148 Identities=34% Similarity=0.642 Sum_probs=126.5
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhH-------HHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGE-------REFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~-------~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++........ +.+.+|+.++..+.| +||+.+++++..
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~ 94 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH-PNIVKLYGLMHN 94 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCC-TTBCCEEEEETT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCC-CCchhhheeecC
Confidence 34578999999999999999999985 78999999965432211 578899999999976 999999999865
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc-----E
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC-----A 157 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~-----v 157 (576)
. . ++||||+++++|.+.+..... .+++..++.++.|++.||.|||+++++|+|+||||+|||++.++. +
T Consensus 95 ~--~--~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 95 P--P--RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp T--T--EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred C--C--eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence 4 2 799999999999988866443 278888999999999999999998877999999999999987776 9
Q ss_pred EEccccccc
Q 036407 158 KISDFGLAR 166 (576)
Q Consensus 158 KLiDFGlA~ 166 (576)
||+|||++.
T Consensus 169 kl~Dfg~~~ 177 (287)
T 4f0f_A 169 KVADFGLSQ 177 (287)
T ss_dssp EECCCTTCB
T ss_pred EeCCCCccc
Confidence 999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=334.76 Aligned_cols=150 Identities=26% Similarity=0.368 Sum_probs=131.8
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch------hHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ------GEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~------~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
.+.+.|++.+.||+|+||.||+|+.. ++.||||++...... ..+.+.+|+.++..+.| |||+.+++++...
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~ 87 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH-PNIITLHDVYENR 87 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCC-TTBCCEEEEEECS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCC-cCCCcEEEEEEeC
Confidence 35678999999999999999999976 789999999764332 24678999999999986 9999999999876
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC----cEEE
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF----CAKI 159 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g----~vKL 159 (576)
..+++||||+++|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 88 --~~~~lv~e~~~gg~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 88 --TDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp --SEEEEEEECCCSCBHHHHHTTCSC---CBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEE
T ss_pred --CEEEEEEEcCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEE
Confidence 789999999999999999876443 788899999999999999999999 99999999999998776 7999
Q ss_pred cccccccccc
Q 036407 160 SDFGLARLKS 169 (576)
Q Consensus 160 iDFGlA~~~~ 169 (576)
+|||++....
T Consensus 161 ~DFG~a~~~~ 170 (361)
T 2yab_A 161 IDFGLAHEIE 170 (361)
T ss_dssp CCCSSCEECC
T ss_pred EecCCceEcC
Confidence 9999987543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=346.33 Aligned_cols=149 Identities=28% Similarity=0.520 Sum_probs=124.5
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-----CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.++|.+.+.||+|+||.||+|+.. +..||||.+.... ......+.+|+.++..+.| +||+++++++... ..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~--~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH-PNIIRLEGVVTKS--KP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSS--SS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeC--Cc
Confidence 457999999999999999999864 5679999997543 2345678999999999976 9999999998766 77
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred eEEEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 8999999999999999976432 2778889999999999999999999 99999999999999999999999999875
Q ss_pred cc
Q 036407 168 KS 169 (576)
Q Consensus 168 ~~ 169 (576)
..
T Consensus 197 ~~ 198 (373)
T 2qol_A 197 LE 198 (373)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=328.51 Aligned_cols=151 Identities=26% Similarity=0.422 Sum_probs=126.6
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch--------------------------hHHHHHHHHHH
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ--------------------------GEREFYNELYF 63 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~--------------------------~~~~~l~EI~i 63 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++...... ..+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 34578999999999999999999875 789999999754321 12458899999
Q ss_pred HHHhccCCceEEEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecc
Q 036407 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGD 143 (576)
Q Consensus 64 Ls~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrD 143 (576)
+..+.| +||+.+++++.......+++||||+++++|.+++.. ..+++..++.++.||+.||.|||+++ |+|+|
T Consensus 90 l~~l~h-~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~D 162 (298)
T 2zv2_A 90 LKKLDH-PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRD 162 (298)
T ss_dssp HHTCCC-TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCC
T ss_pred HHhCCC-CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccC
Confidence 999976 999999999987666899999999999999775432 23788889999999999999999999 99999
Q ss_pred cCCCCeEEcCCCcEEEcccccccccc
Q 036407 144 IKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 144 LKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|||+|||++.++.+||+|||++....
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~ 188 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFK 188 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCHHHEEECCCCCEEEecCCCccccc
Confidence 99999999999999999999987543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=325.41 Aligned_cols=148 Identities=25% Similarity=0.365 Sum_probs=129.1
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--C-------ceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--D-------QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g-------~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
..++|.+.+.||+|+||.||+|+.. + ..||+|.+........+.+.+|+.++..+.| +||+++++++...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH-KHLVLNYGVCVCG 84 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCC-TTBCCEEEEECCT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEEeC
Confidence 3568999999999999999999865 2 4699999976555666789999999999986 9999999999876
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc-------
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC------- 156 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~------- 156 (576)
...++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.
T Consensus 85 --~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 85 --DENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp --TCCEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred --CCCEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccc
Confidence 677999999999999999976432 2678888999999999999999999 999999999999998876
Q ss_pred -EEEcccccccc
Q 036407 157 -AKISDFGLARL 167 (576)
Q Consensus 157 -vKLiDFGlA~~ 167 (576)
++|+|||++..
T Consensus 159 ~~kl~Dfg~~~~ 170 (289)
T 4fvq_A 159 FIKLSDPGISIT 170 (289)
T ss_dssp EEEECCCCSCTT
T ss_pred eeeeccCccccc
Confidence 99999998753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=329.39 Aligned_cols=155 Identities=28% Similarity=0.430 Sum_probs=131.9
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEee
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSS 81 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~ 81 (576)
+....++|.+.+.||+|+||.||+|... +..||||++.... ......+.+|+.++..+.| |||+.+++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~ 96 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH-PHVIKLYGACS 96 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEC
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCC-CceeeEEEEEe
Confidence 3445678999999999999999999862 3789999997543 2334678899999999976 99999999987
Q ss_pred CCCCCeEEEEEeccCCCCHHHHHHhcCC---------------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCee
Q 036407 82 NPKRHRMLLVYELMSNGNLQDALLHKKP---------------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVI 140 (576)
Q Consensus 82 ~~s~~~l~LVmE~~~gGsL~d~L~~~~~---------------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IV 140 (576)
.. ..+++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+
T Consensus 97 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iv 172 (314)
T 2ivs_A 97 QD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LV 172 (314)
T ss_dssp SS--SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred cC--CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Cc
Confidence 66 678999999999999999976432 123778889999999999999999999 99
Q ss_pred ecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 141 HGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 141 HrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|+||||+|||++.++.++|+|||++....
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~ 201 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVY 201 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECT
T ss_pred ccccchheEEEcCCCCEEEcccccccccc
Confidence 99999999999999999999999987543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=318.44 Aligned_cols=150 Identities=23% Similarity=0.338 Sum_probs=126.6
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++..... ...+.+|+.++..+.|++++..+..+.... ...+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~~~ 81 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG--DYNV 81 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEET--TEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCC--CceE
Confidence 35689999999999999999999964 89999999875433 246889999999999976676665554544 7889
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE---cCCCcEEEccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLAR 166 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL---d~~g~vKLiDFGlA~ 166 (576)
+||||+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||+ +.++.+||+|||++.
T Consensus 82 lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEEec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 999999 8999999975432 2788899999999999999999999 9999999999999 478899999999987
Q ss_pred cccC
Q 036407 167 LKSV 170 (576)
Q Consensus 167 ~~~~ 170 (576)
....
T Consensus 157 ~~~~ 160 (296)
T 3uzp_A 157 KYRD 160 (296)
T ss_dssp ECBC
T ss_pred cccc
Confidence 6543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=327.58 Aligned_cols=153 Identities=25% Similarity=0.428 Sum_probs=130.0
Q ss_pred HHHHhhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 8 SVLRRAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 8 ~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
..+....++|++.+.||+|+||.||++... +..||||++..... ....+.+|+.++..+.| +||+++++++... .
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~--~ 92 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSH-EKLVQLYGVCTKQ--R 92 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCC-TTBCCEEEEECSS--S
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCC-CCEeeEEEEEecC--C
Confidence 344556678999999999999999999887 46899999975443 34678999999999986 9999999998765 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++.
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~ 168 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSR 168 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred CeEEEEeccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEccccccc
Confidence 89999999999999999976332 2778889999999999999999999 9999999999999999999999999986
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 169 ~~ 170 (283)
T 3gen_A 169 YV 170 (283)
T ss_dssp GB
T ss_pred cc
Confidence 54
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=334.38 Aligned_cols=159 Identities=30% Similarity=0.457 Sum_probs=122.8
Q ss_pred hHHHHhhcCCCCccceeeccCcEEEEEEEECC-----ceEEEEEeecC--CchhHHHHHHHHHHHHHhccCCceEEEEEE
Q 036407 7 YSVLRRAADSFSPSRLLGQGGFGSVFHATLHD-----QSVAVKVMDSG--SLQGEREFYNELYFASLLEQDDHVVSVLGF 79 (576)
Q Consensus 7 ~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~g-----~~VAVK~i~~~--s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~ 79 (576)
+.++....++|++.+.||+|+||.||+|+... ..||||++... .......+.+|+.++..+.| +||+.++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~ 93 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH-PHVAKLVGV 93 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCC-TTBCCCCEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCC-Cceehhhce
Confidence 34445667889999999999999999998652 27999999754 23345678999999999966 999999999
Q ss_pred eeCCCC----CeEEEEEeccCCCCHHHHHHhcCC---CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEc
Q 036407 80 SSNPKR----HRMLLVYELMSNGNLQDALLHKKP---PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLD 152 (576)
Q Consensus 80 ~~~~s~----~~l~LVmE~~~gGsL~d~L~~~~~---~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd 152 (576)
+..... ...++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~ 171 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLA 171 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEc
Confidence 876522 134899999999999998865321 113778889999999999999999999 99999999999999
Q ss_pred CCCcEEEccccccccc
Q 036407 153 HNFCAKISDFGLARLK 168 (576)
Q Consensus 153 ~~g~vKLiDFGlA~~~ 168 (576)
.++.+||+|||++...
T Consensus 172 ~~~~~kl~Dfg~a~~~ 187 (323)
T 3qup_A 172 EDMTVCVADFGLSRKI 187 (323)
T ss_dssp TTSCEEECCCCC----
T ss_pred CCCCEEEeeccccccc
Confidence 9999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=333.07 Aligned_cols=149 Identities=30% Similarity=0.446 Sum_probs=128.5
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
..++|++.+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|+.++..+.| +||+.+++++... ...|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~--~~~~ 81 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREG--NIQY 81 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCC-TTBCCEEEEEECS--SEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCC-CCCCeEEEEEecC--CeEE
Confidence 3578999999999999999999876 78999999975432 234568899999999977 9999999998876 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
+||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTB---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEEcCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 99999999999988765433 788889999999999999999999 9999999999999999999999999987543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=335.25 Aligned_cols=148 Identities=29% Similarity=0.506 Sum_probs=123.9
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--Cc----eEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQ----SVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~----~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
.++|++.+.||+|+||.||+|+.. ++ .||+|.+.... ......+.+|+.++..+.| +||+.+++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--- 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTS--- 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCB-TTBCCEEEEEESS---
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEecC---
Confidence 467999999999999999999864 33 46888875432 2345678999999999987 9999999999864
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
..++|+|++.+|+|.+++...... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTS--CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred CeEEEEEecCCCcHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCccee
Confidence 478999999999999999775432 778889999999999999999999 9999999999999999999999999987
Q ss_pred ccc
Q 036407 167 LKS 169 (576)
Q Consensus 167 ~~~ 169 (576)
...
T Consensus 166 ~~~ 168 (327)
T 3poz_A 166 LLG 168 (327)
T ss_dssp HHT
T ss_pred Ecc
Confidence 654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=330.40 Aligned_cols=156 Identities=25% Similarity=0.326 Sum_probs=131.4
Q ss_pred CCChHHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhc----cCCceEEEE
Q 036407 4 RFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLE----QDDHVVSVL 77 (576)
Q Consensus 4 ~fs~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~----h~pNIv~Ll 77 (576)
.|++.+.....++|++.+.||+|+||.||+|+.. ++.||||++... ......+..|+.++..+. .|+||+.++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 3566666778899999999999999999999984 789999999642 233456788999999987 359999999
Q ss_pred EEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC----
Q 036407 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH---- 153 (576)
Q Consensus 78 g~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~---- 153 (576)
+++... ..+|+||||+ +++|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 103 ~~~~~~--~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 103 GKFMYY--DHMCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEET--TEEEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCC
T ss_pred ceeeEC--CeeEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEcccccc
Confidence 999876 7899999999 89999999765432 2678889999999999999999999 999999999999975
Q ss_pred ---------------------CCcEEEccccccc
Q 036407 154 ---------------------NFCAKISDFGLAR 166 (576)
Q Consensus 154 ---------------------~g~vKLiDFGlA~ 166 (576)
++.+||+|||++.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~ 210 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCE
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCce
Confidence 5667777777665
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.68 Aligned_cols=149 Identities=20% Similarity=0.323 Sum_probs=130.3
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch---hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~---~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++.+.... ....+..|..++..+.+||||+.+++++... .
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~ 126 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--S 126 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--S
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--C
Confidence 34568999999999999999999976 688999999754322 2245788999998887779999999998876 8
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+||||||+++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEEEcCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceee
Confidence 89999999999999998876543 788899999999999999999999 9999999999999999999999999986
Q ss_pred c
Q 036407 167 L 167 (576)
Q Consensus 167 ~ 167 (576)
.
T Consensus 202 ~ 202 (396)
T 4dc2_A 202 E 202 (396)
T ss_dssp C
T ss_pred e
Confidence 4
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.86 Aligned_cols=147 Identities=21% Similarity=0.335 Sum_probs=129.9
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
.++|++.+.||+|+||.||+|+.. ++.||||++..... .....+..|+.++..+.+||||+.+++++... ..+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~~ 85 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRL 85 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--CEE
Confidence 467999999999999999999976 78999999975432 23456788999999886679999999998876 789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|+||||+++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEecccccc
Confidence 999999999999999876543 788889999999999999999999 99999999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=325.98 Aligned_cols=151 Identities=23% Similarity=0.373 Sum_probs=129.1
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
....++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +||+.+++++... ..
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~--~~ 93 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH-PNIVSLIDVIHSE--RC 93 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCC-TTBCCEEEEECCS--SC
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCC-CCEeeeeeEEccC--CE
Confidence 456789999999999999999999985 78999999975432 224578899999999976 9999999998766 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++||||+++ +|.+.+..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARA 168 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcCCCC-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCcee
Confidence 9999999974 88888876443 2778889999999999999999999 99999999999999999999999999875
Q ss_pred cc
Q 036407 168 KS 169 (576)
Q Consensus 168 ~~ 169 (576)
..
T Consensus 169 ~~ 170 (311)
T 3niz_A 169 FG 170 (311)
T ss_dssp TT
T ss_pred cC
Confidence 43
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=334.23 Aligned_cols=147 Identities=27% Similarity=0.399 Sum_probs=119.8
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCchhHHHHHHHHHH---------------HHHhccC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSLQGEREFYNELYF---------------ASLLEQD 70 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~~~~~~~l~EI~i---------------Ls~L~h~ 70 (576)
..++|++.+.||+|+||.||+|... ++.||||++..... .+..|+.+ +..+. |
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h 107 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG----PLFTELKFYQRAAKPEQIQKWIRTRKLK-Y 107 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH----HHHHHHHHHHHHCCHHHHHHHHHHTTCS-C
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch----hHHHHHHHHHhhhhhHHHHHHHHHhhcc-C
Confidence 4568999999999999999999874 36899999975432 23333333 34444 5
Q ss_pred CceEEEEEEeeCCC--CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCC
Q 036407 71 DHVVSVLGFSSNPK--RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSN 148 (576)
Q Consensus 71 pNIv~Llg~~~~~s--~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeN 148 (576)
+||+.+++++.... ...+||||||+ +++|.+++..... .+++..++.|+.||+.||.|||+++ |+||||||+|
T Consensus 108 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~N 182 (364)
T 3op5_A 108 LGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--RFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASN 182 (364)
T ss_dssp CCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred CCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHH
Confidence 99999999887542 25689999999 9999999977532 2788999999999999999999999 9999999999
Q ss_pred eEEc--CCCcEEEcccccccccc
Q 036407 149 ILLD--HNFCAKISDFGLARLKS 169 (576)
Q Consensus 149 ILLd--~~g~vKLiDFGlA~~~~ 169 (576)
||++ .++.+||+|||+++.+.
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~ 205 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYC 205 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESS
T ss_pred EEEecCCCCeEEEEECCcceecc
Confidence 9999 88999999999997654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.07 Aligned_cols=149 Identities=27% Similarity=0.393 Sum_probs=130.9
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch------hHHHHHHHHHHHHHhccCCceEEEEEEeeCCC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ------GEREFYNELYFASLLEQDDHVVSVLGFSSNPK 84 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~------~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s 84 (576)
..+.|++.+.||+|+||.||+|+.. ++.||||++...... ....+.+|+.++..+.| |||+.+++++...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~- 86 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH-PNVITLHEVYENK- 86 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS-
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEeC-
Confidence 4467999999999999999999976 789999999754322 35678999999999976 9999999999876
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC----cEEEc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF----CAKIS 160 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g----~vKLi 160 (576)
..+++||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++ .+||+
T Consensus 87 -~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 87 -TDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp -SEEEEEEECCCSCBHHHHHTTSSC---CBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred -CEEEEEEEcCCCCCHHHHHHhcCC---cCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 789999999999999999876443 788899999999999999999999 99999999999998877 79999
Q ss_pred ccccccccc
Q 036407 161 DFGLARLKS 169 (576)
Q Consensus 161 DFGlA~~~~ 169 (576)
|||++....
T Consensus 161 Dfg~a~~~~ 169 (326)
T 2y0a_A 161 DFGLAHKID 169 (326)
T ss_dssp CCTTCEECC
T ss_pred ECCCCeECC
Confidence 999987543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=333.93 Aligned_cols=153 Identities=26% Similarity=0.440 Sum_probs=125.5
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecC--CchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSG--SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~--s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
....++|++.+.||+|+||.||+|... ++.||||++... .......+.+|+.++..+.+|+||+.+++++......
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 345689999999999999999999875 789999998643 2334567889999999998679999999999877667
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+|+|||||+ ++|.+++.... ++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRANI----LEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHHTC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecccC-cCHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 8999999996 59998887632 677788889999999999999999 9999999999999999999999999998
Q ss_pred cccC
Q 036407 167 LKSV 170 (576)
Q Consensus 167 ~~~~ 170 (576)
....
T Consensus 158 ~~~~ 161 (388)
T 3oz6_A 158 SFVN 161 (388)
T ss_dssp ESSS
T ss_pred cccc
Confidence 6543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=325.59 Aligned_cols=155 Identities=26% Similarity=0.423 Sum_probs=135.3
Q ss_pred HHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 8 SVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 8 ~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
+++....++|++.+.||+|+||.||+|... +..||||.+.... .....+.+|+.++..+.| +||+.+++++...
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~-- 81 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKH-PNLVQLLGVCTRE-- 81 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCC-TTBCCEEEEECSS--
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCC-CCEeeEEEEEccC--
Confidence 455567788999999999999999999987 7889999997543 345678999999999986 9999999998766
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
..+++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccc
Confidence 778999999999999999976443 23788889999999999999999999 999999999999999999999999998
Q ss_pred cccc
Q 036407 166 RLKS 169 (576)
Q Consensus 166 ~~~~ 169 (576)
....
T Consensus 159 ~~~~ 162 (288)
T 3kfa_A 159 RLMT 162 (288)
T ss_dssp GTSC
T ss_pred eecc
Confidence 7543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=345.78 Aligned_cols=150 Identities=33% Similarity=0.483 Sum_probs=127.1
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecC-CchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSG-SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~-s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
.++|++.+.||+|+||.||+|+.. +..||||++... .......+.+|+.++..+.| +||+.+++++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~-- 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH-QNIVRCIGVSLQS-- 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSS--
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCC-CCCCeEEEEEecC--
Confidence 467889999999999999999853 467999999643 23445578899999999976 9999999998766
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCC----CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC---cEE
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF---CAK 158 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~----~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g---~vK 158 (576)
...++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+|
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEE
Confidence 677999999999999999976431 123778889999999999999999999 99999999999999555 599
Q ss_pred Eccccccccc
Q 036407 159 ISDFGLARLK 168 (576)
Q Consensus 159 LiDFGlA~~~ 168 (576)
|+|||+++..
T Consensus 225 L~DFG~a~~~ 234 (367)
T 3l9p_A 225 IGDFGMARDI 234 (367)
T ss_dssp ECCCHHHHHH
T ss_pred ECCCcccccc
Confidence 9999998643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=348.74 Aligned_cols=150 Identities=25% Similarity=0.436 Sum_probs=132.0
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
....++|++.+.||+|+||.||+|...++.||||+++... ..+.+.+|+.++..+.| +||+++++++.... ..++|
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~-~~~~i 264 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRH-SNLVQLLGVIVEEK-GGLYI 264 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCC-TTBCCEEEEEECTT-SCEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccC-CCEEEEEEEEEcCC-CceEE
Confidence 3456788999999999999999999999999999997543 45679999999999977 99999999987642 47899
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||||+++|+|.+++..... ..++...++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 265 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 9999999999999987543 22577888999999999999999999 99999999999999999999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=328.68 Aligned_cols=152 Identities=26% Similarity=0.392 Sum_probs=128.3
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchh---HHHHHHHHHHHHHhccCCceEEEEEEeeCCCC-
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG---EREFYNELYFASLLEQDDHVVSVLGFSSNPKR- 85 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~---~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~- 85 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++....... ...+.+|+.++..+.| +||+.+++++.....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH-PAIVAVYDTGEAETPA 87 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCC-TTBCCEEEEEEEEETT
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCC-CCcceEEEeeeccCCC
Confidence 45689999999999999999999964 7899999997643322 3467899999888876 999999998765422
Q ss_pred -CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 86 -HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 86 -~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
..+|+||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred CcccEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 356999999999999999976543 678889999999999999999999 99999999999999999999999999
Q ss_pred ccccc
Q 036407 165 ARLKS 169 (576)
Q Consensus 165 A~~~~ 169 (576)
+....
T Consensus 163 a~~~~ 167 (311)
T 3ork_A 163 ARAIA 167 (311)
T ss_dssp C----
T ss_pred ccccc
Confidence 87543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=331.70 Aligned_cols=156 Identities=31% Similarity=0.442 Sum_probs=132.2
Q ss_pred HHHhhcCCCCccceeeccCcEEEEEEEECC-------ceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEe
Q 036407 9 VLRRAADSFSPSRLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFS 80 (576)
Q Consensus 9 ~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~g-------~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~ 80 (576)
.+....++|++.+.||+|+||.||+|...+ ..||+|.+..... .....+.+|+.++..+.+|+||+.+++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 455667889999999999999999998752 4799999975432 34567899999999996569999999998
Q ss_pred eCCCCCeEEEEEeccCCCCHHHHHHhcCC-----------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCe
Q 036407 81 SNPKRHRMLLVYELMSNGNLQDALLHKKP-----------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNI 149 (576)
Q Consensus 81 ~~~s~~~l~LVmE~~~gGsL~d~L~~~~~-----------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNI 149 (576)
... ..+++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+|+||||+||
T Consensus 120 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NI 195 (333)
T 2i1m_A 120 THG--GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNV 195 (333)
T ss_dssp CSS--SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGC
T ss_pred ecC--CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceE
Confidence 766 678999999999999999875321 122578889999999999999999999 99999999999
Q ss_pred EEcCCCcEEEccccccccc
Q 036407 150 LLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 150 LLd~~g~vKLiDFGlA~~~ 168 (576)
|++.++.++|+|||++...
T Consensus 196 l~~~~~~~kl~Dfg~~~~~ 214 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDI 214 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCG
T ss_pred EECCCCeEEECcccccccc
Confidence 9999999999999998644
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=335.53 Aligned_cols=156 Identities=17% Similarity=0.190 Sum_probs=134.9
Q ss_pred hHHHHhhcCCCCccceeecc--CcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEe
Q 036407 7 YSVLRRAADSFSPSRLLGQG--GFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFS 80 (576)
Q Consensus 7 ~~~lk~~~d~Y~i~e~LG~G--sfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~ 80 (576)
.+.+....++|++.+.||+| +||.||+|+.. ++.||||++.... ......+.+|+.++..+.| +||+++++++
T Consensus 17 ~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~ 95 (389)
T 3gni_B 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNH-PNIVPYRATF 95 (389)
T ss_dssp -CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEE
T ss_pred hhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCC-CCCCcEeEEE
Confidence 34455667899999999999 99999999986 7899999997543 2334568889999999987 9999999999
Q ss_pred eCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEc
Q 036407 81 SNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKIS 160 (576)
Q Consensus 81 ~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLi 160 (576)
... ..+|+||||+++++|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 96 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~ 170 (389)
T 3gni_B 96 IAD--NELWVVTSFMAYGSAKDLICTHFMD-GMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLS 170 (389)
T ss_dssp EET--TEEEEEEECCTTCBHHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEEC
T ss_pred EEC--CEEEEEEEccCCCCHHHHHhhhccc-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEc
Confidence 876 7899999999999999999765322 2788889999999999999999999 9999999999999999999999
Q ss_pred cccccccc
Q 036407 161 DFGLARLK 168 (576)
Q Consensus 161 DFGlA~~~ 168 (576)
|||.+...
T Consensus 171 dfg~~~~~ 178 (389)
T 3gni_B 171 GLRSNLSM 178 (389)
T ss_dssp CGGGCEEC
T ss_pred ccccceee
Confidence 99987643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=335.99 Aligned_cols=149 Identities=26% Similarity=0.429 Sum_probs=124.6
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--Cce----EEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQS----VAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~----VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
.++|++.+.||+|+||.||+|+.. ++. ||+|.+.... ......+.+|+.++..+.| +||+.+++++.. .
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~---~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH-AHIVRLLGLCPG---S 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCC-TTBCCEEEEECB---S
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEcC---C
Confidence 468999999999999999999875 333 7888775332 2223456788889999876 999999998853 5
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCccc
Confidence 6899999999999999987642 23677888999999999999999999 9999999999999999999999999987
Q ss_pred cccC
Q 036407 167 LKSV 170 (576)
Q Consensus 167 ~~~~ 170 (576)
....
T Consensus 164 ~~~~ 167 (325)
T 3kex_A 164 LLPP 167 (325)
T ss_dssp GSCC
T ss_pred ccCc
Confidence 6543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=343.42 Aligned_cols=151 Identities=25% Similarity=0.394 Sum_probs=130.6
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
....++|.+.+.||+|+||.||+|+.. ++.||||.+..... .....+.+|+.++..+.| |||+++++++... ..
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~--~~ 186 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH-PNIVRLIGVCTQK--QP 186 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCC-TTBCCEEEEECSS--SS
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEecC--CC
Confidence 344568889999999999999999986 78999999975432 223468899999999976 9999999999766 67
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++||||+++|+|.+++..... .++...++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSRE 262 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred cEEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence 8999999999999999976432 2677888999999999999999999 99999999999999999999999999874
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 263 ~ 263 (377)
T 3cbl_A 263 E 263 (377)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=326.05 Aligned_cols=151 Identities=25% Similarity=0.445 Sum_probs=123.6
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC-----CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
+....++|++.+.||+|+||.||+|+.. +..||+|.+.... ....+.+.+|+.++..+.| |||+++++++..
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~- 87 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-PHIVKLIGVITE- 87 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECS-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CccceEEEEEcc-
Confidence 3455678999999999999999999874 3569999986533 2335678999999999976 999999998743
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
+.+++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||
T Consensus 88 --~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 88 --NPVWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC--
T ss_pred --CccEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECccc
Confidence 567999999999999999976542 2778889999999999999999999 9999999999999999999999999
Q ss_pred ccccc
Q 036407 164 LARLK 168 (576)
Q Consensus 164 lA~~~ 168 (576)
++...
T Consensus 162 ~~~~~ 166 (281)
T 1mp8_A 162 LSRYM 166 (281)
T ss_dssp -----
T ss_pred ccccc
Confidence 98754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=331.99 Aligned_cols=154 Identities=29% Similarity=0.495 Sum_probs=130.9
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC---------CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEee
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH---------DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSS 81 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~---------g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~ 81 (576)
...++|++.+.||+|+||.||+|+.. +..||||++..... .....+.+|+.++..+.+|+||+.+++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 44578999999999999999999863 46799999975432 334678899999999966699999999987
Q ss_pred CCCCCeEEEEEeccCCCCHHHHHHhcCC-------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCC
Q 036407 82 NPKRHRMLLVYELMSNGNLQDALLHKKP-------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSN 148 (576)
Q Consensus 82 ~~s~~~l~LVmE~~~gGsL~d~L~~~~~-------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeN 148 (576)
.. ..+++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+|+||||+|
T Consensus 112 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~N 187 (334)
T 2pvf_A 112 QD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARN 187 (334)
T ss_dssp SS--SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGG
T ss_pred cC--CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccce
Confidence 66 788999999999999999976432 122678889999999999999999999 9999999999
Q ss_pred eEEcCCCcEEEcccccccccc
Q 036407 149 ILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 149 ILLd~~g~vKLiDFGlA~~~~ 169 (576)
||++.++.+||+|||++....
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~ 208 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDIN 208 (334)
T ss_dssp EEECTTCCEEECCCTTCEECT
T ss_pred EEEcCCCCEEEcccccccccc
Confidence 999999999999999987543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=327.88 Aligned_cols=145 Identities=23% Similarity=0.267 Sum_probs=117.6
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhcc-------CCceEEEEEEeeC-
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQ-------DDHVVSVLGFSSN- 82 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h-------~pNIv~Llg~~~~- 82 (576)
..++|++.+.||+|+||.||+|+.. ++.||||++... ......+.+|+.++..+.+ |+||+.+++++..
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 4588999999999999999999865 789999999743 2345678899999999974 5889999998863
Q ss_pred -CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhC-CCCeeecccCCCCeEEcCCCcEEEc
Q 036407 83 -PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL-NPPVIHGDIKPSNILLDHNFCAKIS 160 (576)
Q Consensus 83 -~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~-g~~IVHrDLKPeNILLd~~g~vKLi 160 (576)
.....+||||||+ +++|.+.+..... ..+++..++.|+.||+.||.|||++ + |+||||||+|||++.++.....
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhhhh
Confidence 2347899999999 6677776655432 2278888999999999999999998 9 9999999999999987644333
Q ss_pred cc
Q 036407 161 DF 162 (576)
Q Consensus 161 DF 162 (576)
++
T Consensus 190 ~~ 191 (397)
T 1wak_A 190 LA 191 (397)
T ss_dssp HH
T ss_pred hh
Confidence 33
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=335.95 Aligned_cols=152 Identities=24% Similarity=0.379 Sum_probs=130.2
Q ss_pred HHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 9 VLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 9 ~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
..+...++|.+.+.||+|+||.||+|+.. ++.||||+++... ......+..|..++..+.+||||+.+++++...
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 44567789999999999999999999976 7899999997532 123456788888988886679999999998876
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
..+|+||||+++|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||
T Consensus 91 --~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG 163 (345)
T 1xjd_A 91 --ENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFG 163 (345)
T ss_dssp --SEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred --CEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeECh
Confidence 789999999999999999976543 778889999999999999999999 9999999999999999999999999
Q ss_pred cccc
Q 036407 164 LARL 167 (576)
Q Consensus 164 lA~~ 167 (576)
+++.
T Consensus 164 ~a~~ 167 (345)
T 1xjd_A 164 MCKE 167 (345)
T ss_dssp TCBC
T ss_pred hhhh
Confidence 9864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=352.87 Aligned_cols=152 Identities=26% Similarity=0.421 Sum_probs=132.9
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
+....++|++.+.||+|+||.||+|+.. +..||||.+.... ...+.+.+|+.++..+.| +||+++++++... ..
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~--~~ 290 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKH-PNLVQLLGVCTRE--PP 290 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCC-TTBCCEEEEECSS--SS
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCC-CCEeeEEEEEecC--Cc
Confidence 3445567888999999999999999987 7889999997543 345679999999999976 9999999999776 67
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
++|||||+++|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTT-TSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred EEEEEEccCCCCHHHHHHhcCcC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeeccccee
Confidence 89999999999999999764432 3678888999999999999999999 99999999999999999999999999875
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 368 ~ 368 (495)
T 1opk_A 368 M 368 (495)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.40 Aligned_cols=149 Identities=23% Similarity=0.324 Sum_probs=130.3
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++..... .....+..|..++..+.+|+||+.+++++... .
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~ 94 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--D 94 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--S
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--C
Confidence 45678999999999999999999987 67899999975321 23456788999998887789999999998876 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+|+||||++||+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 89999999999999999976543 778889999999999999999999 9999999999999999999999999986
Q ss_pred c
Q 036407 167 L 167 (576)
Q Consensus 167 ~ 167 (576)
.
T Consensus 170 ~ 170 (353)
T 2i0e_A 170 E 170 (353)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=334.61 Aligned_cols=150 Identities=24% Similarity=0.375 Sum_probs=128.6
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccC-CceEEEEEEeeCCCCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQD-DHVVSVLGFSSNPKRH 86 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~-pNIv~Llg~~~~~s~~ 86 (576)
....+.|++.+.||+|+||.||++... ++.||||++..... .....+.+|+.++..+.|+ +||+.+++++... .
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--~ 82 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--Q 82 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--S
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC--C
Confidence 345678999999999999999999876 68899999975433 2335788999999999875 8999999999876 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.++||||+ .+++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++.
T Consensus 83 ~~~lv~e~-~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 83 YIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIAN 155 (343)
T ss_dssp EEEEEECC-CSEEHHHHHHHSCC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred EEEEEEeC-CCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeeccccc
Confidence 89999995 58899999987543 678888999999999999999999 99999999999996 6889999999987
Q ss_pred ccc
Q 036407 167 LKS 169 (576)
Q Consensus 167 ~~~ 169 (576)
...
T Consensus 156 ~~~ 158 (343)
T 3dbq_A 156 QMQ 158 (343)
T ss_dssp CC-
T ss_pred ccC
Confidence 543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.90 Aligned_cols=146 Identities=26% Similarity=0.424 Sum_probs=128.8
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
.++|++.+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|+.++..+.| |||+++++++... ..+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~--~~~ 81 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-PFIIRMWGTFQDA--QQI 81 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCB-TTBCCEEEEEECS--SEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCC-CCCceEeEEEEeC--CEE
Confidence 467999999999999999999976 78999999975321 234567889999998876 9999999998876 789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|+||||+++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++.
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~ 155 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKY 155 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCccee
Confidence 999999999999999976543 678888999999999999999999 99999999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=323.52 Aligned_cols=149 Identities=28% Similarity=0.461 Sum_probs=127.6
Q ss_pred hcCCCCccc-eeeccCcEEEEEEEEC----CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 13 AADSFSPSR-LLGQGGFGSVFHATLH----DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 13 ~~d~Y~i~e-~LG~GsfG~Vyka~~~----g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
..++|.+.+ .||+|+||.||+|... +..||||++.... ......+.+|+.++..+.| +||+++++++.. .
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~---~ 82 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVCQA---E 82 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEES---S
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCC-CCEeEEEEEecC---C
Confidence 346677777 9999999999999853 6789999997643 3345678999999999976 999999999843 5
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++.
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CcEEEEEeCCCCCHHHHHHhCCc--cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECccccee
Confidence 68999999999999998865432 3788889999999999999999999 9999999999999999999999999987
Q ss_pred ccc
Q 036407 167 LKS 169 (576)
Q Consensus 167 ~~~ 169 (576)
...
T Consensus 159 ~~~ 161 (287)
T 1u59_A 159 ALG 161 (287)
T ss_dssp ECT
T ss_pred eec
Confidence 654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=323.11 Aligned_cols=154 Identities=29% Similarity=0.476 Sum_probs=131.4
Q ss_pred HHHHhhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 8 SVLRRAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 8 ~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
+++....++|++.+.||+|+||.||+|... +..||||.+.... .....+.+|+.++..+.| +||+++++++.. .
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~---~ 80 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH-QRLVRLYAVVTQ---E 80 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCC-TTBCCEEEEECS---S
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCC-cCcceEEEEEcC---C
Confidence 345566788999999999999999999987 4689999997543 345678999999999976 999999998764 4
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++.
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLAR 157 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CcEEEEecCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCcccc
Confidence 58999999999999998865321 12677888999999999999999999 9999999999999999999999999987
Q ss_pred ccc
Q 036407 167 LKS 169 (576)
Q Consensus 167 ~~~ 169 (576)
...
T Consensus 158 ~~~ 160 (279)
T 1qpc_A 158 LIE 160 (279)
T ss_dssp ECS
T ss_pred ccc
Confidence 543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=319.23 Aligned_cols=148 Identities=28% Similarity=0.467 Sum_probs=130.0
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
..++|++.+.||+|+||.||+|... ++.||+|.+..... ..+.+.+|+.++..+.| +||+++++++... ..+++|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~lv 81 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQ--APICLV 81 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCC-TTBCCEEEEECSS--SSCEEE
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCC-CCEeeEEEEEccC--CCeEEE
Confidence 3568899999999999999999985 67899999976443 34678999999999976 9999999998776 678999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++...
T Consensus 82 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV 154 (267)
T ss_dssp ECCCTTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred EeCCCCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEccccccccc
Confidence 999999999999976532 2678888999999999999999999 999999999999999999999999988643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=319.14 Aligned_cols=147 Identities=24% Similarity=0.382 Sum_probs=126.8
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +||+++++++... ..+++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLHDVLHSD--KKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEEET--TEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCC-CCEeeEEeEEEeC--CEEEE
Confidence 68999999999999999999985 78899999975432 234678899999999977 9999999998876 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
||||+++ +|.+.+..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++....
T Consensus 79 v~e~~~~-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 79 VFEFCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEECCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence 9999975 66666654332 2788899999999999999999999 9999999999999999999999999987543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=321.95 Aligned_cols=150 Identities=26% Similarity=0.409 Sum_probs=129.6
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHh-ccCCceEEEEEEeeCCCC--Ce
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLL-EQDDHVVSVLGFSSNPKR--HR 87 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L-~h~pNIv~Llg~~~~~s~--~~ 87 (576)
..+.++|++.+.||+|+||.||+|+.+++.||||++... ....+.+|+.++..+ .+|+||+.+++++..... ..
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 456688999999999999999999999999999999632 345677888888773 245999999999887632 27
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHH--------hCCCCeeecccCCCCeEEcCCCcEEE
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLH--------SLNPPVIHGDIKPSNILLDHNFCAKI 159 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLH--------s~g~~IVHrDLKPeNILLd~~g~vKL 159 (576)
+++||||+++++|.+++.... +++..++.++.||+.||.||| +.+ |+|+||||+|||++.++.+||
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEEE
T ss_pred eEEEEeecCCCcHHHHHhccC----ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEEE
Confidence 899999999999999997642 678889999999999999999 788 999999999999999999999
Q ss_pred cccccccccc
Q 036407 160 SDFGLARLKS 169 (576)
Q Consensus 160 iDFGlA~~~~ 169 (576)
+|||++....
T Consensus 189 ~Dfg~~~~~~ 198 (342)
T 1b6c_B 189 ADLGLAVRHD 198 (342)
T ss_dssp CCCTTCEEEE
T ss_pred EECCCceecc
Confidence 9999987544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=344.22 Aligned_cols=153 Identities=22% Similarity=0.349 Sum_probs=132.2
Q ss_pred HHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 8 SVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 8 ~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
.+++...++|++.+.||+|+||.||+|+.. ++.||||++.+... .....+..|+.++..+.| |||+.+++++..
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~ 140 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFYAFQD 140 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCC-TTBCCEEEEEEC
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEE
Confidence 445567789999999999999999999986 78999999964221 122347789999998876 999999999987
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccc
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDF 162 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDF 162 (576)
. ..+|||||||++|+|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+||
T Consensus 141 ~--~~~~lV~E~~~gg~L~~~l~~~~----~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 D--RYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp S--SEEEEEECCCTTEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCC
T ss_pred C--CEEEEEEeCCCCCcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEecc
Confidence 6 88999999999999999887643 678888999999999999999999 999999999999999999999999
Q ss_pred ccccccc
Q 036407 163 GLARLKS 169 (576)
Q Consensus 163 GlA~~~~ 169 (576)
|+++...
T Consensus 213 G~a~~~~ 219 (410)
T 3v8s_A 213 GTCMKMN 219 (410)
T ss_dssp TTCEECC
T ss_pred ceeEeec
Confidence 9987543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.32 Aligned_cols=152 Identities=23% Similarity=0.352 Sum_probs=128.3
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-----chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-----LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-----~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
..+.|++.+.||+|+||.||+|+.. ++.||||++.... ......+.+|+.++..+.| |||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~-- 98 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH-PHIVELLETYSSD-- 98 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCC-TTBCCEEEEEEET--
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCC-CCCCcEEEEEEeC--
Confidence 3467999999999999999999875 7899999996422 1235678999999999976 9999999998876
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc---EEEcc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC---AKISD 161 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~---vKLiD 161 (576)
..+|+|||||++++|.+.+.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEec
Confidence 78999999999999988775432 2223678889999999999999999999 999999999999986654 99999
Q ss_pred cccccccc
Q 036407 162 FGLARLKS 169 (576)
Q Consensus 162 FGlA~~~~ 169 (576)
||++....
T Consensus 177 fg~a~~~~ 184 (351)
T 3c0i_A 177 FGVAIQLG 184 (351)
T ss_dssp CTTCEECC
T ss_pred CcceeEec
Confidence 99987543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=346.98 Aligned_cols=154 Identities=31% Similarity=0.505 Sum_probs=130.9
Q ss_pred hHHHHhhcCCCCccceeeccCcEEEEEEEECC-ceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 7 YSVLRRAADSFSPSRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 7 ~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~g-~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
...+....++|++.+.||+|+||.||+|...+ ..||||.+.... ...+.+.+|+.++..+.| +||+++++++..
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~--- 250 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH-EKLVQLYAVVSE--- 250 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCC-TTBCCEEEEECS---
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCC-CCEeeEEEEEcC---
Confidence 34445566788999999999999999999874 679999997644 335679999999999977 999999999864
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
..+++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred CceEEEehhhcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccc
Confidence 568999999999999999965321 12677888999999999999999999 999999999999999999999999998
Q ss_pred ccc
Q 036407 166 RLK 168 (576)
Q Consensus 166 ~~~ 168 (576)
+..
T Consensus 328 ~~~ 330 (452)
T 1fmk_A 328 RLI 330 (452)
T ss_dssp C--
T ss_pred eec
Confidence 754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=332.82 Aligned_cols=149 Identities=23% Similarity=0.387 Sum_probs=129.6
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
...++|++.+.||+|+||.||+|... ++.||||++..... ...+.+.+|+.++..+.| |||+++++++... ..
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~--~~ 102 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEE--SF 102 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECS--SE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeC--CE
Confidence 44568999999999999999999876 78999999975433 334578899999999976 9999999999876 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC---CcEEEccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN---FCAKISDFGL 164 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~---g~vKLiDFGl 164 (576)
+|+||||+++++|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSC---CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 9999999999999998876443 788889999999999999999999 9999999999999865 4599999999
Q ss_pred cccc
Q 036407 165 ARLK 168 (576)
Q Consensus 165 A~~~ 168 (576)
+...
T Consensus 178 a~~~ 181 (362)
T 2bdw_A 178 AIEV 181 (362)
T ss_dssp CBCC
T ss_pred ceEe
Confidence 8644
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.59 Aligned_cols=150 Identities=22% Similarity=0.374 Sum_probs=129.6
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
....++|++.+.||+|+||.||+|... ++.||+|++..... .....+.+|+.++..+.| |||+++++++... .
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~--~ 83 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH-PNIVRLHDSISEE--G 83 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCB-TTBCCEEEEEECS--S
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-cCCCeEEEEEEEC--C
Confidence 345678999999999999999999875 78999999976543 234578999999999977 9999999999876 8
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEc---CCCcEEEcccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLD---HNFCAKISDFG 163 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd---~~g~vKLiDFG 163 (576)
.+|+|||||++|+|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~---~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EEEEEEEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 89999999999999998877543 788889999999999999999999 99999999999998 45789999999
Q ss_pred ccccc
Q 036407 164 LARLK 168 (576)
Q Consensus 164 lA~~~ 168 (576)
++...
T Consensus 159 ~a~~~ 163 (444)
T 3soa_A 159 LAIEV 163 (444)
T ss_dssp SCBCC
T ss_pred eeEEe
Confidence 98654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=319.28 Aligned_cols=153 Identities=25% Similarity=0.407 Sum_probs=124.9
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-----hhHHHHHHHHHHHHHhc--cCCceEEEEEEeeC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-----QGEREFYNELYFASLLE--QDDHVVSVLGFSSN 82 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-----~~~~~~l~EI~iLs~L~--h~pNIv~Llg~~~~ 82 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+. .|+||+.+++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 45689999999999999999999954 78999999964221 12346678888887776 25999999999876
Q ss_pred CCC---CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEE
Q 036407 83 PKR---HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKI 159 (576)
Q Consensus 83 ~s~---~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKL 159 (576)
... ..+++|||++. ++|.+++...... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTT-CSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEE
Confidence 432 26899999996 5999998775432 2788899999999999999999999 999999999999999999999
Q ss_pred ccccccccc
Q 036407 160 SDFGLARLK 168 (576)
Q Consensus 160 iDFGlA~~~ 168 (576)
+|||++...
T Consensus 162 ~Dfg~a~~~ 170 (308)
T 3g33_A 162 ADFGLARIY 170 (308)
T ss_dssp CSCSCTTTS
T ss_pred eeCcccccc
Confidence 999998644
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.51 Aligned_cols=153 Identities=23% Similarity=0.332 Sum_probs=132.9
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
..++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +||+.+++++.......++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-KNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECTTTCCEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC-CCCCeEEEeeccCCCCeeE
Confidence 3568999999999999999999987 78999999975332 334677899999999986 9999999999887667899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE----cCCCcEEEcccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL----DHNFCAKISDFGLA 165 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL----d~~g~vKLiDFGlA 165 (576)
+||||+++++|.+++........+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999999876443333788899999999999999999999 9999999999999 77788999999998
Q ss_pred ccc
Q 036407 166 RLK 168 (576)
Q Consensus 166 ~~~ 168 (576)
+..
T Consensus 164 ~~~ 166 (396)
T 4eut_A 164 REL 166 (396)
T ss_dssp EEC
T ss_pred eEc
Confidence 754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=346.59 Aligned_cols=155 Identities=22% Similarity=0.300 Sum_probs=133.5
Q ss_pred hHHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch---hHHHHHHHHHHHHHhccCCceEEEEEEee
Q 036407 7 YSVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLLEQDDHVVSVLGFSS 81 (576)
Q Consensus 7 ~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~---~~~~~l~EI~iLs~L~h~pNIv~Llg~~~ 81 (576)
+.+++...++|++.+.||+|+||.||+|+.. ++.||||++.+.... ....+..|+.++..+.| +||+.+++++.
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~h-p~Iv~l~~~~~ 144 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS-KWITTLHYAFQ 144 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCT-TTBCCEEEEEE
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEe
Confidence 4556677889999999999999999999986 688999999743221 12237889999988866 99999999998
Q ss_pred CCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcc
Q 036407 82 NPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISD 161 (576)
Q Consensus 82 ~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiD 161 (576)
.. ..+|||||||++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 145 ~~--~~~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DD--NNLYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CS--SEEEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECC
T ss_pred eC--CEEEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcc
Confidence 76 889999999999999999976332 2788899999999999999999999 99999999999999999999999
Q ss_pred ccccccc
Q 036407 162 FGLARLK 168 (576)
Q Consensus 162 FGlA~~~ 168 (576)
||+++..
T Consensus 219 FGla~~~ 225 (437)
T 4aw2_A 219 FGSCLKL 225 (437)
T ss_dssp CTTCEEC
T ss_pred hhhhhhc
Confidence 9998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=320.86 Aligned_cols=150 Identities=30% Similarity=0.499 Sum_probs=128.3
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEECC-----ceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLHD-----QSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK 84 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~g-----~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s 84 (576)
....++|.+.+.||+|+||.||+|+..+ ..||||.+.... ......+.+|+.++..+.| +||+.+++++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~-- 84 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH-PHIVKLIGIIEE-- 84 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCC-TTBCCEEEEECS--
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCC-CCcceEEEEEcC--
Confidence 3456789999999999999999998642 359999997643 3445678999999999976 999999999764
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
...++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||+
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred -CCCEEEEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCC
Confidence 346899999999999999976442 2678888999999999999999999 99999999999999999999999998
Q ss_pred cccc
Q 036407 165 ARLK 168 (576)
Q Consensus 165 A~~~ 168 (576)
+...
T Consensus 160 ~~~~ 163 (281)
T 3cc6_A 160 SRYI 163 (281)
T ss_dssp GGCC
T ss_pred Cccc
Confidence 8654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=331.40 Aligned_cols=148 Identities=24% Similarity=0.354 Sum_probs=130.3
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
..++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| |||+.+++++... ..
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~--~~ 115 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVKLEFSFKDN--SN 115 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECS--SE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEcC--CE
Confidence 3468999999999999999999976 78999999965322 234578899999999966 9999999998876 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+|+||||+++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++.
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEccccccee
Confidence 9999999999999999987543 778889999999999999999999 99999999999999999999999999864
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 191 ~ 191 (350)
T 1rdq_E 191 V 191 (350)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=336.37 Aligned_cols=148 Identities=26% Similarity=0.416 Sum_probs=124.7
Q ss_pred hcCCCCcc-ceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeC--CCCCe
Q 036407 13 AADSFSPS-RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN--PKRHR 87 (576)
Q Consensus 13 ~~d~Y~i~-e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~--~s~~~ 87 (576)
..++|.+. +.||+|+||.||+|+.. ++.||||++... ..+.+|+.++.++.+|+||+.+++++.. .....
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 44667776 78999999999999876 788999999632 3567888888777777999999998754 33467
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC---CCcEEEccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH---NFCAKISDFGL 164 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~---~g~vKLiDFGl 164 (576)
+|||||||++|+|.+++..... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 8999999999999999976432 23788899999999999999999999 999999999999997 78999999999
Q ss_pred cccc
Q 036407 165 ARLK 168 (576)
Q Consensus 165 A~~~ 168 (576)
++..
T Consensus 211 a~~~ 214 (400)
T 1nxk_A 211 AKET 214 (400)
T ss_dssp CEEC
T ss_pred cccc
Confidence 8743
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=319.90 Aligned_cols=145 Identities=23% Similarity=0.444 Sum_probs=128.4
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
.++|++.+.||+|+||.||+|+.. ++.||||++... ....+.+|+.++..+.+|+||+.+++++........++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 467999999999999999999865 789999999643 346789999999999977999999999988666889999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC-cEEEcccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF-CAKISDFGLARLKS 169 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g-~vKLiDFGlA~~~~ 169 (576)
|||+.+++|.+++.. ++...++.++.||+.||.|||+++ |+|+||||+|||++.++ .++|+|||++....
T Consensus 112 ~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999988753 567788889999999999999999 99999999999999776 89999999987543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.88 Aligned_cols=146 Identities=25% Similarity=0.392 Sum_probs=125.9
Q ss_pred CCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCc--hhHHHHHHHHHHHHHhcc-CCceEEEEEEeeCCCCCeEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQ-DDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h-~pNIv~Llg~~~~~s~~~l~L 90 (576)
..|++.+.||+|+||.||+|... ++.||||++..... .....+.+|+.++..|.+ |+||+.+++++... ..+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--CEEEE
Confidence 45999999999999999999876 78899999975432 334678999999999986 79999999998876 77999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
||| +.+++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++...
T Consensus 134 v~E-~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSS---CCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEe-cCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 999 558899999987543 677788899999999999999999 99999999999995 5899999999987543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=323.89 Aligned_cols=148 Identities=24% Similarity=0.379 Sum_probs=123.4
Q ss_pred hhcCCCCccceeeccCcEEEEEEEE-----CCceEEEEEeecCCc----hhHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATL-----HDQSVAVKVMDSGSL----QGEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~-----~g~~VAVK~i~~~s~----~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
...++|++.+.||+|+||.||+++. .++.||||++..... .....+.+|+.++..+.| +||+.+++++..
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~ 92 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH-PFIVDLIYAFQT 92 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCC-TTBCCEEEEEEC
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCC-CCccceeEEEEc
Confidence 4457899999999999999999986 378999999975432 233467889999999976 999999999887
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccc
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDF 162 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDF 162 (576)
. ..+|+||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 93 ~--~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Df 165 (327)
T 3a62_A 93 G--GKLYLILEYLSGGELFMQLEREGI---FMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDF 165 (327)
T ss_dssp S--SCEEEEEECCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCC
T ss_pred C--CEEEEEEeCCCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeC
Confidence 6 789999999999999999876543 677888899999999999999999 999999999999999999999999
Q ss_pred ccccc
Q 036407 163 GLARL 167 (576)
Q Consensus 163 GlA~~ 167 (576)
|+++.
T Consensus 166 g~~~~ 170 (327)
T 3a62_A 166 GLCKE 170 (327)
T ss_dssp SCC--
T ss_pred Ccccc
Confidence 98764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.56 Aligned_cols=151 Identities=29% Similarity=0.460 Sum_probs=130.7
Q ss_pred cCCCCccceeeccCcEEEEEEEE------CCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATL------HDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~------~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.++|++.+.||+|+||.||+|++ .++.||||++..........+.+|+.++..+.| +||+.+++++.......
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCC-TTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEEecCCCc
Confidence 45688999999999999999985 378899999987655566789999999999976 99999999988765568
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++..
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 8999999999999999976542 2678889999999999999999999 99999999999999999999999999876
Q ss_pred cc
Q 036407 168 KS 169 (576)
Q Consensus 168 ~~ 169 (576)
..
T Consensus 195 ~~ 196 (326)
T 2w1i_A 195 LP 196 (326)
T ss_dssp CC
T ss_pred cc
Confidence 54
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=314.88 Aligned_cols=150 Identities=25% Similarity=0.381 Sum_probs=132.7
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
.+.++|++.+.||+|+||.||+|... +..+|+|.+..........+.+|+.++..+.| +||+.+++++... ..++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~--~~~~ 82 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH-PNIIRLYETFEDN--TDIY 82 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECS--SEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCC-CCEeeEEEEEecC--CeEE
Confidence 45678999999999999999999986 56899999976555566789999999999976 9999999999876 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE---cCCCcEEEccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLAR 166 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL---d~~g~vKLiDFGlA~ 166 (576)
+||||+++++|.+.+..... +++..++.++.|++.||.|||+++ |+|+||||+|||+ +.++.++|+|||++.
T Consensus 83 lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 99999999999998876543 678889999999999999999999 9999999999999 788999999999886
Q ss_pred ccc
Q 036407 167 LKS 169 (576)
Q Consensus 167 ~~~ 169 (576)
...
T Consensus 158 ~~~ 160 (277)
T 3f3z_A 158 RFK 160 (277)
T ss_dssp ECC
T ss_pred ecc
Confidence 543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=316.56 Aligned_cols=146 Identities=26% Similarity=0.420 Sum_probs=127.5
Q ss_pred CCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCch--hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQ--GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~--~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
++|++.+.||+|+||.||+|+.. ++.||||.+...... ....+.+|+.++..+.| +||+++++++... ..+++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLYDVIHTK--KRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC-TTBCCEEEEEECS--SCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCC-CCEeeeeeEEccC--CeEEEE
Confidence 68999999999999999999976 789999999754322 23578899999999976 9999999999876 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||+++ +|.+++...... +++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++...
T Consensus 79 ~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAF 150 (288)
T ss_dssp EECCSE-EHHHHHHTSTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred EEecCC-CHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence 999975 999888764322 677888999999999999999999 999999999999999999999999988654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=313.93 Aligned_cols=139 Identities=27% Similarity=0.421 Sum_probs=117.6
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
..++|++.+.||+|+||.||+|+.. ++.||||++.... ......+.+|+..+..+.+||||+++++++... ..+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~~ 86 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DHM 86 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeE
Confidence 4578999999999999999999986 8999999997542 334567889999999996669999999999876 789
Q ss_pred EEEEeccCCCCHHHHHHhcCC-CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC
Q 036407 89 LLVYELMSNGNLQDALLHKKP-PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF 155 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~-~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g 155 (576)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~ 152 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTS 152 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC---
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCC
Confidence 999999999999999976421 122678889999999999999999999 99999999999998655
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=320.86 Aligned_cols=150 Identities=29% Similarity=0.464 Sum_probs=124.2
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.+...++|++.+.||+|+||.||+|+..+ .||||++.... ....+.+.+|+.++..+.| +||+.+++++.. ..
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~---~~ 93 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH-VNILLFMGYSTA---PQ 93 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECS---SS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCC-CcEEEEEeeccC---Cc
Confidence 34567889999999999999999998765 59999997543 2334678999999999987 999999997643 56
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++..
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred cEEEEEecCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceeccc
Confidence 7999999999999998865432 3778889999999999999999999 99999999999999999999999998864
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 170 ~ 170 (289)
T 3og7_A 170 K 170 (289)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=336.00 Aligned_cols=148 Identities=26% Similarity=0.401 Sum_probs=130.7
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
..++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| |||+.+++++... ..
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~--~~ 89 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH-PFLVNLWYSFQDE--ED 89 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECS--SE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeC--CE
Confidence 4578999999999999999999876 68899999964321 234578899999999976 9999999999876 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+|+||||+.+|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||++..
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVH---FKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCC---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeee
Confidence 9999999999999999976543 788889999999999999999999 99999999999999999999999999875
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 165 ~ 165 (384)
T 4fr4_A 165 L 165 (384)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=332.64 Aligned_cols=148 Identities=31% Similarity=0.487 Sum_probs=129.5
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
...++|.+.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| |||+.+++++... .
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~--~ 82 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-PHIIKLYDVITTP--T 82 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCC-TTBCCEEEEEECS--S
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeC--C
Confidence 45689999999999999999999974 78999999964321 223578899999999987 9999999999876 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+++||||+ +|+|.+.+..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~ 156 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSN 156 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred EEEEEEECC-CCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccce
Confidence 899999999 7899988876543 778889999999999999999999 9999999999999999999999999986
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 157 ~~ 158 (336)
T 3h4j_B 157 IM 158 (336)
T ss_dssp TT
T ss_pred ec
Confidence 44
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=322.66 Aligned_cols=152 Identities=23% Similarity=0.369 Sum_probs=124.7
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
...++|++.+.||+|+||.||+|... ++.||||++.... ......+.+|+.++..+.| +||+.+++++... .
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~--~ 105 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-PNVIKYYASFIED--N 105 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEET--T
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEcC--C
Confidence 45578999999999999999999864 7899999997532 2334678899999999976 9999999999876 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
.+++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC---
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 8999999999999999886521 1223778889999999999999999999 999999999999999999999999987
Q ss_pred ccc
Q 036407 166 RLK 168 (576)
Q Consensus 166 ~~~ 168 (576)
...
T Consensus 184 ~~~ 186 (310)
T 2wqm_A 184 RFF 186 (310)
T ss_dssp ---
T ss_pred eee
Confidence 643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=316.99 Aligned_cols=151 Identities=24% Similarity=0.388 Sum_probs=130.4
Q ss_pred hhcCCCCcc-ceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 12 RAADSFSPS-RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 12 ~~~d~Y~i~-e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
...+.|++. +.||+|+||.||+|+.. ++.||||++..........+.+|+.++..+.+|+||+.+++++... ..+
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~~~ 86 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--DRF 86 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEE
Confidence 345778885 78999999999999864 7899999998665555678999999999977679999999999876 789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc---EEEcccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC---AKISDFGLA 165 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~---vKLiDFGlA 165 (576)
|+||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++. +||+|||++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRH---FNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEEEEcCCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 999999999999999976543 678888999999999999999999 999999999999988765 999999998
Q ss_pred cccc
Q 036407 166 RLKS 169 (576)
Q Consensus 166 ~~~~ 169 (576)
....
T Consensus 162 ~~~~ 165 (316)
T 2ac3_A 162 SGIK 165 (316)
T ss_dssp C---
T ss_pred cccc
Confidence 7543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=334.10 Aligned_cols=149 Identities=23% Similarity=0.354 Sum_probs=131.3
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
..+.|++.+.||+|+||.||+|... ++.||+|++..........+.+|+.++..+.| +||+.+++++... ..+++
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~--~~~~l 125 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-PKLINLHDAFEDK--YEMVL 125 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS-TTBCCEEEEEECS--SEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCC-cCCCeEEEEEEeC--CEEEE
Confidence 4578999999999999999999876 78999999987665566688999999999976 9999999999876 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC--CCcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH--NFCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~--~g~vKLiDFGlA~~~ 168 (576)
||||+++++|.+.+..... .+++..++.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++...
T Consensus 126 v~E~~~gg~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EEECCCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceec
Confidence 9999999999998865432 2788899999999999999999999 999999999999974 478999999998754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=327.01 Aligned_cols=150 Identities=20% Similarity=0.283 Sum_probs=119.1
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC-----CceEEEEEeecCCchh-----------HHHHHHHHHHHHHhccCCceEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGSLQG-----------EREFYNELYFASLLEQDDHVVSV 76 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s~~~-----------~~~~l~EI~iLs~L~h~pNIv~L 76 (576)
..++|++.+.||+|+||.||+|+.. +..+|||++....... ...+.+|+..+..+.| +||+.+
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h-~ni~~~ 113 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDY-LGIPLF 113 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSC-CCCCCE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccc-cCccee
Confidence 3468999999999999999999974 5789999997543211 1235566777777766 999999
Q ss_pred EEEeeC--CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC
Q 036407 77 LGFSSN--PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN 154 (576)
Q Consensus 77 lg~~~~--~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~ 154 (576)
++++.. .....+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESS
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccC
Confidence 998876 2347899999999 999999887654 3788899999999999999999999 9999999999999887
Q ss_pred C--cEEEcccccccccc
Q 036407 155 F--CAKISDFGLARLKS 169 (576)
Q Consensus 155 g--~vKLiDFGlA~~~~ 169 (576)
+ .+||+|||+++.+.
T Consensus 188 ~~~~~kL~Dfg~a~~~~ 204 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYC 204 (345)
T ss_dssp STTSEEECCCTTCEESS
T ss_pred CCCcEEEEeCCCceecc
Confidence 7 99999999997654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=322.24 Aligned_cols=151 Identities=25% Similarity=0.431 Sum_probs=126.9
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
+....++|++.+.||+|+||.||++...++.||||++.... ..+.+.+|+.++..+.| +||+.+++++... ...++
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~-~~~~~ 91 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRH-SNLVQLLGVIVEE-KGGLY 91 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCC-TTBCCEEEEECCC---CCE
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCC-CCEeeEEEEEEcC-CCceE
Confidence 34456789999999999999999999999999999997543 45678999999999976 9999999987654 25789
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+||||+++++|.+++..... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKE 166 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred EEEecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeecccccc
Confidence 99999999999999875431 12567788899999999999999999 99999999999999999999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=321.01 Aligned_cols=156 Identities=24% Similarity=0.301 Sum_probs=130.8
Q ss_pred HHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecC-----CchhHHHHHHHHHHHHHhccCCceEEEEEEee
Q 036407 9 VLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSG-----SLQGEREFYNELYFASLLEQDDHVVSVLGFSS 81 (576)
Q Consensus 9 ~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~-----s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~ 81 (576)
.+....++|++.+.||+|+||.||+|+.. +..||||++... .......+.+|+.++..+.| +||+++++++.
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~ 98 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH-PNIARLYEVYE 98 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCC-TTBCCEEEEEE
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCC-CCcceeehhhc
Confidence 45566788999999999999999999875 678999999643 22344678999999999976 99999999998
Q ss_pred CCCCCeEEEEEeccCCCCHHHHHHhcC-------------------------------------CCChhhHHHHHHHHHH
Q 036407 82 NPKRHRMLLVYELMSNGNLQDALLHKK-------------------------------------PPELMEWCKRFSIAVD 124 (576)
Q Consensus 82 ~~s~~~l~LVmE~~~gGsL~d~L~~~~-------------------------------------~~~~ls~~~vl~I~~q 124 (576)
.. ..+++||||+++|+|.+++.... ....+++..++.++.|
T Consensus 99 ~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 176 (345)
T 3hko_A 99 DE--QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176 (345)
T ss_dssp CS--SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred cC--CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence 76 78999999999999999885210 0123567788899999
Q ss_pred HHHHHHHHHhCCCCeeecccCCCCeEEcCCC--cEEEcccccccccc
Q 036407 125 IAKGIAYLHSLNPPVIHGDIKPSNILLDHNF--CAKISDFGLARLKS 169 (576)
Q Consensus 125 Il~AL~yLHs~g~~IVHrDLKPeNILLd~~g--~vKLiDFGlA~~~~ 169 (576)
|+.||.|||+++ |+|+||||+|||++.++ .+||+|||++....
T Consensus 177 i~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~ 221 (345)
T 3hko_A 177 IFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFY 221 (345)
T ss_dssp HHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGG
T ss_pred HHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeecccccccc
Confidence 999999999999 99999999999998766 89999999987543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=320.07 Aligned_cols=149 Identities=23% Similarity=0.400 Sum_probs=114.8
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.++|++.+.||+|+||.||+|+.. ++.||||.+..... .....+.+|+.++..+.| +||+++++++... +.+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~--~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH-ENIVRLYDVIHTE--NKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCB-TTBCCEEEEECCT--TEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCC-CCcceEEEEEEEC--CeEEE
Confidence 468999999999999999999865 78999999975432 234678899999999977 9999999998876 78999
Q ss_pred EEeccCCCCHHHHHHhcC---CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 91 VYELMSNGNLQDALLHKK---PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~---~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||||++ ++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 999997 59999886532 1123678888899999999999999999 99999999999999999999999999875
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 158 ~ 158 (317)
T 2pmi_A 158 F 158 (317)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.11 Aligned_cols=148 Identities=27% Similarity=0.375 Sum_probs=130.7
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch------hHHHHHHHHHHHHHhccCCceEEEEEEeeCCC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ------GEREFYNELYFASLLEQDDHVVSVLGFSSNPK 84 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~------~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s 84 (576)
..++|++.+.||+|+||.||+|+.. ++.||||++...... ....+.+|+.++..+.| +||+.+++++...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~- 87 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH-HNVITLHDVYENR- 87 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS-
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCC-CCcceEEEEEecC-
Confidence 4577999999999999999999976 789999999754322 35678999999999986 9999999998876
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC----cEEEc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF----CAKIS 160 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g----~vKLi 160 (576)
..+++||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++ .++|+
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 88 -TDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp -SEEEEEECCCCSCBHHHHHHTCSC---EEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred -CEEEEEEEcCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEc
Confidence 789999999999999999976443 788899999999999999999999 99999999999999887 79999
Q ss_pred cccccccc
Q 036407 161 DFGLARLK 168 (576)
Q Consensus 161 DFGlA~~~ 168 (576)
|||++...
T Consensus 162 Dfg~~~~~ 169 (321)
T 2a2a_A 162 DFGLAHEI 169 (321)
T ss_dssp CCTTCEEC
T ss_pred cCccceec
Confidence 99998654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=328.18 Aligned_cols=149 Identities=25% Similarity=0.396 Sum_probs=121.1
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.....++|++.+.||+|+||.||+|+.. ++.||||++.... ....+.+|+.++..+.| +||+.+++++... ..
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~--~~ 122 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSH-PNIIKLKEIFETP--TE 122 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCC-TTBCCEEEEEECS--SE
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCC-CCCcceeeeEecC--Ce
Confidence 3456678999999999999999999986 6789999997542 34568899999999987 9999999999876 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC---CCcEEEccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH---NFCAKISDFGL 164 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~---~g~vKLiDFGl 164 (576)
+++||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+|||++. ++.+||+|||+
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCSS---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred EEEEEEeCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 9999999999999998876443 778889999999999999999999 999999999999975 88999999998
Q ss_pred cccc
Q 036407 165 ARLK 168 (576)
Q Consensus 165 A~~~ 168 (576)
++..
T Consensus 198 a~~~ 201 (349)
T 2w4o_A 198 SKIV 201 (349)
T ss_dssp ----
T ss_pred cccc
Confidence 8643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.81 Aligned_cols=149 Identities=28% Similarity=0.504 Sum_probs=125.0
Q ss_pred cCCCCccceeeccCcEEEEEEEECC------ceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLHD------QSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~g------~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
..+|.+.+.||+|+||.||+|.... ..||||.+..... .....+.+|+.++..+.| +||+++++++... .
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~ 119 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH-HNIIRLEGVISKY--K 119 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSS--S
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEecC--C
Confidence 4567788999999999999998652 3599999975432 334578899999999976 9999999998765 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CcEEEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcch
Confidence 89999999999999999976432 2778889999999999999999999 9999999999999999999999999987
Q ss_pred ccc
Q 036407 167 LKS 169 (576)
Q Consensus 167 ~~~ 169 (576)
...
T Consensus 196 ~~~ 198 (333)
T 1mqb_A 196 VLE 198 (333)
T ss_dssp ---
T ss_pred hhc
Confidence 543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=324.00 Aligned_cols=155 Identities=19% Similarity=0.264 Sum_probs=131.2
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeC--CCCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN--PKRH 86 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~--~s~~ 86 (576)
....++|++.+.||+|+||.||+++.. ++.||||++..........+.+|+.++..+.| +||+++++++.. ....
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNH-PNILRLVAYCLRERGAKH 103 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCC-TTBCCCCEEEEEEETTEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCC-CCeeeEEEEEEeccCCCc
Confidence 344578999999999999999999964 78999999976665666788999999999976 999999998863 2336
Q ss_pred eEEEEEeccCCCCHHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHK-KPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~-~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
.+++||||+++++|.+++... .....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 889999999999999988762 11233788899999999999999999999 999999999999999999999999987
Q ss_pred ccc
Q 036407 166 RLK 168 (576)
Q Consensus 166 ~~~ 168 (576)
...
T Consensus 182 ~~~ 184 (317)
T 2buj_A 182 NQA 184 (317)
T ss_dssp EES
T ss_pred hhc
Confidence 654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=323.82 Aligned_cols=139 Identities=28% Similarity=0.426 Sum_probs=122.2
Q ss_pred cceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCC
Q 036407 20 SRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSN 97 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~g 97 (576)
.+.||+|+||.||+|+.. ++.||||++... ....+.+|+.++..+.+|+||+.+++++... ..+|+||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--CEEEEEEEccCC
Confidence 378999999999999986 789999999643 3456789999999998779999999999876 789999999999
Q ss_pred CCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC---cEEEccccccccc
Q 036407 98 GNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF---CAKISDFGLARLK 168 (576)
Q Consensus 98 GsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g---~vKLiDFGlA~~~ 168 (576)
++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++...
T Consensus 91 ~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 91 GELFERIKKKKH---FSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp CBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred CcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 999999987543 788899999999999999999999 99999999999997765 8999999998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.66 Aligned_cols=161 Identities=28% Similarity=0.409 Sum_probs=136.7
Q ss_pred CCChHHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEee
Q 036407 4 RFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSS 81 (576)
Q Consensus 4 ~fs~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~ 81 (576)
.++++.+....++|++.+.||+|+||.||+|+.. ++.||||++.... .....+.+|+.++..+.+|+||+.+++++.
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 4677778888999999999999999999999984 7899999997543 334678999999999977799999999987
Q ss_pred CCC----CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcE
Q 036407 82 NPK----RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA 157 (576)
Q Consensus 82 ~~s----~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~v 157 (576)
... ...+++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCE
Confidence 642 4789999999999999999976432 23678888999999999999999999 9999999999999999999
Q ss_pred EEccccccccc
Q 036407 158 KISDFGLARLK 168 (576)
Q Consensus 158 KLiDFGlA~~~ 168 (576)
+|+|||++...
T Consensus 169 kl~Dfg~~~~~ 179 (326)
T 2x7f_A 169 KLVDFGVSAQL 179 (326)
T ss_dssp EECCCTTTC--
T ss_pred EEeeCcCceec
Confidence 99999987643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=320.74 Aligned_cols=150 Identities=25% Similarity=0.392 Sum_probs=126.8
Q ss_pred HhhcCCCCccc-eeeccCcEEEEEEEEC----CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 11 RRAADSFSPSR-LLGQGGFGSVFHATLH----DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 11 k~~~d~Y~i~e-~LG~GsfG~Vyka~~~----g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
....++|.+.+ .||+|+||.||+|... ++.||||++..... .....+.+|+.++..+.| +||+++++++..
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~- 89 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGICEA- 89 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCC-TTBCCEEEEEES-
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEECC-
Confidence 34456788888 9999999999999653 57899999975432 224678999999999976 999999999833
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
..+++||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||
T Consensus 90 --~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 90 --ESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp --SSEEEEEECCTTEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCT
T ss_pred --CCcEEEEEeCCCCCHHHHHHhCcC---CCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCC
Confidence 578999999999999999977543 678889999999999999999999 9999999999999999999999999
Q ss_pred cccccc
Q 036407 164 LARLKS 169 (576)
Q Consensus 164 lA~~~~ 169 (576)
++....
T Consensus 163 ~~~~~~ 168 (291)
T 1xbb_A 163 LSKALR 168 (291)
T ss_dssp TCEECC
T ss_pred cceeec
Confidence 987543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=338.04 Aligned_cols=151 Identities=26% Similarity=0.423 Sum_probs=122.7
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCC---CC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNP---KR 85 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~---s~ 85 (576)
+.++|++.+.||+|+||.||+|+.. ++.||||++.... ......+.+|+.++..+.| +||+.+++++... ..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNH-DHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSCTTTC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCC-CCCCceEEEEecCCcccC
Confidence 4588999999999999999999865 7899999996532 2344678999999999976 9999999998543 23
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
..+|+||||+ +++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVY---LTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCC---CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEecc-ccchhhhcccCCC---CCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccc
Confidence 6799999998 5799998876543 788889999999999999999999 999999999999999999999999999
Q ss_pred ccccC
Q 036407 166 RLKSV 170 (576)
Q Consensus 166 ~~~~~ 170 (576)
+....
T Consensus 204 ~~~~~ 208 (458)
T 3rp9_A 204 RTVDY 208 (458)
T ss_dssp BCTTS
T ss_pred hhccC
Confidence 86654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=331.97 Aligned_cols=146 Identities=23% Similarity=0.363 Sum_probs=128.6
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
...++|++.+.||+|+||.||+++.. ++.||||++..... ....+.+|+.++..+.| +||+++++++... ..++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~--~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRH-PNIVRFKEVILTP--THLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCC-TTBCCEEEEEECS--SEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCC-CCCCcEEEEEeeC--CEEE
Confidence 34678999999999999999999986 78999999975433 33568899999999987 9999999999876 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc--EEEccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC--AKISDFGLAR 166 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~--vKLiDFGlA~ 166 (576)
+||||+++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++
T Consensus 93 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred EEEEeCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 99999999999999876543 788889999999999999999999 999999999999987765 9999999876
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=317.65 Aligned_cols=148 Identities=25% Similarity=0.374 Sum_probs=129.1
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch--hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ--GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~--~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
.++|++.+.||+|+||.||+|+.. ++.||||++...... ....+.+|+.++..+.| +||+.+++++... ..++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~--~~~~ 78 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH-PNLVNLLEVFRRK--RRLH 78 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEET--TEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCC-CCccchhheeecC--CeEE
Confidence 478999999999999999999986 789999998654332 24567899999999987 9999999999876 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
+||||+++++|.+++..... +++..+..++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||++....
T Consensus 79 lv~e~~~~~~l~~~~~~~~~---~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQRG---VPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp EEEECCSEEHHHHHHHTSSC---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEeCCCchHHHHHhhhcC---CCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 99999999999888765443 778889999999999999999999 9999999999999999999999999987543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=309.81 Aligned_cols=148 Identities=24% Similarity=0.376 Sum_probs=128.8
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
..++|++.+.||+|+||.||+|... ++.||+|++..... .....+.+|+.++..+.| +||+++++++... ...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~ 80 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEE--SFH 80 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECS--SEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCC-CCcCeEEEEEEcC--CEE
Confidence 4689999999999999999999876 78999999975432 334578899999999976 9999999999866 788
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc---EEEcccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC---AKISDFGLA 165 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~---vKLiDFGlA 165 (576)
++||||+++++|.+.+..... +++..+..++.||+.||.|||+++ |+|+||||+||+++.++. ++|+|||++
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 999999999999988876543 678889999999999999999999 999999999999986654 999999998
Q ss_pred ccc
Q 036407 166 RLK 168 (576)
Q Consensus 166 ~~~ 168 (576)
...
T Consensus 156 ~~~ 158 (284)
T 3kk8_A 156 IEV 158 (284)
T ss_dssp EEC
T ss_pred EEc
Confidence 644
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.02 Aligned_cols=147 Identities=24% Similarity=0.316 Sum_probs=120.9
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecC---CchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSG---SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~---s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
..++|++.+.||+|+||.||+|+.. ++.||||++... .......+.+|+.++..+.| +||+.+++++... ..
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~--~~ 222 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTALKYSFQTH--DR 222 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSC-TTSCCEEEEEEET--TE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCC-CeEeeEEEEEeeC--CE
Confidence 4567999999999999999999875 789999999753 22233467788888888876 9999999999876 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
+||||||+++++|.+++..... +++..+..++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||+++
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEEEEeeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCce
Confidence 9999999999999998876543 7788899999999999999998 89 9999999999999999999999999986
Q ss_pred c
Q 036407 167 L 167 (576)
Q Consensus 167 ~ 167 (576)
.
T Consensus 298 ~ 298 (446)
T 4ejn_A 298 E 298 (446)
T ss_dssp T
T ss_pred e
Confidence 4
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=339.73 Aligned_cols=157 Identities=23% Similarity=0.264 Sum_probs=134.5
Q ss_pred ChHHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEe
Q 036407 6 SYSVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFS 80 (576)
Q Consensus 6 s~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~ 80 (576)
.+.+++...++|++.+.||+|+||.||+|+.. ++.||||++++... .....+..|+.++..+.| +||+.+++++
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~h-p~Iv~l~~~~ 130 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR-RWITQLHFAF 130 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCT-TTBCCEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCC-CCeeeEEEEE
Confidence 34555667889999999999999999999985 78999999975322 112347888999988866 9999999998
Q ss_pred eCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEc
Q 036407 81 SNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKIS 160 (576)
Q Consensus 81 ~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLi 160 (576)
... ..+||||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 131 ~~~--~~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDE--NYLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECS--SEEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEEC
T ss_pred eeC--CEEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEe
Confidence 876 889999999999999999976432 2778888999999999999999999 9999999999999999999999
Q ss_pred ccccccccc
Q 036407 161 DFGLARLKS 169 (576)
Q Consensus 161 DFGlA~~~~ 169 (576)
|||+++...
T Consensus 205 DFGla~~~~ 213 (412)
T 2vd5_A 205 DFGSCLKLR 213 (412)
T ss_dssp CCTTCEECC
T ss_pred echhheecc
Confidence 999987543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=317.75 Aligned_cols=151 Identities=27% Similarity=0.433 Sum_probs=127.1
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC-----CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
....|++.+.||+|+||.||+|+.. ...+|+|.+.... ......+.+|+.++..+.| +||+.+++++... ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~-~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVLSLLGICLRS-EG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCC-TTBCCCCEEECCS-SS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCC-CCEeeeeeEEEcC-CC
Confidence 3456888999999999999999864 2358999987533 2344678999999999976 9999999987543 36
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
..++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred ceEEEEeCCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccc
Confidence 78999999999999999976432 2677888999999999999999999 9999999999999999999999999987
Q ss_pred ccc
Q 036407 167 LKS 169 (576)
Q Consensus 167 ~~~ 169 (576)
...
T Consensus 177 ~~~ 179 (298)
T 3f66_A 177 DMY 179 (298)
T ss_dssp CCS
T ss_pred ccc
Confidence 543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=312.99 Aligned_cols=152 Identities=26% Similarity=0.414 Sum_probs=126.8
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC----chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS----LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s----~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
..++|++.+.||+|+||.||++... ++.||||++.... ......+.+|+.++..+.| +||+.+++++......
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH-KNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEECC---
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCC-CCeeEEEEEEEcCCCC
Confidence 4589999999999999999999875 6899999996432 2334678999999999976 9999999998766667
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+++||||++++ |.+.+..... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++.
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeecccccc
Confidence 899999999765 7777765432 23788889999999999999999999 9999999999999999999999999987
Q ss_pred ccc
Q 036407 167 LKS 169 (576)
Q Consensus 167 ~~~ 169 (576)
...
T Consensus 158 ~~~ 160 (305)
T 2wtk_C 158 ALH 160 (305)
T ss_dssp ECC
T ss_pred ccC
Confidence 543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=314.74 Aligned_cols=150 Identities=27% Similarity=0.440 Sum_probs=128.0
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeC-------
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN------- 82 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~------- 82 (576)
...++|++.+.||+|+||.||+|+.. ++.||||.+.... ..+.+|+.++..+.| +||+.+++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDH-VNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCC-TTBCCEEEEEEEEEEC---
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCC-CCEEEEeeeEeccccCccc
Confidence 34567999999999999999999986 8899999997543 356789999999976 999999998753
Q ss_pred -------CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC
Q 036407 83 -------PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF 155 (576)
Q Consensus 83 -------~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g 155 (576)
.....+++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETT
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCC
Confidence 223568999999999999999976432 22778889999999999999999999 99999999999999999
Q ss_pred cEEEcccccccccc
Q 036407 156 CAKISDFGLARLKS 169 (576)
Q Consensus 156 ~vKLiDFGlA~~~~ 169 (576)
.++|+|||++....
T Consensus 160 ~~kl~Dfg~~~~~~ 173 (284)
T 2a19_B 160 QVKIGDFGLVTSLK 173 (284)
T ss_dssp EEEECCCTTCEESS
T ss_pred CEEECcchhheecc
Confidence 99999999886543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.13 Aligned_cols=150 Identities=25% Similarity=0.397 Sum_probs=127.4
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchh---HHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG---EREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~---~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
....++|++.+.||+|+||.||+|+.. ++.||||++....... ...+.+|+.++..+.| +||+.+++++...
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~-- 106 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-PHVVPIHDFGEID-- 106 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEET--
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCC-CCeeEEEEEEeeC--
Confidence 345689999999999999999999975 7899999997543222 3678899999999977 9999999998876
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
..+++||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~ 181 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIA 181 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred CeEEEEEEecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccC
Confidence 789999999999999999976543 678889999999999999999999 999999999999999999999999988
Q ss_pred ccc
Q 036407 166 RLK 168 (576)
Q Consensus 166 ~~~ 168 (576)
...
T Consensus 182 ~~~ 184 (309)
T 2h34_A 182 SAT 184 (309)
T ss_dssp ---
T ss_pred ccc
Confidence 643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.99 Aligned_cols=148 Identities=30% Similarity=0.507 Sum_probs=123.6
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--Cce----EEEEEeecC-CchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQS----VAVKVMDSG-SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~----VAVK~i~~~-s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
.++|++.+.||+|+||.||+|+.. ++. ||+|.+... .......+.+|+.++..+.| +||+.+++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~--- 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTS--- 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCB-TTBCCCCEEEESS---
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCC-CCeeEEEEEEecC---
Confidence 578999999999999999999874 443 577777533 23445788999999999987 9999999998864
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
..++|++++.+|+|.+++...... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~v~~~~~~g~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 90 TVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp SEEEEECCCSSCBHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred CceEEEEecCCCcHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 478999999999999999765432 778889999999999999999999 9999999999999999999999999987
Q ss_pred ccc
Q 036407 167 LKS 169 (576)
Q Consensus 167 ~~~ 169 (576)
...
T Consensus 166 ~~~ 168 (327)
T 3lzb_A 166 LLG 168 (327)
T ss_dssp ---
T ss_pred Ecc
Confidence 543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=312.57 Aligned_cols=146 Identities=29% Similarity=0.454 Sum_probs=128.4
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
..++|++.+.||+|+||.||+|+.. +..||||++..... .....+.+|+.++..+.| +||+.+++++... ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~ 83 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH-PNILRLYGYFHDA--TR 83 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECS--SE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCC-CCCcchhheEecC--CE
Confidence 4578999999999999999999876 57899999964322 224568899999999986 9999999999876 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
+++||||+++++|.+.+..... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++.
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~ 157 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSV 157 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred EEEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccc
Confidence 9999999999999998876543 678888999999999999999999 9999999999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=322.54 Aligned_cols=158 Identities=26% Similarity=0.425 Sum_probs=125.4
Q ss_pred HHHHhhcCCCCccceeeccCcEEEEEEEEC-----CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEe
Q 036407 8 SVLRRAADSFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFS 80 (576)
Q Consensus 8 ~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~ 80 (576)
.++....++|.+.+.||+|+||.||+|... +..||||.+.... ......+.+|+.++..+.| +||+++++++
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~ 105 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH-PNVIRLLGVC 105 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCC-TTBCCCCEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCC-CCeeeeeEEE
Confidence 344556678899999999999999999764 3479999997543 2334578899999999976 9999999998
Q ss_pred eCCCC---CeEEEEEeccCCCCHHHHHHhc---CCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC
Q 036407 81 SNPKR---HRMLLVYELMSNGNLQDALLHK---KPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN 154 (576)
Q Consensus 81 ~~~s~---~~l~LVmE~~~gGsL~d~L~~~---~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~ 154 (576)
..... ...++||||+++++|.+++... .....+++..++.++.||+.||.|||+++ |+|+||||+|||++.+
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDD 183 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC
Confidence 76533 2569999999999999988542 12234788899999999999999999999 9999999999999999
Q ss_pred CcEEEccccccccc
Q 036407 155 FCAKISDFGLARLK 168 (576)
Q Consensus 155 g~vKLiDFGlA~~~ 168 (576)
+.+||+|||++...
T Consensus 184 ~~~kl~Dfg~~~~~ 197 (313)
T 3brb_A 184 MTVCVADFGLSKKI 197 (313)
T ss_dssp SCEEECSCSCC---
T ss_pred CcEEEeecCcceec
Confidence 99999999998654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=316.78 Aligned_cols=155 Identities=20% Similarity=0.350 Sum_probs=130.2
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
..++|++.+.||+|+||.||+++.. ++.||+|.+..... ...+.+.+|+.++..+.| +||+++++++.......+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH-PNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCC-CCCCeEEEEEecCCCceE
Confidence 3468999999999999999999975 78999999975432 334678999999999976 999999998876556889
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCC---CCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 89 LLVYELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLN---PPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g---~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ .+|+|+||||+|||++.++.++|+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999999999999986532 1223778889999999999999999865 3499999999999999999999999998
Q ss_pred cccc
Q 036407 165 ARLK 168 (576)
Q Consensus 165 A~~~ 168 (576)
+...
T Consensus 163 ~~~~ 166 (279)
T 2w5a_A 163 ARIL 166 (279)
T ss_dssp HHHC
T ss_pred heee
Confidence 8654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=327.31 Aligned_cols=145 Identities=26% Similarity=0.399 Sum_probs=125.3
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
..++|++.+.||+|+||.||+|+.. ++.||||++..... ...+|+.++..+.+||||+.+++++... ..+|+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDG--KYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECS--SEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcC--CEEEE
Confidence 4578999999999999999999976 78999999975432 2356888888887679999999998876 88999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC----CcEEEccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN----FCAKISDFGLAR 166 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~----g~vKLiDFGlA~ 166 (576)
|||||++|+|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||+... +.+||+|||++.
T Consensus 94 v~E~~~gg~L~~~i~~~~~---~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EECCCCSCBHHHHHHTCTT---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999999999998876543 788899999999999999999999 9999999999998543 359999999987
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 169 ~~ 170 (342)
T 2qr7_A 169 QL 170 (342)
T ss_dssp EC
T ss_pred cC
Confidence 54
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.12 Aligned_cols=149 Identities=30% Similarity=0.504 Sum_probs=126.0
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--Cce--EEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQS--VAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~--VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
.++|++.+.||+|+||.||+|+.. +.. +|||.+.... ......+.+|+.++..+.+|+||+++++++... ..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~ 101 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYL 101 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--Cce
Confidence 368899999999999999999865 444 5999987432 233456889999999996669999999999876 789
Q ss_pred EEEEeccCCCCHHHHHHhcC-------------CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC
Q 036407 89 LLVYELMSNGNLQDALLHKK-------------PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF 155 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~-------------~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g 155 (576)
++||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCCC
Confidence 99999999999999997643 1123788899999999999999999999 99999999999999999
Q ss_pred cEEEccccccc
Q 036407 156 CAKISDFGLAR 166 (576)
Q Consensus 156 ~vKLiDFGlA~ 166 (576)
.+||+|||++.
T Consensus 180 ~~kL~Dfg~~~ 190 (327)
T 1fvr_A 180 VAKIADFGLSR 190 (327)
T ss_dssp CEEECCTTCEE
T ss_pred eEEEcccCcCc
Confidence 99999999876
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=319.23 Aligned_cols=150 Identities=23% Similarity=0.352 Sum_probs=124.8
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhcc----------CCceEEEEEEee
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQ----------DDHVVSVLGFSS 81 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h----------~pNIv~Llg~~~ 81 (576)
.++|++.+.||+|+||.||+|+.. ++.||||++... ......+.+|+.++..+.+ |+||+.+++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 468999999999999999999964 789999999743 2334568899999988873 489999999887
Q ss_pred CC--CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhC-CCCeeecccCCCCeEEc------
Q 036407 82 NP--KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL-NPPVIHGDIKPSNILLD------ 152 (576)
Q Consensus 82 ~~--s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~-g~~IVHrDLKPeNILLd------ 152 (576)
.. ....+++|||++ +++|.+++...... .+++..++.++.||+.||.|||++ + |+|+||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHR-GIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhcc-CCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCCCc
Confidence 53 224789999999 88999998764432 267888999999999999999997 9 99999999999994
Q ss_pred CCCcEEEccccccccc
Q 036407 153 HNFCAKISDFGLARLK 168 (576)
Q Consensus 153 ~~g~vKLiDFGlA~~~ 168 (576)
..+.+||+|||++...
T Consensus 173 ~~~~~kl~Dfg~a~~~ 188 (373)
T 1q8y_A 173 NLIQIKIADLGNACWY 188 (373)
T ss_dssp TEEEEEECCCTTCEET
T ss_pred CcceEEEccccccccc
Confidence 3458999999988643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=312.50 Aligned_cols=152 Identities=27% Similarity=0.446 Sum_probs=131.5
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPK 84 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s 84 (576)
+....++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +||+.+++++...
T Consensus 6 ~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~- 83 (278)
T 3cok_A 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH-PSILELYNYFEDS- 83 (278)
T ss_dssp HCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCC-TTBCCEEEEEECS-
T ss_pred cccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCC-CCeEeEEEEEccC-
Confidence 3445678999999999999999999974 78999999964322 123578899999999976 9999999998876
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
..+++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||+
T Consensus 84 -~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~ 158 (278)
T 3cok_A 84 -NYVYLVLEMCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGL 158 (278)
T ss_dssp -SEEEEEEECCTTEEHHHHHHTCSS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTT
T ss_pred -CeEEEEEecCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecc
Confidence 789999999999999999876432 2788889999999999999999999 99999999999999999999999998
Q ss_pred cccc
Q 036407 165 ARLK 168 (576)
Q Consensus 165 A~~~ 168 (576)
+...
T Consensus 159 ~~~~ 162 (278)
T 3cok_A 159 ATQL 162 (278)
T ss_dssp CEEC
T ss_pred eeec
Confidence 8654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=314.32 Aligned_cols=146 Identities=25% Similarity=0.421 Sum_probs=123.3
Q ss_pred CCccceeeccCcEEEEEEEEC--C---ceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 17 FSPSRLLGQGGFGSVFHATLH--D---QSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~--g---~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
|.+.+.||+|+||.||+|+.. + ..||+|.+..... ...+.+.+|+.++..+.| +||+.+++++.... ...++
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~-~~~~~ 100 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH-PNVLALIGIMLPPE-GLPHV 100 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCC-TTBCCCCEEECCSS-SCCEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEecCC-CCcEE
Confidence 445689999999999999863 2 3699999975332 344678899999999976 99999999987652 44589
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||||+.+++|.+++..... .+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||++...
T Consensus 101 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp EECCCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EEecccCCCHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 9999999999999976432 2678888999999999999999999 999999999999999999999999998744
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=329.22 Aligned_cols=148 Identities=24% Similarity=0.337 Sum_probs=129.7
Q ss_pred cCCCCccceeeccCcEEEEEEEE-----CCceEEEEEeecCC----chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATL-----HDQSVAVKVMDSGS----LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK 84 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~-----~g~~VAVK~i~~~s----~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s 84 (576)
.++|++.+.||+|+||.||+|+. .++.||||++.... ......+.+|+.++..+.+|+||+.+++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence 47899999999999999999987 47899999986432 123345778999999998779999999998776
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
..++|||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 132 -~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 132 -TKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp -TEEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred -ceEEEEeecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 789999999999999999976543 678888999999999999999999 99999999999999999999999999
Q ss_pred cccc
Q 036407 165 ARLK 168 (576)
Q Consensus 165 A~~~ 168 (576)
++..
T Consensus 206 a~~~ 209 (355)
T 1vzo_A 206 SKEF 209 (355)
T ss_dssp EEEC
T ss_pred Ceec
Confidence 8754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=312.06 Aligned_cols=149 Identities=25% Similarity=0.327 Sum_probs=127.2
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
+.|.....||+|+||.||+|+.. +..||||.+........+.+.+|+.++..+.| +||+.+++++... ..+++||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~--~~~~lv~ 98 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSFSEN--GFIKIFM 98 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCC-TTBCCEEEEEEET--TEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCC-CCEeeEeeEEEeC--CcEEEEE
Confidence 44555669999999999999975 68899999986655556778999999999976 9999999999876 7899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC-CCcEEEccccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH-NFCAKISDFGLARLK 168 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~-~g~vKLiDFGlA~~~ 168 (576)
||+++++|.+++........+++..+..++.||+.||.|||+++ |+|+||||+|||++. ++.++|+|||++...
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 99999999999977543334567888889999999999999999 999999999999987 899999999988654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=335.66 Aligned_cols=147 Identities=29% Similarity=0.436 Sum_probs=123.4
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecC--CchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC----
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSG--SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK---- 84 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~--s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s---- 84 (576)
..++|++.+.||+|+||.||+|+.. ++.||||++... .......+.+|+.++..+.| +||+.+++++....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH-KNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCC-TTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCC-CCCCcEEEEEccCCcccc
Confidence 4578999999999999999999875 789999999753 22334678899999999976 99999999986542
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
...+||||||+++ +|.+.+... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~~-----l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTSC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CCeEEEEEeCCCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 3578999999965 566666432 677888899999999999999999 99999999999999999999999999
Q ss_pred cccc
Q 036407 165 ARLK 168 (576)
Q Consensus 165 A~~~ 168 (576)
++..
T Consensus 211 a~~~ 214 (464)
T 3ttj_A 211 ARTA 214 (464)
T ss_dssp C---
T ss_pred eeec
Confidence 8643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=326.02 Aligned_cols=161 Identities=25% Similarity=0.359 Sum_probs=133.3
Q ss_pred CCCCCChHHHH----hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch--------hHHHHHHHHHHHHH
Q 036407 1 PPHRFSYSVLR----RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ--------GEREFYNELYFASL 66 (576)
Q Consensus 1 ~~~~fs~~~lk----~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~--------~~~~~l~EI~iLs~ 66 (576)
||..+++..+. ...++|++.+.||+|+||.||+|+.. ++.||||++...... ....+.+|+.++..
T Consensus 6 p~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 85 (335)
T 3dls_A 6 PPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85 (335)
T ss_dssp ---CEECCHHHHHTTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTT
T ss_pred CcccccccccccCCcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHh
Confidence 44455555553 34568999999999999999999865 789999999764321 22356789999999
Q ss_pred hccCCceEEEEEEeeCCCCCeEEEEEeccCCC-CHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccC
Q 036407 67 LEQDDHVVSVLGFSSNPKRHRMLLVYELMSNG-NLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIK 145 (576)
Q Consensus 67 L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~gG-sL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLK 145 (576)
+.| +||+++++++... ..+++||||+.+| +|.+++..... +++..++.++.||+.||.|||+++ |+|+|||
T Consensus 86 l~h-~~Iv~~~~~~~~~--~~~~lv~e~~~~g~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlk 157 (335)
T 3dls_A 86 VEH-ANIIKVLDIFENQ--GFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYLRLKD--IIHRDIK 157 (335)
T ss_dssp CCC-TTBCCEEEEEECS--SEEEEEEECCTTSCBHHHHHHTCCC---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred CCC-CCEeeEEEEEeeC--CEEEEEEEeCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eEEeccC
Confidence 976 9999999999876 7899999998766 99998876543 788889999999999999999999 9999999
Q ss_pred CCCeEEcCCCcEEEcccccccccc
Q 036407 146 PSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 146 PeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|+|||++.++.+||+|||++....
T Consensus 158 p~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 158 DENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp GGGEEECTTSCEEECCCTTCEECC
T ss_pred HHHEEEcCCCcEEEeecccceECC
Confidence 999999999999999999987543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.20 Aligned_cols=149 Identities=23% Similarity=0.365 Sum_probs=129.1
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
+.++|++.++||+|+||.||+|+.. ++.||||++..... ...+..|+.++..|.|++++..+..++... ...+|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~--~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEG--DYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEET--TEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeC--CEEEE
Confidence 4689999999999999999999965 88999999875432 235789999999999988888887777655 78899
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE---cCCCcEEEcccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLARL 167 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL---d~~g~vKLiDFGlA~~ 167 (576)
||||+ +++|.+++..... .+++..++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.
T Consensus 81 vme~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEECC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 99999 9999999975433 2788899999999999999999999 9999999999999 5889999999999986
Q ss_pred ccC
Q 036407 168 KSV 170 (576)
Q Consensus 168 ~~~ 170 (576)
...
T Consensus 156 ~~~ 158 (483)
T 3sv0_A 156 YRD 158 (483)
T ss_dssp CBC
T ss_pred ccC
Confidence 543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.06 Aligned_cols=148 Identities=24% Similarity=0.422 Sum_probs=127.6
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
...++|.+.+.||+|+||.||+|+.. ++.||||++..........+.+|+.++..+.| +||+.+++++... ..++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~ 82 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-ENIVTLEDIYEST--THYY 82 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCC-TTBCCEEEEEECS--SEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCC-CCeeehhhhcccC--CEEE
Confidence 34568999999999999999999975 78999999986554455678899999999976 9999999998876 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE---cCCCcEEEccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLAR 166 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL---d~~g~vKLiDFGlA~ 166 (576)
+||||+++++|.+.+..... +++..++.++.||+.||.|||+++ |+|+||||+||++ +.++.++|+|||++.
T Consensus 83 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGV---YTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEEEcCCCccHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 99999999999998876543 678888999999999999999999 9999999999999 778899999999875
Q ss_pred c
Q 036407 167 L 167 (576)
Q Consensus 167 ~ 167 (576)
.
T Consensus 158 ~ 158 (304)
T 2jam_A 158 M 158 (304)
T ss_dssp C
T ss_pred e
Confidence 3
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.53 Aligned_cols=143 Identities=26% Similarity=0.435 Sum_probs=121.0
Q ss_pred cceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCC
Q 036407 20 SRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSN 97 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~g 97 (576)
.+.||+|+||.||+|+.. ++.||||++........+.+.+|+.++..+.| +||+++++++... ..++|||||+++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~--~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH-ANLIQLYDAFESK--NDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEECS--SEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCC-CCCCeEEEEEEEC--CEEEEEEeCCCC
Confidence 568999999999999875 78999999987666667789999999999976 9999999999876 789999999999
Q ss_pred CCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE--cCCCcEEEcccccccccc
Q 036407 98 GNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL--DHNFCAKISDFGLARLKS 169 (576)
Q Consensus 98 GsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL--d~~g~vKLiDFGlA~~~~ 169 (576)
++|.+.+..... .+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 171 ~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 171 GELFDRIIDESY--NLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp CEEHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 999988865332 2678888899999999999999999 9999999999999 567899999999987543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=320.17 Aligned_cols=146 Identities=25% Similarity=0.422 Sum_probs=123.9
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchh-HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG-EREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~-~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
++|++.+.||+|+||.||+|+.. ++.||||++....... ...+.+|+.++..+.| +||+.+++++... ..+++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIIHTE--KSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCC-TTBCCEEEEEECS--SCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCC-CCCCeeeeEEeeC--CEEEEE
Confidence 68999999999999999999976 7899999996533211 1234578999999976 9999999999876 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||++ ++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++...
T Consensus 79 ~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 150 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAK 150 (324)
T ss_dssp EECCS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred ecccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence 99996 599988876543 2778888999999999999999999 999999999999999999999999998643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=319.57 Aligned_cols=151 Identities=26% Similarity=0.445 Sum_probs=120.9
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchh-----HHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG-----EREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~-----~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
+....++|++.+.||+|+||.||+|+.. ++.||||++....... ...+.+|+.++..+.| +||+.+++++..
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~ 83 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNIIGLLDAFGH 83 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC-TTBCCEEEEECC
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCC-CCCCeEEEEEee
Confidence 4456789999999999999999999875 7899999997532211 2367899999999976 999999999876
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccc
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDF 162 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDF 162 (576)
. ..+++||||+++ +|.+.+..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+||
T Consensus 84 ~--~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Df 156 (346)
T 1ua2_A 84 K--SNISLVFDFMET-DLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADF 156 (346)
T ss_dssp T--TCCEEEEECCSE-EHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC
T ss_pred C--CceEEEEEcCCC-CHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEec
Confidence 6 778999999975 89888865432 2677788899999999999999999 999999999999999999999999
Q ss_pred cccccc
Q 036407 163 GLARLK 168 (576)
Q Consensus 163 GlA~~~ 168 (576)
|++...
T Consensus 157 g~a~~~ 162 (346)
T 1ua2_A 157 GLAKSF 162 (346)
T ss_dssp GGGSTT
T ss_pred ccceec
Confidence 998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=320.28 Aligned_cols=157 Identities=24% Similarity=0.370 Sum_probs=134.3
Q ss_pred hHHHHhhcCCCCcc-ceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEee
Q 036407 7 YSVLRRAADSFSPS-RLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSS 81 (576)
Q Consensus 7 ~~~lk~~~d~Y~i~-e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~ 81 (576)
++......+.|.+. +.||+|+||.||+|+.. ++.||||++.... ......+.+|+.++..+.+|+||+.+++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 44556666778887 89999999999999876 7899999997532 2335678999999999999999999999998
Q ss_pred CCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC---CCcEE
Q 036407 82 NPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH---NFCAK 158 (576)
Q Consensus 82 ~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~---~g~vK 158 (576)
.. ..+++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++. ++.+|
T Consensus 100 ~~--~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 100 NT--SEIILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp CS--SEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEE
T ss_pred eC--CeEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEE
Confidence 76 789999999999999988754322 23788899999999999999999999 999999999999987 78999
Q ss_pred Eccccccccc
Q 036407 159 ISDFGLARLK 168 (576)
Q Consensus 159 LiDFGlA~~~ 168 (576)
|+|||++...
T Consensus 175 L~Dfg~a~~~ 184 (327)
T 3lm5_A 175 IVDFGMSRKI 184 (327)
T ss_dssp ECCGGGCEEC
T ss_pred EeeCcccccc
Confidence 9999998754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=329.34 Aligned_cols=149 Identities=27% Similarity=0.346 Sum_probs=127.0
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhcc-----CCceEEEEEEeeCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQ-----DDHVVSVLGFSSNPK 84 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h-----~pNIv~Llg~~~~~s 84 (576)
.+.++|++.+.||+|+||.||+|+.. ++.||||++... ......+..|+.++..+.+ |+||+.+++++...
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~- 171 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR- 171 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-
Confidence 34567999999999999999999876 689999999743 2334567889998888864 46999999998876
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc--EEEccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC--AKISDF 162 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~--vKLiDF 162 (576)
..+|+||||+. ++|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 172 -~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 172 -NHICMTFELLS-MNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp -TEEEEEECCCC-CBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCC
T ss_pred -CeEEEEEeccC-CCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeec
Confidence 88999999995 6999988765432 2678889999999999999999999 999999999999999887 999999
Q ss_pred ccccc
Q 036407 163 GLARL 167 (576)
Q Consensus 163 GlA~~ 167 (576)
|++..
T Consensus 247 G~a~~ 251 (429)
T 3kvw_A 247 GSSCY 251 (429)
T ss_dssp TTCEE
T ss_pred cccee
Confidence 98853
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=349.23 Aligned_cols=154 Identities=31% Similarity=0.513 Sum_probs=131.8
Q ss_pred hHHHHhhcCCCCccceeeccCcEEEEEEEECC-ceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 7 YSVLRRAADSFSPSRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 7 ~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~g-~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
...+....++|++.+.||+|+||.||+|.+.+ ..||||++..... ..+.+.+|+.++..|.| +||+++++++..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h-pniv~~~~~~~~--- 333 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRH-EKLVQLYAVVSE--- 333 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCC-TTBCCEEEEECS---
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCC-CCEeeEEEEEee---
Confidence 34445566788999999999999999999884 6799999976443 35679999999999987 999999999864
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
..+||||||+++|+|.+++..... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred ccceEeeehhcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 568999999999999999965321 12677888999999999999999999 999999999999999999999999998
Q ss_pred ccc
Q 036407 166 RLK 168 (576)
Q Consensus 166 ~~~ 168 (576)
+..
T Consensus 411 ~~~ 413 (535)
T 2h8h_A 411 RLI 413 (535)
T ss_dssp TTC
T ss_pred eec
Confidence 654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=305.60 Aligned_cols=147 Identities=27% Similarity=0.396 Sum_probs=129.4
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch------hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ------GEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~------~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
.++|++.+.||+|+||.||+|+.. ++.||+|++...... ....+.+|+.++..+.| +||+.+++++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~-- 80 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH-PNIITLHDIFENK-- 80 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS--
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCC-CCeeehhheecCC--
Confidence 367999999999999999999986 789999999754321 35678999999999986 9999999999876
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC----cEEEcc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF----CAKISD 161 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g----~vKLiD 161 (576)
..+++||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+||+++.++ .++|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred CeEEEEEeecCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEe
Confidence 789999999999999999976443 778889999999999999999999 99999999999998877 899999
Q ss_pred ccccccc
Q 036407 162 FGLARLK 168 (576)
Q Consensus 162 FGlA~~~ 168 (576)
||++...
T Consensus 156 fg~~~~~ 162 (283)
T 3bhy_A 156 FGIAHKI 162 (283)
T ss_dssp CTTCEEC
T ss_pred cccceec
Confidence 9988644
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=322.09 Aligned_cols=149 Identities=24% Similarity=0.404 Sum_probs=124.2
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchh--HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG--EREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~--~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
....++|++.+.||+|+||.||+|+.. ++.||||++....... ...+.+|+.++..+.| +||+.+++++... .
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~ 106 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH-RNIIELKSVIHHN--H 106 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCC-TTBCCEEEEEEET--T
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCC-CCcceEEEEEecC--C
Confidence 355678999999999999999999865 7899999997543322 3467899999999976 9999999999876 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEc-----CCCcEEEcc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLD-----HNFCAKISD 161 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd-----~~g~vKLiD 161 (576)
.+++||||++ ++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+|||++ ..+.+||+|
T Consensus 107 ~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 107 RLHLIFEYAE-NDLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EEEEEEECCS-EEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EEEEEEecCC-CCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECc
Confidence 8999999997 599999877544 778889999999999999999999 99999999999994 455699999
Q ss_pred ccccccc
Q 036407 162 FGLARLK 168 (576)
Q Consensus 162 FGlA~~~ 168 (576)
||++...
T Consensus 181 fg~a~~~ 187 (329)
T 3gbz_A 181 FGLARAF 187 (329)
T ss_dssp TTHHHHH
T ss_pred CCCcccc
Confidence 9998754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=319.88 Aligned_cols=152 Identities=26% Similarity=0.423 Sum_probs=131.9
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch--------hHHHHHHHHHHHHHhccCCceEEEEEEe
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ--------GEREFYNELYFASLLEQDDHVVSVLGFS 80 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~--------~~~~~l~EI~iLs~L~h~pNIv~Llg~~ 80 (576)
....++|++.+.||+|+||.||+|+.. |+.||||++...... ....+.+|+.++..+..|+||+.+++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 445578999999999999999999985 789999999754311 1346789999999996669999999998
Q ss_pred eCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEc
Q 036407 81 SNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKIS 160 (576)
Q Consensus 81 ~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLi 160 (576)
... ...++||||+++++|.+++..... +++..+..++.||+.||.|||+.| |+|+||||+|||++.++.++|+
T Consensus 170 ~~~--~~~~lv~e~~~g~~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 170 ESS--SFMFLVFDLMRKGELFDYLTEKVA---LSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EBS--SEEEEEECCCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEEC
T ss_pred eeC--CEEEEEEEeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEE
Confidence 876 789999999999999999876543 778889999999999999999999 9999999999999999999999
Q ss_pred ccccccccc
Q 036407 161 DFGLARLKS 169 (576)
Q Consensus 161 DFGlA~~~~ 169 (576)
|||++....
T Consensus 243 DfG~~~~~~ 251 (365)
T 2y7j_A 243 DFGFSCHLE 251 (365)
T ss_dssp CCTTCEECC
T ss_pred ecCcccccC
Confidence 999886543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=313.71 Aligned_cols=147 Identities=27% Similarity=0.411 Sum_probs=129.4
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
..+.|++.+.||+|+||.||+|+.. ++.||||++.... ......+.+|+.++..+.| +||+.+++++... ..++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~ 96 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKD--TKLW 96 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCC-TTBCCEEEEEEET--TEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEecC--CeEE
Confidence 3467999999999999999999875 7899999997543 2345678999999999976 9999999998876 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||||+++++|.+++... .+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++...
T Consensus 97 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQL 169 (303)
T ss_dssp EEEECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceec
Confidence 999999999999988642 2678889999999999999999999 999999999999999999999999998654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=318.65 Aligned_cols=158 Identities=23% Similarity=0.374 Sum_probs=132.8
Q ss_pred CCCCChHHHHhhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCc--hhHHHHHHHHHHHHHhcc-CCceEEEE
Q 036407 2 PHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQ-DDHVVSVL 77 (576)
Q Consensus 2 ~~~fs~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h-~pNIv~Ll 77 (576)
+..+.++.+....++|++.+.||+|+||.||++... ++.||||++..... .....+.+|+.++..+.+ ++||+.++
T Consensus 15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp -----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred CCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence 345777788888889999999999999999999876 78899999975432 334678999999999986 79999999
Q ss_pred EEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcE
Q 036407 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA 157 (576)
Q Consensus 78 g~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~v 157 (576)
+++... ..+++||| +.+++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+|||++ ++.+
T Consensus 95 ~~~~~~--~~~~lv~e-~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~~~~ 165 (313)
T 3cek_A 95 DYEITD--QYIYMVME-CGNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGML 165 (313)
T ss_dssp EEEECS--SEEEEEEC-CCSEEHHHHHHHCSS---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEE
T ss_pred EEeecC--CEEEEEEe-cCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE-CCeE
Confidence 998876 78999999 558899999987543 677888899999999999999999 99999999999996 4899
Q ss_pred EEccccccccc
Q 036407 158 KISDFGLARLK 168 (576)
Q Consensus 158 KLiDFGlA~~~ 168 (576)
||+|||++...
T Consensus 166 kL~Dfg~~~~~ 176 (313)
T 3cek_A 166 KLIDFGIANQM 176 (313)
T ss_dssp EECCCSSSCC-
T ss_pred EEeeccccccc
Confidence 99999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=309.50 Aligned_cols=148 Identities=30% Similarity=0.449 Sum_probs=129.3
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
..++|++.+.||+|+||.||+|+.. ++.||||++.... ......+.+|+.++..+.| +||+++++++... ...+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~ 81 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREG--NIQY 81 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCC-TTBCCEEEEEEET--TEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCC-CCceeeeeEEEcC--CEEE
Confidence 3467999999999999999999876 7899999997433 2345678899999999976 9999999998876 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp EEEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 9999999999998876533 2778889999999999999999999 999999999999999999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=324.25 Aligned_cols=157 Identities=33% Similarity=0.475 Sum_probs=128.4
Q ss_pred hHHHH-hhcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecC-CchhHHHHHHHHHHHHHhccCCceEEEE
Q 036407 7 YSVLR-RAADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSG-SLQGEREFYNELYFASLLEQDDHVVSVL 77 (576)
Q Consensus 7 ~~~lk-~~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~-s~~~~~~~l~EI~iLs~L~h~pNIv~Ll 77 (576)
++++. ...++|++.+.||+|+||.||+|+.. +..||||.+... .......+.+|+.++..+.| +||+.++
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~ 99 (327)
T 2yfx_A 21 ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH-QNIVRCI 99 (327)
T ss_dssp GGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEE
T ss_pred hhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCC-CCCCeEE
Confidence 44443 45679999999999999999999832 568999999643 23445678899999999966 9999999
Q ss_pred EEeeCCCCCeEEEEEeccCCCCHHHHHHhcCC----CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC
Q 036407 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH 153 (576)
Q Consensus 78 g~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~----~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~ 153 (576)
+++... ..+|+||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.
T Consensus 100 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~ 175 (327)
T 2yfx_A 100 GVSLQS--LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTC 175 (327)
T ss_dssp EEECSS--SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESC
T ss_pred EEEcCC--CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEec
Confidence 998876 678999999999999999976532 123678889999999999999999999 999999999999984
Q ss_pred ---CCcEEEccccccccc
Q 036407 154 ---NFCAKISDFGLARLK 168 (576)
Q Consensus 154 ---~g~vKLiDFGlA~~~ 168 (576)
+..++|+|||++...
T Consensus 176 ~~~~~~~kl~Dfg~~~~~ 193 (327)
T 2yfx_A 176 PGPGRVAKIGDFGMARDI 193 (327)
T ss_dssp SSTTCCEEECCCHHHHHH
T ss_pred CCCcceEEECcccccccc
Confidence 446999999988643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.51 Aligned_cols=153 Identities=27% Similarity=0.348 Sum_probs=129.0
Q ss_pred HHHhhcCCCCccceeeccCcEEEEEEE-------ECCceEEEEEeecCCchhHHHHHHHHHHHHHhcc--CCceEEEEEE
Q 036407 9 VLRRAADSFSPSRLLGQGGFGSVFHAT-------LHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQ--DDHVVSVLGF 79 (576)
Q Consensus 9 ~lk~~~d~Y~i~e~LG~GsfG~Vyka~-------~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h--~pNIv~Llg~ 79 (576)
++....++|.+.+.||+|+||.||+|+ ..++.||||++... ....+..|+.++..+.+ |+|++.++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 344566789999999999999999994 23789999999654 34467788888877763 4899999999
Q ss_pred eeCCCCCeEEEEEeccCCCCHHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC----
Q 036407 80 SSNPKRHRMLLVYELMSNGNLQDALLHKK--PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH---- 153 (576)
Q Consensus 80 ~~~~s~~~l~LVmE~~~gGsL~d~L~~~~--~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~---- 153 (576)
+... +..|||||||++|+|.+++.... ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.
T Consensus 136 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 136 HLFQ--NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EECS--SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTC
T ss_pred eecC--CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccC
Confidence 9877 78899999999999999997521 1234888999999999999999999999 999999999999998
Q ss_pred -------CCcEEEccccccccc
Q 036407 154 -------NFCAKISDFGLARLK 168 (576)
Q Consensus 154 -------~g~vKLiDFGlA~~~ 168 (576)
++.+||+|||+++..
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~ 233 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDM 233 (365)
T ss_dssp C------CTTEEECCCTTCEEG
T ss_pred ccccccccCCEEEeeCchhhhh
Confidence 899999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=332.12 Aligned_cols=148 Identities=26% Similarity=0.404 Sum_probs=119.7
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHH-HHhccCCceEEEEEEeeCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFA-SLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iL-s~L~h~pNIv~Llg~~~~~s~ 85 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++.+... .....+..|..++ ..+. |+||+.+++++...
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~~-- 111 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTA-- 111 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEEECS--
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEeC--
Confidence 34568999999999999999999986 68899999975432 2233456666653 3444 59999999998876
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
..+|+||||+++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a 186 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRERC---FLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLC 186 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCccc
Confidence 799999999999999999876543 677888889999999999999999 999999999999999999999999998
Q ss_pred cc
Q 036407 166 RL 167 (576)
Q Consensus 166 ~~ 167 (576)
+.
T Consensus 187 ~~ 188 (373)
T 2r5t_A 187 KE 188 (373)
T ss_dssp GG
T ss_pred cc
Confidence 64
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=325.72 Aligned_cols=145 Identities=32% Similarity=0.435 Sum_probs=125.2
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch---hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~---~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
+.|++.+.||+|+||.||+|+.. ++.||||++...... ....+.+|+.++..+.| +||+.+++++... ..++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~--~~~~ 130 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLRE--HTAW 130 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEET--TEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEEC--CeEE
Confidence 45888999999999999999864 789999999754322 23568899999999976 9999999999876 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+||||+. |+|.+.+..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++..
T Consensus 131 lv~e~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp EEEECCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EEEecCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 9999996 588887765332 2778889999999999999999999 99999999999999999999999998764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=329.96 Aligned_cols=152 Identities=26% Similarity=0.411 Sum_probs=117.8
Q ss_pred hhcCCCCc-cceeeccCcEEEEEEEEC----CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 12 RAADSFSP-SRLLGQGGFGSVFHATLH----DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 12 ~~~d~Y~i-~e~LG~GsfG~Vyka~~~----g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
...+.|++ .++||+|+||.||+|+.. ++.||||++..... ...+.+|+.++..|.| +||+.+++++......
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKH-PNVISLQKVFLSHADR 93 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCC-TTBCCCCEEEEETTTT
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCC-CCeeeEeeEEecCCCC
Confidence 34455666 458999999999999964 67899999975432 3467899999999986 9999999999766668
Q ss_pred eEEEEEeccCCCCHHHHHHhcC------CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE----cCCCc
Q 036407 87 RMLLVYELMSNGNLQDALLHKK------PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL----DHNFC 156 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~------~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL----d~~g~ 156 (576)
.+||||||+. ++|.+.+.... ....+++..++.|+.||+.||.|||+++ |+||||||+|||+ +.++.
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTC
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCc
Confidence 9999999996 58888775321 1113778889999999999999999999 9999999999999 67789
Q ss_pred EEEcccccccccc
Q 036407 157 AKISDFGLARLKS 169 (576)
Q Consensus 157 vKLiDFGlA~~~~ 169 (576)
+||+|||+++...
T Consensus 171 ~kl~Dfg~a~~~~ 183 (405)
T 3rgf_A 171 VKIADMGFARLFN 183 (405)
T ss_dssp EEECCTTCCC---
T ss_pred EEEEECCCceecC
Confidence 9999999987543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=307.12 Aligned_cols=152 Identities=25% Similarity=0.366 Sum_probs=131.6
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---------hhHHHHHHHHHHHHHhccCCceEEEEE
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---------QGEREFYNELYFASLLEQDDHVVSVLG 78 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---------~~~~~~l~EI~iLs~L~h~pNIv~Llg 78 (576)
.....++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.+|+||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 3456789999999999999999999985 68999999975431 123567899999999986699999999
Q ss_pred EeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEE
Q 036407 79 FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAK 158 (576)
Q Consensus 79 ~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vK 158 (576)
++... ..+++||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++
T Consensus 92 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~k 164 (298)
T 1phk_A 92 TYETN--TFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIK 164 (298)
T ss_dssp EEECS--SEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEE
T ss_pred eeccC--CeEEEEEeccCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEE
Confidence 99766 889999999999999999976543 678889999999999999999999 99999999999999999999
Q ss_pred Eccccccccc
Q 036407 159 ISDFGLARLK 168 (576)
Q Consensus 159 LiDFGlA~~~ 168 (576)
|+|||++...
T Consensus 165 l~dfg~~~~~ 174 (298)
T 1phk_A 165 LTDFGFSCQL 174 (298)
T ss_dssp ECCCTTCEEC
T ss_pred Eecccchhhc
Confidence 9999988654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=309.93 Aligned_cols=149 Identities=28% Similarity=0.364 Sum_probs=127.0
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeC--CCCCeE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSN--PKRHRM 88 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~--~s~~~l 88 (576)
..|++.+.||+|+||.||+|... +..||+|.+.... ......+.+|+.++..+.| +||+.+++++.. .....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCC-CCeeeeeeeeccccCCCceE
Confidence 44788899999999999999876 6789999987532 2344678899999999976 999999998754 234678
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEc-CCCcEEEcccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLD-HNFCAKISDFGLARL 167 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd-~~g~vKLiDFGlA~~ 167 (576)
++||||+++++|.+++..... +++..++.++.||+.||.|||+.+++|+|+||||+|||++ .++.++|+|||++..
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEecCCCCHHHHHHHccC---CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999999976543 6788889999999999999999876699999999999997 789999999998753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=320.31 Aligned_cols=152 Identities=26% Similarity=0.348 Sum_probs=126.8
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCc-----eEEEEEEeeC
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH-----VVSVLGFSSN 82 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pN-----Iv~Llg~~~~ 82 (576)
.....++|++.+.||+|+||.||+|+.. ++.||||++... ......+..|+.++..+.++++ ++.+++++..
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 3456789999999999999999999876 788999999743 2334567888999999887664 8999998887
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh--CCCCeeecccCCCCeEEc--CCCcEE
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS--LNPPVIHGDIKPSNILLD--HNFCAK 158 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs--~g~~IVHrDLKPeNILLd--~~g~vK 158 (576)
. ..+||||||+. ++|.+++...... .+++..+..++.||+.||.|||. .+ |+||||||+|||++ .++.+|
T Consensus 128 ~--~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~~~--ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 128 R--NHLCLVFEMLS-YNLYDLLRNTNFR-GVSLNLTRKFAQQMCTALLFLATPELS--IIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp T--TEEEEEEECCC-CBHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHTSTTTC--EECCCCSGGGEEESSTTSCCEE
T ss_pred C--CceEEEEecCC-CCHHHHHhhcCcC-CCCHHHHHHHHHHHHHHHHHhccCCCC--EEcCCCCcccEEEecCCCCcEE
Confidence 6 78999999995 5999998765422 26788889999999999999995 56 99999999999995 477899
Q ss_pred Eccccccccc
Q 036407 159 ISDFGLARLK 168 (576)
Q Consensus 159 LiDFGlA~~~ 168 (576)
|+|||++...
T Consensus 202 L~DFG~a~~~ 211 (382)
T 2vx3_A 202 IVDFGSSCQL 211 (382)
T ss_dssp ECCCTTCEET
T ss_pred EEeccCceec
Confidence 9999998643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=320.12 Aligned_cols=155 Identities=23% Similarity=0.351 Sum_probs=130.3
Q ss_pred hHHHHhhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCch-----------hHHHHHHHHHHHHHhccCCceE
Q 036407 7 YSVLRRAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQ-----------GEREFYNELYFASLLEQDDHVV 74 (576)
Q Consensus 7 ~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~-----------~~~~~l~EI~iLs~L~h~pNIv 74 (576)
..++....++|++.+.||+|+||.||+|... ++.||||++...... ....+.+|+.++..+.| +||+
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv 92 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH-PNIL 92 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCC-TTBC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCC-cCcc
Confidence 5678889999999999999999999999865 789999998542211 12678999999999976 9999
Q ss_pred EEEEEeeC---CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE
Q 036407 75 SVLGFSSN---PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL 151 (576)
Q Consensus 75 ~Llg~~~~---~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL 151 (576)
.+++++.. .....+|+||||+. |+|.+.+..... .+++..++.++.||+.||.|||+++ |+|+||||+|||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI--VISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILL 167 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEE
Confidence 99998754 33457899999996 688888875432 3788889999999999999999999 9999999999999
Q ss_pred cCCCcEEEcccccccc
Q 036407 152 DHNFCAKISDFGLARL 167 (576)
Q Consensus 152 d~~g~vKLiDFGlA~~ 167 (576)
+.++.++|+|||++..
T Consensus 168 ~~~~~~kl~Dfg~~~~ 183 (362)
T 3pg1_A 168 ADNNDITICDFNLARE 183 (362)
T ss_dssp CTTCCEEECCTTC---
T ss_pred cCCCCEEEEecCcccc
Confidence 9999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=320.02 Aligned_cols=146 Identities=27% Similarity=0.420 Sum_probs=123.3
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC----
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK---- 84 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s---- 84 (576)
..++|++.+.||+|+||.||+|... ++.||||++.... ......+.+|+.++..+.| +||+.+++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH-KNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCC-CCccceEEeecccccccc
Confidence 4579999999999999999999875 7899999997532 2334568899999999976 99999999987542
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
...+|+||||+++ +|.+.+... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~~~-----~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccceEEEEEcCCC-CHHHHHhhc-----cCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeec
Confidence 2478999999964 788877532 677888899999999999999999 99999999999999999999999999
Q ss_pred ccc
Q 036407 165 ARL 167 (576)
Q Consensus 165 A~~ 167 (576)
+..
T Consensus 174 a~~ 176 (371)
T 2xrw_A 174 ART 176 (371)
T ss_dssp ---
T ss_pred ccc
Confidence 864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=309.14 Aligned_cols=149 Identities=25% Similarity=0.307 Sum_probs=124.4
Q ss_pred hhcCCCCccceeeccCcEEEEEEEE---CCceEEEEEeecCCchhHHHHHHHHHHHHHhccC-----CceEEEEEEeeCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATL---HDQSVAVKVMDSGSLQGEREFYNELYFASLLEQD-----DHVVSVLGFSSNP 83 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~---~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~-----pNIv~Llg~~~~~ 83 (576)
...++|++.+.||+|+||.||+|.. .++.||||++... ......+.+|+.++..+.|. ++++.+++++...
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 4568999999999999999999986 3788999999643 23346788999999888762 2589999988776
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC----------
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH---------- 153 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~---------- 153 (576)
..+++||||+ +++|.+++...... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.
T Consensus 90 --~~~~lv~e~~-~~~l~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 90 --GHICIVFELL-GLSTYDFIKENGFL-PFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp --TEEEEEEECC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC--
T ss_pred --CcEEEEEcCC-CCCHHHHHHhcCCC-CCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCc
Confidence 7899999999 88999998765422 2678889999999999999999999 999999999999987
Q ss_pred ---------CCcEEEcccccccc
Q 036407 154 ---------NFCAKISDFGLARL 167 (576)
Q Consensus 154 ---------~g~vKLiDFGlA~~ 167 (576)
++.++|+|||++..
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~ 186 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATY 186 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEE
T ss_pred cccccccccCCCceEeeCccccc
Confidence 55678888887653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=320.95 Aligned_cols=147 Identities=24% Similarity=0.329 Sum_probs=129.8
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
..++|++.+.||+|+||.||+|+.. +..||+|++.... ......+.+|+.++..+.| +||+.+++++... ..++
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~~~ 107 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSD--GEIS 107 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCC-TTBCCEEEEEEET--TEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCC-CCEEEEeEEEEEC--CEEE
Confidence 3568999999999999999999987 7899999997653 2334678999999999976 9999999998876 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhC-CCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL-NPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~-g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+||||+++++|.+++..... +++..+..++.+++.||.|||+. + |+|+||||+|||++.++.++|+|||++..
T Consensus 108 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEEECCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 99999999999999977543 67888899999999999999984 8 99999999999999999999999998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=335.52 Aligned_cols=150 Identities=30% Similarity=0.553 Sum_probs=128.3
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-------------hhHHHHHHHHHHHHHhccCCceEEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-------------QGEREFYNELYFASLLEQDDHVVSV 76 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-------------~~~~~~l~EI~iLs~L~h~pNIv~L 76 (576)
.+.++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| |||+++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~ 111 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH-PNIIKL 111 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCC-TTBCCE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCC-CCCCeE
Confidence 45688999999999999999999976 68899999975432 224578999999999976 999999
Q ss_pred EEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC-
Q 036407 77 LGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF- 155 (576)
Q Consensus 77 lg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g- 155 (576)
++++... ..+|+|||||++|+|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 112 ~~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 112 FDVFEDK--KYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNS 184 (504)
T ss_dssp EEEEECS--SEEEEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTC
T ss_pred EEEEEcC--CEEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCC
Confidence 9999876 889999999999999998876543 788899999999999999999999 99999999999998776
Q ss_pred --cEEEcccccccccc
Q 036407 156 --CAKISDFGLARLKS 169 (576)
Q Consensus 156 --~vKLiDFGlA~~~~ 169 (576)
.+||+|||++....
T Consensus 185 ~~~~kl~Dfg~a~~~~ 200 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFS 200 (504)
T ss_dssp CSSEEECCCTTCEECC
T ss_pred CccEEEEECCCCEEcC
Confidence 69999999987543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=322.27 Aligned_cols=148 Identities=25% Similarity=0.397 Sum_probs=121.9
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC---
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK--- 84 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s--- 84 (576)
.+.++|++.+.||+|+||.||+|+.. ++.||||.+.... ......+.+|+.++..+.| +||+.+++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH-ENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCB-TTBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCC-cCCCCceeeEecCCccc
Confidence 45678999999999999999999975 7899999996432 2234578899999999986 99999999987542
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 85 -RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 85 -~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
...+|+||||+ +++|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~~----l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHEK----LGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCT
T ss_pred cCceEEEEEecC-CCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeee
Confidence 24679999999 889999887632 677888999999999999999999 9999999999999999999999999
Q ss_pred cccc
Q 036407 164 LARL 167 (576)
Q Consensus 164 lA~~ 167 (576)
+++.
T Consensus 174 ~a~~ 177 (367)
T 1cm8_A 174 LARQ 177 (367)
T ss_dssp TCEE
T ss_pred cccc
Confidence 9864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=333.03 Aligned_cols=149 Identities=28% Similarity=0.487 Sum_probs=129.7
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++.... ......+.+|+.++..+.| |||+++++++... ..
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~--~~ 95 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFEILEDS--SS 95 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS--SE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCC-CCcCeEEEEEEcC--CE
Confidence 35578999999999999999999976 7899999996422 2345678999999999976 9999999999876 88
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEc---CCCcEEEccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLD---HNFCAKISDFGL 164 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd---~~g~vKLiDFGl 164 (576)
+|+|||||.+++|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred EEEEEEcCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 9999999999999998876543 788889999999999999999999 99999999999995 456799999999
Q ss_pred cccc
Q 036407 165 ARLK 168 (576)
Q Consensus 165 A~~~ 168 (576)
+...
T Consensus 171 a~~~ 174 (486)
T 3mwu_A 171 STCF 174 (486)
T ss_dssp TTTB
T ss_pred CeEC
Confidence 8644
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=309.99 Aligned_cols=151 Identities=25% Similarity=0.386 Sum_probs=128.6
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
+.++|.+.+.||+|+||.||+++.. +..+|+|.+.... ......+.+|+.++..+.| +||+++++++... ..++
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~--~~~~ 96 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH-PNIIKIFEVFEDY--HNMY 96 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECS--SEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCC-chHHhHHHheecC--CeEE
Confidence 4578999999999999999999876 7899999997543 2345678999999999977 9999999999866 7899
Q ss_pred EEEeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE---cCCCcEEEcccccc
Q 036407 90 LVYELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLA 165 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL---d~~g~vKLiDFGlA 165 (576)
+||||+++++|.+.+.... ....+++..++.++.||+.||.|||+++ |+|+||||+|||+ +.++.++|+|||++
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 9999999999999885431 1123788889999999999999999999 9999999999999 45678999999998
Q ss_pred ccc
Q 036407 166 RLK 168 (576)
Q Consensus 166 ~~~ 168 (576)
...
T Consensus 175 ~~~ 177 (285)
T 3is5_A 175 ELF 177 (285)
T ss_dssp CC-
T ss_pred eec
Confidence 643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=327.04 Aligned_cols=150 Identities=15% Similarity=0.102 Sum_probs=110.0
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhc-cCCceEEEEE-------Ee
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLE-QDDHVVSVLG-------FS 80 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~-h~pNIv~Llg-------~~ 80 (576)
...|.+.+.||+|+||.||+|+.. ++.||||++..... .....+..|+.++..|. .||||+.++. .+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345889999999999999999965 78999999986543 23456778877777776 3599887553 33
Q ss_pred eCCCC---------------CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHH------HHHHHHHHHHHHHHHhCCCCe
Q 036407 81 SNPKR---------------HRMLLVYELMSNGNLQDALLHKKPPELMEWCKR------FSIAVDIAKGIAYLHSLNPPV 139 (576)
Q Consensus 81 ~~~s~---------------~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~v------l~I~~qIl~AL~yLHs~g~~I 139 (576)
..... ..+||||||++ ++|.+++...... +....+ +.++.||+.||.|||+++ |
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV--YVFRGDEGILALHILTAQLIRLAANLQSKG--L 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc--cchhhhhhhhhHHHHHHHHHHHHHHHHHCC--C
Confidence 22211 45899999998 8999999764211 222333 567799999999999999 9
Q ss_pred eecccCCCCeEEcCCCcEEEccccccccc
Q 036407 140 IHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 140 VHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||||||+|||++.++.+||+|||+++..
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~ 244 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKV 244 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEET
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeec
Confidence 99999999999999999999999998743
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.90 Aligned_cols=148 Identities=27% Similarity=0.401 Sum_probs=130.2
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
..++|.+.+.||+|+||.||++... ++.||+|++.... ......+.+|+.++..+.| +||+.+++++... ..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~--~~ 89 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH-QHVVGFHGFFEDN--DF 89 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECS--SE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCC-CCEeeeeeeeccC--CE
Confidence 4468999999999999999999986 6889999996532 2334678899999999966 9999999999876 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp EEEEEECCTTCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 9999999999999998876543 678889999999999999999999 99999999999999999999999999875
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 165 ~ 165 (294)
T 2rku_A 165 V 165 (294)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=350.91 Aligned_cols=146 Identities=27% Similarity=0.456 Sum_probs=124.8
Q ss_pred CCCccc-eeeccCcEEEEEEEEC----CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 16 SFSPSR-LLGQGGFGSVFHATLH----DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 16 ~Y~i~e-~LG~GsfG~Vyka~~~----g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
+|.+.+ .||+|+||.||+|.+. +..||||+++... ....+.+.+|+.++..+.| +||+++++++.. ..++
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~~---~~~~ 411 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVCQA---EALM 411 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCC-TTBCCEEEEEES---SSEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCC-CCEeeEEEEecc---CCeE
Confidence 344444 7999999999999864 4679999997643 2345789999999999976 999999999875 4589
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|||||+++|+|.+++..... .+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 412 lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEEeCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999999999999865432 3788889999999999999999999 9999999999999999999999999987543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=314.98 Aligned_cols=149 Identities=30% Similarity=0.413 Sum_probs=120.4
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC---C--ceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH---D--QSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK 84 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~---g--~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s 84 (576)
..++|++.+.||+|+||.||+|++. + ..||||++.... ......+.+|+.++..+.| +||+++++++...
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~- 93 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH-RNLIRLYGVVLTP- 93 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCC-CCcccEEEEEccC-
Confidence 4568999999999999999999853 2 368999987542 2334678899999999976 9999999998764
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
..++||||+++++|.+.+..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||+
T Consensus 94 --~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 94 --PMKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred --CceeeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEccccc
Confidence 37899999999999999876432 2678889999999999999999999 99999999999999999999999999
Q ss_pred ccccc
Q 036407 165 ARLKS 169 (576)
Q Consensus 165 A~~~~ 169 (576)
+....
T Consensus 168 ~~~~~ 172 (291)
T 1u46_A 168 MRALP 172 (291)
T ss_dssp CEECC
T ss_pred ccccc
Confidence 87553
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=305.18 Aligned_cols=147 Identities=28% Similarity=0.442 Sum_probs=128.9
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
..++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +||+++++++... ..
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~ 88 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH-PNILRMYNYFHDR--KR 88 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECS--SE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCC-CCEeeEEEEEEcC--CE
Confidence 4578999999999999999999976 67899999964321 224578899999999976 9999999998876 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++||||+++++|.+.+..... +++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 9999999999999999876543 678888999999999999999999 99999999999999999999999998753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=307.10 Aligned_cols=150 Identities=28% Similarity=0.448 Sum_probs=131.5
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
....++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +||+.+++++...
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~-- 83 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH-PHIIKLYQVISTP-- 83 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECS--
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCC-CCEeEEEEEEecC--
Confidence 445689999999999999999999976 78999999964321 234578899999999976 9999999998876
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
..+++||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~ 158 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLS 158 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGG
T ss_pred CeEEEEEeccCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccc
Confidence 789999999999999999976543 678888999999999999999999 999999999999999999999999987
Q ss_pred ccc
Q 036407 166 RLK 168 (576)
Q Consensus 166 ~~~ 168 (576)
...
T Consensus 159 ~~~ 161 (276)
T 2h6d_A 159 NMM 161 (276)
T ss_dssp GCC
T ss_pred ccc
Confidence 643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=350.25 Aligned_cols=149 Identities=23% Similarity=0.311 Sum_probs=130.3
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
...++|++++.||+|+||.||+|+.. ++.||||++.+.. ......+..|..++..+.+|++|+.+++++... .
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~--~ 415 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--D 415 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS--S
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC--C
Confidence 34578999999999999999999976 6789999997532 123456788999999888889999999988765 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+||||||+++|+|.+++..... +++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEEEeCcCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceee
Confidence 89999999999999999987543 788889999999999999999999 9999999999999999999999999987
Q ss_pred c
Q 036407 167 L 167 (576)
Q Consensus 167 ~ 167 (576)
.
T Consensus 491 ~ 491 (674)
T 3pfq_A 491 E 491 (674)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=317.24 Aligned_cols=150 Identities=25% Similarity=0.394 Sum_probs=127.5
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC-----
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPK----- 84 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s----- 84 (576)
.++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +||+.+++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH-ENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCC-TTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccC-CCcccHhheeecccccccc
Confidence 468999999999999999999975 78999999865432 224577899999999986 99999999987643
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 85 -RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 85 -~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
.+.+++||||+++ +|.+.+...... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVK--FTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSC--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccch
Confidence 3678999999965 887777654322 788889999999999999999999 9999999999999999999999999
Q ss_pred cccccc
Q 036407 164 LARLKS 169 (576)
Q Consensus 164 lA~~~~ 169 (576)
++....
T Consensus 170 ~a~~~~ 175 (351)
T 3mi9_A 170 LARAFS 175 (351)
T ss_dssp TCEECC
T ss_pred hccccc
Confidence 987654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=335.57 Aligned_cols=149 Identities=28% Similarity=0.452 Sum_probs=131.5
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
...++|.+.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| |||+++++++... .
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~--~ 89 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH-PHIIKLYQVISTP--S 89 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCC-TTBCCEEEEEECS--S
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEEC--C
Confidence 34688999999999999999999976 88999999975322 234578899999999977 9999999999876 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+|+||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~ 164 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSN 164 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSS---CCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchh
Confidence 89999999999999998875433 788899999999999999999999 9999999999999999999999999987
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 165 ~~ 166 (476)
T 2y94_A 165 MM 166 (476)
T ss_dssp EC
T ss_pred hc
Confidence 54
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.79 Aligned_cols=150 Identities=27% Similarity=0.468 Sum_probs=131.5
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++.... ......+.+|+.++..+.| |||+++++++... .
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~--~ 99 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH-PNIMKLYEFFEDK--G 99 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCC-TTBCCEEEEEECS--S
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeC--C
Confidence 34567999999999999999999976 7899999997543 2345678999999999976 9999999999876 8
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE---cCCCcEEEcccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL---DHNFCAKISDFG 163 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL---d~~g~vKLiDFG 163 (576)
.+++|||||.+++|.+.+..... +++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 174 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFG 174 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSC---CBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred EEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence 89999999999999998876543 788889999999999999999999 9999999999999 467899999999
Q ss_pred cccccc
Q 036407 164 LARLKS 169 (576)
Q Consensus 164 lA~~~~ 169 (576)
++....
T Consensus 175 ~a~~~~ 180 (484)
T 3nyv_A 175 LSTHFE 180 (484)
T ss_dssp HHHHBC
T ss_pred eeEEcc
Confidence 987543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=312.35 Aligned_cols=153 Identities=27% Similarity=0.306 Sum_probs=117.1
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
....++|++.+.||+|+||.||+|+.. ++.||||++..... ........|...+....+|+||+.+++++... ..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--~~ 80 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE--GD 80 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SS
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc--CC
Confidence 345678999999999999999999984 88999999975432 22334444444433334559999999999876 78
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHHHHhC-CCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 88 MLLVYELMSNGNLQDALLHK-KPPELMEWCKRFSIAVDIAKGIAYLHSL-NPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~-~~~~~ls~~~vl~I~~qIl~AL~yLHs~-g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
.++||||++ ++|.+++... .....+++..++.++.||+.||.|||++ + |+|+||||+|||++.++.+||+|||++
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS 157 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCc
Confidence 999999996 4887777541 1122378889999999999999999997 9 999999999999999999999999988
Q ss_pred ccc
Q 036407 166 RLK 168 (576)
Q Consensus 166 ~~~ 168 (576)
...
T Consensus 158 ~~~ 160 (290)
T 3fme_A 158 GYL 160 (290)
T ss_dssp ---
T ss_pred ccc
Confidence 644
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=335.65 Aligned_cols=149 Identities=26% Similarity=0.483 Sum_probs=125.2
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
..+.|++.+.||+|+||.||+|+.. +..||||++.... ......+.+|+.++..+.| |||+++++++... ..+
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~--~~~ 111 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH-PNIMKLYDFFEDK--RNY 111 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCC-TTBCCEEEEEECS--SEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeC--CEE
Confidence 4457999999999999999999986 7889999997543 2334678999999999977 9999999999876 789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC---CcEEEcccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN---FCAKISDFGLA 165 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~---g~vKLiDFGlA 165 (576)
|+|||||++|+|.+.+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.. +.+||+|||++
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 999999999999998876543 678888999999999999999999 9999999999999764 55999999998
Q ss_pred cccc
Q 036407 166 RLKS 169 (576)
Q Consensus 166 ~~~~ 169 (576)
....
T Consensus 187 ~~~~ 190 (494)
T 3lij_A 187 AVFE 190 (494)
T ss_dssp EECB
T ss_pred eECC
Confidence 7543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=329.36 Aligned_cols=147 Identities=27% Similarity=0.449 Sum_probs=119.8
Q ss_pred CCCccceeeccCcEEEEEEEEC-----CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
.|.+.+.||+|+||.||+|+.. ...||||.++... ......+.+|+.++..+.| +||+.+++++.... +..+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~-~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVLSLLGICLRSE-GSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCC-TTBCCCCEEECCCS-SCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEEcCC-CCeE
Confidence 3566789999999999999863 2468999986432 3445678999999999976 99999999876442 5779
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 168 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeeccccccc
Confidence 99999999999999976443 2677888899999999999999999 999999999999999999999999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=318.47 Aligned_cols=152 Identities=25% Similarity=0.398 Sum_probs=129.6
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC--
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK-- 84 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s-- 84 (576)
+..+.++|++.+.||+|+||.||+|+.. ++.||||++.... ......+.+|+.++..+.| +||+.+++++....
T Consensus 22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH-ENIIGINDIIRAPTIE 100 (364)
T ss_dssp BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCC-TTBCCCCEEECCSSTT
T ss_pred eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCccceeEEecCCcc
Confidence 3445679999999999999999999875 7889999997533 2334678899999999976 99999999986542
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 85 -RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 85 -~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
...+|+|||++. ++|.+++.... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||
T Consensus 101 ~~~~~~iv~e~~~-~~L~~~l~~~~----~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg 173 (364)
T 3qyz_A 101 QMKDVYIVQDLME-TDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFG 173 (364)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccceEEEEEcccC-cCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCc
Confidence 257899999996 59999887643 678889999999999999999999 9999999999999999999999999
Q ss_pred cccccc
Q 036407 164 LARLKS 169 (576)
Q Consensus 164 lA~~~~ 169 (576)
++....
T Consensus 174 ~a~~~~ 179 (364)
T 3qyz_A 174 LARVAD 179 (364)
T ss_dssp TCEECC
T ss_pred ceEecC
Confidence 987543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=309.62 Aligned_cols=147 Identities=20% Similarity=0.372 Sum_probs=127.8
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
..++|++.+.||+|+||.||+|+.. ++.||+|++..........+.+|+.++..+.| +||+.+++++... ..+++
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH-PYIVKLLGAYYHD--GKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCC-TTBCCEEEEEECC---CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCC-CCEeeeeeeeeeC--CeEEE
Confidence 4578999999999999999999986 78999999976555556788999999999976 9999999999876 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
||||+++++|.+++...... +++..++.++.||+.||.|||+++ ++|+||||+|||++.++.++|+|||++.
T Consensus 94 v~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred EEEeCCCCcHHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 99999999999988664322 778889999999999999999999 9999999999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=318.09 Aligned_cols=149 Identities=27% Similarity=0.446 Sum_probs=127.9
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch--hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ--GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~--~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++...... ....+.+|+.++..+.| +||+.+++++... ..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~ 98 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH-ENLVNLLEVCKKK--KR 98 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEET--TE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCC-CCEeeEEEEeecC--CE
Confidence 34578999999999999999999986 789999998654332 24567899999999986 9999999999876 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++..
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFART 173 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEEEEecCCcchHHHHHhhccC---CCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCcee
Confidence 9999999999888887655443 778889999999999999999999 99999999999999999999999999865
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 174 ~ 174 (331)
T 4aaa_A 174 L 174 (331)
T ss_dssp -
T ss_pred e
Confidence 4
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=324.51 Aligned_cols=152 Identities=23% Similarity=0.398 Sum_probs=130.8
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC--
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR-- 85 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~-- 85 (576)
.+.++|++.+.||+|+||.||+|+.. ++.||||++.... .....++.+|+.++..+.| +||+.+++++.....
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS-DYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSCTTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCC-CCcceEEEEEecCCCCc
Confidence 35689999999999999999999876 7889999997532 2344678999999999986 999999999875432
Q ss_pred -CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 86 -HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 86 -~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
..+|+||||+. ++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~~~~---l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKTPIF---LTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHSSCC---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEecCC-cCHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCC
Confidence 67899999995 599999876543 788899999999999999999999 99999999999999999999999999
Q ss_pred cccccC
Q 036407 165 ARLKSV 170 (576)
Q Consensus 165 A~~~~~ 170 (576)
++....
T Consensus 176 a~~~~~ 181 (432)
T 3n9x_A 176 ARTINS 181 (432)
T ss_dssp CEEC--
T ss_pred cccccc
Confidence 986544
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=321.35 Aligned_cols=145 Identities=18% Similarity=0.302 Sum_probs=122.0
Q ss_pred cCCCCccceeeccCcEEEEEEEEC----------CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEE--------
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH----------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVS-------- 75 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~----------g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~-------- 75 (576)
.++|++.+.||+|+||.||+|+.. ++.||||++... ..+.+|+.++..+.| +||+.
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h-~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAK-PLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCC-HHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcc-cchhhhhhhhccC
Confidence 478999999999999999999864 578999999744 357889999999976 77765
Q ss_pred -------EEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCC
Q 036407 76 -------VLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSN 148 (576)
Q Consensus 76 -------Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeN 148 (576)
+++++... ...+++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 115 ~~~~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~N 189 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSPK-HVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAEN 189 (352)
T ss_dssp TTCSCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGG
T ss_pred CccCccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCCc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHH
Confidence 56666542 37899999999 9999999986421 23788899999999999999999999 9999999999
Q ss_pred eEEcCCC--cEEEcccccccccc
Q 036407 149 ILLDHNF--CAKISDFGLARLKS 169 (576)
Q Consensus 149 ILLd~~g--~vKLiDFGlA~~~~ 169 (576)
||++.++ .++|+|||+++...
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~ 212 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYC 212 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSS
T ss_pred EEEcCCCCceEEEecCcceeecc
Confidence 9999988 89999999987554
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=315.80 Aligned_cols=148 Identities=27% Similarity=0.401 Sum_probs=130.4
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
..++|.+.+.||+|+||.||+++.. ++.||+|++.... ....+.+.+|+.++..+.| +||+.+++++... ..
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~--~~ 115 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH-QHVVGFHGFFEDN--DF 115 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECS--SE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEecC--Ce
Confidence 3467999999999999999999976 6889999997532 2345678899999999976 9999999999876 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+++||||+++++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++..
T Consensus 116 ~~lv~e~~~~~~L~~~~~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp EEEEECCCTTCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCCCHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 9999999999999998876543 778889999999999999999999 99999999999999999999999999875
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 191 ~ 191 (335)
T 2owb_A 191 V 191 (335)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.88 Aligned_cols=149 Identities=25% Similarity=0.393 Sum_probs=125.2
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--------hhHHHHHHHHHHHHHhccCCceEEEEEEe
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--------QGEREFYNELYFASLLEQDDHVVSVLGFS 80 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--------~~~~~~l~EI~iLs~L~h~pNIv~Llg~~ 80 (576)
....++|.+.+.||+|+||.||+|... ++.||||++..... .....+.+|+.++..+.| |||+++++++
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~ 209 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH-PCIIKIKNFF 209 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCC-TTBCCCCEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCC-CCEeeEEEEE
Confidence 345689999999999999999999876 68999999975321 111247899999999976 9999999987
Q ss_pred eCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC---cE
Q 036407 81 SNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF---CA 157 (576)
Q Consensus 81 ~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g---~v 157 (576)
.. ..+++||||+++++|.+.+..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+
T Consensus 210 ~~---~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 210 DA---EDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp ES---SEEEEEEECCTTCBGGGGTSSSCC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCE
T ss_pred ec---CceEEEEEcCCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceE
Confidence 54 457999999999999887765443 788889999999999999999999 99999999999997544 59
Q ss_pred EEccccccccc
Q 036407 158 KISDFGLARLK 168 (576)
Q Consensus 158 KLiDFGlA~~~ 168 (576)
||+|||+++..
T Consensus 282 kl~DFG~a~~~ 292 (419)
T 3i6u_A 282 KITDFGHSKIL 292 (419)
T ss_dssp EECCSSTTTSC
T ss_pred EEeecccceec
Confidence 99999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=343.59 Aligned_cols=151 Identities=29% Similarity=0.408 Sum_probs=131.6
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +||+.+++++... .
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~--~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSLAYAYETK--D 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS--S
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCC-CCEeeEEEEEeeC--C
Confidence 34577999999999999999999975 78999999965321 234568899999999976 9999999998876 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+||||||++||+|.+++...... .+++..++.|+.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~-~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~ 334 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQA-GFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAV 334 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccce
Confidence 899999999999999988765432 2788899999999999999999999 9999999999999999999999999987
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 335 ~~ 336 (576)
T 2acx_A 335 HV 336 (576)
T ss_dssp EC
T ss_pred ec
Confidence 54
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.89 Aligned_cols=151 Identities=25% Similarity=0.393 Sum_probs=129.6
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCC---CC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNP---KR 85 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~---s~ 85 (576)
.+.++|++.+.||+|+||.||+|+.. ++.||||.+.... ......+.+|+.++..+.| +||+.+++++... ..
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH-ENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSCSTTC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcC-CCcCCeeeeecccccCcc
Confidence 46789999999999999999999976 7899999996433 2334567899999999976 9999999987643 23
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
..+++||||+. ++|.+++.... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVISTQM----LSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEeccC-ccHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEecccc
Confidence 67899999996 59999887632 678889999999999999999999 999999999999999999999999998
Q ss_pred ccccC
Q 036407 166 RLKSV 170 (576)
Q Consensus 166 ~~~~~ 170 (576)
.....
T Consensus 160 ~~~~~ 164 (353)
T 2b9h_A 160 RIIDE 164 (353)
T ss_dssp EECC-
T ss_pred ccccc
Confidence 76543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=310.16 Aligned_cols=149 Identities=30% Similarity=0.425 Sum_probs=124.2
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
+...++|++.+.||+|+||.||+|... ++.||||.+.... ....+.+|+.++..+.| +||+.+++++... ..+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~ 99 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDS-PHVVKYYGSYFKN--TDL 99 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCC-TTBCCEEEEEEET--TEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCC-CCCccEEEEEEeC--CEE
Confidence 355678999999999999999999986 7899999997543 34578899999999976 9999999998876 789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++||||+++++|.+++..... .+++..++.++.+|+.||.|||+++ |+|+||||+||+++.++.++|+|||++...
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 999999999999999874332 2778889999999999999999999 999999999999999999999999988654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.81 Aligned_cols=157 Identities=24% Similarity=0.294 Sum_probs=114.8
Q ss_pred HHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCC--
Q 036407 8 SVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNP-- 83 (576)
Q Consensus 8 ~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~-- 83 (576)
.......++|++.+.||+|+||.||+|+.. ++.||||++..... .......++..+..+.| +||+.+++++...
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h-~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHH-PNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCC-TTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCC-CCcccHHHhhhcccc
Confidence 445677889999999999999999999976 78999999865332 23356677777888876 9999999998642
Q ss_pred ---CCCeEEEEEeccCCCCHHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHHHH--hCCCCeeecccCCCCeEEcC-CCc
Q 036407 84 ---KRHRMLLVYELMSNGNLQDALLH-KKPPELMEWCKRFSIAVDIAKGIAYLH--SLNPPVIHGDIKPSNILLDH-NFC 156 (576)
Q Consensus 84 ---s~~~l~LVmE~~~gGsL~d~L~~-~~~~~~ls~~~vl~I~~qIl~AL~yLH--s~g~~IVHrDLKPeNILLd~-~g~ 156 (576)
....+++||||+++ +|...+.. ......+++..+..++.||+.||.||| +++ |+|+||||+|||++. ++.
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTE
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCc
Confidence 22348899999975 66554432 222233677888899999999999999 888 999999999999996 899
Q ss_pred EEEcccccccccc
Q 036407 157 AKISDFGLARLKS 169 (576)
Q Consensus 157 vKLiDFGlA~~~~ 169 (576)
+||+|||++....
T Consensus 171 ~kl~Dfg~a~~~~ 183 (360)
T 3e3p_A 171 LKLCDFGSAKKLS 183 (360)
T ss_dssp EEECCCTTCBCCC
T ss_pred EEEeeCCCceecC
Confidence 9999999987543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=311.35 Aligned_cols=148 Identities=26% Similarity=0.385 Sum_probs=123.7
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--------hhHHHHHHHHHHHHHhccCCceEEEEEEee
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--------QGEREFYNELYFASLLEQDDHVVSVLGFSS 81 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--------~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~ 81 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +||+.+++++.
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~ 85 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH-PCIIKIKNFFD 85 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCC-TTBCCEEEEEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCC-CCCceEeeEEc
Confidence 34578999999999999999999876 68999999965322 112357899999999976 99999999986
Q ss_pred CCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc---EE
Q 036407 82 NPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC---AK 158 (576)
Q Consensus 82 ~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~---vK 158 (576)
.. .+++||||+++++|.+.+..... +++..++.++.||+.||.|||+++ |+|+||||+|||++.++. +|
T Consensus 86 ~~---~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 86 AE---DYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp SS---SEEEEEECCTTEETHHHHSTTCC---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEE
T ss_pred CC---ceEEEEecCCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEE
Confidence 54 38999999999999998865443 778888999999999999999999 999999999999987654 99
Q ss_pred Eccccccccc
Q 036407 159 ISDFGLARLK 168 (576)
Q Consensus 159 LiDFGlA~~~ 168 (576)
|+|||++...
T Consensus 158 l~Dfg~~~~~ 167 (322)
T 2ycf_A 158 ITDFGHSKIL 167 (322)
T ss_dssp ECCCTTCEEC
T ss_pred EccCccceec
Confidence 9999998754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=320.29 Aligned_cols=152 Identities=20% Similarity=0.331 Sum_probs=121.3
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCC----
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNP---- 83 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~---- 83 (576)
+....++|++.+.||+|+||.||+|+.. ++.||||++..... ...+|+.++..+.| +||+.+++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDH-VNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCC-TTBCCEEEEEEEC----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCC-CCccchhheeeecCccc
Confidence 3456789999999999999999999875 78999999864422 23468999999976 9999999988542
Q ss_pred --------------------------------CCCeEEEEEeccCCCCHHHHHHhc-CCCChhhHHHHHHHHHHHHHHHH
Q 036407 84 --------------------------------KRHRMLLVYELMSNGNLQDALLHK-KPPELMEWCKRFSIAVDIAKGIA 130 (576)
Q Consensus 84 --------------------------------s~~~l~LVmE~~~gGsL~d~L~~~-~~~~~ls~~~vl~I~~qIl~AL~ 130 (576)
....+++||||++ ++|.+.+... .....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 2345899999997 5887777541 11223788889999999999999
Q ss_pred HHHhCCCCeeecccCCCCeEEc-CCCcEEEcccccccccc
Q 036407 131 YLHSLNPPVIHGDIKPSNILLD-HNFCAKISDFGLARLKS 169 (576)
Q Consensus 131 yLHs~g~~IVHrDLKPeNILLd-~~g~vKLiDFGlA~~~~ 169 (576)
|||+++ |+||||||+|||++ .++.+||+|||+++...
T Consensus 156 ~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 193 (383)
T 3eb0_A 156 FIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI 193 (383)
T ss_dssp HHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECC
T ss_pred HHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccC
Confidence 999999 99999999999997 68899999999987543
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.23 Aligned_cols=148 Identities=24% Similarity=0.398 Sum_probs=125.6
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
.++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +||+++++++... +.++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~~~~ 78 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-PNIVKLLDVIHTE--NKLY 78 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCC-TTBCCEEEEEEET--TEEE
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCC-CCeeeEEEEEecC--CceE
Confidence 368999999999999999999976 78999999965432 223578899999999976 9999999999876 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||||+. ++|.+++...... .++...++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++...
T Consensus 79 lv~e~~~-~~L~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 153 (299)
T 2r3i_A 79 LVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF 153 (299)
T ss_dssp EEEECCS-EEHHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred EEEEccc-CCHHHHHHhhhcc-CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHeEEcCCCCEEECcchhhhhc
Confidence 9999996 5999988765422 2677888899999999999999999 999999999999999999999999988654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=308.56 Aligned_cols=149 Identities=22% Similarity=0.321 Sum_probs=121.7
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--C-ceEEEEEeecCCchhHHHHHHHHHHHHHhccCC-----ceEEEEEEeeCC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--D-QSVAVKVMDSGSLQGEREFYNELYFASLLEQDD-----HVVSVLGFSSNP 83 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g-~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~p-----NIv~Llg~~~~~ 83 (576)
...++|++.+.||+|+||.||+|... + ..||||++... ......+.+|+.++..+.|.. +++.+.+++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 45689999999999999999999875 3 68999999643 234567888999999988732 278888887766
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE------------
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL------------ 151 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL------------ 151 (576)
..+|+||||+ +++|.+.+..... ..+++..++.++.||+.||.|||+++ |+|+||||+|||+
T Consensus 95 --~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 95 --GHMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp --TEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC
T ss_pred --CeEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccccc
Confidence 7899999999 6678777765432 22778889999999999999999999 9999999999999
Q ss_pred -------cCCCcEEEcccccccc
Q 036407 152 -------DHNFCAKISDFGLARL 167 (576)
Q Consensus 152 -------d~~g~vKLiDFGlA~~ 167 (576)
+.++.+||+|||++..
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~ 191 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATF 191 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEE
T ss_pred ccccccccCCCcEEEeecCcccc
Confidence 4567788888887653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.19 Aligned_cols=148 Identities=28% Similarity=0.458 Sum_probs=123.1
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeC--------
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN-------- 82 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~-------- 82 (576)
..++|++.+.||+|+||.||+|... ++.||||.+..........+.+|+.++..+.| +||+.+++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDH-DNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECTTSCBCCC-
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCC-CCeeEEEEeccccccccccc
Confidence 4578999999999999999999986 78999999987665666788999999999976 999999998743
Q ss_pred ----CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEc-CCCcE
Q 036407 83 ----PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLD-HNFCA 157 (576)
Q Consensus 83 ----~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd-~~g~v 157 (576)
.....+++||||+. ++|.+++.... +++..++.++.||+.||.|||+++ |+|+||||+|||++ .++.+
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQGP----LLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTTCC----CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhcCC----ccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeE
Confidence 23478899999997 59999886422 677888899999999999999999 99999999999997 56799
Q ss_pred EEccccccccc
Q 036407 158 KISDFGLARLK 168 (576)
Q Consensus 158 KLiDFGlA~~~ 168 (576)
||+|||++...
T Consensus 161 kl~Dfg~~~~~ 171 (320)
T 2i6l_A 161 KIGDFGLARIM 171 (320)
T ss_dssp EECCCTTCBCC
T ss_pred EEccCcccccc
Confidence 99999998754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=346.19 Aligned_cols=141 Identities=27% Similarity=0.436 Sum_probs=122.3
Q ss_pred ceeeccCcEEEEEEEEC----CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEec
Q 036407 21 RLLGQGGFGSVFHATLH----DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~----g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
+.||+|+||.||+|.+. ++.||||+++.... .....+.+|+.++..+.| +||+.+++++.. ..++|||||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~---~~~~lv~E~ 450 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGICEA---ESWMLVMEM 450 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCC-TTBCCEEEEEES---SSEEEEEEC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEec---CCEEEEEEc
Confidence 47999999999999653 47899999975432 235689999999999976 999999999864 457899999
Q ss_pred cCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccccC
Q 036407 95 MSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 95 ~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
+++|+|.+++..... +++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 451 ~~~g~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 451 AELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp CTTEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred cCCCCHHHHHhhCCC---CCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 999999999976543 778889999999999999999999 99999999999999999999999999876543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=312.28 Aligned_cols=155 Identities=24% Similarity=0.358 Sum_probs=117.2
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEE--CCceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATL--HDQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~--~g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
+....++|++.+.||+|+||.||+|.. .++.||||.+.... ......+.+|+.++..+.| +||+.+++++... .
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~ 86 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH-PNIVSYYTSFVVK--D 86 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCC-TTBCCEEEEEESS--S
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCC-CCEeeEEEEEeec--C
Confidence 355678999999999999999999986 47899999986543 2334567889998888876 9999999999876 6
Q ss_pred eEEEEEeccCCCCHHHHHHhc-----CCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcc
Q 036407 87 RMLLVYELMSNGNLQDALLHK-----KPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISD 161 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~-----~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiD 161 (576)
.+++||||+++++|.+++... .....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEe
Confidence 789999999999999988641 11223788899999999999999999999 99999999999999999999999
Q ss_pred cccccccc
Q 036407 162 FGLARLKS 169 (576)
Q Consensus 162 FGlA~~~~ 169 (576)
||++....
T Consensus 165 fg~~~~~~ 172 (303)
T 2vwi_A 165 FGVSAFLA 172 (303)
T ss_dssp CHHHHHCC
T ss_pred ccchheec
Confidence 99887543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=320.60 Aligned_cols=149 Identities=28% Similarity=0.393 Sum_probs=118.1
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCC----CCCe
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNP----KRHR 87 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~----s~~~ 87 (576)
...+|++.+.||+|+||.||+|+.. +..+|+|.+..... ...+|+.++..+.| +||+.+++++... ....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKH-PNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCC-TTBCCEEEEEEEESSSSSCEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCC-CCcceEEEEEEecCCCCCceE
Confidence 3457999999999999999999985 56689988864322 12368899999976 9999999988643 2234
Q ss_pred EEEEEeccCCCCHHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEc-CCCcEEEcccccc
Q 036407 88 MLLVYELMSNGNLQDALLH-KKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLD-HNFCAKISDFGLA 165 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~-~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd-~~g~vKLiDFGlA 165 (576)
+++||||+++ ++...+.. ......+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 113 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 113 LNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 8899999976 44443332 111223778888999999999999999999 99999999999999 7899999999998
Q ss_pred cccc
Q 036407 166 RLKS 169 (576)
Q Consensus 166 ~~~~ 169 (576)
+...
T Consensus 190 ~~~~ 193 (394)
T 4e7w_A 190 KILI 193 (394)
T ss_dssp EECC
T ss_pred cccc
Confidence 7543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=336.89 Aligned_cols=152 Identities=27% Similarity=0.388 Sum_probs=131.5
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
..++|.+.+.||+|+||.||+|+.. ++.||||++.+... .....+.+|+.++..+.| |||+.+++++... ..
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~--~~ 259 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS-RFIVSLAYAFETK--TD 259 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS--SE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCC-CCEeeEEEEEeeC--CE
Confidence 4578999999999999999999975 78999999975322 224578899999999966 9999999998776 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCC-CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKP-PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~-~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
+|+||||++||+|.+++..... ...+++..++.|+.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceee
Confidence 9999999999999999876431 223788889999999999999999999 9999999999999999999999999987
Q ss_pred ccc
Q 036407 167 LKS 169 (576)
Q Consensus 167 ~~~ 169 (576)
...
T Consensus 338 ~~~ 340 (543)
T 3c4z_A 338 ELK 340 (543)
T ss_dssp ECC
T ss_pred ecc
Confidence 543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=329.81 Aligned_cols=151 Identities=19% Similarity=0.246 Sum_probs=120.3
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecC---CchhHHHHHHHHHHHHHhc--cCCceEEEE-------EE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSG---SLQGEREFYNELYFASLLE--QDDHVVSVL-------GF 79 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~---s~~~~~~~l~EI~iLs~L~--h~pNIv~Ll-------g~ 79 (576)
.++|++.+.||+|+||.||+|+.. ++.||||++... .......+.+|+.++..+. +||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467899999999999999999854 899999999743 2234567889996666554 459998887 55
Q ss_pred eeCCCC----------C-----eEEEEEeccCCCCHHHHHHhcCC----CChhhHHHHHHHHHHHHHHHHHHHhCCCCee
Q 036407 80 SSNPKR----------H-----RMLLVYELMSNGNLQDALLHKKP----PELMEWCKRFSIAVDIAKGIAYLHSLNPPVI 140 (576)
Q Consensus 80 ~~~~s~----------~-----~l~LVmE~~~gGsL~d~L~~~~~----~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IV 140 (576)
+..... . ..||||||+ +|+|.+++..... ...+++..++.|+.||+.||.|||+++ |+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 443311 1 378999999 6799999975321 123556788889999999999999999 99
Q ss_pred ecccCCCCeEEcCCCcEEEcccccccc
Q 036407 141 HGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 141 HrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||||||+|||++.++.+||+|||+++.
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~ 255 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVR 255 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEE
T ss_pred cCCCCHHHEEEcCCCCEEEEechhhee
Confidence 999999999999999999999999863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.87 Aligned_cols=146 Identities=25% Similarity=0.380 Sum_probs=118.0
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeC----CCCCeE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN----PKRHRM 88 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~----~s~~~l 88 (576)
.+|++.+.||+|+||.||+|+.. ++.||||.+..... ...+|+.++..+.| +||+.+++++.. ....++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~h-pniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDH-CNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCC-TTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCC-CCccceeeEEeccCCCCcceeE
Confidence 36899999999999999999985 78999999864322 23468999999977 999999988753 223457
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC-CcEEEccccccc
Q 036407 89 LLVYELMSNGNLQDALLHK-KPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN-FCAKISDFGLAR 166 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~-~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~-g~vKLiDFGlA~ 166 (576)
++||||+++ +|.+.+... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 899999975 676665431 11223778889999999999999999999 9999999999999965 578999999987
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 206 ~~ 207 (420)
T 1j1b_A 206 QL 207 (420)
T ss_dssp EC
T ss_pred hc
Confidence 54
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=318.04 Aligned_cols=154 Identities=26% Similarity=0.441 Sum_probs=127.8
Q ss_pred ChHHHHhhcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 6 SYSVLRRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 6 s~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
..+++....++|++.+.||+|+||.||+|+..+ .+|+|++..... .....+.+|+.++..+.| +||+.+++++...
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRH-ENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCC-TTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCC-CCEeEEEEEEecC
Confidence 345556677899999999999999999999865 599999975322 223456788888988876 9999999999876
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
..+++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++ ++.++|+|||
T Consensus 102 --~~~~iv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 102 --PHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp --SCEEEECBCCCSEEHHHHTTSSCC--CCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCS
T ss_pred --CceEEEeecccCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecC
Confidence 679999999999999999876432 2677888999999999999999999 99999999999998 6899999999
Q ss_pred ccccc
Q 036407 164 LARLK 168 (576)
Q Consensus 164 lA~~~ 168 (576)
++...
T Consensus 175 ~~~~~ 179 (319)
T 2y4i_B 175 LFSIS 179 (319)
T ss_dssp CCC--
T ss_pred Ccccc
Confidence 87643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=310.48 Aligned_cols=155 Identities=27% Similarity=0.389 Sum_probs=127.3
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC---CceEEEEEeecCCc--hhHHHHHHHHHHHHHhc--cCCceEEEEEEeeC
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH---DQSVAVKVMDSGSL--QGEREFYNELYFASLLE--QDDHVVSVLGFSSN 82 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~---g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~--h~pNIv~Llg~~~~ 82 (576)
+....++|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+. .|+||+.+++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred ccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 3456689999999999999999999873 68899999964322 12235677888887774 45999999998862
Q ss_pred ---CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEE
Q 036407 83 ---PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKI 159 (576)
Q Consensus 83 ---~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKL 159 (576)
.....+++||||+. ++|.+++...... .+++..++.++.||+.||.|||++| |+|+||||+|||++.++.++|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTT-CSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEE
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEE
Confidence 23478899999997 6999998765432 2678889999999999999999999 999999999999999999999
Q ss_pred ccccccccc
Q 036407 160 SDFGLARLK 168 (576)
Q Consensus 160 iDFGlA~~~ 168 (576)
+|||++...
T Consensus 162 ~Dfg~~~~~ 170 (326)
T 1blx_A 162 ADFGLARIY 170 (326)
T ss_dssp CSCCSCCCC
T ss_pred ecCcccccc
Confidence 999988643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=315.69 Aligned_cols=150 Identities=25% Similarity=0.386 Sum_probs=130.0
Q ss_pred hcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchh-----------------HHHHHHHHHHHHHhccCCceEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQG-----------------EREFYNELYFASLLEQDDHVVS 75 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~-----------------~~~~l~EI~iLs~L~h~pNIv~ 75 (576)
..++|++.+.||+|+||.||+|+..++.||||.+....... ...+.+|+.++..+.| +||+.
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN-EYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC-TTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC-CCcce
Confidence 45799999999999999999999999999999997432211 1688999999999976 99999
Q ss_pred EEEEeeCCCCCeEEEEEeccCCCCHHHH------HHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCC
Q 036407 76 VLGFSSNPKRHRMLLVYELMSNGNLQDA------LLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSN 148 (576)
Q Consensus 76 Llg~~~~~s~~~l~LVmE~~~gGsL~d~------L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeN 148 (576)
+++++... ..+++||||+++++|.++ +.... ...+++..++.++.||+.||.|||+ ++ |+|+||||+|
T Consensus 108 ~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSN 182 (348)
T ss_dssp CSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGG
T ss_pred EEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHh
Confidence 99999876 789999999999999887 44321 2337888999999999999999999 99 9999999999
Q ss_pred eEEcCCCcEEEccccccccc
Q 036407 149 ILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 149 ILLd~~g~vKLiDFGlA~~~ 168 (576)
||++.++.++|+|||++...
T Consensus 183 il~~~~~~~kl~dfg~~~~~ 202 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYM 202 (348)
T ss_dssp EEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCcEEEecccccccc
Confidence 99999999999999988643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.96 Aligned_cols=148 Identities=27% Similarity=0.427 Sum_probs=114.9
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCC----
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNP---- 83 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~---- 83 (576)
.+.++|++.+.||+|+||.||+|... ++.||||++.... ......+.+|+.++..+.| +||+.+++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH-ENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCC-TTBCCCSEEECSCSSGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEecCCccc
Confidence 45689999999999999999999865 7899999996532 2344678899999999986 9999999988653
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
....+|+|+|++ +++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp GCCCCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC--
T ss_pred cCCeEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeecc
Confidence 235689999999 78998888652 2778889999999999999999999 9999999999999999999999999
Q ss_pred cccc
Q 036407 164 LARL 167 (576)
Q Consensus 164 lA~~ 167 (576)
+++.
T Consensus 178 ~a~~ 181 (367)
T 2fst_X 178 LARH 181 (367)
T ss_dssp ----
T ss_pred cccc
Confidence 8863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.01 Aligned_cols=153 Identities=27% Similarity=0.363 Sum_probs=120.7
Q ss_pred HHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch------hHHHHHHHHHHHHHhc---cCCceEEEE
Q 036407 9 VLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ------GEREFYNELYFASLLE---QDDHVVSVL 77 (576)
Q Consensus 9 ~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~------~~~~~l~EI~iLs~L~---h~pNIv~Ll 77 (576)
+.....++|++.+.||+|+||.||+|+.. ++.||||++...... ....+.+|+.++..+. .|+||+.++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34556789999999999999999999874 789999999754321 2234567888888884 459999999
Q ss_pred EEeeCCCCCeEEEEEec-cCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEc-CCC
Q 036407 78 GFSSNPKRHRMLLVYEL-MSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLD-HNF 155 (576)
Q Consensus 78 g~~~~~s~~~l~LVmE~-~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd-~~g 155 (576)
+++... ...++|||+ +.+++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+||+++ .++
T Consensus 105 ~~~~~~--~~~~~v~e~~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 105 DWFETQ--EGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEC-------CEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTT
T ss_pred EEEecC--CeEEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCC
Confidence 998766 678999999 788999999977543 778889999999999999999999 99999999999999 789
Q ss_pred cEEEccccccccc
Q 036407 156 CAKISDFGLARLK 168 (576)
Q Consensus 156 ~vKLiDFGlA~~~ 168 (576)
.++|+|||++...
T Consensus 178 ~~kl~dfg~~~~~ 190 (312)
T 2iwi_A 178 CAKLIDFGSGALL 190 (312)
T ss_dssp EEEECCCSSCEEC
T ss_pred eEEEEEcchhhhc
Confidence 9999999988654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=302.66 Aligned_cols=150 Identities=27% Similarity=0.408 Sum_probs=129.0
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCC--------
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNP-------- 83 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~-------- 83 (576)
.++|++.+.||+|+||.||+|+.. ++.||||.+... ......+.+|+.++..+.| +||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNH-QYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCc-hHHHHHHHHHHhhcchhhhhc
Confidence 467999999999999999999975 789999999642 2334678899999999976 9999999987542
Q ss_pred ---CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEc
Q 036407 84 ---KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKIS 160 (576)
Q Consensus 84 ---s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLi 160 (576)
....+++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCG--GGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcccc--ccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEe
Confidence 24678999999999999999976432 3677888899999999999999999 9999999999999999999999
Q ss_pred ccccccccc
Q 036407 161 DFGLARLKS 169 (576)
Q Consensus 161 DFGlA~~~~ 169 (576)
|||++....
T Consensus 159 dfg~~~~~~ 167 (303)
T 1zy4_A 159 DFGLAKNVH 167 (303)
T ss_dssp CCCCCSCTT
T ss_pred eCcchhhcc
Confidence 999987543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.92 Aligned_cols=149 Identities=26% Similarity=0.411 Sum_probs=120.1
Q ss_pred hhcCCCCccc-eeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeC--CCCC
Q 036407 12 RAADSFSPSR-LLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN--PKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~e-~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~--~s~~ 86 (576)
...++|.+.+ .||+|+||.||+|+.. ++.||||++... .....|+..+..+..|+||+.+++++.. ....
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 3567899865 6999999999999987 789999999643 2234444444444456999999998864 2235
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC---CCcEEEcccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH---NFCAKISDFG 163 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~---~g~vKLiDFG 163 (576)
.+++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++. ++.++|+|||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred eEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 68999999999999999987543 23788899999999999999999999 999999999999976 4569999999
Q ss_pred ccccc
Q 036407 164 LARLK 168 (576)
Q Consensus 164 lA~~~ 168 (576)
++...
T Consensus 177 ~~~~~ 181 (336)
T 3fhr_A 177 FAKET 181 (336)
T ss_dssp TCEEC
T ss_pred cceec
Confidence 88643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.08 Aligned_cols=153 Identities=24% Similarity=0.334 Sum_probs=129.8
Q ss_pred HHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch------hHHHHHHHHHHHHHhcc-CCceEEEEEE
Q 036407 9 VLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ------GEREFYNELYFASLLEQ-DDHVVSVLGF 79 (576)
Q Consensus 9 ~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~------~~~~~l~EI~iLs~L~h-~pNIv~Llg~ 79 (576)
+.....++|++.+.||+|+||.||+|+.. ++.||||++...... ....+.+|+.++..+.+ |+||+.++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 34567789999999999999999999874 789999999754321 22456789999999985 7999999999
Q ss_pred eeCCCCCeEEEEEeccCC-CCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEc-CCCcE
Q 036407 80 SSNPKRHRMLLVYELMSN-GNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLD-HNFCA 157 (576)
Q Consensus 80 ~~~~s~~~l~LVmE~~~g-GsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd-~~g~v 157 (576)
+... ..+++|||++.+ ++|.+++..... +++..++.++.||+.||.|||+++ |+|+||||+|||++ .++.+
T Consensus 117 ~~~~--~~~~lv~e~~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 117 FERP--DSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EECS--SEEEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEE
T ss_pred EecC--CcEEEEEEcCCCCccHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCE
Confidence 9876 789999999976 899999876543 678888999999999999999999 99999999999999 77999
Q ss_pred EEccccccccc
Q 036407 158 KISDFGLARLK 168 (576)
Q Consensus 158 KLiDFGlA~~~ 168 (576)
||+|||++...
T Consensus 190 kL~Dfg~~~~~ 200 (320)
T 3a99_A 190 KLIDFGSGALL 200 (320)
T ss_dssp EECCCTTCEEC
T ss_pred EEeeCcccccc
Confidence 99999988654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.17 Aligned_cols=146 Identities=27% Similarity=0.416 Sum_probs=123.3
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC--
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH-- 86 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~-- 86 (576)
..++|.+.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +||+.+++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH-ENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCC-TTBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCC-CCchhhhhheeccCCccc
Confidence 4578999999999999999999876 78999999975432 234678899999999986 9999999998765321
Q ss_pred --eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 87 --RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 87 --~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
.+|+||||+. ++|.+.+.. .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||+
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred ceeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 3499999996 588776632 1678889999999999999999999 99999999999999999999999998
Q ss_pred ccc
Q 036407 165 ARL 167 (576)
Q Consensus 165 A~~ 167 (576)
+..
T Consensus 191 a~~ 193 (371)
T 4exu_A 191 ARH 193 (371)
T ss_dssp C--
T ss_pred ccc
Confidence 863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=299.27 Aligned_cols=150 Identities=28% Similarity=0.476 Sum_probs=129.8
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
....++|++.+.||+|+||.||+|+.. ++.||||++.... ......+.+|+.++..+.| +||+++++++... .
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~--~ 94 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFEILEDS--S 94 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECS--S
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccC-CCccEEEEEEeCC--C
Confidence 455678999999999999999999975 7899999996532 2345678999999999976 9999999998876 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC---CcEEEcccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN---FCAKISDFG 163 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~---g~vKLiDFG 163 (576)
.+++|||++++++|.+.+..... +++..++.++.||+.||.|||+++ |+|+||||+||+++.+ +.++|+|||
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred eEEEEEEccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccC
Confidence 89999999999999988866543 678889999999999999999999 9999999999999754 479999999
Q ss_pred ccccc
Q 036407 164 LARLK 168 (576)
Q Consensus 164 lA~~~ 168 (576)
++...
T Consensus 170 ~~~~~ 174 (287)
T 2wei_A 170 LSTCF 174 (287)
T ss_dssp GGGTB
T ss_pred cceee
Confidence 87643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=341.41 Aligned_cols=151 Identities=25% Similarity=0.445 Sum_probs=128.6
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC-----CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
+....++|++.+.||+|+||.||+|... +..||||.+.... ....+.+.+|+.++..+.| |||+.+++++..
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~- 462 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-PHIVKLIGVITE- 462 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECS-
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEec-
Confidence 3445577889999999999999999874 3569999986533 2334678999999999976 999999999843
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
+.+++||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 463 --~~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 463 --NPVWIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred --CceEEEEEcCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecC
Confidence 468999999999999999976432 2678888999999999999999999 9999999999999999999999999
Q ss_pred ccccc
Q 036407 164 LARLK 168 (576)
Q Consensus 164 lA~~~ 168 (576)
+++..
T Consensus 537 ~a~~~ 541 (656)
T 2j0j_A 537 LSRYM 541 (656)
T ss_dssp CCCSC
T ss_pred CCeec
Confidence 98754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=305.14 Aligned_cols=152 Identities=24% Similarity=0.269 Sum_probs=122.8
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
...++|++.+.||+|+||.||+|... ++.||||++..... .....+..|+..+....+|+||+++++++... ...
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~--~~~ 96 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE--GDC 96 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--SEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--Cce
Confidence 44688999999999999999999986 88999999975432 23345666766444444559999999999876 789
Q ss_pred EEEEeccCCCCHHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHHHHhC-CCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 89 LLVYELMSNGNLQDALLHK--KPPELMEWCKRFSIAVDIAKGIAYLHSL-NPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~--~~~~~ls~~~vl~I~~qIl~AL~yLHs~-g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
++||||+.+ +|.+++... .....+++..+..++.|++.||.|||+. + |+|+||||+|||++.++.+||+|||++
T Consensus 97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 999999975 888777531 1122377888899999999999999998 9 999999999999999999999999988
Q ss_pred ccc
Q 036407 166 RLK 168 (576)
Q Consensus 166 ~~~ 168 (576)
...
T Consensus 174 ~~~ 176 (327)
T 3aln_A 174 GQL 176 (327)
T ss_dssp CC-
T ss_pred eec
Confidence 643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=316.64 Aligned_cols=157 Identities=27% Similarity=0.369 Sum_probs=118.9
Q ss_pred ChHHHHhhcCCC-CccceeeccCcEEEEEE-EECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCC
Q 036407 6 SYSVLRRAADSF-SPSRLLGQGGFGSVFHA-TLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNP 83 (576)
Q Consensus 6 s~~~lk~~~d~Y-~i~e~LG~GsfG~Vyka-~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~ 83 (576)
++.++....+++ .+.+.||+|+||.||.+ ...++.||||++... ....+.+|+.++..+.+||||+++++++...
T Consensus 5 ~~p~~~~~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 5 NIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp ---CCSCSCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred cccchhhhhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 344444444444 45688999999999654 455899999998643 2346789999998886669999999988766
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCC----hhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC-----
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPE----LMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN----- 154 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~----~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~----- 154 (576)
..+|||||||. |+|.+++....... ...+..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 82 --~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~ 156 (434)
T 2rio_A 82 --RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTA 156 (434)
T ss_dssp --SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHS
T ss_pred --CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCccccc
Confidence 88999999995 69999997644211 1123345679999999999999999 9999999999999754
Q ss_pred --------CcEEEccccccccccC
Q 036407 155 --------FCAKISDFGLARLKSV 170 (576)
Q Consensus 155 --------g~vKLiDFGlA~~~~~ 170 (576)
+.+||+|||+++....
T Consensus 157 ~~~~~~~~~~~kL~DFG~a~~~~~ 180 (434)
T 2rio_A 157 DQQTGAENLRILISDFGLCKKLDS 180 (434)
T ss_dssp CCTTCCCSCEEEECCCTTCEECCC
T ss_pred ccccCCCceEEEEcccccceecCC
Confidence 4899999999876543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=304.75 Aligned_cols=146 Identities=27% Similarity=0.416 Sum_probs=123.9
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC---
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR--- 85 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~--- 85 (576)
..++|.+.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.++..+.| +||+.+++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH-ENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCC-TTBCCCSEEECSCSSGGG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCC-CCcccHhheEeccccccc
Confidence 4578999999999999999999875 78999999965332 234578899999999976 999999999876532
Q ss_pred -CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 86 -HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 86 -~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
..+|+||||+. ++|.+.+.. .+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred ceeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeeccc
Confidence 24699999996 588766532 2678889999999999999999999 99999999999999999999999998
Q ss_pred ccc
Q 036407 165 ARL 167 (576)
Q Consensus 165 A~~ 167 (576)
+..
T Consensus 173 ~~~ 175 (353)
T 3coi_A 173 ARH 175 (353)
T ss_dssp TTC
T ss_pred ccC
Confidence 763
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=297.29 Aligned_cols=150 Identities=23% Similarity=0.300 Sum_probs=112.8
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch-hHHHHHHHHH-HHHHhccCCceEEEEEEeeCCCCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ-GEREFYNELY-FASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~-~~~~~l~EI~-iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
....++|++.+.||+|+||.||+|+.. ++.||||++...... ....+..|+. ++..+ .|+||+.+++++... .
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~--~ 97 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFITN--T 97 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECS--S
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEecC--C
Confidence 344578899999999999999999985 789999999765432 2233444444 44444 459999999999876 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhC-CCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL-NPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~-g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
.+++||||+ ++.+..+...... .+++..++.++.||+.||.|||+. + |+|+||||+|||++.++.++|+|||++
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQG--PIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGIS 172 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred cEEEEEecc-CCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCc
Confidence 899999999 5566665544322 277888999999999999999984 9 999999999999999999999999987
Q ss_pred ccc
Q 036407 166 RLK 168 (576)
Q Consensus 166 ~~~ 168 (576)
...
T Consensus 173 ~~~ 175 (318)
T 2dyl_A 173 GRL 175 (318)
T ss_dssp ---
T ss_pred hhc
Confidence 643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=314.38 Aligned_cols=148 Identities=27% Similarity=0.393 Sum_probs=119.0
Q ss_pred hhcCCCCccceeeccCcEE-EEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 12 RAADSFSPSRLLGQGGFGS-VFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~-Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
....+|.+.+.||+|+||. ||.+...++.||||++...... .+.+|+.++..+..||||+.+++++... ..+||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~~~~l 95 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDR--QFQYI 95 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEET--TEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecC--CEEEE
Confidence 3445688999999999998 5566677999999999754332 3568999999996669999999988766 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC-----CCcEEEcccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH-----NFCAKISDFGLA 165 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~-----~g~vKLiDFGlA 165 (576)
|||||. |+|.+++...... .....++.++.||+.||.|||+++ |+||||||+|||++. ...++|+|||++
T Consensus 96 v~E~~~-g~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEECCS-EEHHHHHHSSSCC--CCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEECCC-CCHHHHHHhcCCC--ccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 999995 5999998765422 233345679999999999999999 999999999999953 336889999998
Q ss_pred cccc
Q 036407 166 RLKS 169 (576)
Q Consensus 166 ~~~~ 169 (576)
+...
T Consensus 171 ~~~~ 174 (432)
T 3p23_A 171 KKLA 174 (432)
T ss_dssp ECC-
T ss_pred eecc
Confidence 7554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=290.88 Aligned_cols=139 Identities=17% Similarity=0.085 Sum_probs=120.0
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch---hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~---~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
..++|++.+.||+|+||.||+|+.. ++.||||++...... ....+.+|+.++..+.| +||+.+++++... +.
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~--~~ 105 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK-PGVARVLDVVHTR--AG 105 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEET--TE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCC-CCcceeeEEEEEC--Cc
Confidence 4578999999999999999999987 789999999765432 23678899999999976 9999999999876 78
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISD 161 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiD 161 (576)
+|+||||++|++|.+++... .....+..|+.||+.||.|||++| |+||||||+|||++.+|.++|++
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~ 172 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAY 172 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECS
T ss_pred EEEEEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEe
Confidence 99999999999999998542 123457779999999999999999 99999999999999999888863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=323.60 Aligned_cols=147 Identities=20% Similarity=0.341 Sum_probs=122.5
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC---CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC--
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH---DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR-- 85 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~---g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~-- 85 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++.... ......+.+|+.++..+.| |||+.+++++.....
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVH-PSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCC-TTBCCEEEEEEEECTTS
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCC-CCcCeEeeeEeecCCCC
Confidence 34589999999999999999999874 6889999986432 2334578899999999976 999999999876422
Q ss_pred -CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 86 -HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 86 -~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
..+||||||+++++|.+.+.. .+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp CEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred CceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEeccc
Confidence 127999999999999887654 2778899999999999999999999 9999999999999875 899999998
Q ss_pred ccc
Q 036407 165 ARL 167 (576)
Q Consensus 165 A~~ 167 (576)
++.
T Consensus 228 a~~ 230 (681)
T 2pzi_A 228 VSR 230 (681)
T ss_dssp CEE
T ss_pred chh
Confidence 864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=282.35 Aligned_cols=147 Identities=27% Similarity=0.421 Sum_probs=125.7
Q ss_pred hhcCCCCcc-ceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeC--CCCC
Q 036407 12 RAADSFSPS-RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN--PKRH 86 (576)
Q Consensus 12 ~~~d~Y~i~-e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~--~s~~ 86 (576)
...++|.+. +.||+|+||.||+|... ++.||||++.. ...+.+|+.++.++.+|+||+.+++++.. ....
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 355778887 78999999999999875 78999999963 24567888888777677999999998864 3347
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC---CCcEEEcccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH---NFCAKISDFG 163 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~---~g~vKLiDFG 163 (576)
.+++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++. ++.++|+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred eEEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 88999999999999999987542 23788899999999999999999999 999999999999998 7889999999
Q ss_pred ccc
Q 036407 164 LAR 166 (576)
Q Consensus 164 lA~ 166 (576)
++.
T Consensus 166 ~a~ 168 (299)
T 3m2w_A 166 FAK 168 (299)
T ss_dssp TCE
T ss_pred ccc
Confidence 875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=292.11 Aligned_cols=148 Identities=22% Similarity=0.330 Sum_probs=122.8
Q ss_pred cCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCc--------hhHHHHHHHHHHHHHhc--------cCCceEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSL--------QGEREFYNELYFASLLE--------QDDHVVSVL 77 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~--------~~~~~~l~EI~iLs~L~--------h~pNIv~Ll 77 (576)
.++|++.+.||+|+||.||+|+.+++.||||++..... .....+.+|+.++..+. .|+||+.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 46799999999999999999999999999999975432 22367889999999887 468998888
Q ss_pred EEeeCC----------------------------CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHH
Q 036407 78 GFSSNP----------------------------KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129 (576)
Q Consensus 78 g~~~~~----------------------------s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL 129 (576)
+.+... ....+|||||||++|++.+.+.. ..+++..++.|+.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 765311 24789999999999976665533 2267889999999999999
Q ss_pred HHHH-hCCCCeeecccCCCCeEEcCCC--------------------cEEEcccccccc
Q 036407 130 AYLH-SLNPPVIHGDIKPSNILLDHNF--------------------CAKISDFGLARL 167 (576)
Q Consensus 130 ~yLH-s~g~~IVHrDLKPeNILLd~~g--------------------~vKLiDFGlA~~ 167 (576)
.||| +++ |+||||||+|||++.++ .+||+|||+++.
T Consensus 175 ~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~ 231 (336)
T 2vuw_A 175 AVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRL 231 (336)
T ss_dssp HHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBE
T ss_pred HHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEe
Confidence 9999 899 99999999999999887 788888888764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=324.54 Aligned_cols=155 Identities=26% Similarity=0.339 Sum_probs=127.3
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecC-CchhHHHHHHHHHHHHHhccCCceEEEEEEeeC----CC
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSG-SLQGEREFYNELYFASLLEQDDHVVSVLGFSSN----PK 84 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~-s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~----~s 84 (576)
...++|++.+.||+|+||.||+|... ++.||||++... .......+.+|+.++..+.| |||+.+++++.. ..
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH-PNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCB-TTBCCEEECCTTTCCCCT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCC-CCCCceeeeecccccccC
Confidence 34589999999999999999999864 789999998754 23345678999999999976 999999998754 22
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc---EEEcc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC---AKISD 161 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~---vKLiD 161 (576)
....++||||+++++|.+++........+++..++.++.+|+.||.|||+++ |+|+||||+|||++.++. ++|+|
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcc
Confidence 4778999999999999999987554334777888999999999999999999 999999999999997664 89999
Q ss_pred cccccccc
Q 036407 162 FGLARLKS 169 (576)
Q Consensus 162 FGlA~~~~ 169 (576)
||++....
T Consensus 168 FG~a~~~~ 175 (676)
T 3qa8_A 168 LGYAKELD 175 (676)
T ss_dssp CCCCCBTT
T ss_pred cccccccc
Confidence 99987543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.69 Aligned_cols=151 Identities=17% Similarity=0.196 Sum_probs=112.9
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch---hHHHHHHHHHHHHHhccCCceEE-------------
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLLEQDDHVVS------------- 75 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~---~~~~~l~EI~iLs~L~h~pNIv~------------- 75 (576)
...|...+.||+|+||.||+|+.. ++.||||++...... ..+.+.+|+.++..+.|..|+..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 344778899999999999999976 899999999743222 24678899988888876432211
Q ss_pred --------EEEEeeCCC---CCeEEEEEeccCCCCHHHHHHh----cCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCee
Q 036407 76 --------VLGFSSNPK---RHRMLLVYELMSNGNLQDALLH----KKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVI 140 (576)
Q Consensus 76 --------Llg~~~~~s---~~~l~LVmE~~~gGsL~d~L~~----~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IV 140 (576)
+..+..... ...++++|+++ +++|.+++.. ......+++..++.++.||+.||.|||+++ |+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ii 233 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LV 233 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 111111111 23467888877 6799988852 122345788889999999999999999999 99
Q ss_pred ecccCCCCeEEcCCCcEEEcccccccc
Q 036407 141 HGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 141 HrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
||||||+|||++.++.+||+|||+++.
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~ 260 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVR 260 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEE
T ss_pred cCCcccceEEEecCCeEEEEeccceee
Confidence 999999999999999999999999764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-28 Score=269.64 Aligned_cols=136 Identities=20% Similarity=0.218 Sum_probs=107.9
Q ss_pred eeccCcEEEEEEE--ECCceEEEEEeecCC----------chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 23 LGQGGFGSVFHAT--LHDQSVAVKVMDSGS----------LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 23 LG~GsfG~Vyka~--~~g~~VAVK~i~~~s----------~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
++.|+.|.+..++ +-|+.|+||++.+.. ....+++.+|+.+|.++.+|+||+++++++.+. ..+||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~~~yL 319 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--QSGWL 319 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--SEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--CEEEE
Confidence 3445555444433 238889999997532 122356899999999998889999999999877 89999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||||++|++|.+.+...+. ++.. .|+.||+.||.|||++| ||||||||+||||+.+|.+||+|||+|+..
T Consensus 320 VMEyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EEecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 9999999999999987654 4443 48899999999999999 999999999999999999999999998754
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.3e-23 Score=229.12 Aligned_cols=133 Identities=21% Similarity=0.328 Sum_probs=104.6
Q ss_pred ccceeeccCcEEEEEEEECCceEEEEEeecCCch--------hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 19 PSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQ--------GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 19 i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~--------~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
..+.||+|+||.||+|...++.+++|........ ..+++.+|+.++..+.| +||+.+..++... ...||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~--~~~~l 416 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKD-FGIPAPYIFDVDL--DNKRI 416 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGG-GTCCCCCEEEEET--TTTEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCC-CCcCceEEEEEeC--CccEE
Confidence 3568999999999999888999999987543221 12457999999999977 9999555555544 55699
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
||||+++++|.+++.. +..++.||+.||.|||+++ |+||||||+|||++. .+||+|||+++...
T Consensus 417 VmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 9999999999998765 3458999999999999999 999999999999998 99999999998654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.3e-19 Score=181.14 Aligned_cols=139 Identities=20% Similarity=0.186 Sum_probs=109.4
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCc------------------hhHHHHHHHHHHHHHhccCC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSL------------------QGEREFYNELYFASLLEQDD 71 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~------------------~~~~~~l~EI~iLs~L~h~p 71 (576)
......|.+.+.||+|+||.||+|... ++.||||++..... .....+.+|+.++..+.| .
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~-~ 164 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-L 164 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-S
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-C
Confidence 334455666699999999999999985 78999999964321 134568899999999984 5
Q ss_pred ceEEEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEE
Q 036407 72 HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILL 151 (576)
Q Consensus 72 NIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILL 151 (576)
++..+++. +..|+||||++|++|.+ +.. .....++.||+.||.|||++| |+||||||+|||+
T Consensus 165 ~v~~~~~~------~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl 226 (282)
T 1zar_A 165 AVPKVYAW------EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLV 226 (282)
T ss_dssp SSCCEEEE------ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEE
T ss_pred CcCeEEec------cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEE
Confidence 55554322 44599999999999987 421 113358999999999999999 9999999999999
Q ss_pred cCCCcEEEcccccccccc
Q 036407 152 DHNFCAKISDFGLARLKS 169 (576)
Q Consensus 152 d~~g~vKLiDFGlA~~~~ 169 (576)
+ ++.++|+|||+++...
T Consensus 227 ~-~~~vkl~DFG~a~~~~ 243 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVEVG 243 (282)
T ss_dssp E-TTEEEECCCTTCEETT
T ss_pred E-CCcEEEEECCCCeECC
Confidence 9 9999999999997543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-17 Score=167.22 Aligned_cols=137 Identities=16% Similarity=0.125 Sum_probs=104.0
Q ss_pred CCccceeeccCcEEEEEEEE--CCce--EEEEEeecCCch------------------------hHHHHHHHHHHHHHhc
Q 036407 17 FSPSRLLGQGGFGSVFHATL--HDQS--VAVKVMDSGSLQ------------------------GEREFYNELYFASLLE 68 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~--~g~~--VAVK~i~~~s~~------------------------~~~~~l~EI~iLs~L~ 68 (576)
|.+.+.||+|+||.||+|.. .|+. ||||+++..... ....+.+|+.++..|.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56789999999999999987 5888 999997543111 1136789999999998
Q ss_pred cCCc--eEEEEEEeeCCCCCeEEEEEeccCC-C----CHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHH-hCCCCee
Q 036407 69 QDDH--VVSVLGFSSNPKRHRMLLVYELMSN-G----NLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLH-SLNPPVI 140 (576)
Q Consensus 69 h~pN--Iv~Llg~~~~~s~~~l~LVmE~~~g-G----sL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLH-s~g~~IV 140 (576)
+ ++ +..++.. ...+|||||+.+ | +|.+.... .+...+..++.||+.||.||| +++ |+
T Consensus 129 ~-~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g--iv 193 (258)
T 1zth_A 129 E-AGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE--LV 193 (258)
T ss_dssp H-TTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC--EE
T ss_pred h-CCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC--EE
Confidence 7 33 2333332 245899999932 3 67665432 223456678999999999999 899 99
Q ss_pred ecccCCCCeEEcCCCcEEEccccccccccC
Q 036407 141 HGDIKPSNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 141 HrDLKPeNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
||||||+|||++. .++|+|||+|.....
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEETTS
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccCCC
Confidence 9999999999988 899999999986544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.49 E-value=4e-14 Score=151.14 Aligned_cols=143 Identities=17% Similarity=0.167 Sum_probs=100.1
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCch---------------h-------HHHHHHHHHHHHHhc
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQ---------------G-------EREFYNELYFASLLE 68 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~---------------~-------~~~~l~EI~iLs~L~ 68 (576)
..---|++...||.|++|.||+|... |+.||||+++..... . ......|+..+.+|.
T Consensus 92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~ 171 (397)
T 4gyi_A 92 ARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY 171 (397)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence 33344899999999999999999865 889999997532110 0 012346777777775
Q ss_pred cCCceEEEEEEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCC
Q 036407 69 QDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSN 148 (576)
Q Consensus 69 h~pNIv~Llg~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeN 148 (576)
+ ..+.....+.. ...+|||||++|++|..+... .....++.||+.+|.+||++| ||||||||.|
T Consensus 172 ~-~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~N 235 (397)
T 4gyi_A 172 E-EGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG--LIHGDFNEFN 235 (397)
T ss_dssp H-TTCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTS
T ss_pred h-cCCCCCeeeec----cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHH
Confidence 4 22221111111 122799999998888653221 122457889999999999999 9999999999
Q ss_pred eEEcCCC----------cEEEccccccccccC
Q 036407 149 ILLDHNF----------CAKISDFGLARLKSV 170 (576)
Q Consensus 149 ILLd~~g----------~vKLiDFGlA~~~~~ 170 (576)
||++.++ .+.|+||+-+-....
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred EEEeCCCCcccccccccceEEEEeCCcccCCC
Confidence 9998776 389999997655443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=2e-11 Score=120.35 Aligned_cols=149 Identities=17% Similarity=0.130 Sum_probs=113.6
Q ss_pred HHHhhcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 9 VLRRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 9 ~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
.+....+.|++...++.|+.+.||++...++.+++|............+.+|+.++..|..+..+..+++++... +..
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~ 85 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWS 85 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC--Cce
Confidence 345566789999999999999999998778899999986422222346889999999997656677888877654 788
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN-------------------------------- 136 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g-------------------------------- 136 (576)
|+|||+++|.+|.+.+... .....++.+++.+|..||+..
T Consensus 86 ~lv~e~i~G~~l~~~~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHCCTT--------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred EEEEEecCCeehhhccCCc--------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 9999999999987653111 112346788888999999710
Q ss_pred -------------------------CCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 137 -------------------------PPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 137 -------------------------~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+.++|+|++|.|||++..+.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 2389999999999998765567999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.92 E-value=2.2e-09 Score=104.15 Aligned_cols=143 Identities=20% Similarity=0.165 Sum_probs=99.1
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCc-eEEEEEEeeCCCCCe
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH-VVSVLGFSSNPKRHR 87 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pN-Iv~Llg~~~~~s~~~ 87 (576)
+.....+|.+....+.|..+.||++... +..+++|+.... ....+..|+.++..+.++.- +..++.+.... +.
T Consensus 15 l~~~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~ 89 (264)
T 1nd4_A 15 WVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GR 89 (264)
T ss_dssp GTTTTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SC
T ss_pred HHHhcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CC
Confidence 4455566766544446667999999765 567999997643 22356788888888877532 55577766554 66
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN------------------------------- 136 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g------------------------------- 136 (576)
.++||||++|.+|. ... .+ ...++.+++..|..||+..
T Consensus 90 ~~~v~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 158 (264)
T ss_dssp EEEEEECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred CEEEEEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence 89999999998873 111 11 1135566667777777532
Q ss_pred -------------------------CCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 137 -------------------------PPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 137 -------------------------~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
..++|+|++|.|||++.++.+.|+||+.+...
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 12899999999999987666679999987644
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.80 E-value=1.4e-08 Score=105.08 Aligned_cols=146 Identities=18% Similarity=0.228 Sum_probs=104.1
Q ss_pred CCccceeeccCcEEEEEEEECCceEEEEEee--cCCc-hhHHHHHHHHHHHHHhccC-CceEEEEEEeeCCCC-CeEEEE
Q 036407 17 FSPSRLLGQGGFGSVFHATLHDQSVAVKVMD--SGSL-QGEREFYNELYFASLLEQD-DHVVSVLGFSSNPKR-HRMLLV 91 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~--~~s~-~~~~~~l~EI~iLs~L~h~-pNIv~Llg~~~~~s~-~~l~LV 91 (576)
....+.|+.|.++.||+....+..+++|+.. .... .....+.+|+.++..|... ..+..++.++..... +..|+|
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred CceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 3356789999999999998888889999876 3321 2234678899999988752 346777777765421 457999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL------------------------------------ 135 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~------------------------------------ 135 (576)
|||++|..+.+... ..++......++.+++..|..||+.
T Consensus 120 me~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 120 MEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99999877643111 1144556667888999999999962
Q ss_pred --------------------CCCeeecccCCCCeEEcCCCc--EEEcccccccc
Q 036407 136 --------------------NPPVIHGDIKPSNILLDHNFC--AKISDFGLARL 167 (576)
Q Consensus 136 --------------------g~~IVHrDLKPeNILLd~~g~--vKLiDFGlA~~ 167 (576)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134899999999999987753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.25 E-value=2.4e-06 Score=86.17 Aligned_cols=139 Identities=21% Similarity=0.288 Sum_probs=93.2
Q ss_pred cceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCc--eEEEEEEeeCCC-CCeEEEEEeccC
Q 036407 20 SRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH--VVSVLGFSSNPK-RHRMLLVYELMS 96 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pN--Iv~Llg~~~~~s-~~~l~LVmE~~~ 96 (576)
.+.++.|.+..||++. ..+++|+.... .....+..|..++..+..+.. +..++....... ....|+||++++
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 5678999999999763 67899986422 334678899999988854222 334444433221 124589999999
Q ss_pred CCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 036407 97 NGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL----------------------------------------- 135 (576)
Q Consensus 97 gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~----------------------------------------- 135 (576)
|.+|.+..... ++..+...++.+++..|..||+.
T Consensus 100 G~~l~~~~~~~-----l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLLNN-----LPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHHHT-----SCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccccc-----CCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 98876533211 33344455666666666666641
Q ss_pred ---------------CCCeeecccCCCCeEEcC--CCcEEEccccccccc
Q 036407 136 ---------------NPPVIHGDIKPSNILLDH--NFCAKISDFGLARLK 168 (576)
Q Consensus 136 ---------------g~~IVHrDLKPeNILLd~--~g~vKLiDFGlA~~~ 168 (576)
.+.++|+|++|.||+++. ...+.|+||+.+...
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 124799999999999988 456789999987654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=2.6e-05 Score=79.26 Aligned_cols=77 Identities=16% Similarity=0.162 Sum_probs=55.8
Q ss_pred cceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccC-C-ceEEEEEEeeCCCCCeEEEEEeccCC
Q 036407 20 SRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQD-D-HVVSVLGFSSNPKRHRMLLVYELMSN 97 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~-p-NIv~Llg~~~~~s~~~l~LVmE~~~g 97 (576)
.+.++.|....||+. +..+++|+-. .......+..|..++..|.++ + .+..++.++.. ..+..++||++++|
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE---CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEeccCC
Confidence 467888999999987 6788999853 223345788999999999763 2 24555555542 23667899999998
Q ss_pred CCHHH
Q 036407 98 GNLQD 102 (576)
Q Consensus 98 GsL~d 102 (576)
.+|.+
T Consensus 98 ~~l~~ 102 (306)
T 3tdw_A 98 QILGE 102 (306)
T ss_dssp EECHH
T ss_pred eECch
Confidence 87765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=2.5e-05 Score=76.71 Aligned_cols=141 Identities=16% Similarity=0.134 Sum_probs=94.5
Q ss_pred CCCCccceeeccCcE-EEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFG-SVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG-~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
..|+. +.+..|..+ .||+.... +..+++|.-... ....+..|...+..|...--+..++.++... +..++|
T Consensus 25 ~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lv 98 (272)
T 4gkh_A 25 YGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLL 98 (272)
T ss_dssp TTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEE
T ss_pred cCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEE
Confidence 34443 345556554 68987654 567899987532 3346778888888886543366677777665 678999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN----------------------------------- 136 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g----------------------------------- 136 (576)
||+++|.++.+...... .....+..++...|.-||...
T Consensus 99 me~l~G~~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (272)
T 4gkh_A 99 TTAIPGKTAFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDER 171 (272)
T ss_dssp EECCCSEEHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGG
T ss_pred EEeeCCccccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccc
Confidence 99999988876554311 111234455556666666321
Q ss_pred ---------------------CCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 137 ---------------------PPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 137 ---------------------~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+.++|+|+.+.|||++..+.+-|+||+.+...
T Consensus 172 ~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 172 NGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred cchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 14789999999999988777789999987643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=1.9e-05 Score=81.01 Aligned_cols=81 Identities=9% Similarity=0.014 Sum_probs=54.1
Q ss_pred ccee-eccCcEEEEEEEEC--------CceEEEEEeecCC---chhHHHHHHHHHHHHHhccC--CceEEEEEEeeCCC-
Q 036407 20 SRLL-GQGGFGSVFHATLH--------DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQD--DHVVSVLGFSSNPK- 84 (576)
Q Consensus 20 ~e~L-G~GsfG~Vyka~~~--------g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~--pNIv~Llg~~~~~s- 84 (576)
.+.| +.|....+|+.... ++.+++|+..... ......+..|+.++..|..+ -.+..++.++....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4677 88989999998765 6789999875322 11123567888888877653 24566766665432
Q ss_pred CCeEEEEEeccCCCCH
Q 036407 85 RHRMLLVYELMSNGNL 100 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL 100 (576)
.+..|+|||+++|..+
T Consensus 105 ~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TSSCEEEEECCCCBCC
T ss_pred cCCceEEEEecCCCCh
Confidence 1356899999987554
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00027 Score=73.85 Aligned_cols=75 Identities=19% Similarity=0.082 Sum_probs=48.4
Q ss_pred cceeeccCcEEEEEEEE--CCceEEEEEeecCCc-------hhHHHHHHHHHHHHHhccC-C-ceEEEEEEeeCCCCCeE
Q 036407 20 SRLLGQGGFGSVFHATL--HDQSVAVKVMDSGSL-------QGEREFYNELYFASLLEQD-D-HVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~--~g~~VAVK~i~~~s~-------~~~~~~l~EI~iLs~L~h~-p-NIv~Llg~~~~~s~~~l 88 (576)
.+.||.|.++.||++.. .++.++||....... ....++..|..++..+... + .+..++.+. . ...
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~--~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C--Ccc
Confidence 57899999999999964 367899998643211 1223567788888877543 2 334455443 2 234
Q ss_pred EEEEeccCCC
Q 036407 89 LLVYELMSNG 98 (576)
Q Consensus 89 ~LVmE~~~gG 98 (576)
++|||++++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 8999999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.0005 Score=69.13 Aligned_cols=75 Identities=12% Similarity=0.221 Sum_probs=41.9
Q ss_pred ceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccC-CceEEEEEEe----eCCCCCeEEEEEecc
Q 036407 21 RLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQD-DHVVSVLGFS----SNPKRHRMLLVYELM 95 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~-pNIv~Llg~~----~~~s~~~l~LVmE~~ 95 (576)
+.|+.|..+.||++...+..+++|+.... ...+..|+.++..|..+ -.+..++... .....+..++||+|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 45665778899999888777999998642 23344555555555431 1223332210 000135679999999
Q ss_pred CCCC
Q 036407 96 SNGN 99 (576)
Q Consensus 96 ~gGs 99 (576)
+|..
T Consensus 114 ~G~~ 117 (346)
T 2q83_A 114 EGRP 117 (346)
T ss_dssp CCBC
T ss_pred cCcc
Confidence 8754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0012 Score=67.88 Aligned_cols=78 Identities=19% Similarity=0.196 Sum_probs=59.5
Q ss_pred CccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccC--CceEEEEEEeeCCCCCeEEEEEecc
Q 036407 18 SPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQD--DHVVSVLGFSSNPKRHRMLLVYELM 95 (576)
Q Consensus 18 ~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~--pNIv~Llg~~~~~s~~~l~LVmE~~ 95 (576)
.-.+.|+.|....+|+....+..+++|+.... ....+..|...+..|... ..+..++.++... +..++|||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvme~l 113 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLLEAL 113 (312)
T ss_dssp CEEEEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEEECC
T ss_pred eeeEEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEEEec
Confidence 34578899999999999887888999987643 345688898888888653 4566777776654 6789999999
Q ss_pred CCCCH
Q 036407 96 SNGNL 100 (576)
Q Consensus 96 ~gGsL 100 (576)
++..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 88643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0012 Score=69.82 Aligned_cols=75 Identities=19% Similarity=0.137 Sum_probs=44.9
Q ss_pred ccceeeccCcEEEEEEEECCceEEEEEeec------CC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 19 PSRLLGQGGFGSVFHATLHDQSVAVKVMDS------GS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 19 i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~------~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
..+.||.|..+.||++...++.++||.... .. ......+..|+..+..-.....+..++.+. . ...+
T Consensus 38 ~i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~--~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--R--TMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--T--TTTE
T ss_pred EEEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--C--CccE
Confidence 457889999999999977678899994321 01 012333444443322111113455565554 2 4569
Q ss_pred EEEecc-CC
Q 036407 90 LVYELM-SN 97 (576)
Q Consensus 90 LVmE~~-~g 97 (576)
+|||++ ++
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 76
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0022 Score=63.98 Aligned_cols=77 Identities=16% Similarity=0.118 Sum_probs=53.7
Q ss_pred CCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCC--ceEEEEEEeeCCCCCeEEEEEe
Q 036407 17 FSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDD--HVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~p--NIv~Llg~~~~~s~~~l~LVmE 93 (576)
..-.+.+|.|..+.||+.... |+.|++|+-..........+..|...|..|.... -+..++.+. . -++|||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~----~~lv~e 90 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D----RTLAME 90 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T----TEEEEE
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C----ceEEEE
Confidence 445678999999999999976 7899999875443333446788999888885421 233444432 2 278999
Q ss_pred ccCCCC
Q 036407 94 LMSNGN 99 (576)
Q Consensus 94 ~~~gGs 99 (576)
+++++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 987653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.002 Score=64.81 Aligned_cols=161 Identities=15% Similarity=0.138 Sum_probs=88.2
Q ss_pred CChHHHHhhcCCCCc-----cceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCc-eEEEEE
Q 036407 5 FSYSVLRRAADSFSP-----SRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH-VVSVLG 78 (576)
Q Consensus 5 fs~~~lk~~~d~Y~i-----~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pN-Iv~Llg 78 (576)
++.+++......|.+ .+.|+.|....+|+....+..+++|+..... ....+..|+.++..|..+.- +..++.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 566777777777765 3456678888999998877789999986521 22345667777777765311 222221
Q ss_pred EeeC----CCCCeEEEEEeccCCCCHH-----------HH---HHhc----CCC-----ChhhHHHHHH-----------
Q 036407 79 FSSN----PKRHRMLLVYELMSNGNLQ-----------DA---LLHK----KPP-----ELMEWCKRFS----------- 120 (576)
Q Consensus 79 ~~~~----~s~~~l~LVmE~~~gGsL~-----------d~---L~~~----~~~-----~~ls~~~vl~----------- 120 (576)
.... ...+..+++|++++|..+. .. ++.. ... ....+...+.
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1100 0125678999999875321 00 1110 000 1111211000
Q ss_pred -HHHHHHHHHHHHHhC-----CCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 121 -IAVDIAKGIAYLHSL-----NPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 121 -I~~qIl~AL~yLHs~-----g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+...+...+..+.+. ...++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 001133344555421 12489999999999998776668999997753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0032 Score=63.19 Aligned_cols=75 Identities=15% Similarity=0.088 Sum_probs=46.6
Q ss_pred CCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEecc-
Q 036407 17 FSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELM- 95 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~- 95 (576)
+.-++.|+.|....+|++ ..+++|+........ .....|+.++..+..+.-...+++++. ..-++|+||+
T Consensus 20 ~~~i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~----~~~~~v~e~i~ 90 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDP----ATGVMVTRYIA 90 (301)
T ss_dssp CCSCEEEESCSSEEEEEE----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECT----TTCCEEEECCT
T ss_pred ccceeEcCCcccccccee----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEEC----CCCEEEEeecC
Confidence 344788999999999998 678899886432111 112457777777765433345555432 2237899999
Q ss_pred CCCCH
Q 036407 96 SNGNL 100 (576)
Q Consensus 96 ~gGsL 100 (576)
+|.+|
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 65444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0084 Score=60.78 Aligned_cols=33 Identities=24% Similarity=0.272 Sum_probs=27.4
Q ss_pred CCeeecccCCCCeEEcCC----CcEEEcccccccccc
Q 036407 137 PPVIHGDIKPSNILLDHN----FCAKISDFGLARLKS 169 (576)
Q Consensus 137 ~~IVHrDLKPeNILLd~~----g~vKLiDFGlA~~~~ 169 (576)
..++|+|+.+.|||++.+ +.+.|+||+.+...+
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 358999999999999874 678999999876543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.40 E-value=0.024 Score=56.96 Aligned_cols=91 Identities=14% Similarity=0.122 Sum_probs=54.0
Q ss_pred CChHHHHhhcCCCCc-----cceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCC-ceEEEE
Q 036407 5 FSYSVLRRAADSFSP-----SRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDD-HVVSVL 77 (576)
Q Consensus 5 fs~~~lk~~~d~Y~i-----~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~p-NIv~Ll 77 (576)
++.+.+......|.+ ...|+ |....||++... |+.+++|....... ....+..|..++..|..+. .+..++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeeccee
Confidence 455555544444432 34566 778889988765 55799999864322 3446677888777776532 123333
Q ss_pred EEeeCC----CCCeEEEEEeccCCC
Q 036407 78 GFSSNP----KRHRMLLVYELMSNG 98 (576)
Q Consensus 78 g~~~~~----s~~~l~LVmE~~~gG 98 (576)
.. ... ..+..++||++++|.
T Consensus 89 ~~-~g~~~~~~~g~~~~l~~~i~G~ 112 (328)
T 1zyl_A 89 AF-NGQTLLNHQGFYFAVFPSVGGR 112 (328)
T ss_dssp CB-TTBSCEEETTEEEEEEECCCCE
T ss_pred ec-CCcEEEEECCEEEEEEEecCCC
Confidence 22 100 125668899999774
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.24 E-value=0.013 Score=62.63 Aligned_cols=71 Identities=17% Similarity=0.127 Sum_probs=48.6
Q ss_pred cceeeccCcEEEEEEEEC---------CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 20 SRLLGQGGFGSVFHATLH---------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~---------g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.+.|+.|....||++... +..+++|+.... .....+..|..++..|..+....++++.+. + .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~----~--g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS----G--GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----T--EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC----C--CE
Confidence 467788889999999864 467899988431 111345678888888876544456666542 1 38
Q ss_pred EEeccCCC
Q 036407 91 VYELMSNG 98 (576)
Q Consensus 91 VmE~~~gG 98 (576)
|+||++|.
T Consensus 150 v~e~l~G~ 157 (429)
T 1nw1_A 150 LEEYIPSR 157 (429)
T ss_dssp EECCCCEE
T ss_pred EEEEeCCc
Confidence 99999763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.15 E-value=0.025 Score=61.07 Aligned_cols=72 Identities=8% Similarity=0.029 Sum_probs=46.8
Q ss_pred cceeeccCcEEEEEEEECC--ceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEeccCC
Q 036407 20 SRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSN 97 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~g--~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~~~g 97 (576)
++.|+.|-...+|++...+ ..+++|+........ ..-..|..++..|....-...+++.+. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~----~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT----N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET----T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC----C--eEEEEeeCC
Confidence 4678888899999998876 789999874321110 012578888888876444456666652 2 359999986
Q ss_pred C
Q 036407 98 G 98 (576)
Q Consensus 98 G 98 (576)
.
T Consensus 186 ~ 186 (458)
T 2qg7_A 186 Y 186 (458)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.12 E-value=0.014 Score=61.62 Aligned_cols=141 Identities=16% Similarity=0.143 Sum_probs=81.2
Q ss_pred cceeeccCcEEEEEEEEC---------CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 20 SRLLGQGGFGSVFHATLH---------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~---------g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.+.|.-|-...+|++... ++.+++|+.-.. ........+|.+++..|....-..++++++.. .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~------g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE------GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT------EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC------cc
Confidence 456777888889998863 367999986321 12334566899888888775555666665532 38
Q ss_pred EEeccCCCCHH--------------HHHH---hcC----CCChhhHHHHHHHHHHHHH-------------------HHH
Q 036407 91 VYELMSNGNLQ--------------DALL---HKK----PPELMEWCKRFSIAVDIAK-------------------GIA 130 (576)
Q Consensus 91 VmE~~~gGsL~--------------d~L~---~~~----~~~~ls~~~vl~I~~qIl~-------------------AL~ 130 (576)
||||++|..|. +.+. ... .....-+.++..++.++-. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999875432 1111 110 0001123344444433311 122
Q ss_pred HH----Hh--CCCCeeecccCCCCeEEcCC----CcEEEcccccccc
Q 036407 131 YL----HS--LNPPVIHGDIKPSNILLDHN----FCAKISDFGLARL 167 (576)
Q Consensus 131 yL----Hs--~g~~IVHrDLKPeNILLd~~----g~vKLiDFGlA~~ 167 (576)
.| .. ....++|+|+.+.|||++.+ +.+.++||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33 22 12258899999999999876 7899999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.79 E-value=0.021 Score=58.78 Aligned_cols=72 Identities=10% Similarity=0.037 Sum_probs=42.7
Q ss_pred cceeeccCcEEEEEEEECC----------ceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 20 SRLLGQGGFGSVFHATLHD----------QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~g----------~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
.+.|+.|....+|++...+ +.+++|+....... ......|..++..|..+..+..+++.. . + +
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~--~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--G--G 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T--E
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--C--c
Confidence 4577788888999998764 67888887542211 112356777777776543344555443 2 2 7
Q ss_pred EEEeccCCC
Q 036407 90 LVYELMSNG 98 (576)
Q Consensus 90 LVmE~~~gG 98 (576)
+||+|++|.
T Consensus 111 ~v~e~i~G~ 119 (369)
T 3c5i_A 111 RIEEWLYGD 119 (369)
T ss_dssp EEEECCCSE
T ss_pred EEEEEecCC
Confidence 899999874
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.43 E-value=0.099 Score=53.58 Aligned_cols=31 Identities=26% Similarity=0.362 Sum_probs=27.1
Q ss_pred CeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 138 PVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 138 ~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
.++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 4899999999999988888999999877643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.92 E-value=0.17 Score=49.93 Aligned_cols=60 Identities=8% Similarity=0.046 Sum_probs=42.8
Q ss_pred CCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEc
Q 036407 98 GNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKIS 160 (576)
Q Consensus 98 GsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLi 160 (576)
-+|.+.|...+.+ +++.++|.++.|++.+|.-+-.... -..+=+.|..|+|..+|.+.+.
T Consensus 33 vSL~eIL~~~~~P--lsEEqaWALc~Qc~~~L~~~~~~~~-~~~~i~~~~~i~l~~dG~V~f~ 92 (229)
T 2yle_A 33 LSLEEILRLYNQP--INEEQAWAVCYQCCGSLRAAARRRQ-PRHRVRSAAQIRVWRDGAVTLA 92 (229)
T ss_dssp EEHHHHHHHHTSC--CCHHHHHHHHHHHHHHHHHHHHTTC-CCCCCCSGGGEEEETTSCEEEC
T ss_pred ccHHHHHHHcCCC--cCHHHHHHHHHHHHHHHHhhhhccc-CCceecCCcceEEecCCceecc
Confidence 3899999887654 8999999999999998877622110 1122234688888888887665
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.06 E-value=0.52 Score=50.34 Aligned_cols=73 Identities=10% Similarity=0.053 Sum_probs=47.4
Q ss_pred cceeeccCcEEEEEEEEC---------CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 20 SRLLGQGGFGSVFHATLH---------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~---------g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
++.|..|-...+|+.... +..|++++....... .....+|..++..|....-...+++.+ . + ++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~--~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--E--GR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--T--EE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--C--CE
Confidence 466777888999999876 578999986432211 111256777777776544445555533 2 2 78
Q ss_pred EEeccCCCC
Q 036407 91 VYELMSNGN 99 (576)
Q Consensus 91 VmE~~~gGs 99 (576)
||+|++|..
T Consensus 148 I~efI~G~~ 156 (424)
T 3mes_A 148 IEEFIDGEP 156 (424)
T ss_dssp EEECCCSEE
T ss_pred EEEEeCCcc
Confidence 999998754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.54 E-value=0.7 Score=48.38 Aligned_cols=29 Identities=28% Similarity=0.377 Sum_probs=24.6
Q ss_pred eeecccCCCCeEE------cCCCcEEEcccccccc
Q 036407 139 VIHGDIKPSNILL------DHNFCAKISDFGLARL 167 (576)
Q Consensus 139 IVHrDLKPeNILL------d~~g~vKLiDFGlA~~ 167 (576)
++|+|+.+.|||+ +.+..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 3457799999998764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 576 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-37 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-17 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-34 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-13 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-33 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-09 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-33 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-13 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-32 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-08 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-32 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-12 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-32 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-15 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-32 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-11 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-32 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-13 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-13 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-31 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-13 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-14 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-31 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-14 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-31 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-14 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-30 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-11 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-30 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-11 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-30 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-04 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-30 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-12 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-30 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-14 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-13 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-30 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-16 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-29 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-08 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-28 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-05 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-28 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-16 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-28 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-16 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-28 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-13 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-28 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-13 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-27 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-12 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-27 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-11 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-27 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-08 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-12 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-05 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-26 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-12 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-26 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-08 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-26 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-09 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-26 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-10 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-25 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-12 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-25 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-07 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-24 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-09 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-24 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-08 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-24 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-07 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-23 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-05 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-23 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-10 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-22 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 0.002 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-22 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-08 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-22 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-06 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-22 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-22 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-08 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-22 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 0.001 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-22 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-05 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-21 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-05 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-21 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-08 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-21 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-06 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-21 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-06 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-20 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-10 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-20 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-06 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-19 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 0.002 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-18 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-08 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-18 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-05 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-17 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-15 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-05 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 7e-37
Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 11/164 (6%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQSVAVKVM--DSGSLQGEREFYNELYFASLLEQDDH 72
+ + +G G FG+V+ H VAVK++ + + Q + F NE+ + +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVN 65
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYL 132
++ +G+S+ P ++ +V + +L L + E K IA A+G+ YL
Sbjct: 66 ILLFMGYSTAP---QLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYL 120
Query: 133 HSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQ 176
H +IH D+K +NI L + KI DFGLA +KS +Q
Sbjct: 121 H--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.6 bits (196), Expect = 4e-17
Identities = 24/136 (17%), Positives = 50/136 (36%), Gaps = 18/136 (13%)
Query: 411 DSAASGEIPKSGGVTSTPSMRGTVCYVAPEY---GAGGDISEKCDVYSYGVLLLVLIAGR 467
D + + G + G++ ++APE S + DVY++G++L L+ G+
Sbjct: 147 DFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206
Query: 468 RPLQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQ 527
P + N + G L + + V + + + CL+
Sbjct: 207 LP----------YSNINNRDQIIFMVGRGYLSPDLSK-VRSNCPKA----MKRLMAECLK 251
Query: 528 KSPALRPSMEEVVGML 543
K RP +++ +
Sbjct: 252 KKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 3e-34
Identities = 46/154 (29%), Positives = 70/154 (45%), Gaps = 9/154 (5%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS-VAVKVMDSGSLQGEREFYNELYFASLLEQDDHV 73
++ LG G FG V+ + + VAVK + GS F E L Q +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQL-QHQRL 70
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLH 133
V + + + ++ E M NG+L D L + K +A IA+G+A++
Sbjct: 71 VRLYAVVTQEPIY---IITEYMENGSLVD-FLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
N IH D++ +NIL+ KI+DFGLARL
Sbjct: 127 ERN--YIHRDLRAANILVSDTLSCKIADFGLARL 158
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.9 bits (168), Expect = 1e-13
Identities = 23/133 (17%), Positives = 48/133 (36%), Gaps = 20/133 (15%)
Query: 411 DSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPL 470
D + I + + + + APE G + K DV+S+G+LL ++ R
Sbjct: 152 DFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
Query: 471 QVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSP 530
+ ++L R +++ + E + LC ++ P
Sbjct: 211 ---------YPGMTNPEVIQNLERGYRMVR------PDNCPEE----LYQLMRLCWKERP 251
Query: 531 ALRPSMEEVVGML 543
RP+ + + +L
Sbjct: 252 EDRPTFDYLRSVL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (320), Expect = 2e-33
Identities = 46/158 (29%), Positives = 69/158 (43%), Gaps = 13/158 (8%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGE---REFYNELYFASLLEQ 69
FS R +G G FG+V+ A + VA+K M Q ++ E+ F L +
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-R 73
Query: 70 DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
+ + G H LV E +HKKP ++ + ++ +G+
Sbjct: 74 HPNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGL 128
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
AYLHS N +IH D+K NILL K+ DFG A +
Sbjct: 129 AYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI 164
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 57.3 bits (138), Expect = 1e-09
Identities = 28/120 (23%), Positives = 40/120 (33%), Gaps = 22/120 (18%)
Query: 424 VTSTPSMRGTVCYVAPEYGAG---GDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEF 480
+ S GT ++APE G K DV+S G+ + L + P
Sbjct: 165 MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----------L 214
Query: 481 QRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVV 540
N MS H+A+N CLQK P RP+ E ++
Sbjct: 215 FNMNAMSALYHIAQNESPALQSGH-----WSEY----FRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-33
Identities = 38/155 (24%), Positives = 69/155 (44%), Gaps = 7/155 (4%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVV 74
+ +G+G FG V VAVK + + + + F E + L + ++V
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQL-RHSNLV 63
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS 134
+LG K + +V E M+ G+L D L + ++ ++D+ + + YL
Sbjct: 64 QLLGVIVEEK-GGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
+H D+ N+L+ + AK+SDFGL + S
Sbjct: 122 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.3 bits (164), Expect = 4e-13
Identities = 23/119 (19%), Positives = 40/119 (33%), Gaps = 19/119 (15%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRAN 484
++ + + V + APE S K DV+S+G+LL + + R + R
Sbjct: 155 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP---------YPRIP 205
Query: 485 LMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGML 543
L + + K+ V C A+RPS ++ L
Sbjct: 206 LKDVVPRVEKGYKM------DAPDGCPPA----VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 1e-32
Identities = 34/154 (22%), Positives = 66/154 (42%), Gaps = 9/154 (5%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
D + LG G FG V+ A + A KV+D+ S + ++ E+ + +
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPN 70
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYL 132
+V +L + + ++ E + G + +L + P + + + + YL
Sbjct: 71 IVKLLDAFYYE--NNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYL 126
Query: 133 HSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
H +IH D+K NIL + K++DFG++
Sbjct: 127 HDNK--IIHRDLKAGNILFTLDGDIKLADFGVSA 158
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (126), Expect = 4e-08
Identities = 21/124 (16%), Positives = 39/124 (31%), Gaps = 23/124 (18%)
Query: 421 SGGVTSTPSMRGTVCYVAPEY-----GAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGS 475
+ + S GT ++APE K DV+S G+ L+ + P
Sbjct: 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP------ 214
Query: 476 PMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPS 535
N M +A++ + + L CL+K+ R +
Sbjct: 215 ----HHELNPMRVLLKIAKSEPPTLAQPSRWSSNF---KDFL-----KKCLEKNVDARWT 262
Query: 536 MEEV 539
++
Sbjct: 263 TSQL 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-32
Identities = 32/162 (19%), Positives = 65/162 (40%), Gaps = 9/162 (5%)
Query: 14 ADSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSL--QGEREFYNELYFASLLEQ 69
A+ + +G G +G + + K +D GS+ ++ +E+ L +
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-K 61
Query: 70 DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALL-HKKPPELMEWCKRFSIAVDIAKG 128
++V + + +V E G+L + K + ++ + +
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 129 IAYLHSLN---PPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+ H + V+H D+KP+N+ LD K+ DFGLAR+
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.5 bits (154), Expect = 9e-12
Identities = 27/116 (23%), Positives = 42/116 (36%), Gaps = 20/116 (17%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRAN 484
+ + GT Y++PE +EK D++S G LL L A P F +
Sbjct: 169 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----------FTAFS 218
Query: 485 LMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVV 540
A + R GK + + E + L RPS+EE++
Sbjct: 219 QKELAGKI-REGKFRRIPYR-----YSDE----LNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 1e-32
Identities = 39/162 (24%), Positives = 70/162 (43%), Gaps = 14/162 (8%)
Query: 21 RLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGF- 79
+G+G FG V+ + VAVK+ S + E+Y +L + ++++ +
Sbjct: 9 ESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVML-RHENILGFIAAD 66
Query: 80 -SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL--- 135
N ++ LV + +G+L D L++ + +A+ A G+A+LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFD-YLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 136 ---NPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQ 174
P + H D+K NIL+ N I+D GLA +
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.9 bits (183), Expect = 2e-15
Identities = 16/127 (12%), Positives = 39/127 (30%), Gaps = 7/127 (5%)
Query: 425 TSTPSMRGTVCYVAPEY------GAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMS 478
+ GT Y+APE + ++ D+Y+ G++ + +
Sbjct: 167 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226
Query: 479 EFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCI-TVALLCLQKSPALRPSME 537
+ + R + + + +AL + + C + A R +
Sbjct: 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286
Query: 538 EVVGMLT 544
+ L+
Sbjct: 287 RIKKTLS 293
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-32
Identities = 36/160 (22%), Positives = 62/160 (38%), Gaps = 10/160 (6%)
Query: 10 LRRAADSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGERE-FYNELYFASL 66
+ D F LG G G VF + +A K++ R EL
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 67 LEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIA 126
++V G + + + E M G+L L + +++ +
Sbjct: 61 C-NSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVI 114
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
KG+ YL + ++H D+KPSNIL++ K+ DFG++
Sbjct: 115 KGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSG 153
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.9 bits (155), Expect = 1e-11
Identities = 28/138 (20%), Positives = 51/138 (36%), Gaps = 23/138 (16%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGS--------- 475
+ S GT Y++PE G S + D++S G+ L+ + GR P+ +
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217
Query: 476 ----------PMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALL----CITV 521
P L S+ + EL+D V + + + +
Sbjct: 218 QVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277
Query: 522 ALLCLQKSPALRPSMEEV 539
CL K+PA R ++++
Sbjct: 278 VNKCLIKNPAERADLKQL 295
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 3e-32
Identities = 47/188 (25%), Positives = 80/188 (42%), Gaps = 32/188 (17%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS-------VAVKVMDSGSLQGERE-FYNELYFASL 66
++ ++LG G FG V +AT + S VAVK++ + ERE +EL +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 67 LEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPP---------------- 110
L +++V++LG + + L++E G+L + L K+
Sbjct: 97 LGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 111 ----ELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
++ + A +AKG+ +L +H D+ N+L+ H KI DFGLAR
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 167 LKSVGENQ 174
N
Sbjct: 213 DIMSDSNY 220
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.1 bits (163), Expect = 9e-13
Identities = 26/137 (18%), Positives = 46/137 (33%), Gaps = 18/137 (13%)
Query: 411 DSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPL 470
D + +I + R V ++APE G + K DV+SYG+LL + +
Sbjct: 207 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266
Query: 471 QVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSP 530
+ + + L +NG ++ A + + C
Sbjct: 267 ---------YPGIPVDANFYKLIQNGFKMDQPFYATEE---------IYIIMQSCWAFDS 308
Query: 531 ALRPSMEEVVGMLTGKL 547
RPS + L +L
Sbjct: 309 RKRPSFPNLTSFLGCQL 325
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 7e-32
Identities = 54/183 (29%), Positives = 80/183 (43%), Gaps = 27/183 (14%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSLQGERE-FYNELYFASL 66
+ S + LG G FG V AT + +VAVK++ + ERE +EL S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 67 LEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPEL-------------- 112
L ++V++LG + L++ E G+L + L K+ +
Sbjct: 83 LGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 113 -MEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVG 171
++ S + +AKG+A+L S N IH D+ NILL H KI DFGLAR
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 172 ENQ 174
N
Sbjct: 199 SNY 201
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (168), Expect = 2e-13
Identities = 20/138 (14%), Positives = 45/138 (32%), Gaps = 18/138 (13%)
Query: 411 DSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPL 470
D + +I + R V ++APE + + DV+SYG+ L L +
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS- 246
Query: 471 QVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSP 530
+ + K +++ + + C P
Sbjct: 247 -----------------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289
Query: 531 ALRPSMEEVVGMLTGKLE 548
RP+ +++V ++ ++
Sbjct: 290 LKRPTFKQIVQLIEKQIS 307
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 2e-31
Identities = 45/156 (28%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 21 RLLGQGGFGSVFHATLHD--QSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSV 76
+G+G F +V+ + VA + L + F E L Q ++V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRF 73
Query: 77 LGF--SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS 134
S+ + ++LV ELM++G L+ L K M+ S I KG+ +LH+
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHT 130
Query: 135 LNPPVIHGDIKPSNILL-DHNFCAKISDFGLARLKS 169
PP+IH D+K NI + KI D GLA LK
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.3 bits (164), Expect = 4e-13
Identities = 17/116 (14%), Positives = 43/116 (37%), Gaps = 19/116 (16%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRAN 484
+ ++ GT ++APE E DVY++G+ +L + P +
Sbjct: 168 SFAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP----------YSECQ 216
Query: 485 LMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVV 540
+ +G D+ + + + C++++ R S+++++
Sbjct: 217 NAAQIYRRVTSGVKPASFDKVAIPEVKE--------IIEGCIRQNKDERYSIKDLL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (303), Expect = 3e-31
Identities = 46/186 (24%), Positives = 79/186 (42%), Gaps = 22/186 (11%)
Query: 5 FSYSVLRRAADSFSPS---------RLLGQGGFGSVFHATLHDQS-----VAVKVMDSG- 49
F++ A F+ +++G G FG V L VA+K + SG
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 50 SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP 109
+ + R+F +E AS++ Q DH + K ++++ E M NG+L ++
Sbjct: 67 TEKQRRDFLSE---ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQN 121
Query: 110 PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
+ + IA G+ YL + +H D+ NIL++ N K+SDFGL+R
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 170 VGENQN 175
+
Sbjct: 180 DDTSDP 185
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 70.2 bits (171), Expect = 8e-14
Identities = 21/127 (16%), Positives = 41/127 (32%), Gaps = 19/127 (14%)
Query: 424 VTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRA 483
TS + + + APE + DV+SYG+++ +++ +
Sbjct: 187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ------ 240
Query: 484 NLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGML 543
+I ++Q + + L C QK RP ++V L
Sbjct: 241 -------------DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 544 TGKLEAP 550
+ P
Sbjct: 288 DKMIRNP 294
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 5e-31
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 9/154 (5%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS-VAVKVMDSGSLQGEREFYNELYFASLLEQDDHV 73
+ + LG G FG V + Q VA+K++ GS E EF E L + +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNL-SHEKL 61
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLH 133
V + G + + + ++ E M+NG L + L + + + + D+ + + YL
Sbjct: 62 VQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLE 117
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+ +H D+ N L++ K+SDFGL+R
Sbjct: 118 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.6 bits (175), Expect = 1e-14
Identities = 20/124 (16%), Positives = 42/124 (33%), Gaps = 19/124 (15%)
Query: 420 KSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSE 479
TS+ + V + PE S K D++++GVL+ + + + P
Sbjct: 151 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM------PYER 204
Query: 480 FQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEV 539
F N + E + Q + + T+ C + RP+ + +
Sbjct: 205 FT-------------NSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKIL 251
Query: 540 VGML 543
+ +
Sbjct: 252 LSNI 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 9e-31
Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 9/161 (5%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHV 73
+S LGQG FG V+ T + VA+K + G+ F E L + + +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKL-RHEKL 74
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLH 133
V + S + +V E MS G+L D L + + + + +A IA G+AY+
Sbjct: 75 VQLYAVVSE---EPIYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQ 174
+H D++ +NIL+ N K++DFGLARL E
Sbjct: 131 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.4 bits (177), Expect = 1e-14
Identities = 26/139 (18%), Positives = 45/139 (32%), Gaps = 22/139 (15%)
Query: 420 KSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSE 479
+ T+ + + + APE G + K DV+S+G+LL L R
Sbjct: 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-- 221
Query: 480 FQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEV 539
++++ V++ E + C +K P RP+ E +
Sbjct: 222 -----------------EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL 264
Query: 540 VGMLTG---KLEAPKLPAE 555
L E P E
Sbjct: 265 QAFLEDYFTSTEPQYQPGE 283
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-30
Identities = 41/162 (25%), Positives = 69/162 (42%), Gaps = 13/162 (8%)
Query: 23 LGQGGFGSVFHATLHD----QSVAVKVMDSGSLQGERE-FYNELYFASLLEQDDHVVSVL 77
LG G FGSV VA+KV+ G+ + + E E L + ++V ++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLI 75
Query: 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNP 137
G ++LV E+ G L L+ K+ + + ++ G+ YL
Sbjct: 76 GVCQA---EALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLE--EK 128
Query: 138 PVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADG 179
+H D+ N+LL + AKISDFGL++ ++ A
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.2 bits (153), Expect = 1e-11
Identities = 21/125 (16%), Positives = 38/125 (30%), Gaps = 19/125 (15%)
Query: 419 PKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMS 478
T+ + + + + APE S + DV+SYGV + ++ + P
Sbjct: 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK------PYK 214
Query: 479 EFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEE 538
+ + +M GK +E E + C RP
Sbjct: 215 KMKGPEVM----AFIEQGKRMECPP-----ECPPE----LYALMSDCWIYKWEDRPDFLT 261
Query: 539 VVGML 543
V +
Sbjct: 262 VEQRM 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 118 bits (297), Expect = 2e-30
Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 9/170 (5%)
Query: 2 PHRFSYSVLRRAADSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYN 59
P +Y + LG G +G V+ +VAVK + +++ E EF
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLK 62
Query: 60 ELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRF 119
E + + ++V +LG + ++ E M+ GNL D L + + +
Sbjct: 63 EAAVMKEI-KHPNLVQLLGVCTRE--PPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLL 118
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
+A I+ + YL IH D+ N L+ N K++DFGL+RL +
Sbjct: 119 YMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 63.2 bits (153), Expect = 1e-11
Identities = 24/136 (17%), Positives = 45/136 (33%), Gaps = 19/136 (13%)
Query: 420 KSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSE 479
T+ + + + APE A S K DV+++GVLL +
Sbjct: 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--------- 216
Query: 480 FQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEV 539
+ +L ++ EL+++ + C Q +P+ RPS E+
Sbjct: 217 YPGIDLS----------QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 266
Query: 540 VGMLTGKLEAPKLPAE 555
+ + E
Sbjct: 267 HQAFETMFQESSISDE 282
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 120 bits (301), Expect = 2e-30
Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 14/162 (8%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSL---QGEREFYNELYFASLLEQ 69
+ FS R++G+GGFG V+ D + A+K +D + QGE NE SL+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 70 DDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAK 127
D +V + P + + + +LM+ G+L L + A +I
Sbjct: 64 GDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRF---YAAEIIL 118
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169
G+ ++H+ V++ D+KP+NILLD + +ISD GLA S
Sbjct: 119 GLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFS 158
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.7 bits (92), Expect = 7e-04
Identities = 24/152 (15%), Positives = 40/152 (26%), Gaps = 34/152 (22%)
Query: 425 TSTPSMRGTVCYVAPEYGAGG-DISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRA 483
+ GT Y+APE G D +S G +L L+ G P + +
Sbjct: 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 219
Query: 484 NLMSWARHLARN--GKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVV- 540
++ A L + +L L++ LQ+ R
Sbjct: 220 MTLTMAVELPDSFSPELRSLLEG--------------------LLQRDVNRRLGCLGRGA 259
Query: 541 ----------GMLTGKLEAPKLPAEFSPSPPS 562
+ + K P P
Sbjct: 260 QEVKESPFFRSLDWQMVFLQKYPPPLIPPRGE 291
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 3e-30
Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 13/157 (8%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSL---QGEREFYNELYFASLLEQ 69
+ F R LG+G FG+V+ A +A+KV+ L E + E+ S L +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-R 64
Query: 70 DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
+++ + G+ + R + L+ E G + L + + + ++A +
Sbjct: 65 HPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANAL 119
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
+Y HS VIH DIKP N+LL KI+DFG +
Sbjct: 120 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSV 154
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.8 bits (155), Expect = 5e-12
Identities = 25/122 (20%), Positives = 46/122 (37%), Gaps = 23/122 (18%)
Query: 420 KSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSE 479
+ ++ GT+ Y+ PE G EK D++S GVL + G+ P
Sbjct: 154 VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP---------- 203
Query: 480 FQRANLMSWARHLAR-NGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEE 538
F+ + ++R + V + + R L+ +P+ RP + E
Sbjct: 204 FEANTYQETYKRISRVEFTFPDFVTEGARDLISR------------LLKHNPSQRPMLRE 251
Query: 539 VV 540
V+
Sbjct: 252 VL 253
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (295), Expect = 4e-30
Identities = 47/191 (24%), Positives = 75/191 (39%), Gaps = 34/191 (17%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD-------QSVAVKVMD-SGSLQGEREFYNELYFASL 66
++ R +G+G FG VF A VAVK++ S + +F E A+L
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE---AAL 69
Query: 67 LEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKP----------------- 109
+ + D+ V M L++E M+ G+L + L P
Sbjct: 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 110 ----PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
P + ++ IA +A G+AYL +H D+ N L+ N KI+DFGL+
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLS 187
Query: 166 RLKSVGENQNQ 176
R +
Sbjct: 188 RNIYSADYYKA 198
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 70.3 bits (171), Expect = 7e-14
Identities = 24/138 (17%), Positives = 45/138 (32%), Gaps = 19/138 (13%)
Query: 411 DSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPL 470
D S I + + + + ++ PE + + DV++YGV+L + +
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242
Query: 471 QVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSP 530
+ ++I V + + L + LC K P
Sbjct: 243 YYGMAHE-------------------EVIYYVRDGNILACPENCPLELYNLMRLCWSKLP 283
Query: 531 ALRPSMEEVVGMLTGKLE 548
A RPS + +L E
Sbjct: 284 ADRPSFCSIHRILQRMCE 301
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 7e-30
Identities = 47/183 (25%), Positives = 75/183 (40%), Gaps = 22/183 (12%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD----QSVAVKVMD-SGSLQGEREFYNELYFASLLEQ 69
+ ++G+G FG V A + A+K M S R+F EL L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 70 DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPEL-------------MEWC 116
+++++LG + + L E +GNL D L + E +
Sbjct: 70 HPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 117 KRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQ 176
+ A D+A+G+ YL IH D+ NIL+ N+ AKI+DFGL+R + V +
Sbjct: 128 QLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 185
Query: 177 ADG 179
Sbjct: 186 GRL 188
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.9 bits (165), Expect = 5e-13
Identities = 25/127 (19%), Positives = 44/127 (34%), Gaps = 19/127 (14%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRAN 484
R V ++A E + DV+SYGVLL +++ +
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------PYCGMT 231
Query: 485 LMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGMLT 544
L + +L + ++ D E + C ++ P RPS +++ L
Sbjct: 232 CAELYEKLPQGYRLEKPLN------CDDE----VYDLMRQCWREKPYERPSFAQILVSLN 281
Query: 545 GKLEAPK 551
LE K
Sbjct: 282 RMLEERK 288
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 7e-30
Identities = 41/154 (26%), Positives = 64/154 (41%), Gaps = 9/154 (5%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHV 73
+ + +G G FG V + VA+K + G+ E +F E L +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKL-SHPKL 62
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLH 133
V + G + LV+E M +G L D + L + +D+ +G+AYL
Sbjct: 63 VQLYGVCLEQAP--ICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
VIH D+ N L+ N K+SDFG+ R
Sbjct: 119 E--ACVIHRDLAARNCLVGENQVIKVSDFGMTRF 150
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.0 bits (189), Expect = 2e-16
Identities = 22/130 (16%), Positives = 45/130 (34%), Gaps = 19/130 (14%)
Query: 420 KSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSE 479
TS+ + V + +PE + S K DV+S+GVL+ + + + S
Sbjct: 152 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-- 209
Query: 480 FQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEV 539
+++E + R + + C ++ P RP+ +
Sbjct: 210 -----------------EVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRL 252
Query: 540 VGMLTGKLEA 549
+ L E+
Sbjct: 253 LRQLAEIAES 262
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 1e-29
Identities = 44/163 (26%), Positives = 69/163 (42%), Gaps = 11/163 (6%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMD-SGSLQGEREFYNELYFASLLEQDD 71
+ + + LG+G +G V A +++VAVK++D ++ E+ +L +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE 63
Query: 72 HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAY 131
+VV G + L E S G L D + M + G+ Y
Sbjct: 64 NVVKFYGHRREG--NIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVY 118
Query: 132 LHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQ 174
LH + + H DIKP N+LLD KISDFGLA + +
Sbjct: 119 LHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (130), Expect = 1e-08
Identities = 25/130 (19%), Positives = 48/130 (36%), Gaps = 19/130 (14%)
Query: 411 DSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDI-SEKCDVYSYGVLLLVLIAGRRP 469
D + + M GT+ YVAPE + +E DV+S G++L ++AG P
Sbjct: 146 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205
Query: 470 LQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKS 529
E+ + + +D A + L + L ++
Sbjct: 206 WDQPSDSCQEYSDWKEKKTYLNPWKK------IDSAPLALLHK------------ILVEN 247
Query: 530 PALRPSMEEV 539
P+ R ++ ++
Sbjct: 248 PSARITIPDI 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 113 bits (283), Expect = 1e-28
Identities = 43/185 (23%), Positives = 73/185 (39%), Gaps = 18/185 (9%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSL---------QGEREFYNELYF 63
+++ P +LG+G V + AVK++D + E+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 64 ASLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAV 123
+ +++ + LV++LM G L D L K + + I
Sbjct: 63 LRKVSGHPNIIQLKDTYETN--TFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMR 117
Query: 124 DIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADGENKN 183
+ + I LH LN ++H D+KP NILLD + K++DFG + GE + G
Sbjct: 118 ALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 175
Query: 184 KAAEL 188
A E+
Sbjct: 176 LAPEI 180
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 44.7 bits (105), Expect = 1e-05
Identities = 22/121 (18%), Positives = 35/121 (28%), Gaps = 23/121 (19%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGD------ISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMS 478
+ GT Y+APE ++ D++S GV++ L+AG P
Sbjct: 164 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--------- 214
Query: 479 EFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEE 538
F M R + + + L P R + EE
Sbjct: 215 -FWHRKQMLMLRMIMSGNYQFGSPEWDDYSD-------TVKDLVSRFLVVQPQKRYTAEE 266
Query: 539 V 539
Sbjct: 267 A 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-28
Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 14/169 (8%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS------VAVKVMDSGSLQGER-EFYNELYFASLL 67
+ +++G G FG V+ L S VA+K + +G + +R +F E A ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE---AGIM 63
Query: 68 EQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAK 127
Q H + K M+++ E M NG L ++ + + IA
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAA 121
Query: 128 GIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQ 176
G+ YL N +H D+ NIL++ N K+SDFGL+R+
Sbjct: 122 GMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 168
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.8 bits (188), Expect = 4e-16
Identities = 18/127 (14%), Positives = 45/127 (35%), Gaps = 19/127 (14%)
Query: 424 VTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRA 483
+T + + + APE + + DV+S+G+++ ++ S
Sbjct: 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------ 220
Query: 484 NLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGML 543
++++ ++ + + + C Q+ A RP ++V +L
Sbjct: 221 -------------EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
Query: 544 TGKLEAP 550
+ AP
Sbjct: 268 DKLIRAP 274
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 2e-28
Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 12/163 (7%)
Query: 20 SRLLGQGGFGSVFHATLHDQS-----VAVKVMDSGSLQGE-REFYNELYFASLLEQDDHV 73
+ ++G+G FG V+H TL D AVK ++ + GE +F E +V
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNV 90
Query: 74 VSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLH 133
+S+LG + L+V M +G+L++ + + +AKG+ +L
Sbjct: 91 LSLLGICLRSE-GSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 134 SLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQ 176
+ +H D+ N +LD F K++DFGLAR E +
Sbjct: 148 --SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.5 bits (190), Expect = 3e-16
Identities = 26/128 (20%), Positives = 46/128 (35%), Gaps = 23/128 (17%)
Query: 419 PKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMS 478
+ V + + V ++A E + K DV+S+GVLL L+ P
Sbjct: 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-------- 234
Query: 479 EFQRANLMSWARHLARNGKLI--ELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSM 536
+ N +L + +L+ E + + V L C +RPS
Sbjct: 235 -YPDVNTFDITVYLLQGRRLLQPEYCPDPLYE------------VMLKCWHPKAEMRPSF 281
Query: 537 EEVVGMLT 544
E+V ++
Sbjct: 282 SELVSRIS 289
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 4e-28
Identities = 37/153 (24%), Positives = 64/153 (41%), Gaps = 15/153 (9%)
Query: 21 RLLGQGGFGSVFHATLHD----QSVAVKVMDSGSLQGE--REFYNELYFASLLEQDDHVV 74
+ LG G FG+V ++VAVK++ + + E E L + ++V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIV 71
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS 134
++G +LV E+ G L L + ++ + ++ G+ YL
Sbjct: 72 RMIGICEAESW---MLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE- 124
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+H D+ N+LL AKISDFGL++
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 156
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.8 bits (165), Expect = 3e-13
Identities = 20/120 (16%), Positives = 38/120 (31%), Gaps = 21/120 (17%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIA-GRRPLQVTGSPMSEFQRA 483
+ + V + APE S K DV+S+GVL+ + G++P ++
Sbjct: 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP----------YRGM 214
Query: 484 NLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGML 543
++ ++++ + LC RP V L
Sbjct: 215 KGS----------EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 8e-28
Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 15/173 (8%)
Query: 14 ADSFSPSRLLGQGGFGSVFHATLHDQS------VAVKVM-DSGSLQGEREFYNELYFASL 66
F ++LG G FG+V+ + VA+K + ++ S + +E +E Y +
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 67 LEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIA 126
+ + HV +LG L+ +LM G L D + K + + V IA
Sbjct: 68 V-DNPHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIA 121
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADG 179
KG+ YL + ++H D+ N+L+ KI+DFGLA+L E + A+G
Sbjct: 122 KGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.8 bits (170), Expect = 1e-13
Identities = 20/156 (12%), Positives = 44/156 (28%), Gaps = 19/156 (12%)
Query: 410 YDSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRP 469
D + + + + ++A E + + DV+SYGV + L+
Sbjct: 153 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212
Query: 470 LQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKS 529
G P SE + ++++ + + + C
Sbjct: 213 P-YDGIPASE------------------ISSILEKGERLPQPPICTIDVYMIMVKCWMID 253
Query: 530 PALRPSMEEVVGMLTGKLEAPKLPAEFSPSPPSRIP 565
RP E++ + P+ +P
Sbjct: 254 ADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 289
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-27
Identities = 47/168 (27%), Positives = 66/168 (39%), Gaps = 16/168 (9%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS-----VAVKVMDSGSL---QGEREFYNELYFASL 66
LG G FG V S VAVK + L + +F E+
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 67 LEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIA 126
L +++ + G P M +V EL G+L D L + L+ R AV +A
Sbjct: 68 L-DHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVA 121
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQ 174
+G+ YL S IH D+ N+LL KI DFGL R ++
Sbjct: 122 EGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.3 bits (161), Expect = 1e-12
Identities = 16/120 (13%), Positives = 31/120 (25%), Gaps = 18/120 (15%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRAN 484
+ + APE S D + +GV L + + + N
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---------WIGLN 219
Query: 485 LMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGMLT 544
+ + G+ + + V + C P RP+ + L
Sbjct: 220 GSQILHKIDKEGERLPRPEDCPQD---------IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-27
Identities = 37/156 (23%), Positives = 70/156 (44%), Gaps = 11/156 (7%)
Query: 21 RLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLG 78
+GQG G+V+ A Q VA++ M+ + NE+ ++ ++V+ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLD 84
Query: 79 FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPP 138
+ +V E ++ G+L D + E + ++ + + + +LHS
Sbjct: 85 SYLVGDE--LWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEFLHSNQ-- 136
Query: 139 VIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQ 174
VIH DIK NILL + K++DFG + +++
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.8 bits (147), Expect = 9e-11
Identities = 23/115 (20%), Positives = 40/115 (34%), Gaps = 18/115 (15%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRAN 484
+ +M GT ++APE K D++S G++ + +I G P + N
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP----------YLNEN 220
Query: 485 LMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEV 539
+ +A NG + + L CL R S +E+
Sbjct: 221 PLRALYLIATNGTP----ELQNPEKLSAI----FRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-27
Identities = 41/171 (23%), Positives = 75/171 (43%), Gaps = 11/171 (6%)
Query: 11 RRAADSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLE 68
++ + F ++LG+G F +V A + A+K+++ + E + ++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 69 QDDH--VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIA 126
+ DH V + + ++ + NG L + E C RF +I
Sbjct: 64 RLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGS--FDETCTRF-YTAEIV 118
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQA 177
+ YLH +IH D+KP NILL+ + +I+DFG A++ S Q +A
Sbjct: 119 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.9 bits (129), Expect = 2e-08
Identities = 27/161 (16%), Positives = 45/161 (27%), Gaps = 38/161 (23%)
Query: 410 YDSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRP 469
D + + S GT YV+PE + D+++ G ++ L+AG P
Sbjct: 150 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
Query: 470 LQVTGSPMSEFQRANLMS-WARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQK 528
F+ N + + + E +++ L
Sbjct: 210 ----------FRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK------------LLVL 247
Query: 529 SPALRPSMEEVVGMLTGK---------------LEAPKLPA 554
R EE+ G K PKL A
Sbjct: 248 DATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 288
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 3e-27
Identities = 48/183 (26%), Positives = 75/183 (40%), Gaps = 24/183 (13%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD-------QSVAVKVMDSGSLQGE-REFYNELYFASL 66
D + LG+G FG V A ++VAVK++ G+ E R +EL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 67 LEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPP-------------ELM 113
+ +VV++LG + P ++++ E GNL L K+ + +
Sbjct: 73 IGHHLNVVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 114 EWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGEN 173
+ +AKG+ +L S IH D+ NILL KI DFGLAR +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 174 QNQ 176
+
Sbjct: 190 YVR 192
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (161), Expect = 1e-12
Identities = 25/135 (18%), Positives = 45/135 (33%), Gaps = 18/135 (13%)
Query: 415 SGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTG 474
+ +I K R + ++APE + + DV+S+GVLL + +
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP---- 236
Query: 475 SPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRP 534
+ + + G + D + L C P+ RP
Sbjct: 237 -----YPGVKIDEEFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRP 282
Query: 535 SMEEVVGMLTGKLEA 549
+ E+V L L+A
Sbjct: 283 TFSELVEHLGNLLQA 297
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 8e-27
Identities = 41/170 (24%), Positives = 73/170 (42%), Gaps = 18/170 (10%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
S++ ++++G G FG V+ A L D + VA+K + RE ++ + DH
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE-------LQIMRKLDH 72
Query: 73 --VVSVLGF----SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIA 126
+V + F + LV + + + A + + + + +
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHN-FCAKISDFGLARLKSVGENQN 175
+ +AY+HS + H DIKP N+LLD + K+ DFG A+ GE
Sbjct: 133 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 7e-05
Identities = 26/129 (20%), Positives = 42/129 (32%), Gaps = 19/129 (14%)
Query: 425 TSTPSMRGTVCYVAPEYGAGG-DISEKCDVYSYGVLLLVLIAGRRP-------------L 470
S + Y APE G D + DV+S G +L L+ G+ +
Sbjct: 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 471 QVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSP 530
+V G+P E R ++ K ++ AL L+ +P
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS-----RLLEYTP 291
Query: 531 ALRPSMEEV 539
R + E
Sbjct: 292 TARLTPLEA 300
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 3e-26
Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 27/176 (15%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD---------QSVAVKVMDSGSLQGE-REFYNELYFA 64
D + LG+G FG V A VAVK++ S + + + + +E+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 65 SLLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPEL------------ 112
++ + +++++LG + + ++ E S GNL++ L ++PP L
Sbjct: 73 KMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 113 -MEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+ S A +A+G+ YL S IH D+ N+L+ + KI+DFGLAR
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.7 bits (154), Expect = 9e-12
Identities = 25/129 (19%), Positives = 45/129 (34%), Gaps = 19/129 (14%)
Query: 415 SGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTG 474
+ +I T + R V ++APE + + DV+S+GVLL + G
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PG 240
Query: 475 SPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRP 534
P+ E L +L+ + + C P+ RP
Sbjct: 241 VPVEE------------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 282
Query: 535 SMEEVVGML 543
+ +++V L
Sbjct: 283 TFKQLVEDL 291
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 107 bits (269), Expect = 3e-26
Identities = 38/178 (21%), Positives = 72/178 (40%), Gaps = 11/178 (6%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
D + LG G FG V + K +++ + NE+ + L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPK 87
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYL 132
++++ + + M+L+ E +S G L D + + M + + +G+ ++
Sbjct: 88 LINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHM 143
Query: 133 HSLNPPVIHGDIKPSNILLDHNFCA--KISDFGLARLKSVGENQNQADGENKNKAAEL 188
H + ++H DIKP NI+ + + KI DFGLA + E + A E+
Sbjct: 144 HEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 199
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 52.4 bits (125), Expect = 6e-08
Identities = 26/147 (17%), Positives = 48/147 (32%), Gaps = 17/147 (11%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRAN 484
T + APE + D+++ GVL VL++G P +
Sbjct: 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA---------GEDD 233
Query: 485 LMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGMLT 544
L + + + E +V LQK P R ++ + +
Sbjct: 234 LETLQNVKRCDWEFDEDAFSSVSPE--------AKDFIKNLLQKEPRKRLTVHDALEHPW 285
Query: 545 GKLEAPKLPAEFSPSPPSRIPFKSRKK 571
K + L + S ++I K ++K
Sbjct: 286 LKGDHSNLTSRIPSSRYNKIRQKIKEK 312
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 107 bits (269), Expect = 3e-26
Identities = 40/178 (22%), Positives = 72/178 (40%), Gaps = 11/178 (6%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
D + LG G FG V T + A K + + + E+ S+L +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPT 84
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYL 132
+V++ + M+++YE MS G L + + + M + + KG+ ++
Sbjct: 85 LVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHM 140
Query: 133 HSLNPPVIHGDIKPSNILL--DHNFCAKISDFGLARLKSVGENQNQADGENKNKAAEL 188
H N +H D+KP NI+ + K+ DFGL ++ G + A E+
Sbjct: 141 HENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 57.4 bits (138), Expect = 2e-09
Identities = 31/147 (21%), Positives = 49/147 (33%), Gaps = 24/147 (16%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRAN 484
S GT + APE G + D++S GVL +L++G P F N
Sbjct: 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP----------FGGEN 229
Query: 485 LMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGMLT 544
R++ + D + + + L P R ++ +
Sbjct: 230 DDETLRNVKSCDWNM---DDSAFSGISED----GKDFIRKLLLADPNTRMTIHQA----- 277
Query: 545 GKLEAPKLPAEFSPSPPSRIPFKSRKK 571
LE P L +P S+IP K
Sbjct: 278 --LEHPWLTPGNAPGRDSQIPSSRYTK 302
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 7e-26
Identities = 39/171 (22%), Positives = 67/171 (39%), Gaps = 14/171 (8%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHDQS-----VAVKVMDSGSLQGERE-FYNELYFASLLE 68
+ R +G+G FG V VA+K + + RE F E
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF- 65
Query: 69 QDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKG 128
H+V ++G + + + ++ EL + G L+ + ++ A ++
Sbjct: 66 DHPHIVKLIGVITE---NPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTA 120
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADG 179
+AYL S +H DI N+L+ N C K+ DFGL+R + G
Sbjct: 121 LAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 169
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (141), Expect = 4e-10
Identities = 19/132 (14%), Positives = 39/132 (29%), Gaps = 19/132 (14%)
Query: 420 KSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSE 479
+ + + ++APE + DV+ +GV + ++
Sbjct: 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218
Query: 480 FQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEV 539
R NG+ + + + ++ C P+ RP E+
Sbjct: 219 IGR----------IENGERLPMPP-----NCPPT----LYSLMTKCWAYDPSRRPRFTEL 259
Query: 540 VGMLTGKLEAPK 551
L+ LE K
Sbjct: 260 KAQLSTILEEEK 271
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 3e-25
Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 20/168 (11%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMD-SGSLQGEREFYNELYFASL 66
+ + SR LGQG FG V+ + VA+K ++ + S++ EF NE AS+
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE---ASV 76
Query: 67 LEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPEL-------MEWCKRF 119
+++ + V + L++ ELM+ G+L+ L +P K
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 120 SIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
+A +IA G+AYL++ +H D+ N ++ +F KI DFG+ R
Sbjct: 137 QMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (161), Expect = 1e-12
Identities = 21/132 (15%), Positives = 47/132 (35%), Gaps = 19/132 (14%)
Query: 417 EIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSP 476
+I ++ V +++PE G + DV+S+GV+L + S
Sbjct: 182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241
Query: 477 MSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSM 536
+++ V + + + + +C Q +P +RPS
Sbjct: 242 E-------------------QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 282
Query: 537 EEVVGMLTGKLE 548
E++ + ++E
Sbjct: 283 LEIISSIKEEME 294
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 5e-25
Identities = 37/164 (22%), Positives = 66/164 (40%), Gaps = 15/164 (9%)
Query: 20 SRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVL 77
S++LG G G V + A+K++ + E+ Q H+V ++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIV 71
Query: 78 GF--SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSL 135
+ R +L+V E + G L + + + + I I + I YLHS+
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFS-RIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 136 NPPVIHGDIKPSNILLDHNFC---AKISDFGLARLKSVGENQNQ 176
N + H D+KP N+L K++DFG A+ + +
Sbjct: 131 N--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 172
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (121), Expect = 2e-07
Identities = 23/115 (20%), Positives = 44/115 (38%), Gaps = 13/115 (11%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRAN 484
S + T YVAPE + CD++S GV++ +L+ G P F +
Sbjct: 168 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----------FYSNH 217
Query: 485 LMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEV 539
++ + + ++ + S E+ + I L+ P R ++ E
Sbjct: 218 GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEF 269
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 3e-24
Identities = 44/178 (24%), Positives = 74/178 (41%), Gaps = 14/178 (7%)
Query: 12 RAADSFSPSRLLGQGGFGSVFHATLH---DQSVAVKVMDSGSLQG--EREFYNELYFASL 66
RA + +G+G +G VF A + VA+K + + + E+
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 67 LEQDDH--VVSVLGF---SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSI 121
LE +H VV + S + ++ LV+E + +P E K +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD--M 121
Query: 122 AVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQADG 179
+ +G+ +LHS V+H D+KP NIL+ + K++DFGLAR+ S
Sbjct: 122 MFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 177
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.6 bits (138), Expect = 1e-09
Identities = 21/122 (17%), Positives = 41/122 (33%), Gaps = 8/122 (6%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQR-- 482
+ S+ T+ Y APE + D++S G + + + + S + + +
Sbjct: 170 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR-GSSDVDQLGKIL 228
Query: 483 -----ANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSME 537
W R +A + ++ + L + L CL +PA R S
Sbjct: 229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288
Query: 538 EV 539
Sbjct: 289 SA 290
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 6e-24
Identities = 29/169 (17%), Positives = 68/169 (40%), Gaps = 12/169 (7%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
+ + + LG+G FG V ++ K + + E+ ++ + +
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIA-RHRN 62
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYL 132
++ + + +++++E +S ++ + + + + S + + + +L
Sbjct: 63 ILHLHESFESM--EELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFL 118
Query: 133 HSLNPPVIHGDIKPSNILLDH--NFCAKISDFGLARLKSVGENQNQADG 179
HS N + H DI+P NI+ + KI +FG AR G+N
Sbjct: 119 HSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT 165
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (125), Expect = 6e-08
Identities = 25/152 (16%), Positives = 50/152 (32%), Gaps = 17/152 (11%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRAN 484
+ + Y APE +S D++S G L+ VL++G P F
Sbjct: 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP----------FLAET 207
Query: 485 LMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGMLT 544
++ N + D+ K + E + L K R + E +
Sbjct: 208 NQQIIENI-MNAEY--TFDEEAFKEISIE----AMDFVDRLLVKERKSRMTASEALQHPW 260
Query: 545 GKLEAPKLPAEFSPSPPSRIPFKSRKKGPVSS 576
K + ++ + + R + + K ++
Sbjct: 261 LKQKIERVSTKVIRTLKHRRYYHTLIKKDLNM 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 6e-24
Identities = 38/166 (22%), Positives = 71/166 (42%), Gaps = 12/166 (7%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGERE---FYNELYFASLLEQ 69
+ F ++LG+G FG VF A Q A+K + + + + E SL +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 70 DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
+ + + V E ++ G+L + + + A +I G+
Sbjct: 62 HPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGL 116
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQN 175
+LHS +++ D+K NILLD + KI+DFG+ + +G+ +
Sbjct: 117 QFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (120), Expect = 2e-07
Identities = 27/148 (18%), Positives = 48/148 (32%), Gaps = 30/148 (20%)
Query: 423 GVTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQR 482
G T + GT Y+APE G + D +S+GVLL ++ G+ P F
Sbjct: 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP----------FHG 205
Query: 483 ANLMS-WARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVV- 540
+ + N +++ L + + P R + +
Sbjct: 206 QDEEELFHSIRMDNPFYPRWLEKEAKDLLVK------------LFVREPEKRLGVRGDIR 253
Query: 541 ------GMLTGKLEAPKLPAEFSPSPPS 562
+ +LE ++ F P S
Sbjct: 254 QHPLFREINWEELERKEIDPPFRPKVKS 281
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-23
Identities = 40/167 (23%), Positives = 69/167 (41%), Gaps = 10/167 (5%)
Query: 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGERE-FYNELYFASLLEQD 70
++ +G+G +G V A + VA+K + Q + E+ +
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RH 65
Query: 71 DHVVSVLGFSSNPKRHRMLLVYELM-SNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
++++ + P +M VY + G LL + + I +G+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGL 122
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQ 176
Y+HS N V+H D+KPSN+LL+ KI DFGLAR+ +
Sbjct: 123 KYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 167
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (104), Expect = 2e-05
Identities = 22/136 (16%), Positives = 43/136 (31%), Gaps = 19/136 (13%)
Query: 419 PKSGGVTSTPSMRGTVCYVAPEYGAGGDI-SEKCDVYSYGVLLLVLIAGRRP-------- 469
P T Y APE ++ D++S G +L +++ R
Sbjct: 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
Query: 470 -----LQVTGSPMSE-FQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVAL 523
L + GSP E + +L ++ + + D + + +
Sbjct: 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK----ALDLLD 276
Query: 524 LCLQKSPALRPSMEEV 539
L +P R +E+
Sbjct: 277 KMLTFNPHKRIEVEQA 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 97.1 bits (241), Expect = 4e-23
Identities = 41/170 (24%), Positives = 70/170 (41%), Gaps = 13/170 (7%)
Query: 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGE---REFYNELYFASLLE 68
+D + +LG GG V A + VAVKV+ + + F E A+ L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL- 64
Query: 69 QDDHVVSVLGF--SSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIA 126
+V+V + P +V E + L+D + + P M + + D
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADAC 121
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQ 176
+ + + H +IH D+KP+NI++ K+ DFG+AR + N
Sbjct: 122 QALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 169
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 58.6 bits (141), Expect = 5e-10
Identities = 31/121 (25%), Positives = 48/121 (39%), Gaps = 18/121 (14%)
Query: 424 VTSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRA 483
VT T ++ GT Y++PE G + + DVYS G +L ++ G P F
Sbjct: 168 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----------FTGD 217
Query: 484 NLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRP-SMEEVVGM 542
+ +S A R + A + L + V L L K+P R + E+
Sbjct: 218 SPVSVAYQHVREDPIP---PSARHEGLSAD----LDAVVLKALAKNPENRYQTAAEMRAD 270
Query: 543 L 543
L
Sbjct: 271 L 271
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 96.8 bits (240), Expect = 1e-22
Identities = 36/168 (21%), Positives = 76/168 (45%), Gaps = 14/168 (8%)
Query: 15 DSFSPSRLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
D + R LG+G + VF A +++ V VK++ +++ E+ L +
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYL 132
++++ +P LV+E ++N + + ++ + +I K + Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY------EILKALDYC 145
Query: 133 HSLNPPVIHGDIKPSNILLDH-NFCAKISDFGLARLKSVGENQNQADG 179
HS+ ++H D+KP N+++DH + ++ D+GLA G+ N
Sbjct: 146 HSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 191
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 37.9 bits (87), Expect = 0.002
Identities = 18/126 (14%), Positives = 36/126 (28%), Gaps = 18/126 (14%)
Query: 432 GTVCYVAPEYGAG-GDISEKCDVYSYGVLLLVLIAGRRPL--------------QVTGSP 476
+ + PE D++S G +L +I + P +V G+
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250
Query: 477 MSE--FQRANLMSWARHLARNGKLIELVDQAVVKSLDREQA-LLCITVALLCLQKSPALR 533
+ N+ R G+ + V S ++ + L+ R
Sbjct: 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310
Query: 534 PSMEEV 539
+ E
Sbjct: 311 LTAREA 316
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 96.6 bits (240), Expect = 1e-22
Identities = 41/171 (23%), Positives = 76/171 (44%), Gaps = 14/171 (8%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGERE-FYNELYFASLLEQDD 71
D + +LG G F V A + VA+K + +L+G+ NE+ + +
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHP 67
Query: 72 HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAY 131
++V++ + + L+ +L+S G L D ++ K + + + Y
Sbjct: 68 NIVALDDIYESGG--HLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKY 122
Query: 132 LHSLNPPVIHGDIKPSNILL---DHNFCAKISDFGLARLKSVGENQNQADG 179
LH ++H D+KP N+L D + ISDFGL++++ G + A G
Sbjct: 123 LHD--LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG 171
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 53.9 bits (129), Expect = 2e-08
Identities = 23/115 (20%), Positives = 37/115 (32%), Gaps = 17/115 (14%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRAN 484
+ + GT YVAPE A S+ D +S GV+ +L+ G P F N
Sbjct: 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP----------FYDEN 213
Query: 485 LMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEV 539
+ + D + ++K P R + E+
Sbjct: 214 DAKLFEQILKAEYEF---DSPYWDDISDS----AKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 95.9 bits (238), Expect = 2e-22
Identities = 40/157 (25%), Positives = 65/157 (41%), Gaps = 13/157 (8%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMD---SGSLQGEREFYNELYFASLLEQ 69
F R LG G FG V + A+KV+ L+ +E S++
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 62
Query: 70 DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
++ + G + ++ M + + + G L L + A ++ +
Sbjct: 63 HPFIIRMWGTFQDAQQIFM--IMDYIEGGELFSLLRKSQRFPNPVAKF---YAAEVCLAL 117
Query: 130 AYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
YLHS +I+ D+KP NILLD N KI+DFG A+
Sbjct: 118 EYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAK 152
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 47.0 bits (111), Expect = 3e-06
Identities = 26/146 (17%), Positives = 53/146 (36%), Gaps = 34/146 (23%)
Query: 429 SMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMS- 487
++ GT Y+APE + ++ D +S+G+L+ ++AG P F +N M
Sbjct: 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP----------FYDSNTMKT 209
Query: 488 WARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALR-----PSMEEVV-- 540
+ + L + ++ V L R + + + R E+V
Sbjct: 210 YEKILNAELRFPPFFNEDVKDLLSR------------LITRDLSQRLGNLQNGTEDVKNH 257
Query: 541 ----GMLTGKLEAPKLPAEFSPSPPS 562
++ KL + + + P
Sbjct: 258 PWFKEVVWEKLLSRNIETPYEPPIQQ 283
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 96.4 bits (239), Expect = 2e-22
Identities = 37/154 (24%), Positives = 64/154 (41%), Gaps = 7/154 (4%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
D F + LG G FG V + A+K++D + ++ + L +L+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYL 132
V S + +V E ++ G + L A I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157
Query: 133 HSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
HSL+ +I+ D+KP N+L+D +++DFG A+
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK 189
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 94.1 bits (233), Expect = 6e-22
Identities = 32/154 (20%), Positives = 57/154 (37%), Gaps = 16/154 (10%)
Query: 21 RLLGQGGFGSVFHAT--LHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLG 78
R +G+G FG +F T L++Q VA+K + +E LL + +V
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 79 FSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPP 138
F +LV +L+ L A + + +H +
Sbjct: 69 FGQEG--LHNVLVIDLLGPSLED---LLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS-- 121
Query: 139 VIHGDIKPSNILLD-----HNFCAKISDFGLARL 167
+++ DIKP N L+ + + DFG+ +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 53.7 bits (128), Expect = 2e-08
Identities = 15/118 (12%), Positives = 37/118 (31%), Gaps = 13/118 (11%)
Query: 426 STPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANL 485
++ GT Y++ G + S + D+ + G + + + G P Q + Q+
Sbjct: 169 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL-KAATNKQKYER 227
Query: 486 MSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEVVGML 543
+ + +L + K + + P + + G+
Sbjct: 228 IGEKKQSTPLRELCAGFPEEFYKYMHY------------ARNLAFDATPDYDYLQGLF 273
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 7e-22
Identities = 37/155 (23%), Positives = 65/155 (41%), Gaps = 7/155 (4%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH 72
+ F +LLG+G FG V + A+K++ + + E + + + +L+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 73 VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYL 132
+ R+ V E + G L L ++ +I + YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF---YGAEIVSALEYL 121
Query: 133 HSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167
HS V++ DIK N++LD + KI+DFGL +
Sbjct: 122 HS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 0.001
Identities = 27/150 (18%), Positives = 44/150 (29%), Gaps = 34/150 (22%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRAN 484
+ + GT Y+APE D D + GV++ ++ GR P F +
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----------FYNQD 209
Query: 485 LMS-WARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSM-----EE 538
+ L + + L L+K P R +E
Sbjct: 210 HERLFELILMEEIRFPRTLSPEAKSLLAG------------LLKKDPKQRLGGGPSDAKE 257
Query: 539 VV------GMLTGKLEAPKLPAEFSPSPPS 562
V+ + + KL F P S
Sbjct: 258 VMEHRFFLSINWQDVVQKKLLPPFKPQVTS 287
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 9e-22
Identities = 37/171 (21%), Positives = 69/171 (40%), Gaps = 14/171 (8%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQG--EREFYNELYFASLLEQD 70
+ +GQG FG VF A Q VA+K + + + E+ LL+ +
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 71 D-----HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDI 125
+ + N + + LV++ + L E + + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR---VMQML 126
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQ 176
G+ Y+H ++H D+K +N+L+ + K++DFGLAR S+ +N
Sbjct: 127 LNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 175
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (99), Expect = 8e-05
Identities = 22/143 (15%), Positives = 43/143 (30%), Gaps = 20/143 (13%)
Query: 413 AASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGG-DISEKCDVYSYGVLLLVLIAGRRP-- 469
A + + K+ + T+ Y PE G D D++ G ++ +
Sbjct: 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223
Query: 470 -----------LQVTGSPMSEFQR--ANLMSWARHLARNGKLIELVDQAVVKSLDREQAL 516
Q+ GS E N + + G+ ++ D+ D
Sbjct: 224 GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPY--- 280
Query: 517 LCITVALLCLQKSPALRPSMEEV 539
+ + L PA R ++
Sbjct: 281 -ALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 93.0 bits (230), Expect = 1e-21
Identities = 36/165 (21%), Positives = 71/165 (43%), Gaps = 11/165 (6%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD-QSVAVKVM--DSGSLQGEREFYNELYFASLLEQDD 71
+ + +G+G +G V+ A + ++ A+K + + E+ L +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHS 60
Query: 72 HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAY 131
++V + R++LV+E + + + + +E S + + GIAY
Sbjct: 61 NIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAY 115
Query: 132 LHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQ 176
H V+H D+KP N+L++ KI+DFGLAR + +
Sbjct: 116 CHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 42.9 bits (100), Expect = 5e-05
Identities = 22/129 (17%), Positives = 44/129 (34%), Gaps = 19/129 (14%)
Query: 425 TSTPSMRGTVCYVAPEYGAG-GDISEKCDVYSYGVLLLVLIAGRRP-------------L 470
T+ Y AP+ G S D++S G + ++ G
Sbjct: 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214
Query: 471 QVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSP 530
++ G+P S+ N+ ++ L ++ +K LD I + L+ P
Sbjct: 215 RILGTPNSK-NWPNVTELPKYDPNFTVYEPLPWESFLKGLDES----GIDLLSKMLKLDP 269
Query: 531 ALRPSMEEV 539
R + ++
Sbjct: 270 NQRITAKQA 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.5 bits (226), Expect = 6e-21
Identities = 38/152 (25%), Positives = 67/152 (44%), Gaps = 13/152 (8%)
Query: 21 RLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYF--ASLLEQDDH--VV 74
LG+G F +V+ A + Q VA+K + G ++ N LL++ H ++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 75 SVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS 134
+L + + LV++ M + + +G+ YLH
Sbjct: 64 GLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHIKA---YMLMTLQGLEYLHQ 118
Query: 135 LNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
++H D+KP+N+LLD N K++DFGLA+
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAK 148
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.9 bits (126), Expect = 3e-08
Identities = 21/148 (14%), Positives = 42/148 (28%), Gaps = 27/148 (18%)
Query: 432 GTVCYVAPEYGAGGD-ISEKCDVYSYGVLLLVLIAGRRP-------------LQVTGSPM 477
T Y APE G D+++ G +L L+ + G+P
Sbjct: 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT 221
Query: 478 SEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSME 537
E ++ I L + + + + + +P R +
Sbjct: 222 EEQWPDMCSLPDYVTFKSFPGIPL--HHIFSAAGDD----LLDLIQGLFLFNPCARITAT 275
Query: 538 EVVGMLTGKLEAPKLPAEFSPSPPSRIP 565
+ L+ P+P ++P
Sbjct: 276 QA-------LKMKYFSNRPGPTPGCQLP 296
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.1 bits (225), Expect = 7e-21
Identities = 37/165 (22%), Positives = 71/165 (43%), Gaps = 11/165 (6%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVM--DSGSLQGEREFYNELYFASLLEQD 70
++F +G+G +G V+ A + VA+K + D+ + E+ L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NH 60
Query: 71 DHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIA 130
++V +L +++ LV+E + + + + S + +G+A
Sbjct: 61 PNIVKLLDVIHTE--NKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 131 YLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQN 175
+ HS V+H D+KP N+L++ K++DFGLAR V
Sbjct: 117 FCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (108), Expect = 5e-06
Identities = 23/125 (18%), Positives = 37/125 (29%), Gaps = 19/125 (15%)
Query: 429 SMRGTVCYVAPE-YGAGGDISEKCDVYSYGVLLLVLIAGRRP-------------LQVTG 474
T+ Y APE S D++S G + ++ R + G
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220
Query: 475 SPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRP 534
+P E + S + K VV LD + ++ L P R
Sbjct: 221 TP-DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDED----GRSLLSQMLHYDPNKRI 275
Query: 535 SMEEV 539
S +
Sbjct: 276 SAKAA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.1 bits (223), Expect = 9e-21
Identities = 38/157 (24%), Positives = 63/157 (40%), Gaps = 16/157 (10%)
Query: 21 RLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGEREFYNELYF---ASLLEQDDH--- 72
LLG GGFGSV+ VA+K ++ + E N LL++
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 73 -VVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAY 131
V+ +L + P +L+ E + ++ ++ S + + + +
Sbjct: 70 GVIRLLDWFERPDSF--VLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRH 125
Query: 132 LHSLNPPVIHGDIKPSNILLDHN-FCAKISDFGLARL 167
H+ V+H DIK NIL+D N K+ DFG L
Sbjct: 126 CHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL 160
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (114), Expect = 1e-06
Identities = 24/116 (20%), Positives = 38/116 (32%), Gaps = 28/116 (24%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGD-ISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRA 483
T GT Y PE+ V+S G+LL ++ G P F+
Sbjct: 164 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----------FEHD 213
Query: 484 NLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEV 539
+ + R + + E C + CL P+ RP+ EE+
Sbjct: 214 EEIIRGQVFFR-------------QRVSSE----CQHLIRWCLALRPSDRPTFEEI 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 89.5 bits (221), Expect = 2e-20
Identities = 33/160 (20%), Positives = 61/160 (38%), Gaps = 14/160 (8%)
Query: 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQ 69
R + + R +G G FG ++ T + VA+K+ + + + E +++
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQG 61
Query: 70 DDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGI 129
+ ++ + + ++V EL+ + +A + I
Sbjct: 62 GVGIPTIRWCGAEGDYN--VMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRI 116
Query: 130 AYLHSLNPPVIHGDIKPSNIL---LDHNFCAKISDFGLAR 166
Y+HS N IH D+KP N L I DFGLA+
Sbjct: 117 EYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 59.9 bits (144), Expect = 2e-10
Identities = 20/151 (13%), Positives = 39/151 (25%), Gaps = 13/151 (8%)
Query: 393 WWLEGFSGELYRARHNSYDSAASGEIPKSGGVTSTPSMRGTVCYVAPEYGAGGDISEKCD 452
L +Y + ++ GT Y + G + S + D
Sbjct: 136 MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDD 195
Query: 453 VYSYGVLLLVLIAGRRPLQVTGSPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDR 512
+ S G +L+ G P Q ++ + K + + + K
Sbjct: 196 LESLGYVLMYFNLGSLPWQ---------GLKAATKRQKYERISEKKMSTPIEVLCKGYPS 246
Query: 513 EQALLCITVALLCLQKSPALRPSMEEVVGML 543
E T C +P + +
Sbjct: 247 E----FATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.5 bits (218), Expect = 6e-20
Identities = 37/164 (22%), Positives = 66/164 (40%), Gaps = 12/164 (7%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSL--QGEREFYNELYFASLLEQD 70
+ +G+G +G+VF A + + VA+K + E LL++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE---ICLLKEL 58
Query: 71 DHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIA 130
H V ++ LV+E + ++ S + KG+
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLG 115
Query: 131 YLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQ 174
+ HS N V+H D+KP N+L++ N K+++FGLAR +
Sbjct: 116 FCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (107), Expect = 7e-06
Identities = 19/124 (15%), Positives = 35/124 (28%), Gaps = 9/124 (7%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRAN 484
+ + S D++S G + L RPL + +R
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216
Query: 485 LMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVAL---------LCLQKSPALRPS 535
+ + + +L D +L+ + L L+ +P R S
Sbjct: 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
Query: 536 MEEV 539
EE
Sbjct: 277 AEEA 280
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.3 bits (210), Expect = 8e-19
Identities = 36/160 (22%), Positives = 67/160 (41%), Gaps = 16/160 (10%)
Query: 15 DSFSPSRLLGQGGFGSVFHATL-----HDQSVAVKVMDSGSL----QGEREFYNELYFAS 65
++F ++LG G +G VF + A+KV+ ++ + E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 66 LLEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDI 125
+ Q +V++ ++ L+ + ++ G L L ++ E +I
Sbjct: 84 HIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG---EI 138
Query: 126 AKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
+ +LH L +I+ DIK NILLD N ++DFGL+
Sbjct: 139 VLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS 176
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.002
Identities = 34/151 (22%), Positives = 51/151 (33%), Gaps = 30/151 (19%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGD--ISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQR 482
GT+ Y+AP+ GGD + D +S GVL+ L+ G P V G S+ +
Sbjct: 185 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244
Query: 483 ANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSM-----E 537
+ R L + + + R L K P R +
Sbjct: 245 SR-----RILKSEPPYPQEMSALAKDLIQR------------LLMKDPKKRLGCGPRDAD 287
Query: 538 EVV------GMLTGKLEAPKLPAEFSPSPPS 562
E+ + L A K+PA F P
Sbjct: 288 EIKEHLFFQKINWDDLAAKKVPAPFKPVIRD 318
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.4 bits (208), Expect = 1e-18
Identities = 45/186 (24%), Positives = 69/186 (37%), Gaps = 20/186 (10%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSLQGER------EFYNELYFASL 66
D + LG G F V A K + + R + E+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 67 LEQDDHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIA 126
+ Q +V+++ N ++L+ EL++ G L D L K+ + + I
Sbjct: 70 I-QHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQIL 123
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCA----KISDFGLARLKSVGENQNQADGENK 182
G+ YLHS + H D+KP NI+L KI DFGLA G G +
Sbjct: 124 NGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 181
Query: 183 NKAAEL 188
A E+
Sbjct: 182 FVAPEI 187
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (128), Expect = 2e-08
Identities = 21/115 (18%), Positives = 39/115 (33%), Gaps = 17/115 (14%)
Query: 425 TSTPSMRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRPLQVTGSPMSEFQRAN 484
++ GT +VAPE + + D++S GV+ +L++G P
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL---------GDTK 221
Query: 485 LMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRPSMEEV 539
+ A A N + + L L K P R ++++
Sbjct: 222 QETLANVSAVNYEFEDEYFSNTSA--------LAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (204), Expect = 7e-18
Identities = 35/160 (21%), Positives = 65/160 (40%), Gaps = 16/160 (10%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVMDSGSL--QGEREFYNELYFASLLEQD 70
+ + +G G +G+V A VA+K + + Y EL + +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RH 76
Query: 71 DHVVSVLGFSSNPKR----HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIA 126
++V+ +L + + LV M G L+ + + + + +
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK---LGEDRIQFLVYQML 131
Query: 127 KGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166
KG+ Y+H+ H D+KP N+ ++ + KI DFGLAR
Sbjct: 132 KGLRYIHAAGII--HRDLKPGNLAVNEDCELKILDFGLAR 169
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 4e-05
Identities = 24/125 (19%), Positives = 46/125 (36%), Gaps = 17/125 (13%)
Query: 429 SMRGTVCYVAPEYGAGGD-ISEKCDVYSYGVLLLVLIAGRRP-------------LQVTG 474
T Y APE ++ D++S G ++ +I G+ ++VTG
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 475 SPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRP 534
+P +EF + A++ + +E D A + + A+ + L R
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRV 293
Query: 535 SMEEV 539
+ E
Sbjct: 294 TAGEA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.7 bits (203), Expect = 1e-17
Identities = 48/196 (24%), Positives = 79/196 (40%), Gaps = 21/196 (10%)
Query: 6 SYSVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNEL 61
+++VL+R + + +G G G V A D++VA+K + + Y EL
Sbjct: 12 TFTVLKR----YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 62 YFASLLEQDDHVVSVLGFSSNPK----RHRMLLVYELMSNGNLQDALLHKKPPELMEWCK 117
+ +++S+L + K + LV ELM Q + +
Sbjct: 68 VLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY--- 123
Query: 118 RFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSVGENQNQA 177
+ + GI +LHS +IH D+KPSNI++ + KI DFGLAR
Sbjct: 124 ---LLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 178
Query: 178 DGENKNKAAELESNCG 193
+A E+ G
Sbjct: 179 VVTRYYRAPEVILGMG 194
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 31/157 (19%), Positives = 55/157 (35%), Gaps = 28/157 (17%)
Query: 430 MRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRP-------------LQVTGSP 476
T Y APE G E D++S G ++ ++ + ++ G+P
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 477 MSEFQRANLMSWARHLARNGKLIELVDQAV----VKSLDREQALLCITVA--LL--CLQK 528
EF + + ++ K L + + D E L + A LL L
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 529 SPALRPSMEEVVGMLTGKLEAPKLPAEFSPSPPSRIP 565
PA R S+++ L+ P + + P+ P
Sbjct: 298 DPAKRISVDDA-------LQHPYINVWYDPAEVEAPP 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.3 bits (192), Expect = 2e-17
Identities = 25/148 (16%), Positives = 49/148 (33%), Gaps = 5/148 (3%)
Query: 21 RLLGQGGFGSVFHATLHD-QSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGF 79
+L+G+G +VF+ VK G ++ Y + F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 80 SSNPKRHRMLLVYELMSNGN-LQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPP 138
+ K + + GN + L+ K + + I + +A +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH--RG 123
Query: 139 VIHGDIKPSNILLDHNFCAKISDFGLAR 166
++HGD+ N+L+ I DF +
Sbjct: 124 IVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.7 bits (185), Expect = 2e-15
Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 15 DSFSPSRLLGQGGFGSVFHATLHD--QSVAVKVM--DSGSLQGEREFYNELYFASLLEQD 70
+ + +G G +GSV A VAVK + S+ + Y EL + +
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KH 76
Query: 71 DHVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIA 130
++V+ +L + + L+++ D K +L + +F + I +G+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLK 135
Query: 131 YLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165
Y+HS + +IH D+KPSN+ ++ + KI DFGLA
Sbjct: 136 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA 168
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (99), Expect = 8e-05
Identities = 22/125 (17%), Positives = 44/125 (35%), Gaps = 17/125 (13%)
Query: 429 SMRGTVCYVAPEYGAG-GDISEKCDVYSYGVLLLVLIAGRRP-------------LQVTG 474
T Y APE ++ D++S G ++ L+ GR L++ G
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236
Query: 475 SPMSEFQRANLMSWARHLARNGKLIELVDQAVVKSLDREQALLCITVALLCLQKSPALRP 534
+P +E + AR+ ++ + ++ A V A+ + L R
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE---KMLVLDSDKRI 293
Query: 535 SMEEV 539
+ +
Sbjct: 294 TAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 73.1 bits (178), Expect = 1e-14
Identities = 34/169 (20%), Positives = 67/169 (39%), Gaps = 15/169 (8%)
Query: 21 RLLGQGGFGSVFHA--TLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDD------- 71
R LG G F +V+ A +++ VA+K++ + E +E+ + D
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSM 77
Query: 72 ---HVVSVLGFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKG 128
H++ +L ++ + + +V G AL+ K + I+ + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 129 IAYLHSLNPPVIHGDIKPSNILLDHN-FCAKISDFGLARLKSVGENQNQ 176
+ Y+H +IH DIKP N+L++ + +A L +
Sbjct: 138 LDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 185
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 27/165 (16%), Positives = 47/165 (28%), Gaps = 35/165 (21%)
Query: 430 MRGTVCYVAPEYGAGGDISEKCDVYSYGVLLLVLIAGRRP-------------------L 470
T Y +PE G D++S L+ LI G +
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 471 QVTGSPMSEF----QRANLMSWARHLARNGKLIELVDQAVVKS----LDREQALLCITVA 522
++ G S + +R L RN ++ V + +++A
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 523 LLCLQKSPALRPSMEEVVGMLTGKLEAPKLPAEFSPSPPSRIPFK 567
LQ P R + + P L + R+P +
Sbjct: 309 SPMLQLDPRKRADAGGL-------VNHPWL-KDTLGMEEIRVPDR 345
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 576 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.77 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.44 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.45 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.07 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.84 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.45 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.75 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=390.38 Aligned_cols=150 Identities=29% Similarity=0.485 Sum_probs=129.0
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
+...++|++.+.||+|+||.||+|++.+ .||||+++... ....+.+.+|+.++..++| |||+++++++.. +.+
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~~~~~~---~~~ 78 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH-VNILLFMGYSTA---PQL 78 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCC-TTBCCEEEEECS---SSC
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCEeeeeEEEec---cEE
Confidence 3446789999999999999999998765 59999997543 3345678999999999976 999999998754 457
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||||||++|+|.+++..... .+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEEEecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeec
Confidence 999999999999999876443 2788899999999999999999999 999999999999999999999999998754
Q ss_pred c
Q 036407 169 S 169 (576)
Q Consensus 169 ~ 169 (576)
.
T Consensus 155 ~ 155 (276)
T d1uwha_ 155 S 155 (276)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=388.41 Aligned_cols=146 Identities=25% Similarity=0.372 Sum_probs=132.3
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
++|++++.||+|+||.||+|+.. |+.||||++........+.+.+|+.+++.+.| |||+++++++... +.+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~--~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVG--DELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEEET--TEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCC-CCEeeEeEEEEEC--CEEEEEE
Confidence 47999999999999999999865 89999999986655566789999999999987 9999999999877 7899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|||++|+|.+++.... +++..+..|+.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 97 Ey~~gg~L~~~~~~~~----l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 97 EYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (293)
T ss_dssp ECCTTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCcHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeec
Confidence 9999999998876532 788899999999999999999999 9999999999999999999999999987543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=388.98 Aligned_cols=155 Identities=20% Similarity=0.353 Sum_probs=124.2
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
.++|++.+.||+|+||.||+|+.. |+.||||.+..... ...+.+.+|+.++..+.| |||+++++++.+.....+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH-PNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCC-TTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCC-CCEeeEEEEEEeCCCCEEE
Confidence 478999999999999999999876 78999999976543 234568899999999977 9999999999876667899
Q ss_pred EEEeccCCCCHHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHHHHhCC---CCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 90 LVYELMSNGNLQDALLHKK-PPELMEWCKRFSIAVDIAKGIAYLHSLN---PPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~-~~~~ls~~~vl~I~~qIl~AL~yLHs~g---~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
||||||++|+|.+++.... ....+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 9999999999999886421 1223788999999999999999999854 23999999999999999999999999998
Q ss_pred cccc
Q 036407 166 RLKS 169 (576)
Q Consensus 166 ~~~~ 169 (576)
+...
T Consensus 162 ~~~~ 165 (269)
T d2java1 162 RILN 165 (269)
T ss_dssp HHC-
T ss_pred eecc
Confidence 7653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=383.91 Aligned_cols=147 Identities=29% Similarity=0.478 Sum_probs=126.9
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
.++|++.+.||+|+||.||+|++. ++.||||+++... ...+.+.+|+.++..++| |||+++++++... +.+++||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~--~~~~lv~ 79 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQ--APICLVF 79 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCC-TTBCCEEEEECSS--SSCEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCC-CCcccccceeccC--CceEEEE
Confidence 357899999999999999999986 6789999997544 345679999999999976 9999999999876 7789999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||++|+|.+++..... .+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 E~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 151 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV 151 (263)
T ss_dssp ECCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred EecCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheec
Confidence 99999999998876433 2678888999999999999999999 999999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-47 Score=389.53 Aligned_cols=156 Identities=26% Similarity=0.437 Sum_probs=136.2
Q ss_pred hHHHHhhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC
Q 036407 7 YSVLRRAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK 84 (576)
Q Consensus 7 ~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s 84 (576)
+++++...++|++.+.||+|+||.||+|++. ++.||||+++... ...+.+.+|+.+++.++| |||+++++++...
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~- 85 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKH-PNLVQLLGVCTRE- 85 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCC-TTBCCEEEEECSS-
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCC-CCEecCCccEeeC-
Confidence 3455666778999999999999999999986 7889999997543 345679999999999977 9999999999866
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
+.++||||||++|+|.+++..... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 86 -~~~~iv~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 86 -PPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred -CeeEEEeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccc
Confidence 788999999999999999876433 23788889999999999999999999 99999999999999999999999999
Q ss_pred ccccc
Q 036407 165 ARLKS 169 (576)
Q Consensus 165 A~~~~ 169 (576)
++...
T Consensus 162 a~~~~ 166 (287)
T d1opja_ 162 SRLMT 166 (287)
T ss_dssp TTTCC
T ss_pred eeecC
Confidence 87543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=385.92 Aligned_cols=148 Identities=30% Similarity=0.447 Sum_probs=129.3
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.++|++.+.||+|+||.||+|+.. ++.||||++..... ...+.+.+|+.+++.+.| |||+++++++... +.+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~~~~~~~~~--~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREG--NIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCC-TTBCCEEEEEEET--TEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCC-CCEeeEeeeeccC--ceeEE
Confidence 478999999999999999999976 78999999976433 234568999999999987 9999999999876 88999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|||||++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 81 vmEy~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp EEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEeccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeec
Confidence 999999999999886543 3788899999999999999999999 9999999999999999999999999997653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=381.02 Aligned_cols=146 Identities=29% Similarity=0.446 Sum_probs=130.1
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++.+.||+|+||.||+|+.. ++.||||++.+... .....+.+|+.++..+.| |||+++++++... +.+|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~--~~~~ 82 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH-PNILRLYGYFHDA--TRVY 82 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECS--SEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCC-CCCCeEEEEEEEC--CEEE
Confidence 57999999999999999999976 78999999964322 234678899999999977 9999999999876 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||||||++|+|.+++..... +++..+..|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 83 ivmEy~~~g~L~~~l~~~~~---l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred EEEeecCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeec
Confidence 99999999999999976554 788899999999999999999999 999999999999999999999999998643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-47 Score=391.37 Aligned_cols=148 Identities=28% Similarity=0.505 Sum_probs=122.7
Q ss_pred CCCCccceeeccCcEEEEEEEEC--C---ceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--D---QSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g---~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
++|++.+.||+|+||.||+|+.. + ..||||.+.... ....+.+.+|+.+++.|+| |||+++++++... ..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~--~~~ 102 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH-PNVIHLEGVVTKS--TPV 102 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSS--SSC
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC-CCCccEEEEEeeC--CEE
Confidence 56777899999999999999875 2 358899886543 3345679999999999976 9999999999776 778
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
++|||||++|+|.+++..... .+++.+++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999999998876443 2788899999999999999999999 999999999999999999999999999765
Q ss_pred c
Q 036407 169 S 169 (576)
Q Consensus 169 ~ 169 (576)
.
T Consensus 179 ~ 179 (299)
T d1jpaa_ 179 E 179 (299)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=387.91 Aligned_cols=153 Identities=27% Similarity=0.472 Sum_probs=128.3
Q ss_pred hcCCCCccceeeccCcEEEEEEEECC-------ceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLHD-------QSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPK 84 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~g-------~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s 84 (576)
..++|++.+.||+|+||.||+|+..+ ..||||.+.... ......+.+|+.++..+.+||||+++++++...
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~- 113 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS- 113 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC-
Confidence 44688999999999999999998642 369999986432 233467899999999997779999999999876
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCC--------------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeeccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKP--------------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDI 144 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~--------------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDL 144 (576)
+.++||||||++|+|.+++..... ...+++..++.|+.||+.||.|||+++ |+||||
T Consensus 114 -~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDl 190 (325)
T d1rjba_ 114 -GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDL 190 (325)
T ss_dssp -SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTC
T ss_pred -CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccC
Confidence 788999999999999999976431 123678889999999999999999999 999999
Q ss_pred CCCCeEEcCCCcEEEcccccccccc
Q 036407 145 KPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 145 KPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
||+|||++.++.+||+|||+|+...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~ 215 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIM 215 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGG
T ss_pred chhccccccCCeEEEeecccccccc
Confidence 9999999999999999999987543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=390.11 Aligned_cols=148 Identities=24% Similarity=0.322 Sum_probs=132.1
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
...++|++++.||+|+||.||+|+.. ++.||||+++... ......+.+|+.+++.++| |||+++++++... ..+
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~--~~~ 79 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSD--GEI 79 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCC-TTBCCEEEEEECS--SEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEEC--CEE
Confidence 34678999999999999999999975 7899999997643 2335678999999999977 9999999999877 789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|||||||++|+|.+++..... +++..+..++.||+.||.|||+ ++ |+||||||+|||++.+|.+||+|||+|+.
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~---l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEEEEcCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 999999999999999976543 7888899999999999999997 68 99999999999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=381.52 Aligned_cols=146 Identities=23% Similarity=0.364 Sum_probs=131.6
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
+.|++++.||+|+||.||+|+.. ++.||||++........+.+.+|+.+++.+.| |||+++++++... +.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~--~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH-PNIVKLLDAFYYE--NNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCC-TTBCCEEEEEEET--TEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeC--CeEEEEE
Confidence 56899999999999999999976 78999999987666666788999999999987 9999999999876 7899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|||++|+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 89 Ey~~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 89 EFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAK 159 (288)
T ss_dssp ECCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhc
Confidence 99999999998765432 2788899999999999999999999 99999999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=383.70 Aligned_cols=148 Identities=24% Similarity=0.380 Sum_probs=131.8
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
.++|++.+.||+|+||.||+|+.. ++.||||++.+... .....+.+|+.+++.+.| |||+++++++... +.+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~--~~~ 83 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLYFTFQDD--EKL 83 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCS-TTBCCEEEEEECS--SEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCC-CCeeEEEEEEEEC--CEE
Confidence 367999999999999999999975 78999999975322 234578999999999977 9999999998876 889
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
|||||||++|+|.+++...+. +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~---l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEccCCCCHHHhhhccCC---CCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceec
Confidence 999999999999998877654 788899999999999999999999 999999999999999999999999999865
Q ss_pred c
Q 036407 169 S 169 (576)
Q Consensus 169 ~ 169 (576)
.
T Consensus 159 ~ 159 (288)
T d1uu3a_ 159 S 159 (288)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=380.78 Aligned_cols=152 Identities=30% Similarity=0.485 Sum_probs=130.5
Q ss_pred HHhhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeE
Q 036407 10 LRRAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 10 lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l 88 (576)
++...++|++.+.||+|+||.||+|++. ++.||||+++... ...+.+.+|+.++..++| |||+++++++.. +.+
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~---~~~ 82 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH-QRLVRLYAVVTQ---EPI 82 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCC-TTBCCEEEEECS---SSC
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCC-CCEeEEEeeecc---CCe
Confidence 3445578999999999999999999987 5789999997544 345679999999999976 999999998754 457
Q ss_pred EEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 89 LLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 89 ~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||||||++|+|.+++..... ..+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEc
Confidence 999999999999987754332 12678889999999999999999999 999999999999999999999999999865
Q ss_pred c
Q 036407 169 S 169 (576)
Q Consensus 169 ~ 169 (576)
.
T Consensus 160 ~ 160 (272)
T d1qpca_ 160 E 160 (272)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=374.96 Aligned_cols=149 Identities=28% Similarity=0.382 Sum_probs=127.1
Q ss_pred CCC-CccceeeccCcEEEEEEEEC--CceEEEEEeecCC--chhHHHHHHHHHHHHHhccCCceEEEEEEeeC--CCCCe
Q 036407 15 DSF-SPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS--LQGEREFYNELYFASLLEQDDHVVSVLGFSSN--PKRHR 87 (576)
Q Consensus 15 d~Y-~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s--~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~--~s~~~ 87 (576)
++| ++.+.||+|+||.||+|+.. ++.||+|.+.... ....+.+.+|+.+++.+.| |||+++++++.. .....
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEEESSSCEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEeeccccCCE
Confidence 344 66778999999999999976 6789999997543 2334578999999999986 999999998864 33467
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEc-CCCcEEEccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLD-HNFCAKISDFGLAR 166 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd-~~g~vKLiDFGlA~ 166 (576)
+|||||||++|+|.+++..... +++..++.++.||+.||.|||+++++|+||||||+|||++ .++.+||+|||+++
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEeCCCCCcHHHHHhcccc---ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 8999999999999999977543 7788889999999999999999887799999999999996 57899999999986
Q ss_pred c
Q 036407 167 L 167 (576)
Q Consensus 167 ~ 167 (576)
.
T Consensus 164 ~ 164 (270)
T d1t4ha_ 164 L 164 (270)
T ss_dssp G
T ss_pred e
Confidence 4
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=376.68 Aligned_cols=149 Identities=28% Similarity=0.504 Sum_probs=125.9
Q ss_pred cCCCCccceeeccCcEEEEEEEECC------ceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLHD------QSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~g------~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
.+.|++.++||+|+||.||+|.+.+ ..||||.++.... .....+.+|+.++..++| |||+++++++... .
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~~~g~~~~~--~ 82 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH-HNIIRLEGVISKY--K 82 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSS--S
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCC-CCEeeeeEEEecC--C
Confidence 4568889999999999999998652 3699999975433 334578999999999976 9999999999876 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+++|||||.++++.+.+..... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ceEEEEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhh
Confidence 78999999999999988766443 2788889999999999999999999 9999999999999999999999999997
Q ss_pred ccc
Q 036407 167 LKS 169 (576)
Q Consensus 167 ~~~ 169 (576)
...
T Consensus 159 ~~~ 161 (283)
T d1mqba_ 159 VLE 161 (283)
T ss_dssp ---
T ss_pred ccc
Confidence 653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.4e-45 Score=382.22 Aligned_cols=151 Identities=25% Similarity=0.380 Sum_probs=134.3
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
.+.++|++.+.||+|+||.||+|+.. |+.||||++........+.+.+|+.++..|+| |||+++++++... +.+|
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~--~~~~ 99 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PTLVNLHDAFEDD--NEMV 99 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCC-TTBCCEEEEEEET--TEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEEC--CEEE
Confidence 34679999999999999999999976 78999999987766667789999999999986 9999999999876 8899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC--CCcEEEcccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH--NFCAKISDFGLARL 167 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~--~g~vKLiDFGlA~~ 167 (576)
||||||++|+|.+++..... .+++..+..|+.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 100 ivmE~~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 99999999999998865432 2889999999999999999999999 999999999999964 57899999999875
Q ss_pred cc
Q 036407 168 KS 169 (576)
Q Consensus 168 ~~ 169 (576)
+.
T Consensus 176 ~~ 177 (350)
T d1koaa2 176 LD 177 (350)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=378.16 Aligned_cols=161 Identities=30% Similarity=0.450 Sum_probs=127.7
Q ss_pred ChHHHHhhcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEE
Q 036407 6 SYSVLRRAADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVL 77 (576)
Q Consensus 6 s~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Ll 77 (576)
+.+.++...++|++.+.||+|+||.||+|+.. ++.||||+++.... .....+..|+..+..+.||+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 44556566688999999999999999999863 35799999975433 33457889999999999999999999
Q ss_pred EEeeCCCCCeEEEEEeccCCCCHHHHHHhcCC-------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeeccc
Q 036407 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKP-------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDI 144 (576)
Q Consensus 78 g~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~-------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDL 144 (576)
+++.... ..+++|||||++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||
T Consensus 84 ~~~~~~~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDl 160 (299)
T d1ywna1 84 GACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 160 (299)
T ss_dssp EEECSTT-SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred eeeccCC-CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcC
Confidence 8876543 578999999999999999975321 123778899999999999999999999 999999
Q ss_pred CCCCeEEcCCCcEEEcccccccccc
Q 036407 145 KPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 145 KPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
||+||||+.++.+||+|||+|+...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~ 185 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIY 185 (299)
T ss_dssp CGGGEEECGGGCEEECC------CC
T ss_pred CccceeECCCCcEEEccCcchhhcc
Confidence 9999999999999999999997543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-46 Score=375.78 Aligned_cols=149 Identities=28% Similarity=0.474 Sum_probs=127.1
Q ss_pred cCCCCccce-eeccCcEEEEEEEEC----CceEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 14 ADSFSPSRL-LGQGGFGSVFHATLH----DQSVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 14 ~d~Y~i~e~-LG~GsfG~Vyka~~~----g~~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.++|.+.+. ||+|+||.||+|.+. +..||||+++... ....+.+.+|+.++..++| |||+++++++.. +.
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~---~~ 82 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVCQA---EA 82 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEES---SS
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCC-CCEeeEeeeecc---Ce
Confidence 356777774 999999999999764 3579999997543 3345679999999999976 999999999865 45
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+|||||||++|+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhc
Confidence 8999999999999998765432 3788899999999999999999999 99999999999999999999999999986
Q ss_pred ccC
Q 036407 168 KSV 170 (576)
Q Consensus 168 ~~~ 170 (576)
...
T Consensus 159 ~~~ 161 (285)
T d1u59a_ 159 LGA 161 (285)
T ss_dssp CTT
T ss_pred ccc
Confidence 543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=368.93 Aligned_cols=148 Identities=26% Similarity=0.449 Sum_probs=130.8
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVY 92 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVm 92 (576)
.++|++.+.||+|+||.||+|+++ ++.||||.++.... ....+.+|+.++..+.| |||+++++++... +.+++||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~H-pnIv~~~g~~~~~--~~~~iv~ 78 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSH-EKLVQLYGVCTKQ--RPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCC-TTBCCEEEEECCS--SSEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCC-CceeeEEEEEeeC--CceEEEE
Confidence 368999999999999999999987 56899999986544 45679999999999976 9999999999876 7899999
Q ss_pred eccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 93 ELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 93 E~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
||+++|+|.+++...... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 79 Ey~~~g~l~~~~~~~~~~--~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp ECCTTEEHHHHHHSGGGC--CCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred EccCCCcHHHhhhccccC--CcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheecc
Confidence 999999999887654332 677788899999999999999999 9999999999999999999999999987543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=373.13 Aligned_cols=140 Identities=27% Similarity=0.439 Sum_probs=120.4
Q ss_pred ceeeccCcEEEEEEEEC----CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEec
Q 036407 21 RLLGQGGFGSVFHATLH----DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYEL 94 (576)
Q Consensus 21 e~LG~GsfG~Vyka~~~----g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE~ 94 (576)
++||+|+||.||+|.+. ++.||||+++.... .....+.+|+.++++++| |||+++++++.. +.++|||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~g~~~~---~~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGICEA---ESWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCC-TTBCCEEEEEES---SSEEEEEEC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCC-CCCceEEEEecc---CCEEEEEEc
Confidence 47999999999999864 36799999964332 234679999999999976 999999999864 357899999
Q ss_pred cCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 95 MSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 95 ~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|++|+|.+++..... +++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~~~g~L~~~l~~~~~---l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 89 AELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALR 158 (277)
T ss_dssp CTTEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred CCCCcHHHHHhhccC---CCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhcc
Confidence 999999999876543 788899999999999999999999 9999999999999999999999999997654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-45 Score=377.36 Aligned_cols=148 Identities=26% Similarity=0.427 Sum_probs=121.8
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
+.+.|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+|+.+++.+.| |||+++++++... +.+|
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~--~~~~ 83 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH-PNIVALDDIYESG--GHLY 83 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCC-TTBCCEEEEEECS--SEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEEC--CEEE
Confidence 4577999999999999999999976 78999999975443 234567899999999976 9999999999876 8899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEc---CCCcEEEccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLD---HNFCAKISDFGLAR 166 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd---~~g~vKLiDFGlA~ 166 (576)
||||||+||+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||+. .++.+||+|||+++
T Consensus 84 lvmE~~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp EEECCCCSCBHHHHHHTCSC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EEEeccCCCcHHHhhhcccC---CCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeE
Confidence 99999999999999976543 788999999999999999999999 99999999999995 47899999999987
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 159 ~~ 160 (307)
T d1a06a_ 159 ME 160 (307)
T ss_dssp --
T ss_pred Ec
Confidence 54
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=367.20 Aligned_cols=149 Identities=27% Similarity=0.386 Sum_probs=131.6
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc------hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL------QGEREFYNELYFASLLEQDDHVVSVLGFSSNPK 84 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~------~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s 84 (576)
+.+.|++.+.||+|+||+||+|+.. |+.||||++.+... ...+.+.+|+.+++.|.| |||+++++++...
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~- 85 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH-PNVITLHEVYENK- 85 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS-
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEEC-
Confidence 4578999999999999999999976 78999999975432 124678999999999977 9999999999877
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC----cEEEc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF----CAKIS 160 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g----~vKLi 160 (576)
..+|||||||++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+
T Consensus 86 -~~~~iv~E~~~gg~L~~~i~~~~~---l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 86 -TDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred -CEEEEEEEcCCCccccchhccccc---cchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEec
Confidence 889999999999999999977553 788899999999999999999999 99999999999998776 49999
Q ss_pred ccccccccc
Q 036407 161 DFGLARLKS 169 (576)
Q Consensus 161 DFGlA~~~~ 169 (576)
|||++....
T Consensus 160 DfG~a~~~~ 168 (293)
T d1jksa_ 160 DFGLAHKID 168 (293)
T ss_dssp CCTTCEECT
T ss_pred chhhhhhcC
Confidence 999987543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-46 Score=380.56 Aligned_cols=144 Identities=32% Similarity=0.447 Sum_probs=127.0
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchh---HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG---EREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~---~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
.|++++.||+|+||.||+|+.. ++.||||++....... .+.+.+|+.++..|.| |||+++++++... +.+||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~--~~~~i 92 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLRE--HTAWL 92 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEET--TEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCC-CCEeeEEEEEEEC--CEEEE
Confidence 3899999999999999999875 7889999997654322 3568899999999986 9999999999876 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|||||.+|+|..++..... +++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 93 v~E~~~~g~l~~~~~~~~~---l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (309)
T ss_dssp EEECCSEEHHHHHHHHTSC---CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EEEecCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccc
Confidence 9999999988766655443 788999999999999999999999 99999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.2e-45 Score=380.50 Aligned_cols=150 Identities=23% Similarity=0.356 Sum_probs=133.5
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
+.++|++++.||+|+||.||+|+.. ++.||||++..........+.+|+.++..|.| |||+.+++++... ..+||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~--~~~~i 103 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-PKLINLHDAFEDK--YEMVL 103 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS-TTBCCEEEEEECS--SEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEEC--CEEEE
Confidence 4578999999999999999999975 88999999987666666788999999999976 9999999999876 88999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEc--CCCcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLD--HNFCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd--~~g~vKLiDFGlA~~~ 168 (576)
|||||+||+|.+.+..... .+++..++.|+.||+.||.|||++| |+||||||+||||+ .++.+||+|||+|+..
T Consensus 104 vmE~~~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEECCCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEcCCCChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceec
Confidence 9999999999887765432 2789999999999999999999999 99999999999998 5689999999998765
Q ss_pred c
Q 036407 169 S 169 (576)
Q Consensus 169 ~ 169 (576)
.
T Consensus 180 ~ 180 (352)
T d1koba_ 180 N 180 (352)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=375.21 Aligned_cols=148 Identities=24% Similarity=0.318 Sum_probs=131.8
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
..++|++++.||+|+||.||+|+.. ++.||||++.+... .....+.+|+.+++.+.| |||+.+++++... ..
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~--~~ 79 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTH--DR 79 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC-TTBCCEEEEEECS--SE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCC-CCEEEEEeeeccc--cc
Confidence 3468999999999999999999975 89999999975322 234678899999999976 9999999999877 89
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+|+|||||+||+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~ 154 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred cccceeccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccc
Confidence 9999999999999999887554 788889999999999999999999 99999999999999999999999999875
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 155 ~ 155 (337)
T d1o6la_ 155 G 155 (337)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-45 Score=375.34 Aligned_cols=158 Identities=29% Similarity=0.480 Sum_probs=134.9
Q ss_pred hHHHHhhcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCch-hHHHHHHHHHHHHHhccCCceEEEEE
Q 036407 7 YSVLRRAADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSLQ-GEREFYNELYFASLLEQDDHVVSVLG 78 (576)
Q Consensus 7 ~~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~~-~~~~~l~EI~iLs~L~h~pNIv~Llg 78 (576)
+.+++.-.++|++.+.||+|+||.||+|+.. ++.||||+++..... ...++.+|+.+++.++| +||+.+++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~ 83 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN-PNIVKLLG 83 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCC-CCccccee
Confidence 4556666788999999999999999999865 367999999754433 35679999999999977 99999999
Q ss_pred EeeCCCCCeEEEEEeccCCCCHHHHHHhcCC---------------------CChhhHHHHHHHHHHHHHHHHHHHhCCC
Q 036407 79 FSSNPKRHRMLLVYELMSNGNLQDALLHKKP---------------------PELMEWCKRFSIAVDIAKGIAYLHSLNP 137 (576)
Q Consensus 79 ~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~---------------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~ 137 (576)
++... ..+++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+++
T Consensus 84 ~~~~~--~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~- 160 (301)
T d1lufa_ 84 VCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK- 160 (301)
T ss_dssp EECSS--SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred eeccC--CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC-
Confidence 99876 788999999999999999865321 112677889999999999999999999
Q ss_pred CeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 138 PVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 138 ~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|+||||||+|||++.++.+||+|||+++...
T Consensus 161 -ivHrDlKp~NILld~~~~~Kl~DFGls~~~~ 191 (301)
T d1lufa_ 161 -FVHRDLATRNCLVGENMVVKIADFGLSRNIY 191 (301)
T ss_dssp -CCCSCCSGGGEEECGGGCEEECCCSCHHHHT
T ss_pred -eEeeEEcccceEECCCCcEEEccchhheecc
Confidence 9999999999999999999999999987543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-44 Score=364.10 Aligned_cols=150 Identities=26% Similarity=0.381 Sum_probs=130.8
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch---hHHHHHHHHHHHHHhccCCceEEEEEEeeCCC--C
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---GEREFYNELYFASLLEQDDHVVSVLGFSSNPK--R 85 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~---~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s--~ 85 (576)
+.++|++.+.||+|+||.||+|+.. ++.||||++...... ....+.+|+.+++.+.| |||+.+++++.... .
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~h-pniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH-PAIVAVYDTGEAETPAG 83 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEEECSSS
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCC-CCCCcccceeeeccCCC
Confidence 4588999999999999999999975 889999999764432 24568999999999877 99999999887543 2
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
..+|||||||+|++|.+.+..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++..+|+|||.+
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~---l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred ceEEEEEECCCCCEehhhhcccCC---CCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhh
Confidence 458999999999999998877654 788899999999999999999999 999999999999999999999999987
Q ss_pred ccc
Q 036407 166 RLK 168 (576)
Q Consensus 166 ~~~ 168 (576)
...
T Consensus 159 ~~~ 161 (277)
T d1o6ya_ 159 RAI 161 (277)
T ss_dssp EEC
T ss_pred hhh
Confidence 654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=372.14 Aligned_cols=150 Identities=31% Similarity=0.522 Sum_probs=128.3
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
...++|++.+.||+|+||.||+|+.. ++.||||++.... ...+.+.+|+.++.+++| +||+++++++.. ..+++
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h-~nIv~~~g~~~~---~~~~l 88 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH-EKLVQLYAVVSE---EPIYI 88 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCC-TTBCCEEEEECS---SSCEE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhccc-CCEeEEEEEEec---CCeEE
Confidence 44578999999999999999999987 4679999997544 345679999999999977 999999999854 45789
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
|||||++|+|..++..... ..+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 89 v~Ey~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp EECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEEecCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhcc
Confidence 9999999999988865321 12788899999999999999999999 9999999999999999999999999987543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=367.77 Aligned_cols=148 Identities=26% Similarity=0.463 Sum_probs=121.5
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC-----CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCC
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~ 86 (576)
..++|++.+.||+|+||.||+|++. +..||||.+..... .....+.+|+.+++.++| |||+++++++.. +
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~---~ 80 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-PHIVKLIGVITE---N 80 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECS---S
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEec---C
Confidence 3468999999999999999999875 24588888864333 334678999999999976 999999999853 5
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+|+|||||++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred eEEEEEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhhe
Confidence 68999999999999988765432 2788899999999999999999999 9999999999999999999999999987
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 157 ~~ 158 (273)
T d1mp8a_ 157 YM 158 (273)
T ss_dssp --
T ss_pred ec
Confidence 54
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.9e-44 Score=368.87 Aligned_cols=146 Identities=27% Similarity=0.428 Sum_probs=129.4
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++++.||+|+||.||+|+.. |+.||||+++... ....+.+.+|+.+++.+.| |||+++++++... ..+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~--~~~~ 80 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-PFIIRMWGTFQDA--QQIF 80 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCB-TTBCCEEEEEECS--SEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccC-cChhheeeeEeeC--Ceee
Confidence 57999999999999999999976 7899999997432 2234678999999999987 9999999999876 8999
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+|||||+||+|...+..... +++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+..
T Consensus 81 ivmE~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred eEeeecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEe
Confidence 99999999999998877554 567778889999999999999999 999999999999999999999999998754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-44 Score=370.42 Aligned_cols=149 Identities=26% Similarity=0.413 Sum_probs=127.3
Q ss_pred hcCCCCccc-eeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeC--CCCCe
Q 036407 13 AADSFSPSR-LLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN--PKRHR 87 (576)
Q Consensus 13 ~~d~Y~i~e-~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~--~s~~~ 87 (576)
+.++|.++. .||+|+||.||+|+.. ++.||||+++.. ..+.+|+.++.++.+||||+++++++.. .....
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 457899875 5999999999999975 789999999632 4577899988888777999999998764 33477
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC---CCcEEEccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH---NFCAKISDFGL 164 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~---~g~vKLiDFGl 164 (576)
+|||||||+||+|.+++..... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++. .+.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccce
Confidence 9999999999999999986543 23889999999999999999999999 999999999999985 46799999999
Q ss_pred ccccc
Q 036407 165 ARLKS 169 (576)
Q Consensus 165 A~~~~ 169 (576)
++...
T Consensus 161 a~~~~ 165 (335)
T d2ozaa1 161 AKETT 165 (335)
T ss_dssp CEECC
T ss_pred eeecc
Confidence 87543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=365.73 Aligned_cols=147 Identities=26% Similarity=0.449 Sum_probs=125.2
Q ss_pred cCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEe
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE 93 (576)
.++|++.+.||+|+||.||+|+++++.||||+++.. ...+.+.+|+.++++++| |||+++++++.... ..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~~-~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRH-SNLVQLLGVIVEEK-GGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTCCC-TTBCCEEEEECCC---CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcH--HHHHHHHHHHHHHHhCCC-CCEeeEEEEEEecC-CcEEEEEe
Confidence 457788999999999999999999999999999643 344678999999999976 99999999986542 56799999
Q ss_pred ccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 94 LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 94 ~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
|+++|+|.+++..... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 y~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~ 152 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKE 152 (262)
T ss_dssp CCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred ccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeeccccccee
Confidence 9999999999865321 23678889999999999999999999 99999999999999999999999998864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=368.10 Aligned_cols=147 Identities=30% Similarity=0.498 Sum_probs=125.5
Q ss_pred CCCCccceeeccCcEEEEEEEEC--C----ceEEEEEeecC-CchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--D----QSVAVKVMDSG-SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g----~~VAVK~i~~~-s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
++|++++.||+|+||.||+|++. + ..||+|.+... .....+.+.+|+.+++.++| |||+++++++... .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~---~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTS---T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCC-TTBCCEEEEEESS---S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEecC---C
Confidence 46999999999999999999875 3 25899988643 23445689999999999976 9999999999764 5
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
.++++|++.+++|.+.+..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred eeEEEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeecccccee
Confidence 6788999999999988876543 3788889999999999999999999 99999999999999999999999999886
Q ss_pred cc
Q 036407 168 KS 169 (576)
Q Consensus 168 ~~ 169 (576)
..
T Consensus 161 ~~ 162 (317)
T d1xkka_ 161 LG 162 (317)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=368.39 Aligned_cols=155 Identities=32% Similarity=0.443 Sum_probs=133.0
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
+.-.++|++.+.||+|+||.||+|++. ++.||||+++.... .....+.+|+.++..+.+||||+++++++..
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 344578999999999999999999863 46899999976543 3455789999999999877999999999987
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCC---------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCC
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKP---------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPS 147 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~---------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPe 147 (576)
. ..++||||||++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+
T Consensus 99 ~--~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~ 174 (311)
T d1t46a_ 99 G--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAAR 174 (311)
T ss_dssp S--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred C--CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccccc
Confidence 6 778999999999999999875431 123678889999999999999999999 999999999
Q ss_pred CeEEcCCCcEEEcccccccccc
Q 036407 148 NILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 148 NILLd~~g~vKLiDFGlA~~~~ 169 (576)
|||++.++.++|+|||+++...
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~ 196 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIK 196 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTT
T ss_pred cccccccCcccccccchheecc
Confidence 9999999999999999987543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=366.52 Aligned_cols=154 Identities=29% Similarity=0.477 Sum_probs=127.5
Q ss_pred hhcCCCCccceeeccCcEEEEEEEECC---------ceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEee
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLHD---------QSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSS 81 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~g---------~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~ 81 (576)
...++|++.+.||+|+||.||+|+..+ ..||||+++.... .....+.+|+..+.++.+||||+.+++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 345789999999999999999998542 4699999976543 334678899999999977799999999998
Q ss_pred CCCCCeEEEEEeccCCCCHHHHHHhcCC-------------CChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCC
Q 036407 82 NPKRHRMLLVYELMSNGNLQDALLHKKP-------------PELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSN 148 (576)
Q Consensus 82 ~~s~~~l~LVmE~~~gGsL~d~L~~~~~-------------~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeN 148 (576)
.. ..+++|||||++|+|.+++..... ...+++.+++.++.||+.||.|||+++ |+||||||+|
T Consensus 90 ~~--~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~N 165 (299)
T d1fgka_ 90 QD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARN 165 (299)
T ss_dssp SS--SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred cC--CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccc
Confidence 76 789999999999999999976432 123788899999999999999999999 9999999999
Q ss_pred eEEcCCCcEEEcccccccccc
Q 036407 149 ILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 149 ILLd~~g~vKLiDFGlA~~~~ 169 (576)
||++.++.+||+|||+++...
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~ 186 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIH 186 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGG
T ss_pred eeecCCCCeEeccchhhcccc
Confidence 999999999999999987543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.5e-43 Score=354.57 Aligned_cols=150 Identities=25% Similarity=0.370 Sum_probs=133.3
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch---------hHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ---------GEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~---------~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
.++|++.+.||+|+||+||+|+.. ++.||||++...... ..+.+.+|+.+++.|..||||+++++++..
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 378999999999999999999975 789999999754321 124688999999999967999999999987
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccc
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDF 162 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDF 162 (576)
. ..+|||||||++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 82 ~--~~~~ivmE~~~~g~L~~~l~~~~~---l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 N--TFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp S--SEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCC
T ss_pred C--cceEEEEEcCCCchHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccc
Confidence 6 899999999999999999987654 789999999999999999999999 999999999999999999999999
Q ss_pred cccccccC
Q 036407 163 GLARLKSV 170 (576)
Q Consensus 163 GlA~~~~~ 170 (576)
|+++.+..
T Consensus 155 G~a~~~~~ 162 (277)
T d1phka_ 155 GFSCQLDP 162 (277)
T ss_dssp TTCEECCT
T ss_pred hheeEccC
Confidence 99876543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-43 Score=368.45 Aligned_cols=146 Identities=25% Similarity=0.362 Sum_probs=130.5
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++++.||+|+||.||+|+.. |+.||||++.+... ...+.+.+|+.++..+.| |||+.+++++... ..++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~--~~~~ 117 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVKLEFSFKDN--SNLY 117 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECS--SEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCC-CcEeecccccccc--cccc
Confidence 68999999999999999999976 89999999964322 234578999999999976 9999999998876 7899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
+||||+.+|+|.+.+..... +++..++.|+.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+..
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~---l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cccccccccchhhhHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 99999999999999877554 788899999999999999999999 999999999999999999999999998754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=368.08 Aligned_cols=150 Identities=29% Similarity=0.504 Sum_probs=127.0
Q ss_pred CCCCccceeeccCcEEEEEEEEC--Cc--eEEEEEeecCC-chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQ--SVAVKVMDSGS-LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~--~VAVK~i~~~s-~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++.+.||+|+||.||+|++. +. .||||.+.... ....+.+.+|+.++..+.+||||+++++++... +.++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--CeeE
Confidence 67889999999999999999875 33 57888876432 334557999999999997669999999999876 8899
Q ss_pred EEEeccCCCCHHHHHHhcC-------------CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCc
Q 036407 90 LVYELMSNGNLQDALLHKK-------------PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFC 156 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~-------------~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~ 156 (576)
+||||+++|+|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGC
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCCCc
Confidence 9999999999999986531 1234788899999999999999999999 999999999999999999
Q ss_pred EEEccccccccc
Q 036407 157 AKISDFGLARLK 168 (576)
Q Consensus 157 vKLiDFGlA~~~ 168 (576)
+||+|||+++..
T Consensus 166 ~kl~DfG~a~~~ 177 (309)
T d1fvra_ 166 AKIADFGLSRGQ 177 (309)
T ss_dssp EEECCTTCEESS
T ss_pred eEEccccccccc
Confidence 999999998643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-43 Score=371.00 Aligned_cols=148 Identities=30% Similarity=0.440 Sum_probs=125.6
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc---hhHHHHHHHHHHHHHhc--cCCceEEEEEEeeCCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL---QGEREFYNELYFASLLE--QDDHVVSVLGFSSNPKRH 86 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~--h~pNIv~Llg~~~~~s~~ 86 (576)
.++|++.++||+|+||.||+|+.. |+.||||++.+... .....+.+|..++..+. +||||+.+++++... +
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--~ 80 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--D 80 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--S
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--C
Confidence 468999999999999999999976 78999999964322 22344566655555554 259999999998876 7
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccc
Q 036407 87 RMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLAR 166 (576)
Q Consensus 87 ~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~ 166 (576)
.+|||||||++|+|.+++..... +++..++.|+.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEEEecCCCcHHHHHHhccc---ccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceee
Confidence 89999999999999999977554 678888999999999999999999 9999999999999999999999999987
Q ss_pred cc
Q 036407 167 LK 168 (576)
Q Consensus 167 ~~ 168 (576)
..
T Consensus 156 ~~ 157 (364)
T d1omwa3 156 DF 157 (364)
T ss_dssp EC
T ss_pred ec
Confidence 54
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-43 Score=361.16 Aligned_cols=149 Identities=18% Similarity=0.292 Sum_probs=131.0
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
.+.++|++.+.||+|+||.||+|+.. ++.||||++.... .....+.+|+.++..+.| |||+++++++... +.+|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~--~~~~ 77 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARH-RNILHLHESFESM--EELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCC-TTBCCEEEEEEET--TEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCC-CCCCeEEEEEEEC--CEEE
Confidence 35689999999999999999999976 7899999997654 334568899999999987 9999999999876 8899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCC--CcEEEcccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHN--FCAKISDFGLARL 167 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~--g~vKLiDFGlA~~ 167 (576)
||||||+||+|.+.+..... .+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 78 lvmE~~~gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhc
Confidence 99999999999999876442 2788999999999999999999999 9999999999999854 5899999999875
Q ss_pred c
Q 036407 168 K 168 (576)
Q Consensus 168 ~ 168 (576)
.
T Consensus 154 ~ 154 (321)
T d1tkia_ 154 L 154 (321)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=356.90 Aligned_cols=142 Identities=26% Similarity=0.393 Sum_probs=118.1
Q ss_pred ccceeeccCcEEEEEEEEC--CceEEEEEeecCCchh-----HHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 19 PSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQG-----EREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 19 i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~-----~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
.+++||+|+||+||+|+.. ++.||||+++...... ...+.+|+.+++.+.| |||+++++++... +.+|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~~~~~~~~~--~~~~iv 78 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNIIGLLDAFGHK--SNISLV 78 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC-TTBCCEEEEECCT--TCCEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCC-CCEeEEEeeeccC--Cceeeh
Confidence 4689999999999999875 7899999996543221 2468899999999987 9999999999877 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||||.++++..+..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 mE~~~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSF 150 (299)
T ss_dssp EECCSEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred hhhhcchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCcccccc
Confidence 99998876665443322 3777888999999999999999999 999999999999999999999999998654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-44 Score=365.66 Aligned_cols=147 Identities=27% Similarity=0.441 Sum_probs=122.4
Q ss_pred cCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHH--HHHHHhccCCceEEEEEEeeCCC--CCeEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNEL--YFASLLEQDDHVVSVLGFSSNPK--RHRML 89 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI--~iLs~L~h~pNIv~Llg~~~~~s--~~~l~ 89 (576)
+.+|.+.+.||+|+||.||+|+++|+.||||++.... ...+..|. ..+..+. ||||+++++++.... ...+|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCCcceEEE
Confidence 4578889999999999999999999999999996432 23344444 4444555 499999999987543 24789
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh--------CCCCeeecccCCCCeEEcCCCcEEEcc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS--------LNPPVIHGDIKPSNILLDHNFCAKISD 161 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs--------~g~~IVHrDLKPeNILLd~~g~vKLiD 161 (576)
||||||++|+|.+++.... +++..++.++.+++.||.|||+ ++ |+||||||+||||+.++.+||+|
T Consensus 78 lv~Ey~~~g~L~~~l~~~~----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~--IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCCGGGEEECTTSCEEECC
T ss_pred EEEecccCCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--eeccccCccceEEcCCCCeEEEe
Confidence 9999999999999997643 6788889999999999999996 36 99999999999999999999999
Q ss_pred ccccccccC
Q 036407 162 FGLARLKSV 170 (576)
Q Consensus 162 FGlA~~~~~ 170 (576)
||+++....
T Consensus 152 FGl~~~~~~ 160 (303)
T d1vjya_ 152 LGLAVRHDS 160 (303)
T ss_dssp CTTCEEEET
T ss_pred cCccccccC
Confidence 999886543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=364.31 Aligned_cols=147 Identities=25% Similarity=0.392 Sum_probs=128.2
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCC---chhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGS---LQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRML 89 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s---~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~ 89 (576)
++|++.+.||+|+||+||+|+.. ++.||||++.+.. ......+..|+.++....+||||+++++++... ..+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--Ccee
Confidence 68999999999999999999985 7999999997532 123346778877776544559999999999877 8899
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||||||++|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ivmEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhc
Confidence 99999999999999977554 678889999999999999999999 999999999999999999999999998743
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=361.74 Aligned_cols=149 Identities=30% Similarity=0.403 Sum_probs=120.3
Q ss_pred cCCCCccceeeccCcEEEEEEEEC-----CceEEEEEeecCCc---hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH-----DQSVAVKVMDSGSL---QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKR 85 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~-----g~~VAVK~i~~~s~---~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~ 85 (576)
.++|++.+.||+|+||.||+|++. ...||||+++.... ...+.+.+|+.+++.+.| |||+++++++..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~~~g~~~~--- 82 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH-RNLIRLYGVVLT--- 82 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCC-TTBCCEEEEECS---
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEee---
Confidence 457999999999999999999864 23689999875432 334578999999999966 999999999965
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
..+++|||||++|+|.+.+..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred cchheeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhh
Confidence 356899999999999988765432 3788899999999999999999999 999999999999999999999999998
Q ss_pred ccccC
Q 036407 166 RLKSV 170 (576)
Q Consensus 166 ~~~~~ 170 (576)
+....
T Consensus 159 ~~~~~ 163 (273)
T d1u46a_ 159 RALPQ 163 (273)
T ss_dssp EECCC
T ss_pred hhccc
Confidence 86543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-43 Score=358.52 Aligned_cols=145 Identities=28% Similarity=0.469 Sum_probs=123.9
Q ss_pred cceeeccCcEEEEEEEECC-----ceEEEEEeecC-CchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEEEe
Q 036407 20 SRLLGQGGFGSVFHATLHD-----QSVAVKVMDSG-SLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLVYE 93 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~g-----~~VAVK~i~~~-s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LVmE 93 (576)
.++||+|+||+||+|++.. ..||||.++.. ......++.+|+.++++++| |||+++++++.... +.+++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~~-~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVLSLLGICLRSE-GSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCC-TTBCCCCEEEEETT-TEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC-CCEeEEeEEEEecC-CceEEEEE
Confidence 5689999999999998752 35899999743 33445789999999999976 99999999986542 67899999
Q ss_pred ccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccccC
Q 036407 94 LMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 94 ~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
||++|+|.+++...... +++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~~~~g~l~~~~~~~~~~--~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp CCTTCBHHHHHHCTTCC--CBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EeecCchhhhhcccccc--chHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 99999999988765432 567778899999999999999999 99999999999999999999999999976543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=356.13 Aligned_cols=150 Identities=25% Similarity=0.352 Sum_probs=121.7
Q ss_pred cCCCCccceeeccCcEEEEEEEEC---CceEEEEEeecCCc--hhHHHHHHHHHHHHHhc--cCCceEEEEEEeeC---C
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH---DQSVAVKVMDSGSL--QGEREFYNELYFASLLE--QDDHVVSVLGFSSN---P 83 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~---g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~--h~pNIv~Llg~~~~---~ 83 (576)
.++|++++.||+|+||.||+|+.. ++.||||++..... .....+.+|+.+++.|. +||||+++++++.. .
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999874 56799999965322 22235678888888775 46999999998753 3
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
....++++||++.++.+......... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchh
Confidence 34688999999988766544433322 3778888899999999999999999 9999999999999999999999999
Q ss_pred cccc
Q 036407 164 LARL 167 (576)
Q Consensus 164 lA~~ 167 (576)
+++.
T Consensus 162 ~~~~ 165 (305)
T d1blxa_ 162 LARI 165 (305)
T ss_dssp SCCC
T ss_pred hhhh
Confidence 8764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=351.78 Aligned_cols=147 Identities=24% Similarity=0.406 Sum_probs=124.5
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
|+|++++.||+|+||.||+|+.. ++.||||++..... .....+.+|+.+++.+.| |||+++++++... ..+|+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H-p~Iv~~~~~~~~~--~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-PNIVKLLDVIHTE--NKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCC-TTBCCEEEEEEET--TEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC-CcEEEeccccccc--cceeE
Confidence 78999999999999999999976 78999999965432 224678999999999976 9999999999876 88999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLK 168 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~ 168 (576)
||||+.+ ++.+.+..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 79 v~e~~~~-~~~~~~~~~~~-~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 79 VFEFLHQ-DLKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF 152 (298)
T ss_dssp EEECCSE-EHHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred EEeecCC-chhhhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceec
Confidence 9999965 55555543322 23788999999999999999999999 999999999999999999999999998754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=353.82 Aligned_cols=148 Identities=24% Similarity=0.351 Sum_probs=126.2
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCch------hHHHHHHHHHHHHHhcc-CCceEEEEEEeeCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQ------GEREFYNELYFASLLEQ-DDHVVSVLGFSSNPK 84 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~------~~~~~l~EI~iLs~L~h-~pNIv~Llg~~~~~s 84 (576)
.++|++.+.||+|+||.||+|+.. ++.||||++...... ...++.+|+.++..+.+ ||||+++++++...
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~- 81 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP- 81 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-
Confidence 468999999999999999999976 789999999753221 12346789999999974 69999999999876
Q ss_pred CCeEEEEEeccCC-CCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC-CCcEEEccc
Q 036407 85 RHRMLLVYELMSN-GNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH-NFCAKISDF 162 (576)
Q Consensus 85 ~~~l~LVmE~~~g-GsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~-~g~vKLiDF 162 (576)
+.+++|||++.+ +++.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+||
T Consensus 82 -~~~~lv~e~~~~~~~l~~~~~~~~~---l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 82 -DSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp -SEEEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCC
T ss_pred -CeEEEEEEeccCcchHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECcc
Confidence 789999999976 578787766543 788899999999999999999999 999999999999985 479999999
Q ss_pred cccccc
Q 036407 163 GLARLK 168 (576)
Q Consensus 163 GlA~~~ 168 (576)
|+|+..
T Consensus 156 G~a~~~ 161 (273)
T d1xwsa_ 156 GSGALL 161 (273)
T ss_dssp TTCEEC
T ss_pred ccceec
Confidence 998643
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-43 Score=357.53 Aligned_cols=154 Identities=31% Similarity=0.490 Sum_probs=130.0
Q ss_pred HhhcCCCCccceeeccCcEEEEEEEEC-------CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeC
Q 036407 11 RRAADSFSPSRLLGQGGFGSVFHATLH-------DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSN 82 (576)
Q Consensus 11 k~~~d~Y~i~e~LG~GsfG~Vyka~~~-------g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~ 82 (576)
+...++|.+.+.||+|+||.||+|.+. ++.||||+++.... .....+.+|+.+++.+.| +||+.+++++..
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQ 94 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCC-TTBCCEEEEECS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCC-CCEeeeeeEEec
Confidence 344578889999999999999999864 46899999975433 334568999999999986 999999999976
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcC-------CCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKK-------PPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF 155 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~-------~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g 155 (576)
. ..+++|||||++|+|.+++.... ....+++..+..|+.|++.||.|||+++ |+||||||+|||++.++
T Consensus 95 ~--~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 95 G--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTC
T ss_pred C--CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCc
Confidence 6 67899999999999999886431 1122567788999999999999999999 99999999999999999
Q ss_pred cEEEcccccccccc
Q 036407 156 CAKISDFGLARLKS 169 (576)
Q Consensus 156 ~vKLiDFGlA~~~~ 169 (576)
.+||+|||+++...
T Consensus 171 ~~Kl~DFGla~~~~ 184 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIY 184 (308)
T ss_dssp CEEECCTTCCCGGG
T ss_pred eEEEeecccceecc
Confidence 99999999987543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.9e-42 Score=344.25 Aligned_cols=147 Identities=24% Similarity=0.380 Sum_probs=127.6
Q ss_pred CCCCccceeeccCcEEEEEEEEC-CceEEEEEeecCCch--hHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQ--GEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~--~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
++|++++.||+|+||.||+|+.. ++.||||+++..... ....+.+|+.+++.+.| |||+++++.+... +..+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~--~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLYDVIHTK--KRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC-TTBCCEEEEEECS--SCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC-CcEEeeeeecccC--CceeEE
Confidence 78999999999999999999877 789999999765432 24678999999999976 9999999999877 789999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKS 169 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~ 169 (576)
||++.++.+..+..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 79 ~e~~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFG 151 (286)
T ss_dssp EECCSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred EEeehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecc
Confidence 99997766655544333 2788999999999999999999999 9999999999999999999999999987543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-41 Score=341.36 Aligned_cols=148 Identities=23% Similarity=0.325 Sum_probs=123.6
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
.++|++.+.||+|+||.||+|+.. ++.||||++..... ...+..|+.+++.+.|+++|+.+..+.... ...++|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~--~~~~iv 81 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG--DYNVMV 81 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEET--TEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecC--CEEEEE
Confidence 468999999999999999999976 78999999875432 235788999999999977787777766655 788999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC---CCcEEEccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH---NFCAKISDFGLARLK 168 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~---~g~vKLiDFGlA~~~ 168 (576)
|||+ +++|.+.+..... .+++..+..++.|++.||.|||+++ |+||||||+|||++. +..++|+|||+|+..
T Consensus 82 me~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEc-CCchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 9999 6677776655432 2788889999999999999999999 999999999999864 457999999999866
Q ss_pred cC
Q 036407 169 SV 170 (576)
Q Consensus 169 ~~ 170 (576)
..
T Consensus 157 ~~ 158 (299)
T d1ckia_ 157 RD 158 (299)
T ss_dssp BC
T ss_pred cc
Confidence 54
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.7e-41 Score=339.02 Aligned_cols=149 Identities=23% Similarity=0.303 Sum_probs=128.6
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
+.++|++.+.||+|+||+||+|+.. ++.||||++.... ....+.+|++++..|.|++|++.+++++... ...++
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~~ 78 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LHNVL 78 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET--TEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecC--CccEE
Confidence 3578999999999999999999965 7899999986543 2235778999999999999999999988766 88999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcC-----CCcEEEcccccc
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDH-----NFCAKISDFGLA 165 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~-----~g~vKLiDFGlA 165 (576)
||||+ +++|.+++..... .++...+..++.|++.||.|||++| |+||||||+|||++. .+.++|+|||+|
T Consensus 79 vme~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEccccee
Confidence 99999 7899998876543 2778888999999999999999999 999999999999974 578999999999
Q ss_pred ccccC
Q 036407 166 RLKSV 170 (576)
Q Consensus 166 ~~~~~ 170 (576)
+....
T Consensus 154 ~~~~~ 158 (293)
T d1csna_ 154 KFYRD 158 (293)
T ss_dssp EESBC
T ss_pred EEccc
Confidence 87654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.8e-41 Score=343.79 Aligned_cols=145 Identities=23% Similarity=0.442 Sum_probs=127.0
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEEE
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLLV 91 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~LV 91 (576)
.++|+++++||+|+||.||+|+.. ++.||||+++.. ....+.+|+.++..+.+|+||+.+++++.......+++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 367999999999999999999975 889999999643 245788999999999877999999999987766889999
Q ss_pred EeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC-cEEEcccccccccc
Q 036407 92 YELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF-CAKISDFGLARLKS 169 (576)
Q Consensus 92 mE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g-~vKLiDFGlA~~~~ 169 (576)
||||.+++|..... .+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+|....
T Consensus 111 ~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 111 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceecc
Confidence 99999999876532 2778889999999999999999999 99999999999998655 68999999987543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=344.36 Aligned_cols=148 Identities=25% Similarity=0.398 Sum_probs=122.0
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC----
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPK---- 84 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s---- 84 (576)
..++|++++.||+|+||+||+|+.. ++.||||++..... ...+.+.+|+.+|+.+.| |||+++++++....
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h-pniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH-ENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCB-TTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCC-CCeeEEEEEeccCccccc
Confidence 5689999999999999999999976 89999999975432 234578899999999977 99999999987542
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
...+||||||| +.+|..++.... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~~~----l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKHEK----LGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEecc-cccHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccccccc
Confidence 24689999999 668888776532 788899999999999999999999 99999999999999999999999999
Q ss_pred cccc
Q 036407 165 ARLK 168 (576)
Q Consensus 165 A~~~ 168 (576)
++..
T Consensus 168 a~~~ 171 (346)
T d1cm8a_ 168 ARQA 171 (346)
T ss_dssp CEEC
T ss_pred eecc
Confidence 8643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-41 Score=340.77 Aligned_cols=150 Identities=23% Similarity=0.333 Sum_probs=121.4
Q ss_pred cCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCC------
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNP------ 83 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~------ 83 (576)
.++|++++.||+|+||+||+|+.. ++.||||++..... .....+.+|+.+++.++| +|++.+++.+...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h-~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH-ENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCC-TTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcC-CCccceEeeeecccccccc
Confidence 378999999999999999999975 78999999865432 234678899999999976 9999999887543
Q ss_pred CCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccc
Q 036407 84 KRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFG 163 (576)
Q Consensus 84 s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFG 163 (576)
....+|+|||+|.++.+........ .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCT
T ss_pred cCceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecc
Confidence 2357899999997765543332222 2677888899999999999999999 9999999999999999999999999
Q ss_pred cccccc
Q 036407 164 LARLKS 169 (576)
Q Consensus 164 lA~~~~ 169 (576)
+++...
T Consensus 163 ~~~~~~ 168 (318)
T d3blha1 163 LARAFS 168 (318)
T ss_dssp TCEECC
T ss_pred eeeecc
Confidence 987654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-41 Score=345.64 Aligned_cols=149 Identities=23% Similarity=0.341 Sum_probs=130.6
Q ss_pred cCCCCccceeeccCcEEEEEEEE-----CCceEEEEEeecCCc----hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC
Q 036407 14 ADSFSPSRLLGQGGFGSVFHATL-----HDQSVAVKVMDSGSL----QGEREFYNELYFASLLEQDDHVVSVLGFSSNPK 84 (576)
Q Consensus 14 ~d~Y~i~e~LG~GsfG~Vyka~~-----~g~~VAVK~i~~~s~----~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s 84 (576)
.++|++++.||+|+||.||+|+. +|+.||||++++... ...+.+.+|+.++.++.|+|||+++++++...
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~- 101 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 101 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence 46799999999999999999985 268899999864321 23456889999999999999999999998877
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
..+++||||+.+|+|.+.+..... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 -~~~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 102 -TKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp -TEEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred -CceeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccc
Confidence 789999999999999999877654 566778889999999999999999 99999999999999999999999999
Q ss_pred ccccc
Q 036407 165 ARLKS 169 (576)
Q Consensus 165 A~~~~ 169 (576)
++...
T Consensus 176 a~~~~ 180 (322)
T d1vzoa_ 176 SKEFV 180 (322)
T ss_dssp EEECC
T ss_pred hhhhc
Confidence 87543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=344.56 Aligned_cols=147 Identities=25% Similarity=0.361 Sum_probs=119.3
Q ss_pred CCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeC----CCCCeEE
Q 036407 16 SFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSN----PKRHRML 89 (576)
Q Consensus 16 ~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~----~s~~~l~ 89 (576)
+|+..++||+|+||+||+|+.. ++.||||++..... ...+|+.++..++| +||+++++++.. ....++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h-~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDH-CNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCC-TTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCC-CCCCcEEEEEEecCccCCceEEE
Confidence 6888999999999999999986 78999999975432 23479999999976 999999998753 2345789
Q ss_pred EEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCC-cEEEccccccccc
Q 036407 90 LVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNF-CAKISDFGLARLK 168 (576)
Q Consensus 90 LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g-~vKLiDFGlA~~~ 168 (576)
||||||+++.+..+.........+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++...
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99999976543333322222233788899999999999999999999 99999999999999775 8999999998754
Q ss_pred c
Q 036407 169 S 169 (576)
Q Consensus 169 ~ 169 (576)
.
T Consensus 174 ~ 174 (350)
T d1q5ka_ 174 V 174 (350)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-40 Score=338.65 Aligned_cols=150 Identities=25% Similarity=0.387 Sum_probs=123.5
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc-hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCC---C
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL-QGEREFYNELYFASLLEQDDHVVSVLGFSSNPK---R 85 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~-~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s---~ 85 (576)
.+.++|++++.||+|+||+||+|+.. ++.||||++..... .....+.+|+.++..|.| |||+.+++++.... .
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~h-p~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH-ENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCC-TTBCCCCEEECCSSTTTC
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCC-CCCCcEEEEEeecccccc
Confidence 35678999999999999999999875 89999999975432 334578999999999977 99999999986542 2
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEcccccc
Q 036407 86 HRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLA 165 (576)
Q Consensus 86 ~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA 165 (576)
..+||++ ++.+|+|.+++.... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~l~~-~~~~g~L~~~l~~~~----l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 84 KDVYLVT-HLMGADLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp CCEEEEE-ECCCEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEE-eecCCchhhhhhcCC----CCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCce
Confidence 3455555 455899999987643 788899999999999999999999 999999999999999999999999998
Q ss_pred cccc
Q 036407 166 RLKS 169 (576)
Q Consensus 166 ~~~~ 169 (576)
....
T Consensus 157 ~~~~ 160 (345)
T d1pmea_ 157 RVAD 160 (345)
T ss_dssp EECC
T ss_pred eecc
Confidence 7543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=330.53 Aligned_cols=148 Identities=24% Similarity=0.357 Sum_probs=130.1
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
++|++++.||+|+||+||+|+.. ++.||||+++.... ....++.+|+.+++.+.| +||+.+++++... ..+++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~--~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLHDVLHSD--KKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEECS--SEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCc-CCEEeeccccccc--cceeE
Confidence 68999999999999999999976 78899999975432 335678999999999987 9999999999887 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccccccccC
Q 036407 91 VYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGLARLKSV 170 (576)
Q Consensus 91 VmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~~~~ 170 (576)
|++++.+++|..++..... +++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++....
T Consensus 79 v~~~~~~~~l~~~~~~~~~---~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EEECCSEEHHHHHHHTTTC---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred Eeeeccccccccccccccc---cchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccC
Confidence 9999999888877765443 677888899999999999999999 99999999999999999999999999876543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-40 Score=340.12 Aligned_cols=146 Identities=28% Similarity=0.410 Sum_probs=120.1
Q ss_pred hcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCC----C
Q 036407 13 AADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNP----K 84 (576)
Q Consensus 13 ~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~----s 84 (576)
+.++|++++.||+|+||+||+|+.. |+.||||++..... ....++.+|+.+++.+.| |||+++++++... .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH-KNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCC-TTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCC-CCeeEEEEEEeccccccc
Confidence 4578999999999999999999976 89999999975432 333568899999999976 9999999998654 3
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
..++|+|||||.++ +.+.+.. .+++..++.++.||+.||.|||++| |+||||||+|||++.++.++++|||+
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CceeEEEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhh
Confidence 47899999999664 4444432 2678889999999999999999999 99999999999999999999999998
Q ss_pred ccc
Q 036407 165 ARL 167 (576)
Q Consensus 165 A~~ 167 (576)
++.
T Consensus 166 ~~~ 168 (355)
T d2b1pa1 166 ART 168 (355)
T ss_dssp ---
T ss_pred hhc
Confidence 764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-40 Score=337.07 Aligned_cols=149 Identities=25% Similarity=0.395 Sum_probs=122.4
Q ss_pred hhcCCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCc--hhHHHHHHHHHHHHHhccCCceEEEEEEeeCC---C
Q 036407 12 RAADSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSL--QGEREFYNELYFASLLEQDDHVVSVLGFSSNP---K 84 (576)
Q Consensus 12 ~~~d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~--~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~---s 84 (576)
.+.++|++++.||+|+||+||+|+.. ++.||||++..... .....+.+|+.+++.|.| +|++.+++++... .
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h-~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH-ENVIGLLDVFTPARSLE 93 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCC-TTBCCCSEEECSCSSTT
T ss_pred cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCC-CCeeeEEEEEeeccccc
Confidence 45789999999999999999999865 89999999975432 334578899999999977 9999999887643 1
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcEEEccccc
Q 036407 85 RHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCAKISDFGL 164 (576)
Q Consensus 85 ~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~vKLiDFGl 164 (576)
....+++|+++.+|+|.+++.... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+|++|||+
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~~~~----l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHTTCC----CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC--
T ss_pred cCceEEEEEeecCCchhhhccccc----ccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccch
Confidence 233455566677999999885432 788999999999999999999999 99999999999999999999999998
Q ss_pred ccc
Q 036407 165 ARL 167 (576)
Q Consensus 165 A~~ 167 (576)
+..
T Consensus 168 a~~ 170 (348)
T d2gfsa1 168 ARH 170 (348)
T ss_dssp --C
T ss_pred hcc
Confidence 753
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-38 Score=324.29 Aligned_cols=150 Identities=23% Similarity=0.312 Sum_probs=117.9
Q ss_pred CCCCccceeeccCcEEEEEEEEC--CceEEEEEeecCCchhHHHHHHHHHHHHHhcc----------CCceEEEEEEeeC
Q 036407 15 DSFSPSRLLGQGGFGSVFHATLH--DQSVAVKVMDSGSLQGEREFYNELYFASLLEQ----------DDHVVSVLGFSSN 82 (576)
Q Consensus 15 d~Y~i~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h----------~pNIv~Llg~~~~ 82 (576)
++|++++.||+|+||+||+|+.. ++.||||+++.... ..+.+.+|+.++..+.| |+||+.+++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999875 79999999975432 34567888888888764 4789999988876
Q ss_pred CCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHh-CCCCeeecccCCCCeEEcCCC------
Q 036407 83 PKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHS-LNPPVIHGDIKPSNILLDHNF------ 155 (576)
Q Consensus 83 ~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs-~g~~IVHrDLKPeNILLd~~g------ 155 (576)
......+++++++..+..............+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccccc
Confidence 6557777777776554433333222222336788899999999999999997 88 99999999999998654
Q ss_pred cEEEcccccccc
Q 036407 156 CAKISDFGLARL 167 (576)
Q Consensus 156 ~vKLiDFGlA~~ 167 (576)
.++++|||.+..
T Consensus 170 ~~kl~dfg~s~~ 181 (362)
T d1q8ya_ 170 QIKIADLGNACW 181 (362)
T ss_dssp EEEECCCTTCEE
T ss_pred eeeEeecccccc
Confidence 389999998753
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.77 E-value=5.1e-19 Score=166.62 Aligned_cols=135 Identities=20% Similarity=0.198 Sum_probs=100.9
Q ss_pred CCccceeeccCcEEEEEEEEC-CceEEEEEeecCCch------------------hHHHHHHHHHHHHHhccCCceEEEE
Q 036407 17 FSPSRLLGQGGFGSVFHATLH-DQSVAVKVMDSGSLQ------------------GEREFYNELYFASLLEQDDHVVSVL 77 (576)
Q Consensus 17 Y~i~e~LG~GsfG~Vyka~~~-g~~VAVK~i~~~s~~------------------~~~~~l~EI~iLs~L~h~pNIv~Ll 77 (576)
+.+.+.||+|+||.||+|+.. |+.||||+++..... .......|+..+..+.+ .+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-LAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-SSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccC-CCcceEE
Confidence 346789999999999999865 789999987532110 01234567788888876 6777766
Q ss_pred EEeeCCCCCeEEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCCCCeeecccCCCCeEEcCCCcE
Q 036407 78 GFSSNPKRHRMLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLNPPVIHGDIKPSNILLDHNFCA 157 (576)
Q Consensus 78 g~~~~~s~~~l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g~~IVHrDLKPeNILLd~~g~v 157 (576)
++.. .+++|||+++..+.+ ++...+..++.|++.+|.|||++| |+||||||+|||++.+ .+
T Consensus 81 ~~~~------~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 81 AWEG------NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EEET------TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EE
T ss_pred EecC------CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CE
Confidence 5431 279999998765432 222334568899999999999999 9999999999999865 48
Q ss_pred EEccccccccccCC
Q 036407 158 KISDFGLARLKSVG 171 (576)
Q Consensus 158 KLiDFGlA~~~~~~ 171 (576)
+|+|||+|.....+
T Consensus 142 ~liDFG~a~~~~~~ 155 (191)
T d1zara2 142 WIIDFPQSVEVGEE 155 (191)
T ss_dssp EECCCTTCEETTST
T ss_pred EEEECCCcccCCCC
Confidence 99999998766543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.44 E-value=4e-07 Score=86.82 Aligned_cols=150 Identities=17% Similarity=0.139 Sum_probs=99.6
Q ss_pred HHHHhhcCCCCccceeeccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCe
Q 036407 8 SVLRRAADSFSPSRLLGQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHR 87 (576)
Q Consensus 8 ~~lk~~~d~Y~i~e~LG~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~ 87 (576)
.+++...+.|+..+..+-++.+.||+....++.+++|............+..|...+..|..+--+..++.+.... +.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC--Cc
Confidence 4566667788876665545567899998888889999986443333334677887777775433355666666554 77
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCChhhHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 036407 88 MLLVYELMSNGNLQDALLHKKPPELMEWCKRFSIAVDIAKGIAYLHSLN------------------------------- 136 (576)
Q Consensus 88 l~LVmE~~~gGsL~d~L~~~~~~~~ls~~~vl~I~~qIl~AL~yLHs~g------------------------------- 136 (576)
.++||++++|.++.+....... ...++.++...++.||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~~~--------~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDEQS--------PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTCSC--------HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred eEEEEEeccccccccccccccc--------HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 8999999998777554322110 1113344444455555311
Q ss_pred --------------------------CCeeecccCCCCeEEcCCCcEEEcccccccc
Q 036407 137 --------------------------PPVIHGDIKPSNILLDHNFCAKISDFGLARL 167 (576)
Q Consensus 137 --------------------------~~IVHrDLKPeNILLd~~g~vKLiDFGlA~~ 167 (576)
+.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1378999999999998776667999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.45 E-value=0.00019 Score=67.24 Aligned_cols=74 Identities=23% Similarity=0.204 Sum_probs=47.5
Q ss_pred eeeccC-cEEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCC-ceEEEEEEeeCCCCCeEEEEEeccCCC
Q 036407 22 LLGQGG-FGSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDD-HVVSVLGFSSNPKRHRMLLVYELMSNG 98 (576)
Q Consensus 22 ~LG~Gs-fG~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~p-NIv~Llg~~~~~s~~~l~LVmE~~~gG 98 (576)
.+..|. .+.||+.... +..+++|....... ..+..|...+..|.... .+..++.+.... +..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEEEeeecc
Confidence 444554 4678998876 45678888754432 23566777776665532 245556665554 6789999999875
Q ss_pred CH
Q 036407 99 NL 100 (576)
Q Consensus 99 sL 100 (576)
++
T Consensus 92 ~~ 93 (255)
T d1nd4a_ 92 DL 93 (255)
T ss_dssp ET
T ss_pred cc
Confidence 54
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.07 E-value=0.00099 Score=67.74 Aligned_cols=76 Identities=18% Similarity=0.099 Sum_probs=47.0
Q ss_pred cceeeccCcEEEEEEEEC--CceEEEEEeec------CCc-hhHHHHHHHHHHHHHhccC--CceEEEEEEeeCCCCCeE
Q 036407 20 SRLLGQGGFGSVFHATLH--DQSVAVKVMDS------GSL-QGEREFYNELYFASLLEQD--DHVVSVLGFSSNPKRHRM 88 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~--g~~VAVK~i~~------~s~-~~~~~~l~EI~iLs~L~h~--pNIv~Llg~~~~~s~~~l 88 (576)
.+.||.|....||++... ++.++||.-.. ... ....+...|...+..+..+ ..+..++.+.. ...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~----~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT----EMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET----TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC----CCC
Confidence 467999999999999754 56899997532 111 1123455677777666432 23555655543 234
Q ss_pred EEEEeccCCCC
Q 036407 89 LLVYELMSNGN 99 (576)
Q Consensus 89 ~LVmE~~~gGs 99 (576)
++|||++.+..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEeccCCcc
Confidence 78999997643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.84 E-value=0.017 Score=55.62 Aligned_cols=64 Identities=13% Similarity=0.108 Sum_probs=41.4
Q ss_pred CCChHHHHhhcCCCCcccee-----eccCcEEEEEEEECCceEEEEEeecCCchhHHHHHHHHHHHHHhcc
Q 036407 4 RFSYSVLRRAADSFSPSRLL-----GQGGFGSVFHATLHDQSVAVKVMDSGSLQGEREFYNELYFASLLEQ 69 (576)
Q Consensus 4 ~fs~~~lk~~~d~Y~i~e~L-----G~GsfG~Vyka~~~g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h 69 (576)
..|-++|.....+|.+.+.. ..|---..|+....+..|++|++.... ....+..|+..+..|.+
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~ 70 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAA 70 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC--CHHHHHHHHHHHHhhhh
Confidence 35778899888999875444 356667789999888889999986432 22234455666666654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.45 E-value=0.026 Score=56.60 Aligned_cols=72 Identities=17% Similarity=0.139 Sum_probs=49.0
Q ss_pred cceeeccCcEEEEEEEEC---------CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCceEEEEEEeeCCCCCeEEE
Q 036407 20 SRLLGQGGFGSVFHATLH---------DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDHVVSVLGFSSNPKRHRMLL 90 (576)
Q Consensus 20 ~e~LG~GsfG~Vyka~~~---------g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pNIv~Llg~~~~~s~~~l~L 90 (576)
++.|+-|-.-.+|++... ...|++++.-. . .......+|..+++.+..+.-..++++++.. ++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~------g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG------GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT------EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC------ce
Confidence 467888999999999864 24566776642 2 2223456788888888775555677777642 68
Q ss_pred EEeccCCCC
Q 036407 91 VYELMSNGN 99 (576)
Q Consensus 91 VmE~~~gGs 99 (576)
|+||++|..
T Consensus 119 I~efi~g~~ 127 (395)
T d1nw1a_ 119 LEEYIPSRP 127 (395)
T ss_dssp EECCCCEEE
T ss_pred EEEEecccc
Confidence 999997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.75 E-value=0.043 Score=53.48 Aligned_cols=68 Identities=16% Similarity=0.199 Sum_probs=41.3
Q ss_pred EEEEEEEEC-CceEEEEEeecCCchhHHHHHHHHHHHHHhccCCc-eEEEEEE---eeCCCCCeEEEEEeccCC
Q 036407 29 GSVFHATLH-DQSVAVKVMDSGSLQGEREFYNELYFASLLEQDDH-VVSVLGF---SSNPKRHRMLLVYELMSN 97 (576)
Q Consensus 29 G~Vyka~~~-g~~VAVK~i~~~s~~~~~~~l~EI~iLs~L~h~pN-Iv~Llg~---~~~~s~~~l~LVmE~~~g 97 (576)
-.||++..+ |..|++|+.+.+.. ...++..|+..+..|....- ++..+.. ......+..+.+++++.|
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 479999875 77899999876543 34567778888877765311 1111110 000123667889999865
|